Unofficial translation
Footnote. Abolished by the Order of the Minister of Health of the Republic of Kazakhstan dated May 18, 2021 No. KR DSM - 41 (effective after the expiration of ten calendar days after the date of its first official publication).In accordance with sub-item 69-1) item 1 article 7 of the Code of the Republic of Kazakhstan dated September 18, 2009 "On public health and health care system" I HEREBY ORDER:
1. To approve Kazakhstan National Drugs Formulary according to annex to this order.
2. The Committee of Pharmacy of the Ministry of Healthcare of the Republic of Kazakhstan in accordance with the procedure, established by the legislation of the Republic of Kazakhstan shall ensure:
1) state registration of this order with the Ministry of Justice of the Republic of Kazakhstan;
2) within ten calendar days from the date of state registration of this order the direction hereof in hard and soft copy in Kazakh and Russian languages to the Republican State Enterprise on the Right of Economic Management “Republican Center of Legal Information of the Ministry of Justice of the Republic of Kazakhstan” for official publication and placement in the Reference Control Bank of the Regulatory Legal Acts of the Republic of Kazakhstan;
3) within ten calendar days from the date of state registration of this order the direction of a copy hereof for official publication in periodical printed press;
4) placing this order on the Internet resource of the Ministry of Healthcare of the Republic of Kazakhstan after its official publication;
5) within ten working days after state registration of this order with the Ministry of Justice of the Republic of Kazakhstan, reporting of information to the Department of Legal Services of the Ministry of Healthcare of the Republic of Kazakhstan on performance of the activities, stipulated by sub-items 1), 2) and 3) of this item.
3. Control over the execution of this order shall be entrusted to Vice-Minister of Healthcare of the Republic of Kazakhstan Tsoy A.V.
4. This order shall be put into effect from the day of its first official publication.
Minister of Healthcare of the Republic of Kazakhstan |
Ye. Birtanov |
Annex to Order No. 931 of the Minister of Healthcare of the Republic of Kazakhstan dated December 8, 2017 |
Kazakhstan National Drugs Formulary
Footnote. The Formulary is in the wording of the order of the Minister of Healthcare of the Republic of Kazakhstan dated April 21.04. 2020 No. KR MHC-40/2020 (shall be enforced upon expiry of ten calendar days its first official publication).
№ | ATC code | Pharmacological group / INN | Trade name | Drugs form, dosage and volume form | Registration certificate number * |
A | Digestive tract and metabolism | ||||
A01 | Dental preparations | ||||
A01A | Dental preparations | ||||
A01AB | Antimicrobials for topical use in the diseases of oral cavity | ||||
A01AB09 | Miconazole | ||||
1 | A01AB09 | Miconazole | Miconaz | oral gel 2% 20 g | RK-MP-5№ 012706 |
A02 | Drugs used in conditions related with acidity disorder | ||||
A02A | Antacids | ||||
A02AF | Antacids in combination with drugs, reducing gases in the intestine | ||||
A02AF02 | Magnesium hydroxide and aluminum hydroxide | ||||
2 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Nosid | chewable tablets 400 mg / 400 mg | RK-MP-5 №019300 |
3 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Coolz ™ | chewable tablets with mint flavor | RK-MP-5 №003252 |
4 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Coolz ™ | chewable tablets | RK-MP-5 №003251 |
5 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Coolz ™ | chewable tablets | RK-MP-5 №003253 |
6 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Maalox® Plus | chewable tablets | RK-MP-5 №021438 |
7 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Coolz ™ | chewable tablets with strawberry flavor | RK-MP-5 №003254 |
8 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Almagel® Neo |
Suspension for internal use | RK-MP-5 №005521 |
9 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Almagel® Neo | Suspension for internal use 10 ml | RK-MP-5 №005521 |
10 | A02AF02 | Magnesium hydroxide and aluminum hydroxide | Simalgel | Suspension for oral use 300 ml | RK-MP-5 №010580 |
A02B | Antiulcer drugs and drugs used for gastroesophageal reflux | ||||
A02BA | Histamine H2 receptors blockers | ||||
A02BA02 | Ranitidine | ||||
11 | A02BA02 | Ranitidine | Ranitidine-AKOS | coated tablets, 0.15 g | RK-MP-5 №003668 |
12 | A02BA02 | Ranitidine | Ranitidine-AKOS |
| RK-MP-5 №003695 |
13 | A02BA02 | Ranitidine | Histac® | film-coated tablets, 150 mg | RK-MP-5 №003418 |
14 | A02BA02 | Ranitidine | Ranisan® | coated tablets, 150 mg | RK-MP-5 №003482 |
15 | A02BA02 | Ranitidine | Aciran ™ -150 | film-coated tablets, 150 mg | RK-MP-5 №003387 |
16 | A02BA02 | Ranitidine | Aciran ™ -300 | film-coated tablets, 300 mg | RK-MP-5 №003388 |
A02BA03 | Famotidine | ||||
17 | A02BA03 | Famotidine | Quamatel® | Lyophilized powder for preparation of solution for injections complete with solvent (0.9% sodium chloride solution), 20 mg | RK-MP-5 №016290 |
18 | A02BA03 | Famotidine | Quamatel® | film-coated tablets, 40 mg | RK-MP-5 №016506 |
19 | A02BA03 | Famotidine | Famo® | film-coated tablets, 40 mg | RK-MP-5 №011351 |
20 | A02BA03 | Famotidine | Quamatel® | film-coated tablets, 20 mg | RK-MP-5 №016505 |
21 | A02BA03 | Famotidine | Famosan® | coated tablets, 20 mg | RK-MP-5 №005534 |
22 | A02BA03 | Famotidine | Famosan® | coated tablets, 40 mg | RK-MP-5 №005550 |
23 | A02BA03 | Famotidine | Gastrosidin | film-coated tablets, 40 mg | RK-MP-5 №007654 |
A02BC | Proton pump inhibitors | ||||
A02BC01 | Omeprazol | ||||
24 | A02BC01 | Omeprazol | Omez | Gastro-resistant сapsules, 10 mg | RK-MP-5 №016781 |
25 | A02BC01 | Omeprazol | Loseprazol® | capsules, 20 mg | RK-MP-5 №008131 |
26 | A02BC01 | Omeprazol | Omez® | gastro-resistant сapsules, 20 mg | RK-MP-5 №016563 |
27 | A02BC01 | Omeprazol | Omeprazol | capsules, 20 mg | RK-MP-5 №021199 |
28 | A02BC01 | Omeprazol | Omez® | gastro-resistant сapsules, 40 mg | RK-MP-5 №016782 |
29 | A02BC01 | Omeprazol | Omez® | lyophilized powder for preparation of solution for injections, 40 mg | RK-MP-5 №009627 |
30 | A02BC01 | Omeprazol | Pleom ™ -20 | Capsules with delayed release, 20 mg | RK-MP-5 №003436 |
31 | A02BC01 | Omeprazol | Omegast® | Gastro-resistant сapsules, 40 mg | RK-MP-5 №004575 |
32 | A02BC01 | Omeprazol | Opredax | gastro-resistant сapsules, 20 mg | RK-MP-5 №017685 |
33 | A02BC01 | Omeprazol | Opredax | gastro-resistant сapsules, 40 mg | RK-MP-5 №017686 |
34 | A02BC01 | Omeprazol | Proton | gastro-resistant сapsules, 20 mg | RK-MP-5 №020801 |
35 | A02BC01 | Omeprazol | Proton | gastro-resistant сapsules, 40 mg | RK-MP-5 №020802 |
36 | A02BC01 | Omeprazol | Omeprazol | capsules, 20 mg | RK-MP-5 №015041 |
37 | A02BC01 | Omeprazol | Omeprazol | capsules, 20 mg | RK-MP-5 №121776 |
38 | A02BC01 | Omeprazol | Ultop® | gastro-resistant сapsules, 20 mg | RK-MP-5 №009680 |
39 | A02BC01 | Omeprazol | Omesize | capsules, 20 mg | RK-MP-5 №023083 |
40 | A02BC01 | Omeprazol | Omeprazol-Teva | gastro-resistant сapsules 10 mg | RK-MP-5 №023752 |
41 | A02BC01 | Omeprazol | Omeprazol- Teva | gastro-resistant сapsules, 20 mg | RK-MP-5 №023753 |
42 | A02BC01 | Omeprazol | Omicap-20 | gastro-resistant сapsules, 20 mg | RK-MP-5 №003657 |
43 | A02BC01 | Omeprazol | Loseprazol® | capsules, 10 mg | RK-MP-5 №014519 |
44 | A02BC01 | Omeprazol | Loseprazole® | Сapsules, 40 mg | RK-MP-5 №014520 |
45 | A02BC01 | Omeprazol | OMEPRAZOL - ADJIO | gastro-resistant сapsules, 20 mg | RK-MP-5 №024415 |
46 | A02BC01 | Omeprazol |
Noltec | Enteric-coated tablets with delayed release, 10 mg | RK-MP-5 №023832 |
47 | A02BC01 | Omeprazol | Omez® Insta | Powder for preparation of suspension for oral administration, 20 mg | RK-MP-5 №019508 |
A02BC02 | Pantoprazole | ||||
48 | A02BC02 | Pantoprazole | Nolpaza® | powder for preparation of solution for injections, 40 mg | RK-MP-5 №020220 |
49 | A02BC02 | Pantoprazole | Controloc | powder for preparation of solution for injections, 40 mg | RK-MP-5 №011369 |
50 | A02BC02 | Pantoprazole | Aspan | enteric-coated tablets, 40 mg | RK-MP-5 №021205 |
51 | A02BC02 | Pantoprazole | Controloc | enteric-coated tablets, 40 mg | RK-MP-5 №011376 |
52 | A02BC02 | Pantoprazole | Nolpaza® | enteric-coated tablets, 40 mg | RK-MP-5 №020529 |
53 | A02BC02 | Pantoprazole | Pantaz | enteric-coated tablets, 40 mg | RK-MP-5 №001833 |
54 | A02BC02 | Pantoprazole | Protonex | enteric-coated tablets, 40 mg | RK-MP-5 №010441 |
55 | A02BC02 | Pantoprazole | PANTA.ZOL | enteric-coated tablets, 40 mg | RK-MP-5 №021252 |
56 | A02BC02 | Pantoprazole | Pantasun | delayed-release tablets, 40 mg | RK-MP-5 №121645 |
57 | A02BC02 | Pantoprazole | Controloc Control | enteric-coated tablets, 20 mg | RK-MP-5 №011377 |
58 | A02BC02 | Pantoprazole | Nolpaza® | enteric-coated tablets, 20 mg | RK-MP-5 №020528 |
59 | A02BC02 | Pantoprazole | Pantasun 20 | delayed-release tablets, 20 mg | RK-MP-5 №022300 |
60 | A02BC02 | Pantoprazole | Ulsepan | lyophilized powder for preparation of solution for injections, 40 mg | RK-MP-5 №020696 |
61 | A02BC02 | Pantoprazole | Ulsepan | enteric-coated tablets, 40 mg | RK-MP-5 №019534 |
62 | A02BC02 | Pantoprazole | Parastamic | lyophilized powder for preparation of solution for injections, 40 mg | RK-MP-5 №023243 |
63 | A02BC02 | Pantoprazole | Pantospey | lyophilized powder for preparation of solution for intravenous administration, 40 mg | RK-MP-5 №022203 |
64 | A02BC02 | Pantoprazole | PAN IV | powder for preparation of solution for intravenous administration, 40 mg | RK-MP-5 №012805 |
65 | A02BC02 | Pantoprazole | 40 Pantap® 40 | enteric-coated tablets, 40 mg | RK-MP-5 №014805 |
66 | A02BC02 | Pantoprazole | Stamic | enteric-coated tablets, 40 mg | RK-MP-5 №021220 |
67 | A02BC02 | Pantoprazole | PANTAZOL | lyophilisate for preparation of solution for injections and infusions, 40 mg | RK-MP-5 №023875 |
68 | A02BC02 | Pantoprazole | Pantospey | enteric-coated tablets, 40 mg | RK-MP-5 №023507 |
69 | A02BC02 | Pantoprazole | Pantospey | enteric-coated tablets, 20 mg | RK-MP-5 №023506 |
70 | A02BC02 | Pantoprazole | PAN- 20 | coated tablets, 20 mg | RK-MP-5 №011627 |
71 | A02BC02 | Pantoprazole | PAN - 40 | coated tablets, 40 mg | RK-MP-5 №011628 |
72 | A02BC02 | Pantoprazole | Pantonex DR-20 | enteric-coated tablets, 20 mg | RK-MP-5 №020960 |
73 | A02BC02 | Pantoprazole | Pantonex DR-40 | enteric-coated tablets 40 mg | RK-MP-5 №020961 |
74 | A02BC02 | Pantoprazole | Nupenta | enteric-coated tablets, 20 mg | RK-MP-5 №023135 |
75 | A02BC02 | Pantoprazole | Nupenta | enteric-coated tablets, 40 mg | RK-MP-5 №023136 |
76 | A02BC02 | Pantoprazole | Panpyur | enteric-coated tablets, 20 mg | RK-MP-5 №023221 |
77 | A02BC02 | Pantoprazole | ZOLOPENT® | delayed-release tablets, 40 mg | RK-MP-5 №020433 |
78 | A02BC02 | Pantoprazole | Protectopase | lyophilized powder for preparation of solution for injections, 40 mg | RK-MP-5 №024277 |
79 | A02BC02 | Pantoprazole | Pantor 20 | enteric-coated tablets, 20 mg | RK-MP-5 №020355 |
80 | A02BC02 | Pantoprazole | Pantor 40 | enteric-coated tablets, 40 mg | RK-MP-5 №020356 |
A02BC03 | Lansoprazole | ||||
81 | A02BC03 | Lansoprazole | Lansobel® | capsules, 30 mg | RK-MP-5 №011007 |
82 | A02BC03 | Lansoprazole | Lanzoptol | capsules, 30 mg | RK-MP-5 №014351 |
83 | A02BC03 | Lansoprazole | Lansoprazole - Teva | capsules, 15 mg | RK-MP-5 №016856 |
84 | A02BC03 | Lansoprazole | Lansoprazole - Teva | capsules, 30 mg | RK-MP-5 №016857 |
85 | A02BC03 | Lansoprazole | Loenzar-sanovel | delayed-release capsules, 30 mg | RK-MP-5 №020487 |
A02BC04 | Rabeprazole | ||||
86 | A02BC04 | Rabeprazole | Promto | enteric-coated tablets, 10 mg | RK-MP-5 №018197 |
87 | A02BC04 | Rabeprazole | Rabegard ™ -10 | enteric-coated tablets, 10 mg | RK-MP-5 №004379 |
88 | A02BC04 | Rabeprazole | Rancifex | enteric-coated tablets, 10 mg | RK-MP-5 №021253 |
89 | A02BC04 | Rabeprazole | Verabez | enteric-coated tablets, 20 mg | RK-MP-5 №022292 |
90 | A02BC04 | Rabeprazole | Verabez | enteric-coated tablets, 10 mg | RK-MP-5 №022291 |
91 | A02BC04 | Rabeprazole | Rancifex | enteric-coated tablets, 20 mg | RK-MP-5 №021254 |
92 | A02BC04 | Rabeprazole | Pariet® | enteric-coated tablets, 10 mg | RK-MP-5 №022371 |
93 | A02BC04 | Rabeprazole | Promto | enteric-coated tablets, 20 mg | RK-MP-5 №018198 |
94 | A02BC04 | Rabeprazole | Pariet® | enteric-coated tablets, 20 mg | RK-MP-5 №019677 |
95 | A02BC04 | Rabeprazole | Rabeloс | enteric-coated tablets, 10 mg | RK-MP-5 №023027 |
96 | A02BC04 | Rabeprazole | Rabeloс | enteric-coated tablets, 20 mg | RK-MP-5 №023073 |
97 | A02BC04 | Rabeprazole | Zulbex® | enteric-coated tablets, 10 mg | RK-MP-5 №019144 |
98 | A02BC04 | Rabeprazole | Zulbex® | enteric-coated tablets 20 mg | RK-MP-5 №019145 |
99 | A02BC04 | Rabeprazole | Rabemak | enteric-coated tablets, 10 mg | RK-MP-5 №023511 |
100 | A02BC04 | Rabeprazole | Rabemak | enteric-coated tablets 20 mg | RK-MP-5 №023512 |
101 | A02BC04 | Rabeprazole | Razo | enteric-coated tablets 20 mg | RK-MP-5 №023543 |
102 | A02BC04 | Rabeprazole | Rabegard ™ -20 | enteric-coated tablets 20 mg | RK-MP-5 №004378 |
103 | A02BC04 | Rabeprazole | Rabivans | enteric-coated tablets 20 mg | RK-MP-5 №023778 |
104 | A02BC04 | Rabeprazole | Rabeprazole -SZ | enteric capsules, 10 mg | RK-MP-5 №023907 |
105 | A02BC04 | Rabeprazole | Rabeprazole -SZ | enteric capsules, 20 mg | RK-MP-5 №023920 |
106 | A02BC04 | Rabeprazole | Barol 20 | enteric capsules, 20 mg | RK-MP-5 №013644 |
A02BC05 | Esomeprazol | ||||
107 | A02BC05 | Esomeprazol | Sompraz | Lyophilisate for preparation of solution for intravenous administration, 40 mg, complete with a solvent (solution of Sodium chloride 0.9%) | RK-MP-5 №020239 |
108 | A02BC05 | Esomeprazol | Ezom IV | Lyophilized powder for preparation of solutions for injections and infusions, complete with a solvent 40 mg | RK-MP-5 №020384 |
109 | A02BC05 | Esomeprazol | Nexium® | lyophilisate for preparation of solution for intravenous administration, 40 mg | RK-MP-5 №012486 |
110 | A02BC05 | Esomeprazol | Nexium | coated tablets, 40 mg | RK-MP-5 №012404 |
111 | A02BC05 | Esomeprazol | Esom® 40 | enteric capsules, 40 mg | RK-MP-5 №022137 |
112 | A02BC05 | Esomeprazol | Esom® 20 | enteric capsules, 20 mg | RK-MP-5 №022138 |
113 | A02BC05 | Esomeprazol | Nexium | coated tablets, 20 mg | RK-MP-5 №012403 |
114 | A02BC05 | Esomeprazol | Pompezo | lyophilized powder for preparation of solution for injections 40 mg | RK-MP-5 №023560 |
115 | A02BC05 | Esomeprazol | C-MESOL | lyophilisate for preparation of solution for injections and infusions, 40 mg | RK-MP-5 №023890 |
116 | A02BC05 | Esomeprazol | Ezolect | Lyophilized powder for preparation of solution for injections and infusions, 40 mg | RK-MP-5 №024076 |
117 | A02BC05 | Esomeprazol | Esomeprazol-J Life | enteric-coated tablets, 40 mg | RK-MP-5 №021011 |
118 | A02BC05 | Esomeprazol | Esomeprazol-J Life | enteric-coated tablets, 20 mg | RK-MP-5 №021012 |
119 | A02BC05 | Esomeprazol | Promex | enteric-coated tablets, 20 mg | RK-MP-5 №021127 |
120 | A02BC05 | Esomeprazol | Promex | enteric-coated tablets, 40 mg | RK-MP-5 №021128 |
121 | A02BC05 | Esomeprazol | Sompraz | film-coated tablets, 20 mg | RK-MP-5 №122114 |
122 | A02BC05 | Esomeprazol | Sompraz | film-coated tablets, 40 mg | RK-MP-5 №122115 |
123 | A02BC05 | Esomeprazol | Mesopral | enteric capsules, hard, 20 mg | RK-MP-5 №022684 |
124 | A02BC05 | Esomeprazol | Mesopral | enteric capsules, hard, 40 mg | RK-MP-5 №022685 |
125 | A02BC05 | Esomeprazol | Emanera® | enteric capsules, 20 mg | RK-MP-5 №019226 |
126 | A02BC05 | Esomeprazol | Emanera® | enteric capsules, 40 mg | RK-MP-5 №019227 |
127 | A02BC05 | Esomeprazol | Nulok | delayed-release capsules, 40 mg | RK-MP-5 №023908 |
128 | A02BC05 | Esomeprazol | Nulok | delayed-release capsules, 20 mg | RK-MP-5 №023911 |
A02BX | Other antiulcer drugs | ||||
A02BX05 | Bismuth subcitrate | ||||
129 | A02BX05 | Bismuth subcitrate | Ulcavis | film-coated tablets, 120 mg | RK-MP-5 №022995 |
130 | A02BX05 | Bismuth subcitrate | De-Nol® | Coated tablets 120 mg | RK-MP-5 №010006 |
131 | A02BX05 | Bismuth subcitrate | De-Nol® | coated tablets 120 mg | RK-MP-5 №023961 |
132 | A02BX05 | Bismuth subcitrate | Gaviscon® | chewable tablets with strawberry flavor 250 mg / 133.5 mg / 80 mg | RK-MP-5 №021337 |
133 | A02BX05 | Bismuth subcitrate | Gaviscon® | mint chewable tablets 250 mg / 133.5 mg / 80 mg | RK-MP-5 №021338 |
134 | A02BX05 | Bismuth subcitrate | Mucogen | coated tablets 100 mg | RK-MP-5 №017569 |
A03 | Drugs for treatment of functional disorders of the gastrointestinal tract | ||||
A03A | Drugs used for intestinal disorders | ||||
A03AA | Synthetic anticholinergics - esters with a tertiary amino group | ||||
A03AA04 | Mebeverine | ||||
135 | A03AA04 | Mebeverine | Meverin | сapsules 0,2 g | RK-MP-5 №020071 |
136 | A03AA04 | Mebeverine | Dusconal Retard | capsules with modified release, 200 mg | RK-MP-5 №023024 |
137 | A03AA04 | Mebeverine | Spaverine | capsules with prolonged release, 200 mg | RK-MP-5 №022931 |
138 | A03AA04 | Mebeverine | Sparex | capsules with modified-release, 200 mg | RK-MP-5 №019337 |
139 | A03AA04 | Mebeverine | Duspatalin® | retard capsules, 200 mg | RK-MP-5 №013750 |
A03AD | Papaverine and its derivatives | ||||
A03AD01 | Papaverine | ||||
140 | A03AD01 | Papaverine | Papaverine | tablets 0.04 g | RK-MP-5 №018448 |
141 | A03AD01 | Papaverine | Papaverine | rectal suppositories, 20 mg | RK-MP-5 №005175 |
142 | A03AD01 | Papaverine | Papaverine hydrochloride | rectal suppositories, 0.02 g | RK-MP-5 №013148 |
143 | A03AD01 | Papaverine | Papaverine hydrochloride | solution for injections 2%, 2 ml | RK-MP-5 №010954 |
144 | A03AD01 | Papaverine | Papaverine | solution for injections, 20 mg / ml 2 ml | RK-MP-5 №022795 |
145 | A03AD01 | Papaverine | Papaverine hydrochloride | solution for injections, 20 mg / ml 2 ml | RK-MP-5 №010314 |
A03AD02 | Drotaverine | ||||
146 | A03AD02 | Drotaverine | Drotaverine | solution for injections, 40 mg / ml 2 ml | RK-MP-5 №022172 |
147 | A03AD02 | Drotaverine | Ple-spa ™ | solution for injections, 40 mg/2 ml 2 ml | RK-MP-5 №013844 |
148 | A03AD02 | Drotaverine | Noschwerin | solution for injections, 20 mg / ml 2 ml | RK-MP-5 №022504 |
149 | A03AD02 | Drotaverine | SPASMOSTOP | solution for injections, 20 mg / ml 2 ml | RK-MP-5 №024192 |
150 | A03AD02 | Drotaverine | No-spa® | solution for injections, 40 mg/2 ml 2 ml | RK-MP-5 №000987 |
151 | A03AD02 | Drotaverine | Drotaverine | solution for injections, 20 mg / ml 2 ml | RK-MP-5 №014099 |
152 | A03AD02 | Drotaverine | Drotaverine hydrochloride | Tablets 40 mg | RK-MP-5 №004434 |
153 | A03AD02 | Drotaverine | SPASMOLYSIN | Rectal suppositories 40 mg | RK-MP-5 №010594 |
154 | A03AD02 | Drotaverine | No-spa® | Tablets 40 mg | RK-MP-5 №000989 |
155 | A03AD02 | Drotaverine | Noschwerin | Tablets 40 mg | RK-MP-5 №010846 |
156 | A03AD02 | Drotaverine | No-spa® forte | Tablets 80 mg | RK-MP-5 №019110 |
157 | A03AD02 | Drotaverine | Drotaverine | Tablets 40 mg | RK-MP-5 №018764 |
158 | A03AD02 | Drotaverine | Ple-spa ™ | Film-coated tablets 40 mg | RK-MP-5 №016474 |
159 | A03AD02 | Drotaverine | Dro Spaz | Tablets 40 mg | RK-MP-5 №021417 |
A03AX | Other drugs used for intestinal disorders | ||||
160 | A03AX | Other drugs used for intestinal disorders | Platyphyllin-Darnitsa | solution for injections 0.2% 1 ml | RK-MP-5 №008566 |
161 | A03AX | Other drugs used for intestinal disorders | Platyphyllin hydrotartrate | solution for injections 0.2% 1 ml | RK-MP-5 №015045 |
162 | A03AX | Other drugs used for intestinal disorders | Platyphyllin hydrotartrate | Solution for injections 0.2% 1 ml | RK-MP-5 №011036 |
A03AX13 | Simethicone | ||||
163 | A03AX13 | Simethicone | Espumisan® | сapsules 40 mg | RK-MP-5 №005061 |
164 | A03AX13 | Simethicone | KOLIKID® | coated tablets, 125 mg | RK-MP-5 №023613 |
165 | A03AX13 | Simethicone | KOLIKID® | oral suspension, 40 mg / ml 30 ml | RK-MP-5 №023904 |
166 | A03AX13 | Simethicone | Bobotik | oral emulsion 66.66 mg / ml 30 ml | RK-MP-5 №015656 |
167 | A03AX13 | Simethicone | Esmizan-ODS | films dispersible in the oral cavity 62.5 mg | RK-MP-5 №023972 |
168 | A03AX13 | Simethicone | Espumisan® L drops for children | oral drops (emulsion) 40 mg | RK-MP-5 №019918 |
A03B | Belladonna and its derivatives | ||||
A03BB | Semisynthetic belladonna alkaloids, quaternary ammonium compounds | ||||
A03BB01 | Hyoscine butyl bromide | ||||
169 | A03BB01 | Hyoscine butyl bromide | Buscopan® | solution for injections, 20 mg/ml 1 ml | RK-MP-5 №000024 |
170 | A03BB01 | Hyoscine butyl bromide | Buscopan® | sugar-coated tablets, 10 mg | RK-MP-5 №016087 |
171 | A03BB01 | Hyoscine butyl bromide | Buscopan® | rectal suppositories, 10mg | RK-MP-5 №016088 |
A03BA | Belladonna alkaloids, tertiary amines | ||||
A03BA01 | Atropine sulfate | ||||
172 | A03BA01 | Atropine sulfate | Atropine sulfate | solution for injections 1mg / ml 1 ml | RK-MP-5 №012809 |
A03F | Gastrointestinal motility stimulants | ||||
A03FA01 | Metoclopramide | ||||
173 | A03FA01 | Metoclopramide | Cerulin® | solution for injections 0.5%, 2 ml | RK-MP-5 №015849 |
174 | A03FA01 | Metoclopramide | Metoclopramide | solution for injections 0.5%, 2 ml | RK-MP-5 №003641 |
175 | A03FA01 | Metoclopramide | Cerucal® | solution for injections 10 mg/2 ml 2 ml | RK-MP-5 №005184 |
176 | A03FA01 | Metoclopramide | Cerucal® | tablets 10 mg | RK-MP-5 №011280 |
177 | A03FA01 | Metoclopramide | Metoclopramide | solution for intravenous and intramuscular administration, 5 mg / ml 2 ml | RK-MP-5 №013188 |
178 | A03FA01 | Metoclopramide | Metoclopramide | tablets 10 mg | RK-MP-5 №003113 |
179 | A03FA01 | Metoclopramide | Metoclopramide-Darnitsa | solution for injections, 0,5 % 2 ml | RK-MP-5 №001379 |
180 | A03FA01 | Metoclopramide | Metoclopramide | solution for intravenous and intramuscular administration, 5 mg / ml 2 ml | RK-MP-5 №022422 |
181 | A03FA01 | Metoclopramide | Cerumed | solution for injections, 10 mg/2 ml 2 ml | RK-MP-5 №024047 |
A03FA03 | Domperidone | ||||
182 | A03FA03 | Domperidone | Damelium | tablets 10 mg | RK-MP-5 №020347 |
183 | A03FA03 | Domperidone | Motinorm® | tablets, 10 mg | RK-MP-5 №009890 |
184 | A03FA03 | Domperidone | Motinorm® | oral drops 5 ml | RK-MP-5 №012907 |
185 | A03FA03 | Domperidone | Motinorm® | syrup 30 ml | RK-MP-5 №012906 |
186 | A03FA03 | Domperidone | Motinorm® | syrup 60 ml | RK-MP-5 №012906 |
187 | A03FA03 | Domperidone | Donium-TK | tablets 10 mg | RK-MP-3 №122158 |
188 | A03FA03 | Domperidone | DOPROKIN | tablets 10 mg | RK-MP-5 №022355 |
189 | A03FA03 | Domperidone | Brulium Lingvatabs | dispersible tablets, 10 mg | RK-MP-5 №014080 |
190 | A03FA03 | Domperidone | Domrid® | coated tablets, 10 mg | RK-MP-5 №121930 |
191 | A03FA03 | Domperidone | Motilium® | film-coated tablets, 10 mg | RK-MP-5 №018410 |
192 | A03FA03 | Domperidone | MOTIGAST 10 | film-coated tablets, 10 mg | RK-MP-5 №024356 |
193 | A03FA03 | Domperidone | Domrid® | Oral suspension 1 mg / ml 60 ml | RK-MP-5 №122063 |
194 | A03FA03 | Domperidone | Domrid® | Oral suspension 1 mg / ml 100 ml | RK-MP-5 №122063 |
A04 | Antiemetic drugs | ||||
A04AA | Serotonin 5ht3 receptor antagonists | ||||
A04AA01 | Ondansetron | ||||
195 | A04AA01 | Ondansetron | Ondansetron | solution for intravenous and intramuscular administration, 2 mg / ml, 2 ml | RK-MP-5 №022567 |
196 | A04AA01 | Ondansetron | Ondansetron | solution for intravenous and intramuscular administration, 2 mg / ml, 4 ml | RK-MP-5 №022567 |
197 | A04AA01 | Ondansetron | Ondansetron | solution for injections 2 mg / ml, 2 ml | RK-MP-5 №013007 |
198 | A04AA01 | Ondansetron | Ondansetron | solution for injections 2 mg / ml, 4 ml | RK-MP-5 №013007 |
199 | A04AA01 | Ondansetron | Ondansetron | solution for intravenous and intramuscular administration, 2 mg / ml, 4 ml | RK-MP-5 №022567 |
200 | A04AA01 | Ondansetron | Ondansetron | solution for intravenous and intramuscular administration, 2 mg / ml, 4 ml | RK-MP-5 №022567 |
201 | A04AA01 | Ondansetron | Ondansetron | solution for injections 4 mg / 2 ml 2 ml | RK-MP-3 №021463 |
202 | A04AA01 | Ondansetron | Emeton | solution for injections, 2 mg / ml 2 ml | RK-MP-5 №021555 |
203 | A04AA01 | Ondansetron | Emeton | solution for injections, 2 mg/ml 4 ml | RK-MP-5 №021555 |
204 | A04AA01 | Ondansetron | Ondansetron | solution for intravenous and intramuscular administration 2 mg 2 ml | RK-MP-5 №013927 |
205 | A04AA01 | Ondansetron | Ondansetron | solution for intravenous and intramuscular administration 2 mg 4 ml | RK-MP-5 №013916 |
A04AA02 | Granisetron | ||||
206 | A04AA02 | Granisetron | Granisetron-Teva | concentrate for preparation of solution for infusions, 1 mg / ml 1 ml | RK-MP-5 №021247 |
207 | A04AA02 | Granisetron | Granisetron-Teva | concentrate for preparation of solution for infusion, 3 mg / 3ml 3 ml | RK-MP-5 №021248 |
A04AD | Other antiemetic drugs | ||||
A04AD12 | Aprepitant | ||||
208 | A04AD12 | Aprepitant | Emend | capsules 125 mg | RK-MP-5 №015509 |
209 | A04AD12 | Aprepitant | Emend | capsules 80 mg | RK-MP-5 №015508 |
A05 | Drugs for the treatment of liver and biliary tract diseases | ||||
A05A | Drugs for the treatment of liver and biliary tract diseases | ||||
A05AA | Bile acid drugs | ||||
A05AA02 | Ursodeoxycholic acid | ||||
210 | A05AA02 | Ursodeoxycholic acid | Ursoliv | capsules 250 mg | RK-MP-5 №018892 |
211 | A05AA02 | Ursodeoxycholic acid | Choludexan | capsules, 300 mg | RK-MP-5 №015800 |
212 | A05AA02 | Ursodeoxycholic acid | Ursozyme® | capsules 250 mg | RK-MP-5 №017901 |
213 | A05AA02 | Ursodeoxycholic acid | URSOCID® | capsules 250 mg | RK-MP-3 №021557 |
214 | A05AA02 | Ursodeoxycholic acid | Ursodex® | capsules 250 mg | RK-MP-5 №018295 |
215 | A05AA02 | Ursodeoxycholic acid | Desursolen® | capsules with modified release, 450 mg | RK-MP-5 №121650 |
216 | A05AA02 | Ursodeoxycholic acid | Sertohol | hard capsules, 300 mg | RK-MP-5 №121673 |
217 | A05AA02 | Ursodeoxycholic acid | URSOSAN | capsules, 250 mg | RK-MP-5 №003942 |
218 | A05AA02 | Ursodeoxycholic acid | GRINTEROL® | capsules, 250 mg | RK-MP-5 №022956 |
219 | A05AA02 | Ursodeoxycholic acid | Ursofalk | capsules, 250 mg | RK-MP-5 №006140 |
220 | A05AA02 | Ursodeoxycholic acid | Ursoflor | gelatin capsules, 300 mg | RK-MP-5 №018957 |
221 | A05AA02 | Ursodeoxycholic acid | Ursolysin | capsules, 150 mg | RK-MP-5 №019540 |
222 | A05AA02 | Ursodeoxycholic acid | Ursolysin | capsules, 300 mg | RK-MP-5 №019541 |
223 | A05AA02 | Ursodeoxycholic acid | Exhole | capsules, 250 mg | RK-MP-5 №019513 |
224 | A05AA02 | Ursodeoxycholic acid | Desursolen | tablets, 300 mg | RK-MP-5 №121649 |
225 | A05AA02 | Ursodeoxycholic acid | Ukrliv | tablets, 250 mg | RK-MP-5 №022725 |
226 | A05AA02 | Ursodeoxycholic acid | URSOSAN® FORTE | film-coated tablets, 500 mg | RK-MP-5 №023987 |
227 | A05AA02 | Ursodeoxycholic acid | Sanursokol | tablets, 150 mg | RK-MP-5 №024350 |
228 | A05AA02 | Ursodeoxycholic acid | Sanursokol | tablets, 300 mg | RK-MP-5 №024351 |
A06 | Laxatives | ||||
A06AB | Contact laxatives | ||||
A06AB02 | Bisacodyl | ||||
229 | A06AB02 | Bisacodyl | Bisacodyl | rectal suppositories 0.01 g | RK-MP-5 №010998 |
230 | A06AB02 | Bisacodyl | Dulcolax® | sugar / enteric coated tablets 5 mg | RK-MP-5 №017372 |
231 | A06AB02 | Bisacodyl | Bisacodyl Grindeks | enteric-coated tablets 5 mg | RK-MP-5 №004800 |
232 | A06AB02 | Bisacodyl | Bisacodyl- Nizhpharm | rectal suppositories 10 mg | RK-MP-5 №010219 |
233 | A06AB02 | Bisacodyl | Bisacodyl | rectal suppositories 10 mg | RK-MP-5 №009754 |
234 | A06AB02 | Bisacodyl | Bisacodyl | rectal suppositories 10 mg | RK-MP-5 №023341 |
235 | A06AB02 | Bisacodyl | Dulcolax® | rectal suppositories 10 mg | RK-MP-5 №016750 |
A06AB08 | Sodium picosulfate | ||||
236 | A06AB08 | Sodium picosulfate | Picolax | oral drops 0.75% 15 ml | RK-MP-5 №013426 |
237 | A06AB08 | Sodium picosulfate | Picolax | oral drops 0.75% 30 ml | RK-MP-5 №013426 |
238 | A06AB08 | Sodium picosulfate | Picolax | tablets 7.5 mg | RK-MP-5 №020172 |
239 | A06AB08 | Sodium picosulfate | Dulcolax® Pico | oral drops, 7.5 mg / ml 15 ml | RK-MP-5 №011189 |
240 | A06AB08 | Sodium picosulfate | Dulcolax® Pico | oral drops, 7.5 mg / ml 30 ml | RK-MP-5 №011189 |
241 | A06AB08 | Sodium picosulfate | Perilax | oral drops, 7.5 mg / ml 30 ml | RK-MP-5 №023069 |
242 | A06AB08 | Sodium picosulfate | Laxigal | oral drops, 7.5 mg / ml 10 ml | RK-MP-5 №006164 |
243 | A06AB08 | Sodium picosulfate | Laxigal | oral drops, 7.5 mg / ml 25 ml | RK-MP-5 №006164 |
244 | A06AB08 | Sodium picosulfate | Regulax® Picosulfate | oral drops, 0.75 g 20 ml | RK-MP-5 №012670 |
245 | A06AB08 | Sodium picosulfate | laxigal | 7,5 м oral drops, 7.5 mg | RK-MP-5 №006164 |
A06AB58 |
Sodium picosulfate | ||||
246 | A06AB58 |
Sodium picosulfate | Pikoprep | powder for preparation of oral solution 10 mg / 3.5 g / 12 g | RK-MP-5 №017969 |
247 | A06AB58 |
Sodium picosulfate | CitraFlit | powder for preparation of oral solution 10 mg / 10.97g / 3.5 g | RK-MP-5 №023958 |
A06AD | Laxatives with osmotic properties | ||||
A06AD04 | Magnesium sulfate | ||||
248 | A06AD04 | Magnesium sulfate | Magnesium sulfate | powder 25 g | RK-MP-5 №010068 |
249 | A06AD04 | Magnesium sulfate | Magnesium sulfate | powder 50 g | RK-MP-5 №010068 |
250 | A06AD04 | Magnesium sulfate | Magnesium sulfate | powder 100 g | RK-MP-5 №010068 |
251 | A06AD04 | Magnesium sulfate | Magnesium sulfate | powder 25 g | RK-MP-5 №003173 |
252 | A06AD04 | Magnesium sulfate | Magnesium sulfate | powder 70 g | RK-MP-5 №003173 |
A06AD11 | Lactulose | ||||
253 | A06AD11 | Lactulose | Duphalac® | syrup 667 g / l 1000 ml | RK-MP-5 №018066 |
254 | A06AD11 | Lactulose | Portalak | syrup 667 g / l 500 ml | RK-MP-5 №121787 |
255 | A06AD11 | Lactulose | Portalak | syrup 667 g / l 250 ml | RK-MP-5 №121787 |
256 | A06AD11 | Lactulose | Duphalac® | syrup 667 g / l 500 ml | RK-MP-5 №018066 |
257 | A06AD11 | Lactulose | Normase | syrup 667 g / l 200 ml | RK-MP-5 №015037 |
258 | A06AD11 | Lactulose | Duphalac® | syrup 667 g / l 200 ml | RK-MP-5 №018066 |
259 | A06AD11 | Lactulose | Lactulose-TK | syrup 667 mg / l 200 ml | RK-MP-5 №023089 |
260 | A06AD11 | Lactulose | Lactulose-TK | syrup 667 mg / l 1000 ml | RK-MP-5 №023089 |
261 | A06AD11 | Lactulose | Lactulose-TK | syrup 667 mg / l 500 ml | RK-MP-5 №023089 |
262 | A06AD11 | Lactulose | Laxolac® | syrup, 67 mg / 120 ml | RK-MP-5 №022481 |
263 | A06AD11 | Lactulose | Lactulose-Teva | syrup, 66.7 g / 100 ml | RK-MP-5 №019382 |
264 | A06AD11 | Lactulose | Duphalac® Fruit | syrup, 667 g / l 200 ml | RK-MP-5 №023580 |
265 | A06AD11 | Lactulose | Duphalac® Fruit | syrup, 667 g / l 500 ml | RK-MP-5 №023580 |
266 | A06AD11 | Lactulose | Normase | syrup, 667 mg / ml 200 ml | RK-MP-5 №023718 |
267 | A06AD11 | Lactulose | Medulak-WM | syrup, 667 mg / ml 250 ml | RK-MP-5 №024162 |
268 | A06AD11 | Lactulose | Transulose | Oral paste 150 g | RK-MP-5 №016779 |
A06AD15 | Macrogol | ||||
269 | A06AD15 | Macrogol | Forlax® | powder for preparation of solution for oral administration, 10 g | RK-MP-5 №005963 |
270 | A06AD15 | Macrogol | Fortrans® | powder for preparation of solution for oral administration | RK-MP-5 №005236 |
271 | A06AD15 | Macrogol | Microlax Plus |
banana powder for preparation of solution for oral administration, | RK-MP-5 №013414 |
272 | A06AD15 | Macrogol | Microlax Plus |
grape powder for preparation of solution for oral administration, | RK-MP-5 №013415 |
273 | A06AD15 | Macrogol | Microlax Plus |
orange powder for preparation of solution for oral administration, | RK-MP-5 №013416 |
274 | A06AD15 | Macrogol | Microlax Plus |
apricot powder for preparation of solution for oral administration, | RK-MP-5 №013417 |
275 | A06AD15 | Macrogol | Microlax Plus |
apple powder for preparation of solution for oral administration, | RK-MP-5 №013418 |
A06AD65 | Macrogol 3350 in combination with other drugs | ||||
276 | A06AD65 | Macrogol 3350 in combination with other drugs | Moviprep® | powder for preparation of solution for oral administration, | RK-MP-5 №019791 |
A06AG | Laxatives in enemas | ||||
A06AG04 | Glycerol | ||||
277 | A06AG04 | Glycerol | Gliroma | rectal solution 3 g | RK-MP-5 №121760 |
278 | A06AG04 | Glycerol | Gliroma | rectal solution 9 g | RK-MP-5 №121761 |
279 | A06AG04 | Glycerol | ADYUlakS | rectal solution 7,5 ml | RK-MP-5 №018889 |
280 | A06AG04 | Glycerol | Paydolax | rectal solution 4 ml | RK-MP-5 №018888 |
281 | A06AG04 | Glycerol | ROMALAX-DF | Rectal solution 9 g | RK-MP-5 №024484 |
282 | A06AG04 | Glycerol | ROMALAX-DF | Rectal solution 3 g | RK-MP-5 №024485 |
A06AX | Other drugs for constipation | ||||
A06AX03 | Lubiproston | ||||
283 | A06AX03 | Lubiproston | Amitiza ™ | capsules, 8 mcg | RK-MP-5 №022688 |
284 | A06AX03 | Lubiproston | Amitiza ™ | capsules, 24 mcg | RK-MP-5 №022690 |
A06AX05 | Prucaloprid | ||||
A07 | Antidiarrheal, intestinal anti-inflammatory and antimicrobial drugs | ||||
A07AA02 | Nystatin | ||||
285 | A07AA02 | Nystatin | Nystatin | coated tablets 500,000 IU | RK-MP-5 №011404 |
286 | A07AA02 | Nystatin | Nystatin | coated tablets 500,000 IU | RK-MP-5 №012814 |
287 | A07AA02 | Nystatin | Nystatin | coated tablets 250,000 IU | RK-MP-5 №012813 |
A07AA11 | Rifaximin | ||||
288 | A07AA11 | Rifaximin | Alpha Normix | film-coated tablets, 200 mg | RK-MP-5 №012837 |
A07AA12 | Fidaxomicin | ||||
289 | А07АА12 | Fidaxomicin | Difiklir | Film-coated tablets, 200 mg | RK-MP-5 №021130 |
A07BA01 | Activated carbon | ||||
290 | A07BA01 | Activated carbon | Activated carbon Ultra-Adsorb | tablets, 0.25 g | RK-MP-5 №016619 |
291 | A07BA01 | Activated carbon | Activated carbon | capsules 200 mg | RK-MP-3 №021043 |
292 | A07BA01 | Activated carbon | Adsorbix® Extra | capsules, 200 mg | RK-MP-5 №015914 |
293 | A07BA01 | Activated carbon | Activated carbon | tablets, 250 mg | RK-MP-5 №016911 |
294 | A07BA01 | Activated carbon | Activated carbon | Tablets 0.25 g | RK-MP-5 №024499 |
A07CA | Anhydrous glucose, sodium chloride, potassium chloride, sodium citrate | ||||
295 | A07CA | Anhydrous glucose, sodium chloride, potassium chloride, sodium citrate | Oral rehydration salt | powder 27.9 g | RK-MP-5 №121720 |
296 | A07CA | Anhydrous glucose, sodium chloride, potassium chloride, sodium citrate | ORS Viva Pharm | powder for preparation of oral solution 20.5 g | RK-MP-5 №022967 |
297 | A07CA | Anhydrous glucose, sodium chloride, potassium chloride, sodium citrate | Regidron | powder for preparation of oral solution, 18.9 g | RK-MP-5 №016344 |
298 | A07CA | Anhydrous glucose, sodium chloride, potassium chloride, sodium citrate | Regid-K | powder for preparation of solution for oral administration, 18.9 g | RK-MP-3 №021263 |
299 | A07CA | Anhydrous glucose, sodium chloride, potassium chloride, sodium citrate | Regidron Optim | powder for preparation of oral solution 10.7 g | RK-MP-5 №016345 |
A07D | Drugs, reducing the peristalsis of the gastrointestinal tract | ||||
A07DA03 | Loperamide | ||||
300 | A07DA03 | Loperamide | Loperamide hydrochloride | capsules 2 mg | RK-MP-5 №009693 |
301 | A07DA03 | Loperamide | Loperamide hydrochloride | capsules 2 mg | RK-MP-5 №013774 |
302 | A07DA03 | Loperamide | Loperamide-TK | capsules 2 mg | RK-MP-5 №016227 |
303 | A07DA03 | Loperamide |
Loperamide hydrochloride "LH" | tablets 0.002 g | RK-MP-5 №001515 |
304 | A07DA03 | Loperamide | Imodium® | capsules, 2 mg | RK-MP-5 №018532 |
305 | A07DA03 | Loperamide | Imodium® | oral dispersible tablets, 2 mg | RK-MP-5 №019906 |
A07E | Intestinal anti-inflammatory drugs | ||||
A07EA06 | Budesonide | ||||
306 | A07EA06 | Budesonide | Cortiment |
tablets with prolonged release, | RK-MP-5 №023278 |
307 | A07EA06 | Budesonide | Budenofalk | capsules, 3 mg | RK-MP-5 №012428 |
A07EC | Aminosalicylic acid and its analogues | ||||
A07EC01 | Sulfasalazine | ||||
308 | A07EC01 | Sulfasalazine | Sulfasalazine | film-coated tablets, 500 mg | RK-MP-5 №003393 |
309 | A07EC01 | Sulfasalazine | Sulfasalazine-EH | enteric coated tablets 500 mg | RK-MP-5 №003273 |
A07EC02 | Mesalazine | ||||
310 | A07EC02 | Mesalazine | Salofalk | Rectal suppositories 1000 mg | RK-MP-5 №021146 |
311 | A07EC02 | Mesalazine | Salofalk | Enteric film-coated tablets 500 mg | RK-MP-5 №006145 |
312 | A07EC02 | Mesalazine | Pentasa | rectal suspension 1 g / 100 ml 100 ml | RK-MP-5 №023334 |
313 | A07EC02 | Mesalazine | Pentasa | rectal suppositories 1000 mg | RK-MP-5 №020246 |
314 | A07EC02 | Mesalazine | Pentasa | granules with prolonged release 2 g | RK-MP-5 №020277 |
315 | A07EC02 | Mesalazine | Mezavant | enteric coated tablets with prolonged release, 1.2 g | RK-MP-5 №121786 |
316 | A07EC02 | Mesalazine | Pentasa | tablets with prolonged release 500 mg | RK-MP-5 №019018 |
317 | A07EC02 | Mesalazine | Asakol | enteric-coated tablets 400 mg | RK-MP-5 №122095 |
318 | A07EC02 | Mesalazine | Pentasa |
granules with prolonged release, | RK-MP-5 №019040 |
319 | A07EC02 | Mesalazine | Mesacol | coated tablets, 400 mg | RK-MP-5 №009852 |
320 | A07EC02 | Mesalazine | Salofalk | enteric film-coated tablets, 250 mg | RK-MP-5 №006142 |
A07XA04 | Racecadotril | ||||
321 | A07XA04 | Racecadotril | Hydrasek | hard gelatin capsules, 100 mg | RK-MP-5 №020022 |
322 | A07XA04 | Racecadotril | Hydrasek | granules for preparation of oral suspension, 10 mg | RK-MP-5 №020023 |
323 | A07XA04 | Racecadotril | Hydrasek | granules for preparation of oral suspension, 30 mg | RK-MP-5 №020024 |
A08 | Anti-obesity drugs | ||||
A08AB | Anti-obesity drugs of peripheral action | ||||
A08AB01 | Orlistat | ||||
324 | A08AB01 | Orlistat | Xenical | capsules, 120 mg | RK-MP-5 №013261 |
325 | A08AB01 | Orlistat | Orsoten® | capsules, 120 mg | RK-MP-5 №016801 |
326 | A08AB01 | Orlistat | Listata | film-coated tablets, 120 mg | RK-MP-5 №022802 |
A09 | Digestive aids (including enzyme preparations) | ||||
A09AA | Enzyme preparations | ||||
A09AA02 | Pancreatin | ||||
327 | A09AA02 | Pancreatin | Mezim® forte |
| RK-MP-5 №012610 |
328 | A09AA02 | Pancreatin | Mezim® forte 10000 | Enteric-coated tablets 10,000 IU | RK-MP-5 №014997 |
329 | A09AA02 | Pancreatin | Pangrol® 10000 | capsules containing enteric-coated minitablets 10,000 IU | RK-MP-5 №020236 |
330 | A09AA02 | Pancreatin | Panzinorm®10000 | capsules 10,000 IU | RK-MP-5 №013295 |
331 | A09AA02 | Pancreatin | Creon® 25000 | enteric-coated capsules containing mini-microspheres 300 mg (25,000 IU) | RK-MP-5 №010898 |
332 | A09AA02 | Pancreatin | Pangrol® 25000 | capsules containing enteric-coated minitablets 25,000 IU | RK-MP-5 №020237 |
333 | A09AA02 | Pancreatin | Micrasim® | capsules, 25,000 IU | RK-MP-5 №016742 |
334 | A09AA02 | Pancreatin | Creon® 10000 | capsules containing mini-microspheres, enteric-coated 150 mg (10,000 IU) | RK-MP-5 №010897 |
335 | A09AA02 | Pancreatin | PENZYM 10000 | enteric film-coated tablets, 10,000 IU | RK-MP-5 №023142 |
336 | A09AA02 | Pancreatin | Pancrim® | enteric-coated tablets 250 mg | RK-MP-5 №009437 |
337 | A09AA02 | Pancreatin | Pancreasim | enteric-coated tablets 8000 lipolytic IU | RK-MP-5 №000992 |
338 | A09AA02 | Pancreatin | Pancreatin | enteric-coated tablets, 25 IU | RK-MP-5 №010039 |
339 | A09AA02 | Pancreatin | Micrasim® | capsules, 10,000 IU | RK-MP-5 №016740 |
340 | A09AA02 | Pancreatin | Pancreoflat | coated tablets 170 mg / 80.028 mg | RK-MP-5 №021470 |
341 | A09AA02 | Pancreatin | Festal® N | enteric and sugar coated tablets 212.5 mg | RK-MP-5 №018369 |
342 | A09AA02 | Pancreatin | Pancreatin 8000 | enteric-coated tablets, 0.24 g | RK-MP-5 №018454 |
343 | A09AA02 | Pancreatin | Panzinorm® forte 20000 | film-coated tablets 279.44 mg | RK-MP-5 №009775 |
344 | A09AA02 | Pancreatin | Pancreatin | enteric-coated tablets, 25 IU | RK-MP-5 №018839 |
345 | A09AA02 | Pancreatin | Creon® 40000 | capsules containing enteric-coated minimicrospheres, 400 mg | RK-MP-5 №019669 |
346 | A09AA02 | Pancreatin | Enzistal P | enteric-coated tablets 89.36 mg | RK-MP-5 №019612 |
347 | A09AA02 | Pancreatin | CREAMED 10000 10000 | capsules with delayed release, 150 mg | RK-MP-5 №024236 |
A10 | Drugs used for diabetes treatment | ||||
A10A | Insulins and their analogues | ||||
A10AB | Insulins and their short-acting analogues | ||||
A10AB01 | Insulin human | ||||
348 | A10AB01 | Insulin human | Actrapid® NM Penfill® | solution for injections 100 IU / ml 3 ml in cartridge | RK-MP-5 №016483 |
349 | A10AB01 | Insulin human | Actrapid® NM | solution for injections 100 IU / ml 10 ml | RK-MP-5 №003379 |
350 | A10AB01 | Insulin human | Vosulin-R | solution for injections 100 IU / ml 10ml | RK-MP-5 №023712 |
351 | A10AB01 | Insulin human | Vosulin-R | solution for injections 100 IU / ml 3 ml | RK-MP-5 №023711 |
352 | A10AB01 | Insulin human | Vosulin-R | solution for injections 100 IU / ml 3 ml | RK-MP-5 №023710 |
353 | A10AB01 | Insulin human | Humulin® Regular | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №003067 |
354 | A10AB01 | Insulin human | Actrapid® NM Penfill® | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №022183 |
355 | A10AB01 | Insulin human | Humulin® Regular | solution for injections, 100 IU / ml 10 ml | RK-MP-5 №011462 |
356 | A10AB01 | Insulin human | Actrapid® NM Penfill® | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №024413 |
A10AB04 | Insulin lispro | ||||
357 | A10AB04 | Insulin lispro | Humalog® | solution for injections, 100 IU / ml 10 ml | RK-MP-5 №020591 |
358 | A10AB04 | Insulin lispro | Humalog® | solution for injection 100 IU / ml 3 ml in cartridge | RK-MP-5 №018135 RK-MP-5 №121946 |
359 | A10AB04 | Insulin lispro | Humalog® QuickPen ™ | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №021085 |
360 | A10AB04 | Insulin lispro | Humalog® Junior QuickPen® | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №023865 |
361 | A10AB04 | Insulin lispro | Humalog® | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №121946 |
362 | A10AB04 | Insulin lispro | Humalog® | solution for injections, 100 IU / ml 3 ml | RK-MP-5 №018135 |
A10AB05 | Insulin aspart | ||||
363 | A10AB05 | Insulin aspart | NovoRapid® FlexPen® | solution for subcutaneous and intravenous administration 100 IU / ml 3 ml | RK-MP-5 №017119 |
364 | A10AB05 | Insulin aspart | NovoRapid® Penfill® | solution for subcutaneous and intravenous administration 100 IU / ml 3 ml | RK-MP-5 №017351 |
365 | A10AB05 | Insulin aspart | NovoRapid® | solution for injections 100 IU / ml 10 ml | RK-MP-5 №021556 |
366 | A10AB05 | Insulin aspart | NovoRapid® FlexPen® | solution for subcutaneous and intravenous administration 100 IU / ml | RK-MP-5 №024396 |
A10AB06 | Insulin glulisine | ||||
367 | A10AB06 | Insulin glulisine | Apidra® SoloStar® | solution for injections 100 IU / ml 3 ml | RK-MP-5 №014329 |
368 | A10AB06 | Insulin glulisine | Apidra® | solution for injections 100 IU / ml 10 ml | RK-MP-5 №016447 |
369 | A10AB06 | Insulin glulisine | Apidra® | solution for injections 100 IU / ml 3 ml | RK-MP-5 №016455 |
A10AC | Insulins and their analogues of medium duration action | ||||
A10AC01 | Insulin human recombinant | ||||
370 | A10AC01 | Insulin human recombinant | Protafan® NM Penfill® | suspension for subcutaneous administration 100 IU / ml 3ml in a cartridge | RK-MP-5 №016309 |
371 | A10AC01 | Insulin human recombinant | Insuman® Basal GT | suspension for subcutaneous administration 100 IU / ml 3ml in a cartridge | RK-MP-5 №018748 |
372 | A10AC01 | Insulin human recombinant | Protafan® NM | suspension for subcutaneous administration 100 IU / ml 10 ml | RK-MP-5 №003883 |
373 | A10AC01 | Insulin human recombinant | Vosulin-N | suspension for subcutaneous administration 100 IU / ml 10 ml | RK-MP-5 №023715 |
374 | A10AC01 | Insulin human recombinant | Vosulin-N | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №023714 |
375 | A10AC01 | Insulin human recombinant | Vosulin-N | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №023713 |
376 | A10AC01 | Insulin human recombinant | Humodar® B 100R | suspension for injections 100 IU / ml 10 ml | RK-MP-5 №013135 |
377 | A10AC01 | Insulin human recombinant | Humulin® NPH | suspension for injections 100 IU / ml 3 ml | RK-MP-5 №018012 |
378 | A10AC01 | Insulin human recombinant | Humulin® NPH | suspension for subcutaneous administration 100 IU / ml 10 ml | RK-MP-5 №011398 |
379 | A10AC01 | Insulin human recombinant | Protafan® NM Penfill® | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №024414 |
380 | A10AC01 | Insulin human recombinant | Humodar® R 100R | Solution for injections, 10 ml | RK-MP-5 №013136 |
A10AD | Insulins for injections and their analogues of medium duration or long-acting in combination with short-acting insulins | ||||
A10AD01 | Insulin human recombinant | ||||
381 | A10AD01 | Insulin human recombinant | Humulin® M3 | suspension for injections 100 IU / ml 3ml in a cartridge | RK-MP-5 №018027 |
382 | A10AD01 | Insulin human recombinant | Mixstard® 30 NM | suspension for subcutaneous administration 100 IU / ml 10 ml | RK-MP-5 №003859 |
383 | A10AD01 | Insulin human recombinant | Mixtard® 30 NM Penfill® | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №019009 |
384 | A10AD01 | Insulin human recombinant | Vosulin-30/70 | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №023709 |
385 | A10AD01 | Insulin human recombinant | Vosulin-30/70 | suspension for subcutaneous administration 100 IU / ml 10 ml | RK-MP-5 №023708 |
386 | A10AD01 | Insulin human recombinant | Vosulin-30/70 | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №023707 |
387 | A10AD01 | Insulin human recombinant | Humulin® M3 | suspension for subcutaneous administration 100 IU / ml 10 ml | RK-MP-5 №011397 |
388 | A10AD01 | Insulin human recombinant | Mixtard® 30 NM Penfill® | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №024421 |
A10AD04 | Insulin lispro | ||||
389 | A10AD04 | Insulin lispro | Humalog® Mix 50 QuickPen ™ | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №021083 |
390 | A10AD04 | Insulin lispro | Humalog® Mix 25 QuickPen ™ | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №021084 |
391 | A10AD04 | Insulin lispro | Humalog® Mix 50 | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №012161 |
392 | A10AD04 | Insulin lispro | Humalog® Mix 50 | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №121947 |
393 | A10AD04 | Insulin lispro | Humalog® Mix 25 | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №019327 |
394 | A10AD04 | Insulin lispro | Humalog® Mix 25 | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №121957 |
A10AD05 | Insulin aspart | ||||
395 | A10AD05 | Insulin aspart | NovoMix® 30 FlexPen® | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №017570 |
396 | A10AD05 | Insulin aspart | NovoMix® 30 FlexPen® | suspension for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №024284 |
A10AE | Insulins and their long-acting analogues | ||||
A10AE04 | Insulin glargine | ||||
397 | A10AE04 | Insulin glargine | Tujeo SoloStar® | solution for injections 300 IU / ml 1.5 ml | RK-MP-5 №022125 |
398 | A10AE04 | Insulin glargine | Basaglar ™ | solution for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №122112 |
399 | A10AE04 | Insulin glargine | Basaglar QuickPen ™ | solution for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №122113 |
400 | A10AE04 | Insulin glargine | Lantus® SoloStar® | solution for injections 100 IU / ml 3 ml | RK-MP-5 №014303 |
401 | A10AE04 | Insulin glargine | Basalog | solution for subcutaneous injections 100 IU / ml 3 ml | RK-MP-5 №023994 |
402 | A10AE04 | Insulin glargine | Insulin Glargin | solution for subcutaneous injections 100 IU / ml 3 ml | RK-MP-5 №023932 |
A10AE05 | Insulin detemir | ||||
403 | A10AE05 | Insulin detemir | Levemir® Penfill® | solution for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №002177 |
404 | A10AE05 | Insulin detemir | Levemir® FlexPen® | solution for subcutaneous administration 100 IU / ml 3 ml in a syringe pen | RK-MP-5 №016810 |
405 | A10AE05 | Insulin detemir | Levemir® FlexPen® | solution for subcutaneous administration 100 IU / ml 3 ml | RK-MP-5 №024412 |
A10AE06 | Insulin degludec | ||||
406 | A10AE06 | Insulin degludec | Tresiba® Penfill® | solution for injections 100 IU / ml 3 ml | RK-MP-5 №020670 |
407 | A10AE06 | Insulin degludec | Tresiba® FlexTouch® | solution for injections 100 IU / ml 3 ml | RK-MP-5 №020668 |
A10B | Oral hypoglycemic drugs | ||||
A10BA | Biguanides | ||||
A10BA02 | Metformin | ||||
408 | A10BA02 | Metformin | Siofor® 500 | film-coated tablets 500 mg | RK-MP-5 №005158 |
409 | A10BA02 | Metformin | Glucophage® | film-coated tablets 500 mg | RK-MP-5 №020405 |
410 | A10BA02 | Metformin | Metfogamma® 500 | film-coated tablets 500 mg | RK-MP-5 №010666 |
411 | A10BA02 | Metformin | Metformin | tablets 500 mg | RK-MP-5 №121807 |
412 | A10BA02 | Metformin | Metsafe | tablets with prolonged release 500 mg | RK-MP-5 №021572 |
413 | A10BA02 | Metformin | Glucophage® | film-coated tablets 850 mg | RK-MP-5 №020406 |
414 | A10BA02 | Metformin | Metfogamma® 850 | film-coated tablets 850 mg | RK-MP-5 №018970 |
415 | A10BA02 | Metformin | Metformin | tablets 850 mg | RK-MP-5 №121806 |
416 | A10BA02 | Metformin | Siofor® 850 | film-coated tablets 850 mg | RK-MP-5 №005172 |
417 | A10BA02 | Metformin | Glucophage® | film-coated tablets 1000 mg | RK-MP-5 №020407 |
418 | A10BA02 | Metformin | Metfogamma®1000 | film-coated tablets 1000 mg | RK-MP-5 №010668 |
419 | A10BA02 | Metformin | Metformin | tablets 1000 mg | RK-MP-5 №121801 |
420 | A10BA02 | Metformin | Siofor® 1000 | film-coated tablets 1000 mg | RK-MP-5 №006274 |
421 | A10BA02 | Metformin | Metsafe | tablets with prolonged release 1000 mg | RK-MP-5 №021571 |
422 | A10BA02 | Metformin | Gluconil® | coated tablets 1000 mg | RK-MP-5 №011018 |
423 | A10BA02 | Metformin | Gluconil® | coated tablets 500 mg | RK-MP-5 №004155 |
424 | A10BA02 | Metformin | Metformin | coated tablets 500 mg | RK-MP-5 №020871 |
425 | A10BA02 | Metformin | Metformin | coated tablets 850 mg | RK-MP-5 №020872 |
426 | A10BA02 | Metformin | Metformin | coated tablets 1000 mg | RK-MP-5 №020873 |
427 | A10BA02 | Metformin | Glucophage® XR | tablets with prolonged release 500 mg | RK-MP-5 №014774 |
428 | A10BA02 | Metformin | Glucophage® | film-coated tablets 850 mg | RK-MP-5 №014845 |
429 | A10BA02 | Metformin | Glucophage® | coated tablets 1000 mg | RK-MP-5 №014846 |
430 | A10BA02 | Metformin | Glucophage® | film-coated tablets 500 mg | RK-MP-5 №014848 |
431 | A10BA02 | Metformin | Glucophage® XR | Tablets with prolonged release 750 mg | RK-MP-5 №021100 |
432 | A10BA02 | Metformin | Glucophage® XR | Tablets with prolonged release 100 mg | RK-MP-5 №021101 |
433 | A10BA02 | Metformin | Formetin® | tablets 0.5 g | RK-MP-5 №121819 |
434 | A10BA02 | Metformin | Gluconil® | coated tablets 850 mg | RK-MP-5 №007294 |
435 | A10BA02 | Metformin | Formetin® | tablets 850 mg | RK-MP-5 №121820 |
436 | A10BA02 | Metformin | Formetin® | tablets 1 g | RK-MP-5 №121821 |
437 | A10BA02 | Metformin | Metformin 1000 | tablets 1000 mg | RK-MP-5 №022858 |
438 | A10BA02 | Metformin | Apsaphage | tablets with prolonged release 500 mg | RK-MP-5 №022861 |
439 | A10BA02 | Metformin | Apsaphage | tablets with prolonged release 1000 mg | RK-MP-5 №022892 |
440 | A10BA02 | Metformin | Apsaphage | tablets with prolonged release 750 mg | RK-MP-5 №023876 |
441 | A10BA02 | Metformin | Insufor | film-coated tablets 500 mg | RK-MP-5 №023754 |
442 | A10BA02 | Metformin | Insufor | film-coated tablets 850 mg | RK-MP-5 №023755 |
443 | A10BA02 | Metformin | Insufor | film-coated tablets 1000 mg | RK-MP-5 №023756 |
444 | A10BA02 | Metformin | Diaformin® | film-coated tablets 1000 mg | RK-MP-5 №023817 |
445 | A10BA02 | Metformin | Apsaphage | tablets with prolonged release 750 mg | RK-MP-5 №023910 |
A10BB | Sulfonylurea derivatives | ||||
A10BB01 | Glibenclamide | ||||
446 | A10BB01 | Glibenclamide | Maninil® 3.5 | tablets 3,5 mg | RK-MP-5 №013487 |
447 | A10BB01 | Glibenclamide | Maninil® 5 | tablets 5 mg | RK-MP-5 №014563 |
A10BB09 | Gliclazide | ||||
448 | A10BB09 | Gliclazide | Glyclada® CP | tablets with modified release60 mg | RK-MP-5 №020187 |
449 | A10BB09 | Gliclazide | Diaglizide® MR | tablets with prolonged release 60 mg | RK-MP-5 №122156 |
450 | A10BB09 | Gliclazide | Gliclazide МВ | tablets with modified release60 mg | RK-MP-5 №022972 |
451 | A10BB09 | Gliclazide | GliDia®MB | tablets with modified release60 mg | RK-MP-5 №023163 |
452 | A10BB09 | Gliclazide | Gliclazide | tablets 80 mg | RK-MP-5 №016493 |
453 | A10BB09 | Gliclazide | Tablet mass GliDia MV | tablets with modified release30 mg | RK-MP-5 №018149 |
454 | A10BB09 | Gliclazide | Gliclazide | tablets with prolonged release30 mg | RK-MP-5 №021416 |
455 | A10BB09 | Gliclazide | Glyclada® | tablets with modified release 30 mg | RK-MP-5 №016085 |
456 | A10BB09 | Gliclazide | Diabeton® MR | tablets with modified release 30 mg | RK-MP-5 №003588 |
457 | A10BB09 | Gliclazide | Glidiab | tablets 80 mg | RK-MP-5 №018768 |
458 | A10BB09 | Gliclazide | Glidiab MB | tablets with modified release 30 mg | RK-MP-5 №018662 |
459 | A10BB09 | Gliclazide | Diaglizide® MR | tablets with prolonged release 30 mg | RK-MP-5 №020294 |
460 | A10BB09 | Gliclazide | Diabeton® MR | tablets with prolonged release 60 mg | RK-MP-5 №023209 |
461 | A10BB09 | Gliclazide | Gliclazide МВ | tablets with modified release 30 mg | RK-MP-5 №022970 |
462 | A10BB09 | Gliclazide | Diabeton® MR | tablets with modified release 60 mg | RK-MP-5 №018105 |
463 | A10BB09 | Gliclazide | Diabeton® MR | tablets with modified release 60 mg | RK-MP-5 №023209 |
A10BB12 | Glimepiride | ||||
464 | A10BB12 | Glimepiride | Glybetic | tablets 1 mg | RK-MP-5 №005821 |
465 | A10BB12 | Glimepiride | Gepirid® 1 | tablets 1 mg | RK-MP-3 №020410 |
466 | A10BB12 | Glimepiride | Glimegamma | tablets 2 mg | RK-MP-5 №017096 |
467 | A10BB12 | Glimepiride | Glybetic | tablets 2 mg | RK-MP-5 №005837 |
468 | A10BB12 | Glimepiride | Gepirid® 2 | tablets 2 mg | RK-MP-3 №020415 |
469 | A10BB12 | Glimepiride | Amaryl® | tablets 2 mg | RK-MP-5 №014450 |
470 | A10BB12 | Glimepiride | Glimegamma | tablets 3 mg | RK-MP-5 №017097 |
471 | A10BB12 | Glimepiride | Glybetic | tablets 3 mg | RK-MP-5 №005838 |
472 | A10BB12 | Glimepiride | Gepirid® 3 | tablets 3mg | RK-MP-3 №020411 |
473 | A10BB12 | Glimepiride | Amaryl® | tablets 3 mg | RK-MP-5 №014451 |
474 | A10BB12 | Glimepiride | Glybetic | tablets 4 mg | RK-MP-5 №005839 |
475 | A10BB12 | Glimepiride | Amaryl® | tablets 4 mg | RK-MP-5 №011904 |
476 | A10BB12 | Glimepiride | Gepirid® 4 | tablets 4 mg | RK-MP-3 №020412 |
477 | A10BB12 | Glimepiride | Gepirid® 6 | tablets 6 mg | RK-MP-3 №020414 |
478 | A10BB12 | Glimepiride | Glorion | tablets 2 mg | RK-MP-5 №016690 |
479 | A10BB12 | Glimepiride | Glorion | tablets 3 mg | RK-MP-5 №016691 |
480 | A10BB12 | Glimepiride | Glorion | tablets 1 mg | RK-MP-5 №016689 |
481 | A10BB12 | Glimepiride | Glorion | tablets 4 mg | RK-MP-5 №016692 |
482 | A10BB12 | Glimepiride | Antaris® | tablets 6 mg | RK-MP-5 №016775 |
483 | A10BB12 | Glimepiride | Getril | tablets 4 mg | RK-MP-5 №013938 |
484 | A10BB12 | Glimepiride | Antaris® | tablets 4 mg | RK-MP-5 №011051 |
485 | A10BB12 | Glimepiride | Diapirid | tablets 4 mg | RK-MP-5 №020336 |
486 | A10BB12 | Glimepiride | Getril | tablets 3 mg | RK-MP-5 №013936 |
487 | A10BB12 | Glimepiride | Antaris® | tablets 3 mg | RK-MP-5 №011050 |
488 | A10BB12 | Glimepiride | Diapirid | tablets 3 mg | RK-MP-5 №020335 |
489 | A10BB12 | Glimepiride | Getril | tablets 2 mg | RK-MP-5 №013937 |
490 | A10BB12 | Glimepiride | Diapirid | tablets 2 mg | RK-MP-5 №020334 |
491 | A10BB12 | Glimepiride | Antaris® | tablets 2 mg | RK-MP-5 №015565 |
492 | A10BB12 | Glimepiride | Getril | tablets 1 mg | RK-MP-5 №013935 |
493 | A10BB12 | Glimepiride | Antaris® | tablets 1 mg | RK-MP-5 №011049 |
494 | A10BB12 | Glimepiride | Glimerid® | tablets 1 mg | RK-MP-5 №018277 |
495 | A10BB12 | Glimepiride | Glimerid® | tablets 2 mg | RK-MP-5 №018278 |
496 | A10BB12 | Glimepiride | Glimerid® | tablets 3 mg | RK-MP-5 №018279 |
497 | A10BB12 | Glimepiride | Glimerid® | tablets 4 mg | RK-MP-5 №018280 |
498 | A10BB12 | Glimepiride | Ilet | tablets 1 mg | RK-MP-5 №021333 |
499 | A10BB12 | Glimepiride | Ilet | tablets 2 mg | RK-MP-5 №021334 |
500 | A10BB12 | Glimepiride | Glisen 2 | tablets 2 mg | RK-MP-5 №021636 |
501 | A10BB12 | Glimepiride | Glimegamma | tablets 4 mg | RK-MP-5 №017098 |
502 | A10BB12 | Glimepiride | Glimegamma | tablets 6 mg | RK-MP-5 №017099 |
503 | A10BB12 | Glimepiride | GEPIRID® 5 | tablets 5 mg | RK-MP-3 №020413 |
504 | A10BB12 | Glimepiride | Insuprid | tablets 1 mg | RK-MP-5 №023308 |
505 | A10BB12 | Glimepiride | Insuprid | tablets 2 mg | RK-MP-5 №023309 |
506 | A10BB12 | Glimepiride | Insuprid | tablets 3 mg | RK-MP-5 №023310 |
507 | A10BB12 | Glimepiride | Insuprid | tablets 4 mg | RK-MP-5 №023311 |
508 | A10BB12 | Glimepiride | Oltar®2 | tablets 2 mg | RK-MP-5 №020535 |
509 | A10BB12 | Glimepiride | Oltar® 3 | tablets 3 mg | RK-MP-5 №020536 |
510 | A10BB12 | Glimepiride | Oltar®4 | tablets 4 mg | RK-MP-5 №020537 |
511 | A10BB12 | Glimepiride | Oltar® 6 | tablets 6 mg | RK-MP-5 №020538 |
A10BD | Combination of biguanides and sulfonylurea derivatives | ||||
A10BD02 | Metformin and sulfonylurea derivatives | ||||
512 | A10BD02 | Metformin and sulfonylurea derivatives | Amaryl® M SR | film-coated tablets of prolonged action 2 mg/500 mg | RK-MP-5 №018478 |
513 | A10BD02 | Metformin and sulfonylurea derivatives | Amaryl® M | film-coated tablets 2 mg/500 mg | RK-MP-5 №013451 |
514 | A10BD02 | Metformin and sulfonylurea derivatives | Glucovans® | film-coated tablets 500 mg/5 mg | RK-MP-5 №018919 |
515 | A10BD02 | Metformin and sulfonylurea derivatives | Antaris M | coated tablets 2 mg/500 mg | RK-MP-5 №015561 |
516 | A10BD02 | Metformin и and sulfonylurea derivatives | Glucoron® | coated tablets 500 mg /5 mg | RK-MP-3 №022420 |
517 | A10BD02 | Metformin and sulfonylurea derivatives | Glucoron® | coated tablets 500mg/2,5 mg | RK-MP-3 №022419 |
518 | A10BD02 | Metformin and sulfonylurea derivatives | Glucoron® | film-coated tablets 500 mg/2,5 mg | RK-MP-5 №018918 |
519 | A10BD02 | Metformin and sulfonylurea derivatives | Bi-Act | film-coated tablets 500 mg/5 mg | RK-MP-5 №024022 |
520 | A10BD02 | Metformin and sulfonylurea derivatives | Bi-Act | film-coated tablets 500 mg/2,5 mg | RK-MP-5 №024023 |
A10BD07 | Metformin and Sitagliptin | ||||
521 | A10BD07 | Metformin and Sitagliptin | Janumet | film-coated tablets , 50 mg/500 mg | RK-MP-5 №020120 |
522 | A10BD07 | Metformin and Sitagliptin | Janumet | film-coated tablets 50 mg/850 mg | RK-MP-5 №020121 |
523 | A10BD07 | Metformin and Sitagliptin | Janumet | film-coated tablets 50 mg/1000 mg | RK-MP-5 №020122 |
524 | A10BD07 | Metformin and Sitagliptin | Janumet | film-coated tablets 50/500 mg | RK-MP-5 №022169 |
525 | A10BD07 | Metformin and Sitagliptin | Janumet | film-coated tablets 50/850 mg | RK-MP-5 №022170 |
526 | A10BD07 | Metformin and Sitagliptin | Janumet | film-coated tablets 50/1000 mg | RK-MP-5 №022171 |
A10BD08 | Metformin and Vildagliptin | ||||
527 | A10BD08 | Metformin and Vildagliptin | Galvusmet® | film-coated tablets 50 mg/850 mg | RK-MP-5 №019363 |
528 | A10BD08 | Metformin and Vildagliptin | Galvusmet® | film-coated tablets 50 mg/1000 mg | RK-MP-5 №021444 |
A10BD11 | Metformin and Linagliptin | ||||
529 | A10BD11 | Metformin and Linagliptin | Jentadueto® | film- coated tablets 2,5mg/1000mg | RK-MP-5 №019900 |
530 | A10BD11 | Metformin and Linagliptin | Jentadueto® | film-coated tablets 2,5mg/850mg | RK-MP-5 №019899 |
A10BD15 | Metformin and dapagliflozin | ||||
531 | A10BD15 | Metformin and dapagliflozin | Xigduo ™ XR | film-coated tablets with prolonged release, 5mg/1000mg | RK-MP-5 №023814 |
532 | A10BD15 | Metformin and dapagliflozin | Xigduo ™ XR | film-coated tablets with prolonged release, 10mg/1000mg | RK-MP-5 №023816 |
533 | A10BD15 | Metformin and dapagliflozin | Xigduo ™ XR | film-coated tablets with prolonged release, 10mg/1000mg | RK-MP-5 №023815 |
A10BD16 |
Metformin | ||||
534 | A10BD16 |
Metformin | Vokanamet® | film-coated tablets, 50mg/1000mg | RK-MP-5 №021628 |
А10ВD20 | Metformin and Empagliflozin | ||||
535 | А10ВD20 | Metformin and Empagliflozin | Sinjardi® | film-coated tablets, 5 mg/850 mg | RK-MP-5 №022592 |
536 | А10ВD20 | Metformin and Empagliflozin | Sinjardi® | film-coated tablets, 12,5 mg/1000 mg | RK-MP-5 №022595 |
537 | А10ВD20 | Metformin and Empagliflozin | Sinjardi® | film-coated tablets, 12,5 mg/850 mg | RK-MP-5 №022594 |
538 | А10ВD20 | Metformin and Empagliflozin | Sinjardi® | film-coated tablets, 5 mg/1000 mg | RK-MP-5 №022593 |
A10BF | Alpha glucosidase inhibitors | ||||
A10BF01 | Acarbose | ||||
539 | A10BF01 | Acarbose | Glucobay | tablets 100 mg | RK-MP-5 №019255 |
540 | A10BF01 | Acarbose | Glucobay | tablets 50 mg | RK-MP-5 №019254 |
A10BG | Thiazolidinediones | ||||
A10BG03 | Pioglitazone | ||||
541 | A10BG03 | Pioglitazone | Zolid | tablets 15 mg | RK-MP-5 №014175 |
542 | A10BG03 | Pioglitazone | Zolid | tablets 30 mg | RK-MP-5 №014174 |
A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors | ||||
A10BH01 | Sitagliptin | ||||
543 | A10BH01 | Sitagliptin | Januvia | film-coated tablets, 25 mg | RK-MP-5 №021350 |
544 | A10BH01 | Sitagliptin | Januvia | film-coated tablets, 50 mg | RK-MP-5 №021351 |
545 | A10BH01 | Sitagliptin | Januvia | tablets 100 mg | RK-MP-5 №021352 |
A10BH02 | Vildagliptin | ||||
546 | A10BH02 | Vildagliptin | Galvus® | tablets, 50 mg | RK-MP-5 №021485 |
A10BH03 | Saxagliptin | ||||
A10BH04 | Alogliptin | ||||
547 | A10BH04 | Alogliptin | Vipidia ™ | film-coated tablets, 12,5 mg | RK-MP-5 №021176 |
548 | A10BH04 | Alogliptin | Vipidiya ™ | film-coated tablets, 25 mg | RK-MP-5 №021177 |
A10BH05 | Linagliptin | ||||
549 | A10BH05 | Linagliptin | TRAZHENTA® | film-coated tablets, 5 mg | RK-MP-5 №018822 |
A10BJ | Analogues of glucagon-like peptide -1 (glp-1) | ||||
A10BJ01 | Exenatid | ||||
550 | A10BJ01 | Exenatid | Baidureon ™ | powder for preparation of suspension for subcutaneous administration of prolonged action complete with solvent 2 mg / 0.65 ml | RK-MP-5 №023957 |
A10BJ02 | Liraglutide | ||||
551 | A10BJ02 | Liraglutide | Victoza® | solution for subcutaneous administration 6 mg / ml, 3 ml | RK-MP-5 №017120 |
A10BJ03 | Lixisenatide | ||||
552 | A10BJ03 | Lixisenatide | Lyxumia | solution for injections 0.05 mg / ml 3 ml | RK-MP-5 №021250 |
553 | A10BJ03 | Lixisenatide | Lyxumia | solution for injections 0.1 mg / ml 3 ml | RK-MP-5 №021249 |
A10BJ05 | Dulaglutide | ||||
554 | A10BJ05 | Dulaglutide | Trulicity ™ | solution for subcutaneous administration 0.75 mg / 0.5 ml | RK-MP-5 №022156 |
555 | A10BJ05 | Dulaglutide | Trulicity ™ | solution for subcutaneous administration 1.5 mg / 0.5 ml | RK-MP-5 №022157 |
A10BK | Sodium glucose co-inhibitor 2 (sglt2) | ||||
A10BK01 | Dapagliflozin | ||||
556 | A10BK01 | Dapagliflozin | Forsiga ™ | film-coated tablets, 10 mg | RK-MP-5 №023472 |
557 | A10BK01 | Dapagliflozin | Forsiga ™ | film-coated tablets, 5 mg | RK-MP-5 №023471 |
A10BK02 | Canagliflozin | ||||
558 | A10BK02 | Canagliflozin | Invokana® | film-coated tablets, 100 mg | RK-MP-5 №021311 |
559 | A10BK02 | Canagliflozin | Invokana® | film-coated tablets, 300 mg | RK-MP-5 №021310 |
A10BK03 | Empagliflozin | ||||
560 | A10BK03 | Empagliflozin | Jardins® | film-coated tablets, 10 mg | RK-MP-5 №121764 |
561 | A10BK03 | Empagliflozin | Jardins® | film-coated tablets, 25 mg | RK-MP-5 №121765 |
A10BX | Other hypoglycemic drugs | ||||
A10BX02 | Repaglinide | ||||
562 | A10BX02 | Repaglinide | Repaglid® | tablets 2 mg | RK-MP-5 №018189 |
563 | A10BX02 | Repaglinide | Repaglid® | tablets 1 mg | RK-MP-5 №018188 |
564 | A10BX02 | Repaglinide | Repaglid® | tablets 0,5 mg | RK-MP-5 №018190 |
565 | A10BX02 | Repaglinide | Insvada | tablets 1 mg | RK-MP-5 №023223 |
A11 |
Vitamins | ||||
A11C | Vitamins A and D and their combinations | ||||
A11CA01 | Retinol | ||||
566 | A11CA01 | Retinol | Retinol acetate (vitamin A) 33,000 IU | capsules 33000 IU | RK-MP-5 №012368 |
A11CC | Vitamin D and its derivatives | ||||
A11CC01 | Ergocalciferol | ||||
567 | A11CC01 | Ergocalciferol | Ergocalciferol (vitamin D 2) | oral oily solution 0.125% 10 ml | RK-MP-5 №020293 |
A11CC02 | Dihydrotachysterol | ||||
A11CC03 | Alfacalcidol | ||||
568 | A11CC03 | Alfacalcidol | ALPHA D3 | capsules 0.25 mcg | RK-MP-5 №013326 |
569 | A11CC03 | Alfacalcidol | ALPHA D3 | capsules 0.5 mcg | RK-MP-5 №013328 |
570 | A11CC03 | Alfacalcidol | ALPHA D3 | capsules 1 mcg | RK-MP-5 №013329 |
A11CC05 | Colecalciferol | ||||
571 | A11CC05 | Colecalciferol | Vigantol® | oral solution oily 0.5mg / ml 10ml | RK-MP-5 №020955 |
572 | A11CC05 | Colecalciferol | D3-Droplet | oral drops 4000 IU / ml 10 ml | RK-MP-5 №021181 |
573 | A11CC05 | Colecalciferol | Vidrop | oral drops, 2800 IU / ml, 15 ml | RK-MP-5 №023110 |
574 | A11CC05 | Colecalciferol | Aquadetrim vitamin D3 | oral drops 15000 IU / ml 10 ml | RK-MP-5 №015670 |
575 | A11CC05 | Colecalciferol | Koledan | oral drops 15000 IU / ml 10 ml | RK-MP-5 №024055 |
576 | A11CC05 | Colecalciferol | Deavit® Neo | oral drops 0.5 mg / ml 10 ml | RK-MP-5 №024204 |
577 | A11CC05 | Colecalciferol | Devit 50,000 | Film-coated tablets, 50000 IU | RK-MP-5 №023446 |
578 | A11CC05 | Colecalciferol | DETRIFORS® 1000 | Capsules 1000 IU | RK-MP-5 №121753 |
A11D | Vitamin B1 and its combination with vitamins B6 and B12 | ||||
A11DA | Vitamin B1 | ||||
A11DA01 | Thiamine | ||||
579 | A11DA01 | Thiamine | Thiamine chloride-Darnitsa (Vitamin B1 - Darnitsa) | solution for injections 5% 1ml | RK-MP-5 №008761 |
580 | A11DA01 | Thiamine | Thiamine hydrochloride (Vitamin B1) | solution for injections 5% 1ml | RK-MP-5 №014645 |
581 | A11DA01 | Thiamine | Thiamine hydrochloride |
solution for injections 50 mg/ml 1ml | RK-MP-5 №015490 |
582 | A11DA01 | Thiamine | Thiamine | solution for intramuscular injection 50 mg / ml 1 ml | RK-MP-5 №019658 |
A11G | Ascorbic acid (including combinations with other drugs) | ||||
A11GA01 | Ascorbic acid | ||||
583 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for injections 50 mg/ml 1ml | RK-MP-5 №012925 |
584 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for injections 50 mg/ml 2ml | RK-MP-5 №012925 |
585 | A11GA01 | Ascorbic acid | Cevikap | oral drops 100 mg / ml 10 ml | RK-MP-5 №004333 |
586 | A11GA01 | Ascorbic acid | Cevikap | oral drops 100 mg / ml 30 ml | RK-MP-5 №004333 |
587 | A11GA01 | Ascorbic acid | Ascorbic acid (Vitamin C) | solution for injections 5%, 2 ml | RK-MP-5 №010541 |
588 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for injections, 50 mg / ml 2 ml | RK-MP-5 №022479 |
589 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for intravenous and intramuscular injections 50mg / ml 2 ml | RK-MP-5 №022472 |
590 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for intravenous and intramuscular administration 5% 2 ml | RK-MP-5 №010027 |
591 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for injections 100 mg / ml 2ml | RK-MP-5 №022480 |
592 | A11GA01 | Ascorbic acid | Ascorbic acid | solution for intravenous and intramuscular administration 50 mg / ml 2 ml | RK-MP-5 №005323 |
593 | A11GA01 | Ascorbic acid | Vitamin C 500 Viva Farm | Tablets chewable 500 mg | RK-MP-5 №018434 |
594 | A11GA01 | Ascorbic acid | Ascorbic acid | Dragee 50 mg | RK-MP-5 №018616 |
595 | A11GA01 | Ascorbic acid | Ascorbic acid | Tablets 25 mg | RK-MP-5 №018334 |
596 | A11GA01 | Ascorbic acid | Ascorbic acid with sugar | Tablets 0.025 г | RK-MP-5 №017421 |
A11H | Other vitamins | ||||
A11HA02 | Pyridoxine | ||||
597 | A11HA02 | Pyridoxine | Pyridoxine hydrochloride | solution for injections 50mg / ml, 1ml | RK-MP-5 №014782 |
598 | A11HA02 | Pyridoxine | Pyridoxine - Darnitsa (Vitamin B6 - Darnitsa) | solution for injections 5%, 1 ml | RK-MP-5 №008636 |
599 | A11HA02 | Pyridoxine | Pyridoxine Hydrochloride (Vitamin B6) | solution for injections 5%, 1 ml | RK-MP-5 №014278 |
A11HA03 | Tocopherol | ||||
600 | A11HA03 | Tocopherol | a-tocopherol acetate (Vitamin E) | capsules 100 IU | RK-MP-5 №012226 |
601 | A11HA03 | Tocopherol | Vitamin E Sanofi | capsules 200 mg | RK-MP-5 №011328 |
602 | A11HA03 | Tocopherol | Vitamin E Sanofi | capsules 400 mg | RK-MP-5 №011329 |
603 | A11HA03 | Tocopherol | Vitamin E | capsules 200 mg | RK-MP-5 №019206 |
604 | A11HA03 | Tocopherol | Vitamin E | capsules 400 mg | RK-MP-5 №019207 |
605 | A11HA03 | Tocopherol | NAT-E 400 ™ | capsules 400 IU | RK-MP-5 №012846 |
606 | A11HA03 | Tocopherol | Vitrum® Vitamin E | capsules 400 IU | RK-MP-5 №015086 |
A12 | Mineral supplements | ||||
A12A | Calcium preparations | ||||
A12AA03 | Calcium gluconate | ||||
607 | A12AA03 | Calcium gluconate | Calcium gluconate stabilized | solution for injections 100 mg / ml, 10 ml | RK-MP-5 №010253 |
608 | A12AA03 | Calcium gluconate | Calcium gluconate stabilized | solution for injections 100 mg / ml, 5 ml | RK-MP-5 №010252 |
609 | A12AA03 | Calcium gluconate | Calcium gluconate | tablets 500 mg | RK-MP-5 №016315 |
610 | A12AA03 | Calcium gluconate | Calcium gluconate | tablets 500 mg | RK-MP-5 №011972 |
611 | A12AA03 | Calcium gluconate | Calcium gluconate | tablets 500 mg | RK-MP-5 №020953 |
612 | A12AA03 | Calcium gluconate | Calcium gluconate- Darnitsa (stabilized) | solution for injections 100 mg / ml, 5 ml | RK-MP-5 №000827 |
A12AX | Calcium carbonate and Colecalciferol | ||||
A14 | Anabolic drugs for systemic use | ||||
A14A | Anabolic steroid drugs | ||||
A14AB | Estrene derivatives | ||||
A14AB01 | Nandrolone | ||||
613 | A14AB01 | Nandrolone | Retabolil | oil solution for injections 50 mg / ml 1 ml | RK-MP-5 №014516 |
A16 | Other drugs for the treatment of diseases of the gastrointestinal tract and metabolic disorders | ||||
A16AA | Amino acids and their derivatives | ||||
A16AA01 | Levocarnitine | ||||
614 | A16AA01 | Levocarnitine | Inestom | oral solution 1 g / 10 ml 10 ml | RK-MP-5 №018078 |
615 | A16AA01 | Levocarnitine | Karnilev | solution for injections 200 mg/ml 5 ml | RK-MP-5 №121708 |
616 | A16AA01 | Levocarnitine | Cartan® | solution for injections 1 g / 5ml | RK-MP-5 №004457 |
617 | A16AA01 | Levocarnitine | Karnilev | oral solution 100 mg / 1 ml 10 ml | RK-MP-5 №121823 |
618 | A16AA01 | Levocarnitine | Metacartin | oral solution, 2 g / 10 ml, 10 ml | RK-MP-5 №023481 |
619 | A16AA01 | Levocarnitine | Cartan | oral solution 1 g / 10 ml | RK-MP-5 №004400 |
620 | A16AA01 | Levocarnitine | Metacartin | solution for injections 1 g / 5 ml | RK-MP-5 №022362 |
621 | A16AA01 | Levocarnitine | Carnitene | solution for intravenous administration, 1 g / 10 ml | RK-MP-5 №020996 |
622 | A16AA01 | Levocarnitine | Karnovis | solution for injections 1000 mg / 5 ml | RK-MP-5 №021431 |
623 | A16AA01 | Levocarnitine | Metacartin | oral solution, 1 g / 10 ml, 10 ml | RK-MP-5 №023480 |
624 | A16AA01 | Levocarnitine |
Inestom | oral solution, 1 g / 5 ml | RK-MP-5 №018079 |
625 | A16AA01 | Levocarnitine |
Almiba | solution for injections 1 g / 5 ml | RK-MP-5 №022315 |
626 | A16AA01 | Levocarnitine | Elkar | oral solution 300 mg / ml 100 ml | RK-MP-5 №020902 |
627 | A16AA01 | Levocarnitine | Almiba | oral solution 1 g / 10 ml | RK-MP-5 №023420 |
A16AB | Enzyme preparations | ||||
A16AB02 | Imiglucerase | orphan | |||
628 | A16AB02 | Imiglucerase | Cerezyme ™ | lyophilisate for preparation of solution for infusions 400 IU | RK-MP-5 №016678 |
629 | A16AB02 | Imiglucerase | Abcertine | lyophilisate for preparation of solution for infusions 400 IU | RK-MP-5 №023249 |
630 | A16AB02 | Imiglucerase | Abcertine | lyophilisate for preparation of solution for infusions 200 IU | RK-MP-5 №023248 |
A16AB03 | Agalzidase alpha | orphan | |||
631 | A16AB03 | Agalzidase alpha | Replagal | 3,5 ml concentrate for preparation of solution for infusions, 1 mg / ml, 3.5 ml | RK-MP-5 №023493 |
A16AB04 | Agalzidase beta | orphan | |||
632 | A16AB04 | Agalzidase beta | Fabrasim | lyophilisate for preparation of concentrate for preparation of solution for infusions, 35 mg in a glass vial | RK-MP-5 №016681 |
633 | A16AB04 | Agalzidase beta | Fabrasim ® | lyophilisate for preparation of concentrate for preparation of solution for infusions, 5 mg | RK-MP-5 №016680 |
A16AB05 | Laronidase | orphan | |||
634 | A16AB05 | Laronidase | Aldurazim® | concentrate for preparation of solution for infusions 100 IU / ml, 5 ml | RK-MP-5 №016685 |
A16AB07 | Alglucosidase | orphan | |||
635 | A16AB07 | Alglucosidase | Mayozyme | powder for preparation of concentrate for preparation of solution for infusions 50 mg | orphan |
A16AB08 | Halsulfase | orphan | |||
636 | A16AB08 | Halsulfase | Naglazim | concentrate for preparation of solution for infusions 1 mg / ml, 5 ml | RK-MP-5 №020729 |
A16AB09 | Idursulfase | orphan | |||
637 | A16AB09 | Idursulfase | Elapraza | concentrate for preparation of solution for infusions 2 mg / ml 3 ml | RK-MP-5 №022911 |
A16AB10 | Velaglucerase alfa | orphan | |||
638 | A16AB10 | Velaglucerase alfa | VPRIV | lyophilisate for preparation of solution for infusions, 400 IU | RK-MP-5 №024128 |
A16AB12 | Elosulfase alpha | orphan | |||
639 | A16AB12 | Elosulfase alpha | Vimizim | concentrate for preparation of solution for infusions 1 mg / ml 5 ml | RK-MP-5 №024088 |
640 | A16AB12 | Elosulfase alpha | Vimizim | concentrate for preparation of solution for infusions 5 mg / 5 ml | orphan |
A16AB16 | Idursulfase beta | ||||
641 | A16AB16 | Idursulfase beta | Hunterase | concentrate for preparation of solution for infusions 2 mg / 3 ml | RK-MP-5 №023725 |
A16AX04 | Nithizinone | orphan | |||
642 | A16AX04 | Nithizinone | Tisinone® | capsules 5 mg | RK-MP-5 №024354 |
643 | A16AX04 | Nithizinone | Tisinone® | capsules 10 mg | RK-MP-5 №024355 |
A16AX07 | Sapropterin | orphan | |||
644 | A16AX07 | Sapropterin | Kuvan | tablets soluble 100 mg | RK-MP-5 №019261 |
B | Hematopoiesis and blood | ||||
B01 | Anticoagulants | ||||
B01AA | Vitamin K antagonists | ||||
B01AA03 | Warfarin | ||||
645 | B01AA03 | Warfarin | Warfarin Nycomed | tablets 2,5 mg | RK-MP-5 №018721 |
646 | B01AA03 | Warfarin | Warfarex® | tablets 5 mg | RK-MP-5 №010198 |
647 | B01AA03 | Warfarin | Warfarex® | tablets 3 mg | RK-MP-5 №010197 |
648 | B01AA03 | Warfarin | Warfarin | tablets 2,5 mg | RK-MP-5 №023563 |
B01AB | Heparin and its derivatives | ||||
B01AB01 | Heparin sodium | ||||
649 | B01AB01 | Heparin sodium | Heparin | solution for injections 5000 IU / ml 5 ml | RK-MP-5 №016565 |
650 | B01AB01 | Heparin sodium | Heparin | solution for injections 5000 IU / ml 10 ml | RK-MP-5 №016565 |
651 | B01AB01 | Heparin sodium | Hepasan® | solution for injections 5000 IU / ml 5 ml | RK-MP-3 №021501 |
652 | B01AB01 | Heparin sodium | Heparin | solution for injections 1000 IU / ml 5 ml | RK-MP-5 №121903 |
653 | B01AB01 | Heparin sodium | Heparin | solution for injections 5000 IU / ml 5 ml | RK-MP-5 №121904 |
654 | B01AB01 | Heparin sodium | HEPARIN - INDAR | solution for injections 5000 IU / ml 5 ml | RK-MP-5 №121907 |
655 | B01AB01 | Heparin sodium | HEPARIN | solution for injections 5000 IU / ml 5 ml | RK-MP-5 №003295 |
B01AB05 | Enoxaparin sodium | ||||
656 | B01AB05 | Enoxaparin sodium | Clexane® | solution for injections in syringes 8000 anti-Xa IU / 0.8 ml | RK-MP-5 №012230 |
657 | B01AB05 | Enoxaparin sodium | Clexane® | ml solution for injections in syringes 6000 anti-Xa IU / 0.6 ml | RK-MP-5 №012229 |
658 | B01AB05 | Enoxaparin sodium | Catenox | solution for injections 4000 anti-Xa IU / 0.4 ml, 0.4 ml in a syringe | RK-MP-5 №021376 |
659 | B01AB05 | Enoxaparin sodium | Clexane® | solution for injections in syringes 4000 anti-Xa IU / 0.4 ml | RK-MP-5 №012228 |
660 | B01AB05 | Enoxaparin sodium | Catenox | solution for injections 2000 anti-Xa IU / 0.2 ml | RK-MP-5 №021375 |
B01AB06 | Nadroparin calcium | ||||
661 | B01AB06 | Nadroparin calcium | Fraxiparine | solution for injections 3800 IU anti-Xa / 0.4ml | RK-MP-5 №004639 |
662 | B01AB06 | Nadroparin calcium | Fraxiparine | solution for injections, 7600 IU anti-Xa/0,8 ml | RK-MP-5 №013682 |
663 | B01AB06 | Nadroparin calcium | Fraxiparine | solution for injections 5700 IU anti-Xa / 0.6ml | RK-MP-5 №013681 |
664 | B01AB06 | Nadroparin calcium | Fraxiparine | solution for injections 2850ME anti-Xa / 0.3ml | RK-MP-5 №013680 |
B01AB11 | Sulodexide | ||||
665 | B01AB11 | Sulodexide | Vessel Due F | capsules 250 LU | RK-MP-5 №003681 |
666 | B01AB11 | Sulodexide | Vessel Due F | solution for injections 600 LU / 2 ml | RK-MP-5 №003682 |
B01AC | Platelet aggregation inhibitors (excluding heparin) | ||||
B01AC04 | Clopidogrel | ||||
667 | B01AC04 | Clopidogrel | Grelid | coated tablets 300 mg | RK-MP-3 №020158 |
668 | B01AC04 | Clopidogrel | Grelid | coated tablets 75 mg | RK-MP-3 №020159 |
669 | B01AC04 | Clopidogrel | Doglix | film-coated tablets 75 mg | RK-MP-5 №021194 |
670 | B01AC04 | Clopidogrel | Karum-sanovel | coated tablets 75 mg | RK-MP-5 №015673 |
671 | B01AC04 | Clopidogrel | Clopidogrel | film-coated tablets 75 mg | RK-MP-5 №021324 |
672 | B01AC04 | Clopidogrel | Klopisan® | coated tablets 75 mg | RK-MP-5 №013881 |
673 | B01AC04 | Clopidogrel | Lodigrel® | coated tablets 75 mg | RK-MP-5 №016881 |
674 | B01AC04 | Clopidogrel | Oneclaps 75 | film-coated tablets 75 mg | RK-MP-5 №121871 |
675 | B01AC04 | Clopidogrel | Plavix® | coated tablets 75 mg | RK-MP-5 №011057 |
676 | B01AC04 | Clopidogrel | Plagril | film-coated tablets 75 mg | RK-MP-5 №017974 |
677 | B01AC04 | Clopidogrel | CLOVIX 300 | film-coated tablets 300 mg | RK-MP-5 №018917 |
678 | B01AC04 | Clopidogrel | Pinogal | film-coated tablets 75 mg | RK-MP-5 №021380 |
679 | B01AC04 | Clopidogrel | CLOVIX 75 | film-coated tablets 75 mg | RK-MP-5 №018916 |
680 | B01AC04 | Clopidogrel | Quorex® | coated tablets 75 mg | RK-MP-5 №018891 |
681 | B01AC04 | Clopidogrel | Instaclop 75 | film-coated tablets 75 mg | RK-MP-5 №121875 |
682 | B01AC04 | Clopidogrel |
Tromborel | film-coated tablets 75 mg | RK-MP-5 №019270 |
683 | B01AC04 | Clopidogrel |
Lopigrol | Film-coated tablets 75 mg | RK-MP-5 №023162 |
684 | B01AC04 | Clopidogrel | Zyllt® | film-coated tablets 75 mg | RK-MP-5 №014750 |
685 | B01AC04 | Clopidogrel | Clopeno | film-coated tablets 75 mg | RK-MP-5 №020915 |
686 | B01AC04 | Clopidogrel | Tsipla klopivas | film-coated tablets 75 mg | RK-MP-5 №122121 |
687 | B01AC04 | Clopidogrel | Clopidogrel-Teva | film-coated tablets 75 mg | RK-MP-5 №121730 |
688 | B01AC04 | Clopidogrel | Klopatsin | film-coated tablets 75 mg | RK-MP-5 №122020 |
689 | B01AC04 | Clopidogrel | Clopidogrel - Teva | coated tablets 75 mg | RK-MP-5 №017653 |
690 | B01AC04 | Clopidogrel | Linkur | film-coated tablets 75 mg | RK-MP-5 №018412 |
691 | B01AC04 | Clopidogrel | CLOPI-75 | film-coated tablets 75 mg | RK-MP-5 №022790 |
692 | B01AC04 | Clopidogrel | Zyllt® | film-coated tablets 75 mg | RK-MP-5 №023109 |
693 | B01AC04 | Clopidogrel | CLOPIREL | film-coated tablets 75 mg | RK-MP-5 №023561 |
694 | B01AC04 | Clopidogrel | CLOPIREL | film-coated tablets 300 mg | RK-MP-5 №023562 |
695 | B01AC04 | Clopidogrel | Clopidogrel STADA® | Film-coated tablets 75 mg | RK-MP-5 №024469 |
B01AC06 | Acetylsalicylic acid | ||||
696 | B01AC06 | Acetylsalicylic acid | Cardiomagnil® | film-coated tablets 75 mg | RK-MP-5 №020820 |
697 | B01AC06 | Acetylsalicylic acid | Aspicard | enteric coated tablets 75 mg | RK-MP-5 №021388 |
698 | B01AC06 | Acetylsalicylic acid | Godasal® | tablets 100 mg | RK-MP-5 №020249 |
699 | B01AC06 | Acetylsalicylic acid | Trombo ACC® | enteric film-coated tablets 100 mg | RK-MP-5 №020386 |
700 | B01AC06 | Acetylsalicylic acid | Cardiomagnil | film-coated tablets 150 mg | RK-MP-5 №020821 |
701 | B01AC06 | Acetylsalicylic acid | Aspicard | enteric-coated tablets 150 mg | RK-MP-5 №021387 |
702 | B01AC06 | Acetylsalicylic acid | Aspirin Cardio® | enteric-coated tablets 300 mg | RK-MP-5 №013405 |
703 | B01AC06 | Acetylsalicylic acid | Aspirin Cardio® | enteric-coated tablets 100 mg | RK-MP-5 №013404 |
704 | B01AC06 | Acetylsalicylic acid | AC-thrombin | enteric-coated tablets 100 mg | RK-MP-5 №010463 |
705 | B01AC06 | Acetylsalicylic acid | ACECARDOL | Enteric tablets 100 mg | RK-MP-5 №014513 |
706 | B01AC06 | Acetylsalicylic acid | Trombopol | enteric-coated tablets 150 mg | RK-MP-5 №015841 |
707 | B01AC06 | Acetylsalicylic acid | Trombopol | enteric-coated tablets 75 mg | RK-MP-5 №015840 |
708 | B01AC06 | Acetylsalicylic acid | ACECARDOL | Enteric tablets 50 mg | RK-MP-5 №014512 |
709 | B01AC06 | Acetylsalicylic acid | Cardisave® | film-coated tablets 150 mg | RK-MP-5 №022694 |
710 | B01AC06 | Acetylsalicylic acid | Cardisave® | film-coated tablets 75 mg | RK-MP-5 №022695 |
711 | B01AC06 | Acetylsalicylic acid | Trombo ACC® | enteric-coated tablets 75 mg | RK-MP-5 №019017 |
712 | B01AC06 | Acetylsalicylic acid | Magnicor | film-coated tablets 75 mg | RK-MP-5 №023001 |
713 | B01AC06 | Acetylsalicylic acid | Trombo ACC® | enteric-coated tablets 50 mg | RK-MP-5 №020385 |
714 | B01AC06 | Acetylsalicylic acid | Trombopol Neo | enteric-coated tablets 75 mg | RK-MP-5 №024261 |
B01AC07 | Dipyridamole | ||||
715 | B01AC07 | Dipyridamole | Curantil®N 25 | film-coated tablets 25 mg | RK-MP-5 №011977 |
B01AC11 | Iloprost | orphan | |||
716 | B01AC11 | Iloprost | Ventavis® | solution for inhalations 10 mcg/ml, 1 ml | RK-MP-5 №020401 |
717 | B01AC11 | Iloprost | Ventavis® | solution for inhalations 10 mcg/ml, 2 ml | RK-MP-5 №020401 |
B01AC22 | Prasugrel | ||||
B01AC23 | Cilostazol | ||||
718 | B01AC23 | Cilostazol | Krurovit | tablets 50 mg | RK-MP-5 №121893 |
719 | B01AC23 | Cilostazol | Krurovit | tablets 100 mg | RK-MP-5 №121894 |
720 | B01AC23 | Cilostazol | Cylozec | tablets 100 mg | RK-MP-5 №022681 |
721 | B01AC23 | Cilostazol | Aducil | tablets 50 mg | RK-MP-5 №022948 |
722 | B01AC23 | Cilostazol | Aducil | tablets 100 mg | RK-MP-5 №022949 |
B01AC24 | Ticagrelor | ||||
723 | B01AC24 | Ticagrelor | Brilinta ™ | film-coated tablets, 90 mg | RK-MP-5 №018487 |
724 | B01AC24 | Ticagrelor | Brilinta ™ | film-coated tablets, 60 mg | RK-MP-5 №023335 |
B01AC27 | Selexipag | orphan | |||
725 | B01AC27 | Selexipag | Apbravi | film-coated tablets 200 mcg | orphan |
726 | B01AC27 | Selexipag | Apbravi | film-coated tablets 400 mcg | orphan |
727 | B01AC27 | Selexipag | Apbravi | film-coated tablets 600 mcg | orphan |
728 | B01AC27 | Selexipag | Apbravi | film-coated tablets 800 mcg | orphan |
729 | B01AC27 | Selexipag | Apbravi | film-coated tablets 1000 mcg | orphan |
730 | B01AC27 | Selexipag | Apbravi | film-coated tablets 1200 mcg | orphan |
731 | B01AC27 | Selexipag | Apbravi | film-coated tablets 1600 mcg | orphan |
B01AD | Enzyme preparations | ||||
B01AD01 | Streptokinase | ||||
732 | B01AD01 | Streptokinase | Tromboflux ™ | lyophilized powder for preparation of solution for injections 1500000 IU | RK-MP-5 №009192 |
B01AD02 | Alteplaza | ||||
733 | B01AD02 | Alteplaza | Aktilize® | lyophilized powder for preparation of solution for intravenous infusions 50 mg | RK-MP-5 №013222 |
734 | B01AD02 | Alteplaza | Revekard | lyophilized powder for preparation of solution for intravenous infusions, complete with solvent - water for injections, 50 mg | RK-MP-5 №024126 |
B01AD04 | Urokinase | ||||
735 | B01AD04 | Urokinase | Urokinase medak | lyophilisate for preparation of solution for infusions 500,000 IU | RK-MP-5 №017166 |
736 | B01AD04 | Urokinase | Urokinase medak | lyophilisate for preparation of solution for infusions 100,000 IU | RK-MP-5 №017165 |
737 | B01AD04 | Urokinase | Urokinase medak | lyophilisate for preparation of solution for infusions 50,000 IU | RK-MP-5 №017164 |
738 | B01AD04 | Urokinase | Urokinase medak | lyophilisate for preparation of solution for infusions 10,000 IU | RK-MP-5 №017163 |
B01AE | Direct thrombin inhibitors | ||||
B01AE06 | Bivalirudin | ||||
B01AE07 | Dabigatran etexilate | ||||
739 | B01AE07 | Dabigatran etexilate | Pradaxa® | capsules 110 mg | RK-MP-5 №018956 |
740 | B01AE07 | Dabigatran etexilate | Pradaxa® | capsules 75 mg | RK-MP-5 №014829 |
741 | B01AE07 | Dabigatran etexilate | Pradaxa® | capsules 150 mg | RK-MP-5 №018979 |
B01AF02 | Apixaban | ||||
742 | B01AF02 | Apixaban | Eliquis | film-coated tablets 2,5 mg | RK-MP-5 №020719 |
743 | B01AF02 | Apixaban | Eliquis | film-coated tablets 5 mg | RK-MP-5 №020720 |
B01AF | Direct inhibitors of factor XA | ||||
B01AF01 | Rivaroxaban | ||||
744 | B01AF01 | Rivaroxaban | Xarelto® | film-coated tablets 10 mg | RK-MP-5 №014326 |
745 | B01AF01 | Rivaroxaban | Xarelto® | film-coated tablets 15 mg | RK-MP-5 №019005 |
746 | B01AF01 | Rivaroxaban | Xarelto® | film-coated tablets 20 mg | RK-MP-5 №019006 |
747 | B01AF01 | Rivaroxaban | Xarelto® | film-coated tablets 2,5 mg | RK-MP-5 №020533 |
B01AX | Other anticoagulants | ||||
B01AX05 | Fondaparinux sodium | ||||
748 | B01AX05 | Fondaparinux sodium | Arixtra | solution for subcutaneous and intravenous administration 2.5 mg / 0.5 ml, 0.5 ml | RK-MP-5 №010383 |
B02 | Hemostatic drugs | ||||
B02A | Fibrinolysis inhibitors | ||||
B02AA | Amino acids | ||||
B02AA01 | Aminocaproic acid | ||||
749 | B02AA01 | Aminocaproic acid | Aminocaproic acid | solution for infusions 5% 100 ml | RK-MP-5 №010484 |
750 | B02AA01 | Aminocaproic acid | Aminocaproic acid | solution for infusions 5% 100 ml | RK-MP-5 №011982 |
751 | B02AA01 | Aminocaproic acid | Aminocaproic acid | solution for infusions 5% 100 ml | RK-MP-5 №023891 |
B02AA02 | Tranexamic acid | ||||
752 | B02AA02 | Tranexamic acid | Tugina | solution for injections 100mg / ml 5 ml | RK-MP-5 №121933 |
753 | B02AA02 | Tranexamic acid | Sangera | solution for injections 100mg / ml 10 ml | RK-MP-5 №023634 |
754 | B02AA02 | Tranexamic acid | Sangera | solution for injections100 mg/ml по 5 ml | RK-MP-5 №023634 |
755 | B02AA02 | Tranexamic acid | Tramin | solution for injections 500mg / 5 ml 5 ml | RK-MP-5 №013143 |
756 | B02AA02 | Tranexamic acid | Tranex | solution for intravenous administration 50 mg / ml, 10 ml | RK-MP-5 №022828 |
757 | B02AA02 | Tranexamic acid | Tranex | solution for intravenous administration 50 mg / ml, 5 ml | RK-MP-5 №022828 |
758 | B02AA02 | Tranexamic acid | VIDANOL® | film-coated tablets 500 mg | RK-MP-5 №121658 |
759 | B02AA02 | Tranexamic acid |
Tranexam | solution for intravenous administration 50 mg / ml, 5 ml | RK-MP-5 №021071 |
760 | B02AA02 | Tranexamic acid | Gemaxam | solution for intravenous administration 50 mg / ml, 5 ml | RK-MP-5 №021303 |
761 | B02AA02 | Tranexamic acid | Tranexam | film-coated tablets 500 mg | RK-MP-5 №021073 |
762 | B02AA02 | Tranexamic acid | Tranexam | film-coated tablets 250 mg | RK-MP-5 №021072 |
763 | B02AA02 | Tranexamic acid | Tranemic | coated tablets 500 mg | RK-MP-5 №023697 |
764 | B02AA02 | Tranexamic acid | Sanksamik | film-coated tablets, 500 mg | RK-MP-5 №023717 |
765 | B02AA02 | Tranexamic acid | Gemotran | solution for injections 100 mg / ml, 5ml | RK-MP-5 №023888 |
766 | B02AA02 | Tranexamic acid | Gemotran | solution for injections 50 mg / ml, 5ml | RK-MP-5 №023889 |
767 | B02AA02 | Tranexamic acid | Tugina | film-coated tablets 500 mg | RK-MP-5 №023930 |
768 | B02AA02 | Tranexamic acid | Pauz-500 | film-coated tablets 500 mg | RK-MP-5 №024145 |
769 | B02AA02 | Tranexamic acid | Trenaksa 250 | coated tablets 250 mg | RK-MP-5 №013439 |
770 | B02AA02 | Tranexamic acid | Trenaksa 500 | coated tablets 500 mg | RK-MP-5 №013440 |
771 | B02AA02 | Tranexamic acid | Trenaksa | solution for intravenous administration 100 mg / ml, 5 ml | RK-MP-5 №024253 |
772 | B02AA02 | Tranexamic acid | Tramin | capsules 500 mg | RK-MP-5 №013202 |
773 | B02AA02 | Tranexamic acid |
Tranma | solution for intravenous administration 500 mg / 5 ml, 5 ml | RK-MP-5 №024426 |
B02AB01 | Aprotinin | ||||
774 | B02AB01 | Aprotinin | Gordox® | solution for injections 100000 KIE, 10ml | RK-MP-5 №016288 |
B02B | Vitamin K and other hemostatics | ||||
B02BA | Vitamin K | ||||
B02BA01 | Fitomenadion | ||||
775 | B02BA01 | Fitomenadion | Amri-K | Solution for intramuscular administration 10 mg / ml, 1 ml | RK-MP-5 №018193 |
B02BA02 | Menadione sodium bisulfite | ||||
776 | B02BA02 | Menadione sodium bisulfite | Vikasol-Darnitsa | Solution for injections 1% 1 ml | RK-MP-5 №000138 |
B02BC | Hemostatic drugs for topical use | ||||
B02BC30 | Hemostatic sponge containing fibrinogen and thrombin | ||||
777 | B02BC30 | Hemostatic sponge containing fibrinogen and thrombin | Tachocomb® | absorbent hemostatic agent, sponge size 9.5x4.8 cm | RK-MP-5 №010583 |
778 | B02BC30 | Hemostatic sponge containing fibrinogen and thrombin | Tachocomb® | absorbent hemostatic agent, sponge size 4.8x4.8 cm | RK-MP-5 №010582 |
779 | B02BC30 | Hemostatic sponge containing fibrinogen and thrombin | Tachocomb® | absorbent hemostatic agent, sponge size 2,5х3,0 cm | RK-MP-5 №010581 |
B02BD | Blood clotting factors | ||||
B02BD01 | Blood clotting factor II, VII, IX b X in combination | ||||
780 | B02BD01 | Blood clotting factor II, VII, IX and X in combination | Octaplex ™ 500 IU |
Lyophilized powder for preparation of solution for intravenous administration, complete with solvent (water for injection) and a set for administration of 500 IU, 20 ml | RK-MP-5 №014192 |
B02BD02 | Blood clotting factor VIII | ||||
781 | B02BD02 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration complete with solvent - water for injections 3000 IU, 5ml | RK-BP-5 №022332 |
782 | B02BD02 | Blood clotting factor VIII | Advate | lyophilisate for preparation of a solution for intravenous administration complete with a solvent - water for injections 2000 IU, 5 ml | RK-BP-5 №022331 |
783 | B02BD02 | Blood clotting factor VIII | Nuvik | lyophilized powder for preparation of solution for intravenous administration, complete with a solvent (water for injection) and a set for the introduction of 2000 IU, 2.5 ml | RK-MP-5 №121962 |
784 | B02BD02 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration complete with a solvent - water for injections 1500 IU, 2ml | RK-BP-5 №022330 |
785 | B02BD03 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration complete with a solvent - water for injections 1500 IU, 5 ml | RK-BP-5 №022330 |
786 | B02BD02 | Blood clotting factor VIII | Nuvik | lyophilized powder for preparation of solution for intravenous administration, complete with a solvent (water for injection) and a set for administration of 1000 IU, 2.5 ml | RK-MP-5 №121960 |
787 | B02BD02 | Blood clotting factor VIII | Octanate® LV | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration 1000, 5 ml | RK-BP-5 №022116 |
788 | B02BD02 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration complete with a solvent - water for injections, 1000 IU, 2ml | RK-BP-5 №022329 |
789 | B02BD03 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration complete with a solvent - water for injections, 1000 IU, 5 ml | RK-BP-5 №022329 |
790 | B02BD02 | Blood clotting factor VIII | Kogenate® FS | lyophilisate for preparation of solution for intravenous administration 1000 IU, 2.5 ml | RK-MP-5 №013230 |
791 | B02BD02 | Blood clotting factor VIII | ReFacto® AF | lyophilized powder for preparation of solution for intravenous administration complete with solvent 1000 IU | RK-MP-5 №020938 |
792 | B02BD02 | Blood clotting factor VIII | Beriate® | lyophilisate for preparation of solution for intravenous administration 1000 IU, 10ml | RK-MP-5 №019421 |
793 | B02BD02 | Blood clotting factor VIII | Octanat® 1000 | lyophilisate for preparation of solution for intravenous administration 1000 IU, 10ml | RK-MP-5 №004915 |
794 | B02BD02 | Blood clotting factor VIII | Octanat® 1000 | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration 1000, 10 ml | RK-BP-5 №023463 |
795 | B02BD02 | Blood clotting factor VIII |
Recombinate | lyophilisate for preparation of solution for intravenous administration 1000 IU, 10ml | RK-MP-5 №013332 |
796 | B02BD02 | Blood clotting factor VIII | Haemoctin® | lyophilisate for preparation of solution for intravenous administration 1000 IU, 10ml | RK-BP-5 №021546 |
797 | B02BD02 | Blood clotting factor VIII |
Emoclot | lyophilisate for preparation of solution for injections complete with solvent - water for injections 1000 IU, 10ml | RK-BP-5 №122041 |
798 | B02BD02 | Blood clotting factor VIII | Nuvik | lyophilized powder for preparation of solution for intravenous administration, complete with a solvent (water for injection) and a set for administration of 500 IU | RK-MP-5 №121959 |
799 | B02BD02 | Blood clotting factor VIII | Octanat® LV |
lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration of 500, | RK-BP-5 №022117 |
800 | B02BD02 | Blood clotting factor VIII | Cohenate® FS | lyophilisate for preparation of solution for intravenous administration 500 IU, 2.5 ml | RK-MP-5 №013229 |
801 | B02BD02 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration, complete with a solvent - water for injections 500 IU | RK-BP-5 №022328 |
802 | B02BD02 | Blood clotting factor VIII | ReFacto® AF | lyophilized powder for preparation of solution for intravenous administration complete with solvent 500 IU | RK-MP-5 №020937 |
803 | B02BD02 | Blood clotting factor VIII | Octanat®500 | lyophilisate for preparation of solution for intravenous administration 500 IU | RK-MP-5 №004914 |
804 | B02BD02 | Blood clotting factor VIII | Octanat®500 | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration, 500 | RK-BP-5 №023462 |
805 | B02BD02 | Blood clotting factor VIII | Recombinate | lyophilisate for preparation of solution for intravenous administration 500 IU | RK-MP-5 №013331 |
806 | B02BD02 | Blood clotting factor VIII | Beriate® | lyophilisate for preparation of solution for intravenous administration 500 IU | RK-MP-5 №019420 |
807 | B02BD02 | Blood clotting factor VIII | Haemoctin® | lyophilisate for preparation of solution for intravenous administration 500 IU | RK-BP-5 №021545 |
808 | B02BD02 | Blood clotting factor VIII | Emoclot | lyophilisate for preparation of solution for injections complete with solvent - water for injections, 500 IU | RK-BP-5 №122040 |
809 | B02BD02 | Blood clotting factor VIII | Nuvik | lyophilized powder for preparation of solution for intravenous administration, complete with a solvent (water for injection) and a set for administration of 250 IU | RK-MP-5 №121958 |
810 | B02BD02 | Blood clotting factor VIII | Cohenate® FS | lyophilisate for preparation of solution for intravenous administration 250 IU | RK-MP-5 №013228 |
811 | B02BD02 | Blood clotting factor VIII | Advate | lyophilisate for preparation of solution for intravenous administration, complete with a solvent - water for injections, 250 IU | RK-BP-5 №022327 |
812 | B02BD02 | Blood clotting factor VIII | Octanat®250 | lyophilisate for preparation of solution for intravenous administration, complete with a solvent - water for injections, 250 IU | RK-MP-5 №004913 |
813 | B02BD02 | Blood clotting factor VIII | Beriate® | lyophilisate for preparation of solution for intravenous administration, complete with a solvent - water for injections, 250 IU | RK-MP-5 №019419 |
814 | B02BD02 | Blood clotting factor VIII | ReFacto® AF | lyophilized powder for preparation of solution for intravenous administration complete with solvent 250 IU | RK-MP-5 №020936 |
815 | B02BD02 | Blood clotting factor VIII | Octanat® 250 | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration 250 IU | RK-BP-5 №023461 |
816 | B02BD02 | Blood clotting factor VIII | Recombinate | lyophilisate for preparation of solution for intravenous administration, complete with a solvent and a set for administration 250 IU | RK-MP-5 №013330 |
817 | B02BD02 | Blood clotting factor VIII | Haemoctin® | lyophilisate for preparation of solution for intravenous administration, complete with a solvent and a set for administration 250 IU | RK-BP-5 №021544 |
818 | B02BD02 | Blood clotting factor VIII | ReFacto® AF | lyophilized powder for preparation of solution for intravenous administration complete with solvent 2000 IU | RK-MP-5 №020939 |
819 | B02BD02 | Blood clotting factor VIII | GreenGen | lyophilized powder for preparation of solution for intravenous administration, complete with solvent (water for injections) 500 IU | RK-MP-5 №020762 |
820 | B02BD02 | Blood clotting factor VIII | Hemorel-A | lyophilized powder for preparation of solution for injections, complete with solvent (sterile water for injections) 250 IU | RK-BP-5 №021289 |
821 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 250 IU | RK-BP-5 №022523 |
822 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 500 IU | RK-BP-5 №022524 |
823 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 750 IU | RK-BP-5 №022525 |
824 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 1000 IU | RK-BP-5 №022526 |
825 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 1500 IU | RK-BP-5 №022527 |
826 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 3000 IU | RK-BP-5 №022529 |
827 | B02BD02 | Blood clotting factor VIII | Eloktat® | lyophilized powder for injections 2000 IU | RK-BP-5 №022528 |
B02BD03 | Anti-inhibitory coagulant complex | ||||
828 | B02BD03 | Anti-inhibitory coagulant complex | Feiba® | lyophilisate for preparation of solution for infusions 1000 IU | RK-MP-5 №018683 |
829 | B02BD03 | Anti-inhibitory coagulant complex | Feiba® | lyophilisate for preparation of solution for infusions 500 IU | RK-MP-5 №018682 |
B02BD04 | Clotting factor IX | ||||
830 | B02BD04 | Clotting factor IX | Factor IX Griffols | lyophilized powder for preparation of solution for infusions 1000 IU | RK-MP-5 №018556 |
831 | B02BD04 | Clotting factor IX | Factor IX Griffols | lyophilisate for preparation of solution for infusions 500 IU | RK-MP-5 №018555 |
832 | B02BD04 | Clotting factor IX | BeneFix® | lyophilized powder for preparation of solution for intravenous administration complete with solvent, 2000 IU | RK-MP-5 №021013 |
833 | B02BD04 | Clotting factor IX | BeneFix® | lyophilized powder for preparation of solution for intravenous administration complete with solvent, 1000 IU | RK-MP-5 №021014 |
834 | B02BD04 | Clotting factor IX | Octanine ™ F | lyophilized powder for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration 1000 IU | RK-MP-5 №014185 |
835 | B02BD04 | Clotting factor IX | Aimafix | lyophilized powder for preparation of solution for intravenous administration complete with solvent, 1000 IU | RK-BP-5 №122069 |
836 | B02BD04 | Clotting factor IX | Immunine | lyophilisate for preparation of solution for infusions, 1200 IU | RK-MP-5 №018681 |
837 | B02BD04 | Clotting factor IX | BeneFix® | lyophilized powder for preparation of solution for intravenous administration complete with solvent, 500 IU | RK-MP-5 №021015 |
838 | B02BD04 | Clotting factor IX | Octanine ™ F | lyophilized powder for preparation of solution for intravenous administration, complete with a solvent (water for injection) and a set for administration, 500 IU | RK-MP-5 №014184 |
839 | B02BD04 | Clotting factor IX | Aimafix | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) and a set for administration of 500 IU | RK-BP-5 №122068 |
840 | B02BD04 | Clotting factor IX | Immunine | lyophilisate for preparation of solution for infusions 600 IU | RK-MP-5 №018680 |
841 | B02BD04 | Clotting factor IX | BeneFix® | lyophilized powder for preparation of solution for intravenous administration complete with solvent 250 IU | RK-MP-5 №021016 |
842 | B02BD04 | Clotting factor IX | Octanine ™ F | lyophilized powder for preparation of solution for infusions, complete with solvent (water for injections) and a set for administration, 250 ME | RK-MP-5 №014183 |
843 | B02BD04 | Clotting factor IX | Mononine® | lyophilisate for preparation of solution for intravenous administration complete with a solvent (water for injections) 500 IU | RK-BP-5 №121757 |
844 | B02BD04 | Clotting factor IX | Mononine® | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) 1000 IU | RK-BP-5 №121758 |
845 | B02BD04 | Clotting factor IX | Alprolix® | lyophilized powder for injections 500 IU | RK-BP-5 №022519 |
846 | B02BD04 | Clotting factor IX | Alprolix® | lyophilized powder for injections 1000 IU | RK-BP-5 №022520 |
847 | B02BD04 | Clotting factor IX | Alprolix® | lyophilized powder for injections 2000 IU | RK-BP-5 №022521 |
848 | B02BD04 | Clotting factor IX | Alprolix® | lyophilized powder for injections 3000 IU | RK-BP-5 №022522 |
849 | B02BD04 | Clotting factor IX | Factor IX Griffols | lyophilisate for preparation of solution for infusions 1500 IU | RK-MP-5 №018557 |
B02BD06 | Clotting factor VIII and von Willebrand factor | ||||
850 | B02BD06 | Clotting factor VIII and von Willebrand factor | Haemate® P | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections) 1000 IU + 2400 IU | RK-BP-5 №021111 |
851 | B02BD06 | Clotting factor VIII and von Willebrand factor | Vilate ™ 500 IU | Lyophilisate for preparation of solution for intravenous administration in a vial complete with a solvent (water for injections with 0.1% polysorbate 80) and a set for administration 500 IU | RK-MP-5 №020624 |
852 | B02BD06 | Clotting factor VIII and von Willebrand factor |
Immunate | lyophilisate for preparation of solution for intravenous administration 500 IU | RK-MP-5 №013497 |
853 | B02BD06 | Clotting factor VIII and von Willebrand factor | Fanhdi® | lyophilisate for preparation of solution for infusions, complete with solvent (water for injections) 500 IU | RK-MP-5 №017430 |
854 | B02BD06 | Clotting factor VIII and von Willebrand factor | Haemate® P | lyophilisate for preparation of solution for intravenous administration, complete with a solvent (water for injections), 500 IU + 1200 IU | RK-BP-5 №021112 |
855 | B02BD06 | Clotting factor VIII and von Willebrand factor | Vilate ™ 450 IU | Lyophilisate for preparation of solution for intravenous administration in a vial complete with a solvent (water for injections with 0.1% polysorbate 80) and a set for administration 450 IU | RK-MP-5 №014213 |
856 | B02BD06 | Clotting factor VIII and von Willebrand factor | Immunate | lyophilisate for preparation of solution for intravenous administration 1000 IU | RK-MP-5 №013498 |
857 | B02BD06 | Clotting factor VIII and von Willebrand factor | Fanhdi® | lyophilisate for preparation of solution for infusions, complete with a solvent (water for injections) 1000 IU | RK-MP-5 №017431 |
858 | B02BD06 | Clotting factor VIII and von Willebrand factor |
Immunate | lyophilisate for preparation of solution for intravenous administration 250 IU | RK-MP-5 №013496 |
859 | B02BD06 | Clotting factor VIII and von Willebrand factor | Fanhdi® | lyophilisate for preparation of solution for infusions 250 IU | RK-MP-5 №017429 |
860 | B02BD06 | Clotting factor VIII and von Willebrand factor | Haemate® P | lyophilisate for preparation of solution for intravenous administration complete with a solvent (water for injections) 250 IU + 600 IU | RK-BP-5 №021109 |
861 | B02BD06 | Clotting factor VIII and von Willebrand factor | Vilate ™ 900 IU | lyophilisate for preparation of solution for intravenous administration in a vial complete with a solvent (water for injections with 0.1% polysorbate 80) and a set for administration 900 IU | RK-MP-5 №014214 |
862 | B02BD06 | Clotting factor VIII and von Willebrand factor | Vilate ™ 1000 IU | lyophilisate for preparation of solution for intravenous administration in a vial complete with a solvent (water for injections with 0.1% polysorbate 80) and a set for administration 1000 IU | RK-MP-5 №020623 |
B02BD08 | Clotting factor VIIa | ||||
863 | B02BD08 | Clotting factor VIIa | Coagil-VII | lyophilisate for preparation of solution for intravenous administration complete with a solvent (water for injections) 2.4 mg | RK-MP-5 №018132 |
864 | B02BD08 | Clotting factor VIIa | Semiclotin | lyophilisate for preparation of solution for intravenous administration complete with a solvent (water for injections) 2.4 mg | RK-MP-5 №023117 |
865 | B02BD08 | Clotting factor VIIa | Coagil-VII | lyophilisate for preparation of solution for intravenous administration complete with a solvent (water for injections) 1.2 mg | RK-MP-5 №018131 |
866 | B02BD08 | Clotting factor VIIa | Semiclotin | lyophilisate for preparation of solution for intravenous administration complete with a solvent (water for injections) 1.2 mg | RK-MP-5 №023116 |
867 | B02BD08 | Clotting factor VIIa | NovoSeven® | lyophilisate for preparation of solution for intravenous administration with a solvent (histidine, water for injections) 1 mg | RK-MP-5 №022184 |
868 | B02BD08 | Clotting factor VIIa | NovoSeven® | lyophilisate for preparation of solution for intravenous administration with a solvent (histidine, water for injections) 2 mg | RK-MP-5 №022185 |
869 | B02BD08 | Clotting factor VIIa | Coagil-VII | lyophilisate for preparation of solution for intravenous administration with a solvent (histidine, water for injections) 4.8 mg | RK-MP-5 №018133 |
B02BX | Other hemostatic drugs for systemic use | ||||
B02BX01 | Etamsilat | ||||
870 | B02BX01 | Etamsilat | Dicinone® | tablets 250 mg | RK-MP-5 №015087 |
871 | B02BX01 | Etamsilat | Etamsilat | solution for injections 12.5%, 2 ml | RK-MP-5 №012601 |
872 | B02BX01 | Etamsilat | Etamsilat | Solution for intravenous and intramuscular administratio12.5%, 2 ml | RK-MP-3 №021445 |
873 | B02BX01 | Etamsilat | Cyclonamine | solution for injections 12.5%, 2 ml | RK-MP-5 №020795 |
874 | B02BX01 | Etamsilat | Dicinone® | solution for injections 250 mg / 2 ml | RK-MP-5 №015107 |
B02BX04 | Romiplostim | ||||
875 | B02BX04 | Romiplostim | Nplate | powder for solution for subcutaneous administration 250 mcg | RK-MP-5 №019786 |
B02BX05 | Eltrombopag | ||||
876 | B02BX05 | Eltrombopag | Revoleyd ™ | film-coated tablets 25 mg | RK-MP-5 №017559 |
877 | B02BX05 | Eltrombopag | Revoleyd ™ | film-coated tablets 50 mg | RK-MP-5 №017558 |
B02BX06 | Emicizumab | orphan | |||
878 | B02BX06 | Emicizumab | Gemlibra | solution for injections 105 mg / 0.7 ml | RK-BP-5 №024341 |
879 | B02BX06 | Emicizumab | Gemlibra | solution for injections 30 mg / 1 ml | RK-BP-5 №024343 |
880 | B02BX06 | Emicizumab | Gemlibra | solution for injections 60 mg / 0.4 ml | RK-BP-5 №024344 |
881 | B02BX06 | Emicizumab | Gemlibra | solution for injections 150 mg / 1 ml | RK-BP-5 №024345 |
B03 | Antianemic drugs | ||||
B03A | Iron preparations | ||||
B03AA | Iron preparations (bivalent) for oral administration | ||||
882 | B03AA | Iron preparations (bivalent) for oral administration | Aktiferrin®-Teva | syrup 100 ml | RK-MP-5 №016262 |
883 | B03AA | Iron preparations (bivalent) for oral administration | Aktiferrin®-Teva | oral drops 30 ml | RK-MP-5 №016244 |
884 | B03AA | Iron preparations (bivalent) for oral administration | Sorbifer® Durules® | coated tablets 320 mg/60 mg | RK-MP-5 №005192 |
B03AA07 | Iron sulfate | ||||
885 | B03AA07 | Iron sulfate | Sorbifer® Durules® | coated tablets (equivalent to 100 mg Fe + 2 - ferrous iron) | RK-MP-5 №005192 |
886 | B03AA07 | Iron sulfate | Ferrovit-S | drops 25 ml | RK-MP-5 №012856 |
887 | B03AA07 | Iron sulfate | Tardiferon® | tablets retard, coated 80 mg | RK-MP-5 №010599 |
888 | B03AA07 | Iron sulfate | Aktiferrin®-Teva | capsules | RK-MP-5 №016535 |
B03AC | Iron preparations for parenteral administration | ||||
889 | B03AC | Iron preparations for parenteral administration | Ferrum Lek® | solution for intramuscular administration 100 mg / 2 ml 2 ml | RK-MP-5 №015589 |
890 | B03AC | Iron preparations for parenteral administration | Venofer® | solution for intravenous administration 20 mg / ml 5 ml | RK-MP-5 №020883 |
891 | B03AC | Iron preparations for parenteral administration | Ferinject® | solution for intravenous administration 50 mg / ml 2 ml | RK-MP-5 №023025 |
892 | B03AC | Iron preparations for parenteral administration | Ferinject® | solution for intravenous administration 50 mg / ml 10 ml | RK-MP-5 №023025 |
893 | B03AC | Iron preparations for parenteral administration | CosmoFer® | solution for injections 50 mg / ml 2 ml | RK-MP-5 №007849 |
894 | B03AC | Iron preparations for parenteral administration | Ferkayl® | solution for injections 50 mg / ml 2 ml | RK-MP-5 №007850 |
895 | B03AC | Iron preparations for parenteral administration | Venofer® | solution for intravenous administration 20 mg / ml 5 ml | RK-MP-5 №122086 |
896 | B03AC | Iron preparations for parenteral administration | Encifer | solution for intravenous administration 2g / 5 ml 5 ml | RK-MP-5 №022929 |
897 | B03AC | Iron preparations for parenteral administration | Fersinol | solution for injections 100 mg / 2 ml, 2 ml | RK-MP-5 №019772 |
898 | B03AC | Iron preparations for parenteral administration | Ferrolek-Zdorovye | solution for injections 50 mg / ml 2 ml | RK-MP-5 №121714 |
899 | B03AC | Iron preparations for parenteral administration | Hemopim | solution for intravenous administration 20 mg / ml 5 ml | RK-MP-5 №023964 |
900 | B03AC | Iron preparations for parenteral administration | Rotafer | solution for injections 100 mg / 2 ml | RK-MP-5 №121987 |
B03AD | Iron preparations in combination with folic acid | ||||
901 | B03AD | Iron preparations in combination with folic acid | Orofer | capsules 100 mg/550 mcg | RK-MP-5 №121829 |
B03AD02 | Ferrous fumarate and Folic acid | ||||
902 | B03AD02 | Ferrous fumarate and Folic acid | Ferretab comp | capsules ретард 54,52 mg/0,54 mg | RK-MP-5 №015591 |
B03AD03 | Ferrous fumarate and Folic acid | ||||
903 | B03AD03 | Ferrous fumarate and Folic acid | Gyno-Tardiferon | coated tablets with prolonged release 0,35 mg/80 mg | RK-MP-5 №014813 |
B03AE | Iron in other combinations | ||||
B03AE10 |
Препараты железа в комбинации с прочими препаратами | ||||
904 | B03AE10 | Iron preparations in combination with other drugs | Ferrovit® -S | syrup 100 ml | RK-MP-5 №018256 |
905 | B03AE10 | Iron preparations in combination with other drugs | Ferrovit® | coated tablets 320 mg/60 mg | RK-MP-5 №013864 |
906 | B03AE10 | Iron preparations in combination with other drugs | Totema | Oral solution 10 ml | RK-MP-5 №012646 |
B03B | Vitamin B12 and folic acid | ||||
B03BA | Cyanocobalamin and its derivatives | ||||
B03BA01 | Cyanocobalamin | ||||
907 | B03BA01 | Cyanocobalamin | Cyanocobalamin (Vitamin B12) | solution for injections 0.02%, 1 ml | RK-MP-5 №010632 |
908 | B03BA01 | Cyanocobalamin | Cyanocobalamin | solution for injections 500mcg / ml 1ml | RK-MP-5 №015491 |
909 | B03BA01 | Cyanocobalamin | Cyanocobalamin (Vitamin B12) | solution for injections 0,05% 1ml | RK-MP-5 №010631 |
910 | B03BA01 | Cyanocobalamin | B12 Ankermann® | Coated tablets 1mg | RK-MP-5 №023612 |
B03BB | Folic acid and its derivatives | ||||
B03BB01 | Folic acid | ||||
911 | B03BB01 | Folic acid | Folacin | tablets 5 mg | RK-MP-5 №019543 |
912 | B03BB01 | Folic acid | Folic acid | tablets 1 mg | RK-MP-5 №016577 |
913 | B03BB01 | Folic acid | Folica | tablets 5 mg | RK-MP-3 №122033 |
914 | B03BB01 | Folic acid | Folic acid | tablets 1 mg | RK-MP-5 №023597 |
915 | B03BB01 | Folic acid | Folic acid | tablets 5 mg | RK-MP-5 №023598 |
916 | B03BB01 | Folic acid | 9 months Folic acid | film-coated tablets 400 mcg | RK-MP-5 №021325 |
917 | B03BB01 | Folic acid | Folic acid | tablets 1 mg | RK-MP-5 №005308 |
918 | B03BB01 | Folic acid | Folispey | tablets 5 mg | RK-MP-5 №023574 |
919 | B03BB01 | Folic acid | Folic acid | tablets 1 mg | RK-MP-5 №020488 |
B03X | Other antianemic drugs | ||||
B03XA | Other stimulants of hematopoiesis | ||||
B03XA01 | Epoetin alpha, beta and zeta | ||||
920 | B03XA01 | Epoetin alpha, beta and zeta | Relipoietin | solution for injections 2000 IU / 0.5 ml, 0.5 ml | RK-BP-5 №021449 |
921 | B03XA01 | Epoetin alpha, beta and zeta | Eprex® | solution for intravenous and subcutaneous administration 40,000 IU / 1 ml | RK-BP-5 №005836 |
922 | B03XA01 | Epoetin alpha, beta and zeta | Binocrit® | solution for injections 40,000 IU / 1 ml | RK-MP-5 №021024 |
923 | B03XA01 | Epoetin alpha, beta and zeta | Eposan | epoetin zeta 40,000 IU / 1.0 ml solution for injections in a syringe | RK-MP-5 №022219 |
924 | B03XA01 | Epoetin alpha, beta and zeta | Eprex® | solution for intravenous and subcutaneous administration 2000 IU / 0.5 ml | RK-BP-5 №009694 |
925 | B03XA01 | Epoetin alpha, beta and zeta | Binocrit® | solution for injections 2000 IU / 1.0 ml | RK-MP-5 №021025 |
926 | B03XA01 | Epoetin alpha, beta and zeta | Recormon | solution for injections 2000 IU / 0.3 ml | RK-MP-5 №015703 |
927 | B03XA01 | Epoetin alpha, beta and zeta | Eposan | epoetin zeta 2000 IU / 0.6 ml solution for injections in a syringe | RK-MP-5 №022215 |
928 | B03XA01 | Epoetin alpha, beta and zeta | Binocrit® | solution for injections 1000 IU / 0.5 ml | RK-MP-5 №021026 |
929 | B03XA01 | Epoetin alpha, beta and zeta | Relipoietin | solution for injections 10000 IU / 1 ml | RK-BP-5 №021451 |
930 | B03XA01 | Epoetin alpha, beta and zeta | Relipoietin | solution for injections 4000 IU / 0.5 ml | RK-BP-5 №021450 |
931 | B03XA01 | Epoetin alpha, beta and zeta | Eposan | 1000 IU / 0.3 ml solution for injections in a syringe | RK-MP-5 №022214 |
932 | B03XA01 | Epoetin alpha, beta and zeta | Eposan | 4000 IU / 0.4 ml solution for injections in a syringe | RK-MP-5 №022216 |
933 | B03XA01 | Epoetin alpha, beta and zeta | Eposan | 6000 IU / 0.6 ml solution for injections in a syringe | RK-MP-5 №022217 |
934 | B03XA01 | Epoetin alpha, beta and zeta | Eposan | 10000 IU / 1 ml solution for injections in a syringe | RK-MP-5 №022218 |
B03XA02 | Darbepoetin alfa | ||||
935 | B03XA02 | Darbepoetin alfa | Aranesp | solution for injections 500 mcg, 1ml | RK-MP-5 №018966 |
936 | B03XA02 | Darbepoetin alfa | Aranesp | solution for injections 30 mcg, 0.3 ml | RK-MP-5 №018960 |
937 | B03XA02 | Darbepoetin alfa | Aranesp | solution for injections 20 mcg, 0.5 ml | RK-MP-5 №018959 |
938 | B03XA02 | Darbepoetin alfa | Aranesp® | solution for injections 10 mcg, 0.4 ml | RK-MP-5 №018958 |
B03XA03 | Methoxy polyethylene glycol-epoetin beta | ||||
939 | B03XA03 | Methoxy polyethylene glycol-epoetin beta | Mircera | solution for intravenous and subcutaneous injections 75 mcg / 0.3 ml | RK-MP-5 №013870 |
940 | B03XA03 | Methoxy polyethylene glycol-epoetin beta | Mircera | solution for intravenous and subcutaneous injections 50 mcg / 0.3 ml | RK-MP-5 №013869 |
B05 | Plasma substitution and perfusion solutions | ||||
B05A | Blood preparations | ||||
B05AA | Blood plasma preparations and plasma substitutes | ||||
B05AA01 | Albumin | ||||
941 | B05AA01 | Albumin | Albunorm ™ | solution for infusions 5% 500 ml | RK-MP-5 №020604 |
942 | B05AA01 | Albumin | Human albumin | solution for infusions 10% 100 ml | RK-MP-5 №000197 |
943 | B05AA02 | Albumin | Human albumin | solution for infusions 10% 50 ml | RK-MP-5 №000197 |
944 | B05AA03 | Albumin | Human albumin | solution for infusions 10% 200 ml | RK-MP-5 №000197 |
945 | B05AA01 | Albumin | Human albumin | solution for infusions 20%,100ml | RK-MP-5 №000192 |
946 | B05AA01 | Albumin | Human albumin | solution for infusions 5%,100ml | RK-MP-5 №000202 |
947 | B05AA01 | Albumin | Albunorm ™ | solution for infusions 5% 250 ml | RK-MP-5 №020604 |
948 | B05AA01 | Albumin | Albunorm ™ | solution for infusions 5% 100 ml | RK-MP-5 №020604 |
949 | B05AA01 | Albumin | Albunorm ™ | solution for infusions 20% 100 ml | RK-MP-5 №020605 |
950 | B05AA02 | Albumin | Albunorm ™ | solution for infusions 20% 50 ml | RK-MP-5 №020605 |
951 | B05AA01 | Albumin | Alburex® | solution for infusions 20% 100 ml | RK-MP-5 №021259 |
952 | B05AA01 | Albumin | Albumin Biopharma | solution for infusions 20% 100 ml | RK-MP-5 №004526 |
953 | B05AA01 | Albumin | Alburex® | solution for infusions 20% 50 ml | RK-MP-5 №021259 |
954 | B05AA01 | Albumin | Albunorm | solution for infusions 20% 50 ml | RK-MP-5 №020605 |
955 | B05AA01 | Albumin | Albumin Biopharma | solution for infusions 10% 100 ml | RK-MP-5 №004531 |
956 | B05AA01 | Albumin | Albumin Biopharma | solution for infusions 10%, 50 ml | RK-MP-5 №004525 |
957 | B05AA01 | Albumin | Albumin Biopharma | solution for infusions 10%, 20 ml | RK-MP-5 №004523 |
958 | B05AA01 | Albumin | Human albumin | solution for infusions 10% 20 ml | RK-MP-5 №000197 |
959 | B05AA01 | Albumin | Human albumin | solution for infusions 10% 50 ml | RK-MP-5 №000197 |
960 | B05AA01 | Albumin | Human albumin | solution for infusions 10% 200 ml | RK-MP-5 №000197 |
961 | B05AA02 | Albumin | Human albumin | solution for infusions 10% 100 ml | RK-MP-5 №000197 |
B05AA05 | Dextran | ||||
962 | B05AA05 | Dextran | Reopolyglyukin | solution for infusions 10% 200 ml | RK-MP-5 №004442 |
963 | B05AA05 | Dextran | Reopolyglyukin | solution for infusions 10% 400 ml | RK-MP-5 №004442 |
964 | B05AA05 | Dextran | Reopolyglyukin - RT | solution for infusions 10% 400 ml | RK-MP-5 №010720 |
965 | B05AA06 | Dextran | Reopolyglyukin - RT | solution for infusions 10% 200 ml | RK-MP-5 №010720 |
966 | B05AA05 | Dextran | Polyglyukin | solution for infusions 6%,200 ml | RK-MP-5 №004450 |
967 | B05AA05 | Dextran | Polyglyukin | solution for infusions 6% 400 ml | RK-MP-5 №004450 |
968 | B05AA05 | Dextran | Dextran 40 | solution for infusions 10% 400 ml | RK-MP-3 №021314 |
969 | B05AA05 | Dextran | Reopolyglyukin | solution for infusions 10% 400 ml | RK-MP-5 №022799 |
970 | B05AA05 | Dextran | Dextran 40 | solution for infusions 10% 200 ml | RK-MP-3 №021314 |
971 | B05AA05 | Dextran | Reopolyglyukin | solution for infusions 10% 200 ml | RK-MP-5 №022799 |
972 | B05AA05 | Dextran | Dextran 40 | solution for infusions 6% 400 ml | RK-MP-3 №021313 |
973 | B05AA05 | Dextran | Dextran 40 | solution for infusions 6% 200 ml | RK-MP-3 №021313 |
B05AA06 | Succinylated gelatin | ||||
974 | B05AA06 | Succinylated gelatin | Gelofusin | solution for infusions 4% 500 ml | RK-MP-5 №008994 |
B05AA07 | Hydroxyethyl starch (pentastarch) | ||||
975 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refortan® N plus | solution for infusions 10% 500 ml | RK-MP-5 №014891 |
976 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refordez-RT | solution for infusions 10% 500 ml | RK-MP-5 №018628 |
977 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refortan® | solution for infusions 6% 500 ml | RK-MP-5 №005069 |
978 | B05AA07 | Hydroxyethyl starch (pentastarch) | Stabizol® | solution for infusions 6% 500 ml | RK-MP-5 №005064 |
979 | B05AA07 | Hydroxyethyl starch (pentastarch) | Gekodez | solution for infusions 60 mg/ml, 400 ml | RK-MP-5 №019611 |
980 | B05AA08 | Hydroxyethyl starch (pentastarch) | Gekodez | solution for infusions 60 mg/ml, 200 ml | RK-MP-5 №019611 |
981 | B05AA07 | Hydroxyethyl starch (pentastarch) | GEK-200 AF | solution for infusions 10% 500 ml | RK-MP-5 №018240 |
982 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refortan® | solution for infusions 6% polyethylene vial, 250ml | RK-MP-5 №005062 |
983 | B05AA07 | Hydroxyethyl starch (pentastarch) | Hestar-200 | solution for infusions 6% 500 ml | RK-MP-5 №009144 |
984 | B05AA07 | Hydroxyethyl starch (pentastarch) | GEK-200 AF | solution for infusions 6% 500 ml | RK-MP-5 №018238 |
985 | B05AA07 | Hydroxyethyl starch (pentastarch) | Hydroxyethyl starch 200 / 0.5 | solution for infusions 6% 500 ml | RK-MP-5 №022277 |
986 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refortan® N | solution for infusions 6% 500 ml | RK-MP-5 №014892 |
987 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refordez-RT | solution for infusions 6% 250 ml | RK-MP-5 №018629 |
988 | B05AA07 | Hydroxyethyl starch (pentastarch) | Refordez-RT | solution for infusions 6% 500 ml | RK-MP-5 №018629 |
989 | B05AA07 | Hydroxyethyl starch (pentastarch) | Hestar-200 | solution for infusions 6%, 250 ml | RK-MP-5 №017635 |
990 | B05AA07 | Hydroxyethyl starch (pentastarch) | Hydroxyethyl starch 130 / 0.4 | solution for infusions 6% 500 ml | RK-MP-5 №022278 |
B05B | solutions for intravenous administration | ||||
B05BA | solutions for parenteral nutrition | ||||
В05ВА01 | Amino acid complex for parenteral nutrition | ||||
991 | В05ВА01 | Amino acid complex for parenteral nutrition | Nephrotect | solution for infusions, 500 ml | RK-MP-5 №021595 |
992 | В05ВА01 | Amino acid complex for parenteral nutrition | Aminoven Infant | solution for infusions 10% 100 ml | RK-MP-5 №021420 |
993 | В05ВА01 | Amino acid complex for parenteral nutrition | Nephrotect | solution for infusions, 250 ml | RK-MP-5 №021595 |
994 | В05ВА01 | Amino acid complex for parenteral nutrition | Aminoplasmal Hepa 10% | solution for infusions10% 500 ml | RK-MP-5 №008887 |
995 | В05ВА01 | Arginine | Nephrotect | solution for infusions, 500 ml | RK-MP-5 №021595 |
996 | В05ВА01 | Arginine | Nephrotect | solution for infusions, 250 ml | RK-MP-5 №021595 |
997 | В05ВА01 | Arginine | Tivortin | solution for infusions 4,2 % 100 ml | RK-MP-5 №019778 |
B05BA02 | Fat emulsions | ||||
998 | B05BA02 | Fat emulsions | SMOFlipid | emulsion for infusions 20%, 100 ml | RK-MP-5 №021591 |
999 | B05BA02 | Fat emulsions | SMOFlipid | emulsion for infusions 20%, 500 ml | RK-MP-5 №021591 |
1000 | B05BA02 | Fat emulsions | Lipofundin MCT / LCT 20% | emulsion for intravenous infusions 20% 500 ml | RK-MP-5 №012243 |
1001 | B05BA02 | Fat emulsions | Lipofundin MCT / LCT 20% | emulsion for intravenous infusions 20% 100 ml | RK-MP-5 №012243 |
1002 | B05BA02 | Fat emulsions | Selepid 10% | fat emulsion for infusions 10 % 500 ml | RK-MP-5 №016579 |
1003 | B05BA02 | Fat emulsions | Lipofundin MCT / LCT 20% | emulsion for intravenous infusions 20% 250 ml | RK-MP-5 №012243 |
1004 | B05BA02 | Fat emulsions | Lipofundin MCT / LCT 10% | emulsion for intravenous infusions 10 % 500 ml | RK-MP-5 №012241 |
B05BA10 | Amino acid complex | ||||
1005 | B05BA10 | Amino acid complex | Infezol® 100 | solution for infusions 500 ml | RK-MP-5 №004464 |
1006 | B05BA10 | Amino acid complex | Infezol® 100 | solution for infusions 250 ml | RK-MP-5 №004464 |
1007 | B05BA10 | Amino acid complex | Numeta G19E | emulsion for infusions 1000 ml | RK-MP-5 №023538 |
1008 | B05BA10 | Amino acid complex | Numeta G16E | emulsion for infusions 500 ml | RK-MP-5 №023537 |
1009 | B05BA10 | Amino acid complex | Infezol® 40 | solution for infusions 500 ml | RK-MP-5 №016342 |
1010 | B05BA10 | Amino acid complex | Selemin 5-S Plus | solution for infusions 500 ml | RK-MP-5 №009065 |
1011 | B05BA10 | Amino acid complex | Aminoplasmal B. Brown 5% E | solution for infusions 500 ml | RK-MP-5 №019390 |
1012 | B05BA10 | Amino acid complex | Numeta G13E | emulsion for infusions 300 ml | RK-MP-5 №023536 |
1013 | B05BA10 | Amino acid complex | NuTRIflex Lipid plus | emulsion for infusions 1875 ml | RK-MP-5 №019243 |
1014 | B05BA10 | Amino acid complex | NuTRIflex Lipid plus special | emulsion for infusions 1875 ml | RK-MP-5 №019247 |
1015 | B05BA10 | Amino acid complex | NuTRIflex Lipid plus peri | emulsion for infusions 1875 ml | RK-MP-5 №019244 |
1016 | B05BA10 | Amino acid complex | NuTRIflex Lipid plus special | emulsion for infusions 1250 ml | RK-MP-5 №019246 |
1017 | B05BA10 | Amino acid complex | NuTRIflex Lipid plus | emulsion for infusions 1250 ml | RK-MP-5 №019249 |
1018 | B05BA10 | Amino acid complex | NuTRIflex Lipid plus peri | emulsion for infusions 1250 ml | RK-MP-5 №019242 |
1019 | B05BA10 | Amino acid complex | Oliklinomel N7-1000 E | emulsion for infusions 1500 ml | RK-MP-5 №017916 |
1020 | B05BA10 | Amino acid complex | Oliklinomel N4-550 E | emulsion for infusions 1500 ml | RK-MP-5 №017913 |
1021 | B05BA10 | Amino acid complex | NuTRIflex Lipid special | emulsion for infusions 625 ml | RK-MP-5 №019241 |
1022 | B05BA10 | Amino acid complex | Infezol® 100 | solution for infusions 250 ml | RK-MP-5 №004464 |
1023 | B05BA10 | Amino acid complex | Infezol® 100 | solution for infusions 500 ml | RK-MP-5 №004464 |
1024 | B05BA10 | Amino acid complex | Aminoplasmal B. Brown 10% E | solution for infusions 10% 500 ml | RK-MP-5 №019389 |
1025 | B05BA10 | Amino acid complex | Selemin 5-S Plus | solution for infusions 200 ml | RK-MP-5 №016679 |
1026 | B05BA10 | Amino acid complex | SMOFKabiven central | emulsion for infusions 986 ml | RK-MP-5 №121989 |
1027 | B05BA10 | Amino acid complex | SMOFKabiven central | emulsion for infusions 1477 ml | RK-MP-5 №121990 |
1028 | B05BA10 | Amino acid complex | SMOFKabiven central | emulsion for infusions 1970 ml | RK-MP-5 №121991 |
1029 | B05BA10 | Amino acid complex | SMOFKabiven central | emulsion for infusions 1904 ml | RK-MP-5 №121992 |
1030 | B05BA10 | Amino acid complex | Oliklinomel N4-550 E | emulsion for infusions 1000 ml | RK-MP-5 №017912 |
1031 | B05BA10 | Amino acid complex | Oliklinomel N4-550 E | emulsion for infusions 2000 ml | RK-MP-5 №017914 |
1032 | B05BA10 | Amino acid complex | Oliklinomel N7-1000 E | emulsion for infusions 1000 ml | RK-MP-5 №017915 |
1033 | B05BA10 | Amino acid complex | Oliklinomel N7-1000 E | emulsion for infusions 2000 ml | RK-MP-5 №017917 |
1034 | B05BA10 | Amino acid complex | Aminoplasmal B. Brown 5% E | solution for infusions 250 ml | RK-MP-5 №019388 |
1035 | B05BA10 | Amino acid complex | Infezol® 40 | solution for infusions 250 ml | RK-MP-5 №016341 |
B05BB01 | Electrolytes | ||||
1036 | B05BB01 | Electrolytes | Trisol | solution for infusions 200 ml | RK-MP-5 №013399 |
1037 | B05BB01 | Electrolytes | Trisol | solution for infusions 400 ml | RK-MP-5 №013399 |
1038 | B05BB01 | Electrolytes | Salin | спрей назальный 0,65%,30ml | RK-MP-5 №009597 |
1039 | B05BB01 | Electrolytes | Sodium chloride- Darnitsa | solution for injections 0.9%, 5 ml | RK-MP-5 №015535 |
1040 | B05BB01 | Electrolytes | Sodium chloride- Darnitsa | solution for injections 0.9%, 10 ml | RK-MP-5 №015536 |
1041 | B05BB01 | Electrolytes | Sterofundin ISO | solution for infusions, 1000 ml | RK-MP-5 №019798 |
1042 | B05BB01 | Electrolytes | Sterofundin ISO | solution for infusions, 500 ml | RK-MP-5 №019798 |
1043 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 400 ml | RK-MP-3 №020643 |
1044 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 500 ml | RK-MP-3 №020643 |
1045 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 500 ml | RK-MP-5 №009408 |
1046 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 250 ml | RK-MP-3 №020643 |
1047 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 250 ml | RK-MP-5 №009407 |
1048 | B05BB01 | Electrolytes |
Disol | solution for infusions 400 ml | RK-MP-5 №013214 |
1049 | B05BB01 | Electrolytes | Acesol | solution for infusions 400 ml | RK-MP-5 №013654 |
1050 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 100 ml | RK-MP-3 №020643 |
1051 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 100 ml | RK-MP-5 №009406 |
1052 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% по 200 ml | RK-MP-3 №020643 |
1053 | B05BB01 | Electrolytes | Disol | solution for infusions 200 ml | RK-MP-5 №013214 |
1054 | B05BB01 | Electrolytes | Acesol | solution for infusions 200 ml | RK-MP-5 №013653 |
1055 | B05BB01 | Electrolytes | Sodium chloride | solution for injections 0,9% 10 ml | RK-MP-5 №011346 |
1056 | B05BB01 | Electrolytes | Sodium chloride | solution for injections 0,9% 10 ml | RK-MP-5 №022534 |
1057 | B05BB01 | Electrolytes | Sodium chloride | solution for injections 0,9% 5 ml | RK-MP-5 №010181 |
1058 | B05BB01 | Electrolytes | Sodium chloride | solution for injections 0,9% 5 ml | RK-MP-5 №022534 |
1059 | B05BB01 | Electrolytes | Chlosol | solution for infusions 200 ml | RK-MP-5 №014591 |
1060 | B05BB01 | Electrolytes | Chlosol | solution for infusions 400 ml | RK-MP-5 №014591 |
1061 | B05BB01 | Electrolytes | Trisol | solution for infusions 200 ml | RK-MP-5 №014775 |
1062 | B05BB01 | Electrolytes | Trisol | solution for infusions 400 ml | RK-MP-5 №014775 |
1063 | B05BB01 | Electrolytes | Disol | solution for infusions 200 ml | RK-MP-5 №014776 |
1064 | B05BB01 | Electrolytes |
Disol | solution for infusions 400 ml | RK-MP-5 №014776 |
1065 | B05BB01 | Electrolytes | Acesol | solution for infusions 200 ml | RK-MP-5 №015525 |
1066 | B05BB01 | Electrolytes | Acesol | solution for infusions 400 ml | RK-MP-5 №015525 |
1067 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 100 ml | RK-MP-5 №020944 |
1068 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 250 ml | RK-MP-5 №020944 |
1069 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 500 ml | RK-MP-5 №020944 |
1070 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 1000 ml | RK-MP-5 №020944 |
1071 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 100 ml | RK-MP-5 №020945 |
1072 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 500 ml | RK-MP-5 №020945 |
1073 | B05BB01 | Electrolytes | Sodium chloride 0.9% | solution for infusions 0,9% 1000 ml | RK-MP-5 №020945 |
1074 | B05BB01 | Electrolytes | Disol | solution for infusions 200 ml | RK-MP-5 №013505 |
1075 | B05BB01 | Electrolytes | Disol | solution for infusions 400 ml | RK-MP-5 №013505 |
1076 | B05BB01 | Electrolytes | Sodium chloride pharmadel | solution for infusions 0,9% 200 ml | RK-MP-5 №021295 |
1077 | B05BB01 | Electrolytes | Sodium chloride pharmadel | solution for infusions 0,9% 250 ml | RK-MP-5 №021295 |
1078 | B05BB01 | Electrolytes | Sodium chloride pharmadel | solution for infusions 0,9% 400 ml | RK-MP-5 №021295 |
1079 | B05BB01 | Electrolytes | Sodium chloride pharmadel | solution for infusions 0,9% 500 ml | RK-MP-5 №021295 |
1080 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 100 ml | RK-MP-5 №017642 |
1081 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 200 ml | RK-MP-5 №017642 |
1082 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 250 ml | RK-MP-5 №017642 |
1083 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 400 ml | RK-MP-5 №017642 |
1084 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions 0,9% 500 ml | RK-MP-5 №017642 |
1085 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions isotonic 0,9% 200 ml | RK-MP-5 №015060 |
1086 | B05BB01 | Electrolytes | Disol | solution for infusions 200 ml | RK-MP-5 №122154 |
1087 | B05BB01 | Electrolytes | Disol | solution for infusions 400 ml | RK-MP-5 №122154 |
1088 | B05BB01 | Electrolytes | Trisol | solution for infusions 200 ml | RK-MP-5 №122159 |
1089 | B05BB01 | Electrolytes | Trisol | solution for infusions 400 ml | RK-MP-5 №122159 |
1090 | B05BB01 | Electrolytes | Biosodi | solution for infusions 8,4% 50 ml | RK-MP-5 №022426 |
1091 | B05BB01 | Electrolytes | SODIUM CHLORIDE | solution for infusions 0,9% 200 ml | RK-MP-5 №019098 |
1092 | B05BB01 | Electrolytes | SODIUM CHLORIDE | solution for infusions 0,9% 500 ml | RK-MP-5 №019098 |
1093 | B05BB01 | Electrolytes | SODIUM CHLORIDE | solution for infusions 0,9% 1000 ml | RK-MP-5 №019098 |
1094 | B05BB01 | Electrolytes | Chlosol | solution for infusions 200 ml | RK-MP-5 №013397 |
1095 | B05BB01 | Electrolytes | Chlosol | solution for infusions 400 ml | RK-MP-5 №013397 |
1096 | B05BB01 | Electrolytes | Acesol | solution for infusions 200 ml | RK-MP-5 №012991 |
1097 | B05BB01 | Electrolytes | Acesol | solution for infusions 400 ml | RK-MP-5 №012991 |
1098 | B05BB01 | Electrolytes | Sterofundin ISO | solution for infusions 250 ml | RK-MP-5 №024265 |
1099 | B05BB01 | Electrolytes | Sterofundin ISO | solution for infusions 500 ml | RK-MP-5 №024266 |
1100 | B05BB01 | Electrolytes | Ringer | solution for infusions 200 ml | RK-MP-5 №020450 |
1101 | B05BB01 | Electrolytes | Ringer | solution for infusions 400 ml | RK-MP-5 №020450 |
1102 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions isotonic 0,9% 200 ml | RK-MP-5 №019967 |
1103 | B05BB01 | Electrolytes | Sodium chloride | solution for infusions isotonic 0,9% 400 ml | RK-MP-5 №019967 |
B05BC | solutions with osmodiuretic action | ||||
B05BC01 | Mannitol | ||||
1104 | B05BC01 | Mannitol | Mannit | solution for infusions 15% 200 ml | RK-MP-5 №009086 |
1105 | B05BC01 | Mannitol | Mannit | solution for infusions 15% 400 ml | RK-MP-5 №009086 |
1106 | B05BC01 | Mannitol | Mannitol-Kelun-Kazpharm | solution for infusions 15% 400 ml | RK-MP-5 №022181 |
1107 | B05BC01 | Mannitol | Mannitol | solution for infusions 15% 400 ml | RK-MP-3 №020712 |
1108 | B05BC01 | Mannitol | Mannitol-Kelun-Kazpharm | solution for infusions 15% 200 ml | RK-MP-5 №022181 |
1109 | B05BC01 | Mannitol | Mannitol | solution for infusions 15% 200 ml | RK-MP-3 №020712 |
B05C |
Irrigation solutions | ||||
B05CB | Saline solutions | ||||
B05CB01 | Sodium chloride | ||||
1110 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,009 1000 ml | RK-MP-3 №019988 |
1111 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 500 ml | RK-MP-3 №019988 |
1112 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 400 ml | RK-MP-3 №019988 |
1113 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 2000 ml | RK-MP-3 №019988 |
1114 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 3000 ml | RK-MP-3 №019988 |
1115 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 400 ml | RK-MP-5 №012531 |
1116 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 250 ml | RK-MP-3 №019988 |
1117 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 200 ml | RK-MP-3 №019988 |
1118 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,009 200 ml | RK-MP-5 №012531 |
1119 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 100 ml | RK-MP-3 №019988 |
1120 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 100 ml | RK-MP-5 №022862 |
1121 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 200 ml | RK-MP-5 №005899 |
1122 | B05CB01 | Sodium chloride | Sodium chloride | solution for infusions 0,9% 400 ml | RK-MP-5 №005884 |
1123 | B05CB01 | Sodium chloride | Sodium chloride NS | solution for infusions 0,9% 500 ml | RK-MP-5 №019969 |
1124 | B05CB01 | Sodium chloride | Sodium chloride NS | solution for infusions 0,9% 250 ml | RK-MP-5 №019969 |
1125 | B05CB01 | Sodium chloride | Sodium chloride NS | solution for infusions 0,9% 100 ml | RK-MP-5 №019969 |
1126 | B05CB01 | Sodium chloride | Sodium chloride | solution for injections isotonic 9 mg/ml 5 ml | RK-MP-5 №010312 |
1127 | B05CB01 | Sodium chloride | Sodium chloride NS | solution for infusions 0,9% 200 ml | RK-MP-5 №019969 |
1128 | B05CB01 | Sodium chloride | Sodium chloride NS | solution for infusions 0,9% 400 ml | RK-MP-5 №019969 |
B05CX | Other irrigation solutions | ||||
B05CX01 | Glucose | ||||
1129 | B05CX01 | Glucose | Glucose 10D | solution for infusions 10% 100 ml | RK-MP-5 №019972 |
1130 | B05CX01 | Glucose | Glucose 10D | solution for infusions 10% 200 ml | RK-MP-5 №019972 |
1131 | B05CX01 | Glucose | Glucose 10D | solution for infusions 10% 250 ml | RK-MP-5 №019972 |
1132 | B05CX01 | Glucose | Glucose 10D | solution for infusions 10% 400 ml | RK-MP-5 №019972 |
1133 | B05CX01 | Glucose | Glucose 10D | solution for infusions 10% 500 ml | RK-MP-5 №019972 |
1134 | B05CX01 | Glucose | Glucose | solution for injections 400 mg/ml 10 ml | RK-MP-5 №017636 |
1135 | B05CX01 | Glucose | Glucose | solution for infusions 5% 500 ml | RK-MP-5 №011849 |
1136 | B05CX01 | Glucose | Glucose | solution for infusions 5% 500 ml | RK-MP-3 №020672 |
1137 | B05CX01 | Glucose | Glucose | solution for infusions 0,05 500 ml | RK-MP-5 №009405 |
1138 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-5 №011849 |
1139 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-5 №004660 |
1140 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-3 №020672 |
1141 | B05CX01 | Glucose | Glucose | solution for infusions 5% 250 ml | RK-MP-5 №011849 |
1142 | B05CX01 | Glucose | Glucose | solution for infusions 5% 250 ml | RK-MP-3 №020672 |
1143 | B05CX01 | Glucose | Glucose | solution for infusions 5% 250 ml | RK-MP-5 №009404 |
1144 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №011849 |
1145 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №004660 |
1146 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-3 №020672 |
1147 | B05CX01 | Glucose | Glucose | solution for infusions 5% 100 ml | RK-MP-5 №011849 |
1148 | B05CX01 | Glucose | Glucose | solution for infusions 5% 100 ml | RK-MP-3 №020672 |
1149 | B05CX01 | Glucose | Glucose | solution for infusions 5% 100 ml | RK-MP-5 №009403 |
1150 | B05CX01 | Glucose | Glucose | solution for infusions 10% 500 ml | RK-MP-5 №011850 |
1151 | B05CX01 | Glucose | Glucose | solution for infusions 10% 400 ml | RK-MP-5 №011850 |
1152 | B05CX01 | Glucose | Glucose | solution for infusions 10% 400 ml | RK-MP-5 №012534 |
1153 | B05CX01 | Glucose | Glucose | solution for infusions 10% 250 ml | RK-MP-5 №011850 |
1154 | B05CX01 | Glucose | Glucose | solution for infusions 10% 500 ml | RK-MP-3 №020671 |
1155 | B05CX01 | Glucose | Glucose | solution for infusions 10% 250 ml | RK-MP-3 №020671 |
1156 | B05CX01 | Glucose | Glucose | solution for infusions 10% 400 ml | RK-MP-3 №020671 |
1157 | B05CX01 | Glucose | Glucose | solution for infusions 10% 200 ml | RK-MP-5 №011850 |
1158 | B05CX01 | Glucose | Glucose | solution for infusions 10% 200 ml | RK-MP-5 №012534 |
1159 | B05CX01 | Glucose | Glucose | solution for infusions 10% 100 ml | RK-MP-3 №020671 |
1160 | B05CX01 | Glucose | Glucose | solution for infusions 10% 200 ml | RK-MP-3 №020671 |
1161 | B05CX01 | Glucose | Glucose | solution for infusions 10% 100 ml | RK-MP-5 №011850 |
1162 | B05CX01 | Glucose | Glucose | solution for intravenous administration 400 mg/ml 10 ml | RK-MP-5 №022535 |
1163 | B05CX01 | Glucose | Glucose | solution for intravenous administration 400 mg/ml 10ml | RK-MP-5 №018405 |
1164 | B05CX01 | Glucose | Glucose | solution for injections 40% 5 ml | RK-MP-5 №014692 |
1165 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №012659 |
1166 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-5 №012659 |
1167 | B05CX01 | Glucose | Glucose 5D | solution for infusions 5% 500 ml | RK-MP-5 №019971 |
1168 | B05CX01 | Glucose | Glucose 5D | solution for infusions 5% 200 ml | RK-MP-5 №019971 |
1169 | B05CX01 | Glucose | Glucose 5D | solution for infusions 5% 250 ml | RK-MP-5 №019971 |
1170 | B05CX01 | Glucose | Glucose 5D | solution for infusions 5% 400 ml | RK-MP-5 №019971 |
1171 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 5% 200 ml | RK-MP-5 №021392 |
1172 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 5% 250 ml | RK-MP-5 №021392 |
1173 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 5% 400 ml | RK-MP-5 №021392 |
1174 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 5% 500 ml | RK-MP-5 №021392 |
1175 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 10% 200 ml | RK-MP-5 №021393 |
1176 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 10% 250 ml | RK-MP-5 №021393 |
1177 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 10% 400 ml | RK-MP-5 №021393 |
1178 | B05CX01 | Glucose | Glucose pharmadel® | solution for infusions 10% 500 ml | RK-MP-5 №021393 |
1179 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №017634 |
1180 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №014995 |
1181 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №017754 |
1182 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-5 №017754 |
1183 | B05CX01 | Glucose | Glucose | solution for infusions 10% 200 ml | RK-MP-5 №017756 |
1184 | B05CX01 | Glucose | Glucose | solution for injections, 400 mg/ml, 5ml | RK-MP-5 №004599 |
1185 | B05CX01 | Glucose | Glucose- Darnitsa | solution for infusions 5 % 200 ml | RK-MP-5 №023261 |
1186 | B05CX01 | Glucose | Glucose- Darnitsa | solution for infusions 5 % 400 ml | RK-MP-5 №023261 |
1187 | B05CX01 | Glucose | Glucose | solution for injections 40% 5 ml | RK-MP-5 №024167 |
1188 | B05CX01 | Glucose | Glucose | solution for injections 40% 10 ml | RK-MP-5 №024168 |
1189 | B05CX01 | Glucose | Glucose 5D | solution for infusions 5% 100 ml | RK-MP-5 №019971 |
1190 | B05CX01 | Glucose | Glucose | solution for injections 40% 10 ml | RK-MP-5 №007025 |
1191 | B05CX01 | Glucose | Glucose | solution for injections 40% 20 ml | RK-MP-5 №007025 |
1192 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №024317 |
1193 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-5 №024317 |
1194 | B05CX01 | Glucose | Glucose | solution for infusions 5% 200 ml | RK-MP-5 №011027 |
1195 | B05CX01 | Glucose | Glucose | solution for infusions 5% 400 ml | RK-MP-5 №011027 |
B05D | peritoneal dialysis solutions | ||||
B05DB | Hypertonic solutions | ||||
1196 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis1,36% 5000 ml | RK-MP-5 №017745 |
1197 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 1,36% 2500 ml | RK-MP-5 №017745 |
1198 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 2,27% 5000 ml | RK-MP-5 №017746 |
1199 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 2,27% 2500 ml | RK-MP-5 №017746 |
1200 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 3,86% 5000 ml | RK-MP-5 №017747 |
1201 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 3,86% 2500 ml | RK-MP-5 №017747 |
1202 | B05DB | Hypertonic solutions | Fizionil 40 with glucose | solution for peritoneal dialysis with glucose 1,36% 2000 ml | RK-MP-5 №018378 |
1203 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 1,36% 2000 ml | RK-MP-5 №017745 |
1204 | B05DB | Hypertonic solutions | Fizionil 40 with glucose | solution for peritoneal dialysis with glucose 2,27% 2000 ml | RK-MP-5 №018377 |
1205 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 2,27% 2000 ml | RK-MP-5 №017746 |
1206 | B05DB | Hypertonic solutions | Dianil PD4 with glucose | solution for peritoneal dialysis 3,86% 2000 ml | RK-MP-5 №017747 |
B05X | Intravenous solution additives | ||||
B05XA | Electrolyte solutions | ||||
B05XA01 | Potassium chloride | ||||
1207 | B05XA01 | Potassium chloride | Potassium chloride | solution for intravenous administration 40 mg/ml 10 ml | RK-MP-5 №013358 |
1208 | B05XA01 | Potassium chloride | Potassium chloride | solution for intravenous administration 40 mg/ml 10 ml | RK-MP-5 №022900 |
1209 | B05XA01 | Potassium chloride | Potassium chloride | solution for intravenous administration 40 mg/ml 5 ml | RK-MP-5 №022900 |
1210 | B05XA01 | Potassium chloride | Potassium chloride | Concentrate for preparation of solution for infusions 40 mg/ml, 10ml | RK-MP-5 №024390 |
1211 | B05XA01 | Potassium chloride | Potassium chloride | Solution for intravenous administration 40 mg/ml, 10ml | RK-MP-5 №024315 |
B05XA05 | Magnesium sulfate | ||||
1212 | B05XA05 | Magnesium sulfate | Magnesium sulfate | solution for injections 250 mg/ml, 5ml | RK-MP-5 №019301 |
1213 | B05XA05 | Magnesium sulfate | Magnesium sulfate- Darnitsa | Solution for intramuscular and intravenous administration 25% 5 ml | RK-MP-5 №015449 |
1214 | B05XA05 | Magnesium sulfate | Magnesium sulfate- Darnitsa | Solution for intramuscular and intravenous administration 25% 10 ml | RK-MP-5 №015449 |
1215 | B05XA05 | Magnesium sulfate | Magnesium sulfate | solution for injections 25% 5 ml | RK-MP-5 №014343 |
1216 | B05XA05 | Magnesium sulfate | Magnesium sulfate | solution for intravenous administration 250 mg/ml, 10ml | RK-MP-5 №018584 |
B05XA07 | Calcium chloride | ||||
1217 | B05XA07 | Calcium chloride | Calcium chloride-Darnitsa | solution for injections10% 5 ml | RK-MP-5 №000142 |
1218 | B05XA07 | Calcium chloride | Calcium chloride | solution for injections10% 5 ml | RK-MP-5 №015110 |
1219 | B05XA07 | Calcium chloride | Calcium chloride | solution for intravenous administration100 mg/ml 10 ml | RK-MP-5 №022337 |
B05XA16 | Custodiol | ||||
B06 | Other hematological drugs | ||||
B06AA | Enzyme preparations | ||||
B06AA03 |
Hyaluronidase | ||||
1220 | B06AA03 | Hyaluronidase | Lidaza-Biopharma | powder for preparation of solution for injections 64 UNITS | RK-MP-5 №022923 |
B06AC01 | Human C1-esterase inhibitor | ||||
1221 | B06AC01 | Human C1-esterase inhibitor | Cinrise | lyophilizate for preparation of solution for intravenous administration 500 IU | orphan |
C | The cardiovascular system | ||||
C01 | Drugs for the treatment of heart disease | ||||
C01A | Cardiac glycosides | ||||
C01AA | Digitalis glycosides | ||||
C01AA05 | Digoxin | ||||
1222 | C01AA05 | Digoxin | Digoxin | solution for injections 0,25 mg/ml, 1ml | RK-MP-5 №013040 |
1223 | C01AA05 | Digoxin | Digoxin Grindeks | tablets 0,25 mg | RK-MP-5 №002437 |
1224 | C01AA05 | Digoxin | Digoxin | tablets 0,25 mg | RK-MP-5 №015693 |
C01B | Class I and III antiarrhythmic drugs | ||||
C01BC | Class IC antiarrhythmic drugs | ||||
C01BC03 | Propafenone | ||||
1225 | C01BC03 | Propafenone | Propanorm® | coated tablets, 300 mg | RK-MP-5 №000391 |
1226 | C01BC03 | Propafenone | Propanorm® | coated tablets, 150 mg | RK-MP-5 №004550 |
C01BD | Class III antiarrhythmic drug | ||||
C01BD01 | Amiodarone Amiodarone | ||||
1227 | C01BD01 | Amiodarone | Santodarone | solution for injections150 mg/3 ml | RK-MP-3 №021464 |
1228 | C01BD01 | Amiodarone | Amiodarone | tablets 200 mg | RK-MP-5 №016246 |
1229 | C01BD01 | Amiodarone | Amiocordin® | solution for injections150 mg/3 ml | RK-MP-5 №021610 |
1230 | C01BD01 | Amiodarone | Amiodarone | solution for injections 50 mg/ml, 3 ml | RK-MP-5 №021569 |
1231 | C01BD01 | Amiodarone | Amiocordin® | tablets 200 mg | RK-MP-5 №003584 |
1232 | C01BD01 | Amiodarone | Cordaron® | tablets divisible 200 mg | RK-MP-5 №013050 |
C01C | Cardiotonic drugs, excluding cardiac glycosides | ||||
C01CA | Adrenergic and dopaminomimetics | ||||
C01CA03 | Norepinephrine | ||||
C01CA04 | Dopamine | ||||
1233 | C01CA04 | Dopamine | Dofamin-Darnitsa | concentrate for preparation of solution for infusions 0.5% 5 ml | RK-MP-5 №014859 |
1234 | C01CA04 | Dopamine | Dofamin-Darnitsa | concentrate for preparation of solution for infusions 4% 5 ml | RK-MP-5 №014860 |
1235 | C01CA04 | Dopamine | Dopamine | solution for injections 4% 5 ml | RK-MP-3 №021477 |
1236 | C01CA04 | Dopamine | Dopamine |
concentrate for preparation of solution for infusions 5 mg/ml, | RK-MP-5 №018894 |
1237 | C01CA04 | Dopamine | Dopamine |
concentrate for preparation of solution for infusions 40 mg/ml, | RK-MP-5 №018895 |
C01CA06 | Phenylephrine | ||||
1238 | C01CA06 | Phenylephrine | Mezaton | solution for injections 10mg/ml, 1ml | RK-MP-5 №012489 |
C01CA07 | Dobutamine | ||||
C01CA24 | Epinephrine | ||||
1239 | C01CA24 | Epinephrine | Adrenaline-Zdorovye | solution for injections 0,18 % 1 ml | RK-MP-5 №011371 |
C01CX | Other cardiotonic drugs | ||||
C01CX08 | Levosimendan | ||||
1240 | C01CX08 | Levosimendan | Simdax |
concentrate for preparation of solution for infusions 2.5 mg/ml, | RK-MP-5 №017616 |
C01D | Peripheral vasodilators used to treat heart diseases | ||||
C01DA | Organic nitrates | ||||
C01DA02 | Nitroglycerine | ||||
1241 | C01DA02 | Nitroglycerine | Nitroglycerine-KZ | tablets sublingual 0,5 mg | RK-MP-5 №014078 |
1242 | C01DA02 | Nitroglycerine | Nitromint® | aerosol sublingual dosed 0.4 mg / dose, 10 g (180 doses) | RK-MP-5 №010074 |
1243 | C01DA02 | Nitroglycerine | Nitroglycerine-Zdorovye | tablets 0,5 mg | RK-MP-5 №023578 |
1244 | C01DA02 | Nitroglycerine | Nitrospray® | Spray sublingual dosed 0.4mg / dose, 10 ml (200 doses) | RK-MP-5 №122021 |
C01DA08 | Isosorbide dinitrate | ||||
1245 | C01DA08 | Isosorbide dinitrate | ISO-MIK | spray sublingual dosed 1.25 mg / dose 15 ml | RK-MP-5 №013582 |
1246 | C01DA08 | Isosorbide dinitrate | Iso-Mik | concentrate for preparation of solution for infusions 1 mg / ml 10 ml | RK-MP-5 №013518 |
1247 | C01DA08 | Isosorbide dinitrate | Isosorbide dinitrate | concentrate for preparation of solution for infusions 0,1% 10 ml | RK-MP-5 №022246 |
1248 | C01DA08 | Isosorbide dinitrate | Iso-Mik Long | tablets of prolonged action 60 mg | RK-MP-5 №018859 |
1249 | C01DA08 | Isosorbide dinitrate | Iso-Mik Long | tablets of prolonged action 40 mg | RK-MP-5 №018858 |
1250 | C01DA08 | Isosorbide dinitrate | Iso-Mik Long | tablets of prolonged action 20 mg | RK-MP-5 №018857 |
1251 | C01DA08 | Isosorbide dinitrate | Isoket® | spray dosed 1.25 mg / dose, 15ml | RK-MP-5 №018953 |
1252 | C01DA08 | Isosorbide dinitrate | Cardiket® | tablets with prolonged release 20 mg | RK-MP-5 №019208 |
1253 | C01DA08 | Isosorbide dinitrate | Cardiket® | tablets with prolonged release 40 mg | RK-MP-5 №019209 |
C01DA14 | Isosorbide mononitrate | ||||
1254 | C01DA14 | Isosorbide mononitrate | Nitrosorbide | tablets 10 mg | RK-MP-5 №002250 |
1255 | C01DA14 | Isosorbide mononitrate | Monosan® | tablets 40 mg | RK-MP-5 №003947 |
1256 | C01DA14 | Isosorbide mononitrate | Monosan® | tablets 20 mg | RK-MP-5 №003943 |
C01E | Other drugs to treat heart diseases | ||||
C01EA | Prostaglandins | ||||
C01EA01 | Alprostadil | ||||
1257 | C01EA01 | Alprostadil | Alprestil | concentrate for preparation of solution for infusions 20 mcg, 1ml | RK-MP-5 №020519 |
1258 | C01EA01 | Alprostadil | VAZOSTENON | concentrate for preparation of solution for infusions 20 mcg, 1ml | RK-MP-5 №023677 |
C01EB | Other drugs to treat heart diseases | ||||
C01EB17 | Ivabradin | ||||
1259 | C01EB17 | Ivabradin | Bravadin® | film-coated tablets, 5 mg | RK-MP-5 №121911 |
1260 | C01EB17 | Ivabradin | Bravadin® | film-coated tablets, 7,5 mg | RK-MP-5 №121912 |
1261 | C01EB17 | Ivabradin | Coraxan® | coated tablets, 5 mg | RK-MP-5 №009978 |
1262 | C01EB17 | Ivabradin | Coraxan® | coated tablets, 7,5 mg | RK-MP-5 №009979 |
1263 | C01EB17 | Ivabradin | Ivab | film-coated tablets, 7,5 mg | RK-MP-5 №022679 |
1264 | C01EB17 | Ivabradin | Ivab | film-coated tablets, 5 mg | RK-MP-5 №022745 |
1265 | C01EB17 | Ivabradin | IVACARD® | film-coated tablets, 5 mg | RK-MP-5 №023941 |
1266 | C01EB17 | Ivabradin | IVACARD® | film-coated tablets, 7,5 mg | RK-MP-5 №023942 |
1267 | C01EB17 | Ivabradin | Raenom® | film-coated tablets, 5 mg | RK-MP-5 №024016 |
1268 | C01EB17 | Ivabradin | Raenom® | film-coated tablets, 7,5 mg | RK-MP-5 №024017 |
C01EB18 | Ranolazine | ||||
1269 | C01EB18 | Ranolazine | Ranexa® | film-coated tablets of prolonged action 1000 mg | RK-MP-5 №018651 |
1270 | C01EB18 | Ranolazine | Ranexa® | film-coated tablets of prolonged action 500 mg | RK-MP-5 №018650 |
1271 | C01EB18 | Ranolazine | RanSV | film-coated tablets with prolonged release, 1000 mg | RK-MP-5 №022775 |
1272 | C01EB18 | Ranolazine | RanSV | film-coated tablets with prolonged release, 500 mg | RK-MP-5 №022774 |
1273 | C01EB18 | Ranolazine | Ranocardum® | film-coated tablets with prolonged release, 1000 mg | RK-MP-5 №022879 |
1274 | C01EB18 | Ranolazine | Ranocardum® | film-coated tablets with prolonged release 750 mg | RK-MP-5 №022880 |
1275 | C01EB18 | Ranolazine | Ranocardum® | film-coated tablets with prolonged release 500 mg | RK-MP-5 №022881 |
C02 | Antihypertensive drugs | ||||
C02A | Centrally acting drugs that reduce the stimulating effect of adrenergic innervation | ||||
C02AB | Methyldopa | ||||
C02AB01 | Methyldopa | ||||
1276 | C02AB01 | Methyldopa | Dopegit® | tablets 250 mg | RK-MP-5 №015863 |
C02AC | Imidazoline receptor agonists | ||||
C02AC01 | Clonidine | ||||
1277 | C02AC01 | Clonidine | Klofelin-Zdorovye | tablets 0,15 mg | RK-MP-5 №014316 |
C02AC05 | Moxonidine | ||||
1278 | C02AC05 | Moxonidine | Moxonidine-Teva | film-coated tablets 0,2 mg | RK-MP-5 №021061 |
1279 | C02AC05 | Moxonidine | Moxonidine-Teva | film-coated tablets 0,4 mg | RK-MP-5 №021062 |
1280 | C02AC05 | Moxonidine | Physiotens® | coated tablets 0,4 mg | RK-MP-5 №121825 |
1281 | C02AC05 | Moxonidine | Physiotens® | coated tablets 0,4 mg | RK-MP-5 №018401 |
1282 | C02AC05 | Moxonidine | Physiotens® | coated tablets 0,2 mg | RK-MP-5 №121824 |
1283 | C02AC05 | Moxonidine | Physiotens® | coated tablets 0,2 mg | RK-MP-5 №018402 |
1284 | C02AC05 | Moxonidine | Physiotens® | film-coated tablets 0,4 mg | RK-MP-5 №024137 |
1285 | C02AC05 | Moxonidine | Physiotens® | film-coated tablets 0,2 mg | RK-MP-5 №024138 |
1286 | C02AC05 | Moxonidine | Moxonidine-SZ | film-coated tablets 0,2 mg | RK-MP-5 №023921 |
1287 | C02AC05 | Moxonidine | Moxonidine-SZ | film-coated tablets 0,4 mg | RK-MP-5 №023905 |
1288 | C02AC05 | Moxonidine | Moxonidine-SZ | film-coated tablets 0,3 mg | RK-MP-5 №023906 |
1289 | C02AC05 | Moxonidine | Physiotens® | coated tablets 0,3 mg | RK-MP-5 №018400 |
1290 | C02AC05 | Moxonidine | Physionext® | film-coated tablets 0,2 mg | RK-MP-5 №022603 |
1291 | C02AC05 | Moxonidine | Physionext® | film-coated tablets 0,3 mg | RK-MP-5 №022604 |
1292 | C02AC05 | Moxonidine | Physionext® | film-coated tablets 0,4 mg | RK-MP-5 №022605 |
1293 | C02AC05 | Moxonidine | Moxonidine | film-coated tablets 0,2 mg | RK-MP-5 №021362 |
1294 | C02AC05 | Moxonidine | Moxonidine | film-coated tablets 0,4 mg | RK-MP-5 №021364 |
C02C | Peripheral antiadrenergic drugs | ||||
C02CA | Alpha-adrenoblockers | ||||
C02CA04 | Doxazosin | ||||
1295 | C02CA04 | Doxazosin | Kardura® | tablets 2 mg | RK-MP-5 №010828 |
1296 | C02CA04 | Doxazosin | Kardura® | tablets 4 mg | RK-MP-5 №010829 |
1297 | C02CA04 | Doxazosin | Zoxon | tablets 2 mg | RK-MP-5 №019430 |
1298 | C02CA04 | Doxazosin | Zoxon | tablets 4 mg | RK-MP-5 №019429 |
1299 | C02CA04 | Doxazosin | Kardura XL® | coated tablets with prolonged release 4 mg | RK-MP-5 №021315 |
1300 | C02CA04 | Doxazosin | Kardura XL® | coated tablets with prolonged release 8 mg | RK-MP-5 №021316 |
C02CA06 | Urapidil | ||||
1301 | C02CA06 | Urapidil | Ebrantil® | solution for intravenous administration 5 mg/ml 5 ml | RK-MP-5 №020597 |
1302 | C02CA06 | Urapidil | Ebrantil® | solution for intravenous administration 5 mg/ml 10 ml | RK-MP-5 №020597 |
1303 | C02CA06 | Urapidil | Tachyben® | solution for intravenous administration 5 mg/ml 5 ml | RK-MP-5 №022025 |
1304 | C02CA06 | Urapidil | Tachyben® | solution for intravenous administration 5 mg/ml 10 ml | RK-MP-5 №022025 |
1305 | C02CA06 | Urapidil | Ebrantil® | Capsules with modified release 30 mg | RK-MP-5 №020589 |
C02K | Other antihypertensive drugs | ||||
C02KX | Other antihypertensive drugs | ||||
C02KX01 | Bosentan | orphan | |||
1306 | C02KX01 | Bosentan | Tracleer® | coated tablets 125 mg | RK-MP-5 №015513 |
1307 | C02KX01 | Bosentan | Pulmofest | film-coated tablets 125 mg | RK-MP-5 №020737 |
1308 | C02KX01 | Bosentan | Tracleer® | coated tablets 125 mg | RK-MP-5 №015511 |
1309 | C02KX01 | Bosentan | Usenta 125® | film-coated tablets 125 mg | RK-MP-5 №020437 |
1310 | C02KX01 | Bosentan | Rankler | film-coated tablets 125 mg | RK-MP-5 №022760 |
1311 | C02KX01 | Bosentan | Rankler | film-coated tablets 62,5 mg | RK-MP-5 №022762 |
1312 | C02KX01 | Bosentan | Tasotan | film-coated tablets 125 mg | RK-MP-5 №022731 |
C02KX02 | Ambrisentan | ||||
1313 | C02KX02 | Ambrisentan | Volibris® | film-coated tablets 5 mg | RK-MP-5 №022096 |
1314 | C02KX02 | Ambrisentan | Volibris® | film-coated tablets 10 mg | RK-MP-5 №022097 |
C02KX04 | Macitentan | orphan | |||
1315 | C02KX04 | Macitentan | Opsamit | tablets 10 mg | |
C02KX05 | Riociguat | ||||
1316 | C02KX05 | Riociguat | Adempas® | film-coated tablets 0,5 mg | RK-MP-5 №021623 |
1317 | C02KX05 | Riociguat | Adempas® | film-coated tablets 1,5 mg | RK-MP-5 №021631 |
1318 | C02KX05 | Riociguat | Adempas® | film-coated tablets 2,5 mg | RK-MP-5 №021626 |
1319 | C02KX05 | Riociguat | Adempas® | film-coated tablets 2 mg | RK-MP-5 №021624 |
1320 | C02KX05 | Riociguat | Adempas® | film-coated tablets 1 mg | RK-MP-5 №021625 |
C03 | Diuretics | ||||
C03A | Thiazide diuretics | ||||
C03AA03 | Hydrochlorothiazide | ||||
1321 | C03AA03 | Hydrochlorothiazide | Hypothiazide® | tablets 100 mg | RK-MP-5 №013403 |
1322 | C03AA03 | Hydrochlorothiazide | Hydrochlorothiazide | tablets 25 mg | RK-MP-5 №021121 |
1323 | C03AA03 | Hydrochlorothiazide | Hypothiazide® | tablets 25 mg | RK-MP-5 №013402 |
C03B | Non-thiazide diuretics | ||||
C03BA04 | Chlorthalidone | ||||
1324 | C03BA04 | Chlorthalidone | Dichlor | tablets 12,5 mg | RK-MP-5 №022611 |
1325 | C03BA04 | Chlorthalidone | Dichlor | tablets 25 mg | RK-MP-5 №022612 |
1326 | C03BA04 | Chlorthalidone | Dichlor | tablets 50 mg | RK-MP-5 №022738 |
C03BA11 | Indapamide | ||||
1327 | C03BA11 | Indapamide | SR-Indamed | Film-coated tablets with prolonged release 1,5 mg | RK-MP-5 №019271 |
1328 | C03BA11 | Indapamide | Arifon® Retard | film-coated tablets with prolonged release 1,5 mg | RK-MP-5 №013605 |
1329 | C03BA11 | Indapamide | Indap® | tablets 2,5 mg | RK-MP-5 №019764 |
1330 | C03BA11 | Indapamide | Indapamide | coated tablets 2,5 mg | RK-MP-5 №016275 |
1331 | C03BA11 | Indapamide | Indapafon | coated tablets 2,5 mg | RK-MP-5 №014122 |
1332 | C03BA11 | Indapamide | Indapamide SR | coated tablets with prolonged release 1,5 mg | RK-MP-5 №016280 |
1333 | C03BA11 | Indapamide | Indapamide- Teva 1.5 mg | film-coated tablets with prolonged release 1,5 mg | RK-MP-5 №014770 |
1334 | C03BA11 | Indapamide | Ravel® SR | Film-coated tablets with prolonged release 1,5 mg | RK-MP-5 №019819 |
1335 | C03BA11 | Indapamide | Indap® | capsules 2,5 mg | RK-MP-5 №010136 |
1336 | C03BA11 | Indapamide | Indamide | coated tablets 2,5 mg | RK-MP-5 №015844 |
1337 | C03BA11 | Indapamide | Indap® | tablets 0,625 mg | RK-MP-5 №019762 |
1338 | C03BA11 | Indapamide | Indap® | tablets 1,25 mg | RK-MP-5 №019763 |
1339 | C03BA11 | Indapamide | Flupamide SR-sanovel | coated tablets with prolonged release1,5 mg | RK-MP-5 №004858 |
1340 | C03BA11 | Indapamide | Indalong | coated tablets with prolonged release 1,5 mg | RK-MP-5 №022645 |
1341 | C03BA11 | Indapamide | Darzox | tablets with prolonged release 1,5 mg | RK-MP-5 №121731 |
1342 | C03BA11 | Indapamide | Indapamide | film-coated tablets 2,5 mg | RK-MP-5 №015884 |
C03C | "Loop" diuretics | ||||
C03CA | Sulfonamide diuretics | ||||
C03CA01 | Furosemide | ||||
1343 | C03CA01 | Furosemide | Furosemide | solution for injections10 mg/ml по 2 ml | RK-MP-5 №011635 |
1344 | C03CA01 | Furosemide | Furosemide | tablets 40 mg | RK-MP-5 №021301 |
1345 | C03CA01 | Furosemide | Furosemide | tablets 40 mg | RK-MP-5 №015734 |
1346 | C03CA01 | Furosemide | Furosemide | solution for injections 1% 2 ml | RK-MP-5 №013872 |
1347 | C03CA01 | Furosemide | Lasix® | solution for intravenous and intramuscular administration 10 mg/ml, 2ml | RK-MP-5 №014653 |
C03CA04 | Torasemide | ||||
1348 | C03CA04 | Torasemide | Trigrim | tablets 10 mg | RK-MP-5 №016739 |
1349 | C03CA04 | Torasemide | Toragamma® 10mg | tablets 10 mg | RK-MP-5 №018040 |
1350 | C03CA04 | Torasemide | Trigrim | tablets 2,5 mg | RK-MP-5 №016737 |
1351 | C03CA04 | Torasemide | Toragamma® 2,5mg | tablets 2,5 mg | RK-MP-5 №018038 |
1352 | C03CA04 | Torasemide | Trigrim | tablets 5 mg | RK-MP-5 №016738 |
1353 | C03CA04 | Torasemide | Torasemide | tablets 5 mg | RK-MP-5 №122127 |
1354 | C03CA04 | Torasemide | Torasemide | tablets 10 mg | RK-MP-5 №122128 |
1355 | C03CA04 | Torasemide | Britomar | tablets with prolonged release 10 mg | RK-MP-5 №016602 |
1356 | C03CA04 | Torasemide | Torsid | tablets 10 mg | RK-MP-5 №015861 |
1357 | C03CA04 | Torasemide | Torsid | tablets 5 mg | RK-MP-5 №015860 |
1358 | C03CA04 | Torasemide | Tadreta | tablets 10 mg | RK-MP-5 №023672 |
1359 | C03CA04 | Torasemide | Tadreta | tablets, 5 mg | RK-MP-5 №023671 |
1360 | C03CA04 | Torasemide | Toragamma® 5mg | tablets 5 mg | RK-MP-5 №018039 |
1361 | C03CA04 | Torasemide | Torasemide | tablets 20 mg | RK-MP-5 №122129 |
1362 | C03CA04 | Torasemide | Britomar | tablets with prolonged release 5 mg | RK-MP-5 №016601 |
C03CC | Aryloxyacetic acid derivatives | ||||
C03D | Potassium-sparing diuretics | ||||
C03DA | Aldosterone antagonists | ||||
C03DA01 | Spironolactone | ||||
1363 | C03DA01 | Spironolactone | Veroshpiron® | tablets 25 mg | RK-MP-5 №014449 |
1364 | C03DA01 | Spironolactone | Veroshpiron® | capsules 100 mg | RK-MP-5 №014161 |
1365 | C03DA01 | Spironolactone | Veroshpiron® | capsules 50 mg | RK-MP-5 №014162 |
1366 | C03DA01 | Spironolactone | Aldaron® | tablets 25 mg | RK-MP-5 №015623 |
1367 | C03DA01 | Spironolactone | Aldaron® | capsules 100 mg | RK-MP-5 №015568 |
1368 | C03DA01 | Spironolactone | Spylacton | film-coated tablets 50 mg | RK-MP-5 №022940 |
1369 | C03DA01 | Spironolactone | Spylacton | film-coated tablets 25 mg | RK-MP-5 №022939 |
1370 | C03DA01 | Spironolactone | Spylacton | film-coated tablets 100 mg | RK-MP-5 №022941 |
1371 | C03DA01 | Spironolactone | Aldaron® | capsules 50 mg | RK-MP-5 №015567 |
C03DA04 | Eplerenone | ||||
1372 | C03DA04 | Eplerenone | Espiro | film-coated tablets 50 mg | RK-MP-5 №020233 |
1373 | C03DA04 | Eplerenone | Espiro | film-coated tablets 25 mg | RK-MP-5 №020232 |
1374 | C03DA04 | Eplerenone | Epnon® | film-coated tablets 25 mg | RK-MP-5 №020747 |
1375 | C03DA04 | Eplerenone | Epnon® | film-coated tablets 50 mg | RK-MP-5 №020746 |
1376 | C03DA04 | Eplerenone | Eplerin | film-coated tablets 50 mg | RK-MP-5 №022682 |
1377 | C03DA04 | Eplerenone | Eplerin | film-coated tablets 25 mg | RK-MP-5 №022683 |
1378 | C03DA04 | Eplerenone | Laylenon | film-coated tablets 25 mg | RK-MP-5 №121954 |
1379 | C03DA04 | Eplerenone | Laylenon | film-coated tablets 50 mg | RK-MP-5 №121955 |
1380 | C03DA04 | Eplerenone | Eplistra-Teva | film-coated tablets 25 mg | RK-MP-5 №021307 |
1381 | C03DA04 | Eplerenone | Eplistra-Teva | film-coated tablets 50 mg | RK-MP-5 №021306 |
C03E | Combination of diuretics with potassium-sparing drugs | ||||
C03EA | Diuretics acting on the cortical segment of the henle loop, in combination with potassium-sparing drugs | ||||
C03EA01 | Hydrochlorothiazide and triamterene | ||||
1382 | C03EA01 | Hydrochlorothiazide and triamterene | Triampur compositum | tablets 25/12,5 mg | RK-MP-5 №015802 |
1383 | C03EA01 | Hydrochlorothiazide and triamterene | NOLAKSEN | coated tablets 25 mg/25 mg | RK-MP-5 №015794 |
C04 | Peripheral vasodilators | ||||
C04AC | Nicotinic acid and its derivatives | ||||
C04AC01 | Nicotinic acid | ||||
1384 | C04AC01 | Nicotinic acid | Nicotinic acid - Darnitsa | solution for injections 1% 1 ml | RK-MP-5 №008762 |
1385 | C04AC01 | Nicotinic acid | Nicotinic acid | solution for injections 1% 1ml | RK-MP-5 №009415 |
C04AD | Purines | ||||
C04AD03 | Pentoxifylline | ||||
1386 | C04AD03 | Pentoxifylline | Trental® 400 | film-coated tablets with prolonged release 400 mg | RK-MP-5 №013837 |
1387 | C04AD03 | Pentoxifylline | Vasonit® retard | film-coated tablets with prolonged release 600 mg | RK-MP-5 №020470 |
1388 | C04AD03 | Pentoxifylline | Trental® | concentrate for preparation of solution for infusions 20 mg / ml 5 ml | RK-MP-5 №004035 |
1389 | C04AD03 | Pentoxifylline | Latren | solution for infusions 0,5mg/ml по 200 ml | RK-MP-5 №122146 |
1390 | C04AD03 | Pentoxifylline | Pentoxifylline | solution for injections 2% 5 ml | RK-MP-5 №010015 |
C05 | Angioprotectors | ||||
C05AD03 | Benzocaine | ||||
1391 | C05AD03 | Benzocaine | Relief® Advance | Rectal suppositories | RK-MP-5 №014747 |
1392 | C05AD03 | Benzocaine | Relief® Advance | Rectal ointment 28.4 g in a tube. | RK-MP-5 №004394 |
C07 | Beta-adrenoblockers | ||||
C07A | Beta-adrenoblockers | ||||
C07AA | Non-selective beta- adrenoblockers | ||||
C07AA05 | Propranolol | ||||
1393 | C07AA05 | Propranolol | Anaprilin | tablets 40 mg | RK-MP-5 №020012 |
1394 | C07AA05 | Propranolol | Hemangiol® | oral solution 3.75 mg / ml 120 ml | RK-MP-5 №022615 |
1395 | C07AA05 | Propranolol | Anaprilin | tablets 40 mg | RK-MP-5 №010290 |
1396 | C07AA05 | Propranolol | Anaprilin | tablets 10 mg | RK-MP-5 №010289 |
C07AB | Selective beta- adrenoblockers | ||||
C07AB02 | Metoprolol | ||||
1397 | C07AB02 | Metoprolol | Metoprolol- ratiopharm | tablets 100 mg | RK-MP-5 №021049 |
1398 | C07AB02 | Metoprolol | Corvitol® 50 | tablets 50 mg | RK-MP-5 №015910 |
1399 | C07AB02 | Metoprolol | Metoprolol- ratiopharm | tablets 50 mg | RK-MP-5 №021050 |
1400 | C07AB02 | Metoprolol | Egilok® | tablets 50 mg | RK-MP-5 №012141 |
1401 | C07AB02 | Metoprolol | Мет XL*50 | coated tablets of prolonged action 50 mg | RK-MP-5 №016554 |
1402 | C07AB02 | Metoprolol | Promerol® | solution for injections 1 mg / ml 5 ml | RK-MP-5 №022443 |
1403 | C07AB02 | Metoprolol | Betaloc® | solution for intravenous administration 1 mg/ml 5 ml | RK-MP-5 №017152 |
1404 | C07AB02 | Metoprolol | Revelol XL 50 | film-coated tablets with prolonged release 50 mg | RK-MP-5 №018775 |
1405 | C07AB02 | Metoprolol | Revelol XL 100 | film-coated tablets with prolonged release 100 mg | RK-MP-5 №018776 |
1406 | C07AB02 | Metoprolol | Betaloc® ZOK | film-coated tablets with prolonged release 200 mg | RK-MP-5 №024392 |
1407 | C07AB02 | Metoprolol | Betaloc® ZOK | film-coated tablets with prolonged release 100 mg | RK-MP-5 №024393 |
1408 | C07AB02 | Metoprolol | Metoprolol | solution for injections 1mg/ml, 5ml | RK-MP-5 №024233 |
1409 | C07AB02 | Metoprolol | Egilok® | tablets 25 mg | RK-MP-5 №012140 |
1410 | C07AB02 | Metoprolol | Egilok® | tablets 100 mg | RK-MP-5 №012142 |
1411 | C07AB02 | Metoprolol | Bloxazok | film-coated tablets with prolonged release 25 mg | RK-MP-5 №023513 |
1412 | C07AB02 | Metoprolol | Bloxazok | film-coated tablets with prolonged release 50 mg | RK-MP-5 №023514 |
1413 | C07AB02 | Metoprolol | Bloxazok | film-coated tablets with prolonged release 100 mg | RK-MP-5 №023516 |
1414 | C07AB02 | Metoprolol | Bloxazok | film-coated tablets with prolonged release 200 mg | RK-MP-5 №023517 |
1415 | C07AB02 | Metoprolol | Metomak | tablets with prolonged release 25 mg | RK-MP-5 №022963 |
1416 | C07AB02 | Metoprolol | Metomak | tablets with prolonged release 50 mg | RK-MP-5 №022964 |
1417 | C07AB02 | Metoprolol | Metomak | tablets with prolonged release 100 mg | RK-MP-5 №022965 |
C07AB03 | Atenolol | ||||
1418 | C07AB03 | Atenolol | Atenolol- Teva | coated tablets 25 mg | RK-MP-5 №010016 |
1419 | C07AB03 | Atenolol | Атенолол-Teva | coated tablets 50 mg | RK-MP-5 №005910 |
C07AB05 | Betaxolol | ||||
1420 | C07AB05 | Betaxolol | Betak | coated tablets 20 mg | RK-MP-5 №009856 |
1421 | C07AB05 | Betaxolol | Betak | film-coated tablets 10 mg | RK-MP-5 №121701 |
C07AB07 | Bisoprolol | ||||
1422 | C07AB07 | Bisoprolol | Niperten® | film-coated tablets 10 mg | RK-MP-5 №018318 |
1423 | C07AB07 | Bisoprolol | Biprol | film-coated tablets 5 mg | RK-MP-5 №016755 |
1424 | C07AB07 | Bisoprolol | Niperten® | film-coated tablets 5 mg | RK-MP-5 №018317 |
1425 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 2,5 mg | RK-MP-5 №021358 |
1426 | C07AB07 | Bisoprolol | Concor® Cor | film-coated tablets 2,5 mg | RK-MP-5 №003593 |
1427 | C07AB07 | Bisoprolol | Bisoprolol | film-coated tablets 10mg | RK-MP-5 №022248 |
1428 | C07AB07 | Bisoprolol | Bisoprolol | film-coated tablets 5 mg | RK-MP-5 №022247 |
1429 | C07AB07 | Bisoprolol |
Biol® | film-coated tablets 2,5 mg | RK-MP-5 №020743 |
1430 | C07AB07 | Bisoprolol |
Bisomor | film-coated tablets 10 mg | RK-MP-5 №019276 |
1431 | C07AB07 | Bisoprolol | Belandzh | film-coated tablets 10 mg | RK-MP-5 №021430 |
1432 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 10 mg | RK-MP-5 №023794 |
1433 | C07AB07 | Bisoprolol | Biprol | film-coated tablets 10 mg | RK-MP-5 №016760 |
1434 | C07AB07 | Bisoprolol | CARDORITHM® | film-coated tablets 10 mg | RK-MP-5 №022822 |
1435 | C07AB07 | Bisoprolol | Bisoprol-Farmak | tablets, 10 mg | RK-MP-5 №022532 |
1436 | C07AB07 | Bisoprolol | Bisoprolol VIVA FARM | coated tablets 10 mg | RK-MP-5 №022198 |
1437 | C07AB07 | Bisoprolol | Bisomor | film-coated tablets 5 mg | RK-MP-5 №019275 |
1438 | C07AB07 | Bisoprolol | Belandzh | film-coated tablets 5 mg | RK-MP-5 №021429 |
1439 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 5 mg | RK-MP-5 №023795 |
1440 | C07AB07 | Bisoprolol | CARDORITHM® | film-coated tablets 5 mg | RK-MP-5 №022821 |
1441 | C07AB07 | Bisoprolol | Bisoprolol VIVA FARM | coated tablets 5 mg | RK-MP-5 №022197 |
1442 | C07AB07 | Bisoprolol | Bisoprol-Farmak | tablets 5 mg | RK-MP-5 №022531 |
1443 | C07AB07 | Bisoprolol | Bisomor | film-coated tablets 2,5 mg | RK-MP-5 №019274 |
1444 | C07AB07 | Bisoprolol | Niperten® | film-coated tablets 2,5 mg | RK-MP-5 №018316 |
1445 | C07AB07 | Bisoprolol | Belandzh | film-coated tablets 2,5 mg | RK-MP-5 №021428 |
1446 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 2,5 mg | RK-MP-5 №023793 |
1447 | C07AB07 | Bisoprolol | Bisoprol-Farmak | tablets 2,5 mg | RK-MP-5 №022536 |
1448 | C07AB07 | Bisoprolol | CARDORITHM® | film-coated tablets 2,5 mg | RK-MP-5 №022820 |
1449 | C07AB07 | Bisoprolol | Bisoprolol VIVA FARM | coated tablets 2,5 mg | RK-MP-5 №022196 |
1450 | C07AB07 | Bisoprolol | Biol® | film-coated tablets 5 mg | RK-MP-5 №020742 |
1451 | C07AB07 | Bisoprolol | Biol® | film-coated tablets 10 mg | RK-MP-5 №020741 |
1452 | C07AB07 | Bisoprolol | Bisoprolol-Teva | tablets 5 mg | RK-MP-5 №024249 |
1453 | C07AB07 | Bisoprolol | Bisoprolol-Teva | tablets 10 mg | RK-MP-5 №024250 |
1454 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 5 mg | RK-MP-5 №019958 |
1455 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 10 mg | RK-MP-5 №019959 |
1456 | C07AB07 | Bisoprolol | Rizoprol | coated tablets 5 mg | RK-MP-5 №023800 |
1457 | C07AB07 | Bisoprolol | Bisoprolol SANTO | coated tablets 10 mg | RK-MP-5 №023486 |
1458 | C07AB07 | Bisoprolol | Bisoprolol SANTO | coated tablets 5 mg | RK-MP-5 №023487 |
1459 | C07AB07 | Bisoprolol | Bisoprolol SANTO | coated tablets 2,5 mg | RK-MP-5 №023489 |
1460 | C07AB07 | Bisoprolol | Bisoprolol - Teva | tablets 2,5mg | RK-MP-5 №019601 |
1461 | C07AB07 | Bisoprolol | Biprol | film-coated tablets 2,5 mg | RK-MP-5 №023011 |
1462 | C07AB07 | Bisoprolol | Bidop® | tablets 2,5 mg | RK-MP-5 №018479 |
1463 | C07AB07 | Bisoprolol | Bidop® | tablets 5 mg | RK-MP-5 №018480 |
1464 | C07AB07 | Bisoprolol | Bidop® | tablets 10 mg | RK-MP-5 №018481 |
1465 | C07AB07 | Bisoprolol | Coronal | film-coated tablets 5 mg | RK-MP-5 №003595 |
1466 | C07AB07 | Bisoprolol | Coronal | film-coated tablets 10 mg | RK-MP-5 №003594 |
1467 | C07AB07 | Bisoprolol | Bisotexa® | tablets 2,5 mg | RK-MP-5 №121713 |
1468 | C07AB07 | Bisoprolol | Bisotexa® | tablets 5 mg | RK-MP-5 №121712 |
1469 | C07AB07 | Bisoprolol | Bisotexa® | tablets 10 mg | RK-MP-5 №121711 |
1470 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 5mg | RK-MP-5 №021359 |
1471 | C07AB07 | Bisoprolol | Bisoprolol | coated tablets 10 mg | RK-MP-5 №021360 |
1472 | C07AB07 | Bisoprolol | Concor® | Film-coated tablets 5 mg | RK-MP-5 №014587 |
1473 | C07AB07 | Bisoprolol | Concor® | Film-coated tablets 10mg | RK-MP-5 №014588 |
C07AB12 | Nebivolol | ||||
1474 | C07AB12 | Nebivolol | Adelol-Teva | tablets 5 mg | RK-MP-5 №021210 |
1475 | C07AB12 | Nebivolol | Nebilet® | tablets 5 mg | RK-MP-5 №014109 |
1476 | C07AB12 | Nebivolol | Taneleb | tablets 5 mg | RK-MP-5 №020123 |
1477 | C07AB12 | Nebivolol | Nexivol | tablets 5 mg | RK-MP-5 №015808 |
1478 | C07AB12 | Nebivolol | Nebiem | tablets 5 mg | RK-MP-5 №021366 |
1479 | C07AB12 | Nebivolol | OD-Neb | tablets 5 mg | RK-MP-5 №019198 |
1480 | C07AB12 | Nebivolol | Nebiem | tablets 10 mg | RK-MP-5 №021367 |
1481 | C07AB12 | Nebivolol | Nebiworld | tablets 5 mg | RK-MP-5 №023599 |
1482 | C07AB12 | Nebivolol | Nebivol | tablets 5 mg | RK-MP-5 №022873 |
1483 | C07AB12 | Nebivolol | Nebiem | tablets 2,5 mg | RK-MP-5 №021365 |
1484 | C07AB12 | Nebivolol | Nebiem | tablets 20 mg | RK-MP-5 №021368 |
1485 | C07AB12 | Nebivolol | Nebilong-5 | tablets 5 mg | RK-MP-5 №021290 |
C07AG | Alpha, beta- adrenoblockers | ||||
C07AG02 | Carvedilol | ||||
1486 | C07AG02 | Carvedilol | Carvidil® | tablets 25 mg | RK-MP-5 №016337 |
1487 | C07AG02 | Carvedilol | Carvidil® | tablets 6,25 mg | RK-MP-5 №016335 |
1488 | C07AG02 | Carvedilol | Carvedilol-Teva | tablets 25 mg | RK-MP-5 №020364 |
1489 | C07AG02 | Carvedilol | Carvedilol-Teva | tablets 6,25 mg | RK-MP-5 №020365 |
1490 | C07AG02 | Carvedilol | Coriol® | tablets 6,25 mg | RK-MP-5 №009788 |
1491 | C07AG02 | Carvedilol | VEDICARDOL | tablets 6,25 mg | RK-MP-5 №014177 |
1492 | C07AG02 | Carvedilol | VEDICARDOL | tablets 12,5 mg | RK-MP-5 №014178 |
1493 | C07AG02 | Carvedilol | VEDICARDOL | tablets 25 mg | RK-MP-5 №014179 |
1494 | C07AG02 | Carvedilol | Talliton® | tablets 6,25 mg | RK-MP-5 №013537 |
1495 | C07AG02 | Carvedilol | Talliton® | tablets 12,5 mg | RK-MP-5 №013538 |
1496 | C07AG02 | Carvedilol | Talliton® | tablets 25 mg | RK-MP-5 №013539 |
1497 | C07AG02 | Carvedilol | Carvedilol-Тева | tablets 12,5 mg | RK-MP-5 №020363 |
1498 | C07AG02 | Carvedilol | Coriol® | tablets 12,5 mg | RK-MP-5 №009789 |
1499 | C07AG02 | Carvedilol | Coriol® | tablets 25 mg | RK-MP-5 №009790 |
1500 | C07AG02 | Carvedilol | Carvidil® | tablets 12,5 mg | RK-MP-5 №016336 |
C07FB07 | Bisoprolol and Amlodipine | ||||
1501 | C07FB07 | Bisoprolol and Amlodipine | Alotendin® | tablets 10 mg/5 mg | RK-MP-5 №017961 |
1502 | C07FB07 | Bisoprolol and Amlodipine | Alotendin® | tablets 5 mg/5 mg | RK-MP-5 №017959 |
1503 | C07FB07 | Bisoprolol and Amlodipine | Niperten® Combi | tablets 5 mg/10 mg | RK-MP-5 №023997 |
1504 | C07FB07 | Bisoprolol and Amlodipine | Niperten® Combi | tablets 10 mg/ 5 mg | RK-MP-5 №023998 |
1505 | C07FB07 | Bisoprolol and Amlodipine | Niperten® Combi | tablets 10 mg/10 mg | RK-MP-5 №023999 |
1506 | C07FB07 | Bisoprolol and Amlodipine | Niperten® Combi | tablets 5 mg/5 mg | RK-MP-5 №023981 |
1507 | C07FB07 | Bisoprolol and Amlodipine | Alotendin® | tablets 5mg/10mg | RK-MP-5 №017960 |
1508 | C07FB07 | Bisoprolol and Amlodipine | Alotendin® | tablets 10mg/10mg | RK-MP-5 №017962 |
1509 | C07FB07 | Bisoprolol and Amlodipine | Bicard AM | Tablets 5 mg/5 mg | RK-MP-5 №024457 |
1510 | C07FB07 | Bisoprolol and Amlodipine | Bicard AM | Tablets 5 mg/10 mg | RK-MP-5 №024458 |
1511 | C07FB07 | Bisoprolol and Amlodipine | Bicard AM | Tablets 10 mg/5 mg | RK-MP-5 №024459 |
1512 | C07FB07 | Bisoprolol and Amlodipine | Bicard AM | Tablets 10 mg/10 mg | RK-MP-5 №024460 |
C08 | Calcium channel blockers | ||||
C08C | Selective calcium channel blockers with a predominant effect on blood vessels | ||||
C08CA | Dihydropyridine derivatives | ||||
C08CA01 | Amlodipine | ||||
1513 | C08CA01 | Amlodipine | Cardilopin® | tablets 10 mg | RK-MP-5 №010251 |
1514 | C08CA01 | Amlodipine | Normodipin® | tablets 10 mg | RK-MP-5 №009547 |
1515 | C08CA01 | Amlodipine |
Stamlo® | tablets 10 mg | RK-MP-5 №011971 |
1516 | C08CA01 | Amlodipine | Tenox® | tablets 10 mg | RK-MP-5 №003280 |
1517 | C08CA01 | Amlodipine | Amlodimed | tablets 5 mg | RK-MP-5 №016525 |
1518 | C08CA01 | Amlodipine | Amlodipine | tablets 5 mg | RK-MP-5 №021183 |
1519 | C08CA01 | Amlodipine | Cardilopin® | tablets 5 mg | RK-MP-5 №010250 |
1520 | C08CA01 | Amlodipine | Normodipin® | tablets 5 mg | RK-MP-5 №009546 |
1521 | C08CA01 | Amlodipine | Stamlo® | tablets 5 mg | RK-MP-5 №011970 |
1522 | C08CA01 | Amlodipine | Tenox® | tablets 5 mg | RK-MP-5 №003279 |
1523 | C08CA01 | Amlodipine | Aladin | tablets 10 mg | RK-MP-5 №022340 |
1524 | C08CA01 | Amlodipine | Norvask® | tablets 10 mg | RK-MP-5 №014062 |
1525 | C08CA01 | Amlodipine | Amlodimed | tablets 10 mg | RK-MP-5 №016526 |
1526 | C08CA01 | Amlodipine | Norvask® | tablets 5 mg | RK-MP-5 №014061 |
1527 | C08CA01 | Amlodipine | Aladin | tablets 5 mg | RK-MP-5 №022341 |
1528 | C08CA01 | Amlodipine | Amod ™ -10 | tablets 10 mg | RK-MP-5 №018853 |
1529 | C08CA01 | Amlodipine | Amod ™ -5 | tablets 5 mg | RK-MP-5 №018852 |
1530 | C08CA01 | Amlodipine |
Avtorex | tablets 10 mg | RK-MP-5 №020426 |
1531 | C08CA01 | Amlodipine | Amlotop® | tablets 10 mg | RK-MP-5 №010607 |
1532 | C08CA01 | Amlodipine | CORONIM® 5 | tablets 5 mg | RK-MP-5 №015666 |
1533 | C08CA01 | Amlodipine | Avtorex | tablets 5 mg | RK-MP-5 №020425 |
1534 | C08CA01 | Amlodipine |
Lopicard | tablets 5 mg | RK-MP-5 №014171 |
1535 | C08CA01 | Amlodipine | Amlotop® | tablets 5 mg | RK-MP-5 №010606 |
1536 | C08CA01 | Amlodipine | CORONIM® 10 | tablets 10 mg | RK-MP-5 №015667 |
1537 | C08CA01 | Amlodipine | Amlodipine Canon | tablets 5 mg | RK-MP-5 №010787 |
1538 | C08CA01 | Amlodipine | Amlodipine Canon | tablets 10 mg | RK-MP-5 №010788 |
1539 | C08CA01 | Amlodipine | Cardilopin® | tablets 2,5 mg | RK-MP-5 №010249 |
1540 | C08CA01 | Amlodipine | Amlodicard | tablets 10 mg | RK-MP-5 №022910 |
1541 | C08CA01 | Amlodipine | Amlodicard | tablets 5 mg | RK-MP-5 №022864 |
1542 | C08CA01 | Amlodipine | Amapin | tablets 5 mg | RK-MP-5 №022741 |
1543 | C08CA01 | Amlodipine | Amapin | tablets 10 mg | RK-MP-5 №022742 |
1544 | C08CA01 | Amlodipine | Amlomax® | tablets 5 mg | RK-MP-5 №022623 |
1545 | C08CA01 | Amlodipine | Amlomax® | tablets 10 mg | RK-MP-5 №022624 |
1546 | C08CA01 | Amlodipine | Amlodicard | tablets 2,5 mg | RK-MP-5 №022629 |
1547 | C08CA01 | Amlodipine | Amlovas | tablets 5 mg | RK-MP-5 №016160 |
1548 | C08CA01 | Amlodipine | Amlovas | tablets 10 mg | RK-MP-5 №016161 |
1549 | C08CA01 | Amlodipine | Kulchek | tablets 5 mg | RK-MP-5 №015874 |
1550 | C08CA01 | Amlodipine | Amlopin | tablets 5 mg | RK-MP-5 №012092 |
1551 | C08CA01 | Amlodipine | Amlopin | tablets 10 mg | RK-MP-5 №012093 |
1552 | C08CA01 | Amlodipine | SEMLOPIN® | Tablets 5 mg | RK-MP-5 №019883 |
1553 | C08CA01 | Amlodipine | SEMLOPIN® | Tablets 2,5 mg | RK-MP-5 №019882 |
1554 | C08CA01 | Amlodipine | Esem | Tablets 5 mg | RK-MP-5 №022409 |
1555 | C08CA01 | Amlodipine | Esem | Tablets 2,5 mg | RK-MP-5 №022407 |
1556 | C08CA01 | Amlodipine | AMLORUS | Tablets 10 mg | RK-MP-5 №013879 |
1557 | C08CA01 | Amlodipine | AMLORUS | Tablets 5 mg | RK-MP-5 №013878 |
1558 | C08CA01 | Amlodipine | Amlodipine | Tablets 5 mg | RK-MP-5 №020794 |
1559 | C08CA01 | Amlodipine | Amlodipine | Tablets 10 mg | RK-MP-5 №020793 |
C08CA05 | Nifedipine | ||||
1560 | C08CA05 | Nifedipine | Cordipin® retard | tablets with sustained release 20 mg | RK-MP-5 №011059 |
1561 | C08CA05 | Nifedipine | Corinfar retard | Coated tablets with prolonged release 20 mg | RK-MP-5 №000407 |
1562 | C08CA05 | Nifedipine | Pharmadipin® | oral drops 2% 5 ml | RK-MP-5 №014415 |
1563 | C08CA05 | Nifedipine | Pharmadipin® | oral drops 2% 25 ml | RK-MP-5 №014415 |
1564 | C08CA05 | Nifedipine | Nifedipine | coated tablets 20 mg | RK-MP-5 №023656 |
1565 | C08CA05 | Nifedipine | Nifedipine | coated tablets 10 mg | RK-MP-5 №023655 |
1566 | C08CA05 | Nifedipine | Nifecard® HL | film-coated tablets with prolonged release 30 mg | RK-MP-5 №012331 |
1567 | C08CA05 | Nifedipine | Nifecard® HL | film-coated tablets with prolonged release 60 mg | RK-MP-5 №012337 |
1568 | C08CA05 | Nifedipine | Corinfar | coated tablets with prolonged release 10 mg | RK-MP-5 №016671 |
C08CA06 | Nimodipine | ||||
1569 | C08CA06 | Nimodipine | Nimotop® | solution for infusions 10 mg/50 ml | RK-MP-5 №011041 |
1570 | C08CA06 | Nimodipine | Nimotop® | film-coated tablets 30 mg | RK-MP-5 №011040 |
1571 | C08CA06 | Nimodipine | Nemotan | film-coated tablets 30 mg | RK-MP-5 №019321 |
C08CA13 | Lercanidipine | ||||
1572 | C08CA13 | Lercanidipine | Lerkamen® 10 | film-coated tablets 10 mg | RK-MP-5 №006012 |
1573 | C08CA13 | Lercanidipine | Lerkamen® 20 | film-coated tablets 20 mg | RK-MP-5 №019923 |
1574 | C08CA13 | Lercanidipine | Zanidip-recordati | film-coated tablets 10 mg | RK-MP-5 №017727 |
1575 | C08CA13 | Lercanidipine | Zanidip-recordati | film-coated tablets 20 mg | RK-MP-5 №017728 |
C08D | Selective calcium channel blockers with direct effects on the heart | ||||
C08DA | Phenylalkylamine derivatives | ||||
C08DA01 | Verapamil | ||||
1576 | C08DA01 | Verapamil | Isoptin® | tablets 40 mg | RK-MP-5 №013857 |
1577 | C08DA01 | Verapamil | Veratard 180 | capsule of prolonged action 180 mg | RK-MP-5 №011495 |
1578 | C08DA01 | Verapamil | Verapamil | film-coated tablets 80 mg | RK-MP-5 №003078 |
1579 | C08DA01 | Verapamil | Verapamil | coated tablets 80 mg | RK-MP-5 №122037 |
C08DB | Benzothiazepine derivatives | ||||
C08DB01 | Diltiazem | ||||
1580 | C08DB01 | Diltiazem | Diltiazem Sobkhan | film-coated tablets 60 mg | RK-MP-5 №122107 |
C09 | Drugs affecting the renin-angiotensin system | ||||
C09A | Angiotensin converting enzyme (ACE) inhibitors | ||||
C09AA01 | Captopril | ||||
1581 | C09AA01 | Captopril | Captopril | tablets 25 mg | RK-MP-5 №009646 |
1582 | C09AA01 | Captopril | Captopril | tablets 25 mg | RK-MP-5 №012330 |
1583 | C09AA01 | Captopril | Captopril Viva Pharm | tablets 25 mg | RK-MP-5 №018187 |
1584 | C09AA01 | Captopril | Captopril- AKOS | tablets 25 mg | RK-MP-5 №003670 |
1585 | C09AA01 | Captopril | Captopril STADA® | tablets 50 mg | RK-MP-5 №022633 |
1586 | C09AA01 | Captopril | Captopril STADA® | tablets 12,5 mg | RK-MP-5 №022634 |
1587 | C09AA01 | Captopril | Captopril STADA® | tablets 25 mg | RK-MP-5 №022621 |
1588 | C09AA01 | Captopril | Captopril | tablets 25 mg | RK-MP-5 №003447 |
C09AA02 | Enalapril | ||||
1589 | C09AA02 | Enalapril | Ednit® | tablets 20 mg | RK-MP-5 №004559 |
1590 | C09AA02 | Enalapril | Enap® | tablets 20 mg | RK-MP-5 №010409 |
1591 | C09AA02 | Enalapril | Berlipril® 20 | tablets 20 mg | RK-MP-5 №011038 |
1592 | C09AA02 | Enalapril | Enap®R | solution for intravenous administration 1,25 mg/ml, 1 ml | RK-MP-5 №010498 |
1593 | C09AA02 | Enalapril | ENALAPRIL | tablets 10 mg | RK-MP-5 №003412 |
1594 | C09AA02 | Enalapril | Berlipril® 10 | tablets 10 mg | RK-MP-5 №011037 |
1595 | C09AA02 | Enalapril | Enap® | tablets 10 mg | RK-MP-5 №011901 |
1596 | C09AA02 | Enalapril | Enap® | tablets 10 mg | RK-MP-5 №010408 |
1597 | C09AA02 | Enalapril |
Enat® | tablets 10 mg | RK-MP-5 №015692 |
1598 | C09AA02 | Enalapril | Ednit® | tablets 5 mg | RK-MP-5 №004557 |
1599 | C09AA02 | Enalapril | Enam® | tablets 5 mg | RK-MP-5 №011900 |
1600 | C09AA02 | Enalapril | Enam® | tablets 2,5 mg | RK-MP-5 №011899 |
1601 | C09AA02 | Enalapril | Enap® | tablets 2,5 mg | RK-MP-5 №012003 |
1602 | C09AA02 | Enalapril | Berlipril® 5 | tablets 5 mg | RK-MP-5 №008270 |
1603 | C09AA02 | Enalapril | Enalaprilаt | solution for injections 1,25 mg/ml 1 ml | RK-MP-3 №021457 |
1604 | C09AA02 | Enalapril | Carlon 10 | tablets 10 mg | RK-MP-5 №015773 |
1605 | C09AA02 | Enalapril | Enap® | tablets 5 mg | RK-MP-5 №010410 |
1606 | C09AA02 | Enalapril | Carlon 5 | tablets 5 mg | RK-MP-5 №015772 |
1607 | C09AA02 | Enalapril | Enalife | tablets 5 mg | RK-MP-5 №022850 |
1608 | C09AA02 | Enalapril | Enalife | tablets 10 mg | RK-MP-5 №022851 |
1609 | C09AA02 | Enalapril | Enalife | tablets 20 mg | RK-MP-5 №022852 |
1610 | C09AA02 | Enalapril | Ednit® | tablets 10 mg | RK-MP-5 №004558 |
C09AA03 | Lisinopril | ||||
1611 | C09AA03 | Lisinopril | Dapril | tablets 5mg | RK-MP-5 №006065 |
1612 | C09AA03 | Lisinopril | Lisinopril-Teva | tablets 5mg | RK-MP-5 №011760 |
1613 | C09AA03 | Lisinopril | Diroton® | tablets 5mg | RK-MP-5 №013824 |
1614 | C09AA03 | Lisinopril | Lisinopril | tablets 5mg | RK-MP-5 №020540 |
1615 | C09AA03 | Lisinopril | Lisinopril | tablets 10 mg | RK-MP-5 №019916 |
1616 | C09AA03 | Lisinopril | Lisinopril | tablets 10 mg | RK-MP-5 №020541 |
1617 | C09AA03 | Lisinopril | Lisinopril-Teva | tablets 10 mg | RK-MP-5 №011759 |
1618 | C09AA03 | Lisinopril | Bagroven | tablets 5 mg | RK-MP-5 №020440 |
1619 | C09AA03 | Lisinopril | Bagroven | tablets 10 mg | RK-MP-5 №020439 |
1620 | C09AA03 | Lisinopril | Bagroven | tablets 20 mg | RK-MP-5 №020438 |
1621 | C09AA03 | Lisinopril | Lisinopril | tablets 5 mg | RK-MP-5 №019915 |
1622 | C09AA03 | Lisinopril | Lisinopril | tablets 20 mg | RK-MP-5 №019917 |
1623 | C09AA03 | Lisinopril | Diroton® | tablets 20 mg | RK-MP-5 №013823 |
1624 | C09AA03 | Lisinopril | Diroton® | tablets 10 mg | RK-MP-5 №013825 |
1625 | C09AA03 | Lisinopril | Lisinopril-Teva | tablets 20 mg | RK-MP-5 №011758 |
1626 | C09AA03 | Lisinopril | Dapril | tablets 10 mg | RK-MP-5 №006097 |
1627 | C09AA03 | Lisinopril | Dapril | tablets 20 mg | RK-LS-5No.006098 |
1628 | C09AA03 | Lisinopril | Lizorez ™-5 | tablets 5 mg | RK-LS-5No.019048 |
1629 | C09AA03 | Lisinopril | Lizorez ™-10 | tablets 10 mg | RK-LS-5No.019049 |
1630 | C09AA03 | Lisinopril | Lisnop 5 | tablets 5 mg | RK-LS-5No.023175 |
1631 | C09AA03 | Lisinopril | Lisnop 10 | tablets 10 mg | RK-LS-5No.023176 |
1632 | C09AA03 | Lisinopril | Rilace-Sanovel 5 | tablets 5 mg | RK-LS-5No.004864 |
1633 | C09AA03 | Lisinopril | Rilace-Sanovel 10 | tablets 10 mg | RK-LS-5No.004865 |
1634 | C09AA03 | Lisinopril | Rilace-Sanovel 20 | tablets 20 mg | RK-LS-5No.004866 |
C09AA04 | Perindopril | ||||
1635 | C09AA04 | Perindopril | Prestarium® 10 mg | coated tablets 10 mg | RK-LS-5No.023211 |
1636 | C09AA04 | Perindopril | Prestarium® 5 mg | coated tablets 5 mg | RK-LS-5No.023210 |
1637 | C09AA04 | Perindopril | Stopress | tablets 8 mg | RK-LS-3No.020971 |
1638 | C09AA04 | Perindopril | Prenessa® | tablets 8 mg | RK-LS-5No.014922 |
1639 | C09AA04 | Perindopril | Stopress® | tablets 8 mg | RK-LS-5No.016745 |
1640 | C09AA04 | Perindopril | Prenessa® | tablets 4 mg | RK-LS-5No.014921 |
1641 | C09AA04 | Perindopril | Stopress | tablets 4 mg | RK-LS-3No.020970 |
1642 | C09AA04 | Perindopril | Stopress® | tablets 4 mg | RK-LS-5No.016744 |
1643 | C09AA04 | Perindopril | Prenessa® CU-TAB® | orodispersible tablets 4 mg | RK-LS-5No.020227 |
1644 | C09AA04 | Perindopril | Prenessa® CU-TAB® | orodispersible tablets 8 mg | RK-LS-5No.020228 |
1645 | C09AA04 | Perindopril | Prestarium® 5mg | coated tablets 5 mg | RK-LS-5No.011490 |
1646 | C09AA04 | Perindopril | Prestarium® 10mg | coated tablets 10 mg | RK-LS-5No.011492 |
1647 | C09AA04 | Perindopril | Adepril® | tablets 4 mg | RK-LS-5No.023150 |
1648 | C09AA04 | Perindopril | Adepril® | tablets 8 mg | RK-LS-5No.023151 |
1649 | C09AA04 | Perindopril | Prestarium® | tablets 4 mg | RK-LS-5No.121691 |
1650 | C09AA04 | Perindopril | Prestarium® | tablets 8 mg | RK-LS-5No.121692 |
1651 | C09AA04 | Perindopril | Prenessa® | tablets 2 mg | RK-LS-5No.014920 |
C09AA05 | Ramipril | ||||
1652 | C09AA05 | Ramipril | Amprilan® | tablets 2,5 mg | RK-LS-5No.012570 |
1653 | C09AA05 | Ramipril | Polpril | capsules 2,5 mg | RK-LS-5No.014331 |
1654 | C09AA05 | Ramipril | Ramizes® | tablets 5 mg | RK-LS-5No.018648 |
1655 | C09AA05 | Ramipril | Amprilan® | tablets 5 mg | RK-LS-5No.012571 |
1656 | C09AA05 | Ramipril | Hartil® | tablets 5 mg | RK-LS-5No.015173 |
1657 | C09AA05 | Ramipril | Polpril | capsules 5 mg | RK-LS-5No.014332 |
1658 | C09AA05 | Ramipril | Ramizes® | tablets 10 mg | RK-LS-5No.018649 |
1659 | C09AA05 | Ramipril | Hartil® | tablets 10 mg | RK-LS-5No.015174 |
1660 | C09AA05 | Ramipril | Polpril | capsules 10 mg | RK-LS-5No.014333 |
1661 | C09AA05 | Ramipril | Piramil® | tablets 5 mg | RK-LS-5No.021538 |
1662 | C09AA05 | Ramipril | Ramipril Viva Pharm | tablets 5 mg | RK-LS-3No.022394 |
1663 | C09AA05 | Ramipril | Piramil® | tablets 10 mg | RK-LS-5No.021540 |
1664 | C09AA05 | Ramipril | Amprilan® | tablets 10 mg | RK-LS-5No.012572 |
1665 | C09AA05 | Ramipril | Ramipril Viva Pharm | tablets 10 mg | RK-LS-3No.022395 |
1666 | C09AA05 | Ramipril | Tritace® | tablets 10 mg | RK-LS-5No.020235 |
1667 | C09AA05 | Ramipril | Amprilan® | tablets 1,25 mg | RK-LS-5No.012569 |
1668 | C09AA05 | Ramipril | Ramizes® | tablets 2,5 mg | RK-LS-5No.018647 |
C09AA09 | Fosinoprilum | ||||
1669 | C09AA09 | Fosinoprilum | Fosicard | tablets 10 mg | RK-LS-5No.010680 |
1670 | C09AA09 | Fosinoprilum | Fosicard | tablets 20 mg | RK-LS-5No.010681 |
1671 | C09AA09 | Fosinoprilum | Fosinoprilum-ratiopharm | tablets 20 mg | RK-LS-5No.021144 |
1672 | C09AA09 | Fosinoprilum | Cardiopril | tablets 10 mg | RK-LS-5No.019332 |
1673 | C09AA09 | Fosinoprilum | Fosinoprilum Viva Pharm | tablets 10 mg | RK-LS-5No.018185 |
1674 | C09AA09 | Fosinoprilum | Cardiopril | tablets 20 mg | RK-LS-5No.019333 |
1675 | C09AA09 | Fosinoprilum | Fosinoprilum Viva Pharm | tablets 20 mg | RK-LS-5No.018186 |
1676 | C09AA09 | Fosinoprilum | Fosinap | tablets 10 mg | RK-LS-5No.019409 |
1677 | C09AA09 | Fosinoprilum | Fosinap | tablets 20 mg | RK-LS-5No.019410 |
C09AA10 | Trandolapril | ||||
C09B | Angiotensin-converting enzyme inhibitors in combination with other drugs | ||||
C09BA | Angiotensin-converting enzyme inhibitors in combination with diuretics | ||||
C09BA01 | Captopril and Hydrochlorothiazide | ||||
1678 | C09BA01 | Captopril and Hydrochlorothiazide | Captopril N VIVA PHARM | tablets 50 mg /25 mg | RK-LS-5No.021637 |
1679 | C09BA01 | Captopril and Hydrochlorothiazide | Kaptospes + N | tablets 50 mg /25 mg | RK-LS-5No.004105 |
C09BA02 | Enalapril and Hydrochlorothiazide | ||||
1680 | C09BA02 | Enalapril and Hydrochlorothiazide | Enap®-N | tablets 10 mg /25 mg | RK-LS-5No.019480 |
1681 | C09BA02 | Enalapril and Hydrochlorothiazide | Eneas® | tablet 10 mg /20 mg | RK-LS-5No.016673 |
1682 | C09BA02 | Enalapril and Hydrochlorothiazide | Berlipril® plus | tablets 10 mg /25 mg | RK-LS-5No.012756 |
1683 | C09BA02 | Enalapril and Hydrochlorothiazide | Enap®-NL | tablets 10 mg /12,5 mg | RK-LS-5No.019481 |
1684 | C09BA02 | Enalapril and Hydrochlorothiazide | Enap®-NL 20 | tablets 20 mg /12,5 mg | RK-LS-5No.010404 |
1685 | C09BA02 | Enalapril and Hydrochlorothiazide | Enalife N | tablets 20 mg /12,5 mg | RK-LS-5No.022503 |
1686 | C09BA02 | Enalapril and Hydrochlorothiazide | Karlon Plus | tablets 20 mg /12,5 mg | RK-LS-5No.015747 |
C09BA03 | Lisinopril and Hydrochlorothiazide | ||||
1687 | C09BA03 | Lisinopril and Hydrochlorothiazide | Rilace-Sanovel plus | tablets 20 mg /12,5 mg | RK-LS-5No.004867 |
C09BA04 | Perindopril and Indapamide | ||||
1688 | C09BA04 | Perindopril and Indapamide | Perindid | film-coated tablets 2,5 mg /0,625 mg | RK-LS-5No.020893 |
1689 | C09BA04 | Perindopril and Indapamide | CoPrenessa® | tablets 2 mg /0,625 mg | RK-LS-5No.016471 |
1690 | C09BA04 | Perindopril and Indapamide | Perindid | film-coated tablets 4 mg /1,25 mg | RK-LS-5No.020894 |
1691 | C09BA04 | Perindopril and Indapamide | CoPrenessa® | tablets 4 mg /1,25 mg | RK-LS-5No.016472 |
1692 | C09BA04 | Perindopril and Indapamide | Noliprel® Bi-Forte | tablet 10 mg /2,5 mg | RK-LS-5No.020070 |
1693 | C09BA04 | Perindopril and Indapamide | Noliprel® Arginine | film-coated tablets 2,5 mg /0,625 mg | RK-LS-5No.012895 |
1694 | C09BA04 | Perindopril and Indapamide | Copemid-Teva | film-coated tablets 2,5 mg /0,625 mg | RK-LS-5No.021161 |
1695 | C09BA04 | Perindopril and Indapamide | Copemid-Teva | film-coated tablets 5 mg /1,25 mg | RK-LS-5No.021160 |
1696 | C09BA04 | Perindopril and Indapamide | Noliprel® Forte Arginine | film-coated tablets 5 mg /1,25 mg | RK-LS-5No.012896 |
1697 | C09BA04 | Perindopril and Indapamide | Co-Prenessa® | tablets 8 mg /2,5 mg | RK-LS-5No.020094 |
1698 | C09BA04 | Perindopril and Indapamide | Prestarium® Combi Arginine | film-coated tablets 5 mg /1,25 mg | RK-LS-5No.013001 |
1699 | C09BA04 | Perindopril and Indapamide | Adepril® Diur | tablets 2 mg /0.625 mg | RK-LS-5No.023186 |
1700 | C09BA04 | Perindopril and Indapamide | Adepril® Diur | tablets 4 mg /1,25 mg | RK-LS-5No.023187 |
1701 | C09BA04 | Perindopril and Indapamide | Noliprel® Arginine | film-coated tablets 2,5 mg /0,625 mg | RK-LS-5No.023379 |
1702 | C09BA04 | Perindopril and Indapamide | Noliprel® Forte Arginine | film-coated tablets 5 mg /1,25 mg | RK-LS-5No.023380 |
1703 | C09BA04 | Perindopril and Indapamide | Noliprel® Bi-Forte | film-coated tablets 10 mg /2,5 mg | RK-LS-5No.023381 |
C09BA06 | Quinapril and Hydrochlorothiazide | ||||
1704 | C09BA06 | Quinapril and Hydrochlorothiazide | Accuzide® | film-coated tablets 20 mg /12,5 mg | RK-LS-5No.015882 |
C09BA09 | Fosinoprilum and Hydrochlorothiazide | ||||
1705 | C09BA09 | Fosinoprilum and Hydrochlorothiazide | Fosicard N | tablets 20 mg /12,5 mg | RK-LS-5No.013910 |
1706 | C09BA09 | Fosinoprilum and Hydrochlorothiazide | Co-Fosinoprilum- Teva | tablets 20 mg /12,5 mg | RK-LS-5No.021054 |
C09BB | Angiotensin-converting enzyme inhibitors in combination with calcium channel blockers | ||||
C09BB03 | Lisinopril and Amlodipine | ||||
1707 | C09BB03 | Lisinopril and Amlodipine | Amlipin | coated tablets 5mg /5 mg | RK-LS-5No.016177 |
1708 | C09BB03 | Lisinopril and Amlodipine | VivaCor® | tablets 5 mg /5 mg | RK-LS-5No.023443 |
1709 | C09BB03 | Lisinopril and Amlodipine | VivaCor® | tablets 20 mg /10 mg | RK-LS-5No.023445 |
1710 | C09BB03 | Lisinopril and Amlodipine | VivaCor® | tablets 10mg /5mg | RK-LS-5No.023444 |
1711 | C09BB03 | Lisinopril and Amlodipine | Equator® | tablets 10 mg /5 mg | RK-LS-5No.009562 |
1712 | C09BB03 | Lisinopril and Amlodipine | Equator® | tablets 20 mg /10 mg | RK-LS-5No.017765 |
1713 | C09BB03 | Lisinopril and Amlodipine | Equator® | tablets 20 mg /5 mg | RK-LS-5No.020564 |
1714 | C09BB03 | Lisinopril and Amlodipine | Tenliza® | tablets 10 mg /5 mg | RK-LS-5No.022441 |
1715 | C09BB03 | Lisinopril and Amlodipine | Tenliza® | tablets 20 mg /10 mg | RK-LS-5No.022442 |
C09BB07 | Ramipril and Amlodipine | ||||
1716 | C09BB07 | Ramipril and Amlodipine | Pyramil® Extra | capsules 10 mg /5 mg | RK-LS-5No.022239 |
1717 | C09BB07 | Ramipril and Amlodipine | Pyramil® Extra | capsules 5 mg /5 mg | RK-LS-5No.022241 |
1718 | C09BB07 | Ramipril and Amlodipine | Hartil® Amlo | capsules 10 mg /5 mg | RK-LS-5No.020061 |
1719 | C09BB07 | Ramipril and Amlodipine | Hartil® Amlo | capsules 5 mg /5 mg | RK-LS-5No.020060 |
1720 | C09BB07 | Ramipril and Amlodipine | Hartil® Amlo | capsules 5 mg /10 mg | RK-LS-5No.020062 |
1721 | C09BB07 | Ramipril and Amlodipine | Hartil® Amlo | capsules 10 mg /10 mg | RK-LS-5No.020063 |
1722 | C09BB07 | Ramipril and Amlodipine | Radinil | capsules 5 mg /5 mg | RK-LS-5No.022640 |
1723 | C09BB07 | Ramipril and Amlodipine | Radinil | capsules 10 mg /10 mg | RK-LS-5No.022641 |
1724 | C09BB07 | Ramipril and Amlodipine | Pyramil® Extra | capsules 5 mg /10 mg | RK-LS-5No.022238 |
1725 | C09BB07 | Ramipril and Amlodipine | Pyramil® Extra | capsules 10 mg /10 mg | RK-LS-5No.022240 |
C09BB10 | Trandolapril and Verapamil | ||||
1726 | C09BB10 | Trandolapril and Verapamil | Tarka® | modified release film-coated tablets 4 mg /240 mg | RK-LS-5No.016560 |
1727 | C09BB10 | Trandolapril and Verapamil | Tarka® | modified release film-coated tablets 2 mg /180 mg | RK-LS-5No.016558 |
C09C | Angiotensin II antagonists | ||||
C09CA01 | Losartan | ||||
1728 | C09CA01 | Losartan | Angisartan ™ -25 | film-coated tablets 25 mg | RK-LS-5No.003850 |
1729 | C09CA01 | Losartan | Angisartan ™ -50 | film-coated tablets 50 mg | RK-LS-5No.003849 |
1730 | C09CA01 | Losartan | Losartan benet | film-coated tablets 100 mg | RK-LS-5No.024049 |
1731 | C09CA01 | Losartan | Losartan benet | film-coated tablets 50 mg | RK-LS-5No.024053 |
1732 | C09CA01 | Losartan | CLOSART ® | film-coated tablets 100 mg | RK-LS-5No.024095 |
1733 | C09CA01 | Losartan | CLOSART ® | film-coated tablets 50 mg | RK-LS-5No.024096 |
1734 | C09CA01 | Losartan | CLOSART ® | film-coated tablets 25 mg | RK-LS-5No.024097 |
1735 | C09CA01 | Losartan | Lorista® | film-coated tablets 25 mg | RK-LS-5No.020397 |
1736 | C09CA01 | Losartan | Lorista® | film-coated tablets 12,5 mg | RK-LS-5No.014731 |
1737 | C09CA01 | Losartan | Losartan-Teva | coated tablets 25 mg | RK-LS-5No.020989 |
1738 | C09CA01 | Losartan | Losartan-Teva | coated tablets 50 mg | RK-LS-5No.020990 |
1739 | C09CA01 | Losartan | Losartan-Teva | coated tablets 100 mg | RK-LS-5No.020991 |
1740 | C09CA01 | Losartan | Losartan | film-coated tablets 50 mg | RK-LS-5No.021255 |
1741 | C09CA01 | Losartan | Lozarel® | film-coated tablets 12,5 mg | RK-LS-5No.121836 |
1742 | C09CA01 | Losartan | Lozarel® | film-coated tablets 25 mg | RK-LS-5No.121837 |
1743 | C09CA01 | Losartan | Lozarel® | film-coated tablets 50 mg | RK-LS-5No.121838 |
1744 | C09CA01 | Losartan | Lozarel® | film-coated tablets 75 mg | RK-LS-5No.121839 |
1745 | C09CA01 | Losartan | Lozarel® | film-coated tablets 100 mg | RK-LS-5No.121840 |
1746 | C09CA01 | Losartan | LORCAR FORT® | film-coated tablets 100 mg | RK-LS-5No.022159 |
1747 | C09CA01 | Losartan | LORKAR® | film-coated tablets 50 mg | RK-LS-5No.022160 |
1748 | C09CA01 | Losartan | Losar-50 | film-coated tablets 50 mg | RK-LS-5No.016332 |
1749 | C09CA01 | Losartan | Losar-25 | film-coated tablets 25 mg | RK-LS-5No.016333 |
1750 | C09CA01 | Losartan | Artamaxan | coated tablets 50 mg | RK-LS-5No.022369 |
1751 | C09CA01 | Losartan | Blocktran | coated tablets 50 mg | RK-LS-5No.016793 |
1752 | C09CA01 | Losartan | Lozap | film-coated tablets 50 mg | RK-LS-5No.018582 |
1753 | C09CA01 | Losartan | Lorista® | film-coated tablets 50 mg | RK-LS-5No.020398 |
1754 | C09CA01 | Losartan | Lorista® | film-coated tablets 100 mg | RK-LS-5No.020399 |
C09CA02 | Eprozartan | ||||
1755 | C09CA02 | Eprozartan | Teveten® | coated tablets 600 mg | RK-LS-5No.003276 |
C09CA03 | Valsartan | ||||
1756 | C09CA03 | Valsartan | SARTOCAD-B | film-coated tablets 80 mg | RK-LS-5No.021319 |
1757 | C09CA03 | Valsartan | Diovan® | film-coated tablets 160 mg | RK-LS-5No.013596 |
1758 | C09CA03 | Valsartan | Vanatex | coated tablets 160 mg | RK-LS-5No.019148 |
1759 | C09CA03 | Valsartan | Valsacor® | film-coated tablets 160 mg | RK-LS-5No.013585 |
1760 | C09CA03 | Valsartan | Vazar | film-coated tablets 160 mg | RK-LS-5No.017600 |
1761 | C09CA03 | Valsartan | Diovan® | film-coated tablets 80 mg | RK-LS-5No.013595 |
1762 | C09CA03 | Valsartan | Vanatex | coated tablets 80 mg | RK-LS-5No.019147 |
1763 | C09CA03 | Valsartan | Valsacor® | film-coated tablets 80 mg | RK-LS-5No.013584 |
1764 | C09CA03 | Valsartan | Vazar | film-coated tablets 80 mg | RK-LS-5No.017599 |
1765 | C09CA03 | Valsartan | Valsartan-Teva | film-coated tablets 40 mg | RK-LS-5No.020979 |
1766 | C09CA03 | Valsartan | Valsartan-Teva | film-coated tablets 80 mg | RK-LS-5No.020980 |
1767 | C09CA03 | Valsartan | Valsartan-Teva | film-coated tablets 160 mg | RK-LS-5No.020981 |
1768 | C09CA03 | Valsartan | Valsacor® | film-coated tablets 40 mg | RK-LS-5No.014832 |
1769 | C09CA03 | Valsartan | SARTOCAD-B | film-coated tablets 40 mg | RK-LS-5No.021318 |
1770 | C09CA03 | Valsartan | SARTOCAD-B | film-coated tablets 160 mg | RK-LS-5No.021320 |
1771 | C09CA03 | Valsartan | Viasart | film-coated tablets 80 mg | RK-LS-5No.024062 |
1772 | C09CA03 | Valsartan | Vazar | film-coated tablets 40 mg | RK-LS-5No.017598 |
1773 | C09CA03 | Valsartan | Valmak | film-coated tablets 40 mg | RK-LS-5No.023020 |
1774 | C09CA03 | Valsartan | Valmak | film-coated tablets 80 mg | RK-LS-5No.023021 |
1775 | C09CA03 | Valsartan | Valmak | film-coated tablets 160 mg | RK-LS-5No.023022 |
1776 | C09CA03 | Valsartan | Valmak | film-coated tablets 320 mg | RK-LS-5No.023023 |
1777 | C09CA03 | Valsartan | Valsacor® | film-coated tablets 320 mg | RK-LS-5No.019063 |
1778 | C09CA03 | Valsartan | Valsar | film-coated tablets 40 mg | RK-LS-5No.023898 |
1779 | C09CA03 | Valsartan | Valsar | film-coated tablets 160 mg | RK-LS-5No.023900 |
1780 | C09CA03 | Valsartan | Valsar | film-coated tablets 320 mg | RK-LS-5No.023901 |
1781 | C09CA03 | Valsartan | Viasart | film-coated tablets 160 mg | RK-LS-5No.024061 |
1782 | C09CA03 | Valsartan | Valsartan-ben | film-coated tablets 80 mg | RK-LS-5No.024086 |
1783 | C09CA03 | Valsartan | Valsartan-ben | film-coated tablets 160 mg | RK-LS-5No.024087 |
1784 | C09CA03 | Valsartan | Valsar | film-coated tablets 80 mg | RK-LS-5No.023899 |
C09CA04 | Irbesartan | ||||
1785 | C09CA04 | Irbesartan | Irbesan® 150 | film-coated tablets 150 mg | RK-LS-3No.019662 |
1786 | C09CA04 | Irbesartan | Irbesan® 300 | film-coated tablets 300 mg | RK-LS-3No.019663 |
1787 | C09CA04 | Irbesartan | Irbesan® 75 | film-coated tablets 75 mg | RK-LS-3No.019661 |
1788 | C09CA04 | Irbesartan | Firmasta® | film-coated tablets 150 mg | RK-LS-5No.014684 |
1789 | C09CA04 | Irbesartan | Irbesartan | film-coated tablets 150 mg | RK-LS-5No.021222 |
1790 | C09CA04 | Irbesartan | Rotazar | film-coated tablets 150 mg | RK-LS-5No.023036 |
1791 | C09CA04 | Irbesartan | Firmasta® | film-coated tablets 75 mg | RK-LS-5No.014683 |
1792 | C09CA04 | Irbesartan | Firmasta® | film-coated tablets 300 mg | RK-LS-5No.014685 |
1793 | C09CA04 | Irbesartan | Arena | tablets 150 mg | RK-LS-5No.021123 |
1794 | C09CA04 | Irbesartan | Irbesartan | film-coated tablets 75 mg | RK-LS-5No.021221 |
1795 | C09CA04 | Irbesartan | Irbesartan | film-coated tablets 300 mg | RK-LS-5No.021223 |
1796 | C09CA04 | Irbesartan | Rotazar | film-coated tablets 300 mg | RK-LS-5No.023035 |
1797 | C09CA04 | Irbesartan | Rotazar | film-coated tablets 75 mg | RK-LS-5No.023037 |
1798 | C09CA04 | Irbesartan | IRBESAN® 75 | film-coated tablets 75 mg | RK-LS-5No.013700 |
1799 | C09CA04 | Irbesartan | IRBESAN®150 | film-coated tablets 150 mg | RK-LS-5No.013701 |
1800 | C09CA04 | Irbesartan | IRBESAN® 300 | film-coated tablets 300 mg | RK-LS-5No.013702 |
1801 | C09CA04 | Irbesartan | IRBESAN® 75 | film-coated tablets 75 mg | RK-LS-5No.013945 |
1802 | C09CA04 | Irbesartan | IRBESAN® 150 | film-coated tablets 150 mg | RK-LS-5No.013946 |
1803 | C09CA04 | Irbesartan | IRBESAN® 300 | film-coated tablets 300 mg | RK-LS-5No.013947 |
C09CA06 | Candesartan | ||||
1804 | C09CA06 | Candesartan | KANTAB® 16 | tablet 16 mg | RK-LS-3No.021635 |
1805 | C09CA06 | Candesartan | Candesartan Viva Farm | tablet 16 mg | RK-LS-3No.022748 |
1806 | C09CA06 | Candesartan | Advant | tablets 16 mg | RK-LS-5No.018304 |
1807 | C09CA06 | Candesartan | KANTAB® 4 | tablet 4 mg | RK-LS-3No.021633 |
1808 | C09CA06 | Candesartan | KANTAB® 8 | tablets 8 mg | RK-LS-3No.021634 |
1809 | C09CA06 | Candesartan | Advant | tablets 8 mg | RK-LS-5No.018303 |
1810 | C09CA06 | Candesartan | Candesartan Viva Farm | tablet 8 mg | RK-LS-3No.022747 |
1811 | C09CA06 | Candesartan | Candesartan ben | tablets 16 mg | RK-LS-5No.023676 |
1812 | C09CA06 | Candesartan | Candesartan ben | tablets, 8 mg | RK-LS-5No.023675 |
1813 | C09CA06 | Candesartan | Kandecor® | tablets 16 mg | RK-LS-5No.019821 |
1814 | C09CA06 | Candesartan | KASARK® | tablets 16 mg | RK-LS-5No.020750 |
1815 | C09CA06 | Candesartan | Onsart | tablet 16 mg | RK-LS-5No.016093 |
1816 | C09CA06 | Candesartan | Kandecor® | tablets 8 mg | RK-LS-5No.019820 |
1817 | C09CA06 | Candesartan | Onsart | tablets 8 mg | RK-LS-5No.016092 |
1818 | C09CA06 | Candesartan | KASARK | tablets 8 mg | RK-LS-5No.022207 |
1819 | C09CA06 | Candesartan | AIRA-sanovel 8 | tablets 8 mg | RK-LS-5No.004862 |
1820 | C09CA06 | Candesartan | AIRA-sanovel 16 | tablets 16 mg | RK-LS-5No.004863 |
1821 | C09CA06 | Candesartan | Candesar® | tablets 4 mg | RK-LS-5No.022867 |
1822 | C09CA06 | Candesartan | Candesar® | tablets 8 mg | RK-LS-5No.022868 |
1823 | C09CA06 | Candesartan | Candesar® | tablets 16 mg | RK-LS-5No.022869 |
1824 | C09CA06 | Candesartan | Kandecor® | tablets 32 mg | RK-LS-5No.019822 |
1825 | C09CA06 | Candesartan | KASARK® | tablets 32 mg | RK-LS-5No.020751 |
C09CA07 | Telmisartan | ||||
1826 | C09CA07 | Telmisartan | Mikardis® | tablets 80 mg | RK-LS-5No.019903 |
1827 | C09CA07 | Telmisartan | TELMITEK® | tablets 80 mg | RK-LS-5No.023366 |
1828 | C09CA07 | Telmisartan | Telsartan | tablets 80 mg | RK-LS-5No.121842 |
1829 | C09CA07 | Telmisartan | Seiftelmee | tablets, 80 mg | RK-LS-5No.020444 |
1830 | C09CA07 | Telmisartan | Telsartan | tablets 40 mg | RK-LS-5No.121841 |
1831 | C09CA07 | Telmisartan | Seiftelmee | tablets 40 mg | RK-LS-5No.020445 |
1832 | C09CA07 | Telmisartan | Telmista® | tablets 40 mg | RK-LS-5No.020946 |
1833 | C09CA07 | Telmisartan | Telmista® | tablets 80 mg | RK-LS-5No.020947 |
1834 | C09CA07 | Telmisartan | Telsakor-Teva | tablets 40 mg | RK-LS-5No.021080 |
1835 | C09CA07 | Telmisartan | Telsakor-Teva | tablets 80 mg | RK-LS-5No.021081 |
1836 | C09CA07 | Telmisartan | Tiregis® | coated tablets 40 mg | RK-LS-5No.021224 |
1837 | C09CA07 | Telmisartan | Tiregis® | coated tablets 80 mg | RK-LS-5No.021225 |
1838 | C09CA07 | Telmisartan | Safitel-80 | tablets 80 mg | RK-LS-5No.121772 |
1839 | C09CA07 | Telmisartan | Tellsey 40 | tablets 40 mg | RK-LS-5No.121791 |
1840 | C09CA07 | Telmisartan | Tellsey 80 | tablets 80 mg | RK-LS-5No.121792 |
1841 | C09CA07 | Telmisartan | Teleact | tablets 40 mg | RK-LS-5No.121963 |
1842 | C09CA07 | Telmisartan | Teleact | tablets 80 mg | RK-LS-5No.121964 |
1843 | C09CA07 | Telmisartan | Telpres | tablets 40 mg | RK-LS-5No.023058 |
1844 | C09CA07 | Telmisartan | Telpres | tablets 80 mg | RK-LS-5No.023059 |
1845 | C09CA07 | Telmisartan | Telpres | tablets 20 mg | RK-LS-5No.023060 |
1846 | C09CA07 | Telmisartan | Telzap® | tablets 40 mg | RK-LS-5No.019843 |
1847 | C09CA07 | Telmisartan | Telzap® | tablets 80 mg | RK-LS-5No.019844 |
1848 | C09CA07 | Telmisartan | Twardox | tablets 40 mg | RK-LS-5No.024066 |
1849 | C09CA07 | Telmisartan | Twardox | tablets 80 mg | RK-LS-5No.024068 |
C09CA08 | Olmesartan medoxomil | ||||
1850 | C09CA08 | Olmesartan medoxomil | Olmechart® | Film-coated tablets 40 mg | RK-LS-5No.024492 |
1851 | C09CA08 | Olmesartan medoxomil | Olmechart® | Film-coated tablets 20 mg | RK-LS-5No.024493 |
1852 | C09CA08 | Olmesartan medoxomil | Olmechart® | Film-coated tablets 5 mg | RK-LS-5No.024495 |
1853 | C09CA08 | Olmesartan medoxomil | Olmechart® | Film-coated tablets 10 mg | RK-LS-5No.024496 |
C09СA09 | Azilsartan medoxomil | ||||
1854 | C09СA09 | Azilsartan medoxomil | Edarbi® | tablets 80 mg | RK-LS-5No.020167 |
1855 | C09СA09 | Azilsartan medoxomil | Edarbi® | tablets 40 mg | RK-LS-5No.020166 |
1856 | C09СA09 | Azilsartan medoxomil | Olymester® | film-coated tablets 10 mg | RK-LS-5No.019094 |
1857 | C09СA09 | Azilsartan medoxomil | Olymester® | film-coated tablets 20 mg | RK-LS-5No.019095 |
1858 | C09СA09 | Azilsartan medoxomil | Olymester® | film-coated tablets 40 mg | RK-LS-5No.019096 |
C09D | Angiotensin II antagonists in combination with other drugs | ||||
C09DA | Angiotensin II antagonists in combination with diuretics | ||||
C09DA01 | Losartan and Hydrochlorothiazide | ||||
1859 | C09DA01 | Losartan and Hydrochlorothiazide | CO-LORCAR® | film-coated tablets 50 mg /12,5 mg | RK-LS-5No.022173 |
1860 | C09DA01 | Losartan and Hydrochlorothiazide | CO-LORCAR®FORT | film-coated tablets 100/25 mg | RK-LS-5No.022174 |
1861 | C09DA01 | Losartan and Hydrochlorothiazide | Lozap Plus | film-coated tablets 50 mg /12,5 mg | RK-LS-5No.018191 |
1862 | C09DA01 | Losartan and Hydrochlorothiazide | Lorista® N | film-coated tablets 50 mg /12,5 mg | RK-LS-5No.012740 |
1863 | C09DA01 | Losartan and Hydrochlorothiazide | Losartan plus | film-coated tablets 50 mg /12.5 mg | RK-LS-5No.024359 |
1864 | C09DA01 | Losartan and Hydrochlorothiazide | Losartan plus | film-coated tablets 100 mg /12.5 mg | RK-LS-5No.024360 |
1865 | C09DA01 | Losartan and Hydrochlorothiazide | Losartan plus | film-coated tablets 100 mg /25 mg | RK-LS-5No.024366 |
1866 | C09DA01 | Losartan and Hydrochlorothiazide | Lorista® ND | film-coated tablets 100mg /25mg | RK-LS-5No.012739 |
1867 | C09DA01 | Losartan and Hydrochlorothiazide | Lorista® H100 | film-coated tablets 100 mg /12,5 mg | RK-LS-5No.019289 |
1868 | C09DA01 | Losartan and Hydrochlorothiazide | Lozarel® Plus | film-coated tablets 50mg /12,5mg | RK-LS-5No.121735 |
1869 | C09DA01 | Losartan and Hydrochlorothiazide | Lozarel® Plus | film-coated tablets 100 mg /25 mg | RK-LS-5No.121734 |
C09DA03 | Valsartan and Hydrochlorothiazide | ||||
1870 | C09DA03 | Valsartan and Hydrochlorothiazide | VAZAR N | film-coated tablets 80 mg /12,5 mg | RK-LS-5No.017680 |
1871 | C09DA03 | Valsartan and Hydrochlorothiazide | Co-Valsartan-Teva | film-coated tablets 80 mg /12,5 mg | RK-LS-5No.021208 |
1872 | C09DA03 | Valsartan and Hydrochlorothiazide | VAZAR N | film-coated tablets 160 mg /12,5 mg | RK-LS-5No.017681 |
1873 | C09DA03 | Valsartan and Hydrochlorothiazide | Co-Valsartan-Teva | film-coated tablets 160 mg /12,5 mg | RK-LS-5No.021207 |
1874 | C09DA03 | Valsartan and Hydrochlorothiazide | VAZAR N | film-coated tablets 160 mg /25 mg | RK-LS-5No.017682 |
1875 | C09DA03 | Valsartan and Hydrochlorothiazide | Co-Valsartan-Teva | film-coated tablets 160 mg /25 mg | RK-LS-5No.021206 |
1876 | C09DA03 | Valsartan and Hydrochlorothiazide | Co-Diovan® | coated tablets 80 mg /12,5 mg | RK-LS-5No.010548 |
1877 | C09DA03 | Valsartan and Hydrochlorothiazide | Co-Diovan® | coated tablets 160/12,5mg | RK-LS-5No.013720 |
1878 | C09DA03 | Valsartan and Hydrochlorothiazide | Valsartan H-ben | film-coated tablets 160/12,5 | RK-LS-5No.024225 |
1879 | C09DA03 | Valsartan and Hydrochlorothiazide | VALMAK-N | film-coated tablets 320 mg / 25 mg | RK-LS-5No.023002 |
1880 | C09DA03 | Valsartan and Hydrochlorothiazide | VALMAK-N | film-coated tablets 80 mg / 12.5 mg | RK-LS-5No.023003 |
1881 | C09DA03 | Valsartan and Hydrochlorothiazide | VALMAK-N | film-coated tablets 160 mg / 25 mg | RK-LS-5No.023004 |
1882 | C09DA03 | Valsartan and Hydrochlorothiazide | VALMAK-N | film-coated tablets 160 mg / 12.5 mg | RK-LS-5No.023005 |
1883 | C09DA03 | Valsartan and Hydrochlorothiazide | VALMAK-N | film-coated tablets 320 mg / 12.5 mg | RK-LS-5No.023006 |
C09DA04 | Irbesartan and hydrochlorothiazide | ||||
1884 | C09DA04 | Irbesartan and hydrochlorothiazide | Co-Irbesan® | film-coated tablets 300mg /12,5mg | RK-LS-3No.020380 |
1885 | C09DA04 | Irbesartan and hydrochlorothiazide | Co-Irbesan® | film-coated tablets 150 mg /12,5 mg | RK-LS-3No.020379 |
1886 | C09DA04 | Irbesartan and hydrochlorothiazide | Rotazar Plus | tablets 150 mg /12,5 mg | RK-LS-5No.022988 |
1887 | C09DA04 | Irbesartan and hydrochlorothiazide | Irbatal- N 300 | tablets 300 mg /12,5 mg | RK-LS-5No.122073 |
1888 | C09DA04 | Irbesartan and hydrochlorothiazide | Converid | film-coated tablets 300mg /12.5 mg | RK-LS-5No.024027 |
1889 | C09DA04 | Irbesartan and hydrochlorothiazide | Converid | film-coated tablets 150mg /12.5 mg | RK-LS-5No.024028 |
1890 | C09DA04 | Irbesartan and hydrochlorothiazide | Co-Irbesan® | film-coated tablets 150 mg /12,5 mg | RK-LS-5No.014019 |
1891 | C09DA04 | Irbesartan and hydrochlorothiazide | Co-Irbesan® | film-coated tablets 300mg /12,5mg | RK-LS-5No.014020 |
1892 | C09DA04 | Irbesartan and hydrochlorothiazide | Irbatal-N 150 | tablets 150 mg /12.5 mg | RK-LS-5No.122072 |
1893 | C09DA04 | Irbesartan and hydrochlorothiazide | Firmasta® N 150 | film-coated tablets 150 mg /12,5 mg | RK-LS-5No.021372 |
1894 | C09DA04 | Irbesartan and hydrochlorothiazide | Firmasta® N 300 | film-coated tablets 300 mg /12,5 mg | RK-LS-5No.021373 |
1895 | C09DA04 | Irbesartan and hydrochlorothiazide | Firmasta® ND 300 | film-coated tablets 300 mg /25 mg | RK-LS-5No.021374 |
C09DA07 | Telmisartan and Hydrochlorothiazide | ||||
1896 | C09DA07 | Telmisartan and Hydrochlorothiazide | Mikardis® Plus | tablets 80 mg /12,5 mg | RK-LS-5No.020193 |
1897 | C09DA07 | Telmisartan and Hydrochlorothiazide | Seiftelmi G | tablets 80 mg /12,5 mg | RK-LS-5No.121986 |
1898 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telmista®N | tablets 80 mg /12,5 mg | RK-LS-5No.020638 |
1899 | C09DA07 | Telmisartan and Hydrochlorothiazide | Co-Telsakor-Teva | tablets 80 mg /12,5 mg | RK-LS-5No.021404 |
1900 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telsartan® N | tablets 80 mg /12,5 mg | RK-LS-5No.022178 |
1901 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telmista® N | tablets 40 mg /12,5 mg | RK-LS-5No.020637 |
1902 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telmista® N | tablets 80 mg /25 mg | RK-LS-5No.020639 |
1903 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telpres plus | tablets 40/12,5 mg | RK-LS-5No.023294 |
1904 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telpres plus | tablets 80/12,5mg | RK-LS-5No.023297 |
1905 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telpres plus | tablets 80/25mg | RK-LS-5No.023298 |
1906 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telsartan® N | tablets 40 mg /12,5 mg | RK-LS-5No.022179 |
1907 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telzap Plus | tablets 40 mg /12.5 mg | RK-LS-5No.121970 |
1908 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telzap Plus | tablets 80 mg /12.5 mg | RK-LS-5No.121971 |
1909 | C09DA07 | Telmisartan and Hydrochlorothiazide | Telzap Plus | tablets 80 mg /25 mg | RK-LS-5No.121972 |
1910 | C09DA07 | Telmisartan and Hydrochlorothiazide | Seiftelmi G | tablets 40 mg /12,5 mg | RK-LS-5No.121985 |
1911 | C09DA07 | Telmisartan and Hydrochlorothiazide | Safitel-N | tablets 40/12,5 mg | RK-LS-5No.121768 |
1912 | C09DA07 | Telmisartan and Hydrochlorothiazide | Tellzi N | tablets 40mg /12,5 mg | RK-LS-5No.121723 |
1913 | C09DA07 | Telmisartan and Hydrochlorothiazide | Co-Telsakor-Teva | tablets 80 mg /25 mg | RK-LS-5No.021403 |
C09DA08 | Olmesartan Medoxomil and Hydrochlorothiazide | ||||
C09DB | Angiotensin II antagonists in combination with calcium channel blockers | ||||
C09DB01 | Valsartan and Amlodipine | ||||
1914 | C09DB01 | Valsartan and Amlodipine | Agvistat® | coated tablets 10mg /160 mg | RK-LS-3No.122149 |
1915 | C09DB01 | Valsartan and Amlodipine | Agvistat® | coated tablets 5 mg /160 mg | RK-LS-3No.122148 |
1916 | C09DB01 | Valsartan and Amlodipine | Eksvalsartan-ben | film-coated tablets 160 mg /10mg | RK-LS-5No.023570 |
1917 | C09DB01 | Valsartan and Amlodipine | Exforge® | film-coated tablets 10 mg /160 mg | RK-LS-5No.014822 |
1918 | C09DB01 | Valsartan and Amlodipine | Exforge® | film-coated tablets 5 mg /160 mg | RK-LS-5No.014821 |
1919 | C09DB01 | Valsartan and Amlodipine | Exforge® | film-coated tablets 5 mg /80 mg | RK-LS-5No.014820 |
1920 | C09DB01 | Valsartan and Amlodipine | Alcapress Plus | film-coated tablets 5mg /160 mg | RK-LS-5No.022666 |
1921 | C09DB01 | Valsartan and Amlodipine | Valodip | film-coated tablets 5mg /80mg | RK-LS-5No.020957 |
1922 | C09DB01 | Valsartan and Amlodipine | Valodip | film-coated tablets 5mg /160mg | RK-LS-5No.020958 |
1923 | C09DB01 | Valsartan and Amlodipine | Valodip | film-coated tablets 10mg /160mg | RK-LS-5No.020959 |
1924 | C09DB01 | Valsartan and Amlodipine | Normotans | coated tablets 5 mg /160 mg | RK-LS-5No.024376 |
1925 | C09DB01 | Valsartan and Amlodipine | Normotans | coated tablets 10 mg /160 mg | RK-LS-5No.024377 |
1926 | C09DB01 | Valsartan and Amlodipine | Vanatex Amlo | coated tablets 10 mg /160 mg | RK-LS-5No.024127 |
1927 | C09DB01 | Valsartan and Amlodipine | Vanatex Amlo | coated tablets 5 mg /80 mg | RK-LS-5No.024124 |
1928 | C09DB01 | Valsartan and Amlodipine | Vanatex Amlo | coated tablets 5 mg /160 mg | RK-LS-5No.024125 |
1929 | C09DB01 | Valsartan and Amlodipine | Tewalsam | film-coated tablets 5 mg /80 mg | RK-LS-5No.023764 |
1930 | C09DB01 | Valsartan and Amlodipine | Tewalsam | film-coated tablets 5 mg /160 mg | RK-LS-5No.023765 |
1931 | C09DB01 | Valsartan and Amlodipine | Tewalsam | film-coated tablets 10 mg /160 mg | RK-LS-5No.023766 |
1932 | C09DB01 | Valsartan and Amlodipine | Axudropin® | film-coated tablets 10 mg /160 mg | RK-LS-5No.023746 |
1933 | C09DB01 | Valsartan and Amlodipine | Axudropin® | film-coated tablets 5 mg /160 mg | RK-LS-5No.023747 |
1934 | C09DB01 | Valsartan and Amlodipine | Axudropin® | film-coated tablets 5 mg /80 mg | RK-LS-5No.023748 |
1935 | C09DB01 | Valsartan and Amlodipine | Artinova-AM | film-coated tablets 10 mg /160 mg | RK-LS-5No.023373 |
1936 | C09DB01 | Valsartan and Amlodipine | Artinova-AM | film-coated tablets 5 mg /160 mg | RK-LS-5No.023374 |
1937 | C09DB01 | Valsartan and Amlodipine | Artinova-AM | film-coated tablets 5 mg /80 mg | RK-LS-5No.023375 |
C09DX04 | Valsartan and Sacubitril | ||||
1938 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 200 mg | RK-LS-5No.023196 |
1939 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 50 mg | RK-LS-5No.023194 |
1940 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 100 mg | RK-LS-5No.023195 |
1941 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 50 mg | RK-LS-5No.023188 |
1942 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 100 mg | RK-LS-5No.023189 |
1943 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 200 mg | RK-LS-5No.023190 |
1944 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 50 mg | RK-LS-5No.023191 |
1945 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 100 mg | RK-LS-5No.023192 |
1946 | C09DX04 | Valsartan and Sacubitril | Uperio ™ | film-coated tablets 200 mg | RK-LS-5No.023193 |
C10 | Lipid-lowering drugs | ||||
C10A | Hypocholesterolemic and hypotriglyceridemic drugs | ||||
C10AA | HMG-COA-reductase inhibitors | ||||
C10AA01 | Simvastatin | ||||
1947 | C10AA01 | Simvastatin | Simecar® 10 | film-coated tablets 10 mg | RK-LS-5No.016209 |
1948 | C10AA01 | Simvastatin | Simecar® 20 | film-coated tablets 20 mg | RK-LS-5No.016210 |
1949 | C10AA01 | Simvastatin | Simekar® 40 | film-coated tablets 40 mg | RK-LS-5No.016624 |
1950 | C10AA01 | Simvastatin | Vasilip® | film-coated tablets 10 mg | RK-LS-5No.005351 |
1951 | C10AA01 | Simvastatin | Simvasterol | coated tablets 10 mg | RK-LS-5No.004722 |
1952 | C10AA01 | Simvastatin | Vasilip® | film-coated tablets 20 mg | RK-LS-5No.005352 |
1953 | C10AA01 | Simvastatin | Simvasterol | coated tablets 20 mg | RK-LS-5No.004723 |
1954 | C10AA01 | Simvastatin | Vasilip® | film-coated tablets 40 mg | RK-LS-5No.005001 |
1955 | C10AA01 | Simvastatin | Simvasterol | coated tablets 40 mg | RK-LS-5No.004724 |
1956 | C10AA01 | Simvastatin | Zovastikor | coated tablets 10 mg | RK-LS-5No.020811 |
1957 | C10AA01 | Simvastatin | Zovastikor | coated tablets 20 mg | RK-LS-5No.020812 |
1958 | C10AA01 | Simvastatin | Brucor | film-coated tablets 20 mg | RK-LS-5No.020854 |
1959 | C10AA01 | Simvastatin | Brucor | film-coated tablets 40 mg | RK-LS-5No.020855 |
1960 | C10AA01 | Simvastatin | Zokor | coated tablets 10 mg | RK-LS-5No.009279 |
1961 | C10AA01 | Simvastatin | Zokor | coated tablets 20 mg | RK-LS-5No.009280 |
C10AA05 | Atorvastatin | ||||
1962 | C10AA05 | Atorvastatin | Tulip® | film-coated tablets, 40 mg | RK-LS-5No.020740 |
1963 | C10AA05 | Atorvastatin | Atoris® | film-coated tablets 40 mg | RK-LS-5No.014849 |
1964 | C10AA05 | Atorvastatin | Liprimar® | film-coated tablets 40 mg | RK-LS-5No.018156 |
1965 | C10AA05 | Atorvastatin | Atribet | film-coated tablets 40 mg | RK-LS-5No.020329 |
1966 | C10AA05 | Atorvastatin | Liprimar® | film-coated tablets 80 mg | RK-LS-5No.018157 |
1967 | C10AA05 | Atorvastatin | Atribet | film-coated tablets, 80 mg | RK-LS-5No.020330 |
1968 | C10AA05 | Atorvastatin | Vasator | film-coated tablets, 20 mg | RK-LS-5No.019169 |
1969 | C10AA05 | Atorvastatin | Liprimar® | film-coated tablets 20 mg | RK-LS-5No.018155 |
1970 | C10AA05 | Atorvastatin | Atorvastatin | film-coated tablets, 20 mg | RK-LS-5No.021218 |
1971 | C10AA05 | Atorvastatin | Atribet | film-coated tablets, 20 mg | RK-LS-5No.020328 |
1972 | C10AA05 | Atorvastatin | Vasator | film-coated tablets, 10 mg | RK-LS-5No.019168 |
1973 | C10AA05 | Atorvastatin | Tulip® | film-coated tablets 10 mg | RK-LS-5No.020738 |
1974 | C10AA05 | Atorvastatin | Atoris® | film-coated tablets 10 mg | RK-LS-5No.009808 |
1975 | C10AA05 | Atorvastatin | Atribet | film-coated tablets, 10 mg | RK-LS-5No.020327 |
1976 | C10AA05 | Atorvastatin | Atorvastatin | film-coated tablets 40 mg | RK-LS-5No.021531 |
1977 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 40 mg | RK-LS-5No.016524 |
1978 | C10AA05 | Atorvastatin | Atorvastatin | film-coated tablets 10 mg | RK-LS-5No.021219 |
1979 | C10AA05 | Atorvastatin | Liprimar® | film-coated tablets 10 mg | RK-LS-5No.018154 |
1980 | C10AA05 | Atorvastatin | Atorvastatin | film-coated tablets 10 mg | RK-LS-5No.021529 |
1981 | C10AA05 | Atorvastatin | Amvastan | film-coated tablets 10 mg | RK-LS-5No.019190 |
1982 | C10AA05 | Atorvastatin | Amvastan | film-coated tablets 20 mg | RK-LS-5No.019191 |
1983 | C10AA05 | Atorvastatin | Atorvastatin-Teva | coated tablets 10 mg | RK-LS-5No.020876 |
1984 | C10AA05 | Atorvastatin | Atorvastatin-Teva | coated tablets 30 mg | RK-LS-5No.020877 |
1985 | C10AA05 | Atorvastatin | Atorvastatin-Teva | coated tablets 40 mg | RK-LS-5No.020878 |
1986 | C10AA05 | Atorvastatin | Atorvastatin-Teva | coated tablets 60 mg | RK-LS-5No.020879 |
1987 | C10AA05 | Atorvastatin | Atorvastatin-Teva | coated tablets 80 mg | RK-LS-5No.020880 |
1988 | C10AA05 | Atorvastatin | Atorvastatin-Teva | coated tablets 20 mg | RK-LS-5No.020881 |
1989 | C10AA05 | Atorvastatin | Atorvastatin | coated tablets 20 mg | RK-LS-5No.021530 |
1990 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 10 mg | RK-LS-5No.016522 |
1991 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 20 mg | RK-LS-5No.016523 |
1992 | C10AA05 | Atorvastatin | Storvas® | film-coated tablets 10 mg | RK-LS-5No.122034 |
1993 | C10AA05 | Atorvastatin | Storvas® | film-coated tablets 20 mg | RK-LS-5No.122035 |
1994 | C10AA05 | Atorvastatin | Storvas® | film-coated tablets 40 mg | RK-LS-5No.122036 |
1995 | C10AA05 | Atorvastatin | Atoris® | film-coated tablets 20 mg | RK-LS-5No.009809 |
1996 | C10AA05 | Atorvastatin | Atorfit 40 | film-coated tablets 40 mg | RK-LS-5No.022886 |
1997 | C10AA05 | Atorvastatin | Torvacard NEO | film-coated tablets 10 mg | RK-LS-5No.023126 |
1998 | C10AA05 | Atorvastatin | Torvacard NEO | film-coated tablets 20 mg | RK-LS-5No.023127 |
1999 | C10AA05 | Atorvastatin | Atokor | film-coated tablets 10 mg | RK-LS-5No.003016 |
2000 | C10AA05 | Atorvastatin | Atokor | film-coated tablets 20 mg | RK-LS-5No.003026 |
2001 | C10AA05 | Atorvastatin | Arvaz ™ -20 | film-coated tablets 20 mg | RK-LS-5No.018943 |
2002 | C10AA05 | Atorvastatin | Atoris® | film-coated tablets 30 mg | RK-LS-5No.019674 |
2003 | C10AA05 | Atorvastatin | Atoris® | film-coated tablets 60 mg | RK-LS-5No.019675 |
2004 | C10AA05 | Atorvastatin | Atoris® | film-coated tablets 80 mg | RK-LS-5No.019676 |
2005 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 10 mg | RK-LS-5No.020501 |
2006 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 20 mg | RK-LS-5No.020502 |
2007 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 40 mg | RK-LS-5No.020503 |
2008 | C10AA05 | Atorvastatin | Atorvasterol | coated tablets 80 mg | RK-LS-5No.020504 |
2009 | C10AA05 | Atorvastatin | ETsET® | coated tablets 80 mg | RK-LS-5No.024292 |
2010 | C10AA05 | Atorvastatin | ETsET® | coated tablets 40 mg | RK-LS-5No.024293 |
2011 | C10AA05 | Atorvastatin | ETsET® | coated tablets 20 mg | RK-LS-5No.024294 |
2012 | C10AA05 | Atorvastatin | ETsET® | coated tablets 10 mg | RK-LS-5No.024295 |
2013 | C10AA05 | Atorvastatin | Tulip® | film-coated tablets 20 mg | RK-LS-5No.020739 |
C10AA07 | Rosuvastatin | ||||
2014 | C10AA07 | Rosuvastatin | Crestor | coated tablets 20 mg | RK-LS-5No.012494 |
2015 | C10AA07 | Rosuvastatin | Ultrax® 20 | film-coated tablets 20 mg | RK-LS-5No.016352 |
2016 | C10AA07 | Rosuvastatin | Ldnil | film-coated tablets 20 mg | RK-LS-5No.018759 |
2017 | C10AA07 | Rosuvastatin | Crestor | coated tablets 10 mg | RK-LS-5No.012493 |
2018 | C10AA07 | Rosuvastatin | Ultrax® 10 | film-coated tablets 10 mg | RK-LS-5No.016353 |
2019 | C10AA07 | Rosuvastatin | Ldnil | coated tablets 10 mg | RK-LS-5No.018758 |
2020 | C10AA07 | Rosuvastatin | Rosustar | film-coated tablets 10 mg | RK-LS-5No.022907 |
2021 | C10AA07 | Rosuvastatin | Rosustar | film-coated tablets 20 mg | RK-LS-5No.022912 |
2022 | C10AA07 | Rosuvastatin | Crestor® | coated tablets 5 mg | RK-LS-5No.017729 |
2023 | C10AA07 | Rosuvastatin | Roxera® | film-coated tablets 5 mg | RK-LS-5No.018083 |
2024 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 5 mg | RK-LS-5No.018354 |
2025 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 40 mg | RK-LS-5No.018357 |
2026 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 10 mg | RK-LS-5No.018355 |
2027 | C10AA07 | Rosuvastatin | Polwasterol | coated tablets 10 mg | RK-LS-5No.019723 |
2028 | C10AA07 | Rosuvastatin | Rosulip® | coated tablets 10 mg | RK-LS-5No.019476 |
2029 | C10AA07 | Rosuvastatin | Roxera® | film-coated tablets 10 mg | RK-LS-5No.018084 |
2030 | C10AA07 | Rosuvastatin | Rofast | film-coated tablets 10 mg | RK-LS-5No.121881 |
2031 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 20 mg | RK-LS-5No.018356 |
2032 | C10AA07 | Rosuvastatin | Polwasterol | coated tablets 20 mg | RK-LS-5No.019724 |
2033 | C10AA07 | Rosuvastatin | Starcrest® | film-coated tablets 20 mg | RK-LS-5No.020913 |
2034 | C10AA07 | Rosuvastatin | Rosulip® | coated tablets 20 mg | RK-LS-5No.019477 |
2035 | C10AA07 | Rosuvastatin | Roxera® | film-coated tablets 20 mg | RK-LS-5No.018085 |
2036 | C10AA07 | Rosuvastatin | Rofast | film-coated tablets 20 mg | RK-LS-5No.121882 |
2037 | C10AA07 | Rosuvastatin | Breaker | film-coated tablets 10 mg | RK-LS-5No.121891 |
2038 | C10AA07 | Rosuvastatin | Breaker | film-coated tablets 20 mg | RK-LS-5No.121892 |
2039 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 5 mg | RK-LS-5No.018358 |
2040 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 40 mg | RK-LS-5No.018361 |
2041 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 10 mg | RK-LS-5No.018359 |
2042 | C10AA07 | Rosuvastatin | Mertenil® | film-coated tablets 20 mg | RK-LS-5No.018360 |
2043 | C10AA07 | Rosuvastatin | Starcrest® | film-coated tablets 5 mg | RK-LS-5No.020911 |
2044 | C10AA07 | Rosuvastatin | Starcrest® | film-coated tablets 10 mg | RK-LS-5No.020912 |
2045 | C10AA07 | Rosuvastatin | Starcrest® | film-coated tablets 40 mg | RK-LS-5No.020914 |
2046 | C10AA07 | Rosuvastatin | Arozvas | film-coated tablets 10 mg | RK-LS-5No.021583 |
2047 | C10AA07 | Rosuvastatin | Arozvas | film-coated tablets 20 mg | RK-LS-5No.021584 |
2048 | C10AA07 | Rosuvastatin | Acorta® | film-coated tablets 10 mg | RK-LS-5No.121979 |
2049 | C10AA07 | Rosuvastatin | Acorta® | film-coated tablets 20 mg | RK-LS-5No.121980 |
2050 | C10AA07 | Rosuvastatin | Rosave 10 | film-coated tablets 10 mg | RK-LS-5No.122017 |
2051 | C10AA07 | Rosuvastatin | Rosave 20 | film-coated tablets 20 mg | RK-LS-5No.122018 |
2052 | C10AA07 | Rosuvastatin | Roxardio® | film-coated tablets 5 mg | RK-LS-5No.022262 |
2053 | C10AA07 | Rosuvastatin | Roxardio® | film-coated tablets 10 mg | RK-LS-5No.022263 |
2054 | C10AA07 | Rosuvastatin | Roxardio® | film-coated tablets 20 mg | RK-LS-5No.022264 |
2055 | C10AA07 | Rosuvastatin | Roxardio® | film-coated tablets 40 mg | RK-LS-5No.022265 |
2056 | C10AA07 | Rosuvastatin | Rosuvin | film-coated tablets 5 mg | RK-LS-5No.022515 |
2057 | C10AA07 | Rosuvastatin | Rosuvin | film-coated tablets 10 mg | RK-LS-5No.022516 |
2058 | C10AA07 | Rosuvastatin | Rosuvin | film-coated tablets 20 mg | RK-LS-5No.022517 |
2059 | C10AA07 | Rosuvastatin | Rosuvin | film-coated tablets 40 mg | RK-LS-5No.022518 |
2060 | C10AA07 | Rosuvastatin | Roxera® | film-coated tablets 40 mg | RK-LS-5No.018086 |
2061 | C10AA07 | Rosuvastatin | Rosustar | film-coated tablets 5 mg | RK-LS-5No.022906 |
2062 | C10AA07 | Rosuvastatin | Rosufast | film-coated tablets 5 mg | RK-LS-5No.023129 |
2063 | C10AA07 | Rosuvastatin | Rosufast | film-coated tablets 10 mg | RK-LS-5No.023130 |
2064 | C10AA07 | Rosuvastatin | Rosufast | film-coated tablets 20 mg | RK-LS-5No.023131 |
2065 | C10AA07 | Rosuvastatin | Rosulip® | coated tablets 5 mg | RK-LS-5No.121915 |
2066 | C10AA07 | Rosuvastatin | Rozumak | film-coated tablets 5 mg | RK-LS-5No.023312 |
2067 | C10AA07 | Rosuvastatin | Rozumak | film-coated tablets 10 mg | RK-LS-5No.023313 |
2068 | C10AA07 | Rosuvastatin | Rozumak | film-coated tablets 20 mg | RK-LS-5No.023314 |
2069 | C10AA07 | Rosuvastatin | Rozumak | film-coated tablets 40 mg | RK-LS-5No.023315 |
2070 | C10AA07 | Rosuvastatin | Rosutor 20 | film-coated tablets 20 mg | RK-LS-5No.023394 |
2071 | C10AA07 | Rosuvastatin | Rosutor 10 | film-coated tablets 10 mg | RK-LS-5No.023395 |
2072 | C10AA07 | Rosuvastatin | Rosutor 5 | film-coated tablets 5 mg | RK-LS-5No.023396 |
2073 | C10AA07 | Rosuvastatin | Polwasterol | coated tablets 5 mg | RK-LS-5No.019722 |
2074 | C10AA07 | Rosuvastatin | Roxera® | film-coated tablets 15 mg | RK-LS-5No.019678 |
2075 | C10AA07 | Rosuvastatin | Roxera® | film-coated tablets 30 mg | RK-LS-5No.019679 |
2076 | C10AA07 | Rosuvastatin | Rosuvastatin-SZ | film-coated tablets 5 mg | RK-LS-5No.023587 |
2077 | C10AA07 | Rosuvastatin | Rosuvastatin-SZ | film-coated tablets 40 mg | RK-LS-5No.023588 |
2078 | C10AA07 | Rosuvastatin | Rosuvastatin-SZ | film-coated tablets 10 mg | RK-LS-5No.023589 |
2079 | C10AA07 | Rosuvastatin | Rosuvastatin-SZ | film-coated tablets 20 mg | RK-LS-5No.023590 |
2080 | C10AA07 | Rosuvastatin | Rosuvastatin-Teva | film-coated tablets 40 mg | RK-LS-5No.023837 |
2081 | C10AA07 | Rosuvastatin | Rosuvastatin-Teva | film-coated tablets 20 mg | RK-LS-5No.023838 |
2082 | C10AA07 | Rosuvastatin | Rosuvastatin-Teva | film-coated tablets 10 mg | RK-LS-5No.023839 |
2083 | C10AA07 | Rosuvastatin | Rosuvastatin-Teva | film-coated tablets 5 mg | RK-LS-5No.023840 |
2084 | C10AA07 | Rosuvastatin | Rovasta | film-coated tablets 20 mg | RK-LS-5No.024109 |
2085 | C10AA07 | Rosuvastatin | Rovasta | film-coated tablets 10 mg | RK-LS-5No.024110 |
2086 | C10AA07 | Rosuvastatin | Rovasta | film-coated tablets 5 mg | RK-LS-5No.024111 |
2087 | C10AA07 | Rosuvastatin | Klivas | film-coated tablets 10 mg | RK-LS-5No.024409 |
2088 | C10AA07 | Rosuvastatin | Klivas | film-coated tablets 20 mg | RK-LS-5No.024399 |
2089 | C10AA07 | Rosuvastatin | Rosuvastatin-LF | coated tablets 5 mg | RK-LS-5No.024361 |
2090 | C10AA07 | Rosuvastatin | Rosuvastatin-LF | coated tablets 10 mg | RK-LS-5No.024362 |
2091 | C10AA07 | Rosuvastatin | Rosuvastatin-LF | coated tablets 20 mg | RK-LS-5No.024363 |
2092 | C10AA07 | Rosuvastatin | Rosulip® | coated tablets 40 mg | RK-LS-5No.019478 |
C10AB | Fibrates | ||||
C10AB05 | Fenofibrate | ||||
2093 | C10AB05 | Fenofibrate | Traikor® | film-coated tablets 145 mg | RK-LS-5No.019646 |
2094 | C10AB05 | Fenofibrate | Lipidex® SR | Prolonged-release capsules 250 mg | RK-LS-5No.014810 |
2095 | C10AB05 | Fenofibrate | FENOFIBRATE Sobhan | capsules 200 mg | RK-LS-5No.122101 |
2096 | C10AB05 | Fenofibrate | Traikor® | film-coated tablets 160 mg | RK-LS-5No.019681 |
C10AX | Other lipid-lowering drugs | ||||
C10AX09 | Ezetimibe | ||||
2097 | C10AX09 | Ezetimibe | Alneksa | tablets 10 mg | RK-LS-5No.019023 |
C10AX13 | Evolocumab | ||||
2098 | C10AX13 | Evolocumab | Repata | hypodermic solution in pre-filled syringe pen 140 mg /ml | No. RK-LS-5No.023664 |
C10B | Lipid modifying agents, combinations | ||||
C10BA02 | Simvastatin and Ezetimibe | ||||
D | Dermatology | ||||
D01 | Antifungal drugs for treating skin conditions | ||||
D01A | Antifungal drugs for external use | ||||
D01AA | Antifungal antibiotics | ||||
2099 | D01AA | Antifungal antibiotics | Roseofungin-AS® | ointment 2% 20 g | RK-LS-5No.023225 |
D01AA01 | Nystatin | ||||
2100 | D01AA01 | Nystatin | Fungostatin® | granules for preparation of suspension for topical application 100 000 IU/ml 7.5 g/50 ml | RK-LS-5No.019093 |
D01AC | Imidazole and triazole derivatives | ||||
D01AC01 | Clotrimazole | ||||
2101 | D01AC01 | Clotrimazole | Candide | cream 1% | RK-LS-5No.014435 |
2102 | D01AC01 | Clotrimazole | Candibene® | cream 1% | RK-LS-5No.018199 |
2103 | D01AC01 | Clotrimazole | Candide | solution for local use1% | RK-LS-5No.013578 |
2104 | D01AC01 | Clotrimazole | Candide | solution for external use 1% | RK-LS-5No.014229 |
2105 | D01AC01 | Clotrimazole | Clotrimazole | solution for external use 1% | RK-LS-5No.003929 |
2106 | D01AC01 | Clotrimazole | Clotrimazole | cream 1% | RK-LS-5No.005354 |
2107 | D01AC01 | Clotrimazole | Clotrimazole | Ointment 1% | RK-LS-5No.019578 |
2108 | D01AC01 | Clotrimazole | Candide | Powder for external use | RK-LS-5No.011978 |
2109 | D01AC01 | Clotrimazole | CLOTRIMAZOL | Cream 1%, 15 g | RK-LS-5No.020660 |
D01AC02 | Miconazole | ||||
2110 | D01AC02 | Miconazole | Miconaz | cream 2% | RK-LS-5No.011812 |
2111 | D01AC02 | Miconazole | Miconazole | cream for external use 20 g | RK-LS-5No.021217 |
2112 | D01AC02 | Miconazole | Miconaz | Powder for external use | RK-LS-5No.003845 |
D01AC08 | Ketoconazole | ||||
2113 | D01AC08 | Ketoconazole | Dermazole® | shampoo 2% 50 ml | RK-LS-5No.014266 |
2114 | D01AC08 | Ketoconazole | Dermazole® | cream 2% 15 g | RK-LS-5No.013158 |
2115 | D01AC08 | Ketoconazole | Mikanisal® | shampoo 20 mg/g | RK-LS-5No.017151 |
2116 | D01AC08 | Ketoconazole | Nizoral® | cream for external use 2% | RK-LS-5No.009839 |
2117 | D01AC08 | Ketoconazole | Nizoral® | shampoo 2% | RK-LS-5No.009831 |
2118 | D01AC08 | Ketoconazole | Ketazol | shampoo 2% | RK-LS-5No.023182 |
2119 | D01AC08 | Ketoconazole | Ketazol | Ointment for external use 2% | RK-LS-5No.023260 |
D01AE | Other antifungal drugs for external use | ||||
D01AE12 | Salicylic acid | ||||
2120 | D01AE12 | Salicylic acid | Salicylic acid | alcohol solution for external use 20 mg/ml 25 ml | RK-LS-5No.019697 |
2121 | D08AE | Salicylic acid | Salicylic acid alcohol solution 2% | alcohol solution for external use 2% 25 ml | RK-LS-5No.009522 |
2122 | D08AE | Salicylic acid | Salicylic acid alcohol solution 2% | alcohol solution for external use 2% 50 ml | RK-LS-5No.009522 |
2123 | D08AE | Salicylic acid | Salicylic acid alcohol solution 2% | alcohol solution for external use 2% 60 ml | RK-LS-5No.009524 |
D01AE15 | Terbinafine | ||||
2124 | D01AE15 | Terbinafine | Finotherb | cream for external use 1% 15 g | RK-LS-5No.022363 |
2125 | D01AE15 | Terbinafine | Terfalin® | cream 1% 15 g | RK-LS-5No.011618 |
2126 | D01AE15 | Terbinafine | Lamikon | spray for external use 1% | RK-LS-5No.005679 |
2127 | D01AE15 | Terbinafine | Terfalin® | spray for topical application 1% | RK-LS-5No.012729 |
2128 | D01AE15 | Terbinafine | Erbinol | cream for external use 10 mg/g | RK-LS-5No.121773 |
2129 | D01AE15 | Terbinafine | Erbinol | spray for external use 1% | RK-LS-5No.019224 |
2130 | D01AE15 | Terbinafine | Exifin® | cream 1% | RK-LS-5No.014091 |
2131 | D01AE15 | Terbinafine | Terbital® | cream for external use 10 mg/g | RK-LS-5No.015631 |
2132 | D01AE15 | Terbinafine | Terbizil® | cream 1% | RK-LS-5No.004549 |
2133 | D01AE15 | Terbinafine | Lamisil | cream for external use 1% | RK-LS-5No.004659 |
2134 | D01AE15 | Terbinafine | Lamisil® | spray 1% | RK-LS-5No.009577 |
2135 | D01AE15 | Terbinafine | Lamikon® | cream 1% | RK-LS-5No.005678 |
2136 | D01AE15 | Terbinafine | TERFALIN® | cream 1% | RK-LS-5No.023476 |
2137 | D01AE15 | Terbinafine | Lamisil® Uno | Solution for external use film-forming 1% 4 g | RK-LS-5No.010192 |
2138 | D01AE15 | Terbinafine | Lamisil Dermgel | Gel 1% 15 g | RK-LS-5No.013703 |
D01AE16 | Amorolfine | ||||
2139 | D01AE16 | Amorolfine | Lotseril® | nail polish 5% 2.5 ml | RK-LS-5No.020818 |
2140 | D01AE16 | Amorolfine | Lotseril® | nail polish 5% 5 ml | RK-LS-5No.020818 |
2141 | D01AE16 | Amorolfine | Fungosept® | nail polish 50 mg/ml | RK-LS-5No.121948 |
2142 | D01AE16 | Amorolfine | Oflomil | nail polish 5% 2.5 ml | RK-LS-5No.024067 |
D01B | Antifungal drugs for systemic use | ||||
D01BA02 | Terbinafine | ||||
2143 | D01BA02 | Terbinafine | Terfalin® | tablets 250 mg | RK-LS-5No.016316 |
2144 | D01BA02 | Terbinafine | Terbizil® | tablets 250 mg | RK-LS-5No.004548 |
2145 | D01BA02 | Terbinafine | Terbinafine | tablets 250 mg | RK-LS-5No.121918 |
2146 | D01BA02 | Terbinafine | Erbinol | tablets 250 mg | RK-LS-5No.021582 |
2147 | D01BA02 | Terbinafine | Exifin® | tablets 250 mg | RK-LS-5No.014443 |
2148 | D01BA02 | Terbinafine | Lamikon® | tablets 0.25 g | RK-LS-5No.005680 |
2149 | D01BA02 | Terbinafine | Medron | tablets 250 mg | RK-LS-5No.018983 |
D02 | Preparations with softening and protective action | ||||
D02AB | Zinc preparations | ||||
2150 | D02AB | Zinc preparations | Zinc ointment | ointment 10% 30 g | RK-LS-5No.003137 |
2151 | D02AB | Zinc preparations | Zinc ointment | Ointment for external use 100mg/g 25 g | RK-LS-5No.011515 |
2152 | D02AB | Zinc preparations | Zinc paste | Paste 30 g | RK-LS-5No.004822 |
2153 | D02AB | Zinc preparations | Zentavex | Ointment 150mg/g 50 g | RK-LS-5No.022029 |
D02AC | Paraffin and fat preparations | ||||
D02AC | Petrolatum | ||||
2154 | D02AC | Petrolatum | Vaseline oil | oil for external use 25 g | RK-LS-5No.013016 |
2155 | D11AX | Petrolatum | Petrolatum | ointment 25 g | RK-LS-5No.012810 |
2156 | D02AC | Petrolatum | Dexeril® | External cream 50 g | RK-LS-5No.020814 |
2157 | D02AC | Petrolatum | Dexeril® | Cream for external use 250 g | RK-LS-5No.020814 |
2158 | D02AC | Petrolatum | Vaseline-DF medical | Ointment for external use 25 g | RK-LS-5No.016473 |
2159 | D02AC | Petrolatum | Petrolatum | Ointment for external use 25 g | RK-LS-5No.003160 |
D02AX | Preparations for treatment of wounds and ulcers | ||||
D03 | Medicines that promote normal scarring | ||||
D03A | Other drugs that contribute to normal scarring | ||||
D03AX | Dexpanthenol | ||||
D03AX03 | Dexpanthenol | ||||
2160 | D03AX03 | Dexpanthenol | Hydrotene | cream for external use 5%, 30 g | RK-LS-5No.022321 |
2161 | D03AX03 | Dexpanthenol | Hydrotene | ointment for external use 5%, 30 g | RK-LS-5No.022322 |
2162 | D03AX03 | Dexpanthenol | HappyDerm Forte | aerosol for external use 58.5 g | RK-LS-5No.020822 |
2163 | D03AX03 | Dexpanthenol | Bepanten® | cream for external use 5% 30 g | RK-LS-5No.005720 |
2164 | D03AX03 | Dexpanthenol | Panthenol-Teva | cream 5% 35 g | RK-LS-5No.012414 |
2165 | D03AX03 | Dexpanthenol | HappyDerm Forte | aerosol for external use 117 g | RK-LS-5No.020822 |
2166 | D03AX03 | Dexpanthenol | Panthenol-Teva | cream 5% 100 g | RK-LS-5No.012414 |
2167 | D03AX03 | Dexpanthenol | Depantol® | ointment for external use 5% 30 g | RK-LS-5No.015737 |
2168 | D03AX03 | Dexpanthenol | RECREOL® | cream for external use 50 mg/g 30 g | RK-LS-5No.024169 |
2169 | D03AX03 | Dexpanthenol | RECREOL® | cream for external use 50 mg/g 50 g | RK-LS-5No.024169 |
2170 | D03AX03 | Dexpanthenol | RECREOL® | ointment for external use 50 mg/g 30 g | RK-LS-5No.024170 |
2171 | D03AX03 | Dexpanthenol | RECREOL® | ointment for external use 50 mg/g 50 g | RK-LS-5No.024170 |
2172 | D03AX03 | Dexpanthenol | Pantoderm | ointment for external use 5% 30 g | RK-LS-5No.023123 |
2173 | D03AX03 | Dexpanthenol | Bepanten® | ointment for external use 5% 3.5 g | RK-LS-5No.005719 |
2174 | D03AX03 | Dexpanthenol | Bepanten® | ointment for external use 5% 30 g | RK-LS-5No.005719 |
2175 | D03AX03 | Dexpanthenol | Bepanten® | ointment for external use 5% 100 g | RK-LS-5No.005719 |
2176 | D03AX03 | Dexpanthenol | Panthenol | aerosol for external use 58 g | RK-LS-5No.001871 |
2177 | D03AX03 | Dexpanthenol | Panthenol | aerosol for external use 116 g | RK-LS-5No.001871 |
2178 | D03AX03 | Dexpanthenol | Panthenol Pharmstandard | aerosol for external use 5% 58 g | RK-LS-5No.016840 |
2179 | D03AX03 | Preparations for treatment of wounds and ulcers | Panthenol spray | aerosol for external use 4.63 g 130 g | RK-LS-5No.014048 |
D05 | Drugs for treatment of psoriasis | ||||
D05AX | Other drugs for external use for treatment of psoriasis | ||||
D05AX52 | Calcipotriol and Betamethasone | ||||
2180 | D05AX52 | Calcipotriol and Betamethasone | Daivobet® | ointment for external use 30 g | RK-LS-5No.020337 |
2181 | D05AX52 | Calcipotriol and Betamethasone | Xamiol® | Gel 15 g | RK-LS-5No.017985 |
2182 | D05AX52 | Calcipotriol and Betamethasone | Xamiol® | Gel 30 g | RK-LS-5No.017985 |
D06 | Antimicrobials for treating skin conditions | ||||
D06AA04 | Tetracycline | ||||
2183 | D06AA04 | Tetracycline | Tetracycline | ointment for external use 3% 15g | RK-LS-5No.010996 |
2184 | D06AA04 | Tetracycline | Tetracycline | ointment for external use 3% 15 g | RK-LS-5No.009606 |
2185 | D06AA04 | Tetracycline | Tetracycline-AKOS | ointment for external use 3% 15 g | RK-LS-5No.015886 |
D06AX02 | Chloramphenicol | ||||
2186 | D06AX02 | Chloramphenicol | Synthomycin | liniment 10% 25 g | RK-LS-5No.005121 |
2187 | D06AX02 | Chloramphenicol | Levomycetin | alcohol solution for external use 1% 10 ml | RK-LS-5No.003174 |
2188 | D06AX02 | Chloramphenicol | Levomycetin | alcohol solution 0.25% 15 ml | RK-LS-5No.015609 |
2189 | D06AX02 | Chloramphenicol | Levomycetin | alcohol solution 0.25% 30 ml | RK-LS-5No.015609 |
2190 | D06AX02 | Chloramphenicol | Levomycetin | alcohol solution 0.25% 60 ml | RK-LS-5No.015612 |
D06AX09 | Mupirocin | ||||
2191 | D06AX09 | Mupirocin | Mupobel® | cream for external use 2% 15 g | RK-LS-5No.022607 |
2192 | D06AX09 | Mupirocin | Mupobel® | cream for external use 2% 30 g | RK-LS-5No.022607 |
2193 | D06AX09 | Mupirocin | Mupobel® | ointment for external use 2% 15 g | RK-LS-5No.022610 |
2194 | D06AX09 | Mupirocin | Mupobel® | ointment for external use 2% 30 g | RK-LS-5No.022610 |
2195 | D06AX09 | Mupirocin | BACTOPIC® | ointment 2% 15 g | RK-LS-5No.023929 |
D06AX13 | Retapamulin | ||||
D06BB03 | Acyclovir | ||||
2196 | D06BB03 | Acyclovir | Acyclostad® | cream 5% 5 g | RK-LS-5No.005401 |
2197 | D06BB03 | Acyclovir | Acyclostad® | cream 5% 2 g | RK-LS-5No.005401 |
2198 | D06BB03 | Acyclovir | Acigerpine | cream for external use 5% 5 g | RK-LS-5No.010737 |
2199 | D06BB03 | Acyclovir | Ulcaril® | cream 5% 2 g | RK-LS-5No.016130 |
2200 | D06BB03 | Acyclovir | Ulcaril® | cream 5% 10 g | RK-LS-5No.016130 |
2201 | D06BB03 | Acyclovir | Acyclovir Belupo | cream for external use 5% 5 g | RK-LS-5No.021281 |
2202 | D06BB03 | Acyclovir | Acyclovir Belupo | cream for external use 5% 2 g | RK-LS-5No.021281 |
2203 | D06BB03 | Acyclovir | Acyclovir Belupo | cream for external use 5% 10 g | RK-LS-5No.021281 |
2204 | D06BB03 | Acyclovir | HERPEVIR® | ointment 2.5% 5 g | RK-LS-5No.010608 |
2205 | D06BB03 | Acyclovir | HERPEVIR® | ointment 2.5% 15 g | RK-LS-5No.010608 |
2206 | D06BB03 | Acyclovir | Medovir | powder for solution for infusion 500mg | RK-LS-5No.016516 |
2207 | D06BB03 | Acyclovir | Zovirax | cream for external use 5% 2 g | RK-LS-5No.012598 |
2208 | D06BB03 | Acyclovir | Acyclovir Santo | ointment for external use 5% 5 g | RK-LS-5No.023082 |
2209 | D06BB03 | Acyclovir | ACYCLOVIR | ointment 5% 5 g | RK-LS-5No.003223 |
D06BB10 | Imichimod | ||||
2210 | D06BB10 | Imichimod | Keraworth | cream for external use 5% 250 mg | RK-LS-5No.020833 |
D06BX | Other antimicrobial drugs | ||||
D06BX01 | Metronidazole | ||||
2211 | D06BX01 | Metronidazole | Rosamet® | cream for external use 1% 25 g | RK-LS-5No.010800 |
2212 | D06BX01 | Metronidazole | Metrogyl® | Gel for external use 10mg/g | RK-LS-5No.004084 |
D07 | Topical corticosteroids for treatment of skin conditions | ||||
D07A | Corticosteroids | ||||
D07AA | Poor corticosteroids | ||||
D07AA02 | Hydrocortisone | ||||
2213 | D07AA02 | Hydrocortisone | Hydrocortisone | ointment for external use 1% 10 g | RK-LS-5No.011405 |
2214 | D07AA02 | Hydrocortisone | Hydrocortisone | ointment for external use 1% 10 g | RK-LS-5No.009806 |
D07AA03 | Prednisolone | ||||
2215 | D07AA03 | Prednisolone | Prednisolone | ointment for external use 0.5% 10 g | RK-LS-5No.010273 |
2216 | D07AA03 | Prednisolone | Prednisolone | ointment for external use 5mg/g 10 g | RK-LS-5No.019981 |
D07AB | Moderately active corticosteroids | ||||
D07AB02 | Hydrocortisone butyrate | ||||
D07AB09 | Triamcinolone | ||||
2217 | D07AB09 | Triamcinolone | Fluorocort® | ointment 0.1% 15 g | RK-LS-5No.002043 |
D07AB10 | Alclomethasone | ||||
2218 | D07AB10 | Alclomethasone | Afloderm | ointment for external use 0.05% 20 g | RK-LS-5No.016153 |
2219 | D07AB10 | Alclomethasone | Afloderm | ointment for external use 0.05% 40 g | RK-LS-5No.016153 |
2220 | D07AB10 | Alclomethasone | Afloderm | cream for external use 0.05% 20 g | RK-LS-5No.016154 |
2221 | D07AB10 | Alclomethasone | Afloderm | cream for external use 0.05% 40 g | RK-LS-5No.016154 |
D07AC | Highly active corticosteroids | ||||
D07AC01 | Betamethasone | ||||
2222 | D07AC01 | Betamethasone | Nobetasone | cream for external use 0.1% 15 g | RK-LS-5No.022398 |
2223 | D07AC01 | Betamethasone | Nobetasone | cream for external use 0.1% 30 g | RK-LS-5No.022398 |
2224 | D07AC01 | Betamethasone | NOBETAZONE® | ointment for external use 0.1% 15 g | RK-LS-5No.022367 |
2225 | D07AC01 | Betamethasone | NOBETAZONE® | ointment for external use 0.1% 30 g | RK-LS-5No.022367 |
2226 | D07AC01 | Betamethasone | Beloderm | ointment for external use 0.05% 15 g | RK-LS-5No.015483 |
2227 | D07AC01 | Betamethasone | Beloderm | ointment for external use 0.05% 15 g | RK-LS-5No.015485 |
2228 | D07AC01 | Betamethasone | Celestoderm-V® | ointment 1 mg 30 g | RK-LS-5No.003779 |
2229 | D07AC01 | Betamethasone | Akriderm | cream for external use 0.05% 15 g | RK-LS-5No.000561 |
2230 | D07AC01 | Betamethasone | Akriderm | cream for external use 0.05% 30 g | RK-LS-5No.000561 |
2231 | D07AC01 | Betamethasone | Akriderm | ointment for external use 0.05% 15 g | RK-LS-5No.023316 |
2232 | D07AC01 | Betamethasone | Akriderm | ointment for external use 0.05% 30 g | RK-LS-5No.023316 |
2233 | D07AC01 | Betamethasone | Moniderm | ointment 1 mg/g 15 g | RK-LS-5No.023850 |
2234 | D07AC01 | Betamethasone | Beloderm Express | Spray for external use 0.05% 20 ml | RK-LS-5No.021178 |
2235 | D07AC01 | Betamethasone | Beloderm Express | Spray for external use 0.05% 50 ml | RK-LS-5No.021178 |
D07AC04 | Fluocinolone acetonide | ||||
2236 | D07AC04 | Fluocinolone acetonide | Sinaflan | ointment for external use 0.025% 10 g | RK-LS-5No.005127 |
2237 | D07AC04 | Fluocinolone acetonide | Sinaflan | ointment for external use 0.025% 15 g | RK-LS-5No.005127 |
2238 | D07AC04 | Fluocinolone acetonide | Flucinar® | gel 0.025% 15 g | RK-LS-5No.016096 |
2239 | D07AC04 | Fluocinolone acetonide | Sinaflan | ointment for external use 0.25 mg/g 15 g | RK-LS-5No.011679 |
2240 | D07AC04 | Fluocinolone acetonide | Flucinar® | ointment for external use 0.025% 15 g | RK-LS-5No.004066 |
D07AC13 | Mometasone | ||||
2241 | D07AC13 | Mometasone | Momat | cream 0.1% 5 g | RK-LS-5No.014779 |
2242 | D07AC13 | Mometasone | Momat | cream 0.1% 15 g | RK-LS-5No.014779 |
2243 | D07AC13 | Mometasone | Momat | ointment 1mg/g 5 g | RK-LS-5No.014710 |
2244 | D07AC13 | Mometasone | Momat | ointment 1mg/g 15 g | RK-LS-5No.014710 |
2245 | D07AC13 | Mometasone | Elokom® | cream 0.1% 15 g | RK-LS-5No.005739 |
2246 | D07AC13 | Mometasone | Moderm | cream 0.1% 15 g | RK-LS-5No.016627 |
2247 | D07AC13 | Mometasone | Moderm | ointment 0.1% 15 g | RK-LS-5No.016628 |
2248 | D07AC13 | Mometasone | Elokom® | ointment 0.1% 15 g | RK-LS-5No.005740 |
2249 | D07AC13 | Mometasone | Mometox | cream 15 g | RK-LS-5No.016297 |
2250 | D07AC13 | Mometasone | Elika | cream 0.1% 30 g | RK-LS-5No.016302 |
2251 | D07AC13 | Mometasone | Elika | ointment 0.1% 30 g | RK-LS-5No.016303 |
2252 | D07AC13 | Mometasone | Upson | cream 0.1% 15 g | RK-LS-5No.017086 |
2253 | D07AC13 | Mometasone | Vegtazone | cream 1 mg/g 15 g | RK-LS-5No.023043 |
2254 | D07AC13 | Mometasone | Mometasone Santo | cream for external use 0.1% 15 g | RK-LS-5No.023122 |
2255 | D07AC13 | Mometasone | Mometasone Santo | cream for external use 0.1% 30 g | RK-LS-5No.023122 |
D07AC14 | Methylprednisolone aceponate | ||||
2256 | D07AC14 | Methylprednisolone aceponate | Advantan® | emulsion 0.1% 20 g | RK-LS-5No.013880 |
2257 | D07AC14 | Methylprednisolone aceponate | Advantan® | fatty ointment 0.1% 15 g | RK-LS-5No.013897 |
2258 | D07AC14 | Methylprednisolone aceponate | Advantan® | cream 0.1% 15 g | RK-LS-5No.015837 |
2259 | D07AC14 | Methylprednisolone aceponate | Advantan® | ointment 0.1% 15 g | RK-LS-5No.015838 |
D07XC01 | Betamethasone and Salicylic Acid | ||||
2260 | D07XC01 | Betamethasone and Salicylic Acid | Novosalik | ointment 30 g | RK-LS-5No.020753 |
2261 | D07XC01 | Betamethasone and Salicylic Acid | Betasalik | ointment 15 g. | RK-LS-5No.003452 |
2262 | D07XC01 | Betamethasone and Salicylic Acid | Belosalik | ointment for external use 15 g | RK-LS-5No.016136 |
2263 | D07XC01 | Betamethasone and Salicylic Acid | Belosalik | ointment for external use 30 g | RK-LS-5No.016136 |
2264 | D07XC01 | Betamethasone and Salicylic Acid | Diprosalik® | ointment 30 g | RK-LS-5No.011576 |
2265 | D07XC01 | Betamethasone and Salicylic Acid | Acricil | ointment for external use 0.05% + 3% 15 g | RK-LS-5No.023557 |
2266 | D07XC01 | Betamethasone and Salicylic Acid | Acricil | ointment for external use 0.05% + 3% 30 g | RK-LS-5No.023557 |
2267 | D07XC01 | Betamethasone and Salicylic Acid | Vegaderm | ointment 0.5 mg/10 mg/1 mg 15 g | RK-LS-5No.023013 |
2268 | D07XC01 | Betamethasone and Salicylic Acid | Triderm® | ointment 15 g. | RK-LS-5No.004943 |
2269 | D07XC01 | Betamethasone and Salicylic Acid | Triacutan® | Cream 15 g | RK-LS-5No.010831 |
2270 | D07XC01 | Betamethasone and Salicylic Acid | Akriderm GK | Cream for external use 0.05% + 0.1% + 1% 15 g | RK-LS-5No.023558 |
2271 | D07XC01 | Betamethasone and Salicylic Acid | Akriderm GK | Cream for external use 0.05% + 0.1% + 1% 30 g | RK-LS-5No.023558 |
2272 | D07XC01 | Betamethasone and Salicylic Acid | Tridox | Cream 15 g | RK-LS-5No.017082 |
2273 | D07XC01 | Betamethasone and Salicylic Acid | Triderm® | Cream 15 g | RK-LS-5No.003781 |
2274 | D07XC01 | Betamethasone and Salicylic Acid | Belosalik lotion | Solution for external use 50 ml | RK-LS-5No.016132 |
2275 | D07XC01 | Betamethasone and Salicylic Acid | Belosalik lotion | Solution for external use 100 ml | RK-LS-5No.016132 |
2276 | D07XC01 | Betamethasone and Salicylic Acid | Belosalik | Spray for external use 50 ml | RK-LS-5No.021258 |
2277 | D07XC01 | Betamethasone and Salicylic Acid | Belosalik | Spray for external use 100 ml | RK-LS-5No.021258 |
D07AD01 | Clobetasol | ||||
2278 | D07AD01 | Clobetasol | Derilife | cream 50 g | RK-LS-5No.022616 |
2279 | D07AD01 | Clobetasol | Dermovate® | cream for external use 0.05% 25 g | RK-LS-5No.009576 |
2280 | D07AD01 | Clobetasol | Dermovate® | ointment for external use 0.05% 25 g | RK-LS-5No.009575 |
2281 | D07AD01 | Clobetasol | Cloveith | cream for external use 0.5 mg/g 25 g | RK-LS-5No.004005 |
2282 | D07AD01 | Clobetasol | Powercourt | cream 15 g | RK-LS-5No.014656 |
2283 | D07AD01 | Clobetasol | Cloveith | ointment for external use 0.5 mg/g 25 g | RK-LS-5No.004004 |
2284 | D07AD01 | Clobetasol | Clobeford | cream for external use 30 grams | RK-LS-5No.023861 |
D08 | Antiseptics and disinfectants | ||||
D08AC | Biguanides and amidines | ||||
D08AC02 | Chlorhexidine | ||||
2285 | D08AC02 | Chlorhexidine | Chlorhexidine bigluconate | solution for external use 0.05% 50 ml | RK-LS-3No.021145 |
2286 | D08AC02 | Chlorhexidine | Chlorhexidine bigluconate | solution for external use 0.05% 100 ml | RK-LS-3No.021145 |
2287 | D08AC02 | Chlorhexidine | Miranistidine-SHF | solution for external use 0.05% 50 ml | RK-LS-5No.023436 |
2288 | D08AC02 | Chlorhexidine | Miranistidine-SHF | solution for external use 0.05% 100 ml | RK-LS-5No.023436 |
2289 | D08AC02 | Chlorhexidine | Chlorhexidine biglunate | solution for external use 0.05% 100 ml | RK-LS-5No.023468 |
2290 | D08AC02 | Chlorhexidine | Miraxidine-DF® | solution for external use 0.05% 10 ml | RK-LS-5No.014538 |
2291 | D08AC02 | Chlorhexidine | Miraxidine-DF® | Spray for external use 0.05% 50 ml | RK-LS-3No.020443 |
2292 | D08AC02 | Chlorhexidine | Miraxidine-DF® | Spray for external use 0.05% 100 ml | RK-LS-3No.020443 |
D08AG | Iodine preparations | ||||
D08AG | Iodine, potassium iodide, glycerin, water | ||||
2293 | D08AG | Iodine, potassium iodide, glycerin, water | Lugol solution with glycerin | solution for external use 25 g | RK-LS-5No.003162 |
2294 | D08AG | Iodine, potassium iodide, glycerin, water | Lugol solution with glycerin | solution 25 ml | RK-LS-5No.009434 |
2295 | D08AG | Iodine, potassium iodide, glycerin, water | Anguillug | Topical spray 25g | RK-LS-3No.122065 |
D08AG02 | Povidone-iodized | ||||
2296 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 1% 1 l | RK-LS-5No.020418 |
2297 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 1% 50 ml | RK-LS-5No.020418 |
2298 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 1% 100 ml | RK-LS-5No.020418 |
2299 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 1%, 30 ml | RK-LS-5No.020418 |
2300 | D08AG02 | Povidone-iodized | Betadine® | ointment for external use 10% 20 g | RK-LS-5No.004388 |
2301 | D08AG02 | Povidone-iodized | Betadine® | solution for external and local use 1 l | RK-LS-5No.016274 |
2302 | D08AG02 | Povidone-iodized | Betadine® | solution for external and local use 30 ml | RK-LS-5No.016274 |
2303 | D08AG02 | Povidone-iodized | Betadine® | solution for external and local use 120 ml | RK-LS-5No.016274 |
2304 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 50 ml | RK-LS-5No.012363 |
2305 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 1 l | RK-LS-5No.012363 |
2306 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 100 ml | RK-LS-5No.012363 |
2307 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use 30 ml | RK-LS-5No.012363 |
2308 | R02AA | Povidone-iodized | Jox | solution for topical application 50 ml | RK-LS-5No.010826 |
2309 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use, 1000 ml | RK-LS-5No.121910 |
2310 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use, 100 ml | RK-LS-5No.121910 |
2311 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use, 30 ml | RK-LS-5No.121910 |
2312 | D08AG02 | Povidone-iodized | Povidone-Iodine | solution for external use, 50 ml | RK-LS-5No.121910 |
2313 | D08AG02 | Povidone-iodized | Povidone-Iodine-DF | solution for external and local use 30 ml | RK-LS-3No.121740 |
2314 | D08AG02 | Povidone-iodized | Povidone-Iodine-DF | solution for external and local use 50 ml | RK-LS-3No.121740 |
2315 | D08AG02 | Povidone-iodized | Povidone-Iodine-DF | solution for external and local use 100 ml | RK-LS-3No.121740 |
2316 | D08AG02 | Povidone-iodized | Povidone-Iodine-DF | Spray for local and external use 30 ml | RK-LS-3No.121741 |
2317 | D08AG02 | Povidone-iodized | Povidone-Iodine-DF | Spray for local and external use 50 ml | RK-LS-3No.121741 |
2318 | D08AG02 | Povidone-iodized | Povidone-Iodine-DF | Spray for local and external use 100 ml | RK-LS-3No.121741 |
D08AG03 | Iodine | ||||
2319 | D08AG03 | Iodine | Iodine | alcohol solution 5% 10 ml | RK-LS-5No.003153 |
2320 | D08AG03 | Iodine | Iodine | alcohol solution 5% 20 ml | RK-LS-5No.003153 |
2321 | D08AG03 | Iodine | Iodine | alcohol solution 5% 10 ml | RK-LS-5No.009525 |
2322 | D08AG03 | Iodine | Iodine | alcohol solution 5% 20 ml | RK-LS-5No.009525 |
2323 | D08AG03 | Iodine | Iodine | alcohol solution 5% 25 ml | RK-LS-5No.009525 |
2324 | D08AG03 | Iodine | Iodine | alcohol solution 5% 30 ml | RK-LS-5No.009525 |
2325 | D08AG03 | Iodine | Iodinol | solution for local and external use iodine 100.0 mg | RK-LS-5No.018028 |
2326 | D08AG03 | Iodine | Iodine | alcohol solution 5% 10 ml | RK-LS-5No.023222 |
2327 | D08AG03 | Iodine | Iodine | alcohol solution 5% 25 ml | RK-LS-5No.023222 |
D08AX | Other antiseptics and disinfectants | ||||
D08AX | Brilliant green | ||||
2328 | D08AX | Brilliant green | Brilliant green alcohol solution 1% | alcohol solution 10 ml | RK-LS-5No.009569 |
2329 | D08AX | Brilliant green | Brilliant green alcohol solution 1% | alcohol solution 20 ml | RK-LS-5No.009569 |
2330 | D08AX | Brilliant green | Brilliant green | alcohol solution 1% 10 ml | RK-LS-5No.003176 |
2331 | D08AX | Brilliant green | Brilliant green | alcohol solution 1% 20 ml | RK-LS-5No.003176 |
2332 | D08AX | Brilliant green | Brilliant green alcohol solution 1% | alcohol solution 30 ml | RK-LS-5No.009569 |
D08AX01 | Hydrogen peroxide | ||||
2333 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 25 ml | RK-LS-5No.014589 |
2334 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 40 ml | RK-LS-5No.014589 |
2335 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide-DF | solution for external use 3% 30 ml | RK-LS-5No.013205 |
2336 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide-DF | solution for external use 3% 40 ml | RK-LS-5No.013205 |
2337 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide-DF | solution for external use 3% 50 ml | RK-LS-5No.013205 |
2338 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 30 ml | RK-LS-5No.009520 |
2339 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 50 ml | RK-LS-5No.009520 |
2340 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 90 ml | RK-LS-5No.009520 |
2341 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 25 ml | RK-LS-5No.009520 |
2342 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 40 ml | RK-LS-5No.009520 |
2343 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 60 ml | RK-LS-5No.009520 |
2344 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide-DF | spray for external use 3% 100 ml | RK-LS-5No.013206 |
2345 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide-DF | spray for external use 3% 30 ml | RK-LS-5No.013206 |
2346 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide-DF | spray for external use 3% 50 ml | RK-LS-5No.013206 |
2347 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 25 ml | RK-LS-5No.003171 |
2348 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 40 ml | RK-LS-5No.003171 |
2349 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 40 ml | RK-LS-5No.022996 |
2350 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | spray for external use 3% 25 ml | RK-LS-3No.121967 |
2351 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | spray for external use 3% 40 ml | RK-LS-3No.121967 |
2352 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 40 ml | RK-LS-5No.024252 |
2353 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 90 ml | RK-LS-5No.024252 |
2354 | D08AX01 | Hydrogen peroxide | Hydrogen peroxide | solution for external use 3% 100 ml | RK-LS-5No.024252 |
2355 | D08AX01 | Hydrogen peroxide | Hydroperite | Tablets for solution preparation for local and external use, 1.5 g | RK-LS-5No.010362 |
D08AX06 | Potassium permanganate | ||||
2356 | D08AX06 | Potassium permanganate | Potassium permanganate | powder 5 g | RK-LS-5No.003175 |
D08AX08 | Ethanol | ||||
2357 | D08AX08 | Ethanol | Ethanol | solution 70% 50 ml in a vial of 50 ml | RK-LS-5No.009473 |
2358 | D08AX08 | Ethanol | Ethanol | solution 70% 50 ml in a vial of 100 ml | RK-LS-5No.009473 |
2359 | D08AX08 | Ethanol | Ethanol | solution 90% 50 ml in a vial | RK-LS-5No.009474 |
2360 | D08AX08 | Ethanol | Ethanol | solution 90% 100 ml in a vial | RK-LS-5No.009474 |
2361 | D08AX08 | Ethanol | Ethanol | solution 70% 30 ml | RK-LS-5No.001467 |
2362 | D08AX08 | Ethanol | Ethanol | solution 70% 60 ml | RK-LS-5No.001467 |
2363 | D08AX08 | Ethanol | Ethanol | solution 70% 50 ml | RK-LS-5No.001467 |
2364 | D08AX08 | Ethanol | Ethanol | solution 70% 90 ml | RK-LS-5No.001467 |
2365 | D08AX08 | Ethanol | Ethyl alcohol 70% | liquid 70% 50 ml | RK-LS-5No.019713 |
2366 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 50 ml | RK-LS-5No.003159 |
2367 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 90 ml | RK-LS-5No.003159 |
2368 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 100 ml | RK-LS-5No.003159 |
2369 | D08AX08 | Ethanol | Ethanol | solution 90% 30 ml | RK-LS-5No.001469 |
2370 | D08AX08 | Ethanol | Ethanol | solution 90% 50 ml | RK-LS-5No.001469 |
2371 | D08AX08 | Ethanol | Ethanol | solution 90% 60 ml | RK-LS-5No.001469 |
2372 | D08AX08 | Ethanol | Ethanol | solution 90% 90 ml | RK-LS-5No.001469 |
2373 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 50 ml | RK-LS-5No.023844 |
2374 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 90 ml | RK-LS-5No.023844 |
2375 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 50 ml | RK-LS-5No.023845 |
2376 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 90 ml | RK-LS-5No.023845 |
2377 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 70% 30 ml | RK-LS-5No.014541 |
2378 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 70% 50 ml | RK-LS-5No.014541 |
2379 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 70% 90 ml | RK-LS-5No.014541 |
2380 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 70% 100 ml | RK-LS-5No.014543 |
2381 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 90% 100 ml | RK-LS-5No.014546 |
2382 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 90% 30 ml | RK-LS-5No.014544 |
2383 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 90% 50 ml | RK-LS-5No.014544 |
2384 | D08AX08 | Ethanol | Ethyl alcohol-DF | solution for external use 90% 90 ml | RK-LS-5No.014544 |
2385 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 50 ml | RK-LS-5No.022957 |
2386 | D08AX08 | Ethanol | Ethanol | solution for external use 70% 90 ml | RK-LS-5No.022957 |
2387 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 50ml | RK-LS-5No.022896 |
2388 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 90 ml | RK-LS-5No.022896 |
2389 | D08AX08 | Ethanol | Ethanol | solution for external use 40% 50 ml | RK-LS-5No.022897 |
2390 | D08AX08 | Ethanol | Ethanol | solution for external use 40% 90 ml | RK-LS-5No.022897 |
2391 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 50 ml | RK-LS-5No.003156 |
2392 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 90 ml | RK-LS-5No.003156 |
2393 | D08AX08 | Ethanol | Ethanol | solution for external use 90% 100 ml | RK-LS-5No.003156 |
2394 | D08AX08 | Ethanol | Ethyl alcohol 90% | Liquid 90% 50 ml | RK-LS-5No.019712 |
2395 | D08AX08 | Ethanol | Ethyl alcohol-DF | Spray for external use 70% 30 ml | RK-LS-5No.015729 |
2396 | D08AX08 | Ethanol | Ethyl alcohol-DF | Spray for external use 70% 50 ml | RK-LS-5No.015729 |
2397 | D08AX08 | Ethanol | Ethyl alcohol-DF | Spray for external use 90% 30 ml | RK-LS-5No.015730 |
2398 | D08AX08 | Ethanol | Ethyl alcohol-DF | Spray for external use 90% 50 ml | RK-LS-5No.015730 |
D10 | Acne drugs | ||||
D10A | Topical acne drugs | ||||
D10AD54 | Isotretinoin and Erythromycin | ||||
2399 | D10AD54 | Isotretinoin and Erythromycin | Munderm Gel | gel for external use 20 mg/0.5 mg 30 g | RK-LS-5No.022672 |
D10AE01 | Benzoyl peroxide | ||||
D10AX03 | Azelaic acid | ||||
2400 | D10AX03 | Azelaic acid | Skinoren® | gel 15% 5 g | RK-LS-5No.014885 |
2401 | D10AX03 | Azelaic acid | Skinoren® | gel 15% 15 g | RK-LS-5No.014885 |
2402 | D10AX03 | Azelaic acid | Skinoren® | gel 15% 30 g | RK-LS-5No.014885 |
2403 | D10AX03 | Azelaic acid | Skinoren® | cream 20% 30 g | RK-LS-5No.000417 |
2404 | D10AX03 | Azelaic acid | Aknestop | cream 30 g | RK-LS-5No.016812 |
2405 | D10AX03 | Azelaic acid | Azelik | gel for external use 15% 5 g | RK-LS-5No.023028 |
2406 | D10AX03 | Azelaic acid | Azelik | gel for external use 15% 15g | RK-LS-5No.023028 |
2407 | D10AX03 | Azelaic acid | Azelik | gel for external use 15% 30 g | RK-LS-5No.023028 |
D10B | Systemic acne drugs | ||||
D10BA01 | Isotretinoin | orphan | |||
2408 | D10BA01 | Isotretinoin | Acnecutan® | capsules 16 mg | RK-LS-5No.021046 |
2409 | D10BA01 | Isotretinoin | Acnecutan® | capsules 8 mg | RK-LS-5No.021045 |
2410 | D10BA01 | Isotretinoin | Roaccutane | capsules 20 mg | RK-LS-5No.000873 |
2411 | D10BA01 | Isotretinoin | Kurakne® | capsules 10 mg | RK-LS-5No.023646 |
2412 | D10BA01 | Isotretinoin | Kurakne® | capsules 20 mg | RK-LS-5No.023647 |
D11 | Other dermatological drugs | ||||
D11AX01 | Minoxidil | ||||
2413 | D11AX01 | Minoxidil | Minoxidil Intel | solution for external use 2% 60 ml | RK-LS-5No.022412 |
2414 | D11AX01 | Minoxidil | Minoxidil Intel | solution for external use 5% 60 ml | RK-LS-5No.022435 |
2415 | D11AX01 | Minoxidil | Revard | solution for external use 50 mg/ml 100 ml | RK-LS-5No.022023 |
2416 | D11AX01 | Minoxidil | Alopexy® 2% | solution for external use 2% 60 ml | RK-LS-5No.020027 |
2417 | D11AX01 | Minoxidil | Alopexy® 5% | solution for external use 5% 60 ml | RK-LS-5No.020028 |
2418 | D11AX01 | Minoxidil | Generolon | Spray for external use 5% 60 ml | RK-LS-5No.024036 |
2419 | D11AX01 | Minoxidil | Generolon | Spray for external use 2% 60 ml | RK-LS-5No.024037 |
D11AH01 | Tacrolimus | ||||
D11AH02 | Pimecrolimus | ||||
2420 | D11AH02 | Pimecrolimus | Elidel® | cream 1% 15 g | RK-LS-5No.013779 |
2421 | D11AH02 | Pimecrolimus | Elidel® | cream 1% 15 g | RK-LS-5No.022698 |
G | Genitourinary system and sex hormones | ||||
G01 | Antiseptics and antimicrobial drugs for treatment of gynecological diseases | ||||
G01A | Antiseptics and antimicrobial drugs for treatment of gynecological diseases (excluding combinations with corticosteroids) | ||||
G01AA | Antibiotics | ||||
G01AA01 | Nystatin | ||||
2422 | G01AA01 | Nystatin | Nystatin | vaginal suppositories 500,000 U | RK-LS-5No.002357 |
G01AC | Quinolone derivatives | ||||
G01AC05 | Dequalinium chloride | ||||
2423 | G01AC05 | Dequalinium chloride | Antibact | vaginal tablets 10 mg | RK-LS-5No.022397 |
2424 | G01AC05 | Dequalinium chloride | Fluomisin® | vaginal tablets 10 mg | RK-LS-5No.021113 |
G01AF | Imidazole derivatives | ||||
2425 | G01AF | Imidazole derivatives | Metostil | vaginal suppositories 200 mg +160 mg + 8 mg | RK-LS-5No.019551 |
2426 | G01AF | Imidazole derivatives | Clomezole | vaginal suppositories 150mg + 200mg +500 mg | RK-LS-5No.010894 |
G01AF01 | Metronidazole | ||||
2427 | G01AF01 | Metronidazole | Trichopolus | vaginal tablets 500 mg | RK-LS-5No.010644 |
2428 | G01AF01 | Metronidazole | Mistol | vaginal suppositories 500 mg | RK-LS-5No.023690 |
2429 | G01AF01 | Metronidazole | Metronidazole | vaginal suppositories 500 mg | RK-LS-5No.002308 |
G01AF02 | Clotrimazole | ||||
2430 | G01AF02 | Clotrimazole | Clotrimazole | vaginal tablets 100 mg | RK-LS-5No.011494 |
2431 | G01AF02 | Clotrimazole | Candide B | vaginal gel 2% 30 g | RK-LS-5No.012446 |
2432 | G01AF02 | Clotrimazole | Clotrimazole | vaginal suppositories 100 mg | RK-LS-5No.009749 |
2433 | G01AF02 | Clotrimazole | Candibene® | vaginal tablets 200 mg | RK-LS-5No.018732 |
2434 | G01AF02 | Clotrimazole | Kanesten® | vaginal tablets 500mg | RK-LS-5No.021231 |
2435 | G01AF02 | Clotrimazole | Kanesten® | vaginal tablets 100 mg | RK-LS-5No.021232 |
2436 | G01AF02 | Clotrimazole | Clotrim | vaginal tablets 100 mg | RK-LS-5No.004765 |
2437 | G01AF02 | Clotrimazole | Candide-B6 | vaginal tablets 100 mg | RK-LS-5No.011333 |
2438 | G01AF02 | Clotrimazole | CLOFAN® | vaginal suppositories 500 mg | RK-LS-5No.023809 |
2439 | G01AF02 | Clotrimazole | CLOFAN® | vaginal suppositories 100 mg | RK-LS-5No.023993 |
2440 | G01AF02 | Clotrimazole | Candibene® | vaginal tablets 100 mg | RK-LS-5No.018731 |
2441 | G01AF02 | Clotrimazole | Clotrimazole | vaginal tablets 100 mg | RK-LS-5No.005353 |
2442 | G01AF02 | Clotrimazole | CLOFAN® | Cream 10% 7 g | RK-LS-5No.121974 |
G01AF04 | Miconazole | ||||
2443 | G01AF04 | Miconazole | Miconazole | vaginal suppositories 100 mg | RK-LS-5No.009691 |
2444 | G01AF04 | Miconazole | Miconaz | Vaginal capsules 400 mg | RK-LS-5No.013144 |
G01AF11 | Ketoconazole | ||||
2445 | G01AF11 | Ketoconazole | Livarol® | vaginal suppositories 400 mg | RK-LS-5No.016696 |
2446 | G01AF11 | Ketoconazole | DERMAZOL® | vaginal suppositories 400 mg | RK-LS-5No.014266 |
2447 | G01AF11 | Ketoconazole | DERMAZOL® | vaginal suppositories 400 mg | RK-LS-5No.023728 |
G01AF12 | Fenticonazole | ||||
2448 | G01AF12 | Fenticonazole | Lomexin | vaginal capsules 200 mg | RK-LS-5No.017146 |
2449 | G01AF12 | Fenticonazole | Lomexin | vaginal capsules 600 mg | RK-LS-5No.017147 |
2450 | G01AF12 | Fenticonazole | Lomexin | vaginal capsules 1000 mg | RK-LS-5No.017148 |
2451 | G01AF12 | Fenticonazole | Lomexin | cream 2% 30 g | RK-LS-5No.017149 |
2452 | G01AF12 | Fenticonazole | Lomexin | cream 2% 78 g | RK-LS-5No.017150 |
G01AX | Other antiseptics and antimicrobials | ||||
G01AX | Chlorhexidine | ||||
2453 | G01AX | Chlorhexidine | Depantol® | vaginal suppositories 0.016 g + 0.1 g | RK-LS-5No.015807 |
2454 | G01AX | Chlorhexidine | Hexicon® | vaginal suppositories 16 mg | RK-LS-5No.016118 |
2455 | G01AX | Chlorhexidine | Hexosept-Rn | vaginal suppositories 16 mg | RK-LS-5No.024070 |
2456 | G01AX | Chlorhexidine | CHLORHEXIDINE EFFECT | vaginal suppositories 16 mg | RK-LS-5No.022411 |
2457 | G01AX | Chlorhexidine | KM - Kalefit® | Suppositories | RK-LS-5No.004448 |
G01AX06 | Furazolidone | ||||
2458 | G01AX06 | Furazolidone | Furazolidone | tablet 50 mg | RK-LS-5No.019339 |
G01AX11 | Povidone iodine | ||||
2459 | G01AX11 | Povidone iodine | Akvidin | vaginal tablets (pessaries) 200 mg | RK-LS-5No.122106 |
2460 | G01AX11 | Povidone iodine | Betadine® | vaginal suppositories 200 mg | RK-LS-5No.009783 |
2461 | G01AX11 | Povidone iodine | Povidone-iodine | vaginal suppositories 200 mg | RK-LS-5No.009752 |
G02 | Other gynecological drugs | ||||
G02A | Drugs that increase the tone of the myometrium | ||||
G02AD | Prostaglandins | ||||
G02AD02 | Dinoprostone | ||||
2462 | G02AD02 | Dinoprostone | GLANDIN-E2 | vaginal gel 2.0 mg/3 g | RK-LS-5No.022947 |
2463 | G02AD02 | Dinoprostone | GLANDIN-E2 | vaginal tablets 3mg | RK-LS-5No.022950 |
G02AD06 | Misoprostol | ||||
2464 | G02AD06 | Misoprostol | Misoprostol | tablets 0.2 mg | RK-LS-5No.009944 |
2465 | G02AD06 | Misoprostol | Mirolyut® | tablets, 200 mcg | RK-LS-5No.018503 |
2466 | G02AD06 | Misoprostol | Misopro | tablets 0.2 mg | RK-LS-5No.122023 |
G02B | Contraceptives for topical use | ||||
G02BA | Intrauterine contraceptives | ||||
G02BA03 | Plastic spirals with progestogens | ||||
2467 | G02BA03 | Plastic spirals with progestogens | Mirena® | intrauterine system 20 mcg/24 h | RK-LS-5No.015812 |
G02C | Other drugs for treatment of gynecological diseases | ||||
G02CB | Prolactin Secretion Inhibitors | ||||
G02CB01 | Bromocriptine | ||||
2468 | G02CB01 | Bromocriptine | Bromocriptine-Richter | tablets 2.5 mg | RK-LS-5No.003958 |
G02CB03 | Atosiban | ||||
2469 | G02CB03 | Cabergoline | Agalates | tablets 0.5 mg, No. 8 | RK-LS-5No.020301 |
2470 | G02CB03 | Cabergoline | Dostinex® | tablets 0.5 mg, No. 2 | RK-LS-5No.012082 |
2471 | G02CB03 | Cabergoline | Dostinex® | tablets 0.5 mg, No. 8 | RK-LS-5No.012082 |
G02CX | Other drugs for use in gynecology | ||||
G02CX01 | Atosiban | ||||
2472 | G02CX01 | Atosiban | Tractocil | concentrate for preparation of solution for infusion 7.5 mg/ml 5 ml | RK-LS-5No.015528 |
2473 | G02CX01 | Atosiban | Tractocil | solution for intravenous injection 7.5 mg/ml 0.9 ml | RK-LS-5No.015662 |
2474 | G02CX01 | Atosiban | Atosiban FarmIdea | concentrate for preparation of solution for infusion 37.5 mg/5 ml | RK-LS-5No.024038 |
2475 | G02CX01 | Atosiban | Atosiban FarmIdea | solution for injection 6.75 mg/0.9 ml | RK-LS-5No.024048 |
2476 | G02CX01 | Atosiban | Atosiban FarmIdea | solution for injection 6.75 mg/0.9 ml | RK-LS-5No.0240348 |
G03 | Sex hormones and modulators of the reproductive system | ||||
G03A | Hormonal contraceptives for systemic use | ||||
G03AA | Progestogens and Estrogens (Fixed Combinations) | ||||
G03AA07 | Levonorgestrel and Ethinylestradiol | ||||
2477 | G03AA07 | Levonorgestrel and Ethinylestradiol | Orlyfic | film-coated tablets, 0.100 mg/0.020 mg | RK-LS-5No.022570 |
2478 | G03AA07 | Levonorgestrel and Ethinylestradiol | Listrella | tablets 0.15 mg/0.03 mg | RK-LS-5No.021541 |
2479 | G03AA07 | Levonorgestrel and Ethinylestradiol | Leverett mini | film-coated tablets 0.1 mg/0.02 mg | RK-LS-5No.122109 |
2480 | G03AA07 | Levonorgestrel and Ethinylestradiol | Rigevidon® | coated tablets 0.03 mg/0.15 mg | RK-LS-5No.014752 |
G03AA09 | Desogestrel and Ethinylestradiol | ||||
2481 | G03AA09 | Desogestrel and Ethinylestradiol | Regulon® | film-coated tablets 0.03 mg/0.15 mg | RK-LS-5No.011399 |
2482 | G03AA09 | Desogestrel and Ethinylestradiol | Novinet® | film-coated tablets 0.02 mg/0.15 mg | RK-LS-5No.011370 |
2483 | G03AA09 | Desogestrel and Ethinylestradiol | Destra | film-coated tablets 0.15 mg + 0.02 mg | RK-LS-5No.023615 |
2484 | G03AA09 | Desogestrel and Ethinylestradiol | Marvelon® | tablets 0.15 mg/0.03 mg | RK-LS-5No.012152 |
2485 | G03AA09 | Desogestrel and Ethinylestradiol | Diaval | film-coated tablets 0.15 mg + 0.03 mg | RK-LS-5No.023883 |
G03AA10 | Gestodene and Ethinylestradiol | ||||
2486 | G03AA10 | Gestodene and Ethinylestradiol | Lindinet 20 | coated tablet 0.075 mg/0.02 mg | RK-LS-5No.014072 |
2487 | G03AA10 | Gestodene and Ethinylestradiol | Logest® | dragee | RK-LS-5No.015836 |
2488 | G03AA10 | Gestodene and Ethinylestradiol | PLEASED | tablet 0.075 mg/0.02 mg | RK-LS-5No.022585 |
2489 | G03AA10 | Gestodene and Ethinylestradiol | Gestadiol | coated tablets 0.075 mg + 0.02 mg | RK-LS-5No.016071 |
2490 | G03AA10 | Gestodene and Ethinylestradiol | Gestadiol plus | coated tablets 0.075 mg/0.030 mg | RK-LS-5No.016072 |
2491 | G03AA10 | Gestodene and Ethinylestradiol | Tamarilla® Mini | coated tablets 0.06 mg/0.015 mg | RK-LS-5No.023104 |
2492 | G03AA10 | Gestodene and Ethinylestradiol | Tamarilla® 30 | tablets 0.075 mg/0.03 mg | RK-LS-5No.023105 |
2493 | G03AA10 | Gestodene and Ethinylestradiol | Tamarilla® 20 | tablets 0.075 mg/0.02 mg | RK-LS-5No.023106 |
2494 | G03AA10 | Gestodene and Ethinylestradiol | Violetta® | film-coated tablets 0.06mg/0.015mg | RK-LS-5No.023548 |
2495 | G03AA10 | Gestodene and Ethinylestradiol | Beatrice | tablets 0.075 mg/0.02 mg | RK-LS-5No.023829 |
G03AA12 | Drospirenone and estrogens | ||||
2496 | G03AA12 | Drospirenone and estrogens | Naraya | film-coated tablets | RK-LS-5No.122092 |
2497 | G03AA12 | Drospirenone and estrogens | Vidora micro | film-coated tablets | RK-LS-5No.122134 |
2498 | G03AA12 | Drospirenone and estrogens | Christie | coated tablets 3 mg + 0.03 mg | RK-LS-5No.021436 |
2499 | G03AA12 | Drospirenone and estrogens | Vidora | film-coated tablets | RK-LS-5No.122133 |
2500 | G03AA12 | Drospirenone and estrogens | Vibin mini | film-coated tablets | RK-LS-5No.022568 |
2501 | G03AA12 | Drospirenone and estrogens | Vibin | film-coated tablets 3 mg/0.03 mg | RK-LS-5No.022569 |
2502 | G03AA12 | Drospirenone and estrogens | Wikspo | film-coated tablets, 3mg/0.02mg | RK-LS-5No.022375 |
2503 | G03AA12 | Drospirenone and estrogens | Jess® | film-coated tablets 3 mg + 0.02 mg | RK-LS-5No.011639 |
2504 | G03AA12 | Drospirenone and estrogens | DIMIA® | film-coated tablets 3 mg + 0.02 mg | RK-LS-5No.019523 |
2505 | G03AA12 | Drospirenone and estrogens | Dronis | film-coated tablets 3 mg + 0.02 mg | RK-LS-5No.021021 |
2506 | G03AA12 | Drospirenone and estrogens | Delsia | film-coated tablets 3 mg + 0.03 mg | RK-LS-5No.021119 |
2507 | G03AA12 | Drospirenone and estrogens | Yarina® | film-coated tablets 3 mg + 0.03 mg | RK-LS-5No.012999 |
2508 | G03AA12 | Drospirenone and estrogens | INNARA | film-coated tablets 3 mg + 0.03 mg | RK-LS-5No.022232 |
2509 | G03AA12 | Drospirenone and estrogens | Susanette® | coated tablets 3 mg/0.02 mg | RK-LS-5No.122080 |
2510 | G03AA12 | Drospirenone and estrogens | Suzana® 20 | coated tablets 3 mg/0.02 mg | RK-LS-5No.122081 |
2511 | G03AA12 | Drospirenone and estrogens | Susana® 30 | film-coated tablets 3mg/0.03 mg | RK-LS-5No.122082 |
2512 | G03AA12 | Drospirenone and estrogens | Midiana® | film-coated tablets 3mg/0.03 mg | RK-LS-5No.017396 |
2513 | G03AA12 | Drospirenone and estrogens | Flamica | film-coated tablets 3mg + 0.02mg | RK-LS-5No.022706 |
2514 | G03AA12 | Drospirenone and estrogens | Flamica | film-coated tablets 3 mg + 0.03 mg | RK-LS-5No.022707 |
G03AA13 | Norelgestromin and Ethinylestradiol | ||||
2515 | G03AA13 | Norelgestromin and Ethinylestradiol | Evra® | transdermal therapeutic system (TTS) 0.6 mg + 6 mg | RK-LS-5No.016276 |
G03AA14 | Nomegestrol and Estradiol | ||||
2516 | G03AA14 | Nomegestrol and Estradiol | Zoeli | film-coated tablets 1.5 mg/2.5 mg | RK-LS-5No.019886 |
G03AB | Progestogens and Estrogens (Sequential Combinations) | ||||
G03AB03 | Levonorgestrel and Ethinylestradiol | ||||
2517 | G03AB03 | Levonorgestrel and Ethinylestradiol | Tri-Regol® | coated tablet 0.03 mg + 0.05 mg | RK-LS-5No.002049 |
2518 | G03AB03 | Levonorgestrel and Ethinylestradiol | Triquilar® | dragee 0.075 mg/0.03 mg/0.05 mg/0.03 mg/0.04 mg + 0.125 mg | RK-LS-5No.015626 |
2519 | G03AB03 | Levonorgestrel and Ethinylestradiol | Triquilar® | dragee 0.075 mg/0.03 mg/0.05 mg/0.03 mg/0.04 mg + 0.125 mg | RK-LS-5No.002049 |
2520 | G03AB03 | Levonorgestrel and Ethinylestradiol | El Eva 28 days | sugar-coated tablets 0.15 mg + 0.03 mg + 75 mg | RK-LS-5No.004112 |
G03AB08 | Dienogest and Estradiol | ||||
2521 | G03AB08 | Dienogest and Estradiol | Klayra® | film-coated tablets 3 mg + 2 mg + 2 mg + 1 mg + 2 mg + 3 mg | RK-LS-5No.019670 |
G03AC | Progestogens | ||||
G03AC03 | Levonorgestrel | ||||
2522 | G03AC03 | Levonorgestrel | BiShua Forte | tablets 1.5 mg | RK-LS-5No.021030 |
2523 | G03AC03 | Levonorgestrel | El Eva EC 72 | film-coated tablets 0.75 mg | RK-LS-5No.004085 |
2524 | G03AC03 | Levonorgestrel | Postinor® | tablets 0.75 mg | RK-LS-5No.013882 |
G03AC09 | Desogestrel | ||||
2525 | G03AC09 | Desogestrel | Desiret | film-coated tablets 0.075 mg | RK-LS-5No.122137 |
2526 | G03AC09 | Desogestrel | Limetic | coated tablets 0.075 ml | RK-LS-5No.022547 |
2527 | G03AC09 | Desogestrel | lactinet®-Richter | film-coated tablets 0.075 mg | RK-LS-5No.013311 |
2528 | G03AC09 | Desogestrel | Modelle Mum | coated tablets 0.075 mg | RK-LS-5No.021138 |
2529 | G03AC09 | Desogestrel | Lacrisse | film-coated tablets 75 mcg | RK-LS-5No.023806 |
G03AD02 | Ulipristal | ||||
2530 | G03AD02 | Ulipristal | Dwella | tablets 30 mg | RK-LS-5No.018537 |
G03B | Androgens | ||||
G03BA | 3-oxoandrostene derivatives | ||||
G03BA03 | Testosterone | ||||
2531 | G03BA03 | Testosterone | Nebido® | solution for intramuscular injection 250 mg/ml 4 ml | RK-LS-5No.009483 |
2532 | G03BA03 | Testosterone | Omnadren® 250 | solution for intramuscular injection, 1 ml | RK-LS-5No.004846 |
2533 | G03BA03 | Testosterone | Omnadren® 250 | solution for intramuscular injection 1000 mg | RK-LS-5No.009483 |
2534 | G03BA03 | Testosterone | Androgel® | Gel for external use 16.2 mg/g 88 g | RK-LS-5No.024177 |
2535 | G03BA03 | Testosterone | Androgel | Gel for external use 10mg/g 5 g | RK-LS-5No.019792 |
2536 | G03BA03 | Testosterone | Androgel® | Gel for external use 16.2 mg/g 88 g | RK-LS-5No.023595 |
G03CA | Natural and semi-synthetic estrogens | ||||
G03CA03 | Estradiol | ||||
2537 | G03CA03 | Estradiol | Divigel | gel for external use 0.1% 1 g | RK-LS-5No.009623 |
2538 | G03CA03 | Estradiol | Divigel | gel for external use 0.1% 0.5 g | RK-LS-5No.009623 |
2539 | G03CA03 | Estradiol | Montadiol | cream 0.1% 25 g | RK-LS-5No.023101 |
2540 | G03CA03 | Estradiol | Proginova® | Sugar-coated tablets 2mg | RK-LS-5No.011426 |
2541 | G03CA03 | Estradiol | Estrogel® | transdermal gel 0.60 mg/g 80 g | RK-LS-5No.024237 |
2542 | G03CA03 | Estradiol | Lenzetto® | Spray transdermal 1.53mg/dose 8.1ml | RK-LS-5No.023635 |
G03CA04 | Estriol | ||||
2543 | G03CA04 | Estriol | Estriol | vaginal suppositories 0.5 mg | RK-LS-5No.009753 |
2544 | G03CA04 | Estriol | Ovestin® | vaginal suppositories 0.5 mg | RK-LS-5No.020956 |
2545 | G03CA04 | Estriol | Estrinorm | vaginal suppositories 0.5 mg | RK-LS-5No.009753 |
G03D | Progestogens | ||||
G03DA | Pregnin derivatives | ||||
G03DA04 | Progesterone | ||||
2546 | G03DA04 | Progesterone | Endometrin | vaginal tablets 100 mg | RK-LS-5No.018716 |
2547 | G03DA04 | Progesterone | Ginoprogest | capsules 100 mg | RK-LS-5No.122045 |
2548 | G03DA04 | Progesterone | Ginoprogest | capsules 200 mg | RK-LS-5No.122046 |
2549 | G03DA04 | Progesterone | Progesterone | solution for injection, oily 1% 1 ml | RK-LS-5No.018713 |
2550 | G03DA04 | Progesterone | Progesterone | solution for injection, oily 2.5% 1 ml | RK-LS-5No.018714 |
2551 | G03DA04 | Progesterone | Utrozhestan® | capsules 100 mg | RK-LS-5No.015741 |
2552 | G03DA04 | Progesterone | Utrozhestan® | capsules 200 mg | RK-LS-5No.015742 |
2553 | G03DA04 | Progesterone | Lutein | vaginal tablets 200 mg | RK-LS-5No.021468 |
2554 | G03DA04 | Progesterone | Lutein | vaginal tablets 100 mg | RK-LS-5No.021469 |
2555 | G03DA04 | Progesterone | Endometrin | vaginal tablets 100 mg | RK-LS-5No.018530 |
2556 | G03DA04 | Progesterone | Refem | soft capsules 100 mg | RK-LS-5No.023250 |
2557 | G03DA04 | Progesterone | Refem | soft capsules 200 mg | RK-LS-5No.023251 |
2558 | G03DA04 | Progesterone | Utrozhestan® | capsules 200 mg | RK-LS-5No.023292 |
2559 | G03DA04 | Progesterone | Utrozhestan® | capsules 100 mg | RK-LS-5No.023293 |
2560 | G03DA04 | Progesterone | Progestogel | Gel for external use 1% 80 g | RK-LS-5No.013667 |
2561 | G03DA04 | Progesterone | Crainon® | Vaginal gel 8% 1.125 g | RK-LS-5No.018975 |
G03DB | Pregnadiene derivatives | ||||
G03DB01 | Dydrogesterone | ||||
2562 | G03DB01 | Dydrogesterone | Dufaston® | tablets 10 mg | RK-LS-5No.014248 |
G03DB08 | Dienogest | ||||
2563 | G03DB08 | Dienogest | Visanne® | tablets 2 mg | RK-LS-5No.017601 |
2564 | G03DB08 | Dienogest | Alvogestin | Film-coated tablets 2 mg | RK-LS-5No.024490 |
G03DC | Estrene derivatives | ||||
G03DC02 | Norethisterone | ||||
2565 | G03DC02 | Norethisterone | Norkolut® | tablets 5 mg | RK-LS-5No.010088 |
G03DC05 | Tibolon | ||||
2566 | G03DC05 | Tibolon | Ladybone | tablets 2.5 mg | RK-LS-5No.017377 |
G03F | Progestogens in combination with estrogens | ||||
G03FB | Progestogens in combination with estrogens (sequential combinations) | ||||
G03FB09 | Levonorgestrel and Estradiol | ||||
2567 | G03FB09 | Levonorgestrel and Estradiol | Klimonorm® | dragee 0.15 mg/2 mg | RK-LS-5No.015628 |
G03G | Gonadotropins and other ovulation stimulants | ||||
G03GA | Gonadotropins | ||||
G03GA01 | Chorionic gonadotropin | ||||
2568 | G03GA01 | Chorionic gonadotropin | Pregnyl® | lyophilisate for solution preparation 1500 IU | RK-LS-5No.023392 |
2569 | G03GA01 | Chorionic gonadotropin | Pregnyl® | lyophilized powder for preparation of solution for intramuscular and subcutaneous injections complete with solvent (0.9% sodium chloride solution for injection) 5000 IU | RK-LS-5No.023391 |
2570 | G03GA01 | Chorionic gonadotropin | Pregnyl® | lyophilized powder for preparation of solution for intramuscular and subcutaneous injections complete with solvent (0.9% sodium chloride solution for injection) 1500 IU | RK-LS-5No.014795 |
2571 | G03GA01 | Chorionic gonadotropin | Horagon | lyophilized powder for preparation of solution for injection complete with solvent 1500 IU | RK-LS-0No.016638 |
2572 | G03GA01 | Chorionic gonadotropin | Horagon | lyophilized powder for preparation of solution for injection, complete with solvent 5000 IU | RK-LS-0No.016639 |
2573 | G03GA01 | Chorionic gonadotropin | Chorionic gonadotropin | lyophilisate for preparation of solution for intramuscular injection of 500 IU | RK-LS-5No.016635 |
2574 | G03GA01 | Chorionic gonadotropin | Chorionic gonadotropin | lyophilisate for preparation of solution for intramuscular injection 1000 IU | RK-LS-5No.016637 |
2575 | G03GA01 | Chorionic gonadotropin | Horapur | lyophilized powder for preparation of solution for injection complete with solvent 1500 IU | RK-LS-5No.023658 |
2576 | G03GA01 | Chorionic gonadotropin | Horapur | lyophilized powder for preparation of solution for injection, complete with solvent 5000 IU | RK-LS-5No.023659 |
G03GA02 | Menopausal gonadotropin | ||||
2577 | G03GA02 | Menopausal gonadotropin | Menopur | lyophilized powder for preparation of solution for injection complete with solvent 75 IU FSH and 75 IU LH | RK-LS-5No.013725 |
2578 | G03GA02 | Menopausal gonadotropin | Menogon | lyophilized powder for preparation of solution for injection complete with solvent 75 IU FSH and 75 IU LH | RK-LS-5No.016581 |
2579 | G03GA02 | Menopausal gonadotropin | Menopur | lyophilized powder for preparation of solution for injection complete with solvent 1200 IU | RK-LS-5No.019141 |
2580 | G03GA02 | Menopausal gonadotropin | Menopur | lyophilized powder for preparation of solution for injection complete with solvent 600 IU | RK-LS-5No.019140 |
G03GA04 | Urofollitropin | ||||
2581 | G03GA04 | Urofollitropin | Fostimon® | lyophilisate for preparation of solution for intramuscular and subcutaneous injection of 75 IU | RK-LS-5No.021615 |
2582 | G03GA04 | Urofollitropin | Bravel | lyophilized powder for preparation of solution for injection complete with solvent 75 IU | RK-LS-5No.014677 |
G03GA05 | Follitropin alpha | ||||
2583 | G03GA05 | Follitropin alpha | Gonal-F® | lyophilized powder for preparation of solution for injection complete with solvent 5.5 mcg (75 IU) | RK-LS-5No.009278 |
2584 | G03GA05 | Follitropin alpha | Gonal-F® | solution for injection 300 IU (22mcg)/0.5 ml | RK-LS-5No.018836 |
2585 | G03GA05 | Follitropin alpha | Gonal-F® | solution for injection 450 IU (33 mcg)/0.75 ml | RK-LS-5No.018837 |
2586 | G03GA05 | Follitropin alpha | Gonal-F® | solution for injection 900 IU (66 mcg)/1.5 ml | RK-LS-5No.018838 |
G03GA06 | Follitropin beta | ||||
2587 | G03GA06 | Follitropin beta | Puregon® | solution for subcutaneous injection 600 IU/0.72 ml 0.78 ml | RK-LS-5No.011266 |
2588 | G03GA06 | Follitropin beta | Puregon® | solution for subcutaneous injection 300 IU/0.36 ml 0.42 ml | RK-LS-5No.011264 |
2589 | G03GA06 | Follitropin beta | Puregon® | solution for intramuscular and subcutaneous injection 100 IU/0.5 ml 0.5 ml | RK-LS-5No.011267 |
2590 | G03GA06 | Follitropin beta | Puregon® | solution for intramuscular and subcutaneous injection 100 IU/0.5 ml 0.5 ml | RK-LS-5No.011267 |
G03GA08 | Choriogonadotropin alpha | ||||
2591 | G03GA08 | Choriogonadotropin alpha | Ovitrel® | solution for injection 250 mcg/0.5 ml 0.5 ml | RK-LS-5No.022920 |
2592 | G03GA08 | Choriogonadotropin alpha | Elonva® | solution for injection 150 mcg/0.5 ml 0.5 ml | RK-LS-5No.018153 |
2593 | G03GA08 | Choriogonadotropin alpha | Elonva® | solution for injection 100 mcg/0.5 ml 0.5 ml | RK-LS-5No.018152 |
2594 | G03GA08 | Choriogonadotropin alpha | Ovitrel® | solution for injection 250 mcg/0.5 ml 0.5 ml | RK-LS-5No.018899 |
G03GA09 | Corifollitropin alpha | ||||
2595 | G03GA09 | Corifollitropin alpha | Elonva® | solution for injection 150 mcg/0.5 ml 0.5 ml | RK-LS-5No.018153 |
2596 | G03GA09 | Corifollitropin alpha | Elonva® | solution for injection 100 mcg/0.5 ml 0.5 ml | RK-LS-5No.018152 |
G03GA30 | Follitropin alpha and Lutropin alpha | ||||
2597 | G03GA30 | Follitropin alpha and Lutropin alpha | Pergoveris® | lyophilized powder for preparation of solution for injection complete with solvent 150/75 HB/ME | RK-LS-5No.019097 |
G03GB | Synthetic ovulation stimulants | ||||
G03GB02 | Clomiphene | ||||
2598 | G03GB02 | Clomiphene | Clostilbegit® | tablets 50 mg | RK-LS-5No.005861 |
G03H | Antiandrogens | ||||
G03HA01 | Cyproterone | ||||
2599 | G03HA01 | Cyproterone | Androkur® Depot | solution for intramuscular injection 300 mg/3 ml, 3 ml | RK-LS-5No.004353 |
2600 | G03HA01 | Cyproterone | Androkur® | tablets 50 mg | RK-LS-5No.016205 |
2601 | G03HA01 | Cyproterone | Zindar-50 | tablets 50 mg | RK-LS-5No.022796 |
2602 | G03HA01 | Cyproterone | Zindar-100 | tablets 100 mg | RK-LS-5No.022800 |
G03X | Other sex hormones and modulators of the reproductive system | ||||
G03XB | Progesterone receptor modulators | ||||
G03XB01 | Mifepristone | ||||
2603 | G03XB01 | Mifepristone | Miropristone | tablets 200 mg | RK-LS-5No.018394 |
2604 | G03XB01 | Mifepristone | Mifetril | tablets 200 mg | RK-LS-5No.122103 |
2605 | G03XB01 | Mifepristone | Mifeprine | tablets 200 mg | RK-LS-5No.022579 |
2606 | G03XB01 | Mifepristone | Mifepristone | tablets 200 mg | RK-LS-5No.009918 |
2607 | G03XB01 | Mifepristone | Femiprevent | tablets 10 mg | RK-LS-5No.022807 |
G03XB02 | Ulipristal | ||||
2608 | G03XB02 | Ulipristal | Esmya® | tablets 5 mg | RK-LS-5No.020014 |
G04 | Drugs for treatment of urological diseases | ||||
G04BD | Drugs for urinary frequency and urinary incontinence | ||||
G04BD04 | Oxybutynin | ||||
2609 | G04BD04 | Oxybutynin | Golaksin | tablets 5 mg | RK-LS-5No.121934 |
2610 | G04BD04 | Oxybutynin | Driptan® | tablets 5 mg | RK-LS-5No.014600 |
G04BD07 | Tolterodine | ||||
G04BD08 | Solifenacin | ||||
2611 | G04BD08 | Solifenacin | Soliget | film-coated tablets 5 mg | RK-LS-5No.020808 |
2612 | G04BD08 | Solifenacin | Soliget | film-coated tablets 10 mg | RK-LS-5No.020809 |
2613 | G04BD08 | Solifenacin | Kinsey | film-coated tablets 5 mg | RK-LS-5No.020984 |
2614 | G04BD08 | Solifenacin | Kinsey | film-coated tablets 10 mg | RK-LS-5No.020985 |
2615 | G04BD08 | Solifenacin | Solfin | film-coated tablets 5 mg | RK-LS-5No.022918 |
2616 | G04BD08 | Solifenacin | Solfin | film-coated tablets 10 mg | RK-LS-5No.022919 |
2617 | G04BD08 | Solifenacin | Vesicar ™ | coated tablets 5 mg | RK-LS-5No.005030 |
2618 | G04BD08 | Solifenacin | Solikem | film-coated tablets 5 mg | RK-LS-5No.024220 |
2619 | G04BD08 | Solifenacin | Solikem | film-coated tablets 10 mg | RK-LS-5No.024221 |
G04BD09 | Trospium chloride | ||||
2620 | G04BD09 | Trospium chloride | Spazmex® | film-coated tablets 15 mg | RK-LS-5No.017988 |
G04BD12 | Mirabegron | ||||
2621 | G04BD12 | Mirabegron | Betmiga | film-coated tablets, extended release 50 mg | RK-LS-5No.020886 |
2622 | G04BD12 | Mirabegron | Betmiga | film-coated tablets with prolonged release 25 mg | RK-LS-5No.020887 |
G04BE | Drugs for treatment of erectile dysfunction | ||||
G04BE03 | Sildenafil | orphan | |||
2623 | G04BE03 | Sildenafil | Sinegra® 25 | film-coated tablets 25 mg | RK-LS-5No.018508 |
2624 | G04BE03 | Sildenafil | Sinegra® 50 | film-coated tablets 50 mg | RK-LS-5No.018509 |
2625 | G04BE03 | Sildenafil | Sinegra® 100 | film-coated tablets 100 mg | RK-LS-5No.018510 |
2626 | G04BE03 | Sildenafil | Silfekt | film-coated tablets 100 mg | RK-LS-5No.023072 |
2627 | G04BE03 | Sildenafil | Silfekt | film-coated tablets 25 mg | RK-LS-5No.023070 |
2628 | G04BE03 | Sildenafil | Silfekt | film-coated tablets 50 mg | RK-LS-5No.023071 |
2629 | G04BE03 | Sildenafil | Silden® | film-coated tablets 100 mg | RK-LS-5No.020954 |
2630 | G04BE03 | Sildenafil | Sildena | film-coated tablets 50 mg | RK-LS-5No.018947 |
2631 | G04BE03 | Sildenafil | Maxigra | coated tablets 50 mg | RK-LS-5No.010330 |
2632 | G04BE03 | Sildenafil | Potential | coated tablets 50 mg | RK-LS-5No.004278 |
2633 | G04BE03 | Sildenafil | Sildenafil-Teva | coated tablets 50 mg | RK-LS-5No.018772 |
2634 | G04BE03 | Sildenafil | Viagra® | film-coated tablets 50 mg | RK-LS-5No.012217 |
2635 | G04BE03 | Sildenafil | Sildena | film-coated tablets 100 mg | RK-LS-5No.018948 |
2636 | G04BE03 | Sildenafil | Maxigra | film-coated tablets 100 mg | RK-LS-5No.010331 |
2637 | G04BE03 | Sildenafil | Potential | film-coated tablets 100 mg | RK-LS-5No.004279 |
2638 | G04BE03 | Sildenafil | Sildenafil-Teva | film-coated tablets 100 mg | RK-LS-5No.018773 |
2639 | G04BE03 | Sildenafil | Viagra® | film-coated tablets 100 mg | RK-LS-5No.012218 |
2640 | G04BE03 | Sildenafil | Olvion | film-coated tablets 50 mg | RK-LS-5No.021236 |
2641 | G04BE03 | Sildenafil | Silmelt | orodispersible tablets 50 mg | RK-LS-5No.021179 |
2642 | G04BE03 | Sildenafil | VIVAIRA | chewable tablets 50 mg | RK-LS-5No.022266 |
2643 | G04BE03 | Sildenafil | Olvion | film-coated tablets 100 mg | RK-LS-5No.021237 |
2644 | G04BE03 | Sildenafil | Silmelt | orodispersible tablets 100 mg | RK-LS-5No.021180 |
2645 | G04BE03 | Sildenafil | Silmelt® | orodispersible tablets 50 mg | RK-LS-5No.021179 |
2646 | G04BE03 | Sildenafil | Silgam | chewable tablets 50 mg | RK-LS-5No.122013 |
2647 | G04BE03 | Sildenafil | Silgam | chewable tablets 100 mg | RK-LS-5No.122014 |
2648 | G04BE03 | Sildenafil | VIVAIRA | chewable tablets 100 mg | RK-LS-5No.022267 |
2649 | G04BE03 | Sildenafil | Sildocad | film-coated tablets 50 mg | RK-LS-5No.021274 |
2650 | G04BE03 | Sildenafil | Sildocad | film-coated tablets 100 mg | RK-LS-5No.021275 |
2651 | G04BE03 | Sildenafil | Vizarsin® | film-coated tablets 25 mg | RK-LS-5No.017612 |
2652 | G04BE03 | Sildenafil | Vizarsin® | film-coated tablets 50 mg | RK-LS-5No.017613 |
2653 | G04BE03 | Sildenafil | Vizarsin® | film-coated tablets 100 mg | RK-LS-5No.017614 |
2654 | G04BE03 | Sildenafil | Moginin | film-coated tablets 50 mg | RK-LS-5No.022243 |
2655 | G04BE03 | Sildenafil | Moginin | film-coated tablets 100 mg | RK-LS-5No.022260 |
2656 | G04BE03 | Sildenafil | Vinix | orodispersible films 50 mg | RK-LS-5No.022590 |
2657 | G04BE03 | Sildenafil | Viasil | coated tablets 50 mg | RK-LS-5No.022644 |
2658 | G04BE03 | Sildenafil | Viasil | film-coated tablets 100 mg | RK-LS-5No.022727 |
2659 | G04BE03 | Sildenafil | Silamax | film-coated tablets 50 mg | RK-LS-5No.022992 |
2660 | G04BE03 | Sildenafil | Silamax | film-coated tablets 100 mg | RK-LS-5No.022993 |
2661 | G04BE03 | Sildenafil | Kamagra 100 | film-coated tablets 100 mg | RK-LS-5No.019158 |
2662 | G04BE03 | Sildenafil | Kamagra 50 | film-coated tablets 50 mg | RK-LS-5No.019157 |
2663 | G04BE03 | Sildenafil | Zimagra-ODS 50 | oral dispersible plates 50 mg | RK-LS-5No.023681 |
2664 | G04BE03 | Sildenafil | CINEGRA® 20 Cardio | film-coated tablets 20 mg | RK-LS-5No.023720 |
2665 | G04BE03 | Sildenafil | Maxigra® White | chewable tablets 25 mg | RK-LS-5No.023726 |
2666 | G04BE03 | Sildenafil | Maxigra® White | chewable tablets 50 mg | RK-LS-5No.023811 |
2667 | G04BE03 | Sildenafil | Maxigra® White | chewable tablets 100 mg | RK-LS-5No.023812 |
2668 | G04BE03 | Sildenafil | Sildenafil-SZ | film-coated tablets 25 mg | RK-LS-5No.023821 |
2669 | G04BE03 | Sildenafil | Sildenafil-SZ | film-coated tablets 50 mg | RK-LS-5No.023822 |
2670 | G04BE03 | Sildenafil | Sildenafil-SZ | film-coated tablets 100 mg | RK-LS-5No.023823 |
2671 | G04BE03 | Sildenafil | CINEGRA® ODT | orodispersible tablets 25 mg | RK-LS-5No.023877 |
2672 | G04BE03 | Sildenafil | CINEGRA® ODT | orodispersible tablets 50 mg | RK-LS-5No.023878 |
2673 | G04BE03 | Sildenafil | CINEGRA® ODT | orodispersible tablets 100 mg | RK-LS-5No.023879 |
2674 | G04BE03 | Sildenafil | CINEGRA® ODT | orodispersible tablets 25 mg | RK-LS-5No.023917 |
2675 | G04BE03 | Sildenafil | CINEGRA® ODT | orodispersible tablets 50 mg | RK-LS-5No.023918 |
2676 | G04BE03 | Sildenafil | CINEGRA® ODT | orodispersible tablets 100 mg | RK-LS-5No.023919 |
2677 | G04BE03 | Sildenafil | Inforce | film-coated tablets 100 mg | RK-LS-5No.023954 |
2678 | G04BE03 | Sildenafil | Arpegra | film-coated tablets 100 mg | RK-LS-5No.020210 |
2679 | G04BE03 | Sildenafil | Vizarsin® Ku-Tab® | lozenge tablets 50 mg | RK-LS-5No.020046 |
2680 | G04BE03 | Sildenafil | Viagra ODT | oral dispersible tablet 50 mg | RK-LS-5No.021068 |
2681 | G04BE03 | Sildenafil | Viataf | film-coated tablets 100 mg | RK-LS-5No.024386 |
2682 | G04BE03 | Sildenafil | Viataf | film-coated tablets 50 mg | RK-LS-5No.024387 |
2683 | G04BE03 | Sildenafil | Viagra® | film-coated tablets 25 mg | RK-LS-5No.024323 |
G04BE08 | Tadalafil | ||||
2684 | G04BE08 | Tadalafil | Silabene | film-coated tablets, 5 mg | RK-LS-5No.023698 |
2685 | G04BE08 | Tadalafil | Silabene | film-coated tablets, 20 mg | RK-LS-5No.023699 |
2686 | G04BE08 | Tadalafil | Cialis® | film-coated tablets 20 mg | RK-LS-5No.012089 |
2687 | G04BE08 | Tadalafil | Cialis® | film-coated tablets 5 mg | RK-LS-5No.020874 |
2688 | G04BE08 | Tadalafil | Tadasip-10 | film-coated tablets 10 mg | RK-LS-5No.022934 |
2689 | G04BE08 | Tadalafil | Tadasip-20 | film-coated tablets 20 mg | RK-LS-5No.022942 |
2690 | G04BE08 | Tadalafil | Arista | film-coated tablets 20 mg | RK-LS-5No.022987 |
2691 | G04BE08 | Tadalafil | Volcron | film-coated tablets 20 mg | RK-LS-5No.024006 |
2692 | G04BE08 | Tadalafil | Redex | film-coated tablets 20 mg | RK-LS-5No.024024 |
2693 | G04BE08 | Tadalafil | Redex | film-coated tablets 10 mg | RK-LS-5No.024025 |
2694 | G04BE08 | Tadalafil | Redex | film-coated tablets 5 mg | RK-LS-5No.024026 |
2695 | G04BE08 | Tadalafil | Talis 20 | coated tablets 20 mg | RK-LS-5No.024085 |
2696 | G04BE08 | Tadalafil | LIFTA | film-coated tablets 20 mg | RK-LS-5No.024186 |
2697 | G04BE08 | Tadalafil | LIFTA | film-coated tablets 10 mg | RK-LS-5No.024187 |
2698 | G04BE08 | Tadalafil | LIFTA | film-coated tablets 5 mg | RK-LS-5No.024189 |
2699 | G04BE08 | Tadalafil | Erlis | film-coated tablets 2.5 mg | RK-LS-5No.024257 |
2700 | G04BE08 | Tadalafil | Erlis | film-coated tablets 5 mg | RK-LS-5No.024258 |
2701 | G04BE08 | Tadalafil | Erlis | film-coated tablets 10 mg | RK-LS-5No.024259 |
2702 | G04BE08 | Tadalafil | Erlis | film-coated tablets 20 mg | RK-LS-5No.024260 |
2703 | G04BE08 | Tadalafil | Erecto-Fast 10 | Oral dispersible films, 10 mg | RK-LS-5No.023969 |
2704 | G04BE08 | Tadalafil | Erecto-Fast 20 | Oral dispersible films, 20 mg | RK-LS-5No.023970 |
2705 | G04BE08 | Tadalafil | Hate | Film-coated tablets 20 mg | RK-LS-5No.024447 |
G04BE09 | Vardenafil | ||||
2706 | G04BE09 | Vardenafil | Levitra® | film-coated tablets 20 mg | RK-LS-5No.017980 |
2707 | G04BE09 | Vardenafil | Levitra® | film-coated tablets 10 mg | RK-LS-5No.017979 |
2708 | G04BE09 | Vardenafil | Levitra® ODT | oral soluble tablets 10 mg | RK-LS-5No.018294 |
2709 | G04BE09 | Vardenafil | Levitra® | film-coated tablets 5 mg | RK-LS-5No.017978 |
G04BE10 | Avanafil | ||||
2710 | G04BE10 | Avanafil | Stendra | tablets 100 mg | RK-LS-5No.022806 |
G04BX | Other urological drugs | ||||
G04BX14 | Dapoxetine | ||||
2711 | G04BX14 | Dapoxetine | Capiton | film-coated tablets 30 mg | RK-LS-5No.021395 |
2712 | G04BX14 | Dapoxetine | Priligy® 30 mg | film-coated tablets 30 mg | RK-LS-5No.021414 |
2713 | G04BX14 | Dapoxetine | Priligy® 60 mg | film-coated tablets 60 mg | RK-LS-5No.021415 |
2714 | G04BX14 | Dapoxetine | Longread | film-coated tablets 30 mg | RK-LS-5No.023030 |
2715 | G04BX14 | Dapoxetine | Longread | film-coated tablets 60 mg | RK-LS-5No.023031 |
2716 | G04BX14 | Dapoxetine | Daporin | film-coated tablets 60 mg | RK-LS-5No.023306 |
2717 | G04BX14 | Dapoxetine | Daporin | film-coated tablets 30 mg | RK-LS-5No.023307 |
2718 | G04BX14 | Dapoxetine | DURALONG | Film-coated tablets 60 mg | RK-LS-5No.024478 |
2719 | G04BX14 | Dapoxetine | DURALONG | Film-coated tablets 30 mg | RK-LS-5No.024479 |
G04C | Drugs for treatment of benign prostatic hyperplasia | ||||
G04CA01 | Alfuzosin | ||||
G04CA02 | Tamsulosin | ||||
2720 | G04CA02 | Tamsulosin | Omarens T | prolonged release tablets 0.4 mg | RK-LS-5No.121816 |
2721 | G04CA02 | Tamsulosin | Omarens | modified release capsules 0.4 mg | RK-LS-5No.121721 |
2722 | G04CA02 | Tamsulosin | Grasulan | modified release capsules 0.4 mg | RK-LS-5No.122089 |
2723 | G04CA02 | Tamsulosin | Omnik Okas® | controlled release coated tablets 0.4 mg | RK-LS-5No.004063 |
2724 | G04CA02 | Tamsulosin | Omnic® | modified release capsules 0.4 mg | RK-LS-5No.013627 |
2725 | G04CA02 | Tamsulosin | Proflosin® | modified release capsules 0.4 mg | RK-LS-5No.018541 |
2726 | G04CA02 | Tamsulosin | Tenise | modified release capsules 0.4 mg | RK-LS-5No.016663 |
2727 | G04CA02 | Tamsulosin | Tamsol® | modified release capsules 0.4 mg | RK-LS-5No.004040 |
2728 | G04CA02 | Tamsulosin | Urimak | modified release capsules 0.4 mg | RK-LS-5No.022406 |
2729 | G04CA02 | Tamsulosin | Fokusin® | modified release capsules 0.4 mg | RK-LS-5No.018703 |
2730 | G04CA02 | Tamsulosin | Alpha M | modified release capsules 0.4 mg | RK-LS-5No.022913 |
2731 | G04CA02 | Tamsulosin | TAMADENA MR | modified release capsules 0.4 mg | RK-LS-5No.023057 |
2732 | G04CA02 | Tamsulosin | Floesi | prolonged-release tablets 0.4 mg | RK-LS-5No.023629 |
2733 | G04CA02 | Tamsulosin | Ranoprost | modified release capsules 0.4 mg | RK-LS-5No.010550 |
2734 | G04CA02 | Tamsulosin | Tamsaprost | modified release capsules 0.4 mg | RK-LS-5No.024123 |
G04CA52 | Tamsulosin and Dutasteride | ||||
2735 | G04CA52 | Tamsulosin and Dutasteride | Duodart® | capsules | RK-LS-5No.019494 |
G04CA53 | Tamsulosin and Solifenacin | ||||
2736 | G04CA53 | Tamsulosin and Solifenacin | Vesomni | modified release film-coated tablets 6 mg/0.4 mg | RK-LS-5No.021047 |
G04CB | Testosterone 5-Alpha-Reductase Inhibitors | ||||
G04CB01 | Finasteride | ||||
2737 | G04CB01 | Finasteride | Proscar | film-coated tablets 5 mg | RK-LS-5No.015607 |
2738 | G04CB01 | Finasteride | Finpros® | film-coated tablets 5 mg | RK-LS-5No.013885 |
2739 | G04CB01 | Finasteride | Penester | film-coated tablets 5 mg | RK-LS-5No.018701 |
G04CB02 | Dutasteride | ||||
2740 | G04CB02 | Dutasteride | Avodart | capsule, 0.5 mg | RK-LS-5No.011903 |
2741 | G04CB02 | Dutasteride | Dutasvite | capsules 0.5 mg | RK-LS-5No.023945 |
2742 | G04CB02 | Dutasteride | Dutastol | Soft capsules, 0.5 mg | RK-LS-5No.024433 |
H | Hormones for systemic use, excluding sex hormones and insulins | ||||
H01 | Hormones of the hypothalamus and pituitary gland and their analogues | ||||
H01A | Hormones of the anterior pituitary gland and their analogs | ||||
H01AC | Somatropin and its analogues | ||||
H01AC01 | Somatropin | ||||
2743 | H01AC01 | Somatropin | Humatrop® | lyophilisate for preparation of solution for injection complete with solvent 6 mg | RK-LS-5No.019069 |
2744 | H01AC01 | Somatropin | Saizen® 8 mg "Click.izi" | lyophilized powder for preparation of solution for injection complete with solvent 8 mg | RK-LS-5No.020033 |
2745 | H01AC01 | Somatropin | Norditropin® NordiLet® | solution for subcutaneous injection 10 mg/1.5 ml 1.5 ml | RK-LS-5No.010266 |
2746 | H01AC01 | Somatropin | Omnitrope® | solution for injection 10 mg/1.5 ml 1.5 ml | RK-LS-5No.020773 |
2747 | H01AC01 | Somatropin | Omnitrope® | solution for injection 15mg/1.5ml 1.5 ml | RK-LS-5No.020772 |
2748 | H01AC01 | Somatropin | Omnitrope® | solution for injection 5mg/1.5ml 1.5 ml | RK-LS-5No.020774 |
2749 | H01AC01 | Somatropin | Somacton | lyophilized powder for preparation of solution for injection complete with solvent 10 mg | RK-LS-5No.016806 |
2750 | H01AC01 | Somatropin | Somacton | lyophilized powder for preparation of solution for injection complete with solvent 4 mg | RK-LS-5No.016805 |
2751 | H01AC01 | Somatropin | NutropinAq® | solution for subcutaneous injection 10mg/2ml (30 IU) | RK-LS-5No.003065 |
2752 | H01AC01 | Somatropin | Jintropin® | lyophilized powder for preparation of solution for subcutaneous injection complete with solvent (water for injection) 4IU 1.33 mg | RK-BP-5No.022697 |
2753 | H01AC01 | Somatropin | Jintropin® | lyophilized powder for preparation of solution for subcutaneous injection complete with solvent (water for injection) 10 IU 3.33 mg 1 ml solvent | RK-BP-5No.022782 |
2754 | H01AC01 | Somatropin | Jintropin® | lyophilized powder for preparation of solution for subcutaneous injection 10IU 3.33 mg | RK-BP-5No.022696 |
2755 | H01AC01 | Somatropin | Jintropin® | lyophilized powder for preparation of solution for subcutaneous injection 4IU 1.33 mg | RK-BP-5No.022781 |
2756 | H01AC01 | Somatropin | Saizen® | solution for injection 12 mg | RK-BP-5No.023855 |
2757 | H01AC01 | Somatropin | Saizen® | solution for injection 20 mg | RK-BP-5No.023856 |
2758 | H01AC01 | Somatropin | Saizen® | solution for injection 6 mg | RK-BP-5No.023854 |
H01B | Posterior pituitary hormones | ||||
H01BA | Vasopressin and its analogues | ||||
H01BA02 | Desmopressin | ||||
2759 | H01BA02 | Desmopressin | Minirin MELT | oral lyophilisate 60 mcg | RK-LS-5No.016703 |
2760 | H01BA02 | Desmopressin | Minirin MELT | oral lyophilisate 120 mcg | RK-LS-5No.016704 |
2761 | H01BA02 | Desmopressin | Minirin MELT | oral lyophilisate 240 mcg | RK-LS-5No.016705 |
2762 | H01BA02 | Desmopressin | Minirin | tablet, 0.1 mg | RK-LS-5No.012521 |
2763 | H01BA02 | Desmopressin | Desmopressin-Teva | tablets 0.1 mg | RK-LS-5No.020135 |
2764 | H01BA02 | Desmopressin | Minirin | tablet, 0.2 mg | RK-LS-5No.012522 |
2765 | H01BA02 | Desmopressin | Desmopressin-Teva | tablets 0.2 mg | RK-LS-5No.020136 |
2766 | H01BA02 | Desmopressin | Octostim | solution for injection 15 mcg/ml, 1 ml 2 ml | RK-LS-5No.122090 |
H01BA04 | Terlipressin | ||||
2767 | H01BA04 | Terlipressin | Remestype | solution for injection 0.1mg/ml, 2 ml | RK-LS-5No.018976 |
2768 | H01BA04 | Terlipressin | Glypressin | lyophilized powder for preparation of solution for injection complete with solvent 1 mg | RK-LS-5No.020276 |
2769 | H01BA04 | Terlipressin | Remestype | solution for injection 0.1 mg/ml 10 ml | RK-LS-5No.018977 |
H01BB | Oxytocin and its analogues | ||||
H01BB02 | Oxytocin | ||||
2770 | H01BB02 | Oxytocin | OXYTOCIN | Solution for injection 5 IU/ml 1 ml | RK-LS-5No.024488 |
2771 | H01BB02 | Oxytocin | Oxytocin Grindeks | solution for injection 5 IU/ml 1 ml | RK-LS-5No.010645 |
2772 | H01BB02 | Oxytocin | Oxytocin Grindeks | solution for injection 5 IU/ml 1 ml | RK-LS-5No.022381 |
2773 | H01BB02 | Oxytocin | Oxytocin | solution for intravenous and intramuscular injection 5 IU/ml, 1 ml | RK-LS-5No.022533 |
2774 | H01BB02 | Oxytocin | Oxytocin-MEZ | solution for intravenous and intramuscular injection 5 IU/ml, 1 ml | RK-LS-5No.016636 |
2775 | H01BB02 | Oxytocin | Oxytocin-Biolek | solution for injection 5 IU/ml 1 ml | RK-LS-5No.012060 |
2776 | H01BB02 | Oxytocin | Oxytocin-Richter | solution for injection 5 IU/ml 1 ml | RK-LS-5No.014562 |
H01BB03 | Carbetocin | ||||
2777 | H01BB03 | Carbetocin | Pabal | solution for injection 100 mcg/ml 1 ml | RK-LS-5No.021570 |
H01C | Hypothalamic hormones | ||||
H01CB | Growth-inhibiting hormones | ||||
H01CB02 | Octreotide | ||||
2778 | H01CB02 | Octreotide | Sandostatin® LAR | microspheres for preparation of suspensions for injection 20 mg with solvent 2 ml | RK-LS-5No.020988 |
2779 | H01CB02 | Octreotide | Sandostatin® LAR | microspheres for preparation of suspensions for injection 30 mg with solvent 2 ml | RK-LS-5No.021187 |
2780 | H01CB02 | Octreotide | Sandostatin® LAR | microspheres for preparation of suspensions for injection 10 mg with solvent 2 ml | RK-LS-5No.021186 |
2781 | H01CB02 | Octreotide | Sandostatin® | solution for subcutaneous injection 0.1 mg/ml 1 ml | RK-LS-5No.004657 |
2782 | H01CB02 | Octreotide | Sandostatin® | solution for subcutaneous injection 0.05 mg/ml 1 ml | RK-LS-5No.004673 |
2783 | H01CB02 | Octreotide | Octreotide depot | lyophilisate for preparation of suspension for intramuscular injection of prolonged action, complete with solvent (Mannitol, solution for injection 0.8%) 20 mg 2 ml | RK-LS-5No.020345 |
2784 | H01CB02 | Octreotide | Octrid | solution for injection 50 mcg/ml 1 ml | RK-LS-5No.010634 |
2785 | H01CB02 | Octreotide | Octra | solution for injection, 0.1 mg/ml 1 ml | RK-LS-5No.019800 |
2786 | H01CB02 | Octreotide | Octrid | solution for injection, 100 mcg/ml | RK-LS-5No.010635 |
H01CB03 | Lanreotide | ||||
2787 | H01CB03 | Lanreotide | Somatulin® Autogel® | solution for injection, prolonged release, 60 mg 266 mg | RK-LS-5No.000349 |
2788 | H01CB03 | Lanreotide | Somatulin® Autogel® | solution for injection of prolonged release 120 mg | RK-LS-5No.000351 |
2789 | H01CB03 | Lanreotide | Somatulin® | lyophilisate for preparation of suspension for intramuscular injection of prolonged action 30 mg | RK-LS-5No.010055 |
2790 | H01CB03 | Lanreotide | Somatulin® Autogel® | solution for injection of prolonged release 90 mg 388 mg | RK-LS-5No.000350 |
H01CB05 | Pasireotide | ||||
2791 | H01CB05 | Pasireotide | Signifor® | solution for injection 0.3 mg/ml 1 ml | RK-LS-5No.121943 |
2792 | H01CB05 | Pasireotide | Signifor® | solution for injection 0.6 mg/ml 1 ml | RK-LS-5No.121944 |
2793 | H01CB05 | Pasireotide | Signifor® | solution for injection 0.9 mg/ml 1 ml | RK-LS-5No.121945 |
2794 | H01CB05 | Pasireotide | Signifor® LAR | Powder for preparation of suspension for intramuscular injection complete with solvent, 60 mg | RK-LS-5No.022161 |
2795 | H01CB05 | Pasireotide | Signifor® LAR | Powder for preparation of suspension for intramuscular injection complete with solvent, 40 mg | RK-LS-5No.022162 |
2796 | H01CB05 | Pasireotide | Signifor® LAR | Powder for preparation of suspension for intramuscular injection complete with solvent, 20 mg | RK-LS-5No.022155 |
H01CC | Antigonadotropin-releasing hormone | ||||
H01CC01 | Ganerelix | ||||
2797 | H01CC01 | Ganerelix | Orgalutran® | solution for injection 0.25mg/0.5ml 0.5ml | RK-LS-5No.015059 |
H01CC02 | Cetrorelix | ||||
2798 | H01CC02 | Cetrorelix | Cetrotide® | lyophilized powder for preparation of solution for injection complete with solvent 0.25 mg | RK-LS-5No.122104 |
2799 | H01CC02 | Cetrorelix | Cetrotide® | lyophilized powder for preparation of solution for injection complete with solvent 0.25 mg | RK-LS-5No.001959 |
H02 | Systemic corticosteroids | ||||
H02A | Systemic corticosteroids | ||||
H02AB | Glucocorticoids | ||||
H02AB01 | Betamethasone | ||||
2800 | H02AB01 | Betamethasone | Betaspan® Depot | suspension for injection, 1 ml | RK-LS-5No.021126 |
2801 | H02AB01 | Betamethasone | Diprospan® | suspension for injection 1 ml | RK-LS-5No.018687 |
2802 | H02AB01 | Betamethasone | Sertospan | suspension for injection 1 ml | RK-LS-5No.023668 |
2803 | H02AB01 | Betamethasone | Diprospan® | suspension for injection 1 ml | RK-LS-5No.015009 |
2804 | H02AB01 | Betamethasone | Betazone | Solution for injection 4 mg/ml 1 ml | RK-LS-5No.023202 |
H02AB02 | Dexamethasone | ||||
2805 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 40 mg | RK-LS-5No.024279 orphan |
2806 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 20 mg | RK-LS-5No.024280 orphan |
2807 | H02AB02 | Dexamethasone | Dexamethasone | solution for injection 4 mg/ml, 1 ml | RK-LS-5No.003394 |
2808 | H02AB02 | Dexamethasone | Dexamethasone-Agio | solution for injection 4 mg/ml 1 ml | RK-LS-5No.023520 |
2809 | H02AB02 | Dexamethasone | Dexamethasone | solution for injection 4 mg/ml 1 ml 2 ml | RK-LS-5No.018102 |
2810 | H02AB02 | Dexamethasone | Dexamethasone Phosphate | solution for injection 4 mg/ml 1 ml | RK-LS-5No.015867 |
2811 | H02AB02 | Dexamethasone | Dexamethasone | tablets 0.5 mg | RK-LS-5No.003395 |
2812 | H02AB02 | Dexamethasone | Dexamethasone | solution for injection 4 mg/ml 1 ml | RK-LS-5No.018102 |
2813 | H02AB02 | Dexamethasone | Dexamethasone | solution for injection 4 mg/ml 2 ml | RK-LS-5No.018102 |
2814 | H02AB02 | Dexamethasone | Dexamed | solution for injection 4 mg/ml, 1 ml | RK-LS-5No.012416 |
2815 | H02AB02 | Dexamethasone | Dexamed | tablets 0.5 mg | RK-LS-5No.010985 |
2816 | H02AB02 | Dexamethasone | Dexamed | tablets 1.5 mg | RK-LS-5No.010986 |
2817 | H02AB02 | Dexamethasone | Xaden | tablets 0.5 mg | RK-LS-5No.022752 |
2818 | H02AB02 | Dexamethasone | Dexamethasone | solution for injection 4 mg/ml 1 ml | RK-LS-5No.020631 |
2819 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 0.5 mg | RK-LS-5No.024288 |
2820 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 40 mg | RK-LS-5No.024279 |
2821 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 20 mg | RK-LS-5No.024280 |
2822 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 8 mg | RK-LS-5No.024281 |
2823 | H02AB02 | Dexamethasone | Dexamethasone - KRKA | tablets 4 mg | RK-LS-5No.024282 |
H02AB04 | Methylprednisolone | orphan | |||
2824 | H02AB04 | Methylprednisolone | Metipred | lyophilized powder for solution preparation, 1000 mg each | RK-LS-5No.023177 |
2825 | H02AB04 | Methylprednisolone | Metipred | lyophilized powder for solution preparation, 250 mg each | RK-LS-5No.023178 |
2826 | H02AB04 | Methylprednisolone | Slideron | tablets 16 mg | RK-LS-5No.022288 |
2827 | H02AB04 | Methylprednisolone | Metipred | tablets 16 mg | RK-LS-5No.016732 |
2828 | H02AB04 | Methylprednisolone | Slideron | tablets 4 mg | RK-LS-5No.022271 |
2829 | H02AB04 | Methylprednisolone | Metipred | tablets 4 mg | RK-LS-5No.016731 |
2830 | H02AB04 | Methylprednisolone | Solu-Medrol® | lyophilisate for preparation of solution for injection 250 mg 4 ml | RK-LS-5No.014908 |
2831 | H02AB04 | Methylprednisolone | Solu-Medrol® | lyophilisate for preparation of solution for injection complete with solvent 500 mg | RK-LS-5No.014909 |
2832 | H02AB04 | Methylprednisolone | Solu-Medrol® | lyophilisate for preparation of solution for injection complete with solvent 1000 mg | RK-LS-5No.014910 |
2833 | H02AB04 | Methylprednisolone | Methylprednisolone Viva Pharm | tablets 4 mg | RK-LS-5No.023863 |
2834 | H02AB04 | Methylprednisolone | Methylprednisolone Viva Pharm | tablets 16 mg | RK-LS-5No.023864 |
H02AB06 | Prednisolone | orphan | |||
2835 | H02AB06 | Prednisolone | Prednisolone | solution for intravenous and intramuscular injection of 30 mg/ml, 1 ml | RK-LS-5No.011406 |
2836 | H02AB06 | Prednisolone | Prednisolone | solution for injection 30 mg/ml 1 ml | RK-LS-5No.022730 |
2837 | H02AB06 | Prednisolone | Prednisolone Nycomed | tablets 5 mg | RK-LS-5No.003997 |
2838 | H02AB06 | Prednisolone | Prednisolone Nycomed | solution for injection 25 mg/ml 1 ml | RK-LS-5No.003998 |
2839 | H02AB06 | Prednisolone | Prednisolone | tablets 5 mg | RK-LS-5No.014013 |
2840 | H02AB06 | Prednisolone | Prednisolone | tablets 5 mg | RK-LS-5No.001162 |
2841 | H02AB06 | Prednisolone | Prednisolone-Darnitsa | tablets 5 mg | RK-LS-5No.015858 |
2842 | H02AB06 | Prednisolone | Prednisolone | solution for injection 30 mg/ml, 1 ml | RK-LS-5No.014919 |
2843 | H02AB06 | Prednisolone | Prednisolone BP | tablets 5 mg | RK-LS-5No.015739 |
2844 | H02AB06 | Prednisolone | Prednisolone | 5 mg tablets | RK-LS-5No.024445 |
H02AB08 | Triamcinolone | ||||
2845 | H02AB08 | Triamcinolone | Kenalog® 40 | suspension for injection 40mg/ml 1 ml | RK-LS-5No.019137 |
2846 | H02AB08 | Triamcinolone | Polcortolone® | tablets 4 mg | RK-LS-5No.001165 |
H02AB09 | Hydrocortisone | ||||
2847 | H02AB09 | Hydrocortisone | Hydrocortisone acetate | suspension for injection 2.5% 2ml | RK-LS-5No.010934 |
2848 | H02AB09 | Hydrocortisone | Hydrocortisone-Richter | microcrystalline suspension for injection 5ml | RK-LS-5No.016463 |
2849 | H02AB09 | Hydrocortisone | Hydrocortisone acetate | suspension for injection 25 mg/ml, 2 ml | RK-LS-5No.012066 |
2850 | H02AB09 | Hydrocortisone | Stericort | Powder for preparation of solution for intravenous and intramuscular injection, 100 mg | RK-LS-5No.022554 |
H03 | Drugs for treatment of thyroid diseases | ||||
H03AA | Thyroid hormones | ||||
H03AA01 | Levothyroxine sodium | ||||
2851 | H03AA01 | Levothyroxine sodium | Eutirox® | tablets 150 mcg | RK-LS-5No.014670 |
2852 | H03AA01 | Levothyroxine sodium | Eutirox® | tablets 125 mcg | RK-LS-5No.014669 |
2853 | H03AA01 | Levothyroxine sodium | Eutirox® | tablets 75 mcg | RK-LS-5No.014667 |
2854 | H03AA01 | Levothyroxine sodium | Eutirox® | tablets 100 mcg | RK-LS-5No.014668 |
2855 | H03AA01 | Levothyroxine sodium | Eutirox® | tablets 50 mcg | RK-LS-5No.014666 |
2856 | H03AA01 | Levothyroxine sodium | Eutirox® | tablets 25 mcg | RK-LS-5No.014665 |
2857 | H03AA01 | Levothyroxine sodium | L-Thyroxin 100 Berlin-Chemie | tablets 100 mcg | RK-LS-5No.014571 |
2858 | H03AA01 | Levothyroxine sodium | L-Thyroxin 50 Berlin-Chemie | tablets 50 mcg | RK-LS-5No.014570 |
2859 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 200 mcg | RK-LS-5No.024378 |
2860 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 175 mcg | RK-LS-5No.024379 |
2861 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 150 mcg | RK-LS-5No.024380 |
2862 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 125 mcg | RK-LS-5No.024381 |
2863 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 100 mcg | RK-LS-5No.024382 |
2864 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 75 mcg | RK-LS-5No.024383 |
2865 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 50 mcg | RK-LS-5No.024384 |
2866 | H03AA01 | Levothyroxine sodium | Levothyrone | tablets 25 mcg | RK-LS-5No.024385 |
H03AA01 | Levothyroxine sodium | ||||
H03BB | Sulfur-containing imidazole derivatives | ||||
H03BB02 | Thiamazole | ||||
2867 | H03BB02 | Thiamazole | Mercazolil-Health | tablets 5 mg | RK-LS-5No.014157 |
2868 | H03BB02 | Thiamazole | Tyrosol® | film-coated tablets 10 mg | RK-LS-5No.020724 |
2869 | H03BB02 | Thiamazole | Tyrosol® | film-coated tablets 5 mg | RK-LS-5No.020723 |
H03C | Iodine drugs | ||||
H03CA | Potassium iodide | ||||
2870 | H03CA | Potassium iodide | Iodomarin® 200 | tablets 200 mcg | RK-LS-5No.010499 |
2871 | H03CA | Potassium iodide | Iodbalance® | tablets 200 mcg | RK-LS-5No.019767 |
2872 | H03CA | Potassium iodide | Iodomarin® 200 | tablets, 0.2 mg | RK-LS-5No.023413 |
2873 | H03CA | Potassium iodide | Iodomarin® 100 | tablets 100 mcg | RK-LS-5No.008273 |
H04 | Pancreatic hormones | ||||
H04A | Hormones decomposing glycogen | ||||
H04AA01 | Glucagon | ||||
2874 | H04AA01 | Glucagon | GlukaGen® 1mg HypoKit | lyophilisate for preparation of solution for injection complete with solvent 1 mg 1 ml | RK-LS-5No.011432 |
H05AA02 | Teriparatide | ||||
2875 | H05AA02 | Teriparatide | Forsteo® | solution for subcutaneous injection 250 mcg/ml 2.4 ml | RK-LS-5No.021064 |
H05 | Calcium regulating drugs | ||||
H05B | Antiparathyroid hormones | ||||
H05BX | Other antiparathyroid drugs | ||||
H05BX01 | Cinacalcet | ||||
2876 | H05BX01 | Cinacalcet | CINESET® | film-coated tablets 90 mg | RK-LS-5No.022853 |
2877 | H05BX01 | Cinacalcet | CINESET® | film-coated tablets 60 mg | RK-LS-5No.022877 |
2878 | H05BX01 | Cinacalcet | Mimpara | film-coated tablets 30 mg | RK-LS-5No.020041 |
2879 | H05BX01 | Cinacalcet | CINESET® | film-coated tablets 30 mg | RK-LS-5No.022876 |
H05BX02 | Paricalcitol | ||||
2880 | H05BX02 | Paricalcitol | Zemplar® | solution for injection 5 mcg/ml, 1 ml | RK-LS-5No.019298 |
H05BX04 | Ethelcalcetide | ||||
2881 | H05BX04 | Ethelcalcetide | Parsabiv | solution for intravenous injection, 2.5 mg/0.5 ml | RK-LS-5No.023620 |
2882 | H05BX04 | Ethelcalcetide | Parsabiv | solution for intravenous injection, 5 mg 1 ml | RK-LS-5No.023621 |
2883 | H05BX04 | Ethelcalcetide | Parsabiv | solution for intravenous injection, 10 mg 2 ml | RK-LS-5No.023618 |
J | Antimicrobials for systemic use | ||||
J01 | Antimicrobials for systemic use | ||||
J01A | Tetracyclines | ||||
J01AA02 | Doxycycline | ||||
2884 | J01AA02 | Doxycycline | Doxycycline-TC | capsules 100 mg | RK-LS-5No.016325 |
2885 | J01AA02 | Doxycycline | Tarox | capsules hard 100 mg | RK-LS-5No.005136 |
2886 | J01AA02 | Doxycycline | Doxycycline | capsules 100 mg | RK-LS-5No.012099 |
2887 | J01AA02 | Doxycycline | Unidox Solutab® | dispersible tablets 100 mg | RK-LS-5No.019172 |
2888 | J01AA02 | Doxycycline | Doxycycline STADA® | tablets 100 mg | RK-LS-5No.011181 |
2889 | J01AA02 | Doxycycline | Doxycycline STADA® | tablets 200 mg | RK-LS-5No.011184 |
2890 | J01AA02 | Doxycycline | Doxilan® | tablets 100 mg | RK-LS-5No.020436 |
J01AA07 | Tetracycline | ||||
2891 | J01AA07 | Tetracycline | Tetracycline | coated tablets 100 mg | RK-LS-5No.012671 |
J01B | Amphenicols | ||||
J01BA01 | Chloramphenicol | ||||
2892 | J01BA01 | Chloramphenicol | Levomycetin | tablets 0,5 g | RK-LS-5No.000122 |
2893 | J01BA01 | Chloramphenicol | Levomycetin-Darnitsa | tablets 500 mg | RK-LS-5No.015686 |
2894 | J01BA01 | Chloramphenicol | Levomycetin-Darnitsa | tablets 250 mg | RK-LS-5No.015685 |
2895 | J01BA01 | Chloramphenicol | Levomycetin | tablets 500 mg | RK-LS-5No.005840 |
2896 | J01BA01 | Chloramphenicol | Levomycetin | tablets 500 mg | RK-LS-5No.010172 |
2897 | J01BA01 | Chloramphenicol | Levomycetin | tablets 0,5 g | RK-LS-5No.019460 |
2898 | J01BA01 | Chloramphenicol | Levomycetin | powder for solution for injection 1 g | RK-LS-5No.009793 |
2899 | J01BA01 | Chloramphenicol | Levomycetin sodium succinate | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.014691 |
2900 | J01BA01 | Chloramphenicol | Levomycetin | tablets 250 mg | RK-LS-5No.005804 |
J01C | Beta-lactam antibiotics - penicillins | ||||
J01CA | Broad-spectrum penicillins | ||||
J01CA01 | Ampicillin | ||||
2901 | J01CA01 | Ampicillin | Ampicillin | powder for solution for injection 1 g | RK-LS-5No.016621 |
2902 | J01CA01 | Ampicillin | Ampicillin | powder for solution for injection 0,5 g | RK-LS-5No.020137 |
2903 | J01CA01 | Ampicillin | Ampicillin | powder for preparation of solution for intramuscular injection 1 g | RK-LS-5No.019728 |
2904 | J01CA01 | Ampicillin | Ampicillin | powder for preparation of solution for intravenous and intramuscular injection 0.5 g | RK-LS-5No.000119 |
2905 | J01CA01 | Ampicillin | Ampicillin | powder for preparation of solution for intramuscular injection of 500 mg | RK-LS-5No.004384 |
2906 | J01CA01 | Ampicillin | Ampicillin | tablets 250 mg | RK-LS-5No.014888 |
2907 | J01CA01 | Ampicillin | Ampicillin | powder for solution for injection 1 g | RK-LS-5No.021598 |
2908 | J01CA01 | Ampicillin | Ampicillin | powder for preparation of solution for intravenous and intramuscular injection of 500 mg | RK-LS-5No.019495 |
2909 | J01CA01 | Ampicillin | Ampicillin | powder for preparation of solution for intravenous and intramuscular injection 1000 mg | RK-LS-5No.019496 |
J01CA04 | Amoxicillin | ||||
2910 | J01CA04 | Amoxicillin | Ospamox® | film-coated tablets 1000 mg | RK-LS-5No.016567 |
2911 | J01CA04 | Amoxicillin | AMOSIN® | tablets 250 mg | RK-LS-5No.014049 |
2912 | J01CA04 | Amoxicillin | AMOSIN® | tablets 500 mg | RK-LS-5No.014050 |
2913 | J01CA04 | Amoxicillin | Amoxil® | tablets 250 mg | RK-LS-5No.003442 |
2914 | J01CA04 | Amoxicillin | Amoxil® | tablets 500 mg | RK-LS-5No.003464 |
2915 | J01CA04 | Amoxicillin | Hikontsil | capsules 250 mg | RK-LS-5No.020127 |
2916 | J01CA04 | Amoxicillin | Hikontsil | Powder for preparation of oral suspension 250 mg/5 ml, 11 g | RK-LS-5No.024481 |
2917 | J01CA04 | Amoxicillin | AMOSIN® | powder for oral suspension 250 mg | RK-LS-5No.016661 |
2918 | J01CA04 | Amoxicillin | AMOSIN® | powder for preparation of oral suspension 500 mg | RK-LS-5No.016662 |
2919 | J01CA04 | Amoxicillin | Ospamox® | powder for preparation of oral suspension 250 mg/5 ml | RK-LS-5No.003908 |
2920 | J01CA04 | Amoxicillin | Ospamox® | powder for preparation of oral suspension 125 mg/5 ml | RK-LS-5No.003887 |
2921 | J01CA04 | Amoxicillin | AMOSIN® | powder for oral suspension 125 mg | RK-LS-5No.016660 |
2922 | J01CA04 | Amoxicillin | Hikontsil | capsules 500 mg | RK-LS-5No.020128 |
2923 | J01CA04 | Amoxicillin | Moxilen | capsules 500 mg | RK-LS-5No.023482 |
2924 | J01CA04 | Amoxicillin | Moxilen | capsules 250 mg | RK-LS-5No.023483 |
2925 | J01CA04 | Amoxicillin | Amoxicillin | capsules 250 mg | RK-LS-5No.019587 |
2926 | J01CA04 | Amoxicillin | Amoxicillin | capsules 500 mg | RK-LS-5No.019588 |
2927 | J01CA04 | Amoxicillin | Hikontsil | capsules 250 mg | RK-LS-5No.020127 |
2928 | J01CA04 | Amoxicillin | Hikontsil | capsules 500 mg | RK-LS-5No.020128 |
2929 | J01CA04 | Amoxicillin | Ospamox® | film-coated tablets, 500 mg | RK-LS-5No.016566 |
2930 | J01CA04 | Amoxicillin | OSPAMOX ® DT | dispersible tablets 1000 mg | RK-LS-5No.022565 |
2931 | J01CA04 | Amoxicillin | OSPAMOX ® DT | dispersible tablets 500 mg | RK-LS-5No.022566 |
2932 | J01CA04 | Amoxicillin | Flemoxin Solutab® | dispersible tablets 1000 mg | RK-LS-5No.005032 |
2933 | J01CA04 | Amoxicillin | Flemoxin Solutab® | dispersible tablets 500 mg | RK-LS-5No.005033 |
2934 | J01CA04 | Amoxicillin | Flemoxin Solutab® | dispersible tablets 125 mg | RK-LS-5No.005034 |
2935 | J01CA04 | Amoxicillin | Flemoxin Solutab® | dispersible tablets 250 mg | RK-LS-5No.005052 |
J01CE | Penicillins sensitive to beta-lactamases | ||||
J01CE01 | Benzylpenicillin | ||||
2936 | J01CE01 | Benzylpenicillin | Benzylpenicillin | powder for preparation of solution for injections 1,000,000 U | RK-LS-5No.020160 |
2937 | J01CE01 | Benzylpenicillin | Benzylpenicillin | powder for preparation of solution for injections 1 000 000 U | RK-LS-5No.004481 |
2938 | J01CE01 | Benzylpenicillin | Benzylpenicillin sodium salt | powder for preparation of solution for intramuscular injection 1,000,000 IU in a vial | RK-LS-5No.004060 |
J01CE08 | Benzathine benzylpenicillin | ||||
J01CE30 | Combination of beta-lactamase sensitive penicillins | ||||
2939 | J01CE30 | Combination of beta-lactamase sensitive penicillins | Bitsillin-3 | Powder for preparing suspension for intramuscular injection 600,000 U | RK-LS-5No.003548 |
2940 | J01CE30 | Combination of beta-lactamase sensitive penicillins | Bitsillin-5 | powder for preparation of suspension for intramuscular injection 1200000 U + 300000 U | RK-LS-5No.004061 |
J01CR | Penicillins with beta-lactamase inhibitors | ||||
J01CR01 | Ampicillin and beta-lactamase inhibitor | ||||
2941 | J01CR01 | Ampicillin and beta-lactamase inhibitor | Sulbatsin | Powder for solution for injection, 1.5 g | RK-LS-5No.015047 |
2942 | J01CR01 | Ampicillin and beta-lactamase inhibitor | Sulbatsin | Powder for solution for injection, 0.75 g | RK-LS-5No.015048 |
J01CR02 | Amoxicillin and beta-lactamase inhibitor | ||||
2943 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Augmentin® | lyophilized powder for preparation of solution for intravenous infusion 2000 mg/200 mg | RK-LS-5No.019434 |
2944 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Augmentin® | powder for preparation of oral suspension 400mg/57mg/5ml | RK-LS-5No.004472 |
2945 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Avimentin | powder for suspension preparation 400 mg/57 mg | RK-LS-5No.022909 |
2946 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Augmentin® | powder for preparation of oral suspension 200 mg/28.5 mg/5 ml | RK-LS-5No.004471 |
2947 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Avimentin | powder for suspension preparation 200 mg/28.5 mg | RK-LS-5No.022908 |
2948 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxicillin + Clavulanic Acid | powder for preparation of solution for intravenous injection 0.5 g + 0.1 g | RK-LS-5No.020148 |
2949 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam | powder for preparation of oral suspension 228.5mg/5ml | RK-LS-5No.018408 |
2950 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam | powder for solution for injection 1200 mg | RK-LS-5No.011347 |
2951 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Augmentin® | powder for preparation of oral suspension 125mg/31.25mg/5ml | RK-LS-5No.005807 |
2952 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam | powder for preparation of oral suspension 156.25 mg/5 ml | RK-LS-5No.018407 |
2953 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam | powder for solution for injection 600 mg | RK-LS-5No.011348 |
2954 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Avimentin | film-coated tablets 1000 mg | RK-LS-5No.022865 |
2955 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Augmentin® | Film-coated tablets 875 mg/125 mg | RK-LS-5No.004473 |
2956 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam 1000 | film-coated tablets 1000 mg | RK-LS-5No.023759 |
2957 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Avimentin | film-coated tablets 375 mg | RK-LS-5No.022875 |
2958 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam | coated tablets 375 mg | RK-LS-5No.011974 |
2959 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® 2X | film-coated tablets 500 mg/125 mg | RK-LS-5No.016456 |
2960 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Augmentin® | Film-coated tablets 500 mg/125 mg | RK-LS-5No.009993 |
2961 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Avimentin | film-coated tablets 625 mg | RK-LS-5No.022874 |
2962 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clawam | film-coated tablets 625 mg | RK-LS-5No.011975 |
2963 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Flemoklav Solutab® | dispersible tablets 250mg + 62.5mg | RK-LS-5No.010209 |
2964 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Flemoklav Solutab® | dispersible tablets 125mg + 31.25mg | RK-LS-5No.010210 |
2965 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® | film-coated tablets 375 mg | RK-LS-5No.004907 |
2966 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Michael 375 | coated tablets 375 mg | RK-LS-5No.015755 |
2967 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Flemoklav Solutab® | dispersible tablets 875mg + 125mg | RK-LS-5No.018076 |
2968 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Medoclav | film-coated tablets 1 g | RK-LS-5No.012912 |
2969 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® QT | dispersible tablets 875 mg/125 mg | RK-LS-5No.020607 |
2970 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Rapiklav | film-coated tablets 875 mg/125 mg | RK-LS-5No.021148 |
2971 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Flemoklav Solutab® | dispersible tablets 500 mg + 125 mg | RK-LS-5No.010208 |
2972 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® QT | dispersible tablets 500 mg/125 mg | RK-LS-5No.020608 |
2973 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxil-K | powder for preparation of solution for injection 1.2 g each | RK-LS-5No.019060 |
2974 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Medoclav | powder for preparation of oral suspension 156.25 mg/5 ml | RK-LS-5No.004851 |
2975 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Enkhantzin | powder for preparation of oral suspension 400 + 57.0 mg/5 ml | RK-LS-5No.017857 |
2976 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clamox | film-coated tablets 625 mg | RK-LS-5No.020994 |
2977 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxil-K 625 | film-coated tablets 500 mg/125 mg | RK-LS-5No.019444 |
2978 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® | powder for preparation of oral suspension 312.5mg/5ml, 25 g of powder in a vial | RK-LS-5No.004904 |
2979 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® 2X | powder for preparation of oral suspension 457 mg/5 ml, 8.75 g in a vial | RK-LS-5No.009272 |
2980 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® | film-coated tablets 625 mg | RK-LS-5No.004916 |
2981 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Michaelav-625 | film-coated tablets 625 mg | RK-LS-5No.015756 |
2982 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Medoclav | film-coated tablets 625 mg | RK-LS-5No.004877 |
2983 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | COACT | coated tablets 875 mg/125 mg | RK-LS-5No.121938 |
2984 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clavirex | film-coated tablets, 875 mg/125 mg | RK-LS-5No.023737 |
2985 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Clavirex | film-coated tablets, 500 mg/125 mg | RK-LS-5No.023736 |
2986 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxicillin + Clavulanic Acid | powder for preparation of solution for intravenous injection 0.5 g + 0.1 g | RK-LS-5No.020148 |
2987 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclanat | powder for preparation of solution for intravenous injection 0.5 g/0.1 g | RK-LS-5No.024391 |
2988 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Hikontsil Kombi | film-coated tablets 500 mg/125 mg | RK-LS-5No.023996 |
2989 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Hikontsil Kombi | film-coated tablets 875 mg/125 mg | RK-LS-5No.023982 |
2990 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Hikontsil Kombi | powder for preparation of oral suspension 400 mg/57 mg/5 ml | RK-LS-5No.023983 |
2991 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Medoclav | coated tablets 375 mg | RK-LS-5No.004853 |
2992 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Medoclav forte | powder for preparation of oral suspension 312.5 mg/5 ml | RK-LS-5No.004925 |
2993 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Enkhantzin | powder for preparation of oral suspension 200 + 28.5 mg/5ml | RK-LS-5No.017856 |
2994 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Rapiklav 250 DT | dispersible tablets 250 mg/62.5 mg | RK-LS-5No.022857 |
2995 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Ecoclave® | powder for oral suspension 250 mg + 62.5 mg/5 ml | RK-LS-5No.022811 |
2996 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Ecoclave® | powder for preparation of oral suspension 125 mg + 31.25 mg/5 ml | RK-LS-5No.022812 |
2997 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Tsimax Plus | film-coated tablets 250 mg/125 mg | RK-LS-5No.022675 |
2998 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Tsimax Plus | film-coated tablets 500 mg/125 mg | RK-LS-5No.022676 |
2999 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Tsimax Plus | film-coated tablets 875 mg/125 mg | RK-LS-5No.022677 |
3000 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Tsimax Plus | powder for preparation of oral suspension 200/28 mg/5 ml | RK-LS-5No.022659 |
3001 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Tsimax Plus | powder for preparation of oral suspension 400/57 mg/5 ml | RK-LS-5No.022660 |
3002 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® | powder for preparation of oral suspension 156.25 mg/5 ml | RK-LS-5No.004905 |
3003 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Sulbamox | powder for preparation of solution for intravenous and intramuscular injection 500mg/250mg | RK-LS-5No.015165 |
3004 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Sulbamox | powder for preparation of solution for intravenous and intramuscular injection 1000mg/500mg | RK-LS-5No.015166 |
3005 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | COACT | coated tablets 250 mg/125 mg | RK-LS-5No.121940 |
3006 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® 2X | powder for preparation of oral suspension 457mg/5ml | RK-LS-5No.009273 |
3007 | J01CR02 | Amoxicillin and beta-lactamase inhibitor | Amoxiclav® 2X | film-coated tablets 875mg/125mg | RK-LS-5No.016457 |
J01CR05 | Piperacillin and Tazobactam | ||||
3008 | J01CR05 | Piperacillin and Tazobactam | Alpitosis - 4.5 | powder for preparation of solution for intravenous injection 4.5 g | RK-LS-5No.122019 |
3009 | J01CR05 | Piperacillin and Tazobactam | Revotaz® | Powder for preparation of solution for intravenous infusion 4.5 g | RK-LS-5No.010156 |
3010 | J01CR05 | Piperacillin and Tazobactam | Piperabactam | powder for solution for injection 4.5 g | RK-LS-5No.023430 |
J01D | Other beta-lactam antibiotics | ||||
J01DB | First generation cephalosporins | ||||
J01DB04 | Cefazolin | ||||
3011 | J01DB04 | Cefazolin | Cefazolin sodium salt | powder for solution for injection 500 mg | RK-LS-5No.018314 |
3012 | J01DB04 | Cefazolin | Cefazolin | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.019432 |
3013 | J01DB04 | Cefazolin | Cefazolin sodium salt | powder for solution for injection 1 g, | RK-LS-5No.014939 |
3014 | J01DB04 | Cefazolin | CEFAZOLIN-AKOS | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.015608 |
3015 | J01DB04 | Cefazolin | Cefazolin | powder for solution for injection 1 g | RK-LS-5No.018798 |
3016 | J01DB04 | Cefazolin | Cefazolin | powder for solution for injection 1g | RK-LS-5No.023091 |
3017 | J01DB04 | Cefazolin | Cefazolin | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.010202 |
3018 | J01DB04 | Cefazolin | Cefazolin sodium salt | Powder for preparation of solution for intramuscular injection complete with solvent (water for injection) 1g | RK-LS-5No.016568 |
J01DB05 | Cefadroxil | ||||
3019 | J01DB05 | Cefadroxil | VALDOCEF | granules for preparation of oral suspension 250 mg/5 ml | RK-LS-5No.022459 |
3020 | J01DB05 | Cefadroxil | Valdocef | capsules 500 mg | RK-LS-5No.121998 |
J01DC | Second generation cephalosporins | ||||
J01DC02 | Cefuroxime | ||||
3021 | J01DC02 | Cefuroxime | Cefuroxime | powder for preparation of solution for intravenous and intramuscular injection 750 mg | RK-LS-5No.019807 |
3022 | J01DC02 | Cefuroxime | Zinnat® | film-coated tablets 250 mg | RK-LS-5No.004695 |
3023 | J01DC02 | Cefuroxime | Megasef® 250 | film-coated tablets 250 mg | RK-LS-5No.005330 |
3024 | J01DC02 | Cefuroxime | Megasef® 500 | film-coated tablets 500 mg | RK-LS-5No.005335 |
3025 | J01DC02 | Cefuroxime | Zinnat® | film-coated tablets 500 mg | RK-LS-5No.019984 |
3026 | J01DC02 | Cefuroxime | MEGASEF® 500 | film-coated tablets 500 mg | RK-LS-3No.019949 |
3027 | J01DC02 | Cefuroxime | MEGASEF® 500 | film-coated tablets 500 mg | RK-LS-5No.005337 |
3028 | J01DC02 | Cefuroxime | MEGASEF® 500 | film-coated tablets 500 mg | RK-LS-5No.019223 |
3029 | J01DC02 | Cefuroxime | Cefuroxime | powder for solution for injection 750 mg | RK-LS-5No.023579 |
3030 | J01DC02 | Cefuroxime | Zocef® | powder for solution for injection 750 mg | RK-LS-5No.005006 |
3031 | J01DC02 | Cefuroxime | Cephiaps | powder for solution for injection 750 mg | RK-LS-5No.022342 |
3032 | J01DC02 | Cefuroxime | Cefuroxime | powder for solution for injection 750 mg | RK-LS-5No.010439 |
3033 | J01DC02 | Cefuroxime | Cephiaps | powder for solution for injection 1.5 g | RK-LS-5No.022343 |
3034 | J01DC02 | Cefuroxime | Zocef® | powder for solution for injection 1.5 g | RK-LS-5No.005013 |
3035 | J01DC02 | Cefuroxime | Cefuroxime | powder for solution for injection 1500 mg | RK-LS-5No.010440 |
3036 | J01DC02 | Cefuroxime | Zinnat® | granules for preparation of oral suspension 125 mg/5 ml | RK-LS-5No.004693 |
3037 | J01DC02 | Cefuroxime | Megasef® 250 | powder for solution for injection complete with solvent (water for injection) 250 mg | RK-LS-5No.019811 |
3038 | J01DC02 | Cefuroxime | Zinnat® | film-coated tablets 125 mg | RK-LS-5No.004694 |
3039 | J01DC02 | Cefuroxime | Auroxetil | tablets 500 mg | RK-LS-5No.022254 |
3040 | J01DC02 | Cefuroxime | Auroxetil | tablets 250 mg | RK-LS-5No.022255 |
3041 | J01DC02 | Cefuroxime | MEGASEF® 250 | film-coated tablets 250mg | RK-LS-3No.019948 |
3042 | J01DC02 | Cefuroxime | MEGASEF® 250 | film-coated tablets 250 mg | RK-LS-5No.005331 |
3043 | J01DC02 | Cefuroxime | MEGASEF® 250 | film-coated tablets 250 mg | RK-LS-5No.019222 |
3044 | J01DC02 | Cefuroxime | Cetil | film-coated tablets 250 mg | RK-LS-5No.010877 |
3045 | J01DC02 | Cefuroxime | Cetil | film-coated tablets 500 mg | RK-LS-5No.010878 |
3046 | J01DC02 | Cefuroxime | Zinnat® | granules for preparation of oral suspension 250 mg/5 ml | RK-LS-5No.019901 |
3047 | J01DC02 | Cefuroxime | Aksetin | powder for solution for injection and infusion 750 mg | RK-LS-5No.019644 |
3048 | J01DC02 | Cefuroxime | Zinacef® | powder for solution for injection 750 mg | RK-LS-5No.004696 |
3049 | J01DC02 | Cefuroxime | Kimacef | powder for solution for injection 1.5 g | RK-LS-5No.004315 |
3050 | J01DC02 | Cefuroxime | Kimacef | powder for solution for injection 0.75 g | RK-LS-5No.004308 |
3051 | J01DC02 | Cefuroxime | Aksetin | powder for preparation of solution for injections and infusions 1.5 g | RK-LS-5No.019645 |
3052 | J01DC02 | Cefuroxime | Zocef® | coated tablets 250 mg | RK-LS-5No.005436 |
3053 | J01DC02 | Cefuroxime | Zocef® | Film-coated tablets 500 mg | RK-LS-5No.005459 |
3054 | J01DC02 | Cefuroxime | Megasef® 750 | powder for solution for injection complete with solvent (water for injection) 750 mg | RK-LS-5No.019812 |
3055 | J01DC02 | Cefuroxime | Megasef® 750 | powder for solution for injection complete with solvent (water for injection) 750 mg | RK-LS-5No.016590 |
3056 | J01DC02 | Cefuroxime | Xorimax® | coated tablets 250 mg | RK-LS-5No.021354 |
3057 | J01DC02 | Cefuroxime | Megasef® 250 | powder for solution for injection complete with solvent (water for injection) 250 mg | RK-LS-5No.016589 |
3058 | J01DC02 | Cefuroxime | Megasef® 250 | powder for solution for injection 250 mg | RK-LS-5No.015643 |
3059 | J01DC02 | Cefuroxime | Megasef® 750 | powder for solution for injection 750 mg | RK-LS-5No.015644 |
3060 | J01DC02 | Cefuroxime | Bioracef® | coated tablets 250 mg | RK-LS-5No.024326 |
3061 | J01DC02 | Cefuroxime | Bioracef® | film-coated tablets 500 mg | RK-LS-5No.024327 |
J01DC03 | Cefamandol | ||||
3062 | J01DC03 | Cefamandol | Tarcefandol | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.022237 |
J01DD | Third generation cephalosporins | ||||
J01DD01 | Cefotaxime | ||||
3063 | J01DD01 | Cefotaxime | Axim | powder for solution for injection 1 g | RK-LS-5No.016604 |
3064 | J01DD01 | Cefotaxime | Cefotaxime | powder for preparation of solution for intravenous and intramuscular injection 1000 mg | RK-LS-5No.013772 |
3065 | J01DD01 | Cefotaxime | Cefotaxime sodium | powder for solution for injection 1 g | RK-LS-3No.021402 |
3066 | J01DD01 | Cefotaxime | TSEFOSIN | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.008742 |
3067 | J01DD01 | Cefotaxime | Cefantral | powder for solution for injection 1g | RK-LS-5No.121669 |
3068 | J01DD01 | Cefotaxime | Cefotaxime | powder for solution for injection 0.5 g | RK-LS-5No.022380 |
3069 | J01DD01 | Cefotaxime | Cefotaxime | powder for solution for injection 1 g | RK-LS-5No.022462 |
3070 | J01DD01 | Cefotaxime | Cefotaxime | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.018323 |
3071 | J01DD01 | Cefotaxime | Cefotaxime | powder for solution for injection 1 g | RK-LS-5No.023842 |
J01DD02 | Ceftazidime | ||||
3072 | J01DD02 | Ceftazidime | Ceftazidime | powder for solution for injection 500 mg | RK-LS-5No.010422 |
3073 | J01DD02 | Ceftazidime | Lemoxol® | powder for solution for injection 1 g | RK-LS-5No.004024 |
3074 | J01DD02 | Ceftazidime | Ceftazidime - Eleas | powder for solution for injection 1 g | RK-LS-3No.019978 |
3075 | J01DD02 | Ceftazidime | Denizide | powder for solution for injection 1 g | RK-LS-5No.023376 |
3076 | J01DD02 | Ceftazidime | Ceftazidime | powder for solution for injection 1000 mg | RK-LS-5No.010423 |
3077 | J01DD02 | Ceftazidime | Zifta-1000 | powder for solution for injection 1000 mg | RK-LS-5No.023078 |
3078 | J01DD02 | Ceftazidime | Lemoxol | powder for solution for injection 2 g | RK-LS-5No.004025 |
3079 | J01DD02 | Ceftazidime | Ceftazidime | powder for solution for injection 2000 mg | RK-LS-5No.010424 |
3080 | J01DD02 | Ceftazidime | Zatsef | powder for solution for injection 1 g | RK-LS-5No.019579 |
3081 | J01DD02 | Ceftazidime | Ceftazidime | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.020269 |
3082 | J01DD02 | Ceftazidime | Tazid® | powder for solution for injection 1 g | RK-LS-5No.005431 |
3083 | J01DD02 | Ceftazidime | Tizim | powder for solution for injection 1 g | RK-LS-5No.009835 |
3084 | J01DD02 | Ceftazidime | Tazid® | powder for solution for injection 2 g | RK-LS-5No.005440 |
3085 | J01DD02 | Ceftazidime | CEFTHAZIDIM-AKOS | powder for solution for injection 1 g | RK-LS-5No.003213 |
3086 | J01DD02 | Ceftazidime | CEFTHAZIDIM-AKOS | powder for solution for injection 2 g | RK-LS-5No.003224 |
3087 | J01DD02 | Ceftazidime | Suprazide | powder for solution for injection 1 g | RK-LS-5No.015719 |
3088 | J01DD02 | Ceftazidime | Suprazide | powder for solution for injection 2 g | RK-LS-5No.015720 |
3089 | J01DD02 | Ceftazidime | Suprazide | powder for solution for injection 0.5 g | RK-LS-5No.015718 |
J01DD04 | Ceftriaxone | ||||
3090 | J01DD04 | Ceftriaxone | Abitrax | powder for preparation of solution for injection complete with solvent (1% solution of lidocaine hydrochloride) 1 g 1 g of the drug in a vial, 3.5 ml of solvent in an ampoule | RK-LS-5No.020620 |
3091 | J01DD04 | Ceftriaxone | Sertocef | powder for preparation of solution for injection complete with solvent (1% solution of lidocaine hydrochloride) 1 g | RK-LS-5No.022323 |
3092 | J01DD04 | Ceftriaxone | Denicef | powder for solution for injection 1 g | RK-LS-5No.023333 |
3093 | J01DD04 | Ceftriaxone | Veracol | powder for preparation of solution for injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 1 g | RK-LS-5No.021614 |
3094 | J01DD04 | Ceftriaxone | Belacef | powder for solution for injection 1 g | RK-LS-5No.022226 |
3095 | J01DD04 | Ceftriaxone | Xon® | powder for solution for injection 1 g | RK-LS-5No.004570 |
3096 | J01DD04 | Ceftriaxone | Axon | powder for solution for injection 1 g | RK-LS-5No.016570 |
3097 | J01DD04 | Ceftriaxone | Avikson | powder for solution for injection 1 g | RK-LS-5No.023342 |
3098 | J01DD04 | Ceftriaxone | Ceph III® | powder for solution for injection 1 g | RK-LS-5No.005046 |
3099 | J01DD04 | Ceftriaxone | Ceftriaxone | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.013733 |
3100 | J01DD04 | Ceftriaxone | Ceph III® | powder for solution for injection 250 mg | RK-LS-5No.018287 |
3101 | J01DD04 | Ceftriaxone | Ceph III® | powder for solution for injection 500 mg | RK-LS-5No.018266 |
3102 | J01DD04 | Ceftriaxone | Ceftriaxone | powder for preparation of solution for intravenous and intramuscular injection, 1 g | RK-LS-5No.013713 |
3103 | J01DD04 | Ceftriaxone | Cefamed | powder for preparation of solution for injection complete with solvent (lidocaine hydrochloride, 1% solution for injection), 0.5 g | RK-LS-5No.011043 |
3104 | J01DD04 | Ceftriaxone | Cefamed | powder for preparation of solution for injection complete with solvent (lidocaine hydrochloride, 1% solution for injection), 1 g | RK-LS-5No.011044 |
3105 | J01DD04 | Ceftriaxone | Ceftriaxone | powder for solution for injection 1 g | RK-LS-5No.018227 |
3106 | J01DD04 | Ceftriaxone | CEFTRIAKSON | powder for preparation of solution for intramuscular and intravenous injection 1 g | RK-LS-5No.015506 |
3107 | J01DD04 | Ceftriaxone | Ceftriaxone-KMP | Powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.005007 |
3108 | J01DD04 | Ceftriaxone | Ceftriaxone-BHFZ | powder for solution for injection 1000 mg | RK-LS-5No.019577 |
3109 | J01DD04 | Ceftriaxone | Abitrax | powder for preparation of solution for injection complete with solvent (1% lidocaine hydrochloride solution) 500 mg | RK-LS-5No.021455 |
3110 | J01DD04 | Ceftriaxone | Ceftriaxone | powder for solution for injection 0.5 g | RK-LS-5No.018226 |
3111 | J01DD04 | Ceftriaxone | Ceph III® + Lido | powder for preparation of solution for intramuscular injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 1 g | RK-LS-5No.016778 |
3112 | J01DD04 | Ceftriaxone | ROTATSEF | Powder for preparation of solution for injection complete with solvent (1% lidocaine hydrochloride solution) 1 g | RK-LS-5No.017622 |
3113 | J01DD04 | Ceftriaxone | Kefaxon | powder for preparation of solution for intramuscular injection complete with solvent 1 g | RK-LS-5No.024134 |
3114 | J01DD04 | Ceftriaxone | Atrix | powder for preparation of solution for intramuscular injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 1 g | RK-LS-5No.020715 |
3115 | J01DD04 | Ceftriaxone | Ceftrox ™ | powder for solution for injection 1 g | RK-LS-5No.011331 |
3116 | J01DD04 | Ceftriaxone | Ceftrox ™ | powder for solution for injection complete with solvent (water for injection) 1 g | RK-LS-5No.011317 |
3117 | J01DD04 | Ceftriaxone | Cef III® + Lido Extra | powder for preparation of solution for intramuscular injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 1 g | RK-LS-5No.023869 |
3118 | J01DD04 | Ceftriaxone | Gerocef | powder for solution for injection complete with solvent (water for injection) 1 g | RK-LS-5No.018985 |
3119 | J01DD04 | Ceftriaxone | Triax | powder for preparation of solution for injection complete with solvent (1% solution of lidocaine hydrochloride) 1 g | RK-LS-5No.019008 |
3120 | J01DD04 | Ceftriaxone | Triax | powder for preparation of solution for intramuscular injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 0.5 g | RK-LS-5No.019007 |
3121 | J01DD04 | Ceftriaxone | Medaxon | powder for solution for injections and infusions 1 g | RK-LS-5No.023372 |
3122 | J01DD04 | Ceftriaxone | Zyban | powder for solution for injections and infusions 1 g | RK-LS-5No.018799 |
3123 | J01DD04 | Ceftriaxone | Torocef | powder for solution for injection 1 g | RK-LS-5No.023301 |
3124 | J01DD04 | Ceftriaxone | Rocefin | powder for intramuscular injection complete with solvent (1% lidocaine solution for injection) 1 g | RK-LS-5No.004499 |
3125 | J01DD04 | Ceftriaxone | Rocefin | powder for intramuscular injection complete with solvent (1% lidocaine solution for injection) 500 mg | RK-LS-5No.004504 |
3126 | J01DD04 | Ceftriaxone | Cefazon | powder for solution for injection 1 g | RK-LS-5No.022945 |
3127 | J01DD04 | Ceftriaxone | Zyban | powder for solution for injections and infusions 2 g | RK-LS-5No.022924 |
3128 | J01DD04 | Ceftriaxone | AVEXON-RATIONAL | powder for solution for injection 1 g | RK-LS-5No.022815 |
3129 | J01DD04 | Ceftriaxone | Medaxon | powder for solution for injections and infusions 2 g | RK-LS-5No.022468 |
3130 | J01DD04 | Ceftriaxone | Tro-ceftriax | powder for solution for injection 1000 mg | RK-LS-5No.022438 |
3131 | J01DD04 | Ceftriaxone | Safabel | powder for preparation of solution for intramuscular injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 0.5 g | RK-LS-5No.022244 |
3132 | J01DD04 | Ceftriaxone | Safabel | powder for preparation of solution for intramuscular injection complete with solvent (lidocaine hydrochloride, solution for injection 1%) 1 g | RK-LS-5No.022204 |
3133 | J01DD04 | Ceftriaxone | Cefaxone | powder for solution for injection 1000 mg | RK-LS-5No.015056 |
3134 | J01DD04 | Ceftriaxone | Ceftriaxone Sandoz® | powder for solution for injection 500 mg | RK-LS-5No.021617 |
3135 | J01DD04 | Ceftriaxone | Ceftriaxone Sandoz® | powder for solution for injection 1000 mg | RK-LS-5No.021619 |
3136 | J01DD04 | Ceftriaxone | Ceftriaxone Sandoz® | powder for solution for injection 2000 mg | RK-LS-5No.021618 |
3137 | J01DD04 | Ceftriaxone | Ceftriaxone | Powder for solution for injection, 1000 mg | RK-LS-5No.024434 |
J01DD08 | Cefixime | ||||
3138 | J01DD08 | Cefixime | Taksim-O-Forte | powder for preparation of oral suspension 100 mg/5 ml | RK-LS-5No.019034 |
3139 | J01DD08 | Cefixime | Taksim-O | coated tablets 200 mg | RK-LS-5No.004563 |
3140 | J01DD08 | Cefixime | Cefim | film-coated tablets 200 mg | RK-LS-5No.011016 |
3141 | J01DD08 | Cefixime | Suprax® Solutab | dispersible tablets 400 mg | RK-LS-5No.019835 |
3142 | J01DD08 | Cefixime | Xifia | film-coated tablets 400 mg | RK-LS-5No.021309 |
3143 | J01DD08 | Cefixime | Suprax® | capsules 400 mg | RK-LS-5No.017744 |
3144 | J01DD08 | Cefixime | Avalekson | powder for solution for injection 1 g | RK-LS-5No.024021 |
3145 | J01DD08 | Cefixime | Zimax | powder for suspension preparation 100 mg/5 ml | RK-LS-5No.020708 |
3146 | J01DD08 | Cefixime | Suprax® | granules for preparation of oral suspension 1.46 g | RK-LS-5No.017836 |
3147 | J01DD08 | Cefixime | Xifia | granules for preparation of oral suspension 100 mg/5ml | RK-LS-5No.021397 |
J01DD12 | Cefoperazone | ||||
3148 | J01DD12 | Cefoperazone | Cephobicide | powder for solution for injection 1 g | RK-LS-5No.019632 |
3149 | J01DD12 | Cefoperazone | Medocef | powder for solution for injection 1 g | RK-LS-5No.015058 |
J01DD13 | Cefpodoxime | ||||
3150 | J01DD13 | Cefpodoxime | Sefpotec® | film-coated tablets 200 mg | RK-LS-5No.022135 |
3151 | J01DD13 | Cefpodoxime | Auropodox | Film-coated tablets 200 mg | RK-LS-5No.121870 |
3152 | J01DD13 | Cefpodoxime | Auropodox | Film-coated tablets 100 mg | RK-LS-5No.121869 |
3153 | J01DD13 | Cefpodoxime | Sefpotec® | film-coated tablets 200 mg | RK-LS-5No.014198 |
3154 | J01DD13 | Cefpodoxime | SEFPOTEC® | film-coated tablets 200 mg | RK-LS-5No.014639 |
3155 | J01DD13 | Cefpodoxime | Pesef | film-coated tablets 100 mg | RK-LS-5No.023170 |
3156 | J01DD13 | Cefpodoxime | Pesef | film-coated tablets 200 mg | RK-LS-5No.023173 |
3157 | J01DD13 | Cefpodoxime | SEFSIDAL-sanovel | film-coated tablets 200 mg | RK-LS-5No.023351 |
3158 | J01DD13 | Cefpodoxime | CEFPODO | film-coated tablets 200 mg | RK-LS-5No.023784 |
3159 | J01DD13 | Cefpodoxime | SEFSIDAL-sanovel | Granules for preparation of oral suspension with solvent (purified water), 50mg/5ml | RK-LS-5No.022723 |
3160 | J01DD13 | Cefpodoxime | SEFSIDAL-sanovel | Granules for preparation of oral suspension with solvent (purified water), 100 mg/5 ml | RK-LS-5No.022724 |
3161 | J01DD13 | Cefpodoxime | SEFPOTEC® | Powder for preparation of oral suspension, 100 mg/5 ml | RK-LS-5No.121978 |
3162 | J01DD13 | Cefpodoxime | SEFSIDAL-sanovel | Granules for preparation of oral suspension with solvent (purified water), 50 mg/5 ml | RK-LS-5No.022723 |
3163 | J01DD13 | Cefpodoxime | SEFSIDAL-sanovel | Granules for preparation of oral suspension with solvent (purified water), 100 mg/5 ml | RK-LS-5No.022724 |
J01DD62 | Cefoperazone and beta-lactamase inhibitor | ||||
3164 | J01DD62 | Cefoperazone and beta-lactamase inhibitor | Superceph-Eleas | powder for solution for injection 2 g | RK-LS-3No.019976 |
3165 | J01DD62 | Cefoperazone and beta-lactamase inhibitor | Avizon - C | powder for solution for injection 2 g | RK-LS-5No.023093 |
3166 | J01DD62 | Cefoperazone and beta-lactamase inhibitor | Cefpraz-S | powder for solution for injection 2 g | RK-LS-5No.017659 |
3167 | J01DD62 | Cefoperazone and beta-lactamase inhibitor | Hepacef Combi | powder for solution for injection 2 g | RK-LS-5No.019522 |
3168 | J01DD62 | Cefoperazone and beta-lactamase inhibitor | Cefpraz-S | powder for solution for injection 1 g | RK-LS-5No.017658 |
J01DE | Fourth generation cephalosporins | ||||
J01DE01 | Cefepim | ||||
3169 | J01DE01 | Cefepim | Denipim | powder for solution for injection 1 g | RK-LS-5No.023404 |
3170 | J01DE01 | Cefepim | Cefepim - Eleas | powder for solution for injection 1 g | RK-LS-3No.019977 |
3171 | J01DE01 | Cefepim | Akpim | powder for solution for injection 1 g | RK-LS-5No.016557 |
3172 | J01DE01 | Cefepim | Ceph IV® | powder for solution for injection 1 g | RK-LS-5No.014898 |
3173 | J01DE01 | Cefepim | Megapim | powder for solution for injection 1 g | RK-LS-5No.020780 |
3174 | J01DE01 | Cefepim | Cefepim | powder for solution for injection 1 g | RK-LS-5No.019072 |
3175 | J01DE01 | Cefepim | Cefepim | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.018399 |
3176 | J01DE01 | Cefepim | Ceph IV® | powder for solution for injection 0.5 g | RK-LS-5No.014897 |
3177 | J01DE01 | Cefepim | Cefepim | powder for preparation of solution for intravenous and intramuscular injection 1 g | RK-LS-5No.020006 |
3178 | J01DE01 | Cefepim | Cefepim | powder for solution for injection 1 g | RK-LS-5No.021155 |
3179 | J01DE01 | Cefepim | Cefepim | powder for solution for injection 0.5 g | RK-LS-5No.019071 |
3180 | J01DE01 | Cefepim | Hypeam | powder for solution for injection 1 g | RK-LS-5No.017923 |
3181 | J01DE01 | Cefepim | Infepim | powder for solution for injection 1 g | RK-LS-5No.022958 |
3182 | J01DE01 | Cefepim | Efipim | powder for solution for injection 1 g | RK-LS-5No.004209 |
J01DH | Carbapenems | ||||
J01DH02 | Meropenem | ||||
3183 | J01DH02 | Meropenem | Meropenem - Eleas | powder for solution for injection 1 g | RK-LS-3No.019973 |
3184 | J01DH02 | Meropenem | Plemonem ™ 0.5g | powder for solution for injection 0.5 g | RK-LS-5No.016816 |
3185 | J01DH02 | Meropenem | Plemonem ™ 1g | powder for solution for injection 1 g | RK-LS-5No.016818 |
3186 | J01DH02 | Meropenem | Merobactrin | powder for solution for injection 1 g | RK-LS-5No.018032 |
3187 | J01DH02 | Meropenem | Meropenem | powder for solution for injection 1 g | RK-LS-5No.016486 |
3188 | J01DH02 | Meropenem | Visvopenem | powder for solution for injection 1 g | RK-LS-5No.022705 |
3189 | J01DH02 | Meropenem | Zaxter | powder for solution for injection 1 g | RK-LS-5No.020421 |
3190 | J01DH02 | Meropenem | Izipenem | powder for preparation of solution for intravenous injection 1 g | RK-LS-5No.023596 |
3191 | J01DH02 | Meropenem | Meropenem | powder for solution for injection 0.5 g | RK-LS-5No.016485 |
3192 | J01DH02 | Meropenem | Merogram | powder for solution for injection 500 mg | RK-LS-5No.122093 |
3193 | J01DH02 | Meropenem | Visvopenem | powder for solution for injection 0.5 g | RK-LS-5No.022704 |
3194 | J01DH02 | Meropenem | Meropenem | Lyophilized powder for solution for intravenous injection 500 mg | RK-LS-5No.019348 |
3195 | J01DH02 | Meropenem | Meropenem | Lyophilized powder for preparation of solution for intravenous injection 1000 mg | RK-LS-5No.019349 |
3196 | J01DH02 | Meropenem | Mepenam | powder for solution for injection 1 g | RK-LS-5No.019491 |
3197 | J01DH02 | Meropenem | Merogram | powder for solution for injection 1000 mg | RK-LS-5No.122094 |
3198 | J01DH02 | Meropenem | Meronem® | lyophilisate for preparation of solution for intravenous injection 0.5 g | RK-LS-5No.017668 |
3199 | J01DH02 | Meropenem | Archimax | powder for preparation of solution for injection and infusion 500 mg | RK-LS-5No.121699 |
3200 | J01DH02 | Meropenem | Meronem® | lyophilisate for preparation of solution for intravenous injection 1 g | RK-LS-5No.017669 |
3201 | J01DH02 | Meropenem | Archimax | powder for solution for injection and infusion 1000 mg | RK-LS-5No.121700 |
3202 | J01DH02 | Meropenem | Vizmero | powder for preparation of solution for injection and infusion 500 mg | RK-LS-5No.121923 |
3203 | J01DH02 | Meropenem | Vizmero | powder for preparation of solution for injections and infusions 100 mg | RK-LS-5No.121924 |
3204 | J01DH02 | Meropenem | Vegapenem | powder for preparation of solution for injection or infusion 500 mg | RK-LS-5No.023458 |
3205 | J01DH02 | Meropenem | Vegapenem | powder for solution for injection or infusion 1000 mg | RK-LS-5No.023459 |
3206 | J01DH02 | Meropenem | Meropenem | powder for preparation of solution for intravenous injection 1 g | RK-LS-5No.024367 |
J01DH03 | Ertapenem | ||||
3207 | J01DH03 | Ertapenem | Ertapik | lyophilized powder for preparation of solution for infusion 1 g | RK-LS-5No.023619 |
3208 | J01DH03 | Ertapenem | Ertapenem-Eleas | lyophilisate for preparation of solution for injection, 1 g | RK-LS-5No.022303 |
3209 | J01DH03 | Ertapenem | Inwanz | lyophilisate for preparation of solution for intravenous injection 1 g | RK-LS-5No.014787 |
3210 | J01DH03 | Ertapenem | Invacar | lyophilized powder for preparation of solution for infusion 1 g | RK-LS-5No.023526 |
J01DH04 | Doripenem | ||||
3211 | J01DH04 | Doripenem | Doripenem - Eleas | powder for preparation of solution for infusion 500 mg | RK-LS-3No.019979 |
3212 | J01DH04 | Doripenem | Doriprex® | powder for preparation of solution for infusion 500 mg | RK-LS-5No.013552 |
3213 | J01DH04 | Doripenem | Dapar | powder for preparation of solution for infusion 500 mg | RK-LS-5No.022758 |
3214 | J01DH04 | Doripenem | Dapar | powder for solution for infusion 250 mg | RK-LS-5No.022759 |
3215 | J01DH04 | Doripenem | DORIPUR 500 | powder for preparation of solution for infusion 500 mg | RK-LS-5No.023928 |
J01DH51 | Imipenem with cilastatin | ||||
3216 | J01DH51 | Imipenem with cilastatin | Imicil - Eleas | powder for preparation of solution for infusion 500 mg/500 mg | RK-LS-3No.019980 |
3217 | J01DH51 | Imipenem with cilastatin | Imipenem + Cilastatin | powder for preparation of solution for intravenous injection 500 mg/500 mg | RK-LS-5No.010367 |
3218 | J01DH51 | Imipenem with cilastatin | Tsilapenem | powder for preparation of solution for infusion 0.5g/0.5g | RK-LS-5No.019130 |
3219 | J01DH51 | Imipenem with cilastatin | Piminam | powder for solution for injection 500 mg/500 mg | RK-LS-5No.018638 |
3220 | J01DH51 | Imipenem with cilastatin | Tsilapenem | powder for solution for infusion 0.25 g/0.25 g | RK-LS-5No.019129 |
3221 | J01DH51 | Imipenem with cilastatin | Aquapen-I | powder for solution for injection 500 mg + 500 mg | RK-LS-5No.023790 |
3222 | J01DH51 | Imipenem with cilastatin | INEMPLUS 500 | powder for preparation of solution for infusion 500 mg/500 mg | RK-LS-5No.023931 |
J01DI02 | Ceftaroline fosamil | ||||
3223 | J01DI02 | Ceftaroline fosamil | Zinforo® | powder for preparation of solution for infusion 600 mg | RK-LS-5No.021294 |
J01E | Sulfonamides and trimethoprim | ||||
J01EE | Sulfonamides in combination with trimethoprim, including derivatives | ||||
J01EE01 | Sulfamethoxazole and Trimethoprim | ||||
3224 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptol | tablets 120 mg | RK-LS-5No.014518 |
3225 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptol | tablets 480 mg | RK-LS-5No.014517 |
3226 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptol | oral suspension 240 mg/5 ml | RK-LS-5No.004653 |
3227 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptol 480 | concentrate for preparation of solution for infusion (80mg + 16mg)/ml, 5 ml | RK-LS-5No.015903 |
3228 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptrim® | oral suspension 120 mg/5 ml | RK-LS-5No.003932 |
3229 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptrim | tablets 480 mg | RK-LS-5No.010960 |
3230 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptrim | tablets 0.4 g/0.08 g | RK-LS-5No.023431 |
3231 | J01EE01 | Sulfamethoxazole and Trimethoprim | Co-trimoxazole Sobhan | tablets 400/80 mg | RK-LS-5No.122147 |
3232 | J01EE01 | Sulfamethoxazole and Trimethoprim | Biseptol | tablets 960 mg | RK-LS-5No.121690 |
J01F | Macrolides and lincosamides | ||||
J01FA | Macrolides | ||||
J01FA02 | Spiramycin | ||||
3233 | J01FA02 | Spiramycin | Spramax | Film-coated tablets 3 million IU | RK-LS-5No.021125 |
3234 | J01FA02 | Spiramycin | Doramycin | film-coated tablets, 3 million IU | RK-LS-5No.018034 |
3235 | J01FA02 | Spiramycin | Macromycin 3.0 million IU | coated tablets 3 million IU | RK-LS-5No.014193 |
3236 | J01FA02 | Spiramycin | Spramax | film-coated tablets 1.5 IU | RK-LS-5No.021124 |
3237 | J01FA02 | Spiramycin | Spiracin | film-coated tablets 1.5 million IU | RK-LS-5No.022797 |
3238 | J01FA02 | Spiramycin | Spiracin | film-coated tablets 3 million IU | RK-LS-5No.022798 |
3239 | J01FA02 | Spiramycin | Spyrex | film-coated tablets 3 million IU | RK-LS-5No.000590 |
3240 | J01FA02 | Spiramycin | Rovamycin® | film-coated tablets 1.5 million IU | RK-LS-5No.012146 |
3241 | J01FA02 | Spiramycin | Rovamycin® | film-coated tablets 3 million IU | RK-LS-5No.012147 |
J01FA01 | Erythromycin |
3242 | J01FA01 | Erythromycin | Erythromycin | enteric coated tablets 250 mg | RK-LS-5No 010098 |
3243 | J01FA01 | Erythromycin | Erythromycin | enteric coated tablets 100 mg | RK-LS-5No 010097 |
3244 | J01FA01 | Erythromycin |
Tarmycin | enteric coated tablets 200 mg | RK-LS-5No 013679 |
3245 | J01FA01 | Erythromycin | Erythromycin | enteric coated tablets 250 mg | RK-LS-5No 003555 |
3246 | J01FA01 | Erythromycin | Erythromycin | Lyophilisate for preparation of solution for intravenous administration, 100 mg | RK-LS-5No 015911 |
J01FA03 |
Midecamycin | ||||
3247 | J01FA03 |
Midecamycin |
Macropen |
granules for preparation of oral suspension 175 mg / 5 ml | RK-LS-5No 003625 |
3248 | J01FA03 |
Midecamycin |
Macropen | film-coated tablets 400 mg | RK-LS-5No 003624 |
J01FA06 | Roxithromycin |
3249 | J01FA06 | Roxithromycin | Roxybel® | 150 mg film coated tablets | RK-LS-5No.004574 |
3250 | J01FA06 | Roxithromycin | Roxithromycin Sandoz® | 150 mg film coated tablets | RK-LS-5No.015769 |
J01FA09 | Clarithromycin | ||||
3251 | J01FA09 | Clarithromycin | Klacid® В.В | 500 mg lyophilized powder for solution for infusion | RK-LS-5No.014631 |
3252 | J01FA09 | Clarithromycin | Klacid® | 500 mg coated tablets | RK-LS-5No.022668 |
3253 | J01FA09 | Clarithromycin | Maxilin | 500 mg lyophilized powder for solution for infusion | RK-LS-5No.023184 |
3254 | J01FA09 | Clarithromycin | Tomiklar | 500 mg film coated tablets | RK-LS-5No.021425 |
3255 | J01FA09 | Clarithromycin | Clariget | 500 mg film coated tablets | RK-LS-5No.014736 |
3256 | J01FA09 | Clarithromycin | Clabel® 500 | 500 mg film coated tablets | RK-LS-5No.010792 |
3257 | J01FA09 | Clarithromycin | Tomiklar | 250 mg film coated tablets | RK-LS-5No.021424 |
3258 | J01FA09 | Clarithromycin | Clariget | 250 mg film coated tablets | RK-LS-5No.014735 |
3259 | J01FA09 | Clarithromycin | Clariget XL |
500 mg prolonged-release, film coated tablets | RK-LS-5No.017724 |
3260 | J01FA09 | Clarithromycin | Clabel® 250 | 250 mg film coated tablets | RK-LS-5No.018468 |
3261 | J01FA09 | Clarithromycin | CLARITRO | 500 mg lyophilized powder for solution for infusion | RK-LS-5No.023956 |
3262 | J01FA09 | Clarithromycin | SR-Claren | 500 mg prolonged-release, film coated tablets | RK-LS-5No.019639 |
3263 | J01FA09 | Clarithromycin | Claranta 500 | 500 mg coated tablets | RK-LS-5No.020899 |
3264 | J01FA09 | Clarithromycin | Fromilid® | 500 mg film coated tablets | RK-LS-5No.009682 |
3265 | J01FA09 | Clarithromycin | Claranta 250 | 250 mg coated tablets | RK-LS-5No.020898 |
3266 | J01FA09 | Clarithromycin | Clarithromycin | 250 mg coated tablets | RK-LS-5No.021594 |
3267 | J01FA09 | Clarithromycin | MERISTAT MR-Sanovel | 500 mg modified-release film coated tablets | RK-LS-5No.017069 |
3268 | J01FA09 | Clarithromycin | Klerimed | 250 mg film coated tablets | RK-LS-5No.019036 |
3269 | J01FA09 | Clarithromycin | Klerimed | 500 mg film coated tablets | RK-LS-5No.019037 |
3270 | J01FA09 | Clarithromycin | MERISTAT - Sanovel 250 | 250 mg coated tablets | RK-LS-5No.010261 |
3271 | J01FA09 | Clarithromycin | Fromilid® | 250 mg film coated tablets | RK-LS-5No.009681 |
3272 | J01FA09 | Clarithromycin | Fromilid® Uno | 500 mg prolonged-release, film coated tablets | RK-LS-5No.005000 |
3273 | J01FA09 | Clarithromycin | Klabax | 500 mg film coated tablets | RK-LS-5No.014679 |
3274 | J01FA09 | Clarithromycin | Klabax OD | 500 mg prolonged-release, film coated tablets | RK-LS-5No.021308 |
3275 | J01FA09 | Clarithromycin | Diklaran | 500 mg film coated tablets | RK-LS-5No.019073 |
3276 | J01FA09 | Clarithromycin | Klabax | 250 mg film coated tablets | RK-LS-5No.014678 |
3277 | J01FA09 | Clarithromycin | Ecozitrin® | 500 mg film coated tablets | RK-LS-5No.018548 |
3278 | J01FA09 | Clarithromycin | Novolid | 500 mg film coated tablets | RK-LS-5No.021304 |
3279 | J01FA09 | Clarithromycin | Ecozitrin® | 250 mg film coated tablets | RK-LS-5No.018547 |
3280 | J01FA09 | Clarithromycin | MERISTAT - Sanovel 125 | 125 mg/5 ml granules and solvent (purified water) for oral suspension | RK-LS-5No.010213 |
3281 | J01FA09 | Clarithromycin | MERISTAT - Sanovel 250 | 250 mg/5 ml granules and solvent (purified water) for oral suspension | RK-LS-5No.010214 |
3282 | J01FA09 | Clarithromycin | Fromilid® | 125 mg/5 ml granules for oral suspension | RK-LS-5No.016484 |
3283 | J01FA09 | Clarithromycin | Klacid® | 250 mg/5 ml granules for oral suspension | RK-LS-5No.016564 |
3284 | J01FA09 | Clarithromycin | Klacid® | 125 mg/5 ml granules for suspension | RK-LS-5No.016562 |
3285 | J01FA09 | Clarithromycin | Clariget | 125 mg/5 ml orange flavor granules for suspension | RK-LS-5No.014734 |
3286 | J01FA09 | Clarithromycin | Klacid® | 250 mg/5 ml granules for suspension | RK-LS-5No.016564 |
3287 | J01FA09 | Clarithromycin | Klacid® | 125 mg/5 ml granules for suspension | RK-LS-5No.016562 |
J01FA10 | Azithromycin | ||||
3288 | J01FA10 | Azithromycin | Zithrotel | 500 mg lyophilized powder for solution for infusion | RK-LS-5No.023279 |
3289 | J01FA10 | Azithromycin | Sumamed® Forte | 200 mg/5 ml, 37.5 ml powder for oral suspension | RK-LS-5No.003533 |
3290 | J01FA10 | Azithromycin | Ziromin | 200 mg/5 ml, 60 ml powder for oral suspension | RK-LS-5No.023401 |
3291 | J01FA10 | Azithromycin | Ziromin | 500 mg lyophilized powder for solution for infusion | RK-LS-5No.023868 |
3292 | J01FA10 | Azithromycin | ZITMAK® 100 | 100 mg/5 ml, 20 ml powder for oral suspension | RK-LS-5No.019119 |
3293 | J01FA10 | Azithromycin | ZITMAK® 200 | 200 mg/5 ml, 30 ml powder for oral suspension | RK-LS-5No.019120 |
3294 | J01FA10 | Azithromycin | ZITMAK® 200 | 200 mg/5 ml, 15 ml powder for oral suspension | RK-LS-5No.019120 |
3295 | J01FA10 | Azithromycin | Zitmak® 500 | 500 mg film coated tablets | RK-LS-5No.014990 |
3296 | J01FA10 | Azithromycin | Jasmed | 500 mg film coated tablets | RK-LS-5No.021509 |
3297 | J01FA10 | Azithromycin | Jasmed | 200 mg/5 ml, 15 ml powder for oral suspension | RK-LS-5No.022954 |
3298 | J01FA10 | Azithromycin | Aratro | 200 mg/5 ml powder for oral suspension | RK-LS-5No.020837 |
3299 | J01FA10 | Azithromycin | AzitRus® |
50 mg powder for oral suspension | RK-LS-5No.020849 |
3300 | J01FA10 | Azithromycin | AzitRus® | 100 mg powder for oral suspension | RK-LS-5No.020850 |
3301 | J01FA10 | Azithromycin | AzitRus® | 200 mg powder for oral suspension | RK-LS-5No.020851 |
3302 | J01FA10 | Azithromycin | Ecomed® | 100 mg/5 ml powder for oral suspension | RK-LS-5No.022718 |
3303 | J01FA10 | Azithromycin | Ecomed® | 200 mg/5 ml powder for oral suspension | RK-LS-5No.022719 |
3304 | J01FA10 | Azithromycin | Zetron | 200 mg/5 ml powder for oral suspension (complete with solvent - purified water) | RK-LS-5No.016822 |
3305 | J01FA10 | Azithromycin | Zitmak® 250 | 250 mg film coated tablets | RK-LS-5No.016449 |
3306 | J01FA10 | Azithromycin | Zitmak® 125 | 125 mg film coated tablets | RK-LS-5No.016450 |
3307 | J01FA10 | Azithromycin | Ziromin | 500 mg coated tablets | RK-LS-5No.016605 |
3308 | J01FA10 | Azithromycin | Azithromycin Sandoz® | 100 mg/5 ml powder for oral suspension | RK-LS-5No.021405 |
3309 | J01FA10 | Azithromycin | Sumamed® | 100 mg/5 ml powder for oral suspension | RK-LS-5No.003550 |
3310 | J01FA10 | Azithromycin | Azithromycin Sandoz® | 200 mg/5 ml powder for oral suspension | RK-LS-5No.021394 |
3311 | J01FA10 | Azithromycin | Sumamed® Forte | 200 mg/5 ml powder for oral suspension | RK-LS-5No.003531 |
3312 | J01FA10 | Azithromycin | Sumamed® Forte | 200 mg/5 ml for volume of 15 ml powder, granules for oral suspension | RK-LS-5No.003532 |
3313 | J01FA10 | Azithromycin | Sumamed | 500 mg lyophilized powder for solution for intravenous infusion | RK-LS-5No.001369 |
3314 | J01FA10 | Azithromycin | Sumamed | 125 mg film coated tablets | RK-LS-5No.002330 |
3315 | J01FA10 | Azithromycin | Sumamed® | 250 mg dispersible tablets | RK-LS-5No.023847 |
3316 | J01FA10 | Azithromycin | Sumamed® | 1000 mg dispersible tablets | RK-LS-5No.023849 |
3317 | J01FA10 | Azithromycin | Zitrox 250 | 250 mg film coated tablets | RK-LS-5No.003616 |
3318 | J01FA10 | Azithromycin | Azibiot® | 500 mg film coated tablets | RK-LS-5No.020853 |
3319 | J01FA10 | Azithromycin | AZIFEX | 500 mg film coated tablets | RK-LS-5No.022147 |
3320 | J01FA10 | Azithromycin | AZIFEX | 250 mg film coated tablets | RK-LS-5No.022148 |
3321 | J01FA10 | Azithromycin | AZO 250 | 250 mg film coated tablets | RK-LS-5No.022234 |
3322 | J01FA10 | Azithromycin | AZO 500 | 500 mg film coated tablets | RK-LS-5No.022242 |
3323 | J01FA10 | Azithromycin | Zyomicin® | 250 mg film coated tablets | RK-LS-5No.018475 |
3324 | J01FA10 | Azithromycin | Zyomicin® | 500 mg film coated tablets | RK-LS-5No.018476 |
3325 | J01FA10 | Azithromycin | Azithromycin | 500 mg film coated tablets | RK-LS-5No.022866 |
3326 | J01FA10 | Azithromycin | V – Azithromycin | 500 mg film coated tablets | RK-LS-5No.023077 |
3327 | J01FA10 | Azithromycin | Azitremis | 500 mg film coated tablets | RK-LS-5No.023299 |
3328 | J01FA10 | Azithromycin | Azitremis | 250 mg film coated tablets | RK-LS-5No.023323 |
3329 | J01FA10 | Azithromycin | Sumamox | 500 mg coated tablets | RK-LS-5No.018974 |
3330 | J01FA10 | Azithromycin | Azibiot® | 100 mg/5 ml powder for oral suspension | RK-LS-5No.023643 |
3331 | J01FA10 | Azithromycin | Azibiot® | 200 mg/5 ml powder for oral suspension | RK-LS-5No.023645 |
3332 | J01FA10 | Azithromycin | Zaha 500 | 500 mg film coated tablets | RK-LS-5No.023721 |
3333 | J01FA10 | Azithromycin | Azitrosize | 500 mg film coated tablets | RK-LS-5No.023830 |
3334 | J01FA10 | Azithromycin | Zinfect | 500 mg film coated tablets | RK-LS-5No.024074 |
3335 | J01FA10 | Azithromycin | Azithromycin Sandoz® | 250 mg film coated tablets | RK-LS-5No.013515 |
3336 | J01FA10 | Azithromycin | Azimed® | 500 mg film coated tablets | RK-LS-5No.018823 |
3337 | J01FA10 | Azithromycin | Azitro® | 500 mg coated tablets | RK-LS-5No.018529 |
3338 | J01FA10 | Azithromycin | Azitrovid | 500 mg film coated tablets | RK-LS-5No.020222 |
3339 | J01FA10 | Azithromycin | AzitRus® Forte | 500 mg film coated tablets | RK-LS-5No.018315 |
3340 | J01FA10 | Azithromycin | Zithrox 500 | 500 mg film coated tablets | RK-LS-5No.003617 |
3341 | J01FA10 | Azithromycin | Sumamed® | 500 mg film coated tablets | RK-LS-5No.013198 |
3342 | J01FA10 | Azithromycin | Azimak | 500 mg capsules | RK-LS-5No.016668 |
3343 | J01FA10 | Azithromycin | Azimak | 250 mg capsules | RK-LS-5No.016666 |
3344 | J01FA10 | Azithromycin | Azicin |
250 mg film coated tablets | RK-LS-5No.021347 |
3345 | J01FA10 | Azithromycin | Azithromycin Sandoz® | 500 mg film coated tablets | RK-LS-5No.013516 |
3346 | J01FA10 | Azithromycin | Azicin | 500 mg film coated tablets | RK-LS-5No.021346 |
3347 | J01FA10 | Azithromycin | Azitro® | 250 mg capsules | RK-LS-5No.005224 |
3348 | J01FA10 | Azithromycin | Azitrox | 500 mg capsules | RK-LS-5No.018350 |
3349 | J01FA10 | Azithromycin | AzitRus® | 250 mg capsules | RK-LS-5No.015516 |
3350 | J01FA10 | Azithromycin | Azithromycin | 250 mg capsules | RK-LS-5No.013867 |
3351 | J01FA10 | Azithromycin | Azithromed | 250 mg capsules | RK-LS-5No.014012 |
3352 | J01FA10 | Azithromycin | Zetron | 250 mg capsules | RK-LS-5No.017145 |
3353 | J01FA10 | Azithromycin | Azitrox | 250 mg capsules | RK-LS-5No.018349 |
3354 | J01FA10 | Azithromycin | Azithromycin | 250 mg capsules | RK-LS-5No.019293 |
3355 | J01FA10 | Azithromycin | Sumamed® | 250 mg capsules | RK-LS-5No.013197 |
3356 | J01FA10 | Azithromycin | Zitrolid® Forte | 500 mg capsules | RK-LS-5No.005305 |
3357 | J01FA10 | Azithromycin | Zomax | 500 mg film coated tablets | RK-LS-5No.016657 |
3358 | J01FA10 | Azithromycin | Sumamed® | 500 mg dispersible tablets | RK-LS-5No.023848 |
3359 | J01FA10 | Azithromycin | Sumamox | 100 mg/5 ml granules for oral suspension | RK-LS-5No.021399 |
3360 | J01FA10 | Azithromycin | Sumamox | 200 mg/5 ml granules for oral suspension | RK-LS-5No.021400 |
J01FF | Lincosamides | ||||
J01FF01 | Clindamycin | ||||
3361 | J01FF01 | Clindamycin | Dalacin® | 150 mg capsules | RK-LS-5No.015896 |
3362 | J01FF01 | Clindamycin | Dalacin® | 300 mg capsules | RK-LS-5No.015897 |
3363 | J01FF01 | Clindamycin | Dalacin® C Phosphate | 300 mg/2 ml solution for injection | RK-LS-5No.015912 |
3364 | J01FF01 | Clindamycin | Dalacin® C Phosphate |
600 mg/4 ml solution for injection | RK-LS-5No.015913 |
3365 | J01FF01 | Clindamycin | Cedd | 300 mg capsules | RK-LS-5No.022403 |
3366 | J01FF01 | Clindamycin | Cedd | 600 mg capsules | RK-LS-5No.022404 |
J01FF02 | Lincomycin | ||||
3367 | J01FF02 | Lincomycin | Lincomycin hydrochloride | 30% 1 ml solution for injection | RK-LS-5No.000107 |
3368 | J01FF02 | Lincomycin | LINCOMYCIN | 300 mg/ml 1 ml solution for intravenous and intramuscular induction | RK-LS-5No.019356 |
3369 | J01FF02 | Lincomycin | Lincomycin hydrochloride | 30% 2 ml solution for injection | RK-LS-5No.000107 |
3370 | J01FF02 | Lincomycin | Lincomycin | 250 mg capsules | RK-LS-5No.018014 |
J01G | Aminoglycosides | ||||
J01GA | Streptomycins | ||||
J01GA01 | Streptomycin | ||||
3371 | J01GA01 | Streptomycin | Streptomycin | 1 g powder for solution for intramuscular induction | RK-LS-5No.014833 |
3372 | J01GA01 | Streptomycin | Streptomycin sulfate | 1 gram powder for solution for injection | RK-LS-5No.023939 |
J01GB | Other aminoglycosides | ||||
J01GB01 | Tobramycin | orphan | |||
3373 | J01GB01 | Tobramycin | Tobi® Podhaler® | 28 mg powder for inhalation in capsules | RK-LS-5No.122055 |
J01GB03 | Gentamicin | ||||
3374 | J01GB03 | Gentamicin | Gentamicin sulfate | 4%, 2 ml solution for injection | RK-LS-5No.015746 |
3375 | J01GB03 | Gentamicin | Gentamicin sulfate | 4%, 2 ml solution for injection | RK-LS-5No.015089 |
J01GB04 | Kanamycin | ||||
3376 | J01GB04 | Kanamycin | Kanamycin sulfate | 1 gram powder for solution for injection | RK-LS-5No.018013 |
J01GB06 | Amikacin | ||||
3377 | J01GB06 | Amikacin | Mercacin | 100 mg/2 ml, 2 ml solution for injection | RK-LS-5No.122053 |
3378 | J01GB06 | Amikacin | Amikacin | 500 mg powder for solution for injection | RK-LS-3No.021481 |
3379 | J01GB06 | Amikacin | Mercacin | 500 mg/2 ml solution for injection | RK-LS-5No.122054 |
3380 | J01GB06 | Amikacin | Amikacin | powder for solution for injection 500 mg | RK-LS-5No.009227 |
3381 | J01GB06 | Amikacin | Selemycin | 500mg/2ml 2 ml solution for injection and infusion | RK-LS-5No.024487 |
J01M | Antibacterial drugs - quinolone derivatives | ||||
J01MA | Fluoroquinolones | ||||
J01MA01 | Ofloxacin | ||||
3382 | J01MA01 | Ofloxacin | Ofloxacin | 2 mg/ml 100 ml solution for infusion | RK-LS-3No.021326 |
3383 | J01MA01 | Ofloxacin | Rofloxan | solution for infusion 2 mg/ml 100 ml | RK-LS-5No.023406 |
3384 | J01MA01 | Ofloxacin | Ofloxacin | solution for infusion 2 mg/ml 100 ml | RK-LS-5No.022352 |
3385 | J01MA01 | Ofloxacin | Ofloxa® | 400 mg coated tablets | RK-LS-5No.015492 |
3386 | J01MA01 | Ofloxacin | Ionofol | 200 mg film coated tablets | RK-LS-5No.018995 |
3387 | J01MA01 | Ofloxacin | Oflomac-200 | 200 mg film coated tablets | RK-LS-5No.024213 |
3388 | J01MA01 | Ofloxacin | Ofloxa® | 200 mg coated tablets | RK-LS-5No.004047 |
3389 | J01MA01 | Ofloxacin | Oflo® | 2 mg/ml, 100 ml solution for infusion | RK-LS-5No.012890 |
3390 | J01MA01 | Ofloxacin | Flociprin | 200 mg film coated tablets200 mg film coated tablets | RK-LS-5No.121908 |
3391 | J01MA01 | Ofloxacin | Flociprin | 400 mg film coated tablets | RK-LS-5No.121909 |
3392 | J01MA01 | Ofloxacin | Rofloxan | 200 mg tablets | RK-LS-5No.017603 |
J01MA02 | Ciprofloxacin | ||||
3393 | J01MA02 | Ciprofloxacin | Ciprox | 0.2%, 100 ml solution for infusion | RK-LS-5No.001822 |
3394 | J01MA02 | Ciprofloxacin | Ciprofloxacin | 0.2%, 100 ml solution for infusion | RK-LS-3No.021327 |
3395 | J01MA02 | Ciprofloxacin | Cifran | 200mg/100ml solution for infusion | RK-LS-5No.015572 |
3396 | J01MA02 | Ciprofloxacin | Sanflox® | 200 mg/100 ml, 100 ml solution for infusion | RK-LS-5No.022626 |
3397 | J01MA02 |
Ciprofloxacin | SISPRES® 750 | 750 mg film coated tablets | RK-LS-3No.019666 |
3398 | J01MA02 | Ciprofloxacin | Ciprofloxacin | 500 mg coated tablets | RK-LS-5No.023448 |
3399 | J01MA02 | Ciprofloxacin | CIPROFLOXACIN | 250 mg coated tablets | RK-LS-5No.013775 |
3400 | J01MA02 | Ciprofloxacin | CIPROFLOXACIN | 500 mg coated tablets | RK-LS-5No.013776 |
3401 | J01MA02 | Ciprofloxacin | Ciprofloxacin Ecociphol® | 250 mg film coated tablets | RK-LS-5No.018993 |
3402 | J01MA02 | Ciprofloxacin | Ciprofloxacin Ecociphol® | 500 mg film coated tablets | RK-LS-5No.018994 |
3403 | J01MA02 | Ciprofloxacin | Cifloxinal® | 250 mg coated tablets | RK-LS-5No.012630 |
3404 | J01MA02 | Ciprofloxacin | Cifloxinal® | 500 mg coated tablets | RK-LS-5No.020788 |
3405 | J01MA02 | Ciprofloxacin | Ciproxa | 500 mg coated tablets | RK-LS-5No.015767 |
3406 | J01MA02 | Ciprofloxacin | Sispres® 500 | 500 mg film coated tablets | RK-LS-5No.011434 |
3407 | J01MA02 | Ciprofloxacin | Ciprofloxacin | 250 mg coated tablets | RK-LS-5No.023447 |
3408 | J01MA02 | Ciprofloxacin | Sispres® 250 | 250 mg film coated tablets | RK-LS-5No.011433 |
3409 | J01MA02 | Ciprofloxacin | V – Ciprofloxacin | 500 mg film coated tablets | RK-LS-5No.023076 |
3410 | J01MA02 | Ciprofloxacin | Ceflox-500 | 500 mg film coated tablets | RK-LS-5No.003435 |
3411 | J01MA02 | Ciprofloxacin | Sifloks | 500 mg coated tablets | RK-LS-5No.010759 |
3412 | J01MA02 | Ciprofloxacin | Ciprinol® | 100 mg/10 ml, 10 ml concentrate for solution for infusion | RK-LS-5No.009251 |
3413 | J01MA02 | Ciprofloxacin | Ciprolet | 200 mg/100 ml, 100 ml solution for infusion | RK-LS-5No.016609 |
3414 | J01MA02 | Ciprofloxacin | Ificipro | 2 mg/ ml,100 ml solution for infusion | RK-LS-5No.016547 |
3415 | J01MA02 | Ciprofloxacin | Ciproxa | 250 mg coated tablets | RK-LS-5No.015768 |
3416 | J01MA02 | Ciprofloxacin | Ciprolet® | 250 mg coated tablets | RK-LS-5No.016507 |
3417 | J01MA02 | Ciprofloxacin | Forcip | 500 mg film coated tablets | RK-LS-5No.021377 |
3418 | J01MA02 | Ciprofloxacin | Ciprolet® | 500 mg coated tablets | RK-LS-5No.016508 |
3419 | J01MA02 | Ciprofloxacin | Cifran | 500 mg film coated tablets | RK-LS-5No.021197 |
3420 | J01MA02 | Ciprofloxacin | Cifran OD | 1000 mg prolonged-release, film coated tablets | RK-LS-5No.016313 |
3421 | J01MA02 | Ciprofloxacin | Cifran OD | 500 mg prolonged-release, film coated tablets | RK-LS-5No.022713 |
3422 | J01MA02 | Ciprofloxacin | Cifran OD | 1000 mg prolonged-release, film coated tablets | RK-LS-5No.022714 |
3423 | J01MA02 | Ciprofloxacin | Flaprox | 500 mg film coated tablets | RK-LS-5No.019733 |
3424 | J01MA02 | Ciprofloxacin | Ificipro | 250 mg film coated tablets | RK-LS-5No.015830 |
3425 | J01MA02 | Ciprofloxacin | Ificipro | 500 mg film coated tablets | RK-LS-5No.015831 |
J01MA06 | Norfloxacin | ||||
3426 | J01MA06 | Norfloxacin | Norbactin | 400 mg film coated tablets | RK-LS-5No.003429 |
3427 | J01MA06 | Norfloxacin | Nolicin® | 400 mg film coated tablets | RK-LS-5No.015621 |
J01MA12 | Levofloxacin | ||||
3428 | J01MA12 | Levofloxacin | Levoximed | 500 mg/100 ml solution for intravenous infusion | RK-LS-5No.022208 |
3429 | J01MA12 | Levofloxacin | Levozin | 500 mg/100 ml solution for infusion | RK-LS-5No.022142 |
3430 | J01MA12 | Levofloxacin | Levoflox | 5 mg/ ml,100 ml solution for infusion | RK-LS-5No.022538 |
3431 | J01MA12 | Levofloxacin | Levaxela® | 5 mg/ ml,100 ml solution for infusion | RK-LS-5No.022765 |
3432 | J01MA12 | Levofloxacin | Levocin-N | 500 mg/100 ml solution for infusion | RK-LS-5No.022374 |
3433 | J01MA12 | Levofloxacin | TIGERON® | 500 mg/100 ml solution for infusion | RK-LS-5No.023052 |
3434 | J01MA12 | Levofloxacin | Leflock-Darnitsa | 0.5%, 100 ml solution for infusion | RK-LS-5No.023494 |
3435 | J01MA12 | Levofloxacin | Primaflox | 500 mg/100 ml solution for infusion | RK-LS-5No.023565 |
3436 | J01MA12 | Levofloxacin | Florox-L | 5 mg/ ml,100 ml solution for infusion | RK-LS-5No.018987 |
3437 | J01MA12 | Levofloxacin | Levocin | 5 mg/ ml,100 ml solution for infusion | RK-LS-5No.018702 |
3438 | J01MA12 | Levofloxacin | Levofloxacin | 5 mg/ ml,100 ml solution for infusion | RK-LS-3No.021341 |
3439 | J01MA12 | Levofloxacin | Levofloxacin | 5 mg/ ml,100 ml solution for infusion | RK-LS-5No.022353 |
3440 | J01MA12 | Levofloxacin | Levofloxacin | 3 mg/ ml,100 ml solution for infusion | RK-LS-3No.021340 |
3441 | J01MA12 | Levofloxacin | Levofloxacin | 2 mg/ ml,100 ml solution for infusion | RK-LS-3No.021339 |
3442 | J01MA12 | Levofloxacin | LEVOZIN 750 | 750 mg film coated tablets | RK-LS-5No.014993 |
3443 | J01MA12 | Levofloxacin | Levoximed | 500 mg film coated tablets | RK-LS-5No.023068 |
3444 | J01MA12 | Levofloxacin | OD-Levox | 500 mg film coated tablets | RK-LS-5No.019272 |
3445 | J01MA12 | Levofloxacin | Levocin | 500 mg film coated tablets | RK-LS-5No.014724 |
3446 | J01MA12 | Levofloxacin | LEVOZIN 500 | 500 mg film coated tablets | RK-LS-5No.014992 |
3447 | J01MA12 | Levofloxacin | LEVOZIN 250 | 250 mg film coated tablets | RK-LS-5No.014991 |
3448 | J01MA12 | Levofloxacin | Levolet | 500 mg/100 ml solution for infusion | RK-LS-5No.017575 |
3449 | J01MA12 | Levofloxacin | Levomac IV | 500 mg/100 ml solution for intravenous infusion | RK-LS-5No.011851 |
3450 | J01MA12 | Levofloxacin | Levofloxacin | 5 mg/ml, 100 ml solution for infusion | RK-LS-5No.019576 |
3451 | J01MA12 | Levofloxacin | Levolet | 250 mg coated tablets | RK-LS-5No.016574 |
3452 | J01MA12 | Levofloxacin | Levofloxacin | 250 mg coated tablets | RK-LS-5No.009948 |
3453 | J01MA12 | Levofloxacin | Alevo | 500 mg film coated tablets | RK-LS-5No.019705 |
3454 | J01MA12 | Levofloxacin | levotor | 500 mg film coated tablets | RK-LS-5No.020998 |
3455 | J01MA12 | Levofloxacin | Glevo 250 | 250 mg film coated tablets | RK-LS-5No.014436 |
3456 | J01MA12 | Levofloxacin | Glevo 500 | 500 mg film coated tablets | RK-LS-5No.014437 |
3457 | J01MA12 | Levofloxacin | Devilon | 500 mg film coated tablets | RK-LS-5No.021317 |
3458 | J01MA12 | Levofloxacin | TIGERON® | 750 mg film coated tablets | RK-LS-5No.122024 |
3459 | J01MA12 | Levofloxacin | TIGERON® | 500 mg film coated tablets | RK-LS-5No.122025 |
3460 | J01MA12 | Levofloxacin | Tavanic | 250 mg film coated tablets | RK-LS-5No.016664 |
3461 | J01MA12 | Levofloxacin | Tavanic | 500 mg film coated tablets | RK-LS-5No.016665 |
3462 | J01MA12 | Levofloxacin | Loxof | 500 mg film coated tablets | RK-LS-5No.022712 |
3463 | J01MA12 | Levofloxacin | Levoflox | 500 mg film coated tablets | RK-LS-5No.022466 |
3464 | J01MA12 | Levofloxacin | Levoflox | 750 mg film coated tablets | RK-LS-5No.022469 |
3465 | J01MA12 | Levofloxacin | Levoflox | 250 mg film coated tablets | RK-LS-5No.022484 |
3466 | J01MA12 | Levofloxacin | Remedia | 250 mg film coated tablets | RK-LS-5No.018414 |
3467 | J01MA12 | Levofloxacin | Remedia | 500 mg film coated tablets | RK-LS-5No.018415 |
3468 | J01MA12 | Levofloxacin | Remedia | 750 mg film coated tablets | RK-LS-5No.018416 |
3469 | J01MA12 | Levofloxacin | Lotor-500 | 500 mg film coated tablets | RK-LS-5No.023503 |
3470 | J01MA12 | Levofloxacin | Levofloxacin-Teva | 500 mg film coated tablets | RK-LS-5No.019994 |
3471 | J01MA12 | Levofloxacin | Primaflox 500 | 500 mg film coated tablets | RK-LS-5No.023779 |
3472 | J01MA12 | Levofloxacin | Primaflox 750 | 750 mg film coated tablets | RK-LS-5No.023780 |
3473 | J01MA12 | Levofloxacin | Lufi -500 | 500 mg film coated tablets | RK-LS-5No.023819 |
3474 | J01MA12 | Levofloxacin | Levolet | 500 mg coated tablets | RK-LS-5No.016575 |
3475 | J01MA12 | Levofloxacin | Levofloxacin | 500 mg coated tablets | RK-LS-5No.014940 |
3476 | J01MA12 | Levofloxacin | Levofloxacin | 500 mg film coated tablets | RK-LS-5No.121810 |
3477 | J01MA12 | Levofloxacin | Levolet | 750 mg tablets | RK-LS-5No.021616 |
3478 | J01MA12 | Levofloxacin | Levomac 250 | 250 mg film coated tablets | RK-LS-5No.003355 |
3479 | J01MA12 | Levofloxacin | Levomac 500 | 500 mg film coated tablets | RK-LS-5No.003356 |
3480 | J01MA12 | Levofloxacin | Potant-Sanovel | 500 mg coated tablets | RK-LS-5No.014996 |
3481 | J01MA12 | Levofloxacin | Levadidoz | 500 mg/100 ml solution for infusion | RK-LS-5No.022539 |
3482 | J01MA12 | Levofloxacin | Tavanic | 5 mg/ml, 100 ml solution for infusion | RK-LS-5No.009968 |
J01MA14 | Maxifloxacin | ||||
3483 | J01MA14 | Maxifloxacin | Neoflox® | 400 mg/100 ml solution for infusion | RK-LS-5No.023688 |
3484 | J01MA14 | Maxifloxacin | Moxifloxacin-Kelun-Kazpharm | 400 mg/250 ml solution for infusion | RK-LS-5No.022372 |
3485 | J01MA14 | Maxifloxacin | Avelox® | 400 mg/250 ml solution for infusion | RK-LS-5No.003600 |
3486 | J01MA14 | Maxifloxacin | Maxifloxacin | 400 mg/250 ml solution for infusion | RK-LS-5No.022351 |
3487 | J01MA14 | Maxifloxacin | Moxicum | 400 mg/250 ml, 250 ml solution for infusion | RK-LS-5No.022175 |
3488 | J01MA14 | Maxifloxacin | Plenmoxi | 400 mg/100 ml, 100 ml solution for infusion | RK-LS-5No.022502 |
3489 | J01MA14 | Maxifloxacin | Rotomoks | 400 mg/250 ml solution for infusion | RK-LS-5No.022298 |
3490 | J01MA14 | Maxifloxacin | Moxivin | 400 mg/250 ml solution for infusion | RK-LS-3No.022732 |
3491 | J01MA14 | Maxifloxacin | Avelox® | 400 mg coated tablets | RK-LS-5No.003599 |
3492 | J01MA14 | Maxifloxacin | Moxispan | 400 mg film coated tablets | RK-LS-5No.021140 |
3493 | J01MA14 | Maxifloxacin | Micromox-400 | 400 mg film coated tablets | RK-LS-5No.021238 |
3494 | J01MA14 | Maxifloxacin | Rotomoks | 400 mg film coated tablets | RK-LS-5No.022312 |
3495 | J01MA14 | Maxifloxacin | Maxifloxacin | 400 mg film coated tablets | RK-LS-5No.022494 |
3496 | J01MA14 | Maxifloxacin | Plenmoxi | 400 mg film coated tablets | RK-LS-5No.022716 |
3497 | J01MA14 | Maxifloxacin | Floxsafe® 400 | 400 mg film coated tablets | RK-LS-5No.022769 |
3498 | J01MA14 | Maxifloxacin | Moxam | film coated tablets | RK-LS-5No.023724 |
3499 | J01MA14 | Maxifloxacin | Moxinorm | 400 mg film coated tablets | RK-LS-5No.019580 |
3500 | J01MA14 | Maxifloxacin | Moxicum | 400 mg film coated tablets | RK-LS-5No.023286 |
3501 | J01MA14 | Maxifloxacin | Moxiflox | 400 mg coated tablets | RK-LS-3No.019966 |
3502 | J01MA14 | Maxifloxacin | Moximak | 400 mg film coated tablets | RK-LS-5No.003618 |
3503 | J01MA14 | Maxifloxacin | Moxipres® | 400 mg film coated tablets | RK-LS-3No.020697 |
J01MB | Other quinolones | ||||
J01MB02 | Nalidixic acid | ||||
J01X | Other antibacterial drugs | ||||
J01XA | Antibiotics of glycopeptide structure | ||||
J01XA01 | Vancomycin | ||||
3504 | J01XA01 | Vancomycin | Vancomycin-Eleas | 1 g powder for solution for infusion | RK-LS-5No.022299 |
3505 | J01XA01 | Vancomycin | Vancomycin-TF | 1000 mg powder for solution for infusion | RK-LS-5No.121932 |
3506 | J01XA01 | Vancomycin | Vancomycin-TF | 500 mg powder for solution for infusion | RK-LS-5No.121931 |
J01XA02 | Teicoplanin | ||||
3507 | J01XA02 | Teicoplanin | Teicoplanin-TF | 400 mg powder for solution for intravenous and intramuscular injection | RK-LS-5No.121928 |
3508 | J01XA02 | Teicoplanin | Teicoplanin-TF | 200 mg powder for solution for intravenous and intramuscular administration | RK-LS-5No.121927 |
3509 | J01XA02 | Teicoplanin | GLITEIK | 400 mg lyophilisate for solution for intravenous and intramuscular induction, complete with a solvent - water for injection | RK-LS-5No.020987 |
J01XB | Polymyxins | ||||
J01XB01 | Colistin (Colistimethate) | ||||
3510 | J01XB01 | Colistin (Colistimethate) | Cometad | powder for solution for injection or infusion 1,000,000 Unit of action | RK-LS-5No.022506 |
3511 | J01XD01 | Metronidazole | Metronidazole | 0.5% 100 ml solution for infusion | RK-LS-3No.021312 |
3512 | J01XD01 | Metronidazole | Metronidazole | 0.5% 100 ml solution for infusion | RK-LS-5No.021066 |
3513 | J01XD01 | Metronidazole | Klion® | 0.5% 100 ml solution for infusion | RK-LS-5No.010270 |
3514 | J01XD01 | Metronidazole | Metronidazole-Darnitsa | 0.5% 100 ml solution for infusion | RK-LS-5No.023657 |
3515 | J01XD01 | Metronidazole | Metrid | 0.5% 100 ml solution for infusion | RK-LS-5No.016129 |
3516 | J01XD01 | Metronidazole | Metronidazole | 5 mg/ml 100 ml solution for infusion | RK-LS-5No.023015 |
3517 | J01XD01 | Metronidazole | Metrogyl | 5 mg/ml 100 ml solution for intravenous induction | RK-LS-5No.016490 |
3518 | J01XD01 | Metronidazole | Trichopol | 0.5% 100 ml solution for intravenous induction | RK-LS-5No.016281 |
3519 | J01XD01 | Metronidazole | Metronidazole-AKOS | 5 mg/ml 100 ml solution for infusion | RK-LS-5No.019399 |
3520 | J01XD01 | Metronidazole | Metronidazole | 250 mg tablets | RK-LS-5No.011223 |
3521 | J01XD01 | Metronidazole | Metronidazole | 250 mg tablets | RK-LS-5No.017942 |
3522 | J01XD01 | Metronidazole | Metronidazole | 250 mg tablets | RK-LS-5No.014342 |
3523 | J01XD01 | Metronidazole | Metronidazole-Health | 250 mg tablets | RK-LS-5No.016135 |
3524 | J01XD01 | Metronidazole | Trichopol | 250 mg tablets | RK-LS-5No.016282 |
3525 | J01XD01 | Metronidazole | Metronidazole | 250 mg tablets | RK-LS-6No.021418 |
J01XD02 | Tinidazol | ||||
3526 | J01XD02 | Tinidazol | Tinidazol | 500 mg film coated tablets | RK-LS-5No.017059 |
J01XD03 | Ornidazole | ||||
3527 | Р01АВ03 | Ornidazole | Ornikap® 250 | 250 mg film coated tablets | RK-LS-5No.019091 |
3528 | Р01АВ03 | Ornidazole | Ornikap® 500 | 500 mg film coated tablets | RK-LS-5No.019092 |
3529 | J01XD03 | Ornidazole | Ornigil | 500 mg film coated tablets | RK-LS-5No.013276 |
3530 | J01XD03 | Ornidazole | OZOL | 500 mg film coated tablets | RK-LS-5No.021079 |
3531 | J01XD03 | Ornidazole | Giro | 500 mg film coated tablets | RK-LS-5No.013932 |
3532 | Р01АВ03 | Ornidazole | Ornisid® forte | 500 mg film coated tablets | RK-LS-5No.004127 |
3533 | Р01АВ03 | Ornidazole | Ornizol | 500 mg film coated tablets | RK-LS-5No.004307 |
3534 | J01XD03 | Ornidazole | Ornidazole | 500 mg film coated tablets | RK-LS-5No.023426 |
3535 | Р01АВ03 | Ornidazole | Ornisid® | 250 mg film coated tablets | RK-LS-5No.011191 |
3536 | Р01АВ03 | Ornidazole | ORGYL® | 500 mg film coated tablets | RK-LS-5No.011691 |
3537 | J01XD03 | Ornidazole | Dazolic | 500 mg film coated tablets | RK-LS-5No.010595 |
3538 | J01XD03 | Ornidazole | Orivans | 500 mg/100 ml solution for infusion | RK-LS-5No.023539 |
3539 | J01XD03 | Ornidazole | OZOL | 5 mg/ml solution for infusion | RK-LS-5No.022883 |
3540 | J01XD03 | Ornidazole | Ornidazole | 500mg/100ml solution for infusion | RK-LS-5No.022361 |
J01XE | Nitrofuran derivatives | ||||
J01XE01 | Nitrofurantoinum | ||||
3541 | J01XE01 | Nitrofurantoinum | Furadonin | 50 mg tablets | RK-LS-5No.019338 |
J01XX | Other antibacterial drugs | ||||
J01XX01 | Phosphomycinum | ||||
3542 | J01XX01 | Phosphomycinum | Berni | 3 g granules for oral solution | RK-LS-5No.022306 |
3543 | J01XX01 | Phosphomycinum | Monural | 3 g granules for oral solution | RK-LS-5No.016799 |
3544 | J01XX01 | Phosphomycinum | Fosfomed | 3 g granular powder for oral solution | RK-LS-5No.023111 |
3545 | J01XX01 | Phosphomycinum | Urfocin | 3 g granules for oral solution | RK-LS-5No.021611 |
3546 | J01XX01 | Phosphomycinum | Uroseptic | 3 g granules for oral solution | RK-LS-5No.021284 |
3547 | J01XX01 | Phosphomycinum | Ecofomural® | 3 g granules for oral solution | RK-LS-5No.023650 |
3548 | J01XX01 | Phosphomycinum | UROGRAM PLUS | 3 g granules for oral solution | RK-LS-5No.024040 |
3549 | J01XX01 | Phosphomycinum | Ecofomural® | 3 g granules for oral solution | RK-LS-5No.023649 |
3550 | J01XX01 | Phosphomycinum | Fosforal | 3 g granules for oral solution | RK-LS-5No.024435 |
3551 | J01XX01 | Phosphomycinum | Fosfomycin-LF | Powder for oral solution | RK-LS-5No.022631 |
J01XX08 | Linezolid | ||||
3552 | J01XX08 | Linezolid | Amizolid | 600 mg film coated tablets | RK-LS-5No.022031 |
3553 | J01XX08 | Linezolid | Linezol | 600 mg film coated tablets | RK-LS-5No.023887 |
3554 | J01XX08 | Linezolid | LINOZIDUM | 2 mg/ml, 300 ml solution for infusion | RK-LS-5No.022209 |
3555 | J01XX08 | Linezolid | Lizolid-600 | 600 mg film coated tablets | RK-LS-5No.015034 |
3556 | J01XX08 | Linezolid | Linolide | 600 mg film coated tablets | RK-LS-5No.022195 |
3557 | J01XX08 | Linezolid | Roulin | 2 mg/ml solution for infusion | RK-LS-5No.022311 |
J02 | Antifungal medications, systemic use | ||||
J02AA | Antibiotics | ||||
J02AA01 | Amphotericin B | orphan | |||
3558 | J02AA01 | Amphotericin B | AmBisome | 50 mg powder for concentrate for dispersion for infusion | RK-LS-5No.023302 |
3559 | J02AA01 | Amphotericin B | Ampholip | 50 mg/10 ml concentrate (lipid complex) for solution for intravenous induction | RK-LS-5No.023874 |
J02AB | Imidazole derivatives | ||||
J02AB02 | Ketoconazole | ||||
3560 | J02AB02 | Ketoconazole | Candazole® | 200 mg tablets | RK-LS-5No.016314 |
3561 | J02AB02 | Ketoconazole | Dermazole® | 200 mg tablets | RK-LS-5No.004058 |
J02AC | Triazole derivatives | ||||
J02AC01 | Fluconazole | ||||
3562 | J02AC01 | Fluconazole | Fluzamed | 2 mg/ml solution for infusion | RK-LS-5No.020387 |
3563 | J02AC01 | Fluconazole | Fangiflu | 150 mg capsules | RK-LS-5No.019166 |
3564 | J02AC01 | Fluconazole | Fobos | 200 mg capsules | RK-LS-5No.020491 |
3565 | J02AC01 | Fluconazole | Fluconazole-Health | 50 mg capsules | RK-LS-5No.014870 |
3566 | J02AC01 | Fluconazole | Fluconazole-Health | 100 mg capsules | RK-LS-5No.014871 |
3567 | J02AC01 | Fluconazole | FCN-150 Aversi | 150 mg capsules | RK-LS-5No.021508 |
3568 | J02AC01 | Fluconazole | Eradikom | 150 mg capsules | RK-LS-5No.017871 |
3569 | J02AC01 | Fluconazole | Flucoric | 150 mg capsules | RK-LS-5No.016870 |
3570 | J02AC01 | Fluconazole | Tibulan | 50 mg capsules | RK-LS-5No.018878 |
3571 | J02AC01 | Fluconazole | Tibulan | 150 mg capsules | RK-LS-5No.018879 |
3572 | J02AC01 | Fluconazole | Lunizol-sanovel | 150 mg capsules | RK-LS-5No.010212 |
3573 | J02AC01 | Fluconazole | Fluconazole-TK | 50 mg capsules | RK-LS-3No.020817 |
3574 | J02AC01 | Fluconazole | Fluconazole | 150 mg capsules | RK-LS-5No.019914 |
3575 | J02AC01 | Fluconazole | Candifix | 150 mg capsules | RK-LS-5No.019818 |
3576 | J02AC01 | Fluconazole | Fluxan | 50 mg capsules | RK-LS-5No.024118 |
3577 | J02AC01 | Fluconazole | Fluxan | 150 mg capsules | RK-LS-5No.024119 |
3578 | J02AC01 | Fluconazole | Fluzamed | 150 mg capsules | RK-LS-5No.022396 |
3579 | J02AC01 | Fluconazole | Fluconazole | 150 mg coated tablets | RK-LS-5No.000027 |
3580 | J02AC01 | Fluconazole | Flukosayz | 150 mg film coated tablets | RK-LS-5No.022933 |
3581 | J02AC01 | Fluconazole | ESZOL® | 100 mg film coated tablets | RK-LS-5No.019075 |
3582 | J02AC01 | Fluconazole | Fluconazole | 100 mg coated tablets | RK-LS-5No.000622 |
3583 | J02AC01 | Fluconazole | Konarex | 150 mg capsules | RK-LS-5No.020744 |
3584 | J02AC01 | Fluconazole | Flunol® 150 | 150 mg capsules | RK-LS-5No.004572 |
3585 | J02AC01 | Fluconazole | Fobos | 150 mg capsules | RK-LS-5No.020490 |
3586 | J02AC01 | Fluconazole | Fluconazole-TK | 100 mg capsules | RK-LS-5No.016576 |
3587 | J02AC01 | Fluconazole | Flunol® 100 | 100 mg capsules | RK-LS-5No.018143 |
3588 | J02AC01 | Fluconazole | FUSYS® DT | 50 mg dispersible tablets | RK-LS-5No.018183 |
3589 | J02AC01 | Fluconazole | FUSYS® | 50 mg tablets | RK-LS-5No.019070 |
3590 | J02AC01 | Fluconazole | FUSYS® | 100 mg tablets | RK-LS-5No.009766 |
3591 | J02AC01 | Fluconazole | FUSYS® | 150 mg tablets | RK-LS-5No.009767 |
3592 | J02AC01 | Fluconazole | FUSYS® | 200 mg tablets | RK-LS-5No.009768 |
3593 | J02AC01 | Fluconazole | Flunol® 50 | 50 mg capsules | RK-LS-5No.014466 |
3594 | J02AC01 | Fluconazole | Fobos | 50 mg capsules | RK-LS-5No.020489 |
3595 | J02AC01 | Fluconazole | Fluconazole | 50 mg coated tablets | RK-LS-5No.000621 |
3596 | J02AC01 | Fluconazole | Flunol® | 25 mg/5 ml 70 ml syrup | RK-LS-3No.121707 |
3597 | J02AC01 | Fluconazole | Fluconazole | 2 mg/ml, 100 ml solution for infusion | RK-LS-3No.021330 |
3598 | J02AC01 | Fluconazole | Diflazon® | 2 mg/ml, 100 ml solution for infusion | RK-LS-5No.012358 |
3599 | J02AC01 | Fluconazole | Intaflu | 0.2% 100 ml solution for infusion | RK-LS-5No.022671 |
3600 | J02AC01 | Fluconazole | FUSYS® | 2 mg/ml, 100 ml solution for infusion | RK-LS-5No.019201 |
3601 | J02AC01 | Fluconazole | Flukonazol-Darnitsa | 0.2% 100 ml solution for infusion | RK-LS-5No.023936 |
3602 | J02AC01 | Fluconazole | Micosan® | 200 mg/100 ml, 100 ml solution for infusion | RK-LS-5No.022558 |
3603 | J02AC01 | Fluconazole | Medoflucon | 200 mg capsules | RK-LS-5No.014458 |
3604 | J02AC01 | Fluconazole | Difluzol | 0.1 g capsules | RK-LS-5No.003465 |
3605 | J02AC01 | Fluconazole | Micosan® | 100 mg capsules | RK-LS-5No.013816 |
3606 | J02AC01 | Fluconazole | Mycosyst® | 100 mg capsules | RK-LS-5No.009542 |
3607 | J02AC01 | Fluconazole | Difluzol | 0.15 g capsules | RK-LS-5No.003466 |
3608 | J02AC01 | Fluconazole | Mycosyst® | 150 mg capsules | RK-LS-5No.009543 |
3609 | J02AC01 | Fluconazole | Fluconazole | 150 mg capsules | RK-LS-5No.009894 |
3610 | J02AC01 | Fluconazole | Fluconazole-TK | 150 mg capsules | RK-LS-5No.016578 |
3611 | J02AC01 | Fluconazole | Difluzol | 0.05 g capsules | RK-LS-5No.003454 |
3612 | J02AC01 | Fluconazole | Medoflucon | 50 mg capsules | RK-LS-5No.014456 |
3613 | J02AC01 | Fluconazole | Mycosyst® | 50 mg capsules | RK-LS-5No.009541 |
3614 | J02AC01 | Fluconazole | Fluconazole | 50 mg capsules | RK-LS-5No.003980 |
3615 | J02AC01 | Fluconazole | Fluconazole | 50 mg capsules | RK-LS-5No.019913 |
3616 | J02AC01 | Fluconazole | Mycosyst® | 2 mg/ml, 100 ml solution for infusion | RK-LS-5No.009540 |
3617 | J02AC01 | Fluconazole | Diflazon® | 150 mg capsules | RK-LS-5No.005350 |
3618 | J02AC01 | Fluconazole | Diflucan® | 150 mg capsules | RK-LS-5No.012048 |
3619 | J02AC01 | Fluconazole | Intaflu | 150 mg capsules | RK-LS-5No.021189 |
3620 | J02AC01 | Fluconazole | Medoflucon | 150 mg capsules | RK-LS-5No.014457 |
3621 | J02AC01 | Fluconazole | Diflazon® | 50 mg capsules | RK-LS-5No.005349 |
3622 | J02AC01 | Fluconazole | Diflucan® | 50 mg capsules | RK-LS-5No.012047 |
3623 | J02AC01 | Fluconazole | Intaflu | 200 mg capsules | RK-LS-5No.021188 |
3624 | J02AC01 | Fluconazole | Diflucan® | 2 mg/ml 50 ml solution for intravenous induction | RK-LS-5No.012262 |
3625 | J02AC01 | Fluconazole | Rofluzol | 150 mg capsules | RK-LS-5No.019691 |
J02AC02 | Itraconazole | ||||
3626 | J02AC02 | Itraconazole | Chitrazol® | 10 mg/ml, 150 ml oral solution | RK-LS-5№018467 |
3627 | J02AC02 | Itraconazole | Mycogal® | 100 mg capsules | RK-LS-5No.015566 |
3628 | J02AC02 | Itraconazole | Teknazol® | 100 mg capsules | RK-LS-5No.014797 |
3629 | J02AC02 | Itraconazole | Chitrazol® | 100 mg coated tablets | RK-LS-5No.019884 |
3630 | J02AC02 | Itraconazole | Itraz | 100 mg capsules | RK-LS-5No.021423 |
3631 | J02AC02 | Itraconazole | Orungal® | 100 mg capsules | RK-LS-5No.006313 |
3632 | J02AC02 | Itraconazole | Itracon® | 100 mg capsules | RK-LS-5No.005682 |
3633 | J02AC02 | Itraconazole | Itracim 100 mg | 100 mg capsules | RK-LS-5No.122138 |
3634 | J02AC02 | Itraconazole | ESZOL® | 100 mg film coated tablets | RK-LS-5No.019075 |
J02АС03 | Voriconazole | ||||
3635 | J02АС03 | Voriconazole | Vfend® | 200 mg lyophilisate for solution for infusion | RK-LS-5No.014469 |
3636 | J02АС03 | Voriconazole | Biflurin | 200 mg film coated tablets | RK-LS-5No.022211 |
3637 | J02АС03 | Voriconazole | Voriol | 50 mg film coated tablets | RK-LS-5No.121693 |
3638 | J02АС03 | Voriconazole | Voriol | 200 mg film coated tablets | RK-LS-5No.121694 |
3639 | J02АС03 | Voriconazole | Riconred | 50 mg film coated tablets | RK-LS-5No.023768 |
3640 | J02АС03 | Voriconazole | Riconred | 200 mg film coated tablets | RK-LS-5No.023772 |
3641 | J02АС03 | Voriconazole | Biflurin | 50 mg film coated tablets | RK-LS-5No.022212 |
3642 | J02АС03 | Voriconazole | Vfend® | 50 mg film coated tablets | RK-LS-5No.014467 |
3643 | J02АС03 | Voriconazole | Voriconazole-KGP | 200 mg lyophilisate for solution for injection | RK-LS-5No.023012 |
3644 | J02АС03 | Voriconazole | Voriol IV | 200 mg lyophilisate for solution for infusion | RK-LS-5No.022930 |
3645 | J02АС03 | Voriconazole | Vfend® | 200 mg film coated tablets | RK-LS-5No.014468 |
J02AC04 | Posaconazole | ||||
3646 | J02AC04 | Posaconazole | Noxafil® | 40mg/ml, 105 ml oral suspension | RK-LS-5No.013411 |
3647 | J02AC04 | Posaconazole | Noxafil® | 100 mg enteric coated tablets | RK-LS-5No.122091 |
J02AX | Other antifungal drugs for systemic use | ||||
J02AX04 | Caspofungin | ||||
3648 | J02AX04 | Caspofungin | Cancidas | 50 mg lyophilisate for solution for infusion | RK-LS-5No.015548 |
3649 | J02AX04 | Caspofungin | Casfocin | 50 mg lyophilisate for concentrate intended for obtaining a solution for infusion | RK-LS-5No.023732 |
3650 | J02AX04 | Caspofungin | Kasgin | 50 mg lyophilized powder for solution for infusion | RK-LS-5No.022785 |
3651 | J02AX04 | Caspofungin | Kasgin | 70 mg lyophilized powder for solution for infusion | RK-LS-5No.022787 |
3652 | J02AX04 | Caspofungin | Kaspovite | 50 mg lyophilized powder for solution for infusion | RK-LS-5No.023801 |
J02AX05 | Micafungin | ||||
3653 | J02AX05 | Micafungin | Mycamine® | 100 mg lyophilisate for solution for infusion | RK-LS-5No.019318 |
3654 | J02AX05 | Micafungin |
Mycamine® | 50 mg lyophilisate for solution for infusion | RK-LS-5No.019317 |
J02AX06 | Anidulafungin | ||||
3655 | J02AX06 | Anidulafungin | Eraxis® | 100 mg lyophilisate for solution for infusion | RK-LS-5No.017762 |
J04 | Preparations active against mycobacteria | ||||
J04A | Anti-tuberculosis drugs | ||||
J04AA01 | Aminosalicylic acid | ||||
3656 | J04AA01 | Aminosalicylic acid | Pask | 600mg/g, 100 g per bag, enteric coated granules | RK-LS-5No.021196 |
3657 | J04AA01 | Aminosalicylic acid | Pask |
600mg/g, 500g per bag | RK-LS-5No.021196 |
3658 | J04AA01 | Aminosalicylic acid | Aminosalicylic acid | 30 mg/ml, 200 ml solution for infusion | RK-LS-5No.020298 |
3659 | J04AA01 | Aminosalicylic acid | Aminosalicylic acid | 30 mg/ml, 400 ml solution for infusion | RK-LS-5No.020298 |
3660 | J04AA01 | Aminosalicylic acid | PASK | 1000 mg enteric coated tablets | RK-LS-5No.022290 |
3661 | J04AA01 | Aminosalicylic acid | Inkopask | 1000 mg enteric coated tablets | RK-LS-6No.021245 |
3662 | J04AA01 | Aminosalicylic acid | PASK-Akri | 1 g enteric coated tablets | RK-LS-5No.022028 |
3663 | J04AA01 | Aminosalicylic acid | PASK | 500 mg enteric coated tablets | RK-LS-5No.022308 |
3664 | J04AA01 | Aminosalicylic acid | Inkopask | 500 mg enteric coated tablets | RK-LS-5No.021246 |
J04AA02 | Aminosalicylate Sodium | ||||
3665 | J04AA02 | Aminosalicylate Sodium | PASK | 800 mg/g per 500 g enteric coated granules | RK-LS-5No.021195 |
3666 | J04AA02 | Aminosalicylate Sodium | PASK | 600 mg/g per 500 g enteric coated granules | RK-LS-5No.021196 |
3667 | J04AA02 | Aminosalicylate Sodium | PASK | 600 mg/g per 100 g enteric coated granules | RK-LS-5No.021196 |
3668 | J04AA02 | Aminosalicylate Sodium | PASK | 800 mg/g per 100 g enteric coated granules | RK-LS-5No.021195 |
3669 | J04AA02 | Aminosalicylate Sodium | PASK | 800 mg/g per 4 g enteric coated granules | RK-LS-5No.021195 |
3670 | J04AA02 | Aminosalicylate Sodium | PASK | 600 mg/g per 4 g enteric coated granules | RK-LS-5No.021196 |
3671 | J04AA02 | Aminosalicylate Sodium | Paskonat | 3%, 400 ml solution for infusion | RK-LS-5No.009664 |
3672 | J04AA02 | Aminosalicylate Sodium | PASK AF | 3%, 400 ml solution for infusion | RK-LS-5No.022755 |
3673 | J04AA02 | Aminosalicylate Sodium | PASK AF | 3%, 200 ml solution for infusion | RK-LS-5No.022755 |
3674 | J04AA02 | Aminosalicylate Sodium | PASK AF | 3%, 100 ml solution for infusion | RK-LS-5No.022755 |
3675 | J04AA02 | Aminosalicylate Sodium | Sodium salt of para-aminosalicylic acid 5.52 g | 12.5 g dosed powder for oral solution | RK-LS-5No.010629 |
3676 | J04AA02 | Aminosalicylate Sodium | PASK sodium 5.52 g | 12.5 g dosed powder for oral solution | RK-LS-5No.009732 |
3677 | J04AA02 | Aminosalicylate Sodium | Macpas | 600 mg modified release granules | RK-LS-5No.013705 |
J04AB | Antibiotics | ||||
J04AB01 | Cycloserine | ||||
3678 | J04AB01 | Cycloserine | Cycloserine | 250 mg capsules | RK-LS-5No.005359 |
3679 | J04AB01 | Cycloserine | Cycloserine | 250 mg capsules | RK-LS-5No.019385 |
J04AB02 | Rifampicin | ||||
3680 | J04AB02 | Rifampicin | Rifampicin | 0.15 g lyophilized powder for solution for intravenous induction | RK-LS-5No.018465 |
3681 | J04AB02 | Rifampicin | Rifampicin | 0.15 g lyophilized powder for solution for intravenous induction | RK-LS-5No.023427 |
3682 | J04AB02 | Rifampicin | R-Cin | 300 mg capsules | RK-LS-5No.013640 |
3683 | J04AB02 | Rifampicin | R-Cin | 150 mg capsules | RK-LS-5No.013639 |
3684 | J04AB02 | Rifampicin | Rifampicin | 150 mg capsules | RK-LS-5No.015696 |
J04AB04 | Rifabutin | ||||
J04AB30 | Capreomycin | ||||
3685 | J04AB30 | Capreomycin | Capreomycin sulfate | 1 g powder for solution for injection | RK-LS-5No.015043 |
J04AC | Isonicotinic acid hydrazide derivatives | ||||
J04AC01 | Isoniazid | ||||
3686 | J04AC01 | Isoniazid | Isoniazid | 100mg/5ml 200 ml syrup | RK-LS-5No.019862 |
3687 | J04AC01 | Isoniazid | Isoniazid-Darnitsa | 10%, 5 ml solution for injection | RK-LS-5No.014862 |
3688 | J04AC01 | Isoniazid | Isoniazid | 100 mg tablets | RK-LS-5No.004873 |
3689 | J04AC01 | Isoniazid | Isoniazid | 300 mg tablets | RK-LS-5No.005247 |
J04AD | Thiocarbamide derivatives | ||||
J04AD01 | Prothionamide | ||||
3690 | J04AD01 | Prothionamide | Prothionamide | 250 mg film coated tablets | RK-LS-5No.023258 |
J04AK | Other anti-tuberculosis drugs | ||||
J04AK01 | Pyrazinamide | ||||
3691 | J04AK01 | Pyrazinamide | Macrosid 500 | 500 mg tablets | RK-LS-5No.024322 |
3692 | J04AK01 | Pyrazinamide | Pyzina | 500 mg tablets | RK-LS-5No.010928 |
3693 | J04AK01 | Pyrazinamide | Pyrazinamide | 400 mg tablets | RK-LS-5No.013319 |
3694 | J04AK01 | Pyrazinamide | Pyrazinamide-D | 150 mg orodispersible tablets | RK-LS-3No.019992 |
3695 | J04AK01 | Pyrazinamide | Pyrazinamide | 500 mg tablet | RK-LS-5No.018805 |
J04AK02 | Ethambutol | ||||
3696 | J04AK02 | Ethambutol | Combutol | 400 mg tablets | RK-LS-5No.020274 |
3697 | J04AK02 | Ethambutol | Ethambutol | 400 mg tablets | RK-LS-5No.015016 |
3698 | J04AK02 | Ethambutol | Ecox-400 | 400 mg film coated tablets | RK-LS-5No.005611 |
3699 | J04AK02 | Ethambutol | Ethambutol | 400 mg tablets | RK-LS-5No.015016 |
3700 | J04AK02 | Ethambutol | Inbutol | 10%, 20 ml solution for injection | RK-LS-5No.019769 |
3701 | J04AK02 | Ethambutol | Inbutol | 10%, 10 ml solution for injection | RK-LS-5No.019769 |
J04AK05 | Bedaquiline | ||||
J04AK06 | Delamanid | ||||
3702 | J04AK06 | Delamanid | Deltyba™ | 50 mg film coated tablets | RK-LS-5No.024251 |
J04AM | Combinations of anti-tuberculosis drugs | ||||
J04AM02 | Rifampicin and Isoniazid | ||||
3703 | J04AM02 | Rifampicin and Isoniazid | Rizef 150/75 | 150mg/75 mg film coated tablets | RK-LS-5No.011146 |
3704 | J04AM02 | Rifampicin and Isoniazid | AKuriT | 150mg/75 mg film coated tablets | RK-LS-5No.024352 |
J04AM05 | Rifampicin, Pyrazinamide and Isoniazid | ||||
3705 | J04AM05 | Rifampicin, Pyrazinamide and Isoniazid | Piref-3 | 150mg/ 400mg/75mg film coated tablets | RK-LS-5No.013670 |
J04AM06 | Rifampicin, Pyrazinamide, Ethambutol and Isoniazid | ||||
3706 | J04AM06 | Rifampicin, Pyrazinamide, Ethambutol and Isoniazid | Piref-4 | 150mg/400mg/275mg/75mg film coated tablets, | RK-LS-5No.013669 |
3707 | J04AM06 | Rifampicin, Pyrazinamide, Ethambutol and Isoniazid | AKuriT-4 | 150 mg/75 mg/400 mg/275 mg film coated tablets | RK-LS-5No.024353 |
J05 | Antiviral drugs for systemic use | ||||
J05A | Direct-acting antiviral drugs | ||||
J05AB | Nucleosides and nucleotides | ||||
J05AB01 | Aciclovir | ||||
3708 | J05AB01 | Aciclovir | Aciclovir-SVS | 200 mg tablets | RK-LS-3No.019709 |
3709 | J05AB01 | Aciclovir | Aciclostad® | 800 mg tablets | RK-LS-5No.005409 |
3710 | J05AB01 | Aciclovir | Ulkaril® 800 | 800 mg tablets | RK-LS-5No.009927 |
3711 | J05AB01 | Aciclovir | Aciclostad® | 400 mg tablets | RK-LS-5No.005408 |
3712 | J05AB01 | Aciclovir | Ulkaril® 400 | 400 mg tablets | RK-LS-5No.018846 |
3713 | J05AB01 | Aciclovir | Aciclostad® | 200 mg tablets | RK-LS-5No.005400 |
3714 | J05AB01 | Aciclovir | Ulkaril® 200 | 200 mg tablets | RK-LS-5No.018845 |
3715 | J05AB01 | Aciclovir | Aciclovir | 200 mg tablets | RK-LS-5No.017952 |
3716 | J05AB01 | Aciclovir | Aciclovir-AKOS | 0.2 g tablets | RK-LS-5No.003211 |
3717 | J05AB01 | Aciclovir | Acyclomax® | 200 mg tablets | RK-LS-5No.015705 |
3718 | J05AB01 | Aciclovir | Aciclovir Belupo | 400 mg film coated tablets | RK-LS-5No.021003 |
3719 | J05AB01 | Aciclovir | Acyclomax® | 400 mg tablets | RK-LS-5No.015706 |
3720 | J05AB01 | Aciclovir | Acyclomax® | 800 mg tablets | RK-LS-5No.015704 |
3721 | J05AB01 | Aciclovir | Repen | 800 mg tablets | RK-LS-5No.019387 |
3722 | J05AB01 | Aciclovir | Medovir | 250 mg powder for solution for infusion | RK-LS-5No.016515 |
3723 | J05AB01 | Aciclovir | Medovir | 500 mg powder for solution for infusion | RK-LS-5No.016516 |
3724 | J05AB01 | Aciclovir | Acyclovir tablets USP | 200 mg tablets | RK-LS-5No.122130 |
3725 | J05AB01 | Aciclovir | Repen | 400 mg tablets | RK-LS-5No.019386 |
3726 | J05AB01 | Aciclovir | Acyclovir tablets USP | 400 mg tablets | RK-LS-5No.122131 |
3727 | J05AB01 | Aciclovir | HERPEVIR® | 400 mg tablets | RK-LS-5No.004312 |
3728 | J05AB01 | Aciclovir | HERPEVIR® | 200 mg tablets | RK-LS-5No.012758 |
3729 | J05AB01 | Aciclovir | Zovirax® | 200 mg tablets | RK-LS-5No.011724 |
J05AB04 | Ribavirin | orphan | |||
3730 | J05AB04 | Ribavirin | Copegus | 200 mg film coated tablets | RK-LS-5No.000663 |
3731 | J05AB04 | Ribavirin | Ribavirin | 200 mg capsules | RK-LS-5No.121997 |
J05AB09 | Famciclovir | ||||
3732 | J05AB09 | Famciclovir | Famciclovir VIVA PHARM | 250 mg film coated tablets | RK-LS-3No.022357 |
3733 | J05AB09 | Famciclovir | Famciclovir-Teva | 500 mg film coated tablets | RK-LS-5No.021131 |
3734 | J05AB09 | Famciclovir | Famciclovir-Teva | 250 mg film coated tablets | RK-LS-5No.021132 |
3735 | J05AB09 | Famciclovir | Famciclovir-Teva | 125 mg film coated tablets | RK-LS-5No.021133 |
3736 | J05AB09 | Famciclovir | Famvir® | 125 mg film coated tablets | RK-LS-5No.016232 |
3737 | J05AB09 | Famciclovir | Viraxa | 500 mg film coated tablets | RK-LS-5No.023270 |
3738 | J05AB09 | Famciclovir | Viraxa | 250 mg film coated tablets | RK-LS-5No.023271 |
3739 | J05AB09 | Famciclovir | Viraxa | 125 mg film coated tablets | RK-LS-5No.023272 |
3740 | J05AB09 | Famciclovir | Famciclovir Viva Pharm | 125 mg coated tablets | RK-LS-3No.022356 |
3741 | J05AB09 | Famciclovir | Famvir® | 250 mg film coated tablets | RK-LS-5No.016269 |
J05AB11 | Valaciclovir | ||||
3742 | J05AB11 | Valaciclovir | Valavir® | 500 mg film coated tablets | RK-LS-5No.015856 |
3743 | J05AB11 | Valaciclovir | Valtrex® | 500 mg film coated tablets | RK-LS-5No.016596 |
3744 | J05AB11 | Valaciclovir | Uviromed | 500 mg film coated tablets | RK-LS-5No.022990 |
3745 | J05AB11 | Valaciclovir | Valavex | 500 mg coated tablets | RK-LS-5No.019443 |
3746 | J05AB11 | Valaciclovir | Valtrovir | 500 mg film coated tablets | RK-LS-5No.018795 |
3747 | J05AB11 | Valaciclovir | Uviromed | 1000 mg film coated tablets | RK-LS-5No.022989 |
3748 | J05AB11 | Valaciclovir | Valtero | 500 mg film coated tablets | RK-LS-5No.023242 |
3749 | J05AB11 | Valaciclovir | Valtero | 1000 mg film coated tablets | RK-LS-5No.023244 |
3750 | J05AB11 | Valaciclovir | VALACITEK | 500 mg film coated tablets | RK-LS-5No.023429 |
3751 | J05AB11 | Valaciclovir | VALACITEK | 1000 mg film coated tablets | RK-LS-5No.023434 |
J05AB14 | Valganciclovir | ||||
3752 | J05AB14 | Valganciclovir | Valcyte | 450 mg coated tablets | RK-LS-5No.012819 |
3753 | J05AB14 | Valganciclovir | Valganciclovir Viva Pharm | 450 mg coated tablets | RK-LS-5No.023377 |
3754 | J05AB14 | Valganciclovir | Valganciclovir-Teva | 450 mg film coated tablets | RK-LS-5No.122002 |
3755 | J05AB14 | Valganciclovir | Gansil | 450 mg film coated tablets | RK-LS-5No.023277 |
3756 | J05AB14 | Valganciclovir | Valgir | 450 mg film coated tablets | RK-LS-5No.022625 |
3757 | J05AB14 | Valganciclovir | Civalgan | 450 mg film coated tablets | RK-LS-5No.023204 |
J05AE | Protease inhibitors | ||||
J05AE03 | Ritonavir | ||||
3758 | J05AE03 | Ritonavir | Norvir | 100 mg film coated tablets | RK-LS-5No.017855 |
J05AE07 | Fosamprenavir | ||||
3759 | J05AE07 | Fosamprenavir | Telzir® | 50 mg/ml, 225 ml oral suspension | RK-LS-5No.018506 |
3760 | J05AE07 | Fosamprenavir | Telzir® | 700 mg film coated tablets | RK-LS-5No.019269 |
J05AE10 | Darunavir | ||||
3761 | J05AE10 | Darunavir | Prezista® | 800 mg film coated tablets | RK-LS-5No.021033 |
3762 | J05AE10 | Darunavir | Prezista® | 600 mg film coated tablets | RK-LS-5No.019607 |
3763 | J05AE10 | Darunavir | Darunavir-AIGF | 600 mg film coated tablets | RK-LS-5No.122111 |
3764 | J05AE10 | Darunavir | Prezista® | 400 mg film coated tablets | RK-LS-5No.019606 |
3765 | J05AE10 | Darunavir | Darunavir-AIGF | 400 mg film coated tablets | RK-LS-5No.122110 |
3766 | J05AE10 | Darunavir | Danavir | 400 mg film coated tablets | RK-LS-5No.023893 |
3767 | J05AE10 | Darunavir | Danavir | 400 mg film coated tablets | RK-LS-5No.023894 |
J05AF | Nucleosides - reverse transcriptase inhibitors | ||||
J05AF01 | Zidovudine | ||||
3768 | J05AF01 | Zidovudine | Retrovir® | 100 mg capsules | RK-LS-5No.011012 |
3769 | J05AF01 | Zidovudine | Zidoas | 100 mg capsules | RK-LS-3No.021549 |
3770 | J05AF01 | Zidovudine | Retrovir® | 10 mg/ml 200 ml oral solution | RK-LS-5No.011013 |
3771 | J05AF01 | Zidovudine | Zidoas | 300 mg coated tablets | RK-LS-3No.021548 |
J05AF02 | Didanosine | ||||
J05AF05 | Lamivudine | ||||
3772 | J05AF05 | Lamivudine | Amiviren | 300 mg film coated tablets | RK-LS-5No.121751 |
3773 | J05AF05 | Lamivudine | Lamias® 150 | 150 mg coated tablets | RK-LS-3No.020657 |
3774 | J05AF05 | Lamivudine | Epivir® | 150 mg film coated tablets | RK-LS-5No.015500 |
3775 | J05AF05 | Lamivudine | Amiviren | 150 mg film coated tablets | RK-LS-5No.121752 |
3776 | J05AF05 | Lamivudine | Zeffix | 100 mg film coated tablets | RK-LS-5No.003545 |
3777 | J05AF05 | Lamivudine | Zeffix ® | 5 mg/ml 240 ml oral solution | RK-LS-5No.016700 |
3778 | J05AF05 | Lamivudine | Mivux® | 100 mg film coated tablets | RK-LS-5No.019229 |
3779 | J05AF05 | Lamivudine | Virolam | 150 mg film coated tablets | RK-LS-5No.016204 |
3780 | J05AF05 | Lamivudine | Lamivudine | 150 mg film coated tablets | RK-LS-5No.023212 |
J05AF06 | Abacavir | ||||
3781 | J05AF06 | Abacavir | Ziagen® | 20 mg/ml, 240 ml in vials, oral solution | RK-LS-5No.011980 |
3782 | J05AF06 | Abacavir | Olitid | 600 mg film coated tablets | RK-LS-5No.121663 |
3783 | J05AF06 | Abacavir | Virakar® | 300 mg coated tablets | RK-LS-3No.021526 |
3784 | J05AF06 | Abacavir | Ziagen® | 300 mg film coated tablets | RK-LS-5No.005698 |
3785 | J05AF06 | Abacavir | Olitid | 300 mg film coated tablets | RK-LS-5No.121662 |
3786 | J05AF06 | Abacavir | Abacavir Tablets USP | 300 mg film coated tablets | RK-LS-5No.019939 |
3787 | J05AF06 | Abacavir | Virol | 300 mg film coated tablets | RK-LS-5No.005491 |
J05AF07 | Tenofovir | ||||
3788 | J05AF07 | Tenofovir disoproxil | Viread | 300 mg film coated tablets | RK-LS-5No.020705 |
3789 | J05AF07 | Tenofovir | Virkil | 300 mg film coated tablets | RK-LS-5No.023505 |
3790 | J05AF07 | Tenofovir | Tenof | 300 mg film coated tablets | RK-LS-5No.023522 |
3791 | J05AF07 | Tenofovir | Getino-B | 300 mg film coated tablets | RK-LS-5No.023164 |
3792 | J05AF07 | Tenofovir | TENOBEL | 300 mg film coated tablets | RK-LS-5No.023606 |
3793 | J05AF07 | Tenofovir | Tenaviron | 300 mg film coated tablets | RK-LS-5No.024075 |
J05AF10 | Entecavir | ||||
3794 | J05AF10 | Entecavir | Tekavir | 0.5 mg film coated tablets | RK-LS-5No.022665 |
3795 | J05AF10 | Entecavir | Tekavir | 1 mg film coated tablets | RK-LS-5No.022744 |
3796 | J05AF10 | Entecavir | Enteka | 0.5 mg film coated tablets | RK-LS-5No.023046 |
3797 | J05AF10 | Entecavir | Enteka | 1 mg film coated tablets | RK-LS-5No.023047 |
3798 | J05AF10 | Entecavir | Enteka | 1 mg film coated tablets | RK-LS-5No.023099 |
3799 | J05AF10 | Entecavir | Kvantavir | 0.5 mg film coated tablets | RK-LS-5No.023951 |
3800 | J05AF10 | Entecavir | Kvantavir | 1 mg film coated tablets | RK-LS-5No.023952 |
3801 | J05AF10 | Entecavir | Entecavir Viva Pharm | 0.5 mg coated tablets | RK-LS-5No.024050 |
J05AF11 | Telbivudine | ||||
J05AG | Non-nucleosides - reverse transcriptase inhibitors | ||||
J05AG01 | Nevirapine | ||||
3802 | J05AG01 | Nevirapine | Viramune® | 50mg/5ml, 240 ml oral suspension | RK-LS-5No.005657 |
3803 | J05AG01 | Nevirapine | Nevirapine | 200 mg tablets | RK-LS-5No.022943 |
3804 | J05AG01 | Nevirapine | Viramune® | 200 mg tablets | RK-LS-5No.016270 |
3805 | J05AG01 | Nevirapine | Nevirapine | 50mg/5ml, 100 ml oral suspension | RK-LS-5No.021443 |
3806 | J05AG01 | Nevirapine | Nevirapine | 50mg/5ml, 240 ml oral suspension | RK-LS-5No.021443 |
3807 | J05AG01 | Nevirapine | Nevir™ | 200 mg tablets | RK-LS-5No.013327 |
3808 | J05AG01 | Nevirapine | Nevipan | 200 mg tablets | RK-LS-5No.016643 |
3809 | J05AG01 | Nevirapine | Nevirpin - AIGF | 200 mg coated tablets | RK-LS-5No.021797 |
3810 | J05AG01 | Nevirapine | Nevirapine | 200 mg tablets | RK-LS-5No.023603 |
3811 | J05AG01 | Nevirapine | Nevimun | 200 mg tablets | RK-LS-5No.122071 |
3812 | J05AG01 | Nevirapine | Nevivir | 200 mg tablets | RK-LS-5No.023892 |
3813 | J05AG01 | Nevirapine | Nevirapine | 200 mg tablets | RK-LS-5No.020782 |
J05AG03 | Efavirenz | ||||
3814 | J05AG03 | Efavirenz | Stocrin | 50 mg coated tablets | Single import |
3815 | J05AG03 | Efavirenz | Stocrin | 200 mg coated tablets | Single import |
3816 | J05AG03 | Efavirenz | Stocrin | 600 mg coated tablets | RK-LS-5No.018110 |
3817 | J05AG03 | Efavirenz | Efavirenz-AIGF | 600 mg film coated tablets | RK-LS-5No.121729 |
3818 | J05AG03 | Efavirenz | Estiva-600 | 600 mg film coated tablets | RK-LS-5No.023601 |
3819 | J05AG03 | Efavirenz | Efavirenz USP | 600 mg film coated tablets | RK-LS-5No.020048 |
3820 | J05AG03 | Efavirenz | Efavirenz-Teva | 600 mg film coated tablets | RK-LS-5No.020848 |
3821 | J05AG03 | Efavirenz | Efavir-600 | 600 mg film coated tablets | RK-LS-5No.122108 |
3822 | J05AG03 | Efavirenz | Efavirenz-AIGF | 100 mg film coated tablets | RK-LS-5No.121728 |
3823 | J05AG03 | Efavirenz | Efavirenz | 600 mg film coated tablets | RK-LS-5No.023633 |
3824 | J05AG03 | Efavirenz | Eferven | 600 mg film coated tablets | RK-LS-5No.005492 |
3825 | J05AG03 | Efavirenz | Efavirenz-AIGF | 600 mg film coated tablets | RK-LS-5No.121729 |
J05AG04 | Etravirine | ||||
3826 | J05AG04 | Etravirine | Intelence® | 100 mg tablets | RK-LS-5No.014509 |
3827 | J05AG04 | Etravirine | Intelence® | 200 mg tablets | RK-LS-5No.021209 |
J05AG05 | Rilpivirine | ||||
3828 | J05AG05 | Rilpivirine | Edurant® | 25 mg film coated tablets | RK-LS-5No.022471 |
J05AH | Neuraminidase inhibitors | ||||
J05AH01 | Zanamivir | ||||
3829 | J05AH01 | Zanamivir | Relenza® | 5 mg/dose powder for inhalation dosed | RK-LS-5No.005403 |
J05AH02 | Oseltamivir | ||||
3830 | J05AH02 | Oseltamivir | Nomides | 75 mg capsules | RK-LS-5No.023160 |
3831 | J05AH02 | Oseltamivir | Nomides | 45 mg capsules | RK-LS-5No.023154 |
3832 | J05AH02 | Oseltamivir | Nomides | 30 mg capsules | RK-LS-5No.023153 |
3833 | J05AH02 | Oseltamivir | Tamiflu | 75 mg capsules | RK-LS-5No.004498 |
3834 | J05AH02 | Oseltamivir | Flustop | 75 mg capsules | RK-LS-5No.022927 |
3835 | J05AH02 | Oseltamivir | Fluvir | 45 mg capsules | RK-LS-5No.023896 |
3836 | J05AH02 | Oseltamivir | Influvir | 75 mg capsules | RK-LS-5No.024041 |
3837 | J05AH02 | Oseltamivir | Fluvir | 75 mg capsules | RK-LS-5No.023897 |
3838 | J05AH02 | Oseltamivir | Fluvir | 30 mg capsules | RK-LS-5No.023895 |
J05AP | Hepatitis C treatment drugs | ||||
J05AP01 | Ribavirin | ||||
3839 | J05AB04 | Ribavirin | Rebetol® | 40 mg/ml, 100 ml oral solution | RK-LS-5No.016876 |
3840 | J05AB04 | Ribavirin | Rivirin® | 200 mg coated tablets | RK-LS-5No.017878 |
3841 | J05AB04 | Ribavirin | Copegus | 200 mg film coated tablets | RK-LS-5No.000663 |
J05AP05 | Simeprevir | ||||
J05AX15 | Sofosbuvir | ||||
3842 | J05AX15 | Sofosbuvir | Grateziano | 400 mg film coated tablets | RK-LS-5No.022703 |
3843 | J05AX15 | Sofosbuvir | VIRSO | 400 mg film coated tablets | RK-LS-5No.023213 |
3844 | J05AX15 | Sofosbuvir | Nucleobuvir | 400 mg film coated tablets | RK-LS-5No.024077 |
3845 | J05AX15 | Sofosbuvir | Valdis | 400 mg film coated tablets | RK-LS-5No.024005 |
3846 | J05AX15 | Sofosbuvir | Sofgen | 400 mg film coated tablets | RK-LS-5No.022490 |
3847 | J05AX15 | Sofosbuvir | Gepcinat | 400 mg film coated tablets | RK-LS-5No.024494 |
J05AP51 | Sofosbuvir and Ledipasvir | ||||
3848 | J05AP51 | Sofosbuvir and Ledipasvir | Harvoni | 90 mg/400 mg film coated tablets | RK-LS-5No.022460 |
3849 | J05AP51 | Sofosbuvir and Ledipasvir | Valdis Plus | 90 mg/400 mg film coated tablets | RK-LS-5No.024020 |
J05AP52 | Dasabuvir, Ombitasvir, Paritaprevir and Ritonavir | ||||
3850 | J05AP52 | Dasabuvir, Ombitasvir, Paritaprevir and Ritonavir | Viekira Pak | tablets set (Dasabuvir – 250 mg film coated tablets; Ombitasvir + Paritaprevir + Ritonavir – 12.5 + 75 mg + 50 mg film coated tablets) | RK-LS-5No.021846 |
J05AR | Combinations of antiviral drugs active against HIV | ||||
J05AR01 | Zidovudine and Lamivudine | ||||
3851 | J05AR01 | Zidovudine and Lamivudine | Duolazide | 300 mg/150 mg coated tablets | RK-LS-3No.021498 |
3852 | J05AR01 | Zidovudine and Lamivudine | Combivir | 300 mg/150 mg coated tablets | RK-LS-5No.010563 |
3853 | J05AR01 | Zidovudine and Lamivudine | Disaverox | 300 mg/150 mg film coated tablets | RK-LS-5No.021638 |
3854 | J05AR01 | Zidovudine and Lamivudine | Lamivudine/Zidovudine Teva | 150 mg/300 mg film coated tablets | RK-LS-5No.021156 |
3855 | J05AR01 | Zidovudine and Lamivudine | Virocomb | 300 mg/150 mg film coated tablets | RK-LS-5No.015597 |
3856 | J05AR01 | Zidovudine and Lamivudine | Zidolam | 150 mg/300 mg film coated tablets | RK-LS-5No.023727 |
3857 | J05AR01 | Zidovudine and Lamivudine | Lamivudine and Zidovudine | 150 mg/300 mg film coated tablets | RK-LS-5No.023000 |
3858 | J05AR01 | Zidovudine and Lamivudine | Lamivudine and Zidovudine | 30 mg/60 mg dispersible tablets | RK-LS-5No.121913 |
J05AR02 | Lamivudine and Abacavir | ||||
3859 | J05AR02 | Lamivudine and Abacavir | Abacavir and Lamivudine | 600 mg/300 mg film coated tablets | RK-LS-5No.020716 |
3860 | J05AR02 | Lamivudine and Abacavir | Kivexa® | 300 mg/702 mg film coated tablets | RK-LS-5No.005697 |
J05AR03 | Tenofovir Disoproxil and Emtricitabine | ||||
3861 | J05AR03 | Tenofovir Disoproxil and Emtricitabine | Truvada | 300 mg/200 mg film coated tablets | RK-LS-5No.020832 |
3862 | J05AR03 | Tenofovir Disoproxil and Emtricitabine | Emtricitabine/Tenofovir | 200 mg/300 mg film coated tablets | RK-LS-5No.023521 |
3863 | J05AR03 | Tenofovir Disoproxil and Emtricitabine | Efavirenz/Emtricitabine/Tenofovir - CRKA | 600 mg/200 mg/245 mg film coated tablets | RK-LS-5No.024219 |
3864 | J05AR03 | Tenofovir Disoproxil and Emtricitabine | Emtricitabine/Tenofovir - CRKA | 200 mg/245 mg film coated tablets | RK-LS-5No.023559 |
J05AR04 | Zidovudine, Lamivudine and Abacavir | ||||
3865 | J05AR04 | Zidovudine, Lamivudine and Abacavir | Trizivir® | 300 mg /150 mg/300 mg film coated tablets | RK-LS-5No.012399 |
J05AR05 | Zidovudine, Lamivudine and Nevirapine | ||||
J05AR06 | Emtricitabine, Tenofovir Disoproxil, and Efavirenz | ||||
3866 | J05AR06 | Emtricitabine, Tenofovir Disoproxil, and Efavirenz | ЕЕТ | 600 mg /200 mg/300 mg film coated tablets | RK-LS-5No.024242 |
3867 | J05AR06 | Emtricitabine, Tenofovir Disoproxil, and Efavirenz | Efavirenz/Emtricitabine/Tenofovir | 600 mg /200 mg/300 mg film coated tablets | RK-LS-5No.023679 |
3868 | J05AR06 | Emtricitabine, Tenofovir Disoproxil, and Efavirenz | Efavirenz, emtricitabine, and tenofovir disoproxil fumarate | 600 mg /200 mg/300 mg film coated tablets | RK-LS-5No.020725 |
3869 | J05AR06 | Emtricitabine, Tenofovir Disoproxil, and Efavirenz | Etenem | 200 mg /200 mg/600 mg film coated tablets | RK-LS-5No.021044 |
J05AR08 | Emtricitabine, Tenofovir Disoproxil, and Rilpivirine | ||||
3870 | J05AR08 | Emtricitabine, Tenofovir Disoproxil, and Rilpivirine | Complera | 300 mg /25 mg/200 mg film coated tablets | RK-LS-5No.022580 |
J05AR10 | Lopinavir and Ritonavir | ||||
3871 | J05AR10 | Lopinavir and Ritonavir | Aluvia | 200 mg/50 mg film coated tablets | RK-LS-5No.014087 |
3872 | J05AR10 | Lopinavir and Ritonavir | Kaletra | 60 ml oral solution | RK-LS-5No.015503 |
3873 | J05AR10 | Lopinavir and Ritonavir | Aluvia | 100 mg/ 25 mg film coated tablets | RK-LS-5No.016561 |
J05AR13 | Lamivudine, Abacavir, and Dolutegravir | ||||
3874 | J05AR13 | Lamivudine, Abacavir, and Dolutegravir | Triumeq® | 50 mg/600 mg/300 mg film coated tablets | RK-LS-5No.022415 |
J05AR14 | Darunavir and Cobicistat | ||||
3875 | J05AR14 | Darunavir and Cobicistat | Rezolsta | 800 mg/150 mg film coated tablets | RK-LS-5No.022425 |
J05AR19 | Emtricitabine, rilpivirine, and tenofovir alafenamide | ||||
3876 | J05AR19 | Emtricitabine, rilpivirine, and tenofovir alafenamide | Odefsey | film coated tablets | RK-LS-5No.024217 |
J05AR22 | Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate | ||||
3877 | J05AR22 | Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate | Symtuza | film coated tablets | RK-LS-5No.024275 |
J05AX | Other antiviral drugs | ||||
J05AX08 | Raltegravir | ||||
3878 | J05AX08 | Raltegravir | Isentress | 400 mg film coated tablets | RK-LS-5No.020768 |
3879 | J05AX08 | Raltegravir | Isentress | 25 mg chewable tablets | RK-LS-5No.021158 |
J05AX09 | Maraviroc | ||||
J05AX12 | Dolutegravir | ||||
3880 | J05AX12 | Dolutegravir | Tivicay® | 50 mg film coated tablets | RK-LS-5No.021169 |
3881 | J05AX12 | Dolutegravir | Virdac | 60 mg film coated tablets | RK-LS-5No.023276 |
3882 | J05AX12 | Dolutegravir | Tivicay | 10 mg film coated tablets | RK-LS-5No.024008 |
3883 | J05AX12 | Dolutegravir | Tivicay | 25 mg film coated tablets | RK-LS-5No.024007 |
J05AX15 | Sofosbuvir | ||||
3884 | J05AX15 | Sofosbuvir | Sofgen | 400 mg film coated tablets | RK-LS-5No.022490 |
J06 | Immune sera and immunoglobulins | ||||
J06A | Immune sera | ||||
J06AA01 | Anti-diphtheria serum | ||||
J06AA02 | Tetanus antitoxin | ||||
J06AA05 | Antigangrenous serum | ||||
J06AA06 | Antirabies serum | ||||
3885 | J06AA06 | Antirabies serum | Equirab (Anti-Rabies Serum) | solution for injection, 1000 IU /5 ml | РК-БП-5No.016464 |
J06B | Immunoglobulins | ||||
J06BA | Normal human immunoglobulin | ||||
J06BA01 | Immunoglobulin (for extravascular administration) | orphan | |||
3886 | J06BA01 | Immunoglobulin (for extravascular administration) | Hizentra® | solution for subcutaneous administration 200 mg/ml, 10 ml | РК-БП-5No.024269 |
3887 | J06BA01 | Immunoglobulin (for extravascular administration) | Hizentra® | solution for subcutaneous administration 200 mg/ml | РК-БП-5No.024270 |
3888 | J06BA01 | Immunoglobulin (for extravascular administration) | Hizentra® | solution for subcutaneous administration 200 mg/ml 50 ml in vial | РК-БП-5No.024271 |
3889 | J06BA01 | Immunoglobulin (for extravascular administration) | Hizentra® | solution for subcutaneous administration 200 mg/ml 5 ml in vial | РК-БП-5No.024272 |
3890 | J06BA01 | Immunoglobulin (for extravascular administration) | Intratect® | solution for infusion, 10%, 100 ml | РК-БП-5No.021519 |
3891 | J06BA01 | Immunoglobulin (for extravascular administration) | Intratect® | solution for infusion, 10%, 10 ml | РК-БП-5No.021519 |
3892 | J06BA01 | Immunoglobulin (for extravascular administration) | Intratect® | solution for infusion, 10%, 200 ml | РК-БП-5No.021519 |
3893 | J06BA01 | Immunoglobulin (for extravascular administration) | Gammanorm | solution for injection 165 mg/ml, 20 ml | RK-LS-5No.018321 |
3894 | J06BA01 | Immunoglobulin (for extravascular administration) | Gammanorm | solution for injection 165 mg/ ml, 10 ml | RK-LS-5No.018320 |
J06BA02 | Immunoglobulin (for intravenous administration) | orphan | |||
3895 | J06BA02 | Immunoglobulin (for intravenous administration) | Panzyga | solution for injection 100 mg/ ml, 50 ml | РК-БП-5No.024174 |
3896 | J06BA02 | Immunoglobulin (for intravenous administration) | Panzyga | solution for infusion 100 mg/ml 100 ml in vial | РК-БП-5No.024175 |
3897 | J06BA02 | Immunoglobulin (for intravenous administration) | Panzyga | solution for infusion 100 mg/ml 200 ml in vial | РК-БП-5No.024176 |
3898 | J06BA02 | Immunoglobulin (for intravenous administration) | Kiovig | solution for infusion 100 mg/ml 10 ml in vial | РК-БП-5No.018125 |
3899 | J06BA02 | Immunoglobulin (for intravenous administration) | Kiovig | solution for infusion 100 mg/ml 25 ml in vial | РК-БП-5No.018126 |
3900 | J06BA02 | Immunoglobulin (for intravenous administration) | Kiovig | solution for infusion 100 mg, 200 ml in vial | РК-БП-5No.018129 |
3901 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 10% | solution for infusion 10%, 60 ml | РК-БП-5No.022176 |
3902 | J06BA02 | Immunoglobulin (for intravenous administration) | Immunorel | solution for intravenous administration 5%, 50 ml | РК-БП-5No.021349 |
3903 | J06BA02 | Immunoglobulin (for intravenous administration) | Immunorel | solution for intravenous administration 5%, 100 ml | РК-БП-5No.021349 |
3904 | J06BA02 | Immunoglobulin (for intravenous administration) | OCTAGAM™ 10% | solution for infusion 10%, 200 ml | RK-LS-5No.014188 |
3905 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 5 % | solution for infusion 5%, 200 ml | RK-LS-5No.019746 |
3906 | J06BA02 | Immunoglobulin (for intravenous administration) | IG VENA | solution for infusion 50mg/ml, 200 ml | РК-БП-5No.122050 |
3907 | J06BA02 | Immunoglobulin (for intravenous administration) | Kiovig | solution for infusion 100mg/ml, 100 ml | РК-БП-5No.018128 |
3908 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 10% | solution for infusion 10%, 100 ml | RK-LS-5No.014188 |
3909 | J06BA02 | Immunoglobulin (for intravenous administration) | Intratect® | solution for infusion 10%, 50 ml | РК-БП-5No.021519 |
3910 | J06BA02 | Immunoglobulin (for intravenous administration) | Kiovig | solution for infusion 100mg/ml, 50 ml | РК-БП-5No.018127 |
3911 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 10% | solution for infusion 10%, 50 ml | RK-LS-5No.014188 |
3912 | J06BA02 | Immunoglobulin (for intravenous administration) | Intratect® | solution for infusion 5%, 50 ml | РК-БП-5No.021518 |
3913 | J06BA02 | Immunoglobulin (for intravenous administration) | Pentaglobin | solution for intravenous administration 50 ml | РК-БП-5No.012734 |
3914 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 5 % | solution for infusion 5%, 50 ml | RK-LS-5No.019746 |
3915 | J06BA02 | Immunoglobulin (for intravenous administration) | IG VENA | solution for infusion 50mg/ml, 50 ml | РК-БП-5No.122048 |
3916 | J06BA02 | Immunoglobulin (for intravenous administration) | Pentaglobin | solution for intravenous administration 100 ml | РК-БП-5No.012734 |
3917 | J06BA02 | Immunoglobulin (for intravenous administration) | Intratect® | solution for infusion 5%, 100 ml | РК-БП-5No.021518 |
3918 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 5 % | solution for infusion 5%, 100 ml | RK-LS-5No.019746 |
3919 | J06BA02 | Immunoglobulin (for intravenous administration) | IG VENA | solution for infusion 50mg/ml, 100 ml | РК-БП-5No.122049 |
3920 | J06BA02 | Immunoglobulin (for intravenous administration) | OCTAGAM™ 10% | solution for infusion 10%, 20 ml | RK-LS-5No.014188 |
3921 | J06BA02 | Immunoglobulin (for intravenous administration) | Bioven Mono | solution for infusion 50 ml | РК-БП-5No.017941 |
3922 | J06BA02 | Immunoglobulin (for intravenous administration) | Octagam™ 5 % | solution for infusion 5%, 20 ml | RK-LS-5No.019746 |
3923 | J06BA02 | Immunoglobulin (for intravenous administration) | IG VENA | solution for infusion 50mg/ml, 20 ml | РК-БП-5No.122047 |
3924 | J06BA02 | Immunoglobulin (for intravenous administration) | Pentaglobin | solution for intravenous administration 10 ml | РК-БП-5No.012734 |
3925 | J06BA02 | Immunoglobulin (for intravenous administration) | Privigen® | solution for infusion 100mg/ml, 100 ml | RK-LS-5No.019616 |
3926 | J06BA02 | Иммуноглобулин (для внутривенного введения) | Flebogamma 10% DIF | solution for infusion 10%, 100 ml | RK-LS-5No.022024 |
3927 | J06BA02 | Immunoglobulin (for intravenous administration) | Flebogamma 10% DIF | solution for infusion 10%, 200 ml | RK-LS-5No.022024 |
3928 | J06BA02 | Immunoglobulin (for intravenous administration) | Privigen® | solution for infusion 100mg/ml, 50 ml | RK-LS-5No.019616 |
3929 | J06BA02 | Immunoglobulin (for intravenous administration) | Privigen® | solution for infusion 100mg/ml, 25 ml | RK-LS-5No.019616 |
3930 | J06BA02 | Immunoglobulin (for intravenous administration) | Privigen® | solution for infusion 100mg/ml, 200 ml | RK-LS-5No.019616 |
3931 | J06BA02 | Immunoglobulin (for intravenous administration) | Flebogamma 10% DIF | solution for infusion 10%, 50 ml | RK-LS-5No.022024 |
J06BB | Specific Immunoglobulin | ||||
J06BB01 | Anti-D immunoglobulin | ||||
3932 | J06BB01 | Anti-D immunoglobulin | Rhesogam N | solution for intravenous and intramuscular administration 1500 IU (300 mg)/2 ml | РК-БП-5No.122132 |
3933 | J06BB01 | Anti-D immunoglobulin | Resonativ™ | solution for intramuscular injection 625 IU/ml, 2 ml | RK-LS-5No.014187 |
3934 | J06BB01 | Anti-D immunoglobulin | Resonativ™ | solution for intramuscular injection 625 IU/ml, 2 ml | RK-LS-5No.014186 |
J06BB04 | Hepatitis B immunoglobulin | ||||
3935 | J06BB04 | Hepatitis B immunoglobulin | Fovepta® | solution for injection in pre-filled syringe 200 IU, 0.4 ml | РК-БП-5No.024159 |
J06BB05 | Rabies immunoglobulin | ||||
3936 | J06BB05 | Rabies immunoglobulin | Rabishield, anti-rabies human monoclonal antibodies | solution for intramuscular injection, 100 IU/2.5 ml | РК-БП-5No.024203 |
3937 | J06BB05 | Rabies immunoglobulin | FAVIRAB, equine antirabies immunoglobulin F (ab ') 2 fragment | solution for intramuscular injection, as well as for, 200-400 IU, 5 ml | РК-БП-5No.021150 |
J06BB09 | Immunoglobulin against cytomegalovirus | ||||
3938 | J06BB09 | Immunoglobulin against cytomegalovirus | NeoCytotect® | solution for i.v. 1000 U/10 ml | РК-БП-5No.012801 |
3939 | J06BB09 | Immunoglobulin against cytomegalovirus | NeoCytotect® | solution for intravenous administration, 50 ml/5000E | РК-БП-5No.012803 |
J06BB12 | Human immunoglobulin against tick-borne encephalitis | ||||
J06BB16 | Palivizumab | ||||
3940 | J06BB16 | Palivizumab | Synagis® | solution for intramuscular injection 50 mg | РК-БП-5No.023137 |
3941 | J06BB16 | Palivizumab | Synagis® | solution for intramuscular injection 100mg/1 ml | РК-БП-5No.023138 |
3942 | J06BB16 | Palivizumab | Synagis | lyophilized powder for solution for injection 100 mg | РК-БП-5No.016120 |
J07 | Vaccines | ||||
J07A | Vaccines for prevention of bacterial infections | ||||
J07AH04 | Meningococcal tetravalent purified polysaccharide antigen | ||||
J07AJ | Pertussis vaccine | ||||
J07AJ52 | Adsorbed diphtheria-tetanus pertussis vaccine containing acellular pertussis component | ||||
3943 | J07AJ52 | Adsorbed diphtheria-tetanus pertussis vaccine containing acellular pertussis component | Adacel, vaccine for the prevention of diphtheria (reduced antigen content), tetanus and pertussis (acellular), combined, adsorbed | suspension for injection 0.5 ml (1 dose) | RK-LS-5No.024420 |
3944 | J07AJ52 | Adsorbed diphtheria-tetanus pertussis vaccine containing acellular pertussis component | Boostrix®, vaccine for prevention of diphtheria, tetanus, pertussis (acellular), adsorbed liquid (Combination Vaccine) | suspension for injection 0.5 ml/dose, 0.5 ml | РК-БП-5No.018911 |
3945 | J07AJ52 | Adsorbed diphtheria-tetanus pertussis vaccine containing acellular pertussis component | Infanrix®, liquid adsorbed acellular pertussis-diphtheria-tetanus vaccine (Combination Vaccine) | suspension for injection 0.5 ml/dose 0.5 ml (1 dose) in syringe | РК-БП-5No.009832 |
J07AK | Vaccine for prevention of plague | ||||
3946 | J07AK | Vaccine for prevention of plague | Plague live dry vaccine | lyophilisate for suspension for cutaneous administration 2 ml | РК-БП-5No.003951 |
J07AL | Vaccine for prevention of pneumococcal infection | ||||
J07AL02 | Pneumococcal purified polysaccharide antigen conjugated | ||||
3947 | J07AL02 | Pneumococcal purified polysaccharide antigen conjugated | Prevenar 13® (pneumococcal polysaccharide conjugate adsorbed inactivated vaccine, liquid) | suspension for intramuscular administration 0.5 ml/dose in glass syringe | РК-БП-5No.016730 |
J07AL52 | Pneumococcal purified polysaccharide antigen and hemophilic infection, conjugated | ||||
3948 | J07AL52 | Pneumococcal purified polysaccharide antigen and hemophilic infection, conjugated | Synflorix (pneumococcal 10-valent polysaccharide and D-protein conjugated non-type Haemophilus influenzae vaccine, adsorbed) | suspension for intramuscular administration 0.5 ml/dose | РК-БП-5No.016356 |
J07AM | Tetanus vaccine | ||||
J07AM51 | Tetanus toxoid in combination with diphtheria toxoid | ||||
3949 | J07AM51 | Tetanus toxoid in combination with diphtheria toxoid | Diphtheria and Tetanus Adsorbed Vaccine (Pediatric) | suspension for injection 5.0 ml (10 doses) | РК-БП-5No.024231 |
3950 | J07AM51 | Tetanus toxoid in combination with diphtheria toxoid | Purified adsorbed diphtheria-tetanus toxoid with reduced antigen content | suspension for injection 5.0 ml (10 doses) | РК-БП-5No.024232 |
J07AN | Vaccine for prevention of tuberculosis | ||||
J07AN01 | Bacillus Calmette-Guerin (BCG) | ||||
3951 | J07AN01 | Bacillus Calmette-Guerin (BCG) | Freeze-dried vaccine BCG glutamate for intradermal administration | lyophilisate for suspension for intradermal administration, 0.5 mg, 20 doses for children | РК-БП-5No.013466 |
3952 | J07AN01 | Bacillus Calmette-Guerin (BCG) | Freeze-dried vaccine BCG glutamate for intradermal administration | lyophilisate for suspension for intradermal administration with solvent 1 ml | РК-БП-5No.024254 |
J07AP | Vaccine for prevention of typhoid fever | ||||
J07AP03 | Typhoid Purified Polysaccharide Vaccine | ||||
J07B | Vaccines for prevention of viral infections | ||||
J07BA | Vaccine for prevention of encephalitis | ||||
J07BA01 |
Tick-borne encephalitis virus | ||||
3953 | J07BA01 |
Tick-borne encephalitis virus | Tick-borne encephalitis vaccine cultural purified concentrated inactivated dry | lyophilisate for suspension for intramuscular administration with solvent - aluminum hydroxide gel 0.5 ml/dose | РК-БП-5No.004967 |
3954 | J07BA01 |
Tick-borne encephalitis virus | Tick-borne encephalitis vaccine cultural purified concentrated inactivated dry (Specific, inactivated tick-borne encephalitis virus (TBE) antigen) | lyophilisate for suspension for intramuscular administration with solvent - aluminum hydroxide gel 0.5 ml/dose | РК-БП-5No.004997 |
J07B | Viral vaccine | ||||
J07BB | Flu vaccine | ||||
J07BB02 | Subunit inactivated influenza vaccine | ||||
3955 | J07BB02 | Subunit inactivated influenza vaccine |
Influvac® Tetra | suspension for injection 0.5ml | РК-БП-5No.024063 |
3956 | J07BB02 | Subunit inactivated influenza vaccine | Vaxigripp Tetra®, inactivated quadrivalent split vaccine for prevention of influenza | suspension for intramuscular and subcutaneous administration 0.5 ml/1 dose | РК-БП-5No.023616 |
3957 | J07BB02 | Subunit inactivated influenza vaccine | Influvac | suspension for injection 0.5ml | РК-БП-5No.014228 |
3958 | J07BB02 | Subunit inactivated influenza vaccine | Grippol® plus (Influenza vaccine trivalent inactivated polymer-subunit) | suspension for intramuscular and subcutaneous administration, 0.5 ml (1 dose) | РК-БП-5No.019456 |
3959 | J07BB02 | Subunit inactivated influenza vaccine | Split inactivated influenza vaccine | suspension for injection 0.5ml | РК-БП-5No.022377 |
3960 | J07BB02 | Subunit inactivated influenza vaccine | Vaxigrip (inactivated split vaccine for the prevention of influenza) | suspension for intramuscular and subcutaneous administration 0.5 ml/1 dose | РК-БП-5No.004986 |
3961 | J07BB02 | Influenza, inactivated, split (split) virus or surface antigen | Grippol® Quadrivalent Influenza vaccine tetravalent inactivated subunit adjuvant | solution for intramuscular and subcutaneous administration 0.5 ml | РК-БП-5No.024489 |
J07BC | Vaccine for prevention of hepatitis | ||||
J07BC01 | Hepatitis B virus - purified antigen | ||||
3962 | J07BC01 | Hepatitis B virus - purified antigen | Euvax B, recombinant vaccine for prevention of hepatitis B | suspension for injection 1 ml | РК-БП-5No.022618 |
3963 | J07BC01 | Hepatitis B virus - purified antigen | Engerix® B (hepatitis B vaccine) | suspension for injection 10 mg 0.5 ml/dose | РК-БП-5No.004770 |
3964 | J07BC01 | Hepatitis B virus - purified antigen | Engerix® B (hepatitis B vaccine) | suspension for injection 20 mg 1 ml/dose | РК-БП-5No.010033 |
3965 | J07BC01 | Hepatitis B virus - purified antigen | Sci-B-Vac, Hepatitis B Vaccine (Recombinant) | suspension for injection 10 mg 1 ml/dose | РК-БП-5No.122157 |
3966 | J07BC01 | Hepatitis B virus - purified antigen | Recombivax HB, hepatitis B vaccine, recombinant | suspension for injection 10 mg/1 ml | РК-БП-5No.021576 |
3967 | J07BC01 | Hepatitis B virus - purified antigen | Recombivax HB, hepatitis B vaccine, recombinant | suspension for injection 5 mg/0.5 ml | РК-БП-5No.021575 |
3968 | J07BC01 | Hepatitis B virus - purified antigen | Hepatitis B vaccine (rDNA) | suspension for injection, 20 mcg/1.0ml | РК-БП-5No.024320 |
J07BC02 | Hepatitis A virus inactivated | ||||
3969 | J07BC02 | Hepatitis A virus inactivated | Ovaxstar A Inactivated Hepatitis A Vaccine | suspension for intramuscular injection 250ME/0.5ml | РК-БП-5No.024072 |
3970 | J07BC02 | Hepatitis A virus inactivated | Vaqta, hepatitis A vaccine, purified, inactivated, adsorbed | suspension for intramuscular administration 0.5 ml (1 dose) | РК-БП-5No.022431 |
3971 | J07BC02 | Hepatitis A virus inactivated | Havrix® 1440 adult, inactivated hepatitis A vaccine | suspension for injection 1 dose/1 ml | РК-БП-5No.004737 |
3972 | J07BC02 | Hepatitis A virus inactivated | Havrix® 720 for children, inactivated hepatitis A vaccine | suspension for injection 1 dose/0.5 ml | РК-БП-5No.005902 |
3973 | J07BC02 | Hepatitis A virus inactivated | Havrix™ 720 for children, inactivated hepatitis A vaccine | suspension for injection 1 dose/0.5 ml | РК-БП-5No.004738 |
3974 | J07BC02 | Hepatitis A virus inactivated | Avaxim 80 (inactivated, adsorbed vaccine for prevention of hepatitis A) | suspension for injection 1 dose/0.5 ml | РК-БП-5No.014593 |
3975 | J07BC02 | Hepatitis A virus inactivated | Havrix™ 1440 adult, inactivated hepatitis A vaccine | suspension for injection 1 dose/1 ml | РК-БП-5No.005901 |
J07BD | Measles vaccine | ||||
J07BD01 | Monovaccine against measles | ||||
3976 | J07BD01 | Monovaccine against measles | Freeze-dried live attenuated measles | lyophilisate for solution for subcutaneous administration with solvent 10 doses 0.5 ml | РК-БП-5No.022966 |
3977 | J07BD01 | Monovaccine against measles | Freeze-dried live attenuated measles | lyophilisate for solution for subcutaneous administration with solvent 1 dose 0.5 ml | РК-БП-5No.022966 |
J07BD52 | Measles, mumps and rubella vaccine | ||||
3978 | J07BD52 | Measles, mumps and rubella vaccine | Priorix™ (live attenuated measles, mumps and rubella) | lyophilisate for solution for injection with solvent 0.5 ml/dose | РК-БП-5No.004775 |
3979 | J07BD52 | Measles, mumps and rubella vaccine | Vaccine against measles, mumps and rubella live attenuated (lyophilized) | lyophilisate for solution for subcutaneous administration 0.5 ml 1 dose | РК-БП-5No.013464 |
J07BE01 | Mumps virus - live weakened | ||||
J07BF | Vaccines for prevention of poliomyelitis | ||||
J07BF02 | Poliomyelitis vaccine oral 1, 2, 3 types | ||||
J07BF04 | Bivalent oral poliomyelitis vaccine 1 and 3 types | ||||
3980 | J07BF04 | Bivalent oral poliomyelitis vaccine 1 and 3 types | Bivalent oral poliomyelitis vaccine 1 and 3 types | oral suspension 20 doses, 2 ml | РК-БП-5No.021251 |
J07BG | Rabies vaccine | ||||
J07BG01 | Rabies virus specific antigen | ||||
3981 | J07BG01 | Rabies virus specific antigen | Indyrab, rabies vaccine | lyophilized powder for solution for intramuscular injection with solvent (0.3% sodium chloride solution 0.5 ml) and disposable syringe included in set 2.5 IU/1 dose | РК-БП-5No.023180 |
3982 | J07BG01 | Rabies virus specific antigen | Speda | lyophilized powder for solution for intramuscular administration with solvent 2.5 IU | РК-БП-5No.020477 |
3983 | J07BG01 | Rabies virus specific antigen | Cultural concentrated purified inactivated dried antirabies vaccine | lyophilisate for solution for intramuscular injection, 1 dose with solvent - water for injection, 1.1 ml | РК-БП-5No.015799 |
3984 | J07BG01 | Rabies virus specific antigen | RABIVAX-S, concentrated purified inactivated rabies vaccine | lyophilisate for solution for intradermal and intramuscular administration, with solvent 2.5 IU | РК-БП-5No.024202 |
J07BK01 | Live attenuated virus Varicella zoster, OKA strain | ||||
3985 | J07BK01 | Live attenuated virus Varicella zoster, OKA strain | Varivax, varicella-zoster virus vaccine, live culture, attenuated | lyophilized powder for suspension for subcutaneous administration with solvent (water for injection) 0.5 ml/ dose | РК-БП-5No.021558 |
3986 | J07BK01 | Live attenuated virus Varicella zoster, OKA strain | Varilrix, varicella-zoster vaccine | lyophilized powder for injection with solvent 0.5 ml/ dose | РК-БП-5No.004870 |
J07BM | Human papillomavirus vaccines | ||||
J07BM01 | Human papillomavirus vaccine (types 6, 11, 16, 18) | ||||
3987 | J07BM01 | Human papillomavirus vaccine (types 6, 11, 16, 18) | Gardasil® Quadrivalent human papilloma virus (types 6, 11, 16, 18) recombinant vaccine | suspension for intramuscular injection 0.5 ml (1 dose) | РК-БП-5No.014205 |
3988 | J07BM01 | Human papillomavirus vaccine (types 6, 11, 16, 18) | Gardasil® Quadrivalent human papilloma virus (types 6, 11, 16, 18) recombinant vaccine | suspension for intramuscular injection 0.5 ml (1 dose) | РК-БП-5No.014206 |
J07BM02 | Human papillomavirus vaccine (types 16, 18) | ||||
3989 | J07BM02 | Human papillomavirus vaccine (types 16, 18) | Cervarix®, recombinant vaccine against Human Papilloma Virus types 16 and 18, containing adjuvant AS04 | suspension for injection 0.5 ml/dose | РК-БП-5No.010155 |
J07C | Combination of vaccines for prevention of viral and bacterial infections | ||||
J07CA02 | Vaccine against diphtheria, whooping cough, poliomyelitis, tetanus | ||||
3990 | J07CA02 | Vaccine against diphtheria, whooping cough, poliomyelitis, tetanus | Tetraxim, vaccine (adsorbed) against diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated) | suspension for injection 0.5 ml/1 dose | РК-БП-5No.021521 |
3991 | J07CA02 | Vaccine against diphtheria, whooping cough, poliomyelitis, tetanus | Infanrix®, liquid adsorbed acellular pertussis-diphtheria-tetanus vaccine (Combination vaccine) | suspension for injection 0.5 ml/dose | РК-БП-5No.009832 |
J07CA06 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, whooping cough, poliomyelitis, tetanus | ||||
3992 | J07CA06 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, whooping cough, poliomyelitis, tetanus | Infanrix IPV + Hib (vaccine for prevention of diphtheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and infection with Haemophilus influenzae type b conjugated (adsorbed)) | suspension for injection with lyophilized powder 0.5 ml (1 dose) | РК-БП-5No.018564 |
3993 | J07CA06 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, whooping cough, poliomyelitis, tetanus | Pentaxim, vaccine for prevention of diphtheria and tetanus, adsorbed; acellular pertussis; inactivated poliomyelitis and infection caused by Haemophilius influenzae influenza (hemophilus influenzae) type b, conjugated | lyophilisate with suspension 0.5 ml/1 dose | РК-БП-5No.013231 |
J07CA09 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, pertussis, polio, tetanus, hepatitis B | ||||
3994 | J07CA09 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, pertussis, polio, tetanus, hepatitis B | Hexaxim®, vaccine (adsorbed) against diphtheria, tetanus, pertussis (acellular), hepatitis B (recombinant rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugated hemophilus infection | suspension for injection 0.5 ml (1 dose) | РК-БП-5No.021471 |
3995 | J07CA09 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, pertussis, polio, tetanus, hepatitis B | Hexaxim® vaccine (adsorbed) against diphtheria, tetanus, pertussis (acellular), hepatitis B (recombinant rDNA), poliomyelitis (inactivated) and Heamophilus influenza (hemophilus influenzae) type b conjugated | suspension for injection 0.5 ml /1 dose | РК-БП-5No.020263 |
3996 | J07CA09 | Vaccine against diphtheria, heamophilus influenza (hemophilus influenzae) type b, pertussis, polio, tetanus, hepatitis B | Infanrix® Hexa (combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, and Haemophilus influenzae type b vaccine) | suspension for injection with lyophilized powder 0.5 ml/ dose | РК-БП-5No.013446 |
3997 | J07CA09 | Vaccine against diphtheria, Haemophilus influenzae type b, pertussis, poliomyelitis, tetanus, hepatitis B | IziSix | suspension for injection 0.5 ml | RK-LS-5No.024497 |
L | Antineoplastic and immunomodulating agents | ||||
L01 | Antineoplastic drugs | ||||
L01A | Alkylating drugs | ||||
L01AA | Nitrogen Mustard Analogues | ||||
L01AA01 | Cyclophosphamide | orphan | |||
3998 | L01AA01 | Cyclophosphamide | Endoxan | powder for solution for intravenous administration 1000 mg | RK-LS-5No.017597 |
3999 | L01AA01 | Cyclophosphamide | Endoxan | powder for solution for intravenous administration 500 mg | RK-LS-5No.017596 |
4000 | L01AA01 | Cyclophosphamide | Cyclophosphamide-Kelun-Kazpharm | lyophilisate for solution for intravenous administration 200 mg | RK-LS-5No.023424 |
4001 | L01AA01 | Cyclophosphamide | Endoxan | powder for solution for intravenous administration 200 mg | RK-LS-5No.017595 |
4002 | L01AA01 | Cyclophosphamide | Endoxan | sugar-coated tablets 50 mg | RK-LS-5No.023045 |
4003 | L01AA01 | Cyclophosphamide | Cyclophosphamide-LENS instant | lyophilisate for solution for intravenous and intramuscular administration 200 mg | RK-LS-5No.013851 |
L01AA02 | Chlorambucil | orphan | |||
L01AA03 | Melphalan | orphan | |||
4004 | L01AA03 | Melphalan | Alkeran® | lyophilized powder for solution for injection 50 mg | orphan |
L01AA06 | Ifosfamide | orphan | |||
4005 | L01AA06 | Ifosfamide | Holoxan | powder for solution for intravenous administration 0.5 g | RK-LS-5No.017040 |
4006 | L01AA06 | Ifosfamide | Holoxan | powder for solution for intravenous administration 1 g | RK-LS-5No.017038 |
4007 | L01AA06 | Ifosfamide | Holoxan | powder for solution for intravenous administration 2 g | RK-LS-5No.017039 |
L01AA09 | Bendamustine | orphan | |||
4008 | L01AA09 | Bendamustine | Ribomustine | powder for concentrate for solution for infusion 100 mg | RK-LS-5No.022458 RK-LS-5№022456 |
4009 | L01AA09 | Bendamustine | Ribomustine | powder for concentrate for solution for infusion 25 mg | RK-LS-5No.022455 |
4010 | L01AA09 | Bendamustine | Ribomustine | powder for concentrate for solution for infusion 25 mg | RK-LS-5No.022457 |
4011 | L01AA09 | Bendamustine | Termustin | lyophilized powder for concentrate for solution for infusion 25 mg | RK-LS-5No.023166 |
4012 | L01AA09 | Bendamustine | Termustin | lyophilized powder for concentrate for solution for infusion 100 mg | RK-LS-5No.023167 |
L01AB | Alkyl sulfonate | ||||
L01AB01 | Busulfan | orphan | |||
L01AB02 | Treosulfan | orphan | |||
4013 | L01AB02 | Treosulfan | Treosulfan Medak | powder for solution for infusion 5 g | RK-LS-5No.121750 |
4014 | L01AB02 | Treosulfan | Treosulfan Medak | powder for solution for infusion 1 g | RK-LS-5No.121749 |
L01AD | Nitrosourea | ||||
L01AD01 | Carmustine | ||||
4015 | L01AD01 | Carmustine | Carmustine | lyophilisate for solution for infusion 100 mg | |
4016 | L01AD01 | Carmustine | BiCNU® | lyophilisate for solution for infusion (100 mg) with solvent | RK-LS-5No.023523 |
L01AX | Other alkylating drugs | ||||
L01AX03 | Temozolomide | ||||
4017 | L01AX03 | Temozolomide | TemoEl | 250 mg capsules | RK-LS-5No.023337 |
4018 | L01AX03 | Temozolomide | Temobel | 250 mg capsules | RK-LS-5No.021229 |
4019 | L01AX03 | Temozolomide | TemoEl | 180 mg capsules | RK-LS-5No.023338 |
4020 | L01AX03 | Temozolomide | TemoEl | 140 mg capsules | RK-LS-5No.023339 |
4021 | L01AX03 | Temozolomide | Temobel | 100 mg capsules | RK-LS-5No.021228 |
4022 | L01AX03 | Temozolomide | Temobel | 20 mg capsules | RK-LS-5No.021227 |
4023 | L01AX03 | Temozolomide | TemoEl | 100 mg capsules | RK-LS-5No.023340 |
4024 | L01AX03 | Temozolomide | Temodal® | 140 mg capsules | RK-LS-5No.018160 |
4025 | L01AX03 | Temozolomide | Temozolomide-Teva | 140 mg capsules | RK-LS-5No.020805 |
4026 | L01AX03 | Temozolomide | Gliotem | 100 mg capsules | RK-LS-5No.121794 |
4027 | L01AX03 | Temozolomide | Gliotem | 180 mg capsules | RK-LS-5No.121795 |
4028 | L01AX03 | Temozolomide | Gliotem | 250 mg capsules | RK-LS-5No.121796 |
4029 | L01AX03 | Temozolomide | Temodal® | 180 mg capsules | RK-LS-5No.018161 |
4030 | L01AX03 | Temozolomide | Temozolomide-Teva | 180 mg capsules | RK-LS-5No.020806 |
4031 | L01AX03 | Temozolomide | Temozolomide-Teva | 20 mg capsules | RK-LS-5No.020803 |
4032 | L01AX03 | Temozolomide | Temozolomide-Teva | 100 mg capsules | RK-LS-5No.020804 |
4033 | L01AX03 | Temozolomide | Temozolomide-Teva | 250 mg capsules | RK-LS-5No.020807 |
4034 | L01AX03 | Temozolomide | Temozolomide | 100 mg hard capsules | RK-LS-5No.022250 |
4035 | L01AX03 | Temozolomide | Temozolomide | 180 mg hard capsules | RK-LS-5No.022252 |
4036 | L01AX03 | Temozolomide | Temozolomide | 20 mg hard capsules | RK-LS-5No.022249 |
4037 | L01AX03 | Temozolomide | Temozolomide | 140 mg hard capsules | RK-LS-5No.022251 |
4038 | L01AX03 | Temozolomide | Dralitem® | 250 mg capsules | RK-LS-5No.018941 |
4039 | L01AX03 | Temozolomide | Dralitem® | 100 mg capsules | RK-LS-5No.018940 |
L01AX04 | Dacarbazine | ||||
4040 | L01AX04 | Dacarbazine | Dacarbazine Medac | 500 mg lyophilized powder for solution for intravenous administration | RK-LS-5No.011766 |
4041 | L01AX04 | Dacarbazine | Dacarbazine Medac | 200 mg lyophilized powder for solution for intravenous administration | RK-LS-5No.011764 |
4042 | L01AX04 | Dacarbazine | Dacarbazine Medac | 200 mg lyophilized powder for solution for intravenous administration | RK-LS-5No.020359 |
4043 | L01AX04 | Dacarbazine | Dacarbazine Medac | 500 mg lyophilized powder for solution for intravenous administration | RK-LS-5No.020360 |
L01B | Antimetabolites | ||||
L01BA | Folic acid analogs | ||||
L01BA01 | Methotrexate | orphan | |||
4044 | L01BA01 | Methotrexate | Methotrexat Medac 1000 mg | solution for injection 1000 mg/10 ml | orphan |
4045 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.6 ml | RK-LS-5No.022840 |
4046 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.6 ml | RK-LS-5No.020261 |
4047 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.55 ml | RK-LS-5No.022841 |
4048 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.55 ml | RK-LS-5No.020260 |
4049 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.5 ml | RK-LS-5No.022842 |
4050 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.5 ml | RK-LS-5No.020259 |
4051 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.45 ml | RK-LS-5No.022843 |
4052 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.45 ml | RK-LS-5No.020258 |
4053 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.4 ml | RK-LS-5No.022844 |
4054 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.4 ml | RK-LS-5No.020257 |
4055 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.35 ml | RK-LS-5No.022845 |
4056 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.35 ml | RK-LS-5No.020256 |
4057 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.3 ml | RK-LS-5No.022846 |
4058 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.3 ml | RK-LS-5No.020255 |
4059 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.25 ml | RK-LS-5No.022847 |
4060 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.25 ml | RK-LS-5No.020254 |
4061 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.2 ml | RK-LS-5No.022848 |
4062 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.2 ml | RK-LS-5No.020253 |
4063 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.15 ml | RK-LS-5No.022849 |
4064 | L01BA01 | Methotrexate | Metoject® | solution for injection 50 mg/ml, 0.15 ml | RK-LS-5No.020252 |
4065 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection 20 mg/1 ml, 1 ml | RK-LS-5No.121688 |
4066 | L01BA01 | Methotrexate | Methotrexate-Kelun-Kazpharm | solution for injection 20 mg/2 ml, 2 ml | RK-LS-5No.023255 |
4067 | L01BA01 | Methotrexate | Methotrexate-Kelun-Kazpharm | solution for injection 15 mg/ 1.5 ml | RK-LS-5No.023254 |
4068 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection 15 mg/ 0.75 ml | RK-LS-5No.121687 |
4069 | L01BA01 | Methotrexate | Metoject® | solution for injection 10 mg/ ml 2 ml | RK-LS-5No.015105 |
4070 | L01BA01 | Methotrexate | Methotrexate-Kelun-Kazpharm | solution for injection 10 mg/ 1ml | RK-LS-5No.023253 |
4071 | L01BA01 | Methotrexate | Metoject® | solution for injection 10 mg/ ml 1 ml | RK-LS-5No.015103 |
4072 | L01BA01 | Methotrexate | Metoject® | solution for injection 10 mg/ ml, 1.5 ml | RK-LS-5No.015104 |
4073 | L01BA01 | Methotrexate | Metoject® | solution for injection 10 mg/ ml, 0.75 ml | RK-LS-5No.015102 |
4074 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection 10 mg/ 0.5 ml | RK-LS-5No.121686 |
4075 | L01BA01 | Methotrexate | Methotrexate-Kelun-Kazpharm | solution for injection 7.5 mg/ 0.75 ml | RK-LS-5No.023252 |
4076 | L01BA01 | Methotrexate | Methotrexate | 5 mg film coated tablets | RK-LS-5No.020525 |
4077 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection, 25mg / 1.25ml | RK-LS-5No.121689 |
4078 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection, 7.5mg/ 0.375ml | RK-LS-5No.121685 |
4079 | L01BA01 | Methotrexate | Methotrexate | 2.5 mg film coated tablets | RK-LS-5No.020524 |
4080 | L01BA01 | Methotrexate | Methotrexate | 2.5 mg coated tablets | RK-LS-5No.009914 |
4081 | L01BA01 | Methotrexate | Methotrexat Medac 1000 mg | solution for injection 1000 mg /10 ml | not registered (orphan drug) |
4082 | L01BA01 | Methotrexate | Metorthrit Rompharm | solution for injection in pre-filled syringes, 10 mg/ml | RK-LS-5No.024014 |
4083 | L01BA01 | Methotrexate | Metorthrit Rompharm | solution for injection 10 mg/ ml, 2.5 ml in syringe | RK-LS-5No.015106 |
4084 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection in pre-filled syringes, 10 mg/ml | RK-LS-5No.024012 |
4085 | L01BA01 | Methotrexate | Metorthrit Rompharm | solution for injection 10 mg/ ml, 1.5 ml in syringe | RK-LS-5No.024013 |
4086 | L01BA01 | Methotrexate | Metorthrit Rompharm | solution for injection 10 mg/ ml, 0.75 ml in syringe | RK-LS-5No.024019 |
4087 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection 20 mg/1 ml, 1 ml | RK-LS-5No.121688 |
4088 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection 15 mg/ 0.75 ml | RK-LS-5No.121687 |
4089 | L01BA01 | Methotrexate | Methotrexate Sandoz® | solution for injection 10 mg/ 0.5 ml | RK-LS-5No.121686 |
4090 | L01BA02 | Methotrexate | Methotrexate | concentrate for solution for infusion 5000 mg/50 ml | not registered (orphan drug) |
4091 | L01BA03 | Methotrexate | Methotrexate | concentrate for solution for infusion 500 mg/5 ml | not registered (orphan drug) |
L01BA04 | Pemetrexed | orphan | |||
4092 | L01BA04 | Pemetrexed | Pemetrexed-Kelun-Kazpharm | lyophilisate for solution for infusion 500 mg | RK-LS-5No.023140 |
4093 | L01BA04 | Pemetrexed | Pemetrexed-Kelun-Kazpharm | lyophilisate for solution for infusion 500 mg | RK-LS-5No.022305 |
4094 | L01BA04 | Pemetrexed | Martxel | lyophilisate for solution for infusion 500 mg | RK-LS-5No.022194 |
4095 | L01BA04 | Pemetrexed | Pemetrepol | lyophilisate for solution for infusion 500 mg | RK-LS-5No.023088 |
4096 | L01BA04 | Pemetrexed | Alimta™ | lyophilisate for solution for infusion 500 mg | RK-LS-5No.003686 |
4097 | L01BA04 | Pemetrexed | Pemetrexed-Kelun-Kazpharm | lyophilisate for solution for infusion 100 mg | RK-LS-5No.022304 |
4098 | L01BA04 | Pemetrexed | Pemetrexed-Kelun-Kazpharm | lyophilisate for solution for infusion 100 mg | RK-LS-5No.023139 |
4099 | L01BA04 | Pemetrexed | Alimta® | lyophilisate for solution for infusion 100 mg | RK-LS-5No.017757 |
4100 | L01BA04 | Pemetrexed | Martxel | lyophilisate for solution for infusion 100 mg | RK-LS-5No.022166 |
4101 | L01BA04 | Pemetrexed | Pemetrepol | lyophilisate for solution for infusion 100 mg | RK-LS-5No.023087 |
4102 | L01BA04 | Pemetrexed | Petrexa® | lyophilisate for solution for infusion 500 mg | RK-LS-5No.022297 |
4103 | L01BA04 | Pemetrexed | Pemgem | lyophilisate for solution for infusion 500 mg | RK-LS-5No.022870 |
4104 | L01BA04 | Pemetrexed | Pemgem | lyophilisate for solution for infusion 100 mg | RK-LS-5No.022871 |
4105 | L01BA04 | Pemetrexed | Praxed | lyophilisate for solution for infusion 100 mg | RK-LS-5No.023319 |
4106 | C07AB02 | Metoprolol | Met ХL 100 | 100 mg film coated tablets, sustained release | RK-LS-5No.023029 |
4107 | L01BA04 | Pemetrexed | Pemetrexed | lyophilized powder for solution for infusion 500 mg | RK-LS-5No.023061 |
4108 | L01BA04 | Pemetrexed | Alvoxed | lyophilisate for solution for infusion 100 mg | RK-LS-5No.023215 |
4109 | L01BA04 | Pemetrexed | Alvoxed | lyophilisate for solution for infusion 500 mg | RK-LS-5No.023216 |
4110 | L01BA04 | Pemetrexed | Pemetrexed Teva | lyophilisate for solution for infusion 100 mg | RK-LS-5No.023240 |
4111 | L01BA04 | Pemetrexed | Pemetrexed Teva | lyophilisate for solution for infusion 500 mg | RK-LS-5No.023241 |
4112 | L01BA04 | Pemetrexed | Praxed | lyophilisate for solution for infusion 500 mg | RK-LS-5No.023320 |
L01BB | Purine analogs | ||||
L01BB02 | Mercaptopurine | orphan | |||
L01BB03 | Tioguanine | ||||
L01BB04 | Cladribine | orphan | |||
4113 | L01BB04 | Cladribine | Leicladin | 0.1% solution for injection | RK-LS-5No.016918 |
L01BB05 | Fludarabine | orphan | |||
4114 | L01BB05 | Fludarabine | Fludarabine-Kelun-Kazpharm | concentrate for solution for infusion 50 mg/2 ml | RK-LS-5No.023228 |
4115 | L01BB05 | Fludarabine | Fludarabine SK | 10 mg coated tablets | RK-LS-5No.022928 |
4116 | L01BB05 | Fludarabine | Fludarabine-Teva | concentrate for solution for infusion 25 mg/ml, 2 ml | RK-LS-5No.014863 |
4117 | L01BB05 | Fludarabine | Fludara® | 10 mg film coated tablets | RK-LS-5No.003365 |
4118 | L01BB05 | Fludarabine | Fludarabine SK | lyophilized powder for solution for injection, 50 mg | RK-LS-5No.023103 |
4119 | L01BB05 | Fludarabine | Fludarabine SK | concentrate for solution for intravenous administration 50 mg/2ml | RK-LS-5No.023062 |
4120 | L01BB05 | Fludarabine | fludameda | concentrate for solution for injection or infusion, 25 mg/ ml | RK-LS-5No.023200 |
L01BC | Pyrimidine analogs | ||||
L01BC01 | Cytarabine | orphan | |||
4121 | L01BC01 | Cytarabine | CITU | solution for injection 1000 mg/10ml | RK-LS-5No.024325 |
L01BC02 | Fluorouracil | ||||
4122 | L01BC02 | Fluorouracil | Fluorouracil-LENS | solution for intravascular administration 50 mg/ml | RK-LS-5No.013839 |
4123 | L01BC03 | Tegafur | Ftorafur® | 400 mg capsules | RK-LS-5No.003860 |
L01BC05 | Gemcitabine | ||||
4124 | L01BC05 | Gemcitabine | Gemcitabine medac | 1500 mg lyophilisate for solution for infusion | RK-LS-5No.018146 |
4125 | L01BC05 | Gemcitabine | Gemcitabine medac | 1000 mg lyophilisate for solution for infusion | RK-LS-5No.018145 |
4126 | L01BC05 | Gemcitabine | Gemcitabine-Kelun-Kazpharm | 1000 mg lyophilisate for solution for infusion | RK-LS-5No.023147 |
4127 | L01BC05 | Gemcitabine | Gemcitabine medac | 200 mg lyophilisate for solution for infusion | RK-LS-5No.018144 |
4128 | L01BC05 | Gemcitabine | Gemcitabine-Kelun-Kazpharm | 200 mg lyophilisate for solution for infusion | RK-LS-5No.023146 |
4129 | L01BC05 | Gemcitabine | Gemtan | lyophilisate for solution for injection, 1 g | RK-LS-5No.023943 |
4130 | L01BC05 | Gemcitabine | Gemtaz | lyophilized powder for solution for intravenous administration 1000 mg | RK-LS-5No.016617 |
4131 | L01BC05 | Gemcitabine | Gemtaz | lyophilized powder for solution for intravenous administration 200 mg | RK-LS-5No.016616 |
4132 | L01BC05 | Gemcitabine | Ribozar | lyophilized powder for solution for intravenous administration 200 mg | RK-LS-5No.023007 |
L01BC06 | Capecitabine | ||||
4133 | L01BC06 | Capecitabine | Ecansya® | 150 mg film coated tablets | RK-LS-5No.020584 |
4134 | L01BC06 | Capecitabine | Capecitabine | 150 mg film coated tablets | RK-LS-5No.021184 |
4135 | L01BC06 | Capecitabine | Xeloda | 500 mg coated tablets | RK-LS-5No.014411 |
4136 | L01BC06 | Capecitabine | Capecitabine | 500 mg film coated tablets | RK-LS-5No.021185 |
4137 | L01BC06 | Capecitabine | Kapfuro® | 500 mg film coated tablets | RK-LS-5No.022560 |
4138 | L01BC06 | Capecitabine | Ecansya® | 500 mg film coated tablets | RK-LS-5No.020585 |
4139 | L01BC06 | Capecitabine | Xalvobin | 500 mg film coated tablets | RK-LS-5No.021174 |
4140 | L01BC06 | Capecitabine | Capecitabine Accord | 500 mg film coated tablets | RK-LS-5No.022478 |
4141 | L01BC06 | Capecitabine | Citabin | 500 mg film coated tablets | RK-LS-5No.020829 |
4142 | L01BC06 | Capecitabine | Capecitabine Accord | 150 mg film coated tablets | RK-LS-5No.022423 |
4143 | L01BC06 | Capecitabine | Capecitabine-Teva | 500 mg film coated tablets | RK-LS-5No.019805 |
4144 | L01BC06 | Capecitabine | Kakseta | 500 mg film coated tablets | RK-LS-5No.020353 |
4145 | L01BC06 | Capecitabine | Kapetral | 500 mg film coated tablets | RK-LS-5No.122039 |
4146 | L01BC06 | Capecitabine | Xalvobin | 150 mg film coated tablets | RK-LS-5No.021173 |
4147 | L01BC06 | Capecitabine | Kapetral | 150 mg film coated tablets | RK-LS-5No.122038 |
4148 | L01BC06 | Capecitabine | Capegard-500 | 500 mg film coated tablets | RK-LS-5No.022726 |
4149 | L01BC06 | Capecitabine | Capecitabine Grindex | 150 mg film coated tablets | RK-LS-5No.022736 |
4150 | L01BC06 | Capecitabine | Capecitabine Grindex | 500 mg film coated tablets | RK-LS-5No.022779 |
4151 | L01BC06 | Capecitabine | Kakseta | 150 mg film coated tablets | RK-LS-5No.020352 |
L01BC07 | Azacitidine | orphan | |||
4152 | L01BC07 | Azacitidine | Vidaza | lyophilisate for suspension for subcutaneous administration 100 mg | RK-LS-5No.121977 |
4153 | L01BC07 | Azacitidine | Vidaza | lyophilisate for suspension for subcutaneous administration 100 mg | RK-LS-5No.121977 |
L01BC08 | Decitabine | orphan | |||
4154 | L01BC08 | Decitabine | Decicip | lyophilized powder for solution for infusion 50 mg | RK-LS-5No.022829 |
4155 | L01BC08 | Decitabine | Dacogen | lyophilisate for solution for infusion 50 mg | RK-LS-5No.020784 |
L01C | Herbal alkaloids and other natural products | ||||
L01CA | Vinca alkaloids and analogues | ||||
L01CA01 | Vinblastine | orphan | |||
4156 | L01CA01 | Vinblastine | Vinblastin-LANS | lyophilisate for solution for intravenous administration, 5 mg | RK-LS-5No.021214 |
L01CA02 | Vincristine | ||||
L01CA04 | Vinorelbine | ||||
4157 | L01CA04 | Vinorelbine | Vinelbine | concentrate for solution for infusion 50 mg/5 ml | RK-LS-5No.021491 |
4158 | L01CA04 | Vinorelbine | Vinorelbine Kelun-Kazpharm | concentrate for solution for infusion 50 mg/5 ml | RK-LS-5No.022275 |
4159 | L01CA04 | Vinorelbine | Vinorelbine Kelun-Kazpharm | concentrate for solution for infusion 10 mg/1 ml, 1 ml | RK-LS-5No.022274 |
4160 | L01CA04 | Vinorelbine | Vinorelbine medac | concentrate for solution for infusion 10 mg/ml | RK-LS-5No.021147 |
4161 | L01CA04 | Vinorelbine | Navelbine | concentrate for solution for infusion 10 mg/ml | RK-LS-5No.005338 |
4162 | L01CA04 | Vinorelbine | Navelbine | concentrate for solution for infusion 10 mg/ml | RK-LS-5No.021493 |
4163 | L01CA04 | Vinorelbine | Velbimeda | concentrate for solution for infusion 10 mg/ml | RK-LS-5No.023280 |
4164 | L01CA04 | Vinorelbine | Velbimeda | concentrate for solution for infusion 10 mg/ml | RK-LS-5No.023281 |
4165 | L01CA04 | Vinorelbine | Navelbine | concentrate for solution for infusion, 50 mg/5 ml | RK-LS-5No.005346 |
4166 | L01CA04 | Vinorelbine | Navelbine | 20 mg capsule | RK-LS-5No.020162 |
4167 | L01CA04 | Vinorelbine | Navelbine | 30 mg capsule | RK-LS-5No.020163 |
L01CB | Podophyllotoxin Derivatives | ||||
L01CB01 | Etoposide | orphan | |||
4168 | L01CB01 | Etoposide | Fytosid | solution for injection 100mg/ 5ml, 5 ml | RK-LS-5No.122139 |
L01CD | Taxoids | ||||
L01CD01 | Paclitaxel | ||||
4169 | L01CD01 | Paclitaxel | Paclitaxel-Kelun-Kazpharm | concentrate for solution for infusion, 300 mg/50 ml | RK-LS-5No.022475 |
4170 | L01CD01 | Paclitaxel | Paclitaxel Medac | concentrate for solution for infusion 6 mg/ml, 50 ml | RK-LS-5No.018706 |
4171 | L01CD01 | Paclitaxel | Paclitaxel-Kelun-Kazpharm | concentrate for solution for infusion 60mg/10 ml | RK-LS-3No.121656 |
4172 | L01CD01 | Paclitaxel | Paclitaxel Medac | concentrate for solution for infusion 6 mg/ml, 5 ml | RK-LS-5No.018704 |
4173 | L01CD01 | Paclitaxel | Paclitaxel Medac | concentrate for solution for infusion 6 mg/ml | RK-LS-5No.018705 |
4174 | L01CD01 | Paclitaxel | Paclitaxel-Kelun-Kazpharm | concentrate for solution for infusion 30 mg/5 ml | RK-LS-3No.121655 |
4175 | L01CD01 | Paclitaxel | Paclitaxel-Kelun-Kazpharm | concentrate for solution for infusion 100 mg/16.7 ml | RK-LS-3No.121657 |
4176 | L01CD01 | Paclitaxel | Paclitaxel | concentrate for solution for infusion 100 mg/16.7 ml | RK-LS-5No.021386 |
4177 | L01CD01 | Paclitaxel | Paclitaxel-Teva | concentrate for solution for infusion 100 mg/16.7 ml | RK-LS-5No.013729 |
4178 | L01CD01 | Paclitaxel | Paclitaxel | concentrate for solution for infusion 30 mg/5 ml | RK-LS-5No.021385 |
4179 | L01CD01 | Paclitaxel | Paclitaxel-Teva | concentrate for solution for infusion 30 mg/5 ml | RK-LS-5No.013728 |
4180 | L01CD01 | Paclitaxel | Paclitaxel-Teva | concentrate for solution for infusion 300 mg/50 ml | RK-LS-5No.013731 |
4181 | L01CD01 | Paclitaxel | Paclitaxel-TEVA | concentrate for solution for infusion 150mg/25ml | RK-LS-5No.013730 |
4182 | L01CD01 | Paclitaxel | Intaxel | concentrate for solution for infusion 30 mg/5 ml | RK-LS-5No.021573 |
4183 | L01CD01 | Paclitaxel | Intaxel | concentrate for solution for infusion 100 mg/17 ml | RK-LS-5No.021574 |
4184 | L01CD01 | Paclitaxel | Paclikal | lyophilisate for solution for infusion 60 mg | RK-LS-5No.023415 |
4185 | L01CD01 | Paclitaxel | Paclikal | lyophilisate for solution for infusion 60 mg | RK-LS-5No.023416 |
4186 | L01CD01 | Paclitaxel | Nanotaxel | concentrate for solution for infusion 100 mg | RK-LS-5No.023432 |
4187 | L01CD01 | Paclitaxel | Nanotaxel | concentrate for solution for infusion 300 mg | RK-LS-5No.023433 |
4188 | L01CD01 | Paclitaxel | Taxomed | concentrate for solution for infusion 6 mg/ml | RK-LS-5No.023953 |
4189 | L01CD01 | Paclitaxel | Taxomed | concentrate for solution for infusion 6 mg/ml | RK-LS-5No.023959 |
4190 | L01CD01 | Paclitaxel | Taxomed | concentrate for solution for infusion 6 mg/ml | RK-LS-5No.023963 |
L01CD02 | Docetaxel | ||||
4191 | L01CD02 | Docetaxel | Docetaxel-Kelun-Kazpharm | concentrate for solution for infusion 80 mg/4 ml | RK-LS-3No.121654 ДД |
4192 | L01CD02 | Docetaxel | Docetaxel Accord | concentrate for solution for infusion 80 mg/4 ml | RK-LS-5No.122136 |
4193 | L01CD02 | Docetaxel | Docetaxel-Kelun-Kazpharm | concentrate for solution for infusion 20 mg/ml | RK-LS-3No.121653 |
4194 | L01CD02 | Docetaxel | Docetaxel Accord | concentrate for solution for infusion 20 mg/1ml | RK-LS-5No.122135 |
4195 | L01CD02 | Docetaxel | Docetaxel-Kelun-Kazpharm | concentrate for solution for infusion 20 mg/4ml | RK-LS-3No.121654 |
4196 | L01CD02 | Docetaxel | Taxotere® | concentrate for solution for infusion 20 mg/1ml | RK-LS-5No.018175 |
4197 | L01CD02 | Docetaxel | Docetaxel-Teva | concentrate for solution for infusion 20 mg | RK-LS-5No.021426 |
4198 | L01CD02 | Docetaxel | Taxotere® | concentrate for solution for infusion 80 mg/4ml | RK-LS-5No.018176 |
4199 | L01CD02 | Docetaxel | Docetaxel-Teva | concentrate for solution for infusion 80 mg | RK-LS-5No.021427 |
4200 | L01CD02 | Docetaxel | Docesen | concentrate for solution for infusion with solvent, 80 mg/2.36 ml | RK-LS-5No.020922 |
4201 | L01CD02 | Docetaxel | Docesen | concentrate for solution for infusion with solvent, 20mg/0.61 ml | RK-LS-5No.020923 |
4202 | L01CD02 | Docetaxel | Tautax | concentrate for solution for infusion 20 mg/1 ml | RK-LS-5No.021057 |
4203 | L01CD02 | Docetaxel | Tautax | concentrate for solution for infusion 40 mg/2 ml | RK-LS-5No.021058 |
4204 | L01CD02 | Docetaxel | Tautax | concentrate for solution for infusion 80 mg/4 ml | RK-LS-5No.021059 |
4205 | L01CD02 | Docetaxel | Tautax | concentrate for solution for infusion 110 mg/5.5 ml | RK-LS-5No.021060 |
4206 | L01CD02 | Docetaxel | Tolnexa | concentrate for solution for infusion 20 mg/ml | RK-LS-5No.021495 |
4207 | L01CD02 | Docetaxel | Tolnexa | concentrate for solution for infusion 20 mg/ml | RK-LS-5No.021496 |
4208 | L01CD02 | Docetaxel | Tolnexa | concentrate for solution for infusion 20 mg/ml | RK-LS-5No.021497 |
4209 | L01CD02 | Docetaxel | Zenoter | concentrate for solution for infusion with solvent, 20mg/0.5ml | RK-LS-5No.121798 |
4210 | L01CD02 | Docetaxel | Zenoter | concentrate for solution for infusion with solvent, 80mg/2ml | RK-LS-5No.121799 |
4211 | L01CD02 | Docetaxel | Docetaxel-Kelun-Kazpharm | concentrate for solution for infusion, 40mg/1ml | RK-LS-5No.022182 |
4212 | L01CD02 | Docetaxel | Docetaxel-Kelun-Kazpharm | concentrate for solution for infusion, 120 mg/6 ml | RK-LS-5No.022895 |
4213 | L01CD02 | Docetaxel | Docetaxel-Kelun-Kazpharm | concentrate for solution for infusion, 160 mg/8 ml | RK-LS-5No.022898 |
4214 | L01DC03 | Mitomycin C | Mitomycin medac | lyophilized powder for solution for injection, infusion or intravesical administration, 20 mg in 1 vial | orphan |
4215 | L01DC03 | Mitomycin C | Mitomycin medac | lyophilized powder for solution for injection, infusion or intravesical administration, 40 mg in 1 vial | orphan |
L01X | Other antineoplastic drugs | ||||
L01XA | Platinum compounds | ||||
L01XA01 | Cisplatin | ||||
4216 | L01XA01 | Cisplatin | Cisplatin-Kelun Kazpharm | concentrate for solution for infusion 50 mg/50 ml | RK-LS-5No.022276 |
4217 | L01XA01 | Cisplatin | Cisplatin-Kelun Kazpharm | concentrate for solution for infusion 20 mg/20 ml | RK-LS-5No.023014 |
4218 | L01XA01 | Cisplatin | Cisplatin-LENS | concentrate for solution for infusion, 0.5 mg | RK-LS-5No.014385 |
4219 | L01XA01 | Cisplatin | Kemoplat | solution for injection, 50mg/100ml | RK-LS-5No.022606 |
4220 | L01XA01 | Cisplatin | Kemoplat | solution for injection, 10mg/20ml | RK-LS-5No.022559 |
L01XA02 | Carboplatin | ||||
4221 | L01XA02 | Carboplatin | Carboplatin medak | concentrate for solution for infusion 10 mg 15 ml | RK-LS-5No.023985 |
4222 | L01XA02 | Carboplatin | Carboplatin-Kelun-Kazpharm | concentrate for solution for infusion 150 mg/15 ml | RK-LS-5No.023492 |
4223 | L01XA02 | Carboplatin | Carboplatin-Kelun-Kazpharm | concentrate for solution for infusion 10 mg/ml, 1 ml | RK-LS-5No.023490 |
4224 | L01XA02 | Carboplatin | Carboplatin-Kelun-Kazpharm | concentrate for solution for infusion 50mg/5ml, 5 ml | RK-LS-5No.023491 |
4225 | L01XA02 | Carboplatin | Carboplatin-LENS | concentrate for solution for infusion 10 mg/ml 15 ml | RK-LS-5No.013840 |
4226 | L01XA02 | Carboplatin | Kemocarb | solution for injection 150mg/ 15ml 15 ml | RK-LS-5No.013064 |
4227 | L01XA02 | Carboplatin | Carboplatin-LENS | concentrate for solution for infusion 10 mg/ml 15 ml | RK-LS-5No.013840 |
4228 | L01XA02 | Carboplatin | Kemocarb | solution for injection 450mg/ 45ml 45 ml | RK-LS-5No.013065 |
4229 | L01XA02 | Carboplatin | Carbomedac | concentrate for solution for infusion 10 mg/45 ml | |
4230 | L01XA02 | Carboplatin | Ribocarbo-L | concentrate for solution for infusion 10 mg/ml, 60 ml | RK-LS-5No.023691 |
4231 | L01XA02 | Carboplatin | Ribocarbo-L | concentrate for solution for infusion 10 mg/ml, 45 ml | RK-LS-5No.023692 |
4232 | L01XA02 | Carboplatin | Ribocarbo-L | concentrate for solution for infusion 10 mg/ml, 15 ml | RK-LS-5No.023693 |
4233 | L01XA02 | Carboplatin | Ribocarbo-L | concentrate for solution for infusion 10 mg/ml, 5 ml | RK-LS-5No.023694 |
4234 | L01XA02 | Carboplatin | Carboplatin medak | concentrate for solution for infusion 10 mg/ml, 45 ml | RK-LS-5No.023984 |
L01XA03 | Oxaliplatin | orphan | |||
4235 | L01XA03 | Oxaliplatin | Oxaliplatin-Kelun-Kazpharm | concentrate for solution for infusion 50 mg/10 ml, 10 ml | RK-LS-5No.022270 |
4236 | L01XA03 | Oxaliplatin | Oxaliplatin medak | powder for solution for infusion 50 mg | RK-LS-5No.014582 |
4237 | L01XA03 | Oxaliplatin | Oxaliplatin medak | powder for solution for infusion 100 mg | RK-LS-5No.014583 |
4238 | L01XA03 | Oxaliplatin | Oxaliplatin | lyophilized powder for solution for infusion, 100 mg | RK-LS-5No.023321 |
4239 | L01XA03 | Oxaliplatin | Oxaliplatin | lyophilized powder for solution for infusion, 50 mg | RK-LS-5No.023322 |
4240 | L01XA03 | Oxaliplatin | Oxaliplatin-Teva | concentrate for solution for infusion 5 mg/ml 10 ml | RK-LS-5No.016820 |
4241 | L01XA03 | Oxaliplatin | Oxaliplatin-Teva | concentrate for solution for infusion 5 mg/ml 20 ml | RK-LS-5No.016821 |
L01XC | Monoclonal antibodies | ||||
4242 | L01XC | Monoclonal Antibodies (Nimotuzumab) | Nimotuzumab® | concentrate for solution for infusion 5 mg/ml 10 ml | РК-БП-5No.023564 |
L01XC02 | Rituximab | orphan | |||
4243 | L01XC02 | Rituximab | Mabthera | solution for subcutaneous injection 1600 mg/13.4 ml | RK-LS-5No.023257 |
4244 | L01XC02 | Rituximab | Mabthera | solution for subcutaneous injection 1400 mg/11.7 ml | RK-LS-5No.022464 |
4245 | L01XC02 | Rituximab | Truxima | concentrate for solution for intravenous infusion 500 mg/50 ml | RK-LS-5No.023577 |
4246 | L01XC02 | Rituximab | Mabthera | concentrate for solution for intravenous infusion 500 mg/50 ml | RK-LS-5No.021270 |
4247 | L01XC02 | Rituximab | Mabthera | concentrate for solution for intravenous infusion 500 mg/50 ml | RK-LS-5No.007994 |
4248 | L01XC02 | Rituximab | Mabthera | concentrate for solution for intravenous infusion 500 mg/50 ml, 50 ml | RK-LS-5No.023353 |
4249 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 50 ml | RK-LS-5No.022289 |
4250 | L01XC02 | Rituximab | Rituximab | concentrate for solution for infusion 10 mg/ml, 50 ml | RK-LS-5No.023141 |
4251 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 10 ml | RK-LS-5No.022289 |
4252 | L01XC02 | Rituximab | Rituximab | concentrate for solution for infusion 10 mg/ml, 10 ml | RK-LS-5No.023115 |
4253 | L01XC02 | Rituximab | Mabthera | concentrate for solution for intravenous infusion 100 mg/10 ml, 10 ml | RK-LS-5No.021269 |
4254 | L01XC02 | Rituximab | Mabthera | concentrate for solution for intravenous infusion 100 mg/10 ml | RK-LS-5No.007993 |
4255 | L01XC02 | Rituximab | Mabthera | concentrate for solution for intravenous infusion 100 mg/10 ml, 10 ml | RK-LS-5No.023352 |
4256 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 10 ml | RK-LS-5No.021965 |
4257 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 30 ml | RK-LS-5No.021965 |
4258 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 50 ml | RK-LS-5No.021965 |
4259 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 10 ml | RK-LS-5No.023205 |
4260 | L01XC02 | Rituximab | Acellbia® | concentrate for solution for infusion 10 mg/ml, 50 ml | RK-LS-5No.023206 |
4261 | L01XC02 | Rituximab | Truxima | concentrate for solution for intravenous infusion, 100 mg/10 ml | RK-LS-5No.023576 |
4262 | L01XC02 | Rituximab | Truxima | concentrate for solution for intravenous infusion, 500 mg/50 ml | RK-LS-5No.023594 |
4263 | L01XC02 | Rituximab | Truxima | concentrate for solution for intravenous infusion, 100 mg/10 ml | RK-LS-5No.023581 |
L01XC03 | Trastuzumab | ||||
4264 | L01XC03 | Trastuzumab | Trastuzumab | lyophilisate for concentrate for solution for infusion 440 mg, 20 ml | RK-LS-5No.023112 |
4265 | L01XC03 | Trastuzumab | Trastuzumab | lyophilisate for concentrate for solution for infusion 440 mg, with solvent - bacteriostatic water for injection, 20 ml | РК-БП-5No.023665 |
4266 | L01XC03 | Trastuzumab | Trastuzumab | lyophilisate for concentrate for solution for infusion, 150 mg | RK-LS-5No.022647 |
4267 | L01XC03 | Trastuzumab | Trastuzumab | lyophilisate for concentrate for solution for infusion, 440 mg, 20 ml | RK-LS-5No.022648 |
4268 | L01XC03 | Trastuzumab | Herceptin | lyophilized powder for concentrate for infusion solution with solvent 440 mg, 20 ml | RK-LS-5No.004273 |
4269 | L01XC03 | Trastuzumab | Herceptin | lyophilized powder for concentrate for infusion solution 440 mg | RK-LS-5No.023230 |
4270 | L01XC03 | Trastuzumab | Herceptin | solution for injection 120 mg/ ml, 5 ml | RK-LS-5No.022261 |
4271 | L01XC03 | Trastuzumab | Herzuma® | lyophilized powder for concentrate, for solution for infusion 150 mg | РК-БП-5No.024466 |
4272 | L01XC03 | Trastuzumab | Herzuma® | lyophilized powder for concentrate, for solution for infusion 150 mg | РК-БП-5No.024468 |
4273 | L01XC03 | Trastuzumab | Herzuma® | Lyophilized powder for concentrate, for solution for infusion with solvent 440 mg | РК-БП-5No.024467 |
4274 | L01XC03 | Trastuzumab | Herzuma® | Lyophilized powder for concentrate, for solution for infusion with solvent 440 mg | РК-БП-5No.024465 |
L01XC06 | Cetuximab | ||||
4275 | L01XC06 | Cetuximab | Erbitux® | solution for infusion 5mg/ml, 20 ml | RK-LS-5No.013421 |
L01XC07 | Bevacizumab | ||||
4276 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 16 ml | RK-LS-5No.023114 |
4277 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 16 ml | RK-LS-5No.023687 |
4278 | L01XC07 | Bevacizumab | Avastin | concentrate for solution for infusion 400 mg/16 ml, 16 ml | RK-LS-5No.009863 |
4279 | L01XC07 | Bevacizumab | Avastin | concentrate for solution for infusion 400 mg/16 ml, 16 ml | RK-LS-5No.019084 |
4280 | L01XC07 | Bevacizumab | Avastin | concentrate for solution for infusion 400 mg/16 ml, 16 ml | RK-LS-5No.023296 |
4281 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 4 ml | RK-LS-5No.023113 |
4282 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 4 ml | РК-БП-5No.023685 |
4283 | L01XC07 | Bevacizumab | Avastin | concentrate for solution for infusion 100 mg/4 ml, 4 ml | RK-LS-5No.023295 |
4284 | L01XC07 | Bevacizumab | Avastin | concentrate for solution for infusion 100 mg/4 ml, 4 ml | RK-LS-5No.009862 |
4285 | L01XC07 | Bevacizumab | Avastin | concentrate for solution for infusion 100 mg/4 ml, 4 ml | RK-LS-5No.019083 |
4286 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 0.5 ml | RK-LS-5No.022649 |
4287 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 4 ml | RK-LS-5No.022650 |
4288 | L01XC07 | Bevacizumab | Bevacizumab | concentrate for solution for infusion 25 mg/ml, 16 ml | RK-LS-5No.022651 |
4289 | L01XC07 | Bevacizumab | Avegra® | concentrate for solution for infusion, 25 ml, 0.5 ml | RK-LS-5No.023282 |
4290 | L01XC07 | Bevacizumab | Avegra® | concentrate for solution for infusion, 25 ml, 4 ml | RK-LS-5No.023283 |
4291 | L01XC07 | Bevacizumab | Avegra® | concentrate for solution for infusion, 25 ml, 16 ml | RK-LS-5No.023284 |
L01XC08 | Panitumumab | ||||
4292 | L01XC08 | Panitumumab | Vektibiks | concentrate for solution for infusion 20 mg/ml (100 mg/5 ml), 5 ml | RK-LS-5No.020049 |
4293 | L01XC08 | Panitumumab | Vektibiks | concentrate for solution for infusion 20 mg/ml (400 mg/20 ml), 20 ml | RK-LS-5No.020050 |
L01XC10 | Ofatumumab | ||||
4294 | L01XC10 | Ofatumumab | Arzerra® | concentrate for solution for infusion 100 mg, 5 ml | RK-LS-5No.020279 |
4295 | L01XC10 | Ofatumumab | Arzerra® | concentrate for solution for infusion 1000 mg, 50 ml | RK-LS-5No.020278 |
L01XC12 | Brentuximab vedotin | orphan | |||
4296 | L01XC12 | Brentuximab vedotin | Adcetris® | powder for concentrate for solution for infusion 50 mg | RK-LS-5No.020641 |
L01ХС13 | Pertuzumab | ||||
4297 | L01ХС13 | Pertuzumab | Perjeta | concentrate for infusion solution 420 mg/14 ml | RK-LS-5No.021585 |
L01XC14 | Trastuzumab emtansine | ||||
4298 | L01XC14 | Trastuzumab emtansine | Kadcyla | lyophilized powder for concentrate for infusion solution 100 mg | RK-LS-5No.121695 |
4299 | L01XC14 | Trastuzumab emtansine | Kadcyla | lyophilized powder for concentrate for infusion solution 160 mg | RK-LS-5No.121696 |
L01XC15 | Obinutuzumab | ||||
4300 | L01XC15 | Obinutuzumab | Gaxyva | concentrate for infusion solution 1000 mg/40 ml | RK-LS-5No.121935 |
L01XC18 | Pembrolizumab | ||||
4301 | L01XC18 | Pembrolizumab | Keytruda | solution for intravenous infusion 25 mg/ml 4 ml | РК-БП-5No.021845 |
L01XC21 | Ramucirumab | ||||
4302 | L01XC21 | Ramucirumab | Cyramza™ | concentrate for solution for infusion 10 mg/ml 10 ml | RK-LS-5No.022614 |
4303 | L01XC21 | Ramucirumab | Cyramza™ | concentrate for solution for infusion 10 mg/ml 50 ml | RK-LS-5No.022614 |
L01XC24 | Daratumumab | orphan | |||
4304 | L01XC24 | Daratumumab | Darzalex | concentrate for solution for infusion, 400mg/20 ml, 20 ml | РК-БП-5No.023400 orphan |
4305 | L01XC24 | Daratumumab | Darzalex | concentrate for solution for infusion, 100mg/5 ml, 5 ml | РК-БП-5No.023399 orphan |
L01XE | Protein kinase inhibitors | ||||
L01XE01 | Imatinib | orphan | |||
4306 | L01XE01 | Imatinib | Neopax® | 100 mg film coated tablets | RK-LS-5No.020526 |
4307 | L01XE01 | Imatinib | Immutin® 400 | 400 mg film coated tablets | RK-LS-3No.019472 |
4308 | L01XE01 | Imatinib | Glivec® | 400 mg coated tablets | RK-LS-5No.014234 |
4309 | L01XE01 | Imatinib | Immutin®100 | 100 mg film coated tablets | RK-LS-5No.016320 |
4310 | L01XE01 | Imatinib | Zilinhib | 100 mg film coated tablets | RK-LS-5No.021527 |
4311 | L01XE01 | Imatinib | Zilinhib | 400 mg film coated tablets | RK-LS-5No.021528 |
4312 | L01XE01 | Imatinib | Imatinib-Adamed | 100 mg hard capsules | RK-LS-5No.022596 |
4313 | L01XE01 | Imatinib | Imatinib-Adamed | 400 mg hard capsules | RK-LS-5No.022599 |
4314 | L01XE01 | Imatinib | Redivec® | 100 mg capsules | RK-LS-5No.023544 |
4315 | L01XE01 | Imatinib | Redivec® | 400 mg capsules | RK-LS-5No.023545 |
4316 | L01XE01 | Imatinib | IMMUTIN® 100 | 100 mg capsules | RK-LS-3No.020867 |
4317 | L01XE01 | Imatinib | Glivec® | 100 mg coated tablets | RK-LS-5No.014233 |
4318 | L01XE01 | Imatinib | Imatinib AMRING | 50 mg capsules | RK-LS-5No.024357 |
4319 | L01XE01 | Imatinib | Imatinib AMRING | 100 mg capsules | RK-LS-5No.024349 |
4320 | L01XE01 | Imatinib | Neopax® | 400 mg film coated tablets | RK-LS-5No.020527 |
4321 | L01XE01 | Imatinib | Imatinib AqVida | 100 mg capsules | RK-LS-5No.024429 |
4322 | L01XE01 | Imatinib | Imatinib AqVida | 200 mg capsules | RK-LS-5No.024430 |
4323 | L01XE01 | Imatinib | Imatinib AqVida | 400 mg capsules | RK-LS-5No.024431 |
L01XE02 | Gefitinib | ||||
4324 | L01XE02 | Gefitinib | Gefitero | 250 mg film coated tablets | RK-LS-5No.023600 |
4325 | L01XE02 | Gefitinib | Iressa® | 250 mg coated tablets | RK-LS-5No.017376 |
4326 | L01XE02 | Gefitinib | GEFITIN® | 250 mg film coated tablets | RK-LS-5No.022133 |
L01XE03 | Erlotinib | ||||
4327 | L01XE03 | Erlotinib | Tarceva | 100 mg film coated tablets | RK-LS-5No.020900 |
4328 | L01XE03 | Erlotinib | Tarceva | 150 mg film coated tablets | RK-LS-5No.020901 |
4329 | L01XE03 | Erlotinib | ERTINOB® 150 | 150 mg film coated tablets | RK-LS-5No.022136 |
4330 | L01XE03 | Erlotinib | ERTINOB® 100 | 100 mg film coated tablets | RK-LS-5No.022134 |
L01XE04 | Sunitinib | ||||
4331 | L01XE04 | Sunitinib | Sutent | 25 mg capsules | RK-LS-5No.010308 |
4332 | L01XE04 | Sunitinib | Sutent | 50 mg capsules | RK-LS-5No.010309 |
4333 | L01XE04 | Sunitinib | Sutent | 12,5 mg capsules | RK-LS-5No.010310 |
L01XE05 | Sorafenib | ||||
4334 | L01XE05 | Sorafenib | Nexavar® | 200 mg film coated tablets | RK-LS-5No.011933 |
L01XE06 | Dasatinib | orphan | |||
4335 | L01XE06 | Dasatinib | ZATINIB® 70 | 70 mg film coated tablets | RK-LS-5No.022366 |
4336 | L01XE06 | Dasatinib | ZATINIB® 50 | 50 mg film coated tablets | RK-LS-5No.022365 |
L01XE07 | Lapatinib | ||||
4337 | L01XE07 | Lapatinib | Tyverb | 250 mg film coated tablets | RK-LS-5No.013294 |
L01XE08 | Nilotinib | orphan | |||
4338 | L01XE08 | Nilotinib | Tasigna® | 200 mg capsules | RK-LS-5No.013836 |
4339 | L01XE08 | Nilotinib | Tasigna® | 150 mg capsules | RK-LS-5No.020682 |
4340 | L01XE08 | Nilotinib | NILOTIN® | 200 mg capsules | RK-LS-5No.024400 |
4341 | L01XE08 | Nilotinib | NILOTIN® | 150 mg capsules | RK-LS-5No.024401 |
L01XE10 | Everolimus | ||||
4342 | L01XE10 | Everolimus | Afinitor® | 10 mg tablets | RK-LS-5No.019539 |
4343 | L01XE10 | Everolimus |
Sertiсan® | 0,25 mg tablets | RK-LS-5No.121920 |
4344 | L01XE10 | Everolimus | Sertiсan® | 0,75 mg tablets | RK-LS-5No.121921 |
4345 | L01XE10 | Everolimus | Afinitor® | 5 mg tablets | RK-LS-5No.019538 |
L01XE11 | Pazopanib | ||||
4346 | L01XE11 | Pazopanib | Votrient | 400 mg film coated tablets | RK-LS-5No.017862 |
4347 | L01XE11 | Pazopanib | Votrient | 200 mg tablets | RK-LS-5No.017861 |
L01XE13 | Afatinib | ||||
4348 | L01XE13 | Afatinib | Giotrif® | 50 mg film coated tablets | RK-LS-5No.022286 |
4349 | L01XE13 | Afatinib | Giotrif® | 40 mg film coated tablets | RK-LS-5No.022285 |
4350 | L01XE13 | Afatinib | Giotrif® | 30 mg film coated tablets | RK-LS-5No.022287 |
4351 | L01XE13 | Afatinib | Giotrif® | 20 mg film coated tablets | RK-LS-5No.022256 |
L01XE15 | Vemurafenib | ||||
4352 | L01XE15 | Vemurafenib | Zelboraf | 240 mg film coated tablets | RK-LS-5No.020338 |
L01XE16 | Crizotinib | ||||
4353 | L01XE16 | Crizotinib | Xalkori® | 250 mg capsules | RK-LS-5No.020769 |
4354 | L01XE16 | Crizotinib | Xalkori® | 200 mg capsules | RK-LS-5No.020770 |
L01XE17 | Axitinib | ||||
4355 | L01XE17 | Axitinib | Inlyta® | 5 mg film coated tablets | RK-LS-5No.020885 |
4356 | L01XE17 | Axitinib | Inlyta® | 1 mg film coated tablets | RK-LS-5No.020884 |
L01XE18 | Ruxolitinib | orphan | |||
4357 | L01XE18 | Ruxolitinib | Jaakafi® | 20 mg tablets | RK-LS-5No.021460 |
4358 | L01XE18 | Ruxolitinib | Jaakafi® | 15 mg tablets | RK-LS-5No.021459 |
4359 | L01XE18 | Ruxolitinib | Jaakafi® | 5 mg tablets | RK-LS-5No.021458 |
L01ХЕ21 | Regorafenib | ||||
4360 | L01ХЕ21 | Regorafenib | Stivarga® | 40 mg film coated tablets | RK-LS-5No.020781 |
L01XE23 | Dabrafenib | ||||
4361 | L01XE23 | Dabrafenib | Tafinlar® | 75 mg capsules | RK-LS-5No.020852 |
L01XE25 | Trametinib | ||||
4362 | L01XE25 | Trametinib | Mekinist® | 0.5 mg film coated tablets | RK-LS-5No.023075 |
4363 | L01XE25 | Trametinib | Mekinist® | 0.5 mg film coated tablets | RK-LS-5No.023049 |
4364 | L01XE25 | Trametinib | Mekinist® | 2 mg film coated tablets | RK-LS-5No.023050 |
4365 | L01XE25 | Trametinib | Mekinist® | 2 mg film coated tablets | RK-LS-5No.023074 |
L01XE27 | Ibrutinib | orphan | |||
4366 | L01XE27 | Ibrutinib | Imbruvica® | 140 mg capsules | RK-LS-5No.021240 |
L01XE28 | Ceritinib | ||||
4367 | L01XE28 | Ceritinib | Zykadia™ | 150 mg capsules | RK-LS-5No.022282 |
L01XE31 | Nintedanib | orphan | |||
4368 | L01XE31 | Nintedanib | Vargatef® | 150 mg soft capsules | RK-LS-5No.022500 |
4369 | L01XE31 | Nintedanib | Vargatef® | 100 mg soft capsules | RK-LS-5No.022499 |
L01XE33 | Palbociclib | ||||
4370 | L01XE33 | Palbociclib | Aybrans™ | 100 mg capsules | RK-LS-5No.023345 |
4371 | L01XE33 | Palbociclib | Aybrans™ | 125 mg capsules | RK-LS-5No.023346 |
4372 | L01XE33 | Palbociclib | Aybrans™ | 75 mg capsules | RK-LS-5No.023344 |
L01XE35 | Osimertinib | ||||
4373 | L01XE35 | Osimertinib | Tagrisso™ | 40 mg film coated tablets | RK-LS-5No.023566 |
4374 | L01XE35 | Osimertinib | Tagrisso™ | 80 mg film coated tablets | RK-LS-5No.023567 |
L01XE36 | Alectinib | ||||
4375 | L01XE36 | Alectinib | Alecensa | 150 mg capsules | RK-LS-5No.024157 |
L01ХЕ38 | Cobimetinib | ||||
4376 | L01ХЕ38 | Cobimetinib | Cotellic | 20 mg film coated tablets | RK-LS-5No.022643 |
L01XE42 | Ribociclib | ||||
4377 | L01XE42 | Ribociclib | Kisqali™ | 200 mg film coated tablets | RK-LS-5No.023757 |
L01XE43 | Brigatinib | ||||
4378 | L01XE43 | Brigatinib | Alunbrig™ | 30 mg film coated tablets | RK-LS-5No.024244 |
4379 | L01XE43 | Brigatinib | Alunbrig™ | 90 mg film coated tablets | RK-LS-5No.024245 |
4380 | L01XE43 | Brigatinib | Alunbrig™ | 180 mg film coated tablets | RK-LS-5No.024246 |
4381 | L01XE43 | Brigatinib | Alunbrig™ | 30 mg film coated tablets | RK-LS-5No.024244 |
4382 | L01XE43 | Brigatinib | Alunbrig™ | 90 mg film coated tablets | RK-LS-5No.024245 |
L01XX | Other antineoplastic drugs | ||||
4383 | L01XX | Other antineoplastic drugs | Simawax -EGF®, recombinant epidermal growth factor vaccine with diluent (Montanid ISA51VG) | emulsion for injection 0.8 mg/dose, 0.8 ml | РК-БП-5No.023568 |
L01XX02 | Asparaginase | orphan | |||
4384 | L01XX02 | Asparaginase | Asparaginase medac 10,000 units | lyophilisate for solution for intravenous and intramuscular administration 10000 MU | RK-LS-5No.015040 |
4385 | L01XX02 | Asparaginase | Asparaginase medac 5000 units | lyophilisate for solution for intravenous and intramuscular administration 50000 MU | RK-LS-5No.015039 |
4386 | L01XX02 | Asparaginase | Vero-asparaginase | lyophilisate for solution for intravenous and intramuscular administration 10000 MU | RK-LS-5No.020888 |
4387 | L01XX02 | Asparaginase | Spectrila | lyophilized powder for preparation of concentrate, for preparation of solution for infusion 10000 MU | RK-LS-5No.023946 |
L01XX05 | Hydroxycarbamide | ||||
4388 | L01XX05 | Hydroxycarbamide | Hydroxycarbamide | 500 mg capsules | RK-LS-5No.021384 |
4389 | L01XX05 | Hydroxycarbamide | Hydroxycarbamide | 250 mg capsules | RK-LS-5No.021383 |
4390 | L01XX05 | Hydroxycarbamide | Hydroxycarbamide Medac | 500 mg capsules | RK-LS-5No.014327 |
L01XX14 | Tretinoin | orphan | |||
4391 | L01XX14 | Tretinoin | Vesanoid | 10 mg capsules | RK-LS-5No.122150 |
L01XX17 | Topotecan | ||||
4392 | L01XX17 | Topotecan | Hycamtin® | lyophilisate for solution for infusion, 4 mg | RK-LS-5No.016187 |
L01XX19 | Irinotecan | ||||
4393 | L01XX19 | Irinotecan | Camptomeda | concentrate for solution for infusion 20mg/ml 15 ml | RK-LS-5No.023121 |
4394 | L01XX19 | Irinotecan | Riboirino 20 mg/ml | concentrate for solution for infusion 20 mg/2 ml | RK-LS-5No.022809 |
4395 | L01XX19 | Irinotecan | Riboirino 20 mg/ml | concentrate for solution for infusion 20 mg/5 ml | RK-LS-5No.022809 |
4396 | L01XX19 | Irinotecan | Riboirino 20 mg/ml | concentrate for solution for infusion 20 mg/15 ml | RK-LS-5No.022809 |
4397 | L01XX19 | Irinotecan | Riboirino 20 mg/ml | concentrate for solution for infusion 20 mg/25 ml | RK-LS-5No.022809 |
4398 | L01XX19 | Irinotecan | Irinotecan medac | concentrate for solution for infusion 20 mg/ml, 15 ml (300 mg) | RK-LS-5No.020001 |
4399 | L01XX19 | Irinotecan | Irinotecan medac | concentrate for solution for infusion 20 mg/ml, 5 ml (100 mg) | RK-LS-5No.020000 |
4400 | L01XX19 | Irinotecan | Irinotecan Actavis | concentrate for solution for infusion 100 mg/5 ml | RK-LS-5No.018567 |
4401 | L01XX19 | Irinotecan | Irinotecan medac | concentrate for solution for infusion 20 mg/ml, 2 ml (40 mg) | RK-LS-5No.019999 |
4402 | L01XX19 | Irinotecan | Irinotecan Actavis | concentrate for solution for infusion 40 mg/2 ml, 2 ml | RK-LS-5No.018566 |
4403 | L01XX19 | Irinotecan | Camptomeda | concentrate for solution for infusion 20mg/ml, 2 ml | RK-LS-5No.023119 |
4404 | L01XX19 | Irinotecan | Camptomeda | concentrate for solution for infusion 20mg/ml, 5 ml | RK-LS-5No.023120 |
L01XX24 | Pegaspargase | orphan | |||
4405 | L01XX24 | Pegaspargase | Oncaspar® | solution for injection 3750 MU 5 ml | RK-LS-5No.001434 |
L01XX32 | Bortezomib | orphan | |||
4406 | L01XX32 | Bortezomib | Velcade® | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.021476 |
4407 | L01XX32 | Bortezomib | Bortepol | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.022622 |
4408 | L01XX32 | Bortezomib | Bortero | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.022307 |
4409 | L01XX32 | Bortezomib | Vortemiel | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.022772 |
4410 | L01XX32 | Bortezomib | Velcade® | lyophilisate for solution for intravenous and subcutaneous administration of 3 mg | RK-LS-5No.022427 |
4411 | L01XX32 | Bortezomib | Velcade® | lyophilisate for solution for intravenous administration 1 mg | RK-LS-5No.021475 |
4412 | L01XX32 | Bortezomib | Bartizar | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.023382 |
4413 | L01XX32 | Bortezomib | Mibzo | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.023966 |
4414 | L01XX32 | Bortezomib | Bortezomib Sandoz® | lyophilized powder for solution for intravenous administration 1 mg | RK-LS-5No.024397 |
4415 | L01XX32 | Bortezomib | Bortezomib Teva | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.023053 |
4416 | L01XX32 | Bortezomib | Mayborte | lyophilisate for solution for intravenous and subcutaneous administration of 3.5 mg | RK-LS-5No.022642 |
4417 | L01XX32 | Bortezomib | Vortemiel | lyophilisate for solution for intravenous administration 1 mg | RK-LS-5No.024474 |
L01XX35 | Anagrelide | orphan | |||
4418 | L01XX35 | Anagrelide | Thromboreductin | 0.5 mg capsules | RK-LS-5No.018982 |
L01XX42 | Panobinostat | ||||
4419 | L01XX42 | Panobinostat | Faridak™ | 20 mg capsules | RK-LS-5No.022588 |
4420 | L01XX42 | Panobinostat | Faridak™ | 15 mg capsules | RK-LS-5No.022587 |
4421 | L01XX42 | Panobinostat | Faridak™ | 10 mg capsules | RK-LS-5No.022586 |
L01XX43 | Vismodegib | ||||
4422 | L01XX43 | Vismodegib | Erivedge | 150 mg capsules | RK-LS-5No.021560 |
L01XX50 | Ixazomib | ||||
4423 | L01XX50 | Ixazomib | Ninlaro® | 4 mg capsules | RK-LS-5No.023324 |
4424 | L01XX50 | Ixazomib | Ninlaro® | 3 mg capsules | RK-LS-5No.023325 |
4425 | L01XX50 | Ixazomib | Ninlaro® | 2.3 mg capsules | RK-LS-5No.023326 |
L01XX52 | Venetoclax | orphan | |||
4426 | L01XX52 | Venetoclax | Venclexta | 10 mg film coated tablets | RK-LS-5No.024330 |
4427 | L01XX52 | Venetoclax | Venclexta | 50 mg film coated tablets | RK-LS-5No.024331 |
4428 | L01XX52 | Venetoclax | Venclexta | 100 mg film coated tablets | RK-LS-5No.024332 |
L02 | Antineoplastic hormonal drugs | ||||
L02A | Hormones and their derivatives | ||||
L02AE | Analogues of gonadotropin-releasing hormone | ||||
L02AE01 | Buserelin | ||||
L02AE02 | Leuprorelin | ||||
4429 | L02AE02 | Leuprorelin | Eligard® | lyophilisate for solution for subcutaneous administration with solvent 45 mg | RK-LS-5No.018819 |
4430 | L02AE02 | Leuprorelin | Eligard® | lyophilisate for solution for subcutaneous administration with solvent 22.5 mg | RK-LS-5No.018818 |
4431 | L02AE02 | Leuprorelin | Lucrin Depot | lyophilized powder for suspension for intramuscular and subcutaneous administration with solvent in pre-filled two-chamber syringe (PDS) 11.25 mg | RK-LS-5No.017716 |
4432 | L02AE02 | Leuprorelin | PROLIDEX® | lyophilized powder for suspension for injection with solvent, 3.75 mg | RK-LS-5No.021136 |
L02AE03 | Goserelin | ||||
4433 | L02AE03 | Goserelin | Zoladex™ | sustained-release implant for subcutaneous administration 10.8 mg | RK-LS-5No.018523 |
4434 | L02AE03 | Goserelin | Reseligo | prolonged release implant for subcutaneous administration, 3.6 mg | RK-LS-5No.024247 |
4435 | L02AE03 | Goserelin | Zoladex® | prolonged release implant for subcutaneous administration, 3.6 mg | RK-LS-5No.003869 |
L02AE04 | Triptorelin | ||||
4436 | L02AE04 | Triptorelin | Diphereline® 11,25 mg | lyophilisate for suspension for intramuscular administration of prolonged action with solvent 11.25 mg, 2 ml | RK-LS-5No.014844 |
4437 | L02AE04 | Triptorelin | Diphereline® 3,75 mg | lyophilisate for suspension for intramuscular administration of prolonged action with solvent 3.75 mg, 2 ml | RK-LS-5No.003064 |
4438 | L02AE04 | Triptorelin | Decapeptyl Depot | lyophilisate for suspension for injection with solvent 3.75 mg, 1 ml | RK-LS-5No.011393 |
4439 | L02AE04 | Triptorelin | Decapeptyl | solution for injection 0.1 mg/ ml, 1 ml | RK-LS-5No.011392 |
4440 | L02AE04 | Triptorelin | Diphereline® | lyophilisate for solution for subcutaneous administration with solvent (0.9% sodium chloride solution) 0.1 mg, 1 ml | RK-LS-5No.005487 |
L02B | Hormone antagonists and their analogues | ||||
L02BA | Antiestrogens | ||||
L02BA01 | Tamoxifen | ||||
4441 | L02BA01 | Tamoxifen | Tamoxifen | 20 mg tablets | RK-LS-5No.004137 |
L02BA02 | Toremifene | ||||
4442 | L02BA02 | Toremifene | Fareston | 60 mg tablets | RK-LS-5No.016607 |
4443 | L02BA02 | Toremifene | Fareston | 20 mg tablets | RK-LS-5No.016606 |
4444 | L02BA02 | Toremifene | Toremifene Viva Farm | 20 mg tablets | RK-LS-5No.023518 |
4445 | L02BA02 | Toremifene | Toremifene Viva Farm | 60 mg tablets | RK-LS-5No.023519 |
L02BA03 | Fulvestrant | ||||
4446 | L02BA03 | Fulvestrant | Faslodex™ | solution for intramuscular injection in syringe 250 mg/5 ml, 5 ml | RK-LS-5No.019052 |
4447 | L02BA03 | Fulvestrant | Fulvestrant-Teva | solution for intramuscular injection in syringe 250 mg/5 ml, 5 ml | RK-LS-5No.023542 |
4448 | L02BA03 | Fulvestrant | Fulvestrant Sandoz® | solution for intramuscular injection 250 mg/5 ml, 5 ml | RK-LS-5No.024179 |
4449 | L02BA03 | Fulvestrant | Fulveject | solution for intramuscular injection in syringe 250 mg/5 ml, 5 ml | RK-LS-5No.024215 |
4450 | L02BA03 | Fulvestrant | Eranfu | solution for intramuscular injection in syringe 250 mg/5 ml, 5 ml | RK-LS-5No.023851 |
4451 | L02BA03 | Fulvestrant | Fulvestrant EVER Pharma | solution for intramuscular injection in syringe 250 mg/5 ml | RK-LS-5No.024438 |
L02BB | Antiandrogens | ||||
L02BB03 | Bicalutamide | ||||
4452 | L02BB03 | Bicalutamide | Casodex® | 150 mg coated tablets | RK-LS-5No.017134 |
4453 | L02BB03 | Bicalutamide | Calutide-50 | 50 mg film coated tablets | RK-LS-5No.022818 |
4454 | L02BB03 | Bicalutamide | Calumid® | 150 mg film coated tablets | RK-LS-5No.010857 |
4455 | L02BB03 | Bicalutamide | Calumid® | 50 mg coated tablets | RK-LS-5No.008291 |
4456 | L02BB03 | Bicalutamide | Casodex® | 50 mg coated tablets | RK-LS-5No.003868 |
4457 | L02BB03 | Bicalutamide | Bicalutamide Accord | 50 mg film coated tablets | RK-LS-5No.022302 |
4458 | L02BB03 | Bicalutamide | Bicalutamide Grindex | 50 mg film coated tablets | RK-LS-5No.014815 |
L02BB04 | Enzalutamide | ||||
4459 | L02BB04 | Enzalutamide | Xtandi | 40 mg capsules | RK-LS-5No.121644 |
L02BG | Enzyme inhibitors | ||||
L02BG03 | Anastrozole | ||||
4460 | L02BG03 | Anastrozole | Armotraz | 1 mg film coated tablets | RK-LS-5No.022816 |
4461 | L02BG03 | Anastrozole | Anastrozole | 1 mg film coated tablets | RK-LS-5No.121942 |
4462 | L02BG03 | Anastrozole | Anastrozole-Teva | 1 mg film coated tablets | RK-LS-5No.020993 |
4463 | L02BG03 | Anastrozole | AXASTROL® | 1 mg film coated tablets | RK-LS-5No.016482 |
4464 | L02BG03 | Anastrozole | Anastrozole Accord | 1 mg film coated tablets | RK-LS-5No.022324 |
4465 | L02BG03 | Anastrozole | Anastrozole | 1 mg film coated tablets | RK-LS-5No.022022 |
4466 | L02BG03 | Anastrozole | Arimidex® | 1 mg coated tablets | RK-LS-5No.003893 |
L02BG04 | Letrozole | ||||
4467 | L02BG04 | Letrozole | Alvozol | 2.5 mg film coated tablets | RK-LS-5No.019968 |
4468 | L02BG04 | Letrozole | Femara® | 2.5 mg film coated tablets | RK-LS-5No.003795 |
4469 | L02BG04 | Letrozole | Etruzil® | 2.5 mg coated tablets | RK-LS-5No.016509 |
4470 | L02BG04 | Letrozole | Letrozole-Teva | 2.5 mg film coated tablets | RK-LS-5No.121777 |
4471 | L02BG04 | Letrozole | Lortanda | 2.5 mg film coated tablets | RK-LS-5No.021442 |
4472 | L02BG04 | Letrozole | Letrozole Accord | 2.5 mg film coated tablets | RK-LS-5No.022485 |
4473 | L02BG04 | Letrozole | Letrozole Actavis | 2.5 mg film coated tablets | RK-LS-5No.019320 |
L02BG06 | Exemestane | ||||
L02BX | Other hormone antagonists and similar drugs | ||||
L02BX02 | Degarelix | ||||
4474 | L02BX02 | Degarelix | Firmagon | lyophilized powder for solution for injection with solvent, 80 mg | RK-LS-5No.017566 |
4475 | L02BX02 | Degarelix | Firmagon | lyophilized powder for solution for injection with solvent, 120 mg | RK-LS-5No.017567 |
L02BX03 | Abiraterone | ||||
4476 | L02BX03 | Abiraterone | Зигитерон | 250 mg tablets | RK-LS-5No.024338 |
4477 | L02BX03 | Abiraterone | ABIRATERONE NV | 250 mg tablets | RK-LS-5No.024319 |
4478 | L02BX03 | Abiraterone | Teronred | 250 mg film coated tablets | RK-LS-5No.023872 |
4479 | L02BX03 | Abiraterone | Zytiga® | 500 mg film coated tablets | RK-LS-5No.023378 |
4480 | L02BX03 | Abiraterone | Zytiga® | 250 mg tablets | RK-LS-5No.019490 |
4481 | L02BX03 | Abiraterone | Arabitro | 250 mg tablets | RK-LS-5No.023285 |
4482 | L02BX03 | Abiraterone | Ateron | 250 mg tablets | RK-LS-5No.023455 |
L03 | Immunostimulants | ||||
L03AA | Colony-stimulating factors | ||||
L03AA02 | Filgrastim | orphan | |||
4483 | L03AA02 | Filgrastim | Zarcio® | solution for injections and infusions 30 million units/0.5 ml, 0.5 ml | RK-LS-5No.021586 |
4484 | L03AA02 | Filgrastim | TevaGrastim | solution for subcutaneous and intravenous administration 48 million MU/0.8 ml, 0.8 ml | RK-LS-5No.019512 |
4485 | L03AA02 | Filgrastim | Zarcio® | solution for injection and infusion 48 MU/0.5 ml, 0.5 ml | RK-LS-5No.021587 |
4486 | L03AA02 | Filgrastim | TevaGrastim | solution for subcutaneous and intravenous administration 30 MU/0.5 ml, 0.5 ml | RK-LS-5No.019511 |
L03AA10 | Lenograstim | ||||
4487 | L03AA10 | Lenograstim | Granocyte® 34 | lyophilisate for solution for intravenous and subcutaneous administration with solvent 33.6 million MU, 1 ml | RK-LS-5No.011030 |
L03AA13 | Pegfilgrastim | orphan | |||
4488 | L03AA13 | Pegfilgrastim | Neulastim | solution for subcutaneous administration 6 mg (10 mg/ml), 0.6 ml | RK-LS-5No.012566 |
L03AA14 | Lipegfilgrastim | ||||
L03AB | Interferons | ||||
L03AB04 | Interferon alfa-2a | ||||
4489 | L03AB04 | Interferon alfa-2a | Roferon-A | solution for injection, 4.5 million MU/0.5ml | RK-LS-5No.012821 |
L03AB05 | Interferon alfa-2b | orphan | |||
4490 | L03AB05 | Interferon alfa-2b | Intron А® | solution for injection 18 million MU/1.2 ml (6 doses of 3 million MU) 1.2 ml | RK-LS-5No.010814 |
4491 | L03AB05 | Interferon alfa-2b | Nazoferon® | Nasal drops, 100000 MU/ml 5 ml | РК-БП-5No.020632 |
4492 | L03AB05 | Interferon alfa-2b | Nazoferon® | Nasal spray, 100000 MU/ml 5 ml | РК-БП-5No.020645 |
4493 | L03AB05 | Interferon alfa-2b | VIFERON® | gel for topical application, 36000 MU/g 12 g | RK-LS-5No.017849 |
4494 | L03AB05 | Interferon alfa-2b | VIFERON® | ointment for topical application, 40000 MU/g 12 g | RK-LS-5No.017837 |
4495 | L03AB05 | Interferon alfa-2b | Genferon® Lite | nasal drops, 10000 MU 10 ml | РК-БП-5No.022416 |
4496 | L03AB05 | Interferon alfa-2b | VIFERON® | Rectal suppositories, 150000 MU | RK-LS-5No.014686 |
4497 | L03AB05 | Interferon alfa-2b | VIFERON® | Rectal suppositories, 500000 MU | RK-LS-5No.014687 |
4498 | L03AB05 | Interferon alfa-2b | VIFERON® | Rectal suppositories, 1000000 MU | RK-LS-5No.014688 |
4499 | L03AB05 | Interferon alpha-2b | VIFERON® | Rectal suppositories, 3000000 MU | RK-LS-5No.014689 |
L03AB07 | Interferon beta-1a | ||||
4500 | L03AB07 | Interferon beta-1a | CinnoVex | lyophilisate for solution for intramuscular administration, with solvent and set for administration 30 mg (6 million MU), 1 ml | RK-LS-5No.021547 |
4501 | L03AB07 | Interferon beta-1a | Avonex® | solution for intramuscular injection 30 mg/0.5 ml, 0.5 ml | RK-LS-5No.121917 |
4502 | L03AB07 | Interferon beta-1a | Avonex® | solution for intramuscular injection 30 mg/0.5 ml, 0.5 ml | РК-БП-5No.022325 |
4503 | L03AB07 | Interferon beta-1a | Rebif® | solution for injection 44 mg/0.5 ml, 0.5 ml | RK-LS-5No.000177 |
4504 | L03AB07 | Interferon beta-1a | Rebif® | solution for injection 22 mg/0.5 ml, 0.5 ml | RK-LS-5No.000176 |
L03AB08 | Interferon beta-1b | ||||
4505 | L03AB08 | Interferon beta-1b | Betaferon® | lyophilisate for solution for subcutaneous administration with solvent, 0.3 mg (9.6 million MU) | RK-LS-5No.003524 |
4506 | L03AB08 | Interferon beta-1b | Interbetine | lyophilisate for solution for subcutaneous administration with solvent 0.3 mg | РК-БП-5No.024194 |
L03AB10 | Peginterferon alfa-2b | ||||
4507 | L03AB10 | Peginterferon alfa-2b | PegAltevir® | lyophilisate for solution for subcutaneous administration with solvent 100 mg, 0.7 ml | RK-LS-5No.022268 |
4508 | L03AB10 | Peginterferon alfa-2b | PegAltevir® | lyophilisate for solution for subcutaneous administration with solvent 120 mg, 0.7 ml | RK-LS-5No.022269 |
L03AB11 | Peginterferon alfa-2a | ||||
4509 | L03AB11 | Peginterferon alfa-2a | Pegasys | solution for injection 180 mg/0.5 ml | RK-LS-5No.012328 |
L03АВ13 | Peginterferon beta-1a | orphan | |||
4510 | L03АВ13 | Peginterferon beta-1a | Plegridy® | solution for injection 63 mg/0.5 ml | РК-БП-5No.022429 |
4511 | L03АВ13 | Peginterferon beta-1a | Plegridy® | solution for injection 94 mg/0.5 ml | РК-БП-5No.022429 |
4512 | L03АВ13 | Peginterferon beta-1a | Plegridy® | solution for injection 125 mg/0.5 ml | РК-БП-5No.022430 |
L03AC | Interleukins | ||||
L03AC01 | Aldesleukin | ||||
L03AX | Other immunostimulants | ||||
4513 | L03AX | Other immunostimulants | KM-Ginseng | 0.005 g suppositories | RK-LS-5No.014372 |
4514 | L03AX | Other immunostimulants | Methyluracil | 0.5 g rectal suppositories | RK-LS-5No.012743 |
4515 | L03AX | Other immunostimulants | Methyluracil | 500 g rectal suppositories | RK-LS-5No.010794 |
4516 | L03AX | Other immunostimulants | Ismigen | 7 mg sublingual tablets | RK-LS-5No.020635 |
L03AX03 | BCG vaccine (Bacillus Calmette-Guerin Live) | ||||
4517 | L03AX03 | BCG vaccine (Bacillus Calmette-Guerin Live) | URO-BCG Medac | powder and solvent for suspension for intravesical administration, from 2x108 to 3x109 viable units | РК-БП-5No.015766 |
L03AX13 | Glatiramer acetate | ||||
4518 | L03AX13 | Glatiramer acetate | Glatirat | solution for subcutaneous administration 20 mg/ml 1 ml | RK-LS-5No.023792 |
4519 | L03AX13 | Glatiramer acetate | Copaxone®-Teva | solution for subcutaneous administration 40 mg/ml 1 ml | RK-LS-5No.022126 |
4520 | L03AX13 | Glatiramer acetate | Copaxone®-Teva | solution for subcutaneous administration 20 mg/ml 1 ml | RK-LS-5No.121941 |
4521 | L03AX13 | Glatiramer acetate | Copaxone®-Teva | solution for subcutaneous administration 40 mg/ml 1 ml | RK-LS-5No.022236 |
4522 | L03AX13 | Glatiramer acetate | Copaxone®-Teva | solution for subcutaneous administration 20 mg/ml 1 ml | RK-LS-5No.017374 |
L03AX15 | Mifamurtide | ||||
4523 | L03AX15 | Mifamurtide | Mepact® | powder for concentrate for dispersion solution for infusion 4 mg/50 ml | RK-LS-5No.020199 |
L04 | Immunosuppressants | ||||
L04A | Immunosuppressants | ||||
L04AA | Selective immunosuppressants | ||||
L04AA03 | Anti-lymphocyte immunoglobulin (horse) | ||||
4524 | L04AA03 | Anti-lymphocyte immunoglobulin (horse) | Atgam® | solution for injection 50 mg/ml, 5 ml | RK-LS-5No.023716 |
L04AA04 | Immunoglobulin antithymocyte (rabbit) | orphan | |||
4525 | L04AA04 | Immunoglobulin antithymocyte (rabbit) | Thymoglobuline | lyophilisate for solution for infusion 25 mg | РК-БП-5No.018130 |
L04AA06 | Mycophenolic acid | orphan | |||
4526 | L04AA06 | Mycophenolic acid | Mycophenolate Mofetil 250 mg Capsules | 250 mg capsules | RK-LS-5No.024337 |
4527 | L04AA06 | Mycophenolic acid | Mysept-500 | 500 mg film coated tablets | RK-LS-5No.019304 |
4528 | L04AA06 | Mycophenolic acid | Mysept-250 | 250 mg capsules | RK-LS-5No.019305 |
4529 | L04AA06 | Mycophenolic acid | Mayfenax | 500 mg film coated tablets | RK-LS-5No.016921 |
4530 | L04AA06 | Mycophenolic acid | Micoran | 500 mg capsules | RK-LS-5No.121732 |
4531 | L04AA06 | Mycophenolic acid | Micop | 250 mg capsules | RK-LS-5No.023016 |
4532 | L04AA06 | Mycophenolic acid | Myfortic® | 360 mg enteric coated tablets | RK-LS-5No.014108 |
4533 | L04AA06 | Mycophenolic acid | Mycophenolate Mofetil Accord | 500 mg film coated tablets | RK-LS-5No.022859 |
4534 | L04AA06 | Mycophenolic acid | Myfortic® | 180 mg enteric coated tablets | RK-LS-5No.014107 |
4535 | L04AA06 | Mycophenolic acid | Mycophenolate Mofetil Accord | 250 mg capsules | RK-LS-5No.022860 |
4536 | L04AA06 | Mycophenolic acid | Mycokem | 250 mg capsules | RK-LS-5No.019735 |
4537 | L04AA06 | Mycophenolic acid | Cellcept | 250 mg capsules | RK-LS-5No.004241 |
4538 | L04AA06 | Mycophenolic acid | Mayfenax | 250 mg capsules | RK-LS-5No.016920 |
L04AA13 | Leflunomide | ||||
4539 | L04AA13 | Leflunomide | Bageda | 10 mg film coated tablets | RK-LS-5No.023529 |
4540 | L04AA13 | Leflunomide | Bageda | 20 mg film coated tablets | RK-LS-5No.023533 |
4541 | L04AA13 | Leflunomide | Ehlafra | 20 mg film coated tablets | RK-LS-5No.020156 |
4542 | L04AA13 | Leflunomide | Lefno™ | 20 mg film coated tablets | RK-LS-5No.016712 |
L04AA18 | Everolimus | ||||
4543 | L04AA18 | Everolimus | Sertiсan® | 0.75 mg tablets | RK-LS-5No.121921 |
4544 | L04AA18 | Everolimus | Sertiсan® | 0.25 mg tablets | RK-LS-5No.121920 |
L04AA23 | Natalizumab | orphan | |||
4545 | L04AA23 | Natalizumab | Tysabri® | concentrate for solution for infusion 300 mg/15 ml | RK-LS-5No.020175 |
L04AA25 | Eculizumab | orphan | |||
L04AA26 | Belimumab | orphan | |||
4546 | L04AA26 | Belimumab | Benlista | lyophilisate for solution for infusion 120 mg, 5 ml | РК-БП-5No.018914 |
4547 | L04AA26 | Belimumab | Benlista | lyophilisate for solution for infusion 400 mg, 20 ml | РК-БП-5No.018915 |
L04AA31 | Teriflunomide | ||||
4548 | L04AA31 | Teriflunomide | Femorix | 14 mg film coated tablets | RK-LS-5No.023813 |
4549 | L04AA31 | Teriflunomide | Aubagio® | 14 mg film coated tablets | RK-LS-5No.023124 |
4550 | L04AA31 | Teriflunomide | Aubagio® | 14 mg film coated tablets | RK-LS-5No.023124 |
L04AA33 | Teriflunomide | ||||
4551 | L04AA33 | Vedolizumab | Entyvio® | powder for concentrate for preparation of solution for infusion, 300 mg | RK-LS-5No.022402 |
L04AA36 | Ocrelizumab | orphan | |||
4552 | L04AA36 | Ocrelizumab | Ocrevus | concentrate for solution for infusion, 300 mg/10 ml | RK-LS-5No.024011 |
L04AB | Tumor necrosis factor alfa (TNF-alfa) inhibitors | ||||
L04AB01 | Etanercept | orphan | |||
4553 | L04AB01 | Etanercept | Enbrel My Click | solution for injection in pre-filled syringe pens, 50 mg, 1 ml | RK-LS-5No.021439 |
4554 | L04AB01 | Etanercept | Enbrel | solution for subcutaneous administration 50 mg, 1 ml | RK-LS-5No.019652 |
4555 | L04AB01 | Etanercept | Enbrel Lio | lyophilized powder for solution for injection with solvent (water for injection) 25 mg | RK-LS-5No.021440 |
4556 | L04AB01 | Etanercept | Enbrel | solution for subcutaneous administration 25 mg, 0.5 ml | RK-LS-5No.019651 |
L04AB02 | Infliximab | orphan | |||
4557 | L04AB02 | Infliximab | Flammegis® | lyophilized powder for preparation of concentrate for solution for intravenous administration 100 mg | RK-LS-5No.020035 |
4558 | L04AB02 | Infliximab | Remicade® | lyophilized powder for concentrate for solution for intravenous administration 100 mg | РК-БП-5No.019692 |
L04AB04 | Adalimumab | orphan | |||
4559 | L04AB04 | Adalimumab | Humira® | solution for injection 40 mg/0.8 ml, 0.8 ml | РК-БП-5No.020286 |
4560 | L04AB04 | Adalimumab | Humira® | solution for injection 40 mg/0.8 ml, 0.8 ml | RK-LS-5No.021522 |
4561 | L04AB04 | Adalimumab | Humira® | solution for injection 40 mg/0.4 ml, 0.4 ml | РК-БП-5No.023227 |
4562 | L04AB04 | Adalimumab | Humira® | solution for subcutaneous administration 40mg/0.4ml, 0.4 ml | РК-БП-5No.023226 |
L04AB06 | Golimumab | ||||
4563 | L04AB06 | Golimumab | Simponi® | solution for injection 50 mg/0.5 ml, 0.5 ml | РК-БП-5No.020824 |
4564 | L04AB06 | Golimumab | Simponi® | solution for injection 100 mg/1 ml, 1 ml | РК-БП-5No.121643 |
L04AB06 | Golimumab | ||||
L04AC | Interleukin inhibitors | ||||
L04AC02 | Basiliximab | ||||
4565 | L04AC02 | Basiliximab | Simulect® | lyophilisate for injection/infusion solution with solvent (water for injection) 20 mg, 5 ml | RK-LS-5No.014725 |
L04AC03 | Anakinra | orphan | |||
4566 | L04AC03 | Anakinra | Kineret | 100 mg/0.67 ml, pre-filled syringe, SOBI | orphan |
L04AC05 | Ustekinumab | ||||
4567 | L04AC05 | Ustekinumab | Stelara® | solution for injection 90 mg/ml 1 ml | РК-БП-5No.023289 |
4568 | L04AC05 | Ustekinumab | Stelara® | solution for injection 45 mg/ 0.5 ml, 0.5 ml | РК-БП-5No.023288 |
4569 | L04AC05 | Ustekinumab | Stelara® | concentrate for solution for infusion 130 mg, 26ml | РК-БП-5No.023287 |
L04AC07 | Tocilizumab | orphan | |||
4570 | L04AC07 | Tocilizumab | Actemra | concentrate for infusion solution 400 mg/20 ml, 20 ml | RK-LS-5No.014976 |
4571 | L04AC07 | Tocilizumab | Actemra | concentrate for infusion solution 200 mg/10 ml, 10 ml | RK-LS-5No.014975 |
4572 | L04AC07 | Tocilizumab | Actemra | solution for subcutaneous injection 162 mg/0.9 ml, 0.9 ml | RK-LS-5No.022414 |
4573 | L04AC07 | Tocilizumab | Actemra | concentrate for infusion solution 80 mg/4 ml, 4 ml | RK-LS-5No.014974 |
L04AC08 | Canakinumab | orphan | |||
4574 | L04AC08 | Canakinumab | Ilaris® | solution for subcutaneous administration, 150 mg/ml | orphan |
L04AC10 | Secukinumab | ||||
4575 | L04AC10 | Secukinumab | Cosentyx® | solution for subcutaneous administration 150 mg/ml 1 ml | RK-LS-5No.024318 |
L04AD | Calcineurin inhibitors | ||||
L04AD01 | Cyclosporine | orphan | |||
4576 | L04AD01 | Cyclosporine | Sandimmun® Neoral® | oral solution 100mg/ml 50 ml | RK-LS-5No.121828 |
4577 | L04AD01 | Cyclosporine | Panimun Bioral | 100 mg capsules | RK-LS-5No.014581 |
4578 | L04AD01 | Cyclosporine | Sandimmun® Neoral® | 100 mg capsules | RK-LS-5No.003822 |
4579 | L04AD01 | Cyclosporine | Equoral | 100 mg capsules | RK-LS-5No.009871 |
4580 | L04AD01 | Cyclosporine | Panimun Bioral | 50 mg capsules | RK-LS-5No.014580 |
4581 | L04AD01 | Cyclosporine | Equoral | 50 mg capsules | RK-LS-5No.009870 |
4582 | L04AD01 | Cyclosporine | Sandimmun® Neoral® | 50 mg capsules | RK-LS-5No.003821 |
4583 | L04AD01 | Cyclosporine | Panimun Bioral). | 25 mg capsules | RK-LS-5No.014579 |
4584 | L04AD01 | Cyclosporine | Sandimmun® Neoral® | 25 mg capsules | RK-LS-5No.003793 |
4585 | L04AD01 | Cyclosporine | Equoral | 25 mg capsules | RK-LS-5No.009869 |
L04AD02 | Tacrolimus | orphan | |||
4586 | L04AD02 | Tacrolimus | Prograf® | 5 mg capsules | RK-LS-5No.010350 |
4587 | L04AD02 | Tacrolimus | Rangraf | 0.5 mg capsules | RK-LS-5No.121755 |
4588 | L04AD02 | Tacrolimus | Rangraf | 1 mg capsules | RK-LS-5No.121754 |
4589 | L04AD02 | Tacrolimus | Prograf ® | concentrate for solution for intravenous administration 5 mg/ml 1 ml | RK-LS-5No.010353 |
4590 | L04AD02 | Tacrolimus | Advagraf® | 5 mg prolonged-release capsule | RK-LS-5No.018308 |
4591 | L04AD02 | Tacrolimus | Advagraf® | 1 mg prolonged-release capsules | RK-LS-5No.018307 |
4592 | L04AD02 | Tacrolimus |
Prograf® | 1 mg capsules | RK-LS-5No.010351 |
4593 | L04AD02 | Tacrolimus | Tacrolimus-Teva | 1 mg capsules | RK-LS-5No.020614 |
4594 | L04AD02 | Tacrolimus | Prograf® | 0.5 mg capsules | RK-LS-5No.010352 |
4595 | L04AD02 | Tacrolimus | Envarsus® | 4 mg prolonged-release tablets | RK-LS-5No.024195 |
4596 | L04AD02 | Tacrolimus | Advagraf® | 0.5 mg prolonged-release capsules | RK-LS-5No.018306 |
4597 | L04AD02 | Tacrolimus | Tacrolimus-Teva | 0.5 mg capsules | RK-LS-5No.020613 |
4598 | L04AD02 | Tacrolimus | Envarsus® | 1 mg prolonged-release tablets | RK-LS-5No.024196 |
4599 | L04AD02 | Tacrolimus | Envarsus® | 0.75 mg prolonged-release tablets | RK-LS-5No.024197 |
4600 | L04AD02 | Tacrolimus | Advagraf® | 3 mg prolonged-release capsules | RK-LS-5No.020111 |
L04AX | Other immunosuppressants | ||||
L04AX02 | Thalidomide | orphan | |||
L04AX04 | Lenalidomide | orphan | |||
4601 | L04AX04 | Lenalidomide | Lenalidomide | 20 mg capsules | RK-LS-5No.024402 |
4602 | L04AX04 | Lenalidomide | Lenalidomide | 15 mg capsules | RK-LS-5No.024403 |
4603 | L04AX04 | Lenalidomide | Lenalidomide | 5 mg capsules | RK-LS-5No.024404 |
4604 | L04AX04 | Lenalidomide | Lenalidomide | 2.5 mg capsules | RK-LS-5No.024405 |
4605 | L04AX04 | Lenalidomide | Lenalidomide | 25 mg capsules | RK-LS-5No.024406 |
4606 | L04AX04 | Lenalidomide | Lenalidomide | 10 mg capsules | RK-LS-5No.024407 |
4607 | L04AX04 | Lenalidomide | Lenalidomide | 7.5 mg capsules | RK-LS-5No.024408 |
4608 | L04AX04 | Lenalidomide | Lenangio | 5 mg capsules | RK-LS-5No.024299 |
4609 | L04AX04 | Lenalidomide | Lenangio | 10 mg capsules | RK-LS-5No.024300 |
4610 | L04AX04 | Lenalidomide | Lenangio | 15 mg capsules | RK-LS-5No.024301 |
4611 | L04AX04 | Lenalidomide | Lenangio | 25 mg capsules | RK-LS-5No.024302 |
4612 | L04AX04 | Lenalidomide | Revlimid® | 15 mg capsules | RK-LS-5No.020648 |
4613 | L04AX04 | Lenalidomide | Revlimid® | 25 mg capsules | RK-LS-5No.020649 |
4614 | L04AX04 | Lenalidomide | Revlimid® | 10 mg capsules | RK-LS-5No.020648 |
4615 | L04AX04 | Lenalidomide | Revlimid® | 5 mg capsules | RK-LS-5No.020647 |
4616 | L04AX04 | Lenalidomide | Revlimid® | 2.5 mg capsules | RK-LS-5No.023237 |
4617 | L04AX04 | Lenalidomide | Revlimid® | 7.5 mg capsules | RK-LS-5No.023238 |
4618 | L04AX04 | Lenalidomide | Revlimid® | 20 mg capsules | RK-LS-5No.023239 |
4619 | L04AX04 | Lenalidomide | Revlimid® | 5 mg capsules | RK-LS-5No.020646 |
L04AX05 | Pirfenidone | orphan | |||
4620 | L04AX05 | Pirfenidone | Esbriet | 267 mg capsules | RK-LS-5No.022577 |
4621 | L04AX05 | Pirfenidone | PIRFEKT® | 200 mg film coated tablets | RK-LS-5No.024248 |
4622 | L04AX05 | Pirfenidone | Esbriet | 267 mg film coated tablets | RK-LS-5No.024364 |
4623 | L04AX05 | Pirfenidone | Esbriet | 801 mg film coated tablets | RK-LS-5No.024365 |
M | Musculoskeletal system | ||||
M01 | Anti-inflammatory and anti-rheumatic drugs | ||||
M01A | Non-steroidal anti-inflammatory and antirheumatic drugs | ||||
M01AB | Acetic acid derivatives | ||||
M01AB01 | Indometacin | ||||
4624 | M01AB01 | Indometacin | Indometacin Sopharma | 25 mg enteric coated tablets | RK-LS-5No.011720 |
4625 | M01AB01 | Indometacin | Indometacin | 100 mg rectal suppositories | RK-LS-5No.018583 |
4626 | M01AB01 | Indometacin | Indometacin | 50 mg rectal suppositories | RK-LS-5No.020797 |
M01AB05 | Diclofenac Sodium | ||||
4627 | M01AB05 | Diclofenac Sodium | Clodifen | solution for intravenous and intramuscular administration 75 mg/3 ml, 3 ml | RK-LS-5No.024368 |
4628 | M01AB05 | Diclofenac Sodium | Diklofarm | solution for injection 25 mg/ml 3 ml | RK-LS-5No.024227 |
4629 | M01AB05 | Diclofenac Sodium |
DICLOSAFE® | 50 mg rectal suppositories | RK-LS-5No.023852 |
4630 | M01AB05 | Diclofenac Sodium | DINAPAR AQ | solution for injection 75 mg, 1 ml | RK-LS-5No.023652 |
4631 | M01AB05 | Diclofenac Sodium | DICLOSAFE® | 100 mg rectal suppositories | RK-LS-5No.023623 |
4632 | M01AB05 | Diclofenac Sodium | Diclofenac STADA® | 50 mg suppositories | RK-LS-5No.010512 |
4633 | M01AB05 | Diclofenac Sodium | Maxi™-50 | 50 mg enteric coated tablets | RK-LS-5No.003255 |
4634 | M01AB05 | Diclofenac Sodium | Naklofen | 100 mg prolonged-release film-coated tablets | RK-LS-5No.004843 |
4635 | M01AB05 | Diclofenac Sodium | Naklofen duo | 75 mg capsules | RK-LS-5No.009787 |
4636 | M01AB05 | Diclofenac Sodium | Diclofenac | 50 mg rectal suppositories | RK-LS-5No.018605 |
4637 | M01AB05 | Diclofenac Sodium | 100 mg enteric capsules with prolonged release | RK-LS-5No.003875 | |
4638 | M01AB05 | Diclofenac Sodium | Diclofenac-Ratiopharm | 50 mg suppositories | RK-LS-5No.003873 |
4639 | M01AB05 | Diclofenac Sodium | Diclofenac-Ratiopharm | solution for intramuscular administration 75 mg/2 ml, 2 ml | RK-LS-5No.004751 |
4640 | M01AB05 | Diclofenac Sodium | Maxi™-75 | solution for intramuscular injection 75 mg/3 ml, 3 ml | RK-LS-5No.009047 |
4641 | M01AB05 | Diclofenac Sodium | Diclodin | 100 mg rectal suppositories | RK-LS-5No.016923 |
4642 | M01AB05 | Diclofenac Sodium | Olfen™-100 SR Depocaps™ | 100 mg prolonged-release capsules | RK-LS-5No.017072 |
4643 | M01AB05 | Diclofenac Sodium | Ortofen-Health | 25 mg enteric-coated tablets | RK-LS-5No.016299 |
4644 | M01AB05 | Diclofenac Sodium | ARGETT DUO | 75 mg modified-release hard capsules | RK-LS-5No.021596 |
4645 | M01AB05 | Diclofenac Sodium | Olfen™ -100 Rectocaps | 100 mg rectal capsules | RK-LS-5No.004396 |
4646 | M01AB05 | Diclofenac Sodium | Almiral | solution for injection 75mg/3ml 3 ml | RK-LS-5No.000657 |
4647 | M01AB05 | Diclofenac Sodium | DICLOFENAC-AKOS | solution for intramuscular administration 25 mg/ml 3 ml | RK-LS-5No.009246 |
4648 | M01AB05 | Diclofenac Sodium | Naklofen | solution for injection 75 mg/3 ml 3 ml | RK-LS-5No.004844 |
4649 | M01AB05 | Diclofenac Sodium | Dicloberl® N 75 | solution for injection 75 mg/3 ml 3 ml | RK-LS-5No.012683 |
4650 | M01AB05 | Diclofenac Sodium | Diclofenac | solution for intramuscular administration 25 mg/ml 3 ml | RK-LS-5No.005268 |
4651 | M01AB05 | Diclofenac Sodium | Diclofenac-Ratiopharm | 100 mg suppositories | RK-LS-5No.003874 |
4652 | M01AB05 | Diclofenac Sodium | Diclofenac | 100 mg rectal suppositories | RK-LS-5No.002319 |
4653 | M01AB05 | Diclofenac Sodium | Diclofenac STADA® | 100 mg suppositories | RK-LS-5No.010511 |
4654 | M01AB05 | Diclofenac Sodium | Diclofenac-Ratiopharm® | 50 mg enteric coated tablets | RK-LS-5No.003871 |
4655 | M01AB05 | Diclofenac Sodium | Dicloberl® retard | 100 mg prolonged-release capsules | RK-LS-5No.012871 |
4656 | M01AB05 | Diclofenac Sodium | Diclomec® | 75 mg/3 ml solution for intramuscular injection | RK-LS-5No.012622 |
4657 | M01AB05 | Diclofenac Sodium | Diclofenac-Ratiopharm | 25 mg enteric coated tablets | RK-LS-5No.003870 |
4658 | M01AB05 | Diclofenac Sodium | Voltaren® | solution for injection 75mg/3ml | RK-LS-5No.013877 |
4659 | M01AB05 | Diclofenac Sodium | Voltaren® | 50 mg enteric coated tablets | RK-LS-5No.013520 |
4660 | M01AB05 | Diclofenac Sodium | Diclogen | solution for intravenous and intramuscular administration 75mg/3ml 3 ml | RK-LS-5No.011701 |
4661 | M01AB05 | Diclofenac Sodium | Diclomec® | 50g gel for topical application | RK-LS-5No.012568 |
M01AB08 | Etodolac | ||||
4662 | M01AB08 | Etodolac | Etodin® SR | 600 mg prolonged-release film-coated tablets | RK-LS-3No.020494 |
4663 | M01AB08 | Etodolac | ETODIN FORT® | 400 mg film coated tablets | RK-LS-5No.010974 |
4664 | M01AB08 | Etodolac | Etodomed - 400 | 400 mg film coated tablets | RK-LS-5No.022333 |
4665 | M01AB08 | Etodolac | Etova | 400 mg film coated tablets | RK-LS-5No.022513 |
4666 | M01AB08 | Etodolac | Etova | 500 mg film coated tablets | RK-LS-5No.022514 |
M01AB15 | Ketorolac | ||||
4667 | M01AB15 | Ketorolac | Ketorolac | 10 mg coated tablets | RK-LS-5No.014255 |
4668 | M01AB15 | Ketorolac | Ketorol® | 10 mg film coated tablets | RK-LS-5No.003762 |
4669 | M01AB15 | Ketorolac | Ketorolac | 10 mg coated tablets | RK-LS-5No.021211 |
4670 | M01AB15 | Ketorolac | Ketorolac Rompharm | solution for intravenous and intramuscular administration, 30 mg/ml | RK-LS-5No.018893 |
4671 | M01AB15 | Ketorolac | Ketrel | 10 mg coated tablets | RK-LS-5No.017834 |
4672 | M01AB15 | Ketorolac | KETOROLAC | solution for intravenous and intramuscular administration 30 mg/ml 1 ml | RK-LS-5No.013789 |
4673 | M01AB15 | Ketorolac | Ketanov | 10 mg film coated tablets | RK-LS-5No.022709 |
4674 | M01AB15 | Ketorolac | Madredol | solution for injection, 30 mg/ml, 1 ml | RK-LS-5No.022780 |
4675 | M01AB15 | Ketorolac | Dolomine® | solution for intramuscular administration 30 mg/ml 1 ml | RK-LS-5No.012868 |
4676 | M01AB15 | Ketorolac | Ketalgin | 10 mg tablets | RK-LS-5No.010029 |
4677 | M01AB15 | Ketorolac | Medrolgin | solution for injection 30 mg/ml, 1 ml | RK-LS-5No.022281 |
4678 | M01AB15 | Ketorolac | Ketorol® | solution for intramuscular administration 30 mg/ml 1 ml | RK-LS-5No.003763 |
4679 | M01AB15 | Ketorolac | Ketorolac | 10 mg film coated tablets | RK-LS-5No.019754 |
4680 | M01AB15 | Ketorolac | Ketorosan | solution for injection 30 mg/ml, 1 ml | RK-LS-5No.023730 |
4681 | M01AB15 | Ketorolac | Ketanov | solution for intramuscular administration 30 mg/ml, 1 ml | RK-LS-5No.018301 |
4682 | M01AB15 | Ketorolac | ASPRIX | dosed nasal spray, 15.75 mg/dose, 4 ml | RK-LS-5No.024328 |
4683 | M01AB15 | Ketorolac | Ketorol® | Gel, 30 g | RK-LS-5No.019285 |
4684 | M01AB15 | Ketorolac | Ketorol® | Gel, 50 g | RK-LS-5No.019285 |
M01AB16 | Aceclofenac | ||||
4685 | M01AB16 | Aceclofenac | Airtal® | 100 mg film coated tablets | RK-LS-5No.015898 |
4686 | M01AB16 | Aceclofenac | Infenac | 100 mg film coated tablets | RK-LS-5No.013356 |
4687 | M01AB16 | Aceclofenac | Mobenac | 100 mg film coated tablets | RK-LS-5No.019295 |
4688 | M01AB16 | Aceclofenac | DICLOTOL | 100 mg film coated tablets | RK-LS-5No.020560 |
4689 | M01AB16 | Aceclofenac | Actinac 100 | 100 mg film coated tablets | RK-LS-5No.017842 |
4690 | M01AB16 | Aceclofenac | Acecloran® | 100 mg coated tablets | RK-LS-5No.016307 |
4691 | M01AB16 | Aceclofenac | Airtal® | powder for suspension for oral administration, 100 mg | RK-LS-5No.121668 |
M01AC | Oxycams | ||||
M01AC01 | Piroxicam | ||||
4692 | M01AC01 | Piroxicam | Brexin® | tablets | RK-LS-5No.023360 |
M01AC02 | Tenoxicam | ||||
4693 | M01AC02 | Tenoxicam | Artoxan | lyophilized powder for solution for injection with solvent 20 mg | RK-LS-5No.017137 |
4694 | M01AC02 | Tenoxicam | Artoxan | 20 mg film coated tablets | RK-LS-5No.023231 |
4695 | M01AC02 | Tenoxicam | Texikam | lyophilized powder for solution for injection, with solvent (water for injection) 20 mg | RK-LS-5No.023214 |
4696 | M01AC02 | Tenoxicam | Tenoliof | lyophilisate for solution for injection with solvent (water for injection) 20 mg, 2 ml | RK-LS-5No.024428 |
4697 | M01AC02 | Tenoxicam | Artoxan | 20 mg rectal suppositories | RK-LS-5No.023065 |
M01AC05 | Lornoxicam | ||||
4698 | M01AC05 | Lornoxicam | Xefocam | 8 mg film coated tablets | RK-LS-5No.019987 |
4699 | M01AC05 | Lornoxicam | Xefocam rapid | 8 mg coated tablets | RK-LS-5No.004993 |
4700 | M01AC05 | Lornoxicam | Nyufokam | 4 mg film coated tablets | RK-LS-5No.021296 |
4701 | M01AC05 | Lornoxicam | Nyufokam | 8 mg film coated tablets | RK-LS-5No.021291 |
4702 | M01AC05 | Lornoxicam | Xefocam | lyophilisate for solution for intravenous and intramuscular administration 8 mg | RK-LS-5No.020054 |
4703 | M01AC05 | Lornoxicam | Lornoxicam Viva Pharm | 4 mg coated tablets | RK-LS-5No.024267 |
4704 | M01AC05 | Lornoxicam | Lornoxicam Viva Pharm | 8 mg coated tablets | RK-LS-5No.024268 |
4705 | M01AC05 | Lornoxicam | Velose | 8 mg film coated tablets | RK-LS-5No.024214 |
4706 | M01AC05 | Lornoxicam | Lornoxicam-Alvogen | 8 mg film coated tablets | RK-LS-5No.023359 |
4707 | M01AC05 | Lornoxicam | LORITIS FAST | 8 mg film coated tablets | RK-LS-5No.022576 |
4708 | M01AC05 | Lornoxicam | Zornika-8 | 8 mg film coated tablets | RK-LS-5No.021002 |
4709 | M01AC05 | Lornoxicam | LARFIX® | 8 mg coated tablets | RK-LS-5No.020678 |
4710 | M01AC05 | Lornoxicam | Xefocam | 4 mg film coated tablets | RK-LS-5No.019986 |
M01AC06 | Meloxicam | ||||
4711 | M01AC06 | Meloxicam | Movasin | 15 mg tablets | RK-LS-5No.013657 |
4712 | M01AC06 | Meloxicam | Movasin | 7.5 mg tablets | RK-LS-5No.013656 |
4713 | M01AC06 | Meloxicam | Meloksevin | 7.5 mg tablets | RK-LS-5No.024369 |
4714 | M01AC06 | Meloxicam | Meloxicam | solution for injection 15mg/1.5 ml, 1.5 ml | RK-LS-5No.024285 |
4715 | M01AC06 | Meloxicam | EXISTEN-sanovel | solution for intramuscular injection, 15 mg/1.5 ml, 1.5 ml | RK-LS-5No.017369 |
4716 | M01AC06 | Meloxicam | Movalis® | 7.5 mg tablets | RK-LS-5No.016716 |
4717 | M01AC06 | Meloxicam | Meloflam® | 15 mg tablets | RK-LS-5No.010336 |
4718 | M01AC06 | Meloxicam | Melbek® | solution for intramuscular injection, 15 mg/1.5 ml, 1.5 ml | RK-LS-5No.019703 |
4719 | M01AC06 | Meloxicam | Revmoxicam® | solution for injection 1% 1.5 ml | RK-LS-5No.011649 |
4720 | M01AC06 | Meloxicam | Melox | 7.5 mg tablets | RK-LS-5No.009758 |
4721 | M01AC06 | Meloxicam | Movasin | 7.5 mg tablets | RK-LS-5No.013656 |
4722 | M01AC06 | Meloxicam | Meloxicam-Teva | solution for injection 15 mg/1.5 ml, 1.5 ml | RK-LS-5No.014257 |
4723 | M01AC06 | Meloxicam | Movalis® | 15 mg tablets | RK-LS-5No.016709 |
4724 | M01AC06 | Meloxicam | Meloxicam | 7.5 mg tablets | RK-LS-5No.022530 |
4725 | M01AC06 | Meloxicam | Meloxicam | 15 mg tablets | RK-LS-5No.022537 |
4726 | M01AC06 | Meloxicam | Amelotex® | 7.5 mg tablets | RK-LS-5No.018139 |
4727 | M01AC06 | Meloxicam | Amelotex® | 15 mg tablets | RK-LS-5No.018140 |
4728 | M01AC06 | Meloxicam | Gramell | solution for injection 15 mg/1.5 ml, 1.5 ml | RK-LS-5No.022717 |
4729 | M01AC06 | Meloxicam | Meloflex Rompharm | solution for intramuscular administration 15 mg/1.5 ml, 1.5 ml | RK-LS-5No.022763 |
4730 | M01AC06 | Meloxicam | Meloxicam | 7.5 mg rectal suppositories | RK-LS-5No.018385 |
4731 | M01AC06 | Meloxicam | Meloxicam | 15 mg rectal suppositories | RK-LS-5No.018386 |
4732 | M01AC06 | Meloxicam | Meloxicam | 7.5 mg tablets | RK-LS-5No.023054 |
4733 | M01AC06 | Meloxicam | Meloxicam | 15 mg tablets | RK-LS-5No.023055 |
4734 | M01AC06 | Meloxicam | Meloxicam | 7.5 mg tablets | RK-LS-5No.019715 |
4735 | M01AC06 | Meloxicam | Meloflam® | 7.5 mg tablets | RK-LS-5No.010337 |
4736 | M01AC06 | Meloxicam | Artrozan® | 15 mg tablets | RK-LS -5No.018991 |
4737 | M01AC06 | Meloxicamum | Melox | 15 mg tablets | RK-LS-5№009759 |
4738 | M01AC06 | Meloxicamum | Meloxicam-Ratiopharm | 15 mg tablets | RK-LS-5№019716 |
4739 | M01AC06 | Meloxicamum | Meloxicam-Ratiopharm | 7.5 mg tablets | RK-LS-5№014194 |
4740 | M01AC06 | Meloxicamum | Meloxicam-Ratiopharm | 15 mg tablets | RK-LS-5№014195 |
4741 | M01AC06 | Meloxicamum | Movalis® | 15 mg/1.5 ml solution for intramuscular injection, 1.5 ml | RK-LS-5№015515 |
4742 | M01AC06 | Meloxicamum | Meloxicam-Teva | 15 mg tablets | RK-LS-5№021107 |
4743 | M01AC06 | Meloxicamum | Meloxicam-Teva | 7.5 mg tablets | RK-LS-5№021108 |
4744 | M01AC06 | Meloxicamum | Amelotex® | 10 mg/ml solution for intramuscular injection,1.5 ml | RK-LS-5№014417 |
4745 | M01AC06 | Meloxicamum | Artrozan® | 6mg/ml solution for intramuscular injection, 2.5 ml | RK-LS-5№021411 |
4746 | M01AC06 | Meloxicamum | Meloxicam-N | 10mg/ml solution for injection, 1.5 ml | RK-LS-5№021525 |
4747 | M01AC06 | Meloxicamum | Movasin | 15 mg tablets | RK-LS-5№013657 |
4748 | M01AC06 | Meloxicamum | Loxidol | 15mg/1.5 ml solution for injection, 1.5 ml | RK-LS-5№022905 |
4749 | M01AC06 | Meloxicamum | Reklin | 15mg/1.5ml solution for intramuscular injection, 1.5 ml | RK-LS-5№022030 |
4750 | M01AC06 | Meloxicamum | Reumoxicam® | 15 mg tablets | RK-LS-5№010193 |
4751 | M01AC06 | Meloxicamum | MELBEK FORT® | 15 mg tablets | RK-LS-5№004689 |
4752 | M01AC06 | Meloxicamum | Reumoxicam® | 7.5 mg tablets | RK-LS-5№010194 |
4753 | M01AC06 | Meloxicamum | MELBEK® | 7.5 mg tablets | RK-LS-5№004687 |
4754 | M01AC06 | Meloxicamum | Loxidol | 15 mg tablets | RK-LS-5№019660 |
4755 | M01AC06 | Meloxicamum | Loxidol | 15 mg rectal suppositories | RK-LS-5№019530 |
M01AE | Propionic acid derivatives | ||||
M01AE01 | Ibuprophenum | ||||
4756 | M01AE01 | Ibuprophenum | Intrafen | 800 mg/8 ml intravenous solution, 8 ml | RK-LS-5№024422 |
4757 | M01AE01 | Ibuprophenum | Intrafen | 400 mg/4 ml intravenous solution, 4 ml | RK-LS-5№024423 |
4758 | M01AE01 | Ibuprophenum | Ibuprofen-Teva | 400 mg coated tablets | RK-LS-5№014622 |
4759 | M01AE01 | Ibuprophenum | Ibufen D | 100 mg/5 ml oral suspension, 100 ml | RK-LS-5№015569 |
4760 | M01AE01 | Ibuprophenum | Ibufen D | 100 mg/5 ml oral suspension, 120 ml | RK-LS-5№015569 |
4761 | M01AE01 | Ibuprophenum | MIG® for children | 100 mg/5 ml oral suspension, 100 ml | RK-LS-5№020492 |
4762 | M01AE01 | Ibuprophenum | Ibuprofen Viva Farm | 200 mg coated tablets | RK-LS-5№122119 |
4763 | M01AE01 | Ibuprophenum | Ibuprofen Viva Farm | 400 mg coated tablets | RK-LS-5№122120 |
4764 | M01AE01 | Ibuprophenum | MIG® 400 | film-coated tablets | RK-LS-5№010633 |
4765 | M01AE01 | Ibuprophenum | Gofen 200 | 200 mg capsules | RK-LS-5№023508 |
4766 | M01AE01 | Ibuprophenum | Gofen 400 | 400 mg capsules | RK-LS-5№023509 |
4767 | M01AE01 | Ibuprophenum | RIBOL | 20 mg/1 ml oral suspension, 100 ml | RK-LS-5№023386 |
4768 | M01AE01 | Ibuprophenum | RIBOL | 20 mg/1 ml oral suspension, 200 ml | RK-LS-5№023386 |
4769 | M01AE01 | Ibuprophenum | Ibukem | 200 mg film-coated tablets | RK-LS-5№024475 |
4770 | M01AE01 | Ibuprophenum | Ibukem | 400 mg film-coated tablets | RK-LS-5№024477 |
4771 | M01AE01 | Ibuprophenum | Caffetin Lady | 200 mg film-coated tablets | RK-LS-5№023229 |
4772 | M01AE01 | Ibuprophenum | Novigan® Neo | 400 mg film-coated tablets | RK-LS-5№023201 |
4773 | M01AE01 | Ibuprophenum | Nurofen® for children | 100 mg/5 ml orange oral suspension, 100 ml | RK-LS-5№011246 |
4774 | M01AE01 | Ibuprophenum | Nurofen® for children | 100 mg/5 ml orange oral suspension, 150 ml | RK-LS-5№011246 |
4775 | M01AE01 | Ibuprophenum | Nurofen® for children | 100 mg/5 ml strawberry oral suspension, 100 ml | RK-LS-5№011247 |
4776 | M01AE01 | Ibuprophenum | Nurofen® for children | 100 mg/5 ml strawberry oral suspension, 150 ml | RK-LS-5№011247 |
4777 | M01AE01 | Ibuprophenum | Faspic |
400 mg coated tablets | RK-LS-5№018573 |
4778 | M01AE01 | Ibuprophenum | Ibufen® mini Junior | 100 mg softgel capsules | RK-LS-5№023056 |
4779 | M01AE01 | Ibuprophenum | Ibufen® D Forte | 200 mg/5 ml oral suspension, 100 ml | RK-LS-5№018923 |
4780 | M01AE01 | Ibuprophenum | Nurofen® |
200 mg coated tablets | RK-LS-5№018120 |
4781 | M01AE01 | Ibuprophenum | Ibufen Baby | 60 mg rectal suppositories | RK-LS-5№022551 |
4782 | M01AE01 | Ibuprophenum | Ibufen Baby | 125 mg rectal suppositories | RK-LS-5№022552 |
4783 | M01AE01 | Ibuprophenum | Ibufen® Ultra | 200 mg capsules | RK-LS-5№018920 |
4784 | M01AE01 | Ibuprophenum | Ribol |
400 mg film-coated tablets | RK-LS-5№022543 |
4785 | M01AE01 | Ibuprophenum | Ribol |
200 mg film-coated tablets | RK-LS-5№022496 |
4786 | M01AE01 | Ibuprophenum | Inforin | 200 mg film-coated tablets | RK-LS-5№022399 |
4787 | M01AE01 | Ibuprophenum | Neofen | 60 mg rectal suppositories | RK-LS-5№022201 |
4788 | M01AE01 | Ibuprophenum | MIG® 400 | 400 mg film-coated tablets | RK-LS-5№022193 |
4789 | M01AE01 | Ibuprophenum | Neofen Forte | 400 mg film-coated tablets | RK-LS-5№022163 |
4790 | M01AE01 | Ibuprophenum | Ibupar forte | 400 mg film-coated tablets | RK-LS-5№122085 |
4791 | M01AE01 | Ibuprophenum | MIG® forte for children | 200 mg/5 ml oral suspension, 100 ml | RK-LS-5№121805 |
4792 | M01AE01 | Ibuprophenum | Orafen | 100 mg/5 ml oral suspension, 200 ml | RK-LS-5№121797 |
4793 | M01AE01 | Ibuprophenum | New Ne-Bol | 400 mg film-coated tablets | RK-LS-5№121759 |
4794 | M01AE01 | Ibuprophenum | Ibufen® D Forte | 200mg/5ml raspberry oral suspension | RK-LS-5№021577 |
4795 | M01AE01 | Ibuprophenum | Ibufen® D Forte | 200mg/5 ml strawberry oral suspension, 40 ml | RK-LS-5№021504 |
4796 | M01AE01 | Ibuprophenum | Ibufen® D Forte | 200mg/5 ml strawberry oral suspension, 100 ml | RK-LS-5№021504 |
4797 | M01AE01 | Ibuprophenum | Nurofen® Express | 200 mg capsules | RK-LS-5№021331 |
4798 | M01AE01 | Ibuprophenum | Ibufen® | 100mg/5ml oral suspension, 100 ml | RK-LS-5№003031 |
4799 | M01AE01 | Ibuprophenum | Ibuprofen | 200 mg coated tablets | RK-LS-5№019771 |
4800 | M01AE01 | Ibuprophenum | Ibuprofen-Teva | 200 mg coated tablets | RK-LS-5№014621 |
4801 | M01AE01 | Ibuprophenum | Ne-Bol | 100 mg/5ml oral suspension, 100 ml | RK-LS-5№121929 |
4802 | M01AE01 | Ibuprophenum | Ibupar | 200 mg coated tablets | RK-LS-5№122084 |
4803 | M01AE01 | Ibuprophenum | Intrafen | 800 mg/8 ml intravenous solution, 8 ml | RK-LS-5№121926 |
4804 | M01AE01 | Ibuprophenum | Intrafen | 400 mg/4 ml intravenous solution, 4 ml | RK-LS-5№121925 |
4805 | M01AE01 | Ibuprophenum | Inforin | 100 mg/5 ml suspension, 100 ml | RK-LS-5№022413 |
4806 | M01AE01 | Ibuprophenum | Bofen | 100 mg/5 ml oral suspension, 100 ml | RK-LS-5№022962 |
4807 | M01AE01 | Ibuprophenum | BEFRON® | 100 mg/5 ml suspension, 100 ml | RK-LS-5№019116 |
4808 | M01AE01 | Ibuprophenum | Inforin | 400 mg film-coated tablets | RK-LS-5№022400 |
4809 | M01AE01 | Ibuprophenum | Ibuprofen Viva Farm | 400 mg coated tablets | RK-LS-5№122120 |
4810 | M01AE01 | Ibuprophenum | Ibuprofen Viva Farm | 200 mg coated tablets | RK-LS-5№122119 |
4811 | M01AE01 | Ibuprophenum | Ibuprofen | 200 mg coated tablets | RK-LS-5№017841 |
4812 | M01AE01 | Ibuprophenum | Brufen® |
600 mg effervescent granules | RK-LS-5№021406 |
M01AE02 | Naproxenum | ||||
4813 | M01AE02 | Naproxenum | Nalgesin® Forte | 550 mg coated tablets | RK-LS-5№009799 |
4814 | M01AE02 | Naproxenum | Nalgesin® | 275 mg film-coated tablets | RK-LS-5№009798 |
4815 | M01AE02 | Naproxenum | Naproff | 550 mg film-coated tablets | RK-LS-5№018778 |
4816 | M01AE02 | Naproxenum | Anapran EC | 250 mg enteric-coated tablets | RK-LS-5№022739 |
4817 | M01AE02 | Naproxenum | Anapran EC | 500 mg enteric-coated tablets | RK-LS-5№022740 |
4818 | M01AE02 | Naproxenum | Aksen fort | 550 mg tablets | RK-LS-5№022149 |
4819 | M01AE02 | Naproxenum | Sinaks | 550 mg coated tablets | RK-LS-5№021239 |
M01AE03 | Ketoprophenum | ||||
4820 | M01AE03 | Ketoprophenum | Ketonal® | 50 mg capsule | RK-LS-5№004285 |
4821 | M01AE03 | Ketoprophenum | Ketonal® | 100 mg/2 ml solution for injection | RK-LS-5№004281 |
4822 | M01AE03 | Ketoprophenum | Ketonal® forte | 100 mg film-coated tablets | RK-LS-5№004284 |
4823 | M01AE03 | Ketoprophenum | Ketoprofen Rompharm | 50 mg/ml solution for intravenous and intramuscular injection, 2 ml | RK-LS-5№018832 |
4824 | M01AE03 | Ketoprophenum | Artrum | 2.5% topical gel, 30 g | RK-LS-5№121802 |
4825 | M01AE03 | Ketoprophenum | Artrum | 5% topical gel, 30 g | RK-LS-5№121803 |
4826 | M01AE03 | Ketoprophenum | Artrocol | 100 mg/2 ml solution for injection | RK-LS-5№022313 |
4827 | M01AE03 | Ketoprophenum | Ketotop® | 100 mg/2ml solution for intravenous and intramuscular injection, 2 ml | RK-LS-5№013002 |
4828 | M01AE03 | Ketoprophenum | Ketonal® | 100 mg suppositories | RK-LS-5№004280 |
4829 | M01AE03 | Ketoprophenum | Artrum | 100 mg rectal suppositories | RK-LS-5№121660 |
4830 | M01AE03 | Ketoprophenum | Ketonal® DUO | 150 mg modified-release capsule | RK-LS-5№003761 |
4831 | M01AE03 | Ketoprophenum | Ketotop® | 50 mg capsules | RK-LS-5№018675 |
4832 | M01AE03 | Ketoprophenum | Ketotop® forte | 100 mg coated tablets | RK-LS-5№018346 |
4833 | M01AE03 | Ketoprophenum | Flamax® | 50 mg/ml solution for intramuscular injection | RK-LS-5№012867 |
4834 | M01AE03 | Ketoprophenum | Febrofid | 100 mg coated tablets | RK-LS-5№018348 |
M01AE09 | Flurbiprophenum | ||||
4835 | M01AE09 | Flurbiprophenum | Majezik-sanovel SR | 200 mg delayed-release capsules | RK-LS-5№022722 |
4836 | M01AE09 | Flurbiprophenum | Majezik-sanovel | 100 mg coated tablets | RK-LS-5№010472 |
4837 | M01AE09 | Flurbiprophenum | MAPROFEN® | 100 mg film-coated tablets | RK-LS-5№018933 |
M01AE17 | Dexketoprophenum | ||||
4838 | M01AE17 | Dexketoprophenum | DEXTANOL | 25 mg film-coated tablets | RK-LS-5№019061 |
4839 | M01AE17 | Dexketoprophenum | Dexalgin® | 25 mg film-coated tablets | RK-LS-5№005063 |
4840 | M01AE17 | Dexketoprophenum | Deceton | 25 mg film-coated tablets | RK-LS-5№020080 |
4841 | M01AE17 | Dexketoprophenum | Sertofen | 25 mg film-coated tablets | RK-LS-5№121698 |
4842 | M01AE17 | Dexketoprophenum | Infen - 25 | 25 mg film-coated tablets | RK-LS-5№121988 |
4843 | M01AE17 | Dexketoprophenum | Mialdex | 25 mg film-coated tablets | RK-LS-5№023402 |
4844 | M01AE17 | Dexketoprophenum | Dexalgin® sachet | 25 mg oral granules | RK-LS-5№020734 |
4845 | M01AE17 | Dexketoprophenum | DEXTANOL | 50 mg/2 ml solution for intravenous and intramuscular injection, 2 ml | RK-LS-5№020454 |
4846 | M01AE17 | Dexketoprophenum | Keywer | 50 mg/2 ml solution for injection, 2 ml | RK-LS-5№023902 |
4847 | M01AE17 | Dexketoprophenum | Deceton | 50 mg/2 ml solution for injection, 2 ml | RK-LS-5№023807 |
4848 | M01AE17 | Dexketoprophenum | Mialdex | 50 mg/2 ml solution for injection, 2 ml | RK-LS-5№023403 |
4849 | M01AE17 | Dexketoprophenum | Sertofen | 50 mg/2 ml solution for injection/concentrate for solution for infusion, 2 ml | RK-LS-5№121822 |
4850 | M01AE17 | Dexketoprophenum | Dexalgin® inject | 50 mg/2 ml solution for intravenous and intramuscular injection, 2 ml | RK-LS-5№021492 |
M01AE53 | Interaction of Ketoprophenum with other drugs | ||||
M01AH | Coxibs | ||||
M01AH01 | Celecoxibum | ||||
4851 | M01AH01 | Celecoxibum | Celcox | 100 mg capsules | RK-LS-5№014961 |
4852 | M01AH01 | Celecoxibum | Dilaxa® | 200 mg capsules | RK-LS-5№020967 |
4853 | M01AH01 | Celecoxibum | Sagacoxib | 200 mg capsules | RK-LS-5№022114 |
4854 | M01AH01 | Celecoxibum | Sagacoxib | 100 mg capsules | RK-LS-5№022115 |
4855 | M01AH01 | Celecoxibum | Rancelex | 100 mg capsules | RK-LS-5№022710 |
4856 | M01AH01 | Celecoxibum | Rancelex | 200 mg capsules | RK-LS-5№022711 |
4857 | M01AH01 | Celecoxibum | Celcox | 200 mg capsules | RK-LS-5№014960 |
4858 | M01AH01 | Celecoxibum | Dilaxa® | 100 mg capsules | RK-LS-5№020966 |
M01AH05 | Etoricoxibum | ||||
4859 | M01AH05 | Etoricoxibum | Arcoxia |
60 mg film-coated tablets | RK-LS-5№015575 |
4860 | M01AH05 | Etoricoxibum | Exinef |
30 mg film-coated tablets | RK-LS-5№022470 |
4861 | M01AH05 | Etoricoxibum | Exinef |
60 mg film-coated tablets | RK-LS-5№121704 |
4862 | M01AH05 | Etoricoxibum | Exinef |
90 mg film-coated tablets | RK-LS-5№121705 |
4863 | M01AH05 | Etoricoxibum | Exinef |
120 mg film-coated tablets | RK-LS-5№121706 |
4864 | M01AH05 | Etoricoxibum | Arcoxia |
30 mg film-coated tablets | RK-LS-5№022602 |
4865 | M01AH05 | Etoricoxibum | Etoricoxib-Teva |
30 mg film-coated tablets | RK-LS-5№023496 |
4866 | M01AH05 | Etoricoxibum | Etoricoxib-Teva |
60 mg film-coated tablets | RK-LS-5№023497 |
4867 | M01AH05 | Etoricoxibum | Etocox |
60 mg film-coated tablets | RK-LS-5№023499 |
4868 | M01AH05 | Etoricoxibum | Etocox |
90 mg film-coated tablets | RK-LS-5№023500 |
4869 | M01AH05 | Etoricoxibum | Etocox |
120 mg film-coated tablets | RK-LS-5№023501 |
4870 | M01AH05 | Etoricoxibum | Etoricoxib-Teva |
90 mg film-coated tablets | RK-LS-5№023534 |
4871 | M01AH05 | Etoricoxibum | Etoricoxib-Teva |
120 mg film-coated tablets | RK-LS-5№023535 |
4872 | M01AH05 | Etoricoxibum | Kostarox® |
120 mg film-coated tablets | RK-LS-5№023742 |
4873 | M01AH05 | Etoricoxibum | Kostarox® |
90 mg film-coated tablets | RK-LS-5№023743 |
4874 | M01AH05 | Etoricoxibum | Kostarox® |
60 mg film-coated tablets | RK-LS-5№023744 |
4875 | M01AH05 | Etoricoxibum | Kostarox® |
30 mg film-coated tablets | RK-LS-5№023745 |
4876 | M01AH05 | Etoricoxibum | Arcoxia |
120 mg film-coated tablets | RK-LS-5№015577 |
4877 | M01AH05 | Etoricoxibum | Arcoxia |
90 mg film-coated tablets | RK-LS-5№015576 |
M01C | Basic anti-rheumatic drugs | ||||
M01CC | Penicillamine and similar drugs | ||||
M01CC01 | Penicillamine | orphan drug | |||
M02 | Topical pain medications for musculoskeletal disorders | ||||
M02A | Topical pain medications for musculoskeletal disorders | ||||
M02AA | Topical non-steroidal anti-inflammatory drugs | ||||
M02AA07 | Piroxicamum | ||||
M02AA10 | Ketoprophenum | ||||
4878 | M02AA10 | Ketoprophenum | Febrofid | 2.5% topical gel, 50 g | RK-LS-5№005392 |
4879 | M02AA10 | Ketoprophenum | Fastum® gel | gel, 50 g | RK-LS-5№017900 |
4880 | M02AA10 | Ketoprophenum | Fastum® gel | gel,100 g | RK-LS-5№017900 |
4881 | M02AA10 | Ketoprophenum | Febrofid | 2.5% topical gel, 30 g | RK-LS-5№005392 |
4882 | M02AA10 | Ketoprophenum | Febrofid | 2.5% topical gel, 50 g | RK-LS-5№005392 |
4883 | M02AA10 | Ketoprophenum | Ketoprofen | 25 mg/g topical gel, 30g | RK-LS-5№021110 |
4884 | M02AA10 | Ketoprophenum | Ketonal® | 2.5% gel, 50 g | RK-LS-5№003420 |
4885 | M02AA10 | Ketoprophenum | Ketonal® | 5% cream, 30 g | RK-LS-5№004282 |
4886 | M02AA10 | Ketoprophenum | Artrum | 5% topical gel, 30 g | RK-LS-5№121803 |
4887 | M02AA10 | Ketoprophenum |
Artrocol | 2.5 % gel, 45 g | RK-LS-5№024054 |
4888 | M02AA10 | Ketoprophenum | Fort-gel | 2.5 % gel, 50 g | RK-LS-5№023977 |
4889 | M02AA10 | Ketoprophenum | Ketoprofen | 2.5% topical gel, 50 g | RK-LS-5№018868 |
4890 | M02AA10 | Ketoprophenum | Valusal® | 25 mg/g topical gel | RK-LS-5№016183 |
4891 | M02AA10 | Ketoprophenum | Valusal® | 25 mg/g topical gel | RK-LS-5№016184 |
4892 | M02AA10 | Ketoprophenum | Artrum | 2.5% topical gel, 30 g | RK-LS-5№121802 |
4893 | M02AA10 | Ketoprophenum | Ketoprofen | 50 mg capsules | RK-LS-5№024029 |
4894 | M02AA10 | Ketoprophenum | Ketotop® | transdermal patch | RK-LS-5№015544 |
4895 | M02AA10 | Ketoprophenum | Kefentek | 30g patch | RK-LS-5№018707 |
M02AA13 | Ibuprophenum | ||||
4896 | M02AA13 | Ibuprophenum | Dolgit® cream | topical gel, 20g | RK-LS-5№012587 |
4897 | M02AA13 | Ibuprophenum | Dolgit® cream | topical gel, 50g | RK-LS-5№012587 |
4898 | M02AA13 | Ibuprophenum | Dolgit® cream | topical gel, 100g | RK-LS-5№012587 |
4899 | M02AA13 | Ibuprophenum | Ne-Bol | 5% gel, 30 g | RK-LS-5№019940 |
4900 | M02AA13 | Ibuprophenum | Ibufen® | 100 mg/g topical gel | RK-LS-5№022746 |
4901 | M02AA13 | Ibuprophenum | Ribol | 5% gel, 60 g | RK-LS-5№022497 |
4902 | M02AA13 | Ibuprophenum | Ribol Stick | 5% gel, 60 g | RK-LS-5№022495 |
4903 | M02AA13 | Ibuprophenum | Neofen | 50 mg/g spray for topical treatment | RK-LS-5№022139 |
M02AA15 | Diclophenacum | ||||
4904 | M02AA15 | Diclophenacum | Diclofenac sodium | 10 mg/g skin ointment, 30 g | RK-LS-5№019411 |
4905 | M02AA15 | Diclophenacum | DICLOFENAC-AKOS | 1% ointment, 30 g | RK-LS-5№014965 |
4906 | M02AA15 | Diclophenacum | ORTOFLEX® | 20 mg/g skin ointment, 30 g | RK-LS-5№004217 |
4907 | M02AA15 | Diclophenacum | ORTOFLEX® | 20 mg/g skin ointment, 50 g | RK-LS-5№004217 |
4908 | M02AA15 | Diclophenacum | Clodifen | 5% gel, 45 g | RK-LS-5№020230 |
4909 | M02AA15 | Diclophenacum | DICLOSAFE® Forte Emulgel | 2% topical gel, 30 g | RK-LS-5№024416 |
4910 | M02AA15 | Diclophenacum | DICLOSAFE® Emulgel | 1% topical gel, 30 g | RK-LS-5№024417 |
4911 | M02AA15 | Diclophenacum | Clodifen | 5 % gel, 45g | RK-LS-5№024273 |
4912 | M02AA15 | Diclophenacum | Almiral | 1% topical gel | RK-LS-5№024112 |
4913 | M02AA15 | Diclophenacum | Diclopharm | 1 % topical gel | RK-LS-5№024089 |
4914 | M02AA15 | Diclophenacum | Diclopharm | 5% topical gel | RK-LS-5№024080 |
4915 | M02AA15 | Diclophenacum | Diclac® | 5% gel, 50 g | RK-LS-5№020815 |
4916 | M02AA15 | Diclophenacum | Diclac® | 5% gel, 100 g | RK-LS-5№020815 |
4917 | M02AA15 | Diclophenacum | Naklofen | 11.6 mg/g gel, 60 g | RK-LS-5№020083 |
4918 | M02AA15 | Diclophenacum | Voltaren Emulgel | 1 % topical gel, 20 g | RK-LS-5№011756 |
4919 | M02AA15 | Diclophenacum | Voltaren Emulgel | 1 % topical gel, 50 g | RK-LS-5№011756 |
4920 | M02AA15 | Diclophenacum | Diclofenac | 1 % topical gel, 25 g | RK-LS-5№019640 |
4921 | M02AA15 | Diclophenacum | Diclofenac-ratiopharm Em-gel | 1 % gel, 50 g | RK-LS-5№019258 |
4922 | M02AA15 | Diclophenacum | Voltaren Emulgel | 2% topical gel, 50 g | RK-LS-5№023357 |
4923 | M02AA15 | Diclophenacum | Diclogen | 1 % topical gel, 30g | RK-LS-5№010735 |
4924 | M02AA15 | Diclophenacum | Diclofenac-ratiopharm | 1% topical gel, 30 g | RK-LS-5№003872 |
4925 | M02AA15 | Diclophenacum | Fanigan® day | 50 mg/g topical gel, 30 g | RK-LS-5№022132 |
4926 | M02AA15 | Diclophenacum | Fanigan® day | 50 mg/g topical gel, 100 g | RK-LS-5№022132 |
4927 | M02AA15 | Diclophenacum | Diclofenac | 5% topical gel, 30 g | RK-LS-5№021514 |
4928 | M02AA15 | Diclophenacum | Diclofenac | 5% topical gel, 50 g | RK-LS-5№021514 |
4929 | M02AA15 | Diclophenacum | Diclofenac | 5% topical gel, 100 g | RK-LS-5№021514 |
4930 | M02AA15 | Diclophenacum | Argett spray | 4% spray for topical treatment, 12.5 g | RK-LS-5№019395 |
4931 | M02AA15 | Diclophenacum | Argett spray | 4% spray for topical treatment, 25 g | RK-LS-5№019395 |
4932 | M02AA15 | Diclophenacum | Itami | medicinal patch, 140 mg | RK-LS-5№018750 |
4933 | M02AA15 | Diclophenacum | Dynapar QPS | 4% topical solution, 15 ml | RK-LS-5№023651 |
4934 | M02AA15 | Diclophenacum | Dynapar QPS | 4% topical solution, 30 ml | RK-LS-5№023651 |
4935 | M02AA15 | Diclophenacum | Diclofenac-ratiopharm 140 mg | patch | RK-LS-5№015804 |
M02AA23 | Indomethacinum | ||||
4936 | M02AA23 | Indomethacinum | Indometacin | 100 mg/g skin ointment | RK-LS-5№010518 |
4937 | M02AA23 | Indomethacinum | Indometacin Sopharma | 10% ointment, 40 g | RK-LS-5№014143 |
M02AX | Other topical pain medications for musculoskeletal disorders | ||||
M02AX | Camphora | ||||
4938 | M02AX | Camphora | Camphor spirit | 10% alcohol solution, 50 ml | RK-LS-5№003178 |
4939 | M02AX | Camphora | Camphor spirit | 10% alcohol solution, 30 ml | RK-LS-5№003178 |
4940 | M02AX | Camphora | Camphor spirit | 10% solution, 50 ml | RK-LS-5№009519 |
4941 | M02AX | Camphora | Camphor spirit | 10% solution, 40 ml | RK-LS-5№009519 |
4942 | M02AX | Camphora | Camphor spirit | 10% solution, 30 ml | RK-LS-5№009519 |
4943 | M02AX | Camphora | Camphor spirit | 10% solution, 25 ml | RK-LS-5№009519 |
M03 | Muscle relaxants | ||||
M03A | Peripherally acting muscle relaxants | ||||
M03AB | Choline derivatives | ||||
M03AB01 | Suxamethonium chloride | ||||
4944 | M03AB01 | Suxamethonium chloride | Dithylin-Darnitsa | 2% solution for injection, 5 ml | RK-LS-5№016134 |
4945 | M03AB01 | Suxamethonium chloride | Lysthenon® | 0.1 g/5 ml solution for injection, 5 ml | RK-LS-5№015881 |
4946 | M03AB01 | Suxamethonium chloride | Polsuxan | 100 mg/5 ml solution for injection, 5 ml | RK-LS-5№021409 |
M03AC | Other quaternary ammonium compounds | ||||
M03AC04 | Atracuria besylate | ||||
4947 | M03AC04 | Atracuria besylate | Tracrium® | 25 mg/2.5 ml intravenous solution, 2.5 ml | RK-LS-5№012157 |
4948 | M03AC04 | Atracuria besylate | Atracurium Kalceks | 10 mg/ml intravenous solution, 5 ml | RK-LS-5№024276 |
4949 | M03AC04 | Atracuria besylate | Atracurium Kalceks | 10 mg/ml intravenous solution, 2.5 ml | RK-LS-5№024276 |
M03AC06 | Pipecuronium bromide | ||||
4950 | M03AC06 | Pipecuronium bromide | Arduan® | lyophilized powder and solvent for intravenous solution (0.9% sodium chloride solution), 4 mg | RK-LS-5№014612 |
4951 | M03AC06 | Pipecuronium bromide |
Arkuron | lyophilized powder for solution for injection, 4 mg | RK-LS-5№014769 |
M03AC09 | Rocuronium bromide | ||||
4952 | M03AC09 | Rocuronium bromide | Romeran | 10 mg/ml intravenous solution, 10 ml | RK-LS-5№023731 |
4953 | M03AC09 | Rocuronium bromide | Romeran | 10 mg/ml intravenous solution, 5 ml | RK-LS-5№023731 |
4954 | M03AC09 | Rocuronium bromide | Esmeron® | 10 mg/ml intravenous solution, 5 ml | RK-LS-5№018093 |
4955 | M03AC09 | Rocuronium bromide | Rokuronium Kalceks | 100 mg/ml intravenous solution, 5 ml | RK-LS-5№024439 |
4956 | M03AC09 | Rocuronium bromide | Rokuronium | 10 mg/ml intravenous solution, 10 ml | RK-LS-5№024462 |
4957 | M03AC09 | Rocuronium bromide | Rokuronium | 10 mg/ml intravenous solution, 5 ml | RK-LS-5№024463 |
M03AX01 | Botulinum toxin type a-hemagglutinin complex | ||||
4958 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Neuronox | 50 units lyophilized powder for solution for injection | RK-LS-5№020217 |
4959 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Neuronox | 100 units lyophilized powder for solution for injection | RK-LS-5№020218 |
4960 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Neuronox | 200 units lyophilized powder for solution for injection | RK-LS-5№020219 |
4961 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Dysport® | 500 units lyophilisate for solution for intramuscular and subcutaneous injection | RK-BP-5№015757 |
4962 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Dysport® | 300 units lyophilisate for solution for intramuscular and subcutaneous injection | RK-BP-5№020468 |
4963 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Xeomin | 50 units lyophilisate for solution for injection | RK-BP-5№022385 |
4964 | M03AX01 | Botulinum toxin type a-hemagglutinin complex | Xeomin | 100 units lyophilisate for solution for injection | RK-BP-5№022386 |
M09AX03 | Ataluren | orphan drug | |||
4965 | M09AX03 | Ataluren | Translarna | 125 mg granules for oral suspension | orphan drug |
4966 | M09AX03 | Ataluren | Translarna | 250 mg granules for oral suspension | orphan drug |
4967 | M09AX03 | Ataluren | Translarna | 1000 mg granules for oral suspension | orphan drug |
M09AX07 | Nusinersenum | orphan drug | |||
4968 | M09AX07 | Nusinersenum | Spinraza | 2.4 mg/ml solution for intrathecal injection, 5 ml | orphan drug |
M03B | Centrally acting muscle relaxants | ||||
M03BX02 | Tizanidium | ||||
4969 | M03BX02 | Tizanidium | Rotalud | 4 mg tablets | RK-LS-5№024324 |
4970 | M03BX02 | Tizanidium | Rotalud | 2 mg tablets | RK-LS-5№024321 |
4971 | M03BX02 | Tizanidium | Tizanil | 2 mg tablets | RK-LS-5№003962 |
4972 | M03BX02 | Tizanidium | Tizanil | 4 mg tablets | RK-LS-5№003961 |
M03BX04 | Tolperisonum | ||||
4973 | M03BX04 | Tolperisonum | Mydocalm® | 50 mg film-coated tablets | RK-LS-5№012351 |
4974 | M03BX04 | Tolperisonum | Mydocalm® | 150 mg film-coated tablets | RK-LS-5№012352 |
4975 | M03BX04 | Tolperisonum | Respanol | 150 mg film-coated tablets | RK-LS-5№023303 |
4976 | M03BX04 | Tolperisonum | Respanol | 50 mg film-coated tablets | RK-LS-5№023304 |
M04AA01 | Allopurinolum | ||||
4977 | M04AA01 | Allopurinolum | Milurit® | 100 mg tablets | RK-LS-5№122059 |
4978 | M04AA01 | Allopurinolum | Milurit® | 300 mg tablets | RK-LS-5№122060 |
4979 | M04AA01 | Allopurinolum | Allopurinol | 100 mg tablets | RK-LS-5№011249 |
4980 | M04AA01 | Allopurinolum | Milurit® | 200 mg tablets | RK-LS-5№024297 |
4981 | M04AA01 | Allopurinolum | Milurit® | 150 mg tablets | RK-LS-5№024298 |
M04AA03 | Febuxostatum | ||||
4982 | M04AA03 | Febuxostatum | Adenuric® 120 mg | 120 mg film-coated tablets | RK-LS-5№021116 |
4983 | M04AA03 | Febuxostatum | Inxanta 80 | 80 mg film-coated tablets | RK-LS-5№121719 |
4984 | M04AA03 | Febuxostatum | Adenuric ®120 mg | 120 mg film-coated tablets | RK-LS-5№022562 |
4985 | M04AA03 | Febuxostatum | Adenuric ® 80 mg | 80 mg film-coated tablets | RK-LS-5№022564 |
4986 | M04AA03 | Febuxostatum | Adenuric ® 80 mg | 80 mg film-coated tablets | RK-LS-5№021115 |
M05 | Drugs for treating bone diseases | ||||
M05B | Drugs affecting bone mineralization | ||||
M05BA | Bisphosphonates | ||||
M05BA02 | Clodronic acid | ||||
4987 | M05BA02 | Clodronic acid | Bonefos® | 800 mg film-coated tablets | RK-LS-5№014114 |
4988 | M05BA02 | Clodronic acid | Bonefos® | 400 mg capsules | RK-LS-5№002327 |
4989 | M05BA02 | Clodronic acid | Sindronat | 60mg/ml concentrate for solution for infusion, 5ml | RK-LS-5№016922 |
4990 | M05BA02 | Clodronic acid | Bonefos® | 60 mg/ml concentrate for intravenous solution, 5 ml | RK-LS-5№009506 |
M05BA03 | Pamidronic acid | ||||
4991 | M05BA03 | Pamidronic acid | Pamidronate medac | 90 mg/30 ml concentrate for solution for infusion, 30 ml | RK-LS-5№014963 |
4992 | M05BA03 | Pamidronic acid | Pamidronate medac | 30 mg/10 ml concentrate for solution for infusion, 10 ml | RK-LS-5№014962 |
M05BA04 | Alendronic acid | ||||
4993 | M05BA04 | Alendronic acid | Londromax | 70 mg tablets | RK-LS-5№024289 |
4994 | M05BA04 | Alendronic acid | Ostemax 70 comfort | 70 mg tablets | RK-LS-5№010442 |
4995 | M05BA04 | Alendronic acid | Alendronate sodium | 10 mg tablets | RK-LS-5№020999 |
4996 | M05BA04 | Alendronic acid | Alendronate sodium | 70 mg tablets | RK-LS-5№021000 |
4997 | M05BA04 | Alendronic acid | ALBELOK sanovel | 70 mg tablets | RK-LS-5№014905 |
4998 | M05BA04 | Alendronic acid | Bonil Plus | 70 mg/5600 IU tablets | RK-LS-5№023990 |
4999 | M05BA04 | Alendronic acid | Bonil | 70 mg/2800 IU tablets | RK-LS-5№024079 |
5000 | M05BA04 | Alendronic acid | Ostalon® | 70 mg film-coated tablets | RK-LS-5№004596 |
M05BA06 | Ibandronic acid | orphan drug | |||
5001 | M05BA06 | Ibandronic acid | Osagrand® | 150 mg film-coated tablets | RK-LS-5№021139 |
5002 | M05BA06 | Ibandronic acid | I-Fos | 150 mg film-coated tablets | RK-LS-5№022405 |
5003 | M05BA06 | Ibandronic acid | Bobviva | 150 mg film-coated tablets | RK-LS-5№005110 |
5004 | M05BA06 | Ibandronic acid | Boneost | 150 mg film-coated tablets | RK-LS-5№023831 |
5005 | M05BA06 | Ibandronic acid | Ibandronat-Teva | 150 mg film-coated tablets | RK-LS-5№019260 |
5006 | M05BA06 | Ibandronic acid | Bonviva |
3mg/3ml solution for intravenous infusion, 3 ml | RK-LS-5№012812 |
M05BA08 | Zoledronic acid | ||||
5007 | M05BA08 | Zoledronic acid | Zolex | 4 mg/5 ml concentrate for solution for infusion | RK-LS-5№024425 |
5008 | M05BA08 | Zoledronic acid | Osteolex | 5 mg/100 ml solution for infusion, 100 ml | RK-LS-5№024424 |
5009 | M05BA08 | Zoledronic acid | Zobon | lyophilized powder for intravenous solution, 4 mg, 5 ml | RK-LS-5№018244 |
5010 | M05BA08 | Zoledronic acid | Zobon | 5 mg/100 ml solution for infusion, 100 ml | RK-LS-5№121770 |
5011 | M05BA08 | Zoledronic acid | Aclasta® | 5 mg/100 ml solution for infusion, 100 ml | RK-LS-5№004510 |
5012 | M05BA08 | Zoledronic acid | Zometa® | 4mg/5ml concentrate for solution for infusion, 5 ml | RK-LS-5№005510 |
5013 | M05BA08 | Zoledronic acid | Zoledronic acid-Kelun-Kazpharm |
4 mg/5 ml concentrate for solution for infusion, 5 ml | RK-LS-5№023425 |
5014 | M05BA08 | Zoledronic acid | Zoledronat-Teva |
4 mg/5 ml concentrate for solution for infusion, 5 ml | RK-LS-5№121861 |
5015 | M05BA08 | Zoledronic acid | Zolemeda |
4 mg/5 ml concentrate for solution for infusion, 5 ml | RK-LS-5№023259 |
5016 | M05BA08 | Zoledronic acid | Zoldris | lyophilisate for solution for injection and infusion, 4mg | RK-LS-5№022771 |
5017 | M05BA08 | Zoledronic acid | Zoldris |
4mg/5ml concentrate for solution for infusion | RK-LS-5№022810 |
M05BB | Bisphosphonates and calcium supplements | ||||
M05BB03 | Alendronic acid and colecalciferol | ||||
M05BX | Other drugs affecting bone mineralization | ||||
M05BX03 | Strontium ranelate | ||||
5018 | M05BX03 | Strontium ranelate | Sumilos | granules for oral suspension, 2g | RK-LS-5№022227 |
M05BX04 | Denosumab | ||||
5019 | M05BX04 | Denosumab | Prolia® | 60 mg/ml solution for subcutaneous injection, 1 ml | RK-BP-5№018769 |
5020 | M05BX04 | Denosumab | XGEVA® | 70 mg/ml solution for subcutaneous injection, 120 mg (1.7 ml) | RK-LS-5№019749 |
5021 | M09AX06 | Eteplirsen | Exondys 51™ | 100 mg/2 ml (50 mg/ml) injection for intravenous infusion after dilution | orphan drug |
5022 | M09AX06 | Eteplirsen | Exondys 51™ | 500 mg/10 ml (50 mg/ml) injection for intravenous infusion after dilution | orphan drug |
N | Nervous system | ||||
N01 | Anesthetics | ||||
N01A | General anesthetics | ||||
N01AB | Halogenated hydrocarbons | ||||
N01AB01 | Halothanum | ||||
5023 | N01AB01 | Halothanum | Halothane | liquid for inhalation anesthesia, 250 ml | RK-LS-5№018654 |
N01AB06 | Isofluranum | ||||
5024 | N01AB06 | Isofluranum | Isoflurane | liquid for inhalation anesthesia, 100 ml | RK-LS-5№018634 |
5025 | N01AB06 | Isofluranum | Isotroy 250 | liquid for inhalation anesthesia, 250 ml | RK-LS-5№023630 |
5026 | N01AB06 | Isofluranum | Isotropy 100 | liquid for inhalation anesthesia, 100 ml | RK-LS-5№023631 |
5027 | N01AB06 | Isofluranum | Isoflurane | liquid for inhalation anesthesia, 250 ml | RK-LS-5№018634 |
N01AB08 | Sevofluranum | ||||
5028 | N01AB08 | Sevofluranum | Sevoflurane | solution for inhalation anesthesia, 250 ml | RK-LS-5№018164 |
5029 | N01AB08 | Sevofluranum | Sevorane | inhalation vapour liquid, 250 ml | RK-LS-5№018098 |
5030 | N01AB08 | Sevofluranum | Sevotroy 250 | inhalation vapour liquid, 250 ml | RK-LS-5№023625 |
5031 | N01AB08 | Sevofluranum | Sevo-Anesteran | inhalation vapour liquid, 250 mg | RK-LS-5№024114 |
5032 | N01AB08 | Sevofluranum | Sevo-Anesteran | inhalation vapour liquid, 100 mg | RK-LS-5№024117 |
5033 | N01AB08 | Sevofluranum |
Sevorane | inhalation vapour liquid, 250 ml | RK-LS-5№024256 |
N01AF | Barbiturates | ||||
N01AF03 | Thiopentalum | ||||
5034 | N01AF03 | Sodium thiopental | Thiopental - KMP | lyophilized powder for solution for injection, 1 g | RK-LS-5№000327 |
N01AH | Opioid analgesics | ||||
N01AH01 | Fentanylum | ||||
5035 | N01AH01 | Fentanylum | Fentanyl | 0.005% solution for injection, 2 ml | RK-LS-5№008570 |
5036 | N01AH01 | Fentanylum | Fentanyl | 0.005% solution for injection, 2 ml | RK-LS-5№015713 |
N01AX | Other general anesthetics | ||||
N01AX03 | Ketaminum | ||||
5037 | N01AX03 | Ketaminum | Ketamine | 50 mg/ml solution for injection, 2 ml | RK-LS-5№003486 |
5038 | N01AX03 | Ketaminum | Ketamine | 500 mg/10ml solution for injection | RK-LS-5№016527 |
5039 | Ketamine | Ketaminum | Calypsol® | 50 mg/ml solution for injection, 10 ml | RK-LS-5№014773 |
5040 | N01AX03 | Ketaminum | Ketamine | 50 mg/ml solution for injection, 10 ml | RK-LS-5№003486 |
5041 | N01AX03 | Ketaminum | Ketamine | 50 mg/ml solution for injection, 2 ml | RK-LS-5№003486 |
N01AX10 | Propofolum | ||||
5042 | N01AX10 | Propofolum | AVEFOL | emulsion for injection and infusion, 0.01, 50 ml | RK-LS-5№121826 |
5043 | N01AX10 | Propofolum | Propofol –Lipuro 1% | 10 mg/ml intravenous emulsion, 50 ml | RK-LS-5№014716 |
5044 | N01AX10 | Propofolum | Propofol Kabi | 10 mg/ml intravenous emulsion, 50ml | RK-LS-5№024151 |
5045 | N01AX10 | Propofolum | Propofol Kabi | 10 mg/ml intravenous emulsion, 20ml | RK-LS-5№024152 |
5046 | N01AX10 | Propofolum | Propofol Kabi | 20 mg/ml intravenous emulsion, 50ml | RK-LS-5№024153 |
5047 | N01AX10 | Propofolum | AVEFOL | emulsion for injection and infusion, 0.01, 20 ml | RK-LS-5№121827 |
5048 | N01AX10 | Propofolum | Propofol – Lipuro 1% | 10 mg/ml intravenous emulsion, 20 ml | RK-LS-5№014715 |
5049 | N01AX10 | Propofolum | AVIFOL® | 1% emulsion for injection, 10 ml | RK-LS-5№023935 |
5050 | N01AX10 | Propofolum | AVIFOL® | 1% emulsion for injection, 20 ml | RK-LS-5№023935 |
5051 | N01AX10 | Propofolum |
Diprofol | 20 mg/ml emulsion for infusion, 50 ml | RK-LS-5№024471 |
5052 | N01AX10 | Propofolum | Diprofol | 10 mg/ml emulsion for infusion, 20 ml | RK-LS-5№024472 |
N01AX11 | Sodium oxybate | ||||
5053 | N01AX11 | Sodium oxybate | Sodium oxybutyrate | 200 mg/ml solution for injection, 10 ml | RK-LS-5№014369 |
5054 | N01AX11 | Sodium oxybate | Sodium oxybutyrate | 200 mg/ml solution for injection, 5 ml | RK-LS-5№014369 |
N01AX63 | Nitrous oxide | ||||
5055 | N01AX63 | Nitrous oxide | Nitrous oxide | compressed gas, 6.2 kg | RK-LS-5№021465 |
N01B | Local anesthetics | ||||
N01BA | Aminobenzoic acid esters | ||||
N01BA02 | Procainum | ||||
5056 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 5 ml | RK-LS-5№010320 |
5057 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 5 ml | RK-LS-5№010747 |
5058 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 5 ml | RK-LS-5№017629 |
5059 | N01BA02 | Procainum | Novocaine | 5 mg/ml solution for injection, 5 ml | RK-LS-5№003855 |
5060 | N01BA02 | Procainum | Novocaine | 2% solution for injection, 2 ml | RK-LS-5№010375 |
5061 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 5 ml | RK-LS-5№010747 |
5062 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 2 ml | RK-LS-5№010373 |
5063 | N01BA02 | Procainum | Novocaine-Darnitsa | 0.5% solution for injection, 5 ml | RK-LS-5№000150 |
5064 | N01BA02 | Procainum | Novocaine | 5 mg/ml solution for injection, 5 ml | RK-LS-5№022465 |
5065 | N01BA02 | Procainum | Novocaine | 5 mg/ml solution for injection, 10 ml | RK-LS-5№022465 |
5066 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 5 ml | RK-LS-5№024166 |
5067 | N01BA02 | Procainum | Novocaine | 0.5% solution for injection, 5 ml | RK-LS-5№010373 |
5068 | N01BA02 | Procainum | Novocaine | 5 mg/ml solution for injection, 5ml | RK-LS-5№022474 |
5069 | N01BA02 | Procainum | Novocaine | 5 mg/ml solution for injection, 10 ml | RK-LS-5№022474 |
N01BB | Amides | ||||
N01BB01 | Bupivacainum | ||||
5070 | N01BB01 | Bupivacainum | Bupivacaine -М | 0.5% solution for injection, 5 ml | RK-LS-5№009464 |
5071 | N01BB01 | Bupivacainum | Bupivacaine Grindex Spinal | 5 mg/ml solution for injection, 4 ml | RK-LS-5№010790 |
5072 | N01BB01 | Bupivacainum | Bupivacaine spinal | 5 mg/ml solution for injection, 4 ml | RK-LS-5№022582 |
5073 | N01BB01 | Bupivacainum | Bupivacaine | 5 mg/ml solution for injection, 10 ml | RK-LS-5№022584 |
5074 | N01BB01 | Bupivacainum | Bupivacaine Grindex Spinal | 5mg/ml solution for injection, 4 ml | RK-LS-5№023064 |
5075 | N01BB01 | Bupivacainum | Bupivacaine Grindex | 5 mg/ml solution for injection, 10 ml | RK-LS-5№010789 |
5076 | N01BB01 | Bupivacainum | Bupivacaine Grindex | 5mg/ml solution for injection, 10 ml | RK-LS-5№023172 |
N01BB02 | Lidocainum | ||||
5077 | N01BB02 | Lidocainum | Lidocaine | 10% aerosol, 38 g | RK-LS-5№010030 |
5078 | N01BB02 | Lidocainum | Lidocaine hydrochloride | 1% solution for injection, 3.5 ml | RK-LS-5№013599 |
5079 | N01BB02 | Lidocainum | Lidocaine hydrochloride | 20 mg/ml solution for injection, 2 ml | RK-LS-5№021605 |
5080 | N01BB02 | Lidocainum | Lidocaine hydrochloride | 10 mg/ml solution for injection, 5 ml | RK-LS-5№021606 |
5081 | N01BB02 | Lidocainum | Lidocaine | 20 mg/ml solution for injection, 2 ml | RK-LS-5№017630 |
5082 | N01BB02 | Lidocainum | Lidocaine | 1% solution for injection, 5ml | RK-LS-5№023161 |
5083 | N01BB02 | Lidocainum | Lidocaine | 20 mg/ml solution for injection, 2ml | RK-LS-5№019325 |
5084 | N01BB02 | Lidocainum | LIDOCAINE HYDROCHLORIDE-DF | 10 mg/ml solution for injection, 5 ml | RK-LS-5№023473 |
5085 | N01BB02 | Lidocainum | LIDOCAINE HYDROCHLORIDE-DF | 10 mg/ml solution for injection, 3.5 ml | RK-LS-5№023474 |
5086 | N01BB02 | Lidocainum | LIDOCAINE HYDROCHLORIDE-DF | 20 mg/ml solution for injection, 2 ml | RK-LS-5№023475 |
5087 | N01BB02 | Lidocainum | Lidocaine | 10 mg/ml solution for injection, 3.5 ml | RK-LS-5№023602 |
5088 | N01BB02 | Lidocainum | Lidocaine hydrochloride | 2% solution for injection, 2 ml | RK-LS-5№013600 |
5089 | N01BB02 | Lidocainum | Versatis | 5% medicinal patch | RK-LS-5№023686 |
5090 | N01BB02 | Lidocainum | Lidocaine -DF | 10% spray for topical treatment, 38g | RK-LS-5№022653 |
N01BB03 | Mepivacaine | ||||
5091 | N01BB03 | Mepivacaine | Mepivastesin | 3% solution for submucosal injection in dentistry, 1.7ml | RK-LS-5№016461 |
5092 | N01BB03 | Mepivacaine | Skandonest 3% | 30 mg/ml solution for injection, 1.8 ml | RK-LS-5№018205 |
N01BB09 | Ropivacaine | ||||
5093 | N01BB09 | Ropivacaine | Naropin | 10 mg/ml solution for injection, 10 ml | RK-LS-5№012507 |
5094 | N01BB09 | Ropivacaine | Naropin | 2 mg/ml solution for injection, 20 ml | RK-LS-5№012505 |
5095 | N01BB09 | Ropivacaine | Naropin | 7.5 mg/ml solution for injection, 10 ml | RK-LS-5№012506 |
5096 | N01BB09 | Ropivacaine | Ropivin | 10 mg/ml solution for injection, 10 ml | RK-LS-5№022637 |
5097 | N01BB09 | Ropivacaine | Ropivin | 10 mg/ml solution for injection, 20 ml | RK-LS-5№022637 |
5098 | N01BB09 | Ropivacaine | Ropivin | 2 mg/ml solution for injection, 20 ml | RK-LS-5№022600 |
5099 | N01BB09 | Ropivacaine | Ropivin | 2 mg/ml solution for injection, 10 ml | RK-LS-5№022600 |
5100 | N01BB09 | Ropivacaine | Ropivin | 2 mg/ml solution for injection, 100 ml | RK-LS-5№022600 |
5101 | N01BB09 | Ropivacaine | Ropivin | 5 mg/ml solution for injection, 10 ml | RK-LS-5№022635 |
5102 | N01BB09 | Ropivacaine | Ropivin | 5 mg/ml solution for injection, 20 ml | RK-LS-5№022635 |
5103 | N01BB09 | Ropivacaine |
Naropin | 5 mg/ml solution for injection, 10 ml | RK-LS-5№020451 |
5104 | N01BB09 | Ropivacaine | Ropivin | 7.5 mg/ml solution for injection, 10 ml | RK-LS-5№022636 |
5105 | N01BB09 | Ropivacaine | Ropivin | 7.5 mg/ml solution for injection, 20 ml | RK-LS-5№022636 |
N01BB20 | Lidocaine and Prilocaine | ||||
5106 | N01BB20 | Lidocaine and Prilocaine | Xylocream | cream for cutaneous use, 30g | RK-LS-5№023550 |
5107 | N01BB20 | Lidocaine and Prilocaine | Xylocream | cream for cutaneous use, 5 g | RK-LS-5№023550 |
5108 | N01BB20 | Lidocaine and Prilocaine | Anesta | cream for cutaneous use, 5 g | RK-LS-5№023719 |
5109 | N01BB20 | Lidocaine and Prilocaine | Anesta | cream for cutaneous use, 30 g | RK-LS-5№023719 |
5110 | N01BB20 | Lidocaine and Prilocaine | Anesta | cream for cutaneous use, 60 g | RK-LS-5№023719 |
5111 | N01BB20 | Lidocaine and Prilocaine | Acriol Pro | 2.5%/2.5% cream for topical and cutaneous use, 5 g | RK-LS-5№023948 |
5112 | N01BB20 | Lidocaine and Prilocaine | Acriol Pro | 2.5%/2.5% cream for topical and cutaneous use, 30 g | RK-LS-5№023948 |
5113 | N01BB20 | Lidocaine and Prilocaine | Acriol Pro | 2.5%/2.5% cream for topical and cutaneous use, 100 g | RK-LS-5№023948 |
5114 | N01BB20 | Lidocaine and Prilocaine | Xylocream | cream for cutaneous use, 5 g | RK-LS-5№023550 |
5115 | N01BB20 | Lidocaine and Prilocaine | Xylocream | cream for cutaneous use, 30 g | RK-LS-5№023550 |
N01BB52 | Chlorhexidine and Lidocaine | ||||
5116 | N01BB52 | Chlorhexidine and Lidocaine | Cathejell with lidocaine | topical gel, 12.5 g | RK-LS-5№013306 |
N01BB58 | Articaine and Epinephrine | ||||
N01BX | Other local anesthetics | ||||
N01BX04 | Capsaicinum | ||||
N02 | Analgesics | ||||
N02A | Opioids | ||||
N02AA | Natural opium alkaloids | ||||
N02AA01 | Morphinum | ||||
5117 | N02AA01 | Morphinum | Morphine hydrochloride | 1% solution for injection, 1 ml | RK-LS-5№010526 |
5118 | N02AA01 | Morphinum | Morphine hydrochloride | 1% solution for injection, 1 ml | RK-LS-5№015880 |
5119 | N02AA01 | Morphinum | Morphine sulfate VIC | 10 mg tablet | RK-LS-5№023133 |
5120 | N02AA01 | Morphinum | Morphine sulfate VIC | 5 mg tablet | RK-LS-5№023132 |
N02AA55 | Oxycodone and Naloxone | ||||
5121 | N02AA55 | Oxycodone and Naloxone | Targin | 5 mg/2.5 mg sustained-release film-coated tablets | RK-LS-5№023156 |
5122 | N02AA55 | Oxycodone and Naloxone | Targin | 20 mg/10 mg sustained-release film-coated tablets | RK-LS-5№023158 |
5123 | N02AA55 | Oxycodone and Naloxone | Targin | 40 mg/20 mg sustained-release film-coated tablets | RK-LS-5№023157 |
5124 | N02AA55 | Oxycodone and Naloxone | Targin | 10 mg/5 mg sustained-release film-coated tablets | RK-LS-5№023159 |
N02AB | Phenylpiperidine derivatives | ||||
N02AB | Trimeperidinum | ||||
5125 | N02AB | Trimeperidinum | Promedol | 2% solution for injection, 1 ml | RK-LS-5№010525 |
5126 | N02AB | Trimeperidinum | Promedol | 2% solution for injection, 1 ml | RK-LS-5№010158 |
N02AB03 | Fentanylum | ||||
5127 | N02AB03 | Fentanylum | Matrifen™ | 75 mcg/hr transdermal therapeutic system | RK-LS-5№020395 |
5128 | N02AB03 | Fentanylum | Durogesic | 100 mcg/hr transdermal therapeutic system | RK-LS-5№023332 |
5129 | N02AB03 | Fentanylum | Durogesic | 12.5 mcg/hr transdermal therapeutic system | RK-LS-5№023328 |
5130 | N02AB03 | Fentanylum | Durogesic | 75 mcg/hr transdermal therapeutic system | RK-LS-5№023331 |
5131 | N02AB03 | Fentanylum | Durogesic | 50 mcg/hr transdermal therapeutic system | RK-LS-5№023330 |
5132 | N02AB03 | Fentanylum | Matrifen™ | 50 mcg/hr transdermal therapeutic system | RK-LS-5№020394 |
5133 | N02AB03 | Fentanylum | Matrifen™ | 100 mcg/hr transdermal therapeutic system | RK-LS-5№020396 |
5134 | N02AB03 | Fentanylum | Matrifen™ | 12.5 mcg/hr transdermal therapeutic system | RK-LS-5№020392 |
5135 | N02AB03 | Fentanylum | Durogesic | 25 mcg/hr transdermal therapeutic system | RK-LS-5№023329 |
5136 | N02AB03 | Fentanylum | Matrifen™ | 25 mcg/hr transdermal therapeutic system | RK-LS-5№020393 |
5137 | N02AB03 | Fentanylum | Fentavera | 25 mcg/hr transdermal therapeutic system | RK-LS-5№024034 |
5138 | N02AB03 | Fentanylum | Fentavera | 50 mcg/hr transdermal therapeutic system | RK-LS-5№024033 |
5139 | N02AB03 | Fentanylum | Fentavera | 75 mcg/hr transdermal therapeutic system | RK-LS-5№024032 |
5140 | N02AB03 | Fentanylum | Fentavera | 100 mcg/hr transdermal therapeutic system | RK-LS-5№024031 |
5141 | N02AB03 | Fentanylum | Fentavera | 12.5 mcg/hr transdermal therapeutic system | RK-LS-5№024030 |
N02AF | Morphine derivatives | ||||
N02AF02 | Nalbuphinum | ||||
5142 | N02AF02 | Nalbuphinum | Rubufin | 20 mg/ml solution for injection, 1ml | RK-LS-5№122031 |
5143 | N02AF02 | Nalbuphinum | Rubufin | 10 mg/ml solution for injection, 1.0 ml | RK-LS-5№122030 |
5144 | N02AF02 | Nalbuphinum | Enfin | 5 mg/ml solution for injection, 1ml | RK-LS-5№023979 |
5145 | N02AF02 | Nalbuphinum |
Enfin | 10 mg/ml solution for injection, 1 ml | RK-LS-5№023980 |
N02AX | Other opioids | ||||
N02AX02 | Tramadolum | ||||
5146 | N02AX02 | Tramadolum | Tramadol Lannacher | 200 mg retard film-coated tablets | RK-LS-5№014709 |
5147 | N02AX02 | Tramadolum | Tramadol | 50 mg capsules | RK-LS-5№015658 |
5148 | N02AX02 | Tramadolum | Tramadol - М | 5 % solution for injection, 2 ml | RK-LS-5№018696 |
5149 | N02AX02 | Tramadolum | Tramadol | 50 mg/1 ml solution for injection, 2 ml | RK-LS-5№014142 |
5150 | N02AX02 | Tramadolum | Tramadol | 50 mg capsules | RK-LS-5№121793 |
5151 | N02AX02 | Tramadolum | Tramadol Lannacher | 150 mg retard film-coated tablets | RK-LS-5№014708 |
5152 | N02AX02 | Tramadolum | Tramadol | 50 mg capsules | RK-LS-5№005475 |
5153 | N02AX02 | Tramadolum | Tramadol | 50 mg capsules | RK-LS-5№005476 |
5154 | N02AX02 | Tramadolum | Tramadol Lannacher | 100 mg/2 ml solution for injection, 2 ml | RK-LS-5№013923 |
5155 | N02AX02 | Tramadolum | Tramadol hydrochloride | 5% solution for injection, 2 ml | RK-LS-5№015519 |
5156 | N02AX02 | Tramadolum | Tramadol Lannacher | 100 mg retard film-coated tablets | RK-LS-5№013921 |
5157 | N02AX02 | Tramadolum | Tramadol Lannacher | 50 mg film-coated tablets | RK-LS-5№013925 |
5158 | N02AX02 | Tramadolum |
Mabron | 100 mg/2 ml solution for injection, 2 ml | RK-LS-5№009171 |
5159 | N02AX02 | Tramadolum | Tramadol | 5% solution for injection, 2 ml | RK-LS-5№014045 |
5160 | N02AX02 | Tramadolum | Tramadol | 5% solution for injection, 1 ml | RK-LS-5№014045 |
5161 | N02AX02 | Tramadolum | Tramadol | 50 mg film-coated tablets | RK-LS-3№019591 |
5162 | N02AX02 | Tramadolum |
Mabron | 50 mg capsules | RK-LS-5№009170 |
N02B | Analgesics and antipyretics | ||||
N02BA | Salicylic acid and its derivatives | ||||
N02BA01 | Acetylsalicylic acid | ||||
5163 | N02BA01 | Acetylsalicylic acid | Acetylsalicylic acid | 500 mg tablets | RK-LS-5№012881 |
5164 | N02BA01 | Acetylsalicylic acid | Thrombo ASS® | 50 mg enteric-coated tablets | RK-LS-5№020385 |
5165 | N02BA01 | Acetylsalicylic acid | Cardiomagnyl | 150 mg film-coated tablets | RK-LS-5№020821 |
5166 | N02BA01 | Acetylsalicylic acid | Aspicard | 150 mg enteric-coated tablets | RK-LS-5№021387 |
5167 | N02BA01 | Acetylsalicylic acid | Aspicard | 75 mg enteric-coated tablets | RK-LS-5№021388 |
5168 | N02BA01 | Acetylsalicylic acid |
Trombopol | 75 mg enteric-coated tablets | RK-LS-5№015840 |
5169 | N02BA01 | Acetylsalicylic acid | Trombopol | 150 mg enteric-coated tablets | RK-LS-5№015841 |
5170 | N02BA01 | Acetylsalicylic acid | Acetylsalicylic acid | 500 mg tablets | RK-LS-5№015676 |
5171 | N02BA01 | Acetylsalicylic acid | Acetylsalicylic acid | 500 mg tablets | RK-LS-5№017057 |
5172 | N02BA01 | Acetylsalicylic acid | AS-trombin | 100 mg enteric-coated tablets | RK-LS-5№010463 |
5173 | N02BA01 | Acetylsalicylic acid | Cor-Teva 50 | 50 mg tablets | RK-LS-5№019114 |
5174 | N02BA01 | Acetylsalicylic acid | Cor-Teva 100 | 100 mg tablets | RK-LS-5№019115 |
5175 | N02BA01 | Acetylsalicylic acid | Acetylsalicylic acid | 0.5 g tablets | RK-LS-5№010131 |
5176 | N02BA01 | Acetylsalicylic acid | Thrombo ASS® | 100 mg enteric-coated tablets | RK-LS-5№020386 |
5177 | N02BA01 | Acetylsalicylic acid | Aspirin cardio ® | 100 mg enteric-coated tablets | RK-LS-5№013404 |
5178 | N02BA01 | Acetylsalicylic acid | Aspirin cardio ® | 300 mg enteric-coated tablets | RK-LS-5№013405 |
5179 | N02BA01 | Acetylsalicylic acid | Cardiomagnyl® | 75 mg film-coated tablets | RK-LS-5№020820 |
5180 | N02BA01 | Acetylsalicylic acid | Godasal® | 100 mg tablets | RK-LS-5№020249 |
5181 | N02BA01 | Acetylsalicylic acid | Trombopol Neo | 75 mg enteric-coated tablets | RK-LS-5№024261 |
5182 | N02BA01 | Acetylsalicylic acid | Thrombo ASS® | 75 mg enteric-coated tablets | RK-LS-5№019017 |
5183 | N02BA01 | Acetylsalicylic acid | Upsarin UPSA | 500 mg effervescent tablets | RK-LS-5№004022 |
5184 | N02BA01 | Acetylsalicylic acid | Aspirin® Effect | 500 mg oral granules | RK-LS-5№021419 |
N02BB | Pyrazolones | ||||
N02BB02 | Metamizole sodium | ||||
5185 | N02BB02 | Metamizole sodium | Baralgin® M | 500 mg/ml solution for injection, 5 ml | RK-LS-5№016260 |
5186 | N02BB02 | Metamizole sodium |
Analgin | 500 mg/ml solution for intravenous and intramuscular injection, 2 ml | RK-LS-5№022652 |
5187 | N02BB02 | Metamizole sodium | BARASPASM | 500 mg/ml solution for injection, 2 ml | RK-LS-5№024165 |
5188 | N02BB02 | Metamizole sodium | Analgin | 500 mg/ml solution for injection, 2 ml | RK-LS-5№010232 |
5189 | N02BB02 | Metamizole sodium | Analgin | 50% solution for injection, 2 ml | RK-LS-5№010438 |
5190 | N02BB02 | Metamizole sodium | Tempalgin® М | 500 mg tablets | RK-LS-5№020109 |
5191 | N02BB02 | Metamizole sodium | Analgin | 500 mg tablets | RK-LS-5№011176 |
5192 | N02BB02 | Metamizole sodium | Analgin | 500 mg tablets | RK-LS-5№009567 |
5193 | N02BB02 | Metamizole sodium | Baralgin® М | 500 mg tablets | RK-LS-5№016261 |
5194 | N02BB02 | Metamizole sodium |
Analgin | 500 mg tablets | RK-LS-5№121895 |
N02BE | Anilides | ||||
N02BE01 | Paracetamolum | ||||
5195 | N02BE01 | Paracetamolum | Efferalgan | 500 mg effervescent tablets | RK-LS-5№002434 |
5196 | N02BE01 | Paracetamolum | Panadol® Advance | 500mg film-coated tablets | RK-LS-5№021215 |
5197 | N02BE01 | Paracetamolum | Efferalgan | 80 mg rectal suppositories | RK-LS-5№005193 |
5198 | N02BE01 | Paracetamolum | Efferalgan | 300 mg rectal suppositories | RK-LS-5№005213 |
5199 | N02BE01 | Paracetamolum | Paracetamol | 200 mg tablets | RK-LS-5№012095 |
5200 | N02BE01 | Paracetamolum | Paracetamol | 0.5g tablets | RK-LS-5№015674 |
5201 | N02BE01 | Paracetamolum | Paracetamol | 500 mg tablets | RK-LS-5№014702 |
5202 | N02BE01 | Paracetamolum | Taylol® | 120 mg/5 ml oral suspension, 100 ml | RK-LS-5№010808 |
5203 | N02BE01 | Paracetamolum | Taylol® 6 Plus | 250 mg/5 ml oral suspension, 100 ml | RK-LS-5№010807 |
5204 | N02BE01 | Paracetamolum | Paracetamol | 250 mg rectal suppositories | RK-LS-5№009728 |
5205 | N02BE01 | Paracetamolum | Cefecon® D | 250 mg rectal suppositories | RK-LS-5№016504 |
5206 | N02BE01 | Paracetamolum | Paramolan | 125 mg rectal suppositories | RK-LS-5№121762 |
5207 | N02BE01 | Paracetamolum | Paramolan | 250 mg rectal suppositories | RK-LS-5№121763 |
5208 | N02BE01 | Paracetamolum | Children’s Panadol® | 250 mg rectal suppositories | RK-LS-5№017368 |
5209 | N02BE01 | Paracetamolum | Children’s Panadol | 120 mg/5 ml oral suspension for children, 100 ml | RK-LS-5№004163 |
5210 | N02BE01 | Paracetamolum | Panadol® | 500 mg film-coated tablets | RK-LS-5№016066 |
5211 | N02BE01 | Paracetamolum | Children’s Panadol® | 125 mg rectal suppositories | RK-LS-5№003756 |
5212 | N02BE01 | Paracetamolum | Paracetamol | 0.5 g tablets | RK-LS-5№008635 |
5213 | N02BE01 | Paracetamolum | Efferalgan | 150 mg rectal suppositories | RK-LS-5№005212 |
5214 | N02BE01 | Paracetamolum | Rectol-125 | 125 mg rectal suppositories | RK-LS-5№022669 |
5215 | N02BE01 | Paracetamolum | Rectol-250 | 250 mg rectal suppositories | RK-LS-5№022670 |
5216 | N02BE01 | Paracetamolum | Paracetamol | 125 mg rectal suppositories | RK-LS-5№009727 |
5217 | N02BE01 | Paracetamolum | PARACETAMOL | 120 mg/5 ml oral suspension, 100 ml | RK-LS-5№018925 |
5218 | N02BE01 | Paracetamolum | Cefecon® D | 100 mg rectal suppositories | RK-LS-5№016503 |
5219 | N02BE01 | Paracetamolum | Paracetamol Viva Pharm | 80 mg rectal suppositories | RK-LS-5№023826 |
5220 | N02BE01 | Paracetamolum | Paracetamol Viva Pharm | 150 mg rectal suppositories | RK-LS-5№023827 |
5221 | N02BE01 | Paracetamolum | Paracetamol Viva Pharm | 300 mg rectal suppositories | RK-LS-5№023828 |
5222 | N02BE01 | Paracetamolum | Paracetamol B.Braun | 10 mg/ml solution for infusion, 50 ml | RK-LS-5№024051 |
5223 | N02BE01 | Paracetamolum | Paracetamol B.Braun | 10 mg/ml solution for infusion, 100 ml | RK-LS-5№024052 |
5224 | N02BE01 | Paracetamolum | Paracetamol Rowtech | 1 % solution for infusion, 100 ml | RK-LS-5№023171 |
5225 | N02BE01 | Paracetamolum | Pardifen | 30 mg/ml oral suspension, 100 ml | RK-LS-5№022486 |
5226 | N02BE01 | Paracetamolum | Efferalgan | oral suspension, 90 ml | RK-LS-5№002290 |
5227 | N02BE01 | Paracetamolum | Paramolan | 24 mg/ml oral suspension, 200 ml | RK-LS-5№121722 |
5228 | N02BE01 | Paracetamolum | Paracetamol | 200 mg tablets | RK-LS-5№020629 |
N02C | Antimigraine drugs | ||||
N02CC | Selective 5-HT1 receptor agonists | ||||
N02CC01 | Sumatriptan | ||||
5229 | N02CC01 | Sumatriptan | Sumamigren | 100 mg film-coated tablets | RK-LS-5№018446 |
5230 | N02CC01 | Sumatriptan | Sumamigren | 50 mg film-coated tablets | RK-LS-5№018445 |
N02CC03 | Zolmitriptanum | ||||
5231 | N02CC03 | Zolmitriptanum | Zolmigren® | 2.5 mg film-coated tablets | RK-LS-5№018389 |
5232 | N02CC03 | Zolmitriptanum | Migtera® 5.0 | 5 mg film-coated tablets | RK-LS-3№121672 |
5233 | N02CC03 | Zolmitriptanum | Migtera® 2.5 | 2.5 mg film-coated tablets | RK-LS-3№121671 |
N02CC06 | Eletriptanum | ||||
5234 | N02CC06 | Eletriptanum | Relpax® | 40 mg film-coated tablets | RK-LS-5№010953 |
N03 | Anti-epileptic drugs | ||||
N03A | Anti-epileptic drugs | ||||
N03AA | Barbiturates and their derivatives | ||||
N03AA02 | Phenobarbitalum | ||||
5235 | N03AA02 | Phenobarbitalum | Phenobarbital | 100 mg tablets | RK-LS-5№013580 |
N03AE | Benzodiazepine derivatives | ||||
N03AE01 | Clonazepamum | ||||
5236 | N03AE01 | Clonazepamum | Clonazepam Sobhan | 2 mg tablets | RK-LS-5№122102 |
5237 | N03AE01 | Clonazepamum | Clonazepam | 2 mg tablets | RK-LS-5№011029 |
N03AF | Carboxamide derivatives | ||||
N03AF01 | Carbamazepinum | ||||
5238 | N03AF01 | Carbamazepinum | Zeptol SR 400 | 400 mg controlled-release film-coated tablets | RK-LS-5№010565 |
5239 | N03AF01 | Carbamazepinum | Zeptol SR 200 | 200 mg controlled-release film-coated tablets | RK-LS-5№010564 |
5240 | N03AF01 | Carbamazepinum |
Carbalex | 200 mg tablets | RK-LS-5№014317 |
5241 | N03AF01 | Carbamazepinum | Carbamazepine | 200 mg tablets | RK-LS-5№013247 |
5242 | N03AF01 | Carbamazepinum | Finlepsin | 200 mg tablets | RK-LS-5№013786 |
5243 | N03AF01 | Carbamazepinum | Finlepsin 400 retard | 400 mg sustained-release tablets | RK-LS-5№015883 |
5244 | N03AF01 | Carbamazepinum | Finlepsin 200 retard | 200 mg sustained-release tablets | RK-LS-5№015893 |
5245 | N03AF01 | Carbamazepinum | MEZACAR® | 200 mg tablets | RK-LS-5№019783 |
5246 | N03AF01 | Carbamazepinum | Mezacar® SR | 400 mg sustained-release tablets | RK-LS-5№019782 |
5247 | N03AF01 | Carbamazepinum | Carbamazepine | 200 mg tablets | RK-LS-5№018383 |
N03AF02 | Oxcarbazepine | ||||
5248 | N03AF02 | Oxcarbazepine | Oxapin® | 300 mg film-coated tablets | RK-LS-5№018849 |
N03AG | Fatty acid derivatives | ||||
N03AG01 | Valproic acid | ||||
5249 | N03AG01 | Valproic acid | Convulex® | syrup for children, 100 ml | RK-LS-5№014720 |
5250 | N03AG01 | Valproic acid | Valproic acid | 100 mg/ml solution for injection, 5 ml | RK-LS-5№024311 |
5251 | N03AG01 | Valproic acid | Convulex® | oral drops, 100 ml | RK-LS-5№014719 |
5252 | N03AG01 | Valproic acid | Convulex® | 150 mg delayed-release capsules | RK-LS-5№014765 |
5253 | N03AG01 | Valproic acid | Convulex® | 500 mg delayed-release capsules | RK-LS-5№014767 |
5254 | N03AG01 | Valproic acid | Convulex® | 300 mg sustained-release film-coated tablets | RK-LS-5№014717 |
5255 | N03AG01 | Valproic acid | Convulex® | 500 mg sustained-release film-coated tablets | RK-LS-5№014718 |
5256 | N03AG01 | Valproic acid | Depakine® | 5 g/100 ml syrup, 150 ml | RK-LS-5№019795 |
5257 | N03AG01 | Valproic acid | Convulex® | 300 mg delayed-release capsules | RK-LS-5№014766 |
5258 | N03AG01 | Valproic acid | Depakine®Chrono | 500 mg divisible sustained-release film-coated tablets | RK-LS-5№021170 |
5259 | N03AG01 | Valproic acid | Depakine®Chrono | 300 mg divisible sustained-release film-coated tablets | RK-LS-5№021134 |
5260 | N03AG01 | Valproic acid | Depakine®Chrono | 300 mg divisible sustained-release film-coated tablets | RK-LS-5№021135 |
5261 | N03AG01 | Valproic acid | Depakine®Chronosphere™ | 500 mg sustained-release granules, 1.5 g | RK-LS-5№013590 |
5262 | N03AG01 | Valproic acid | Depakine®Chrono | 500 mg sustained-release tablets | RK-LS-5№014555 |
5263 | N03AG01 | Valproic acid | Depakine®Chronosphere™ | 250 mg sustained-release granules, 0.75 g | RK-LS-5№013589 |
5264 | N03AG01 | Valproic acid | DEPAKINE ® CHRONO | 300 mg divisible sustained-release film-coated tablets | RK-LS-5№013747 |
5265 | N03AG01 | Valproic acid | Convulex | 100 mg/ml solution for injection, 5 ml | RK-LS-5№003615 |
N03AX | Other anti-epileptic drugs | ||||
N03AX09 | Lamotriginum | ||||
5266 | N03AX09 | Lamotriginum | Lamepil | 25 mg tablets | RK-LS-5№021009 |
5267 | N03AX09 | Lamotriginum | Lamepil | 100 mg tablets | RK-LS-5№021007 |
5268 | N03AX09 | Lamotriginum | Lamepil | 50 mg tablets | RK-LS-5№021008 |
5269 | N03AX09 | Lamotriginum | Lamotrix | 25 mg tablets | RK-LS-5№013459 |
5270 | N03AX09 | Lamotriginum | Lamotrix | 50 mg tablets | RK-LS-5№013460 |
5271 | N03AX09 | Lamotriginum | Lamictal® | 2 mg chewable/dispersible tablets | RK-LS-5№121830 |
5272 | N03AX09 | Lamotriginum | Lamictal® | 100 mg chewable tablets | RK-LS-5№011586 |
5273 | N03AX09 | Lamotriginum | Lamictal® | 50 mg chewable tablets | RK-LS-5№011589 |
5274 | N03AX09 | Lamotriginum | Ridzhinol® | 50 mg tablets | RK-LS-5№019648 |
5275 | N03AX09 | Lamotriginum | Lamictal® | 25 mg chewable tablets | RK-LS-5№011588 |
5276 | N03AX09 | Lamotriginum | Ridzhinol® | 25 mg tablets | RK-LS-5№019647 |
5277 | N03AX09 | Lamotriginum | Lamictal® | 5 mg chewable tablets | RK-LS-5№011585 |
5278 | N03AX09 | Lamotriginum | Lamotrix | 100 mg tablets | RK-LS-5№013461 |
5279 | N03AX09 | Lamotriginum | LANISTOR® | 100 mg tablets | RK-LS-5№024453 |
5280 | N03AX09 | Lamotriginum | LANISTOR® | 50 mg tablets | RK-LS-5№024454 |
5281 | N03AX09 | Lamotriginum | LANISTOR® | 25 mg tablets | RK-LS-5№024455 |
N03AX11 | Topiramatum | ||||
5282 | N03AX11 | Topiramatum | Topirol | 25 mg tablets | RK-LS-5№018689 |
5283 | N03AX11 | Topiramatum | Topirol | 50 mg tablets | RK-LS-5№018690 |
5284 | N03AX11 | Topiramatum | Topivite | 50 mg film-coated tablets | RK-LS-5№023797 |
5285 | N03AX11 | Topiramatum | Topamax® | 50 mg capsules | RK-LS-5№010414 |
5286 | N03AX11 | Topiramatum | Epiramat-Teva | 50 mg film-coated tablets | RK-LS-5№020056 |
5287 | N03AX11 | Topiramatum | Topamax® | 25 mg capsules | RK-LS-5№003911 |
5288 | N03AX11 | Topiramatum | Epimat 50 | 50 mg film-coated tablets | RK-LS-5№021446 |
5289 | N03AX11 | Topiramatum | Epiramat-Teva | 200 mg film-coated tablets | RK-LS-5№020058 |
5290 | N03AX11 | Topiramatum | Topivite | 25 mg film-coated tablets | RK-LS-5№023796 |
5291 | N03AX11 | Topiramatum | Epiramat-Teva | 25 mg tablets | RK-LS-5№020055 |
5292 | N03AX11 | Topiramatum | Epiramat-Teva | 100 mg tablets | RK-LS-5№020057 |
N03AX12 | Gabapentinum | ||||
5293 | N03AX12 | Gabapentinum | Tebantin® | 300 mg capsules | RK-LS-5№003993 |
5294 | N03AX12 | Gabapentinum | Epigan | 300 mg capsules | RK-LS-5№015900 |
5295 | N03AX12 | Gabapentinum | Neogab | 400 mg capsules | RK-LS-5№013251 |
5296 | N03AX12 | Gabapentinum | Neogab | 300 mg capsules | RK-LS-5№013250 |
5297 | N03AX12 | Gabapentinum | Neuropentin | 300 mg capsules | RK-LS-5№021632 |
5298 | N03AX12 | Gabapentinum | Epigan | 400 mg capsules | RK-LS-5№015901 |
5299 | N03AX12 | Gabapentinum | Gabagamma® | 100 mg capsules | RK-LS-5№022977 |
5300 | N03AX12 | Gabapentinum | Gabagamma® | 300 mg capsules | RK-LS-5№022978 |
5301 | N03AX12 | Gabapentinum | Gabagamma® | 400 mg capsules | RK-LS-5№022979 |
5302 | N03AX12 | Gabapentinum | Neogab | 100 mg capsules | RK-LS-5№013249 |
N03AX14 | Levetiracetamum | ||||
5303 | N03AX14 | Levetiracetamum | Levetiracetam-Teva | 250 mg film-coated tablets | RK-LS-5№020931 |
5304 | N03AX14 | Levetiracetamum | Levipil | 250 mg film-coated tablets | RK-LS-5№021276 |
5305 | N03AX14 | Levetiracetamum | Levetiracetam-Teva | 500 mg film-coated tablets | RK-LS-5№020930 |
5306 | N03AX14 | Levetiracetamum | Levipil | 500 mg film-coated tablets | RK-LS-5№021277 |
5307 | N03AX14 | Levetiracetamum | Levetiracetam-Teva | 1000 mg film-coated tablets | RK-LS-5№020928 |
5308 | N03AX14 | Levetiracetamum | Levipil | 1000 mg film-coated tablets | RK-LS-5№021279 |
5309 | N03AX14 | Levetiracetamum | Keppra® | 100 mg/ml oral suspension, 300 ml | RK-LS-5№014608 |
5310 | N03AX14 | Levetiracetamum | Keppra® | 1000 mg film-coated tablets | RK-LS-5№014390 |
5311 | N03AX14 | Levetiracetamum | Levipil | 750 mg film-coated tablets | RK-LS-5№021278 |
5312 | N03AX14 | Levetiracetamum | Levebrain | 1000 mg film-coated tablets | RK-LS-5№023038 |
5313 | N03AX14 | Levetiracetamum | Levebrain | 500 mg film-coated tablets | RK-LS-5№023039 |
5314 | N03AX14 | Levetiracetamum | Keppra® | 250 mg film-coated tablets | RK-LS-5№014389 |
5315 | N03AX14 | Levetiracetamum | Keppra® | 500 mg film-coated tablets | RK-LS-5№014410 |
5316 | N03AX14 | Levetiracetamum | Levetiracetam-Teva | 750 mg film-coated tablets | RK-LS-5№020929 |
5317 | N03AX14 | Levetiracetamum | Levebrain | 250 mg film-coated tablets | RK-LS-5№023040 |
5318 | N03AX14 | Levetiracetamum | Levetiracetam Grindeks | 250 mg film-coated tablets | RK-LS-5№023143 |
5319 | N03AX14 | Levetiracetamum | Levetiracetam Grindeks | 500 mg film-coated tablets | RK-LS-5№023144 |
5320 | N03AX14 | Levetiracetamum | Levetiracetam Grindeks | 1000 mg film-coated tablets | RK-LS-5№023145 |
5321 | N03AX14 | Levetiracetamum | Levipil XR | 750 mg sustained-release tablets | RK-LS-5№023611 |
5322 | N03AX14 | Levetiracetamum | LOGUFEN® | 250 mg film-coated tablets | RK-LS-5№024108 |
5323 | N03AX14 | Levetiracetamum | LOGUFEN® | 500 mg film-coated tablets | RK-LS-5№024113 |
5324 | N03AX14 | Levetiracetamum | Epix | 1000 mg film-coated tablets | RK-LS-5№015588 |
5325 | N03AX14 | Levetiracetamum | Epix | 500 mg film-coated tablets | RK-LS-5№015586 |
5326 | N03AX14 | Levetiracetamum | Epix | 250 mg film-coated tablets | RK-LS-5№015587 |
5327 | N03AX14 | Levetiracetamum | Levipil XR | 500 mg sustained-release tablets | RK-LS-5№023610 |
5328 | N03AX14 | Levetiracetamum | Levetra | 500 mg/5 ml concentrate for intravenous solution, 5 ml | RK-LS-5№024142 |
N03AX16 | Pregabalinum | ||||
5329 | N03AX16 | Pregabalinum | Alyse | 75 mg capsules | RK-LS-5№020113 |
5330 | N03AX16 | Pregabalinum | Lyrica® | 75 mg capsules | RK-LS-5№011792 |
5331 | N03AX16 | Pregabalinum | Pregabalin-Richter | 75 mg capsules | RK-LS-5№020856 |
5332 | N03AX16 | Pregabalinum | Maxgalin | 75 mg capsules | RK-LS-5№021328 |
5333 | N03AX16 | Pregabalinum | Alyse | 150 mg capsules | RK-LS-5№020115 |
5334 | N03AX16 | Pregabalinum | Lyrica® | 150 mg capsules | RK-LS-5№011793 |
5335 | N03AX16 | Pregabalinum | Pregabalin-Richter | 150 mg capsules | RK-LS-5№020857 |
5336 | N03AX16 | Pregabalinum |
Maxgalin | 150 mg capsules | RK-LS-5№021329 |
5337 | N03AX16 | Pregabalinum | Pregasafe | 150 mg capsules | RK-LS-5№122123 |
5338 | N03AX16 | Pregabalinum | Axogurd-300 | 300 mg capsules | RK-LS-5№121788 |
5339 | N03AX16 | Pregabalinum | Axogurd -75 | 75 mg capsules | RK-LS-5№121789 |
5340 | N03AX16 | Pregabalinum | Axogurd -150 | 150 mg capsules | RK-LS-5№121790 |
5341 | N03AX16 | Pregabalinum | Pregasafe | 300 mg capsules | RK-LS-5№122124 |
5342 | N03AX16 | Pregabalinum | Pregabio® | 75 mg capsules | RK-LS-5№022699 |
5343 | N03AX16 | Pregabalinum | Pregabio® | 100 mg capsules | RK-LS-5№022700 |
5344 | N03AX16 | Pregabalinum | Pregabio® | 150 mg capsules | RK-LS-5№022701 |
5345 | N03AX16 | Pregabalinum | Pregabio® | 300 mg capsules | RK-LS-5№022702 |
5346 | N03AX16 | Pregabalinum | Algerika | 75 mg capsules | RK-LS-5№022734 |
5347 | N03AX16 | Pregabalinum | Algerika | 150 mg capsules | RK-LS-5№022735 |
5348 | N03AX16 | Pregabalinum | Neurofit | 75 mg capsules | RK-LS-5№022803 |
5349 | N03AX16 | Pregabalinum | Neurofit | 150 mg capsules | RK-LS-5№022804 |
5350 | N03AX16 | Pregabalinum | Neurofit | 300 mg capsules | RK-LS-5№022805 |
5351 | N03AX16 | Pregabalinum | Replica | 75 mg capsules | RK-LS-5№023107 |
5352 | N03AX16 | Pregabalinum | Replica | 300 mg capsules | RK-LS-5№023108 |
5353 | N03AX16 | Pregabalinum | Replica | 150 mg capsules | RK-LS-5№023275 |
5354 | N03AX16 | Pregabalinum | Pregabalin | 75 mg capsules | RK-LS-5№023361 |
5355 | N03AX16 | Pregabalinum | Pregabalin | 300 mg capsules | RK-LS-5№023362 |
5356 | N03AX16 | Pregabalinum | Pregabalin | 150 mg capsules | RK-LS-5№023363 |
5357 | N03AX16 | Pregabalinum | Pregabin | 75 mg capsules | RK-LS-5№023604 |
5358 | N03AX16 | Pregabalinum | Pregabin | 150 mg capsules | RK-LS-5№023605 |
5359 | N03AX16 | Pregabalinum | Aplen 75 | 75 mg capsules | RK-LS-5№023769 |
5360 | N03AX16 | Pregabalinum | Lyrica® | 300 mg capsules | RK-LS-5№011794 |
5361 | N03AX16 | Pregabalinum | GABALIR® | 150 mg capsules | RK-LS-5№023666 |
5362 | N03AX16 | Pregabalinum | GABALIR® | 75 mg capsules | RK-LS-5№023667 |
5363 | N03AX16 | Pregabalinum | Galara | 150 mg capsules | RK-LS-5№023704 |
5364 | N03AX16 | Pregabalinum | Galara | 75 mg capsules | RK-LS-5№023706 |
5365 | N03AX16 | Pregabalinum | Aplen 150 | 150 mg capsules | RK-LS-5№023773 |
5366 | N03AX16 | Pregabalinum | Alyse | 300 mg capsules | RK-LS-5№020114 |
5367 | N03AX16 | Pregabalinum | ZONIK® | 150 mg capsules | RK-LS-5№024078 |
5368 | N03AX16 | Pregabalinum | PAGAMAX® 25 | 75 mg capsules | RK-LS-3№121675 |
5369 | N03AX16 | Pregabalinum | PAGAMAX® 75 | 25 mg capsules | RK-LS-3№121676 |
5370 | N03AX16 | Pregabalinum | PAGAMAX® 150 | 150 mg capsules | RK-LS-3№121677 |
5371 | N03AX16 | Pregabalinum | PAGAMAX® 300 | 300 mg capsules | RK-LS-3№121678 |
5372 | N03AX16 | Pregabalinum | Pregabalin-Richter | 300 mg capsules | RK-LS-5№020858 |
5373 | N03AX16 | Pregabalinum | ZONIK® | 75 mg capsules | RK-LS-5№024216 |
5374 | N03AX16 | Pregabalinum | Pregasafe | 75 mg capsules | RK-LS-5№122122 |
N03AX18 | Lacosamide | ||||
5375 | N03AX18 | Lacosamide | Vimpat® | 10 mg/ml solution for infusion, 20 ml | RK-LS-5№017943 |
5376 | N03AX18 | Lacosamide | Vimpat® | 50 mg film-coated tablets | RK-LS-5№017945 |
5377 | N03AX18 | Lacosamide | Vimpat® | 100 mg film-coated tablets | RK-LS-5№017946 |
5378 | N03AX18 | Lacosamide | Vimpat® | 200 mg film-coated tablets | RK-LS-5№017947 |
5379 | N03AX18 | Lacosamide | Vimpat® | 150 mg film-coated tablets | RK-LS-5№017949 |
N03AX21 | Retigabinum | ||||
N04 | Antiparkinson drugs | ||||
N04A | Central anticholinergic drugs | ||||
N04AA | Tertiary amines | ||||
N04AA01 | Trihexyphenidyl | ||||
5380 | N04AA01 | Trihexyphenidyl | Cyclodol | 2 mg tablets | RK-LS-5№003347 |
5381 | N04AA01 | Trihexyphenidyl | Cyclodol Grindeks | 2 mg tablets | RK-LS-5№011004 |
N04B | Dopaminergic drugs | ||||
N04BA | Dopa and dopa derivatives | ||||
N04BA02 | Levodopa and Carbidopa | ||||
5382 | N04BA02 | Levodopa and Carbidopa | Nakom® | 250 mg/25 mg tablets | RK-LS-5№016121 |
5383 | N04BA02 | Levodopa and Carbidopa | Levokom® | 250mg/25mg tablets | RK-LS-5№003125 |
5384 | N04BA02 | Levodopa and Carbidopa | Levocarbisan | 250 mg/25 mg tablets | RK-LS-5№019932 |
N04BA03 | Levodopa, Carbidopa and Entacapone | ||||
N04BB | Adamantane derivatives | ||||
N04BB01 | Amantadinum | ||||
N04BC | Dopamine receptor stimulants | ||||
N04BC05 | Pramipexole | ||||
5385 | N04BC05 | Pramipexole | Mirapex® PV | 3 mg sustained-release tablets | RK-LS-5№016926 |
5386 | N04BC05 | Pramipexole | Pramipex | 0.25 mg tablets | RK-LS-5№020447 |
5387 | N04BC05 | Pramipexole | Pramipex | 1 mg tablets | RK-LS-5№020448 |
5388 | N04BC05 | Pramipexole | Mirapex® PV | 1.5 mg sustained-release tablets | RK-LS-5№018328 |
5389 | N04BC05 | Pramipexole | Mirapex® PV | 0.75 mg sustained-release tablets | RK-LS-5№016925 |
5390 | N04BC05 | Pramipexole | Pramixol | 0.25 mg tablets | RK-LS-5№023798 |
5391 | N04BC05 | Pramipexole | Pramixol | 1 mg tablets | RK-LS-5№023799 |
5392 | N04BC05 | Pramipexole | Mirapex® PV | 0.375 mg sustained-release tablets | RK-LS-5№018327 |
N04BC06 | Cabergolinum | ||||
N04BC08 | Rotigotinum | ||||
N04BD | Monoamine oxidase-B inhibitors | ||||
N04BD02 | Rasagilinum | ||||
5393 | N04BD02 | Rasagilinum | Azilect | 1 mg tablets | RK-LS-5№021074 |
N05 | Psycholeptics | ||||
N05A | Antipsychotic drugs | ||||
N05AA | Aliphatic phenothiazine derivatives | ||||
N05AA01 | Chlorpromazine | ||||
5394 | N05AA01 | Chlorpromazine | Aminazine-Zdorovye | 25 mg coated tablets | RK-LS-5№014548 |
5395 | N05AA01 | Chlorpromazine | Aminazine | 100 mg film-coated tablets | RK-LS-5№023098 |
5396 | N05AA01 | Chlorpromazine | Aminazine | 50 mg film-coated tablets | RK-LS-5№023097 |
5397 | N05AA01 | Chlorpromazine | Aminazine | 25 mg film-coated tablets | RK-LS-5№023096 |
5398 | N05AA01 | Chlorpromazine | Aminazine | 2.50% solution for injection, 2 ml | RK-LS-5№011676 |
N05AA02 | Levomepromazinum | ||||
5399 | N05AA02 | Levomepromazinum | Tisercin® | 25 mg/1 ml solution for injection | RK-LS-5№009631 |
5400 | N05AA02 | Levomepromazinum | Tisercin® | 25 mg coated tablets | RK-LS-5№004387 |
N05AB | Piperazine phenothiazine derivatives | ||||
N05AB02 | Fluphenazine | ||||
5401 | N05AB02 | Fluphenazine | Moditen® Depo | 25 mg/ml solution for injection | RK-LS-5№019453 |
N05AB04 | Prochlorperazine | ||||
5402 | N05AB04 | Prochlorperazine | VERTINEX® | 5 mg tablets | RK-LS-5№020830 |
N05AB06 | Trifluoperazinum | ||||
5403 | N05AB06 | Trifluoperazinum | Triftazin-Darnitsa | 0.2% solution for injection, 1 ml | RK-LS-5№009647 |
5404 | N05AB06 | Trifluoperazinum | Triftazin-Zdorovye | 5 mg coated tablets | RK-LS-5№013845 |
N05AD | Butyrophenone derivatives | ||||
N05AD01 | Haloperidolum | ||||
5405 | N05AD01 | Haloperidolum | Haloperidol decanoate | 50mg/ml oily solution for injection, 1 ml | RK-LS-5№010234 |
5406 | N05AD01 | Haloperidolum | Haloperidol Forte | 5 mg tablets | RK-LS-5№014616 |
5407 | N05AD01 | Haloperidolum | Haloperidol-Richter | 1.5 mg tablets | RK-LS-5№014617 |
5408 | N05AD01 | Haloperidolum | Haloperidol-Richter | solution for injection, 5 mg | RK-LS-5№014515 |
5409 | N04BB01 | Amantadinum | PK-Merz | 100 mg film-coated tablets | RK-LS-5№014837 |
5410 | N04BB01 | Amantadinum | PK-Merz | solution for infusion, 200 mg | RK-LS-5№014836 |
N04BC | Dopamine receptor stimulants | ||||
N04BC05 | Pramipexole | ||||
5411 | N04BC05 | Pramipexole | Mirapex® PV |
3 mg sustained-release tablets | RK-LS-5№016926 |
5412 | N04BC05 | Pramipexole | Pramipex | 0.25 mg tablets | RK-LS-5№020447 |
5413 | N04BC05 | Pramipexole | Ptamipex | 1 mg tablets | RK-LS-5№020448 |
5414 | N04BC05 | Pramipexole | Mirapex® PV | 1.5 mg sustained-release tablets | RK-LS-5№018328 |
5415 | N04BC05 | Pramipexole | Mirapex® PV | 0.75 mg sustained-release tablets | RK-LS-5№016925 |
5416 | N04BC05 | Pramipexole | Pramixol | 0.25 mg tablets | RK-LS-5№023798 |
5417 | N04BC05 | Pramipexole |
Pramixol | 1 mg tablets | RK-LS-5№023799 |
5418 | N04BC05 | Pramipexole | Mirapex® PV | 0.375 mg sustained-release tablets | RK-LS-5№018327 |
N04BC06 | Cabergolinum | ||||
N04BC08 | Rotigotinum | ||||
5419 | G02CB03 | Cabergolinum | Agalates | 0.5 mg tablets | RK-LS-5№020301 |
5420 | G02CB03 | Cabergolinum | Dostinex® | 0.5 mg tablets | RK-LS-5№012082 |
N04BD | Monoamine oxidase-B inhibitors | ||||
N04BD02 | Rasagilinum | ||||
5421 | N04BD02 | Rasagilinum | Azilect | 1 mg tablets | RK-LS-5№021074 |
N05 | Psycholeptics | ||||
N05A | Antipsychotic drugs | ||||
N05AA | Aliphatic phenothiazine derivatives | ||||
N05AA01 | Chlorpromazine | ||||
5422 | N05AA01 | Chlorpromazine | Aminazin-Zdorovye | 25 mg film-coated tablets | RK-LS-5№014548 |
5423 | N05AA01 | Chlorpromazine | Aminazin | 100 mg film-coated tablets | RK-LS-5№023098 |
5424 | N05AA01 | Chlorpromazine | Aminazin | 50 mg film-coated tablets | RK-LS-5№023097 |
5425 | N05AA01 | Chlorpromazine | Aminazin | 25 mg film-coated tablets | RK-LS-5№023096 |
5426 | N05AA01 | Chlorpromazine | Aminazin | 25 mg/ml solution for injection, 2 ml | RK-LS-5№011676 |
N05AA02 | Levomepromazinum | ||||
5427 | N05AA02 | Levomepromazinum | Tisercin® | 25 mg/1 ml solution for injection | RK-LS-5№009631 |
5428 | N05AA02 | Levomepromazinum | Tisercin® |
| RK-LS-5№004387 |
N05AB | Piperazine phenothiazine derivatives | ||||
N05AB02 | Fluphenazine | ||||
5429 | N05AB02 | Fluphenazine | Moditen® Depo | 25 mg/ml solution for injection | RK-LS-5№019453 |
N05AB04 | Prochlorperazine | ||||
5430 | N05AB04 | Prochlorperazine | VERTINEX® | 5 mg tablets | RK-LS-5№020830 |
N05AB06 | Trifluoperazinum | ||||
5431 | N05AB06 | Trifluoperazinum | Triftazin-Darnitsa | 0.2% solution for injection, 1 ml | RK-LS-5№009647 |
5432 | N05AB06 | Trifluoperazinum | Triftazin-Zdorovye | 5 mg coated tablets | RK-LS-5№013845 |
N05AD | Butyrophenone derivatives | ||||
N05AD01 | Haloperidolum | ||||
5433 | N05AD01 | Haloperidolum | Haloperidol decanoate | 50 mg/ml oily solution for injection, 1 ml | RK-LS-5№010234 |
5434 | N05AD01 | Haloperidolum | Haloperidol Forte | 5 mg tablets | RK-LS-5№014616 |
5435 | N05AD01 | Haloperidolum | Haloperidol-Richter | 1.5 mg tablets | RK-LS-5№014617 |
5436 | N05AD01 | Haloperidolum | Haloperidol-Richter | solution for injection, 5 mg | RK-LS-5№014515 |
5437 | N05AD01 | Haloperidolum | Halopril | 0.5% solution for injection, 1 ml | RK-LS-5№000418 |
N05AF | Thioxanthene derivatives | ||||
N05AF05 | Zuclopenthixol | ||||
N05AH | Diazepine, Thiazepine and Oxazepine derivatives | ||||
N05AH02 | Clozapinum | ||||
5438 | N05AH02 | Clozapinum | Azaleptol | 25 mg tablets | RK-LS-5№018246 |
5439 | N05AH02 | Clozapinum | Azaleptol | 100 mg tablets | RK-LS-5№018247 |
N05AH03 | Olanzapine | ||||
5440 | N05AH03 | Olanzapine | Olanz ODT | 10 mg orodispersible tablets | RK-LS-5№023450 |
5441 | N05AH03 | Olanzapine | OLFREX | 20 mg film-coated tablets | RK-LS-5№022154 |
5442 | N05AH03 | Olanzapine | OLFREX | 15 mg film-coated tablets | RK-LS-5№022150 |
5443 | N05AH03 | Olanzapine | Olfrex | 10 mg film-coated tablets | RK-LS-5№022151 |
5444 | N05AH03 | Olanzapine | Olfrex |
10 mg orodispersible tablets | RK-LS-5№022153 |
5445 | N05AH03 | Olanzapine | Ferzapin | 10 mg film-coated tablets | RK-LS-5№020866 |
5446 | N05AH03 | Olanzapine | OLFREX | 7.5 mg film-coated tablets | RK-LS-5№022152 |
5447 | N05AH03 | Olanzapine | Olfrex | 5 mg film-coated tablets | RK-LS-5№022140 |
5448 | N05AH03 | Olanzapine | Olfrex |
5 mg orodispersible tablets | RK-LS-5№022141 |
5449 | N05AH03 | Olanzapine | Ferzapin | 5 mg film-coated tablets | RK-LS-5№020865 |
N05AH04 | Quetiapinum | ||||
5450 | N05AH04 | Quetiapinum | Qutipin | 300 mg film-coated tablets | RK-LS-5№020497 |
5451 | N05AH04 | Quetiapinum | Quentiax® | 300 mg film-coated tablets | RK-LS-5№017055 |
5452 | N05AH04 | Quetiapinum | Quentiax ® | 200 mg film-coated tablets | RK-LS-5№017054 |
5453 | N05AH04 | Quetiapinum | Ketiap® | 100 mg film-coated tablets | RK-LS-5№018810 |
5454 | N05AH04 | Quetiapinum | Qutipin | 200 mg film-coated tablets | RK-LS-5№020496 |
5455 | N05AH04 | Quetiapinum | Quentiax ® |
25 mg film-coated tablets | RK-LS-5№017052 |
5456 | N05AH04 | Quetiapinum | Quentiax ® |
100 mg film-coated tablets | RK-LS-5№017053 |
5457 | N05AH04 | Quetiapinum | Qutipin |
100 mg film-coated tablets | RK-LS-5№020495 |
5458 | N05AH04 | Quetiapinum | Ketiap® |
200 mg film-coated tablets | RK-LS-5№018812 |
N05AL | Benzamides | ||||
N05AL01 | Sulpiridum | ||||
5459 | N05AL01 | Sulpiridum | Betamax |
200 mg film-coated tablets | RK-LS-5№016754 |
5460 | N05AL01 | Sulpiridum | Betamax |
100 mg film-coated tablets | RK-LS-5№016753 |
5461 | N05AL01 | Sulpiridum | Prosulpin | 200 mg tablets | RK-LS-5№019638 |
5462 | N05AL01 | Sulpiridum | Prosulpin® | 50 mg tablets | RK-LS-5№019637 |
5463 | N05AL01 | Sulpiridum | Betamax |
50 mg film-coated tablets | RK-LS-5№016752 |
5464 | N05AL01 | Sulpiridum | Betamax | 50 mg tablets | RK-LS-5№023477 |
5465 | N05AL01 | Sulpiridum | Betamax | 200 mg tablets | RK-LS-5№023479 |
5466 | N05AL01 | Sulpiridum | Betamax | 100 mg tablets | RK-LS-5№023478 |
N05AL05 | Amisulpridum | ||||
5467 | N05AL05 | Amisulpridum | Solian® | 100 mg/ml oral solution | RK-LS-5№016877 |
5468 | N05AL05 | Amisulpridum | Ривокс |
400 mg film-coated tablets | RK-LS-5№020382 |
5469 | N05AL05 | Amisulpridum | Solian® | 200 mg tablets | RK-LS-5№020841 |
5470 | N05AL05 | Amisulpridum | Solian® |
400 mg coated tablets | RK-LS-5№020842 |
5471 | N05AL05 | Amisulpridum | Soleron | 100 mg tablets | RK-LS-5№023552 |
5472 | N05AL05 | Amisulpridum | Soleron | 200 mg tablets | RK-LS-5№023553 |
5473 | N05AL05 | Amisulpridum | Aktiprol | 200 mg tablets | RK-LS-5№024135 |
5474 | N05AL05 | Amisulpridum | Aktiprol | 400 mg tablets | RK-LS-5№024136 |
5475 | N05AL05 | Amisulpridum | Solian® |
400 mg coated tablets | RK-LS-5№003748 |
5476 | N05AL05 | Amisulpridum | Rivox | 200 mg tablets | RK-LS-5№020381 |
5477 | N05AL05 | Amisulpridum | Solian® | 200 mg tablets | RK-LS-5№003749 |
5478 | N05AL05 | Amisulpridum | Tiaprosan® | 100 mg tablets | RK-LS-5№020077 |
N05AX | Other antipsychotic drugs | ||||
N05AX08 | Risperidonum | ||||
5479 | N05AX08 | Risperidonum | Rileptid® | 2 mg coated tablets | RK-LS-5№003562 |
5480 | N05AX08 | Risperidonum | Rispaxol® | 2 mg coated tablets | RK-LS-5№010769 |
5481 | N05AX08 | Risperidonum | Sedarex | 2 mg coated tablets | RK-LS-5№016669 |
5482 | N05AX08 | Risperidonum | Torendo® |
1 mg film-coated tablets | RK-LS-5№021162 |
5483 | N05AX08 | Risperidonum | Torendo® |
2 mg film-coated tablets | RK-LS-5№021163 |
5484 | N05AX08 | Risperidonum | Torendo® |
3 mg film-coated tablets | RK-LS-5№021164 |
5485 | N05AX08 | Risperidonum | Eperon | 4 mg coated tablets | RK-LS-5№016513 |
5486 | N05AX08 | Risperidonum | Sedarex |
1 mg coated tablets | RK-LS-5№016667 |
5487 | N05AX08 | Risperidonum | Respirox |
1 mg film-coated tablets | RK-LS-5№016686 |
5488 | N05AX08 | Risperidonum | Risperidon SАNТО |
2 mg film-coated tablets | RK-LS-5№022756 |
5489 | N05AX08 | Risperidonum | Risperidon SАNТО | 4 mg film-coated tablets | RK-LS-5№022757 |
5490 | N05AX08 | Risperidonum | Rileptid® | 3 mg coated tablets | RK-LS-5№003563 |
5491 | N05AX08 | Risperidonum | Eperon | 2 mg coated tablets | RK-LS-5№016511 |
5492 | N05AX08 | Risperidonum | Rileptid® | 4 mg coated tablets | RK-LS-5№003564 |
5493 | N05AX08 | Risperidonum | Rispaxol® | 4 mg coated tablets | RK-LS-5№010770 |
5494 | N05AX08 | Risperidonum | Sedarex | 4 mg coated tablets | RK-LS-5№016670 |
5495 | N05AX08 | Risperidonum | Sizodon | 4 mg film-coated tablets | RK-LS-5№010779 |
5496 | N05AX08 | Risperidonum | Torendo® | 4 mg film-coated tablets | RK-LS-5№021165 |
5497 | N05AX08 | Risperidonum | Sizodon | 2 mg film-coated tablets | RK-LS-5№010778 |
5498 | N05AX08 | Risperidonum | Respirox | 2 mg film-coated tablets | RK-LS-5№016687 |
5499 | N05AX08 | Risperidonum | Respirox | 4 mg film-coated tablets | RK-LS-5№016688 |
5500 | N05AX08 | Risperidonum | Rispolept Consta® | powder and solvent for extended-release oral suspension for intramuscular injection, 37.5 mg | RK-LS-5№013625 |
5501 | N05AX08 | Risperidonum | Rispolept Consta® | powder and solvent for extended-release oral suspension for intramuscular injection, 25 mg | RK-LS-5№013624 |
5502 | N05AX08 | Risperidonum | Risperidone | 1 mg/ml oral suspension, 30 ml | RK-LS-5№019617 |
5503 | N05AX08 | Risperidonum | Risperidone | 4 mg tablets | RK-LS-5№014727 |
5504 | N05AX08 | Risperidonum | Risperidone | 4 mg film-coated tablets | RK-LS-5№020691 |
5505 | N05AX08 | Risperidonum | Risperidone | 2 mg tablets | RK-LS-5№014726 |
5506 | N05AX08 | Risperidonum | Respongyl | 2 mg film-coated tablets | RK-LS-5№020690 |
N05AX12 | Aripiprazole | ||||
5507 | N05AX12 | Aripiprazole | ABYZOLE® | 30 mg tablets | RK-LS-3№021042 |
5508 | N05AX12 | Aripiprazole | ABYZOLE® | 20 mg tablets | RK-LS-3№021041 |
5509 | N05AX12 | Aripiprazole | ABYZOLE® | 15 mg tablets | RK-LS-3№021040 |
5510 | N05AX12 | Aripiprazole | ABYZOLE® | 10 mg tablets | RK-LS-3№021039 |
5511 | N05AX12 | Aripiprazole | ABYZOLE® | 5 mg tablets | RK-LS-3№021038 |
5512 | N05AX12 | Aripiprazole | Aripegis® ODT |
10 mg orodispersible tablets | RK-LS-5№023066 |
5513 | N05AX12 | Aripiprazole | Aripegis® | 30 mg tablets | RK-LS-5№021472 |
5514 | N05AX12 | Aripiprazole | Aripegis® | 15 mg tablets | RK-LS-5№021473 |
5515 | N05AX12 | Aripiprazole | Aripegis® | 10 mg tablets | RK-LS-5№021474 |
5516 | N05AX12 | Aripiprazole | AMDOAL® | 10 mg tablets | RK-LS-5№022925 |
5517 | N05AX12 | Aripiprazole | AMDOAL® | 15 mg tablets | RK-LS-5№022926 |
5518 | N05AX12 | Aripiprazole | Aripegis® ODT | 15 mg orodispersible tablets | RK-LS-5№023067 |
N05AX13 | Paliperidone | ||||
5519 | N05AX13 | Paliperidone | Trevicta | suspension for sustained-release injection, 263 mg, 1.315 ml | RK-LS-5№022776 |
5520 | N05AX13 | Paliperidone | Trevicta | suspension for sustained-release injection, 525 mg, 2.621 ml | RK-LS-5№022778 |
5521 | N05AX13 | Paliperidone | Trevicta | suspension for sustained-release injection, 350 mg, 1750 ml | RK-LS-5№022777 |
5522 | N05AX13 | Paliperidone | Xeplion® | 150 mg/1.5 ml extended-release suspension for intramuscular injection | RK-LS-5№019152 |
5523 | N05AX13 | Paliperidone | Xeplion® | 100 mg/1 ml extended-release suspension for intramuscular injection | RK-LS-5№019151 |
5524 | N05AX13 | Paliperidone | Xeplion® | 75 mg/0.75 ml extended-release suspension for intramuscular injection | RK-LS-5№019150 |
5525 | N05AX13 | Paliperidone | Invega® | 9 mg sustained-release coated tablets | RK-LS-5№019529 |
5526 | N05AX13 | Paliperidone | Invega® | 6 mg sustained-release coated tablets | RK-LS-5№019528 |
5527 | N05AX13 | Paliperidone | Invega® | 3 mg sustained-release coated tablets | RK-LS-5№019527 |
N05AX15 | Cariprazine | ||||
5528 | N05AX15 | Cariprazine | Reagila® | 1.5 mg capsules | RK-LS-5№024084 |
5529 | N05AX15 | Cariprazine | Reagila® | 3 mg capsules | RK-LS-5№024083 |
5530 | N05AX15 | Cariprazine | Reagila® | 4.5 mg capsules | RK-LS-5№024082 |
5531 | N05AX15 | Cariprazine | Reagila® | 6 mg capsules | RK-LS-5№024081 |
N05B | Anxiolytics | ||||
5532 | N05B | Anxiolytics (Tofisopam) | Grandaxin® | 50 mg tablets | RK-LS-5№010520 |
N05BA | Benzodiazepine derivatives | ||||
N05BA01 | Diazepamum | ||||
5533 | N05BA01 | Diazepamum | Relium | 5 mg film-coated tablets | RK-LS-5№011025 |
5534 | N05BA01 | Diazepamum | Bruzepam | 10 mg/2 ml solution for injection | RK-LS-5№014022 |
5535 | N05BA01 | Diazepamum | Relanium | 5 mg/ml solution for intramuscular and intravenous injection, 2 ml | RK-LS-5№014355 |
5536 | N05BA01 | Diazepamum | Sibazon | 0.5 % solution for injection, 2 ml | RK-LS-5№016235 |
5537 | N05BA01 | Diazepamum | DIAZEPEKS® | 5 mg tablets | RK-LS-5№017963 |
N05BA02 | Chlordiazepoxide | ||||
5538 | N05BA02 | Chlordiazepoxide | Elenium | 10 mg film-coated tablets | RK-LS-5№011026 |
N05BA04 | Oxazepamum | ||||
5539 | N05BA04 | Oxazepamum | Nozepam 10mg | 10 mg tablets | RK-LS-5№019312 |
5540 | N05BA04 | Oxazepamum | Tazepam | 10 mg film-coated tablets | RK-LS-5№011288 |
N05BA12 | Alprazolamum | ||||
5541 | N05BA12 | Alprazolamum | Zolomax® | 0.25 mg tablets | RK-LS-5№010728 |
5542 | N05BA12 | Alprazolamum | Zolomax® | 1 mg tablets | RK-LS-5№010729 |
N05BB | Diphenylmethane derivatives | ||||
N05BB01 | Hydroxyzinum | ||||
5543 | N05BB01 | Hydroxyzinum | Atarax® | 25 mg film-coated tablets | RK-LS-5№010521 |
N05C | Hypnotics and sedatives | ||||
N05CF | Benzodiazepine-like drugs | ||||
N05CF01 | Zopiclonum | ||||
5544 | N05CF01 | Zopiclonum | Imovane® | 7.5 mg film-coated tablets | RK-LS-5№018441 |
5545 | N05CF01 | Zopiclonum | Sonnat®-KMP | 7.5 mg film-coated tablets | RK-LS-5№004311 |
5546 | N05CF01 | Zopiclonum | SOMNOL® | 7.5 mg film-coated tablets | RK-LS-5№010691 |
5547 | N05CF01 | Zopiclonum | Dobroson® | 7.5 mg film-coated tablets | RK-LS-5№024065 |
5548 | N05CF01 | Zopiclonum | Sonex | 7.5 mg film-coated tablets | RK-LS-5№022578 |
5549 | N05CF01 | Zopiclonum | Sonlife | 7.5 mg film-coated tablets | RK-LS-5№121877 |
N05CF03 | Zaleplonum | ||||
5550 | N05CF03 | Zaleplonum | Selofen® | 10 mg capsules | RK-LS-5№121835 |
N05C | Hypnotics and sedatives | ||||
5551 | N05C | Hypnotics and sedatives | MELAXEN® | 3 mg coated tablets | RK-LS-5№010903 |
N05CM | Other hypnotics and sedatives | ||||
N05CM18 | Dexmedetomidine | ||||
5552 | N05CM18 | Dexmedetomidine | Dexmedetomidine-Teva | 100 mg/ml concentrate for solution for infusion, 5 ml | RK-LS-5№024388 |
5553 | N05CM18 | Dexmedetomidine | Dexmedetomidine-Teva | 100 mg/ml concentrate for solution for infusion, 2 ml | RK-LS-5№024388 |
5554 | N05CM18 | Dexmedetomidine | Dexmedetomidine hydrochloride | 100 mcg/ml concentrate for solution for infusion, 4 ml | RK-LS-5№024308 |
5555 | N05CM18 | Dexmedetomidine | Dexdor | 100 mcg/ml concentrate for solution for infusion, 4 ml | RK-LS-5№020367 |
5556 | N05CM18 | Dexmedetomidine | Dexdor | 100 mcg/ml concentrate for solution for infusion, 10 ml | RK-LS-5№020368 |
5557 | N05CM18 | Dexmedetomidine | Dexmedetomidine EVER Pharma | 100 mcg/ml concentrate for solution for infusion, 2 ml | RK-LS-5№024102 |
5558 | N05CM18 | Dexmedetomidine | Dexmedetomidine EVER Pharma | 100 mcg/ml concentrate for solution for infusion, 4 ml | RK-LS-5№024102 |
5559 | N05CM18 | Dexmedetomidine | Dexmedetomidine EVER Pharma | 100 mcgг/ml concentrate for solution for infusion, 10 ml | RK-LS-5№024102 |
5560 | N05CM18 | Dexmedetomidine | Dexmedetomidine hydrochloride | 100 mcg/ml concentrate for solution for infusion | RK-LS-5№024224 |
5561 | N05CM18 | Dexmedetomidine | Dexdor | 100 mcg/ml concentrate for solution for infusion, 2 ml | RK-LS-5№020366 |
5562 | N05CM18 | Dexmedetomidine | Dexmedetomidine Calcex | 100 mcg/ml concentrate for solution for infusion, 2 ml | RK-LS-5№024440 |
N06 | Psychoanaleptics | ||||
N06A | Antidepressants | ||||
N06AA | Non-selective monoamine reuptake inhibitors | ||||
N06AA02 | Imipramine | ||||
N06AA09 | Amitriptylinum | ||||
5563 | N06AA09 | Amitriptylinum | Amitripsan | 25 mg coated tablets | RK-LS-5№020147 |
5564 | N06AA09 | Amitriptylinum | Amitriptyline | 25 mg coated tablets | RK-LS-5№005488 |
5565 | N06AA09 | Amitriptylinum | Amitripsan | 20 mg/2ml solution for injection, 2ml | RK-LS-5№021410 |
5566 | N06AA09 | Amitriptylinum | AMITRIPTYLINE-AKOS | 20 mg/2 ml solution for injection, 2 ml | RK-LS-5№013691 |
5567 | N06AA09 | Amitriptylinum | Amitriptyline hydrochloride | 25 mg tablets | RK-LS-5№009697 |
5568 | N06AA09 | Amitriptylinum | Amitriptyline | 25 mg coated tablets | RK-LS-5№022186 |
N06AB | Selective serotonin reuptake inhibitors | ||||
N06AB03 | Fluoxetinum | ||||
5569 | N06AB03 | Fluoxetinum | Fluoxetine Lannacher | 20 mg capsules | RK-LS-5№014887 |
5570 | N06AB03 | Fluoxetinum | DEPRES | 20 mg capsules | RK-LS-5№016176 |
N06AB04 | Citalopramum | ||||
5571 | N06AB04 | Citalopramum | Citol® | 40 mg film-coated tablets | RK-LS-5№004990 |
5572 | N06AB04 | Citalopramum | Citol® | 20 mg film-coated tablets | RK-LS-5№000035 |
N06AB05 | Paroxetinum | ||||
5573 | N06AB05 | Paroxetinum | Rexetin® | 20 mg film-coated tablets | RK-LS-5№004672 |
N06AB06 | Sertralinum | ||||
5574 | N06AB06 | Sertralinum | Asentra® | 100 mg film-coated tablets | RK-LS-5№013353 |
5575 | N06AB06 | Sertralinum | Asentra® | 50 mg film-coated tablets | RK-LS-5№013352 |
5576 | N06AB06 | Sertralinum | Solotik 100 | 100 mg film-coated tablets | RK-LS-5№016659 |
5577 | N06AB06 | Sertralinum | MISOL® 50 | 50 mg film-coated tablets | RK-LS-5№014521 |
5578 | N06AB06 | Sertralinum | MISOL® 100 | 100 mg film-coated tablets | RK-LS-5№014522 |
5579 | N06AB06 | Sertralinum | Solotik 50 | 50 mg film-coated tablets | RK-LS-5№016658 |
5580 | N06AB06 | Sertralinum | MISOL® 50 | 50 mg film-coated tablets | RK-LS-5№014640 |
5581 | N06AB06 | Sertralinum | MISOL® 100 | 100 mg film-coated tablets | RK-LS-5№014641 |
5582 | N06AB06 | Sertralinum | MISOL® 100 | 100 mg film-coated tablets | RK-LS-5№019284 |
5583 | N06AB06 | Sertralinum | MISOL® 100 | 50 mg film-coated tablets | RK-LS-5№019283 |
N06AВ08 | Fluvoxamine | ||||
5584 | N06AВ08 | Fluvoxamine | Fevarin® | 100 mg coated tablets | RK-LS-5№015905 |
5585 | N06AВ08 | Fluvoxamine | Fluvoxin 100 | 100 mg film-coated tablets | RK-LS-5№003094 |
5586 | N06AВ08 | Fluvoxamine | Fluvoxin 50 | 50 mg film-coated tablets | RK-LS-5№003014 |
N06AB10 | Escitalopramum | ||||
5587 | N06AB10 | Escitalopramum | Elicea® Q-tab® | 20 mg orodispersible tablets | RK-LS-5№122028 |
5588 | N06AB10 | Escitalopramum | Elicea® Q-tab® |
5 mg orodispersible tablets | RK-LS-5№122026 |
5589 | N06AB10 | Escitalopramum | Elicea® Q-tab® |
10 mg orodispersible tablets | RK-LS-5№122027 |
5590 | N06AB10 | Escitalopramum | Citolex | 10 mg film-coated tablets | RK-LS-5№015454 |
5591 | N06AB10 | Escitalopramum | Elicea® | 10 mg film-coated tablets | RK-LS-5№018113 |
5592 | N06AB10 | Escitalopramum | Citolex | 20 mg film-coated tablets | RK-LS-5№015455 |
5593 | N06AB10 | Escitalopramum | Sevpram | 5 mg film-coated tablets | RK-LS-5№021369 |
5594 | N06AB10 | Escitalopramum | Sevpram | 20 mg film-coated tablets | RK-LS-5№021371 |
5595 | N06AB10 | Escitalopramum | Elicea® | 5 mg film-coated tablets | RK-LS-5№018112 |
5596 | N06AB10 | Escitalopramum | Escita® 10 | 10 mg film-coated tablets | RK-LS-5№013735 |
5597 | N06AB10 | Escitalopramum | Escita® 20 | 20 mg film-coated tablets | RK-LS-5№013768 |
5598 | N06AB10 | Escitalopramum | Escita® 10 | 10 mg film-coated tablets | RK-LS-5№014065 |
5599 | N06AB10 | Escitalopramum | Escita® 20 | 20 mg film-coated tablets | RK-LS-5№014066 |
5600 | N06AB10 | Escitalopramum | Medolapram | 10 mg film-coated tablets | RK-LS-5№023585 |
5601 | N06AB10 | Escitalopramum | Medolapram | 20 mg film-coated tablets | RK-LS-5№023586 |
5602 | N06AB10 | Escitalopramum | Elicea® | 20 mg film-coated tablets | RK-LS-5№018114 |
5603 | N06AB10 | Escitalopramum | ESCITA® | 20 mg film-coated tablets | RK-LS-5№022981 |
5604 | N06AB10 | Escitalopramum | Sevpram | 10 mg film-coated tablets | RK-LS-5№021370 |
5605 | N06AB10 | Escitalopramum | Escita® | 10 mg film-coated tablets | RK-LS-5№022980 |
5606 | N06AB10 | Escitalopramum | Estan | 200 mg film-coated tablets | RK-LS-5№024482 |
5607 | N06AB10 | Escitalopramum | Estan | 100 mg film-coated tablets | RK-LS-5№024483 |
5608 | N06AB10 | Escitalopramum | Citolex | 10 mg/ml oral drops, 15 ml | RK-LS-5№015453 |
N06BC01 | Caffeine and sodium benzoate | ||||
5609 | N06BC01 | Caffeine and sodium benzoate | Caffeine and sodium benzoate- Darnitsa | 10 % solution for injection, 1 ml | RK-LS-5№015573 |
5610 | N06BC01 | Caffeine and sodium benzoate | Caffeine and sodium benzoate | 200 mg/ml solution for subcutaneous injection, 1 ml | RK-LS-5№018225 |
N06AX | Other antidepressants | ||||
N06AX03 | Mianserinum | ||||
5611 | N06AX03 | Mianserinum | Menser | 30 mg film-coated tablets | RK-LS-5№022581 |
N06AX05 | Trazodonum | ||||
5612 | N06AX05 | Trazodonum | Trittico® | 150 mg sustained-release tablets | RK-LS-5№019504 |
N06AX11 | Mirtazapinum | ||||
5613 | N06AX11 | Mirtazapinum | Mirzaten® | 30 mg film-coated tablets | RK-LS-5№021298 |
5614 | N06AX11 | Mirtazapinum | Mirzaten® | 45 mg film-coated tablets | RK-LS-5№021299 |
5615 | N06AX11 | Mirtazapinum | Mirzaten® Q-tab® | 15 mg orodispersible tablets | RK-LS-5№122098 |
5616 | N06AX11 | Mirtazapinum | Mirzaten® Q-tab® | 30 mg orodispersible tablets | RK-LS-5№122099 |
5617 | N06AX11 | Mirtazapinum | Mirzaten® Q-tab® | 45 mg orodispersible tablets | RK-LS-5№122100 |
5618 | N06AX11 | Mirtazapinum | Mirtel | 30 mg film-coated tablets | RK-LS-5№018367 |
N06AX16 | Venlafaxine | ||||
5619 | N06AX16 | Venlafaxine | Alventa® | 150 mg modified-release capsules | RK-LS-5№014786 |
5620 | N06AX16 | Venlafaxine | Venlarel | 75 mg sustained-release capsules | RK-LS-5№023734 |
5621 | N06AX16 | Venlafaxine | Venlarel | 37.5 mg sustained-release capsules | RK-LS-5№023733 |
5622 | N06AX16 | Venlafaxine | Venlarel | 150 mg sustained-release capsules | RK-LS-5№023735 |
5623 | N06AX16 | Venlafaxine | Velaxin® | 37.5 mg tablets | RK-LS-5№015852 |
5624 | N06AX16 | Venlafaxine | Velaxin® | 50 mg tablets | RK-LS-5№015853 |
5625 | N06AX16 | Venlafaxine | Velaxin® | 75 mg tablets | RK-LS-5№015854 |
5626 | N06AX16 | Venlafaxine | Alventa® | 37.5 mg modified-release capsules | RK-LS-5№014784 |
5627 | N06AX16 | Venlafaxine | Prefaxine | 37.5 mg sustained-release capsules | RK-LS-5№017926 |
5628 | N06AX16 | Venlafaxine | Venlaxor® | 37.5 mg tablets | RK-LS-5№004252 |
5629 | N06AX16 | Venlafaxine | Velaxin® | 150 mg sustained-release capsules | RK-LS-5№005012 |
5630 | N06AX16 | Venlafaxine | Prefaxine | 150 mg sustained-release capsules | RK-LS-5№017928 |
5631 | N06AX16 | Venlafaxine | Velaxin® | 75 mg sustained-release capsules | RK-LS-5№005010 |
5632 | N06AX16 | Venlafaxine | Venlaxor® | 75 mg tablets | RK-LS-5№004257 |
5633 | N06AX16 | Venlafaxine | Prefaxine | 75 mg sustained-release capsules | RK-LS-5№017927 |
5634 | N06AX16 | Venlafaxine | Alventa® | 75 mg mofified-release capsules | RK-LS-5№014785 |
N06AX21 | Duloxetine | ||||
5635 | N06AX21 | Duloxetine | Duloxvite | 60 mg enteric capsules | RK-LS-5№024312 |
5636 | N06AX21 | Duloxetine | Drualix | 60 mg enteric capsules | RK-LS-5№024100 |
5637 | N06AX21 | Duloxetine | Drualix | 30 mg enteric capsules | RK-LS-5№024101 |
5638 | N06AX21 | Duloxetine | Duloxenta | 30 mg enteric capsules | RK-LS-5№022728 |
5639 | N06AX21 | Duloxetine | Duloxenta | 60 mg enteric capsules | RK-LS-5№022729 |
5640 | N06AX21 | Duloxetine | Symbalta® | 60 mg capsules | RK-LS-5№002430 |
5641 | N06AX21 | Duloxetine | Duzela | 60 mg sustained-release capsules | RK-LS-5№020186 |
5642 | N06AX21 | Duloxetine | Duxet | 60 mg sustained-release capsules | RK-LS-5№022764 |
5643 | N06AX21 | Duloxetine | Dulokem | 30 mg sustained-release capsules | RK-LS-5№122015 |
5644 | N06AX21 | Duloxetine | Dulokem | 60 mg sustained-release capsules | RK-LS-5№122016 |
5645 | N06AX21 | Duloxetine | Duxet | 30 mg sustained-release capsules | RK-LS-5№022761 |
N06AX22 | Agomelatinum | ||||
5646 | N06AX22 | Agomelatinum | Valdoxan | 25 mg tablets | RK-LS-5№018656 |
N06D | Anti-dementia drugs | ||||
N06DA | Cholinesterase inhibitors | ||||
N06DA02 | Donepezilum | ||||
5647 | N06DA02 | Donepezilum | Donepezil-DT-Teva |
5 mg orodispersible tablets | RK-LS-5№121899 |
5648 | N06DA02 | Donepezilum | Donepezil-DT-Teva |
10 mg orodispersible tablets | RK-LS-5№121900 |
5649 | N06DA02 | Donepezilum | Alzepil® | 10 mg coated tablets | RK-LS-5№015771 |
5650 | N06DA02 | Donepezilum | ALZANSER® 10 | 10 mg orodispersible tablets | RK-LS-3№020409 |
5651 | N06DA02 | Donepezilum | SERVONEX® | 10 mg orodispersible tablets | RK-LS-5№020765 |
5652 | N06DA02 | Donepezilum | Yasnal® | 5 mg orodispersible tablets | RK-LS-5№014349 |
5653 | N06DA02 | Donepezilum | Yasnal® | 10 mg orodispersible tablets | RK-LS-5№014350 |
5654 | N06DA02 | Donepezilum | Donepezil-Teva | 5 mg orodispersible tablets | RK-LS-5№121901 |
5655 | N06DA02 | Donepezilum | Donepezil-Teva | 10 mg film-coated tablets | RK-LS-5№121902 |
5656 | N06DA02 | Donepezilum | Alzidon | 5 mg film-coated tablets | RK-LS-5№121983 |
5657 | N06DA02 | Donepezilum | ALZANSER 5 | 5 mg film-coated tablets | RK-LS-3№020408 |
5658 | N06DA02 | Donepezilum | Alzepil® | 5 mg coated tablets | RK-LS-5№015770 |
5659 | N06DA02 | Donepezilum | SERVONEX® | 5 mg film-coated tablets | RK-LS-5№020766 |
N06DA03 | Rivastigminum | ||||
N06DA04 | Galantaminum | ||||
5660 | N06DA04 | Galantaminum | Nivalin® | 10 mg/ml solution for injection in ampoules, 1 ml | RK-LS-5№011160 |
5661 | N06DA04 | Galantaminum | Nivalin® | 5 mg/ml solution for injection, 1 ml | RK-LS-5№011159 |
5662 | N06DA04 | Galantaminum | Nivalin® | 5 mg tablets | RK-LS-5№010820 |
5663 | N06DA04 | Galantaminum | Nivalin® | 10 mg tablets | RK-LS-5№010821 |
5664 | N06DA04 | Galantaminum | Nivalin® | 2.5 mg/ml solution for injection, 1 ml | RK-LS-5№011158 |
N06DX01 | Memantinum | ||||
5665 | N06DX01 | Memantinum | Memantine | 10 mg film-coated tablets | RK-LS-5№024305 |
5666 | N06DX01 | Memantinum | Memantine | 20 mg film-coated tablets | RK-LS-5№024306 |
5667 | N06DX01 | Memantinum | Denigma memaxine | 5 mg film-coated tablets | RK-LS-5№021507 |
5668 | N06DX01 | Memantinum | Memaxine | 10 mg film-coated tablets | RK-LS-5№016200 |
5669 | N06DX01 | Memantinum | Memantin-Teva | 10 mg film-coated tablets | RK-LS-5№121709 |
5670 | N06DX01 | Memantinum | Memantin-Teva | 20 mg film-coated tablets | RK-LS-5№121710 |
5671 | N06DX01 | Memantinum | Maruxa® | 10 mg film-coated tablets | RK-LS-5№121843 |
5672 | N06DX01 | Memantinum | Maruxa® | 20 mg film-coated tablets | RK-LS-5№121844 |
5673 | N06DX01 | Memantinum | Nermont | 10 mg film-coated tablets | RK-LS-5№121961 |
5674 | N06DX01 | Memantinum | Tingrex® | 10 mg film-coated tablets | RK-LS-5№024171 |
5675 | N06DX01 | Memantinum | Alceba | 10 mg film-coated tablets | RK-LS-5№020790 |
5676 | N06DX01 | Memantinum | Denigma | 10 mg film-coated tablets | RK-LS-5№021506 |
5677 | N06DX01 | Memantinum | Memaxine | 10 mg/g oral drops, 100 g | RK-LS-5№016201 |
N07 | Other nervous system drugs | ||||
N07A | Parasympathomimetics | ||||
N07AA | Anticholinesterases | ||||
N07AA01 | Neostigmine bromide | ||||
5678 | N07AA01 | Neostigmine bromide | Proserin-Darnitsa | 0.05% solution for injection, 1 ml | RK-LS-5№015466 |
5679 | N07AA01 | Neostigmine bromide | Proserin | 0.5 mg/ml solution for injection, 1 ml | RK-LS-5№010914 |
5680 | N07AA01 | Neostigmine bromide | Proserin | 0.5 mg/ml solution for injection, 1 ml | RK-LS-5№022410 |
N07AA02 | Pyridostigmine bromide | ||||
5681 | N07AA02 | Pyridostigmine bromide | Kalymin 60 N | 60 mg tablets | RK-LS-5№009630 |
N07B | Drugs for treating psychological or physiological addiction to various substances | ||||
N07BA03 | Varenicline | ||||
5682 | N07BA03 | Varenicline | Champix® | 1 mg film-coated tablets | RK-LS-5№011819 |
5683 | N07BA03 | Varenicline | Champix® | 0.5 mg + 1.0 mg film-coated tablets | RK-LS-5№011810 |
N07BB | Drugs for treating alcohol addiction | ||||
N07BB01 | Disulfiramum | ||||
5684 | N07BB01 | Disulfiramum | Esperal® | 500 mg tablets | RK-LS-5№003622 |
5685 | N07BB01 | Disulfiramum | Teturam | 150 mg tablets | RK-LS-5№009581 |
5686 | N07BB01 | Disulfiramum | Alcoson® | 500 mg tablets | RK-LS-5№006129 |
5687 | N07BB01 | Disulfiramum | Teturam | 150 mg tablets | RK-LS-5№012716 |
N07BB04 | Naltrexonum | ||||
5688 | N07BB04 | Naltrexonum | Antaxone | 50 mg capsules | RK-LS-5№009266 |
5689 | N07BB04 | Naltrexonum | Vivitrol® | 380 mg powder for extended-release suspension for intramuscular injection, 4 ml | RK-LS-5№014801 |
N07C | Antivertigo drugs | ||||
N07CA01 | Betahistinum | ||||
5690 | N07CA01 | Betahistinum | Polvertic | 8 mg tablets | RK-LS-5№016517 |
5691 | N07CA01 | Betahistinum | Polvertic | 16 mg tablets | RK-LS-5№016518 |
5692 | N07CA01 | Betahistinum | Vestibo | 24 mg tablets | RK-LS-5№017380 |
5693 | N07CA01 | Betahistinum | Polvertic | 24 mg tablets | RK-LS-5№016519 |
5694 | N07CA01 | Betahistinum | Alfinor | 24 mg tablets | RK-LS-5№020563 |
5695 | N07CA01 | Betahistinum | Betahist 24 | 24 mg tablets | RK-LS-5№019067 |
5696 | N07CA01 | Betahistinum | Moreserc | 24 mg tablets | RK-LS-5№021190 |
5697 | N07CA01 | Betahistinum | Brustin | 16 mg tablets | RK-LS-5№020843 |
5698 | N07CA01 | Betahistinum | Betaserc® | 8 mg tablets | RK-LS-5№018569 |
5699 | N07CA01 | Betahistinum | Betaserc® | 16 mg tablets | RK-LS-5№018570 |
5700 | N07CA01 | Betahistinum | Betaserc® | 24 mg tablets | RK-LS-5№018571 |
5701 | N07CA01 | Betahistinum | KernHistine | 8 mg tablets | RK-LS-5№022826 |
5702 | N07CA01 | Betahistinum | KernHistine | 16 mg tablets | RK-LS-5№022872 |
5703 | N07CA01 | Betahistinum | Alfinor | 8 mg tablets | RK-LS-5№018088 |
5704 | N07CA01 | Betahistinum | Alfinor | 16 mg tablets | RK-LS-5№018089 |
5705 | N07CA01 | Betahistinum | Betavert | 16 mg tablets | RK-LS-5№018676 |
5706 | N07CA01 | Betahistinum | Betavert | 24 mg tablets | RK-LS-5№018677 |
5707 | N07CA01 | Betahistinum | Betahistine-Teva | 16 mg tablets | RK-LS-5№014258 |
5708 | N07CA01 | Betahistinum | Betahistine-Teva | 24 mg tablets | RK-LS-5№014259 |
5709 | N07CA01 | Betahistinum | Vestinorm | 24 mg tablets | RK-LS-5№017889 |
5710 | N07CA01 | Betahistinum | Betahist 16 | 16 mg tablets | RK-LS-5№019066 |
5711 | N07CA01 | Betahistinum | Moreserc | 16 mg tablets | RK-LS-5№021191 |
5712 | N07CA01 | Betahistinum | Vestinorm® | 16 mg tablets | RK-LS-5№017888 |
5713 | N07CA01 | Betahistinum | Betahist 8 | 8 mg tablets | RK-LS-5№019068 |
N07CA02 | Cinnarizinum | ||||
5714 | N07CA02 | Cinnarizinum | Stugeron® | 25 mg tablets | RK-LS-5№002047 |
5715 | N07CA02 | Cinnarizinum | Cinnarizine | 25 mg tablets | RK-LS-5№121817 |
5716 | N07CA02 | Cinnarizinum | Cinnarizine Sopharma | 25 mg tablets | RK-LS-5№020039 |
N07XX09 | Dimethyl fumarate | orphan drug | |||
5717 | N07XX09 | Dimethyl fumarate | Tecfidera® | 120 mg hard enteric capsules | RK-LS-5№022326 |
5718 | N07XX09 | Dimethyl fumarate |
Tecfidera® | 240 mg hard enteric capsules | RK-LS-5№022354 |
N07XX02 | Riluzolum | orphan drug | |||
5719 | N07XX02 | Riluzolum | Borizol | 50 mg film-coated tablets | RK-LS-5№020992 |
5720 | N07XX02 | Riluzolum | Рилусан | 50 mg coated tablets | RK-LS-5№121814 |
N07XX06 | Tetrabenazine | ||||
5721 | N07XX06 | Tetrabenazine | Tetmodis | 25 mg tablets | RK-LS-5№018934 |
P | Antiparasitic drugs, insecticides and repellents | ||||
P02 | Anthelmintic drugs | ||||
P02B | Anti-trematode drugs | ||||
P02BA01 | Praziquantel | ||||
P02C | Drugs for treating nematodiasis | ||||
P02CA | Benzimidazole derivatives | ||||
P02CA01 | Mebendazolum | ||||
5722 | P02CA01 | Mebendazolum |
Vermox | 100 mg tablets | RK-LS-5№010231 |
P02CA03 | Albendazolum | ||||
5723 | P02CA03 | Albendazolum | Albezole® | 400 mg/10 ml suspension, 10 ml | RK-LS-5№122051 |
5724 | P02CA03 | Albendazolum | Intazole | 400 mg tablets | RK-LS-5№021137 |
5725 | P02CA03 | Albendazolum | Albezole® | 400 mg tablets | RK-LS-5№019329 |
5726 | P02CA03 | Albendazolum | Andazole | 200 mg film-coated tablets | RK-LS-5№121812 |
5727 | P02CA03 | Albendazolum | Nemozole | 400 mg film-coated tablets | RK-LS-5№016208 |
5728 | P02CA03 | Albendazolum | Zentel | 4% oral suspension, 10 ml | RK-LS-5№005716 |
5729 | P02CA03 | Albendazolum | Zentel | 400 mg tablets | RK-LS-5№005717 |
5730 | P02CA03 | Albendazolum | Gelmadol | 200 mg film-coated tablets | RK-LS-5№021118 |
5731 | P02CA03 | Albendazolum | Intazole | 200 mg/5 ml oral suspension, 10 ml in a bottle | RK-LS-5№022674 |
5732 | P02CA03 | Albendazolum | Nemozole | 100 mg/5 ml oral suspension, 10 ml in a bottle | RK-LS-5№016173 |
P02CC | Tetrahydropyrimidine derivatives | ||||
P02CC01 | Pyrantelum | ||||
5733 | P02CC01 | Pyrantelum | Pyrantel | 250 mg/5ml oral suspension, 15 ml | RK-LS-5№003032 |
5734 | P02CC01 | Pyrantelum | Helmintox | 250 mg film-coated tablets | RK-LS-5№002448 |
5735 | P02CC01 | Pyrantelum |
Helmintox | 125 mg/2.5 ml oral suspension, 15 ml | RK-LS-5№002447 |
5736 | P02CC01 | Pyrantelum | Pyrantel | 250 mg tablets | RK-LS-5№009475 |
P02CE | Imidazothiazole derivatives | ||||
P02CE01 | Levamisolum | ||||
5737 | P02CE01 | Levamisolum |
Decaris | 50 mg tablets | RK-LS-5№012008 |
5738 | P02CE01 | Levamisolum |
Decaris | 150 mg tablets | RK-LS-5№012009 |
P03 | Drugs against ectoparasites (including itch mites), insecticides and repellents | ||||
P03A | Drugs against ectoparasites (including itch mites) | ||||
P03AA | Sulfur besieged | ||||
5739 | P03AA | Sulfur besieged | simple sulfur ointment | 33% skin ointment, 25 g | RK-LS-5№003170 |
5740 | P03AA | Sulfur besieged | Sulfur ointment | 33.3% ointment, 40 g | RK-LS-5№009346 |
5741 | P03AA | Sulfur besieged | Sulfur ointment | 33.3% ointment, 25 g | RK-LS-5№009346 |
P03AC | Pyrethrins (including synthetic compounds) | ||||
P03AC04 | Permethrinum | ||||
5742 | P03AC04 | Permethrinum | Pedex | 0.5% topical gel, 40 g | RK-LS-5№004113 |
5743 | P03AC04 | Permethrinum | Pedex | 0.5% topical solution, 60 ml | RK-LS-5№004115 |
5744 | P03AC04 | Permethrinum | Bactericidal permethrin ointment | topical gel, 40 g | RK-LS-5№004125 |
5745 | P03AC04 | Permethrinum | Permethrin | 0.5% spray, 50 g | RK-LS-5№021264 |
P03AX | Other drugs against ectoparasites | ||||
P03AX01 | Benzyl benzoate | ||||
5746 | P03AX01 | Benzyl benzoate | Benzyl benzoate Grindeks | 200 mg/g skin ointment, 30 g | RK-LS-5№004170 |
R | Respiratory system | ||||
R01 | Drugs for treating nasal disorders | ||||
R01A | Decongestants and other topical medications | ||||
R01AA | Sympathomimetics | ||||
R01AA04 | Phenylephrinum | ||||
5747 | R01AA04 | Phenylephrinum | Nazol® Kids | Nasal spray, 10 ml | RK-LS-5№012278 |
5748 | R01AA04 | Phenylephrinum | Nazol® Kids | Nasal spray, 15 ml | RK-LS-5№012278 |
5749 | R01AA04 | Phenylephrinum | Nazol® Baby | Nasal drops for babies and children, 10 ml | RK-LS-5№014746 |
R01AA05 | Oxymetazoline | ||||
5750 | R01AA05 | Oxymetazoline | Oxivin-DF® | 0.01% nasal drops, 10 ml | RK-LS-3№121737 |
5751 | R01AA05 | Oxymetazoline | Oxivin-DF® | 0.025 % nasal drops, 10 ml | RK-LS-3№121738 |
5752 | R01AA05 | Oxymetazoline | Oxivin-DF® | 0.05% nasal drops, 10 ml | RK-LS-3№121739 |
5753 | R01AA05 | Oxymetazoline | Nazol® | Nasal spray, 10 ml | RK-LS-5№007918 |
5754 | R01AA05 | Oxymetazoline | Nasivin® Sensitive | 11.25 mcg/dose metered dose nasal spray, 10 ml | RK-LS-5№019814 |
5755 | R01AA05 | Oxymetazoline | Nasivin® Sensitive | 22.5 mcg/dose metered dose nasal spray, 10 ml | RK-LS-5№019815 |
5756 | R01AA05 | Oxymetazoline | Nasivin® Sensitive | 11.25 mcg/dose metered dose nasal spray, 10 ml | RK-LS-5№019816 |
5757 | R01AA05 | Oxymetazoline | Nasivin® Sensitive | 22.5 mcg/dose metered dose nasal spray, 10 ml | RK-LS-5№019817 |
5758 | R01AA05 | Oxymetazoline | Glazal oxy®plus | 0.025% eye and nose drops, 10 ml | RK-LS-5№011150 |
5759 | R01AA05 | Oxymetazoline | Oxinazin® | 0.01% nasal spray for babies,10 ml | RK-LS-5№016591 |
5760 | R01AA05 | Oxymetazoline | Oxinazin® | 0.05% nasal spray, 15 ml | RK-LS-5№016593 |
5761 | R01AA05 | Oxymetazoline | Rinoxil-N | 0.25 mg/ml nasal drops, solution, 10 ml | RK-LS-5№021356 |
5762 | R01AA05 | Oxymetazoline | Rinoxil-N | 0.5 mg/ml nasal drops, solution, 10 ml | RK-LS-5№021357 |
5763 | R01AA05 | Oxymetazoline | Glazal-oxy® | 0.01% nasal drops, 5 ml | RK-LS-5№011149 |
5764 | R01AA05 | Oxymetazoline | Rint with menthol | 0.5 mg/ml nasal spray,10 ml | RK-LS-5№021010 |
5765 | R01AA05 | Oxymetazoline | Rint moisturizing | 0.5 mg/ml nasal spray, 10 ml | RK-LS-5№021031 |
5766 | R01AA05 | Oxymetazoline | Rinazoline® | 0.05 % nasal spray, 15 ml | RK-LS-5№014661 |
5767 | R01AA05 | Oxymetazoline | Rinazoline | 0.01 % nasal drops, 10 ml | RK-LS-5№014662 |
5768 | R01AA05 | Oxymetazoline | Oxivin-DF® | 0.025% nasal spray, 10 ml | RK-LS-5№121725 |
5769 | R01AA05 | Oxymetazoline | Oxivin-DF® | 0.05% nasal spray, 10 ml | RK-LS-5№121726 |
5770 | R01AA05 | Oxymetazoline | Oxinazin® | 0.025% nasal spray for children, 10 ml | RK-LS-5№016592 |
5771 | R01AA05 | Oxymetazoline | Nasivin® | 0.25 % nasal drops, 10 ml | RK-LS-5№019264 |
5772 | R01AA05 | Oxymetazoline | Nasivin® Sensitive | 0.01 % nasal drops, 5 ml | RK-LS-5№019813 |
5773 | R01AA05 | Oxymetazoline | Nasivin® | 0.01% nasal drops, 5 ml | RK-LS-5№019263 |
5774 | R01AA05 | Oxymetazoline | Glazal-oxy® | 0.05% nasal drops, 10 ml | RK-LS-5№011162 |
5775 | R01AA05 | Oxymetazoline | Nasivin® | 0.05% nasal drops, 10 ml | RK-LS-5№019265 |
5776 | R01AA05 | Oxymetazoline | Rinazoline | 0.05% nasal drops, 10 ml | RK-LS-5№014664 |
5777 | R01AA05 | Oxymetazoline | Rinazoline | 0.025% nasal drops, 10 ml | RK-LS-5№014663 |
5778 | R01AA05 | Oxymetazoline | Nasivin® | 0.05% nasal drops, 10 ml | RK-LS-5№019266 |
5779 | R01AA05 | Oxymetazoline | Nazol® Advance | nasal spray, 10 ml | RK-LS-5№011503 |
5780 | R01AA05 | Oxymetazoline | Nazol® Advance | nasal spray, 15 ml | RK-LS-5№011503 |
R01AA07 | Xylometazoline | ||||
5781 | R01AA07 | Xylometazoline | Fastorik™-N | 0.1% nasal drops, 10 ml | RK-LS-5№009117 |
5782 | R01AA07 | Xylometazoline | Galazolin® | 0.1% nasal drops, 10 ml | RK-LS-5№010227 |
5783 | R01AA07 | Xylometazoline | Fastorik™-N | 0.05% nasal drops, 10 ml | RK-LS-5№009116 |
5784 | R01AA07 | Xylometazoline | Galazolin® | 0.05% nasal drops, 10 ml | RK-LS-5№010228 |
5785 | R01AA07 | Xylometazoline | “Zolotaya svezda” drops | 0.05% nasal drops, 10 ml | RK-LS-5№015762 |
5786 | R01AA07 | Xylometazoline | “Zolotaya svezda” drops | 0.1% nasal drops, 10 ml | RK-LS-5№015764 |
5787 | R01AA07 | Xylometazoline | Otrisol-DF® | 0.05% nasal drops, 10ml | RK-LS-3№020376 |
5788 | R01AA07 | Xylometazoline | Otrisol-DF® | 0.1% nasal drops, 10 ml | RK-LS-3№020377 |
5789 | R01AA07 | Xylometazoline | Nazaxil® | 0.1 % nasal drops, 10 ml | RK-LS-5№014018 |
5790 | R01AA07 | Xylometazoline | Nazaxil® | 0.05 % nasal drops, 10 ml | RK-LS-5№014017 |
5791 | R01AA07 | Xylometazoline | Xylometazolin-Teva | 0.05% nasal drops, 10ml | RK-LS-5№019106 |
5792 | R01AA07 | Xylometazoline | Xylometazolin-Teva | 0.1 % nasal drops, 10 ml | RK-LS-5№019107 |
5793 | R01AA07 | Xylometazoline | Nasazis-xylo | 0.1 % nasal drops, 10 ml | RK-LS-5№024229 |
5794 | R01AA07 | Xylometazoline | Nasazis-xylo | 0.05% nasal drops, 10 ml | RK-LS-5№024230 |
5795 | R01AA07 | Xylometazoline | Pharmazolin® | 0.1% nasal drops, 10 ml | RK-LS-5№016466 |
5796 | R01AA07 | Xylometazoline | Pharmazolin® | 0.05% nasal drops, 10 ml | RK-LS-5№016465 |
5797 | R01AA07 | Xylometazoline | Otrivin | 0.05% nasal drops for children, 10 ml | RK-LS-5№014866 |
5798 | R01AA07 | Xylometazoline | Xymelin® | 0.05% nasal drops, 10 ml | RK-LS-5№009805 |
5799 | R01AA07 | Xylometazoline | Xymelin® | 0.1% nasal drops, 10 ml | RK-LS-5№004937 |
5800 | R01AA07 | Xylometazoline | Otrivin | 0.1% metered dose nasal spray,10 ml | RK-LS-5№014864 |
5801 | R01AA07 | Xylometazoline | Galazolin® | 0.05% nasal gel, 10 g | RK-LS-5№014397 |
5802 | R01AA07 | Xylometazoline | Galazolin® | 0.1% nasal gel, 10 ml | RK-LS-5№014398 |
5803 | R01AA07 | Xylometazoline | Tyzine® | 0.05% metered dose nasal spray,10 ml | RK-LS-5№020241 |
5804 | R01AA07 | Xylometazoline | Tyzine® | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№020240 |
5805 | R01AA07 | Xylometazoline | Rhinomaris®Advance | 0.05% metered dose nasal spray, 10 ml | RK-LS-5№024103 |
5806 | R01AA07 | Xylometazoline | Rhinomaris®Advance | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№024105 |
5807 | R01AA07 | Xylometazoline | Xymelin® Eco with menthol | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№024091 |
5808 | R01AA07 | Xylometazoline | Xymelin® Eco | 0.05% metered dose nasal spray, 10 ml | RK-LS-5№024092 |
5809 | R01AA07 | Xylometazoline | Xymelin® Eco | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№024093 |
5810 | R01AA07 | Xylometazoline | Eucazolin® Aqua | 1 mg/g nasal spray, 10 ml | RK-LS-5№013223 |
5811 | R01AA07 | Xylometazoline | Xylometazolin-Teva | 0.05% metered dose nasal spray, 10 ml | RK-LS-5№019108 |
5812 | R01AA07 | Xylometazoline | Xylometazolin-Teva | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№019109 |
5813 | R01AA07 | Xylometazoline | Nazaxil® | 0.05% nasal spray, 15 ml | RK-LS-5№015114 |
5814 | R01AA07 | Xylometazoline | Nazaxil® | 0.1% nasal spray, 15 ml | RK-LS-5№015115 |
5815 | R01AA07 | Xylometazoline | Otrisol-DF® | 0.1% nasal spray with an odour of menthol and eucalyptus, 10 ml | RK-LS-5№023198 |
5816 | R01AA07 | Xylometazoline | Doctor Theiss Rhinotheiss | 0.1% nasal spray, 10 ml | RK-LS-5№018495 |
5817 | R01AA07 | Xylometazoline | Otrivin | 0.1% metered dose nasal spray with an odour of menthol and eucalyptus, 10 ml | RK-LS-5№003831 |
5818 | R01AA07 | Xylometazoline | Otrisol-DF® | 0.05% nasal spray, 10 ml | RK-LS-3№020373 |
5819 | R01AA07 | Xylometazoline | Otrisol-DF® | 0.1% nasal spray, 10 ml | RK-LS-3№020374 |
5820 | R01AA07 | Xylometazoline | Snoop® | 0.05% nasal spray, 10 ml | RK-LS-5№018449 |
5821 | R01AA07 | Xylometazoline | Snoop® | 0.05% nasal spray, 15 ml | RK-LS-5№018449 |
5822 | R01AA07 | Xylometazoline | Snoop® | 0.1% nasal spray, 10 ml | RK-LS-5№018450 |
5823 | R01AA07 | Xylometazoline | Snoop® | 0.1% nasal spray, 15 ml | RK-LS-5№018450 |
5824 | R01AA07 | Xylometazoline | Rhinomaris® | 0.05% metered dose nasal spray, 10 ml | RK-LS-5№018660 |
5825 | R01AA07 | Xylometazoline | Rhinomaris® | 0.05% metered dose nasal spray, 15 ml | RK-LS-5№018660 |
5826 | R01AA07 | Xylometazoline | Rhinomaris® | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№018661 |
5827 | R01AA07 | Xylometazoline | Rhinomaris® | 0.1% metered dose nasal spray, 15 ml | RK-LS-5№018661 |
5828 | R01AA07 | Xylometazoline | Xymelin® | 0.1% nasal spray, 15 ml | RK-LS-5№004936 |
5829 | R01AA07 | Xylometazoline | Xymelin® | 0.05% nasal spray, 15 ml | RK-LS-5№004928 |
5830 | R01AA07 | Xylometazoline | Snoop® | 0.05% nasal spray, 15 ml | RK-LS-5№121853 |
5831 | R01AA07 | Xylometazoline | Snoop® | 0.1% nasal spray, 15 ml | RK-LS-5№121854 |
5832 | R01AA07 | Xylometazoline | Zolotaya zvezda spray | 0.1% nasal spray, 15 ml | RK-LS-5№015763 |
5833 | R01AA07 | Xylometazoline | TYZINE® BIO | 0.1% metered dose nasal spray, 10 ml | RK-LS-5№021454 |
5834 | R01AA07 | Xylometazoline | Pharmazolin® N | 1 mg/ml nasal spray, 15 ml | RK-LS-5№015731 |
R01AD | Corticosteroids | ||||
R01AD01 | Beclomethasone | ||||
5835 | R01AD01 | Beclomethasone | Nasobec | 50 mcg/dose metered dose intranasal spray, 25 g (200 doses) | RK-LS-5№004325 |
R01AD12 | Fluticasone furoate | ||||
5836 | R01AD12 | Fluticasone furoate | Avamys® | 27.5 mcg/dose metered dose nasal spray, 120 doses | RK-LS-5№013177 |
R01AC03 | Azelastinum | ||||
5837 | R01AC03 | Azelastinum | Allergodil® | 140 mcg/dose metered dose nasal spray, 10 ml | RK-LS-5№018990 |
R03 | Drugs for treating bronchial asthma | ||||
R03A | Inhaled sympathomimetics | ||||
R03AC | Selective beta-2 adrenergic agonists | ||||
R03AC02 | Salbutamolum | ||||
5838 | R03AC02 | Salbutamolum | Vertasort | 100 mcg/dose metered dose aerosol for inhalation, 200 doses | RK-LS-5№024316 |
5839 | R03AC02 | Salbutamolum | Salbutamol | 100 mcg/dose metered dose aerosol for inhalation, 200 doses (12 ml) | RK-LS-5№021286 |
5840 | R03AC02 | Salbutamolum | Ventolin® respirator solution® | 5 mg/ml nebuliser solution, 20 ml | RK-LS-5№006081 |
5841 | R03AC02 | Salbutamolum | Salbutamol | 100 mcg/dose metered dose aerosol for inhalation, 200 doses | RK-LS-5№000838 |
5842 | R03AC02 | Salbutamolum | Asthalin | 100 mcg/dose metered dose aerosol for inhalation, 200 doses | RK-LS-5№018791 |
5843 | R03AC02 | Salbutamolum | Salbutamol | 100 mcg/dose metered dose aerosol for inhalation, 200 doses | RK-LS-5№019225 |
5844 | R03AC02 | Salbutamolum | Ventolin® | 100 mcg/dose metered dose aerosol for inhalation, 200 doses | RK-LS-5№004652 |
R03AC18 | Indacaterolum | ||||
5845 | R03AC18 | Indacaterolum | Onbrez® Breezhaler® | 150 mcg inhalation powder, capsules | RK-LS-5№019852 |
5846 | R03AC18 | Indacaterolum | Onbrez® Breezhaler® | 300 mcg inhalation powder, capsules | RK-LS-5№019853 |
R03AC19 | Olodaterolum | ||||
5847 | R03AC19 | Olodaterolum | Striverdi® Respimat® | 2.5 mcg/inhalation solution for inhalation,4 ml | RK-LS-5№121771 |
R03AK | Sympathomimetics in combination with corticosteroids or other drugs, excluding anticholinergics | ||||
R03AK06 | Salmeterol and Fluticasone | ||||
5848 | R03AK06 | Salmeterol and Fluticasone | Asaris | 50 mcg/100 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№023781 |
5849 | R03AK06 | Salmeterol and Fluticasone | Tevacomb | 25/50 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№021533 |
5850 | R03AK06 | Salmeterol and Fluticasone | Tevacomb | 25/125 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№021534 |
5851 | R03AK06 | Salmeterol and Fluticasone | Tevacomb | 25/250 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№021535 |
5852 | R03AK06 | Salmeterol and Fluticasone | Asaris | 50 mcg/500 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№023783 |
5853 | R03AK06 | Salmeterol and Fluticasone | Pefsal | 25 mcg, 50 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№023354 |
5854 | R03AK06 | Salmeterol and Fluticasone | Pefsal | 25 mcg, 125 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№023355 |
5855 | R03AK06 | Salmeterol and Fluticasone | Pefsal | 25 mcg, 250 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№023356 |
5856 | R03AK06 | Salmeterol and Fluticasone | Seroflo 50 | 25/50 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№023640 |
5857 | R03AK06 | Salmeterol and Fluticasone | Seroflo 125 | 25/125 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№023641 |
5858 | R03AK06 | Salmeterol and Fluticasone | Seroflo 250 | 25/250 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№023642 |
5859 | R03AK06 | Salmeterol and Fluticasone | Sirdupla | 25 mcg/250 mcg metered dose aerosol for inhalation | RK-LS-5№024104 |
5860 | R03AK06 | Salmeterol and Fluticasone | Sirdupla | 25 mcg/125 mcg metered dose aerosol for inhalation | RK-LS-5№024106 |
5861 | R03AK06 | Salmeterol and Fluticasone | Seretide ™ Evohaler ™ | 25/250 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№005356 |
5862 | R03AK06 | Salmeterol and Fluticasone | Seretide ™ Evohaler ™ | 25/50 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№005355 |
5863 | R03AK06 | Salmeterol and Fluticasone | Airtac | 25 mcg+250 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№021051 |
5864 | R03AK06 | Salmeterol and Fluticasone | Saltrol | 25/250 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№023484 |
5865 | R03AK06 | Salmeterol and Fluticasone | Seretide ™ Multidisc™ | 50 mcg/500 mcg powder for inhalation, 60 doses | RK-LS-5№003892 |
5866 | R03AK06 | Salmeterol and Fluticasone | AirFluSal® Forspiro® | 50 mcg/500 mcg metered dose powder for inhalation, 12.5 mg of the drug (1 dose) | RK-LS-5№021590 |
5867 | R03AK06 | Salmeterol and Fluticasone | Salmerix | 50 mcg/500 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№022953 |
5868 | R03AK06 | Salmeterol and Fluticasone | Flusalio | 50 mcg/500 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№023369 |
5869 | R03AK06 | Salmeterol and Fluticasone | AirFluSal® Forspiro® | 50/250 mcg metered dose powder for inhalation, 12.5 mg of the drug (1 dose) | RK-LS-5№021589 |
5870 | R03AK06 | Salmeterol and Fluticasone | Seretide ™ Multidisc™ | 50 mcg/250 mcg powder for inhalation, 60 doses | RK-LS-5№003891 |
5871 | R03AK06 | Salmeterol and Fluticasone | Salmerix | 50 mcg/250 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№022952 |
5872 | R03AK06 | Salmeterol and Fluticasone | FLUTIAIR-S 250 | powder for inhalation in capsules and inhaler | RK-LS-5№020554 |
5873 | R03AK06 | Salmeterol and Fluticasone | Flusalio | 250/50 mcg metered dose powder for inhalation | RK-LS-5№023368 |
5874 | R03AK06 | Salmeterol and Fluticasone | Seretide ™ Evohaler ™ | 25/125mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№005357 |
5875 | R03AK06 | Salmeterol and Fluticasone | Airtac | 25 mcg+125 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№021052 |
5876 | R03AK06 | Salmeterol and Fluticasone | Saltrol | 25/125 mcg metered dose aerosol for inhalation, 120 doses | RK-LS-5№023485 |
5877 | R03AK06 | Salmeterol and Fluticasone | Seretide ™ Multidisc™ | 50 mcg/100 mcg powder for inhalation, 60 doses | RK-LS-5№003890 |
5878 | R03AK06 | Salmeterol and Fluticasone | Salmerix | 50 mcg/100 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№022951 |
5879 | R03AK06 | Salmeterol and Fluticasone |
Flusalio | 50 mcg/100 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№023367 |
5880 | R03AK06 | Salmeterol and Fluticasone | Airtac | 25mcg+50mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№021053 |
5881 | R03AK06 | Salmeterol and Fluticasone | Asaris | 50 mcg/250 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№023782 |
5882 | R03AK06 | Salmeterol and Fluticasone | Proair Bronchial | 250 mcg/50 mcg hard capsules with inhalation powder and inhaler | RK-LS-5№022476 |
5883 | R03AK06 | Salmeterol and Fluticasone | Proair Bronchial | 250 mcg/50 mcg hard capsules with inhalation powder and inhaler | RK-LS-5№022477 |
R03AK07 | Formoterol and Budesonide | ||||
5884 | R03AK07 | Formoterol and Budesonide | Airbufo ™ Forspiro® | 160mcg/4.5mcg/dose metered dose powder for inhalation | RK-LS-5№024336 |
5885 | R03AK07 | Formoterol and Budesonide | Symbicort® Turbuhaler® | 160/4.5mcg/dose powder for inhalation, 120 doses | RK-LS-5№011414 |
5886 | R03AK07 | Formoterol and Budesonide | DuoResp Spiromax | 160 mcg/4.5 mcg metered dose powder for inhalation, 120 doses | RK-LS-5№023571 |
5887 | R03AK07 | Formoterol and Budesonide | Bufomix Easyhailer | 160/4.5 mcg powder for inhalation, 120 doses | RK-LS-5№022199 |
5888 | R03AK07 | Formoterol and Budesonide | Bufomix Easyhailer | 160/4.5 mcg powder for inhalation, 60 doses | RK-LS-5№022199 |
5889 | R03AK07 | Formoterol and Budesonide | DuoResp Spiromax | 320 mcg/9 mcg metered dose powder for inhalation | RK-LS-5№023572 |
5890 | R03AK07 | Formoterol and Budesonide | Symbicort® Turbuhaler® | 320/9 mcg/dose metered dose powder for inhalation, 60 doses | RK-LS-5№018526 |
5891 | R03AK07 | Formoterol and Budesonide | Symbicort® Turbuhaler® | 80/4.5 mcg/dose metered dose powder for inhalation, 120 doses | RK-LS-5№011413 |
5892 | R03AK07 | Formoterol and Budesonide | Symbicort® Turbuhaler® | 160/4.5 mcg/dose metered dose powder for inhalation, 60 doses | RK-LS-5№011412 |
5893 | R03AK07 | Formoterol and Budesonide | Symbicort® Turbuhaler® | 80/4.5 mcg/dose metered dose powder for inhalation, 60 doses | RK-LS-5№011411 |
5894 | R03AK07 | Formoterol and Budesonide | Bufomix Easyhailer | 160/4.5 mcg powder for inhalation, 60 doses | RK-LS-5№022199 |
5895 | R03AK07 | Formoterol and Budesonide | Bufomix Easyhailer | 160/4.5 mcg metered dose powder for inhalation, 120 doses | RK-LS-5№022199 |
5896 | R03AK07 | Formoterol and Budesonide | Formisonide | 80 mcg/4.5 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№024141 |
5897 | R03AK07 | Formoterol and Budesonide | Formisonide | 80 mcg/4.5 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№024141 |
5898 | R03AK07 | Formoterol and Budesonide | Formisonide | 80 mcg/4.5 mcg metered dose powder for inhalation,120 doses | RK-LS-5№024141 |
5899 | R03AK07 | Formoterol and Budesonide | Formisonide | 320 mcg/9 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№024139 |
5900 | R03AK07 | Formoterol and Budesonide | Formisonide | 320 mcg/9 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№024139 |
5901 | R03AK07 | Formoterol and Budesonide | Formisonide | 320 mcg/9 mcg metered dose powder for inhalation, 120 doses | RK-LS-5№024139 |
5902 | R03AK07 | Formoterol and Budesonide | Flusort F | 12 mcg+250 mcg/dose powder for inhalation in capsules, 30 doses | RK-LS-5№122155 |
5903 | R03AK07 | Formoterol and Budesonide | Sinecort | 200 mcg+6 mcg metered dose aerosol for inhalation,120 doses | RK-LS-5№023628 |
5904 | R03AK07 | Formoterol and Budesonide | Formisonide | 160 mcg/4.5 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№024140 |
5905 | R03AK07 | Formoterol and Budesonide | Formisonide | 160 mcg/4.5 mcg metered dose powder for inhalation, 60 doses | RK-LS-5№024140 |
5906 | R03AK07 | Formoterol and Budesonide | Formisonide | 160 mcg/4.5 mcg metered dose powder for inhalation, 120 doses | RK-LS-5№024140 |
5907 | R03AK07 | Formoterol and Budesonide | Symbicort ™ Rapihaler | 160/4.5 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№023871 |
5908 | R03AK07 | Formoterol and Budesonide | Symbicort ™ Rapihaler | 80/4.5 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№023870 |
R03AK08 | Beclomethasone dipropionate and formoterol fumarate | ||||
5909 | R03AK08 | Beclomethasone dipropionate and formoterol fumarate | Foster® | 100mcg/6mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№023940 |
R03AK10 | Vilanterol and Fluticasone furoate | ||||
5910 | R03AK10 | Vilanterol and Fluticasone furoate | Relvar® Ellipta® | 184mcg/22 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№021462 |
5911 | R03AK10 | Vilanterol and Fluticasone furoate | Relvar® Ellipta® | 92mcg/22 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№021461 |
R03AL | Sympathomimetics in combination with anticholinergics, including triple combinations with corticosteroids | ||||
R03AL01 | Fenoterol and Ipratropium bromide | ||||
5912 | R03AL01 | Fenoterol and Ipratropium bromide | Berodual® | 500 mcg/250 mcg/ml inhalation solution, 20 ml | RK-LS-5№014273 |
5913 | R03AL01 | Fenoterol and Ipratropium bromide | Berodual® N | 10 ml metered dose aerosol for inhalation, 200 doses | RK-LS-5№010908 |
R03AL03 | Vilanterol and Umeclidinium bromide | ||||
5914 | R03AL03 | Vilanterol and Umeclidinium bromide | ANORO®ELLIPTA® | 22mcg/55 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№021600 |
R03AL04 | Indacaterol maleate and Glycopyrronium bromide | ||||
5915 | R03AL04 | Indacaterol maleate and Glycopyrronium bromide | Ultibro ™ Breezhaler® | 110/50mcg powder for inhalation in capsules | RK-LS-5№121800 |
R03AL05 | Formoterol and Aclidinium bromide | ||||
5916 | R03AL05 | Formoterol and Aclidinium bromide | Brimica® Genuair® | 340mcg/12mg powder for inhalation | RK-LS-5№022789 |
R03АL06 | Olodaterol and Tiotropium bromide | ||||
5917 | R03АL06 | Olodaterol and Tiotropium bromide | Spiolto® Respimat® | 2.5 mcg+2.5 mcg/1 inhalation solution for inhalation and Respimat® inhaler, 4 ml | RK-LS-5№022545 |
R03B | Other inhaled medications for treating bronchial asthma | ||||
R03BA | Glucocorticoids | ||||
R03BA01 | Beclomethasone | ||||
5918 | R03BA01 | Beclomethasone | Beclazone Eco Easy Breath | 250 mcg/dose metered dose breath-activated aerosol for inhalation, 200 doses | RK-LS-5№019759 |
5919 | R03BA01 | Beclomethasone | Beclazone Eco Easy Breath | 100 mcg/dose metered dose breath-activated aerosol for inhalation, 200 doses | RK-LS-5№019758 |
R03BA02 | Budesonidum | ||||
5920 | R03BA02 | Budesonidum | Busonid | 200 mcg/dose metered dose aerosol for inhalation, 300 doses | RK-LS-5№021143 |
5921 | R03BA02 | Budesonidum | Budesonide | 200 mcg metered dose aerosol for inhalation | RK-LS-5№023169 |
5922 | R03BA02 | Budesonidum | Pulmicort® | 0.25 mg/ml metered dose inhalation suspension | RK-LS-5№017365 |
5923 | R03BA02 | Budesonidum | Pulmicort® | 0.5 mg/ml metered dose inhalation suspension | RK-LS-5№017366 |
5924 | R03BA02 | Budesonidum | Cortiment |
9 mg sustained-release tablets | RK-LS-5№023278 |
R03BA05 | Fluticasonum | ||||
5925 | R03BA05 | Fluticasonum | Flixotide ™ 250 | 250 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№004663 |
5926 | R03BA05 | Fluticasonum | Flixotide ™ 125 | 125 mcg/dose metered dose aerosol for inhalation, 60 doses | RK-LS-5№004664 |
5927 | R03BA05 | Fluticasonum | Flixotide ™ 50 | 50 mcg/dose metered dose aerosol for inhalation, 120 doses | RK-LS-5№010057 |
R03BA07 | Mometasonum | ||||
5928 | R03BA07 | Mometasonum | Nasonex® | 50mcg/dose metered dose nasal spray, 18 g (140 doses) | RK-LS-5№014790 |
5929 | R03BA07 | Mometasonum | Nasonex® | 50mcg/dose metered dose nasal spray, 10 g (60 doses) | RK-LS-5№014790 |
5930 | R03BA07 | Mometasonum | Asmanex® | 200 mcg/dose powder for inhalation | RK-LS-5№019961 |
5931 | R03BA07 | Mometasonum | Asmanex® | 400 mcg/dose powder for inhalation | RK-LS-5№019962 |
R03BA08 | Cyclesonidum | ||||
5932 | R03BA08 | Cyclesonidum | Alvesco® | 160 mcg metered dose aerosol for inhalation, 5 ml | RK-LS-5№021018 |
5933 | R03BA08 | Cyclesonidum | Alvesco® | 80 mcg metered dose aerosol for inhalation, 5 ml | RK-LS-5№021017 |
R03BB | Cholinergic antagonists | ||||
R03BB01 | Ipratropium bromide | ||||
5934 | R03BB01 | Ipratropium bromide | Iprosan | 20 mcg/dose metered dose aerosol for inhalation, 10 ml | RK-LS-5№023185 |
5935 | R03BB01 | Ipratropium bromide | Atrodil® | 20 mcg/dose metered dose aerosol for inhalation, 10 ml | RK-LS-5№023185 |
R03BB04 | Tiotropium bromide | ||||
5936 | R03BB04 | Tiotropium bromide | Spiriva® Respimat® | 2.5mcg/inhalation solution for inhalation and Respimat® inhaler, 4 ml | RK-LS-5№014869 |
5937 | R03BB04 | Tiotropium bromide | Spiriva® | 18 mcg capsules with powder for inhalation and HandiHaler® inhaler | RK-LS-5№010034 |
5938 | R03BB04 | Tiotropium bromide | Tevatropium | 13 mcg capsules with powder for inhalation and inhaler | RK-LS-5№023767 |
5939 | R03BB04 | Tiotropium bromide | Srivasso® | 18 mcg capsules with powder for inhalation and HandiHaler® inhaler | RK-LS-5№024283 |
R03BB05 | Aclidinium bromide | ||||
5940 | R03BB05 | Aclidinium bromide | Bretaris® Genuair® | 322 mcg/dose powder for inhalation | RK-LS-5№021283 |
5941 | R03BB05 | Aclidinium bromide | Bretaris® Genuair® | powder for inhalation, 60 doses | RK-LS-5№021282 |
R03BB06 | Glycopyrronium bromide | ||||
5942 | R03BB06 | Glycopyrronium bromide | Seebri® Breezhaler® | 50 mcg powder for inhalation in capsules | RK-LS-5№021604 |
R03BB07 | Umeclidinium bromide | ||||
5943 | R03BB07 | Umeclidinium bromide | Incruse® Ellipta® | 55 mcg metered dose powder for inhalation, 30 doses | RK-LS-5№121756 |
R03D | Other drugs for systemic use to treat bronchial asthma | ||||
R03DA | Xanthine derivatives | ||||
R03DA04 | Theophyllinum | ||||
5944 | R03DA04 | Theophyllinum | Theotard | 350 mg modified-release capsules | RK-LS-5№021487 |
5945 | R03DA04 | Theophyllinum | Theotard | 200 mg modified-release capsules | RK-LS-5№021486 |
5946 | R03DA04 | Theophyllinum | Theophyl® CP 300 | 300 mg modified-release capsules | RK-LS-5№009964 |
5947 | R03DA04 | Theophyllinum | Theophyl ® СР 100 | 100 mg modified-release capsules | RK-LS-5№005568 |
5948 | R03DA04 | Theophyllinum | Theophyl ® СР 200 | 200 mg modified-release capsules | RK-LS-5№009963 |
R03DA05 | Aminophyllinum | ||||
5949 | R03DA05 | Aminophyllinum | Euphyllin | 24 mg/ml intravenous solution, 5 ml | RK-LS-5№019836 |
5950 | R03DA05 | Aminophyllinum | Euphyllin | 150 mg tablets | RK-LS-5№019292 |
5951 | R03DA05 | Aminophyllinum | Euphyllin | 0.15g tablets | RK-LS-5№019359 |
5952 | R03DA05 | Aminophyllinum | Euphyllin | 150 mg tablets | RK-LS-5№015553 |
5953 | R03DA05 | Aminophyllinum | Euphyllin | 24 mg/ml intravenous solution, 5 ml | RK-LS-5№018340 |
5954 | R03DA05 | Aminophyllinum | Euphyllin | 2.4% solution for injection, 5 ml | RK-LS-5№000096 |
5955 | R03DA05 | Aminophyllinum | Euphyllin | 150 mg tablets | RK-LS-5№000126 |
R03DC | Leukotriene receptor antagonists | ||||
R03DC03 | Montelukastum | ||||
5956 | R03DC03 | Montelukastum | Asmenol | 5 mg chewable tablets | RK-LS-5№018861 |
5957 | R03DC03 | Montelukastum | Asmenol | 10 mg film-coated tablets | RK-LS-5№018869 |
5958 | R03DC03 | Montelukastum | Airolucast® | 10 mg film-coated tablets | RK-LS-5№005672 |
5959 | R03DC03 | Montelukastum | Asmenol | 4 ml chewable tablets | RK-LS-5№018860 |
5960 | R03DC03 | Montelukastum | Airolucast® | 4 mg chewable tablets | RK-LS-5№005671 |
5961 | R03DC03 | Montelukastum | Glemont | 10 mg film-coated tablets | RK-LS-5№021204 |
5962 | R03DC03 | Montelukastum | Glemont chewable tablets | 4 mg chewable tablets | RK-LS-5№021515 |
5963 | R03DC03 | Montelukastum | Glemont chewable tablets | 5 mg chewable tablets | RK-LS-5№021516 |
5964 | R03DC03 | Montelukastum | M-KAST | 4 mg chewable tablets | RK-LS-5№121867 |
5965 | R03DC03 | Montelukastum | M-KAST | 5 mg chewable tablets | RK-LS-5№121868 |
5966 | R03DC03 | Montelukastum | Diffalon | 4 mg chewable tablets | RK-LS-5№122001 |
5967 | R03DC03 | Montelukastum | Diffalon | 10 mg film-coated tablets | RK-LS-5№121993 |
5968 | R03DC03 | Montelukastum | NOTTA-sanovel | 4 mg chewable tablets | RK-LS-5№016767 |
5969 | R03DC03 | Montelukastum | NOTTA-sanovel | 10 mg film-coated tablets | RK-LS-5№016768 |
5970 | R03DC03 | Montelukastum | NOTTA-sanovel | 5 mg chewable tablets | RK-LS-5№016772 |
5971 | R03DC03 | Montelukastum | Montid | 10 mg film-coated tablets | RK-LS-5№122152 |
5972 | R03DC03 | Montelukastum | Montemac | 4 mg chewable tablets | RK-LS-5№022167 |
5973 | R03DC03 | Montelukastum | Montemac | 5 mg chewable tablets | RK-LS-5№022168 |
5974 | R03DC03 | Montelukastum | Montid | 4 mg chewable tablets | RK-LS-5№022294 |
5975 | R03DC03 | Montelukastum | Montid | 5 mg chewable tablets | RK-LS-5№022295 |
5976 | R03DC03 | Montelukastum | Monler | 10 mg film-coated tablets | RK-LS-5№022436 |
5977 | R03DC03 | Montelukastum | Monkasta® | 10 mg film-coated tablets | RK-LS-5№022661 |
5978 | R03DC03 | Montelukastum | Monkasta® | 5 mg chewable tablets | RK-LS-5№022662 |
5979 | R03DC03 | Montelukastum | Monkasta® | 4 mg chewable tablets | RK-LS-5№022663 |
5980 | R03DC03 | Montelukastum | Montemac 10 | 10 mg film-coated tablets | RK-LS-5№022689 |
5981 | R03DC03 | Montelukastum | Airolucast® | 5 mg chewable tablets | RK-LS-5№005688 |
5982 | R03DC03 | Montelukastum | Almont 10 | 10 mg film-coated tablets | RK-LS-5№023673 |
5983 | R03DC03 | Montelukastum | MONLER | 5 mg chewable tablets | RK-LS-5№023804 |
5984 | R03DC03 | Montelukastum | MONLER | 4 mg chewable tablets | RK-LS-5№023805 |
5985 | R03DC03 | Montelukastum | Culento | 4 mg oral granules for children | RK-LS-5№023976 |
5986 | R03DC03 | Montelukastum | MONTUM | 10 mg film-coated tablets | RK-LS-5№024010 |
5987 | R03DC03 | Montelukastum | Montelukast | 4 mg chewable tablets | RK-LS-5№024129 |
5988 | R03DC03 | Montelukastum | Montelukast | 5 mg chewable tablets | RK-LS-5№024130 |
5989 | R03DC03 | Montelukastum | Montelukast | 10 mg film-coated tablets | RK-LS-5№024131 |
5990 | R03DC03 | Montelukastum | Breathezy | 5 mg chewable tablets | RK-LS-5№020777 |
5991 | R03DC03 | Montelukastum | Myteka | 10 mg coated tablets | RK-LS-5№013043 |
5992 | R03DC03 | Montelukastum | Clast® 10 | 10 mg film-coated tablets | RK-LS-5№019252 |
5993 | R03DC03 | Montelukastum | Clast® 10 | 10 mg chewable tablets | RK-LS-3№019643 |
5994 | R03DC03 | Montelukastum | Montiget | 10 mg film-coated tablets | RK-LS-5№013933 |
5995 | R03DC03 | Montelukastum | Divlaksin | 10 mg film-coated tablets | RK-LS-5№022655 |
5996 | R03DC03 | Montelukastum | Myteka | 5 mg coated tablets | RK-LS-5№013045 |
5997 | R03DC03 | Montelukastum | Clast® 5 | 5 mg chewable tablets | RK-LS-3№019642 |
5998 | R03DC03 | Montelukastum | CLAST® 5 | 5 mg film-coated tablets | RK-LS-5№019251 |
5999 | R03DC03 | Montelukastum | Montiget | 5 mg chewable tablets | RK-LS-5№017688 |
6000 | R03DC03 | Montelukastum | Divlaksin | 5 mg chewable tablets | RK-LS-5№022657 |
6001 | R03DC03 | Montelukastum | Myteka | 4 mg chewable tablets | RK-LS-5№013044 |
6002 | R03DC03 | Montelukastum | Montiget | 4 mg granules | RK-LS-5№017721 |
6003 | R03DC03 | Montelukastum | Montiget | 4 mg chewable tablets | RK-LS-5№017689 |
6004 | R03DC03 | Montelukastum | Breathezy | 4 mg chewable tablets | RK-LS-5№020776 |
6005 | R03DC03 | Montelukastum | Clast® 4 | 4 mg chewable tablets | RK-LS-3№019641 |
6006 | R03DC03 | Montelukastum | Divlaksin | 4 mg chewable tablets | RK-LS-5№022656 |
R03DX | Other drugs for systemic use to treat bronchial asthma | ||||
R03DX05 | Omalizumabum | ||||
6007 | R03DX05 | Omalizumabum | Xolair® | 150 mg powder for solution for injection and solvent | RK-LS-5№121775 |
R03DX07 | Roflumilast | ||||
6008 | R03DX07 | Roflumilast | Rofilas | 0.5mg tablets | RK-LS-5№022751 |
6009 | R03DX07 | Roflumilast | Daxas | 0.,5 mg film-coated tablets | RK-LS-5№017931 |
R05 | Cough and cold drugs | ||||
R05C | Expectorants, excluding combinations with antitussives | ||||
R05CB | Mucolytics | ||||
R05CB01 | Acetylcysteinum | orphan drug | |||
6010 | R05CB01 | Acetylcysteinum | Fluimucil | 20 mg/ml oral solution, 100 ml | RK-LS-5№020416 |
6011 | R05CB01 | Acetylcysteinum | Fluimucil | 20 mg/ml oral solution, 200 ml | RK-LS-5№020416 |
6012 | R05CB01 | Acetylcysteinum | Fluimucil | 40 mg/ml oral solution, 200 ml | RK-LS-5№020417 |
6013 | R05CB01 | Acetylcysteinum | ACC® Active | 600 mg oral powder | RK-LS-5№024042 |
6014 | R05CB01 | Acetylcysteinum | ACC® junior | 20 mg/ml oral solution, 100 ml | RK-LS-5№121847 |
6015 | R05CB01 | Acetylcysteinum | ACC® | 20 mg/ml oral solution, 200 ml | RK-LS-5№121848 |
6016 | R05CB01 | Acetylcysteinum | ACC® 200 | 200 mg powder for oral solution, 3 g | RK-LS-5№012523 |
6017 | R05CB01 | Acetylcysteinum | AC Teva | 200 mg granules for oral solution | RK-LS-5№015780 |
6018 | R05CB01 | Acetylcysteinum | ACC® 600 | 600 mg effervescent tablets | RK-LS-5№012367 |
6019 | R05CB01 | Acetylcysteinum | Acetylcysteine | 100 mg powder for oral solution | RK-LS-5№121746 |
6020 | R05CB01 | Acetylcysteinum | Acetylcysteine | 200 mg powder for oral solution | RK-LS-5№121747 |
6021 | R05CB01 | Acetylcysteinum | AC Teva | 600 mg effervescent tablets | RK-LS-5№019101 |
6022 | R05CB01 | Acetylcysteinum | TRACTUS | 600 mg powder for oral solution | RK-LS-5№023469 |
6023 | R05CB01 | Acetylcysteinum | ACC® Hot Drink | 600 mg powder for oral solution | RK-LS-5№020785 |
6024 | R05CB01 | Acetylcysteinum | Fluimucil | solution for injection and infusion, 100 mg/ml | RK-LS-5№018165 |
6025 | R05CB01 | Acetylcysteinum | ACC® 200 | 200 mg effervescent tablets | RK-LS-5№024121 |
6026 | R05CB01 | Acetylcysteinum | Acetylcysteine Viva Pharm | 200 mg powder for oral solution | RK-LS-5№024132 |
6027 | R05CB01 | Acetylcysteinum | Acetylcysteine Viva Pharm | 600 mg powder for oral solution | RK-LS-5№024133 |
6028 | R05CB01 | Acetylcysteinum | ACC® 600 | 600 mg effervescent tablets | RK-LS-5№021302 |
6029 | R05CB01 | Acetylcysteinum | Fluimucil | 600 mg effervescent tablets | RK-LS-5№016795 |
6030 | R05CB01 | Acetylcysteinum | ACC® 100 | 100 mg effervescent tablets | RK-LS-5№021482 |
6031 | R05CB01 | Acetylcysteinum | ACC® 200 | 200 mg effervescent tablets | RK-LS-5№021483 |
6032 | R05CB01 | Acetylcysteinum | Fluimucil | 200 mg granules for oral solution | RK-LS-5№014693 |
6033 | R05CB01 | Acetylcysteinum |
Asibrox | 600 mg effervescent tablets | RK-LS-5№020342 |
6034 | R05CB01 | Acetylcysteinum | Asibrox | 200 mg effervescent tablets | RK-LS-5№020341 |
R05CB03 | Carbocisteinum | ||||
6035 | R05CB03 | Carbocisteinum | Mucosol | 375 mg capsules | RK-LS-5№011519 |
6036 | R05CB03 | Carbocisteinum |
Fluditec | 5 % syrup | RK-LS-5№014412 |
6037 | R05CB03 | Carbocisteinum | Mucosol | Syrup, 120 ml | RK-LS-5№011518 |
6038 | R05CB03 | Carbocisteinum | Mucosol | Syrup for children, 120 ml | RK-LS-5№011517 |
R05CB06 | Ambroxolum | ||||
6039 | R05CB06 | Ambroxolum | BRONCHORUS | 3 mg/ml syrup | RK-LS-5№013687 |
6040 | R05CB06 | Ambroxolum | Lasolvan® MAX | 75 mg sustained-release capsules | RK-LS-5№020767 |
6041 | R05CB06 | Ambroxolum | Ambrobene 75 mg | 75 mg retard capsules | RK-LS-5№013173 |
6042 | R05CB06 | Ambroxolum | Flavamed® cough solution for children | 15 mg/5 ml oral solution | RK-LS-5№005753 |
6043 | R05CB06 | Ambroxolum | Ambrobene® | 30 mg tablets | RK-LS-5№004013 |
6044 | R05CB06 | Ambroxolum | Flavamed® Forte | 60 mg effervescent tablets | RK-LS-5№017738 |
6045 | R05CB06 | Ambroxolum | Bronchobru Muco | 6 mg/1 ml syrup | RK-LS-5№122105 |
6046 | R05CB06 | Ambroxolum | Ambrobene | 7.5 mg/ml solution in a bottle, 40 ml | RK-LS-5№004023 |
6047 | R05CB06 | Ambroxolum | Ambro® | 7.5 mg/ml oral and inhalation solution in a bottle, 40 ml | RK-LS-5№020013 |
6048 | R05CB06 | Ambroxolum | Lasolvan | 15mg/2ml oral and inhalation solution in a bottle | RK-LS-5№016719 |
6049 | R05CB06 | Ambroxolum | Ambrobene® | 7.5mg/ml solution in a bottle, 100ml | RK-LS-5№004023 |
6050 | R05CB06 | Ambroxolum | Ambrobene ® | 7.5mg/ml solution in a bottle, 40ml | RK-LS-5№004023 |
6051 | R05CB06 | Ambroxolum | Ambrobene | solution for injection, 15 mg/2 ml | RK-LS-5№004010 |
6052 | R05CB06 | Ambroxolum | SEKRAZOL® | 30 mg/5 ml syrup, 150 ml | RK-LS-5№016348 |
6053 | R05CB06 | Ambroxolum |
Lasolex | 7.5 mg/ml solution for injection | RK-LS-5№021434 |
6054 | R05CB06 | Ambroxolum | Ambroxol | 30 mg tablets | RK-LS-5№003443 |
6055 | R05CB06 | Ambroxolum | Mukex | 30 mg tablets | RK-LS-5№016301 |
6056 | R05CB06 | Ambroxolum | Ambro® | 30mg/5ml syrup, 100ml | RK-LS-5№010433 |
6057 | R05CB06 | Ambroxolum | Ambrosan® | 15mg/5ml syrup, 100ml | RK-LS-5№010434 |
6058 | R05CB06 | Ambroxolum | Ambrosan® | 30 mg tablets | RK-LS-5№003302 |
6059 | R05CB06 | Ambroxolum | Lasolvan® | 30 mg tablets | RK-LS-5№005022 |
6060 | R05CB06 | Ambroxolum | Ambrobene® | 15 mg/5 ml syrup, 100 ml | RK-LS-5№004012 |
6061 | R05CB06 | Ambroxolum | Ambrobene® | 60 mg tablets | RK-LS-5№018607 |
6062 | R05CB06 | Ambroxolum | Bronolac | 30 mg/5 ml syrup, 100 ml | RK-LS-5№022750 |
6063 | R05CB06 | Ambroxolum | Bronolac | 30 mg/5 ml syrup, 200 ml | RK-LS-5№022750 |
6064 | R05CB06 | Ambroxolum | Ambrosol | 30 mg/5 ml syrup, 100 ml | RK-LS-5№018109 |
6065 | R05CB06 | Ambroxolum | Flavamed® | 30 mg tablets | RK-LS-5№005727 |
6066 | R05CB06 | Ambroxolum | Halixol® | 3 mg/ml syrup, 100 ml | RK-LS-5№012392 |
6067 | R05CB06 | Ambroxolum | Halixol® | 30 mg tablets | RK-LS-5№011783 |
6068 | R05CB06 | Ambroxolum | Ambro® | 30 mg tablets | RK-LS-5№011598 |
6069 | R05CB06 | Ambroxolum | Ambrolytin® | 15 mg/5 ml syrup, 100 ml | RK-LS-5№005513 |
6070 | R05CB06 | Ambroxolum | Lasolvan® junior | 15 mg/5 ml syrup, 100 ml | RK-LS-5№014082 |
6071 | R05CB06 | Ambroxolum | Lasolvan® | 30 mg/5ml syrup, 100 ml | RK-LS-5№014083 |
6072 | R05CB06 | Ambroxolum | Ambroxol | 30 mg tablets | RK-LS-5№004949 |
6073 | R05CB06 | Ambroxolum | BRONCHORUS | 30 mg tablets | RK-LS-5№018643 |
6074 | R05CB06 | Ambroxolum | Ambro® | 7.5 mg/ml oral and inhalation solution in a bottle, 100 ml | RK-LS-5№020013 |
6075 | R05CB06 | Ambroxolum | Ambro® | 7.5 mg/ml oral and inhalation solution in a bottle, 40 ml | RK-LS-5№020013 |
6076 | R05CB06 | Ambroxolum | SEKRAZOL® FOR CHILDREN | 15 mg/5 ml syrup, 100 ml | RK-LS-5№016349 |
6077 | R05CB06 | Ambroxolum | Ambro | solution for injection, 15 mg/2 ml 2 ml | RK-LS-5№010604 |
6078 | R05CB06 | Ambroxolum | Lasolvan® MAX | 75 mg sustained-release capsules | RK-LS-5№020767 |
6079 | R05CB06 | Ambroxolum | Solfran® | 30 mg tablets | RK-LS-5№015824 |
6080 | R05CB06 | Ambroxolum | Sekrazol® | 30 mg tablets | RK-LS-5№018929 |
6081 | R05CB06 | Ambroxolum | Ambroxol hydrochloride | 30 mg tablets | RK-LS-5№010028 |
6082 | R05CB06 | Ambroxolum | Ambroxol 30 | 30 mg/5 ml syrup, 100 ml | RK-LS-5№023791 |
6083 | R05CB06 | Ambroxolum | Ambroxol 15 | 15 mg/5 ml syrup | RK-LS-5№023437 |
6084 | R05CB06 | Ambroxolum | Bronolac | 30 mg tablets | RK-LS-5№018507 |
6085 | R05CB06 | Ambroxolum | Bronolac | 15 mg/5 ml syrup, 100 ml | RK-LS-5№022749 |
6086 | R05CB06 | Ambroxolum | Bronolac | 15 mg/5 ml syrup, 200 ml | RK-LS-5№022749 |
6087 | R05CB06 | Ambroxolum | Lasolvan® | 15 mg pastilles | RK-LS-5№014104 |
6088 | R05CB06 | Ambroxolum | Ambrosan® | 50 ml oral drops | RK-LS-5№014902 |
6089 | R05CB06 | Ambroxolum | Ambrosan® | 100 ml oral drops | RK-LS-5№014903 |
6090 | R05CB06 | Ambroxolum | Flavamed®Max 30 mg/5 ml cough solution | 30 mg/5 ml oral solution, 100 ml | RK-LS-5№021022 |
R05CB13 | Dornase alfa | orphan drug | |||
6091 | R05CB13 | Dornase alfa | Pulmozyme | 1 mg/ml inhalation solution, 2.5 ml | orphan drug |
6092 | R05CB13 | Dornase alfa | Tigeraza | 2.5 mg/2.5 ml inhalation solution | orphan drug |
R05CB15 | Erdosteinum | ||||
6093 | R05CB15 | Erdosteinum | Mucitus | 300 mg capsules | RK-LS-5№021005 |
6094 | R05CB15 | Erdosteinum | Mucitus | 150 mg capsules | RK-LS-5№021006 |
6095 | R05CB15 | Erdosteinum | Ermucin ® | 300 mg capsules | RK-LS-5№013529 |
6096 | R05CB15 | Erdosteinum | Ermucin | 175 mg/5 ml granules for oral suspension, 50 g | RK-LS-5№013171 |
R06 | Antihistamines for systemic use | ||||
R06AA | Aminoalkyl ethers | ||||
R06AA02 | Diphenhydraminum | ||||
6097 | R06AA02 | Diphenhydraminum | Dimedrol | 1% solution for injection, 1 ml | RK-LS-5№000964 |
6098 | R06AA02 | Diphenhydraminum | Dimedrol-Darnitsa | 50 mg tablets | RK-LS-5№015098 |
6099 | R06AA02 | Diphenhydraminum | Dimedrol | 1% solution for injection, 1 ml | RK-LS-5№010372 |
6100 | R06AA02 | Diphenhydraminum | Dimedrol | 10 mg/ml solution for intravenous and intramuscular injection, 1 ml | RK-LS-5№022473 |
6101 | R06AA02 | Diphenhydraminum | Dermodrin | 100 ml oral solution | RK-LS-5№022658 |
R06AA04 | Clemastinum | ||||
6102 | R06AA04 | Clemastinum |
Tavegyl | 1 mg tablets | RK-LS-5№005090 |
R06AC | Substituted ethylenediamines | ||||
R06AC03 | Chloropyramine | ||||
6103 | R06AC03 | Chloropyramine | Suprastin® | 25 mg tablets | RK-LS-5№015728 |
6104 | R06AC03 | Chloropyramine | Suprastin® | 20 mg/ml solution for injection, 1 ml | RK-LS-5№015727 |
6105 | R06AC03 | Chloropyramine | Antigistin | 20 mg/ml solution for injection, 1 ml | RK-LS-5№021622 |
6106 | R06AC03 | Chloropyramine | Allergopress | 2% solution for injection, 1 ml | RK-LS-3№021453 |
6107 | R06AC03 | Chloropyramine | Allergosan® | 25 mg coated tablets | RK-LS-5№011297 |
R06AD | Phenothiazine derivatives | ||||
R06AD02 | Promethazinum | ||||
6108 | R06AD02 | Promethazinum | Pipolphen® | 25 mg/ml solution for injection, 2 ml | RK-LS-5№014671 |
R06AE | Piperazine derivatives | ||||
R06AE07 | Cetirizinum | ||||
6109 | R06AE07 | Cetirizinum | Zetrinal® | 10 mg film-coated tablets | RK-LS-5№012050 |
6110 | R06AE07 | Cetirizinum | Parlazin® | 10 mg coated tablets | RK-LS-5№014618 |
6111 | R06AE07 | Cetirizinum | Parlazin® | 10mg/ml oral drops, 20 ml | RK-LS-5№014619 |
6112 | R06AE07 | Cetirizinum | Cetrine® | 10mg/ml oral drops, 10 ml | RK-LS-5№121896 |
6113 | R06AE07 | Cetirizinum | Cetrine® | 10mg/ml oral drops, 20 ml | RK-LS-5№121896 |
6114 | R06AE07 | Cetirizinum | Terix | 10 mg coated tablets | RK-LS-5№121995 |
6115 | R06AE07 | Cetirizinum | Cetirizine | 10 mg/ml oral drops, 20 ml | RK-LS-5№023085 |
6116 | R06AE07 | Cetirizinum | Zyrtec® | 10 mg/ml oral drops, 10 ml | RK-LS-5№019492 |
6117 | R06AE07 | Cetirizinum | Cetrine® | 10 mg film-coated tablets | RK-LS-5№003698 |
6118 | R06AE07 | Cetirizinum | Zodac® | 10 mg coated tablets | RK-LS-5№019361 |
6119 | R06AE07 | Cetirizinum | Zyrtec® | 10 mg film-coated tablets | RK-LS-5№010523 |
6120 | R06AE07 | Cetirizinum | Rolinoz | 10 mg film-coated tablets | RK-LS-5№023593 |
6121 | R06AE07 | Cetirizinum | Cvetox | 1 mg/1 ml oral solution, 120 ml | RK-LS-5№021027 |
6122 | R06AE07 | Cetirizinum | Nosmin® | 10 mg coated tablets | RK-LS-5№004043 |
6123 | R06AE07 | Cetirizinum | Cvetox | 10 mg film-coated tablets | RK-LS-5№020863 |
6124 | R06AE07 | Cetirizinum | Rolinoz | 10 mg/ml oral drops, 20 ml | RK-LS-5№017858 |
6125 | R06AE07 | Cetirizinum | Zodac® | 10 mg/ml drops, 20 ml | RK-LS-5№004167 |
6126 | R06AE07 | Cetirizinum | Novex Cetirizine | Syrup, 60 ml | RK-LS-5№024094 |
6127 | R06AE07 | Cetirizinum | Zetrinal® | 5 mg/5 ml syrup, 100 ml | RK-LS-5№011928 |
6128 | R06AE07 | Cetirizinum | Zetrinal® | 5 mg/5 ml syrup, 200 ml | RK-LS-5№011928 |
6129 | R06AE07 | Cetirizinum | Terix | 5mg/5ml syrup, 100 ml | RK-LS-5№121996 |
R06AE09 | Levocetirizinum | ||||
6130 | R06AE09 | Levocetirizinum | Pollezin® | Oral drops, 20 ml | RK-LS-5№016542 |
6131 | R06AE09 | Levocetirizinum | Pollezin® | 5 mg coated tablets | RK-LS-5№016541 |
6132 | R06AE09 | Levocetirizinum | Xyzal | 5 mg/ml oral drops, 10 ml | RK-LS-5№014453 |
6133 | R06AE09 | Levocetirizinum | Xyzal | 5 mg film-coated tablets | RK-LS-5№014977 |
6134 | R06AE09 | Levocetirizinum | Contrahist allergy | 5 mg film-coated tablets | RK-LS-5№121809 |
6135 | R06AE09 | Levocetirizinum | Cesera® | 5 mg film-coated tablets | RK-LS-5№122032 |
6136 | R06AE09 | Levocetirizinum | Cetlo | 5 mg film-coated tablets | RK-LS-5№022808 |
6137 | R06AE09 | Levocetirizinum | Cetrimak | 5 mg film-coated tablets | RK-LS-5№022814 |
6138 | R06AE09 | Levocetirizinum | Allerway | 5 mg film-coated tablets | RK-LS-5№023168 |
6139 | R06AE09 | Levocetirizinum | Zodac® Express | 5 mg film-coated tablets | RK-LS-5№023460 |
6140 | R06AE09 | Levocetirizinum | Levosetil | 5 mg film-coated tablets | RK-LS-5№023582 |
6141 | R06AE09 | Levocetirizinum | Levarizin | 5 mg film-coated tablets | RK-LS-5№020430 |
6142 | R06AE09 | Levocetirizinum | L-Cet® | 5 mg film-coated tablets | RK-LS-5№015743 |
6143 | R06AE09 | Levocetirizinum | Aller-Nol | 5 mg orodispersible films | RK-LS-5№023971 |
6144 | R06AE09 | Levocetirizinum | Contrahist | 0.5 mg/ml oral solution, 200 ml | RK-LS-5№022583 |
R06AX | Other antihistamines for systemic use | ||||
R06AX13 | Loratadinum | ||||
6145 | R06AX13 | Loratadinum | Claritin® | 1 mg/ml syrup, 120 ml | RK-LS-5№016144 |
6146 | R06AX13 | Loratadinum | Loraktiv™ | 10 mg tablets | RK-LS-5№016199 |
6147 | R06AX13 | Loratadinum | LORIZAN® | 10 mg tablets | RK-LS-5№004314 |
6148 | R06AX13 | Loratadinum | Lomilan® | 10 mg tablets | RK-LS-5№010751 |
6149 | R06AX13 | Loratadinum | Clarisan | 10 mg tablets | RK-LS-5№023488 |
6150 | R06AX13 | Loratadinum | Claritin® | 10 mg tablets | RK-LS-5№013886 |
6151 | R06AX13 | Loratadinum | Lorizan | Syrup, 100 ml | RK-LS-5№016641 |
6152 | R06AX13 | Loratadinum | Loratal® | 10 mg tablets | RK-LS-5№005332 |
R06AX17 | Ketotifenum | ||||
6153 | R06AX17 | Ketotifenum | Ketotifen | 1 mg tablets | RK-LS-5№006314 |
6154 | R06AX17 | Ketotifenum | Ketotifen Sopharma | 1 mg tablets | RK-LS-5№012558 |
6155 | R06AX17 | Ketotifenum | Ketotifen | 1 mg tablets | RK-LS-5№020721 |
6156 | R06AX17 | Ketotifenum | Ketotifen | 1 mg tablets | RK-LS-5№015825 |
R06AX26 | Fexofenadinum | ||||
6157 | R06AX26 | Fexofenadinum | Telfast® | 180 mg film-coated tablets | RK-LS-5№016273 |
6158 | R06AX26 | Fexofenadinum | FEXOFEN-sanovel 120 | 120 mg film-coated tablets | RK-LS-5№010710 |
6159 | R06AX26 | Fexofenadinum | FEXOFEN-sanovel 180 | 180 mg film-coated tablets | RK-LS-5№010711 |
6160 | R06AX26 | Fexofenadinum | Fexet | 180 mg film-coated tablets | RK-LS-5№014170 |
6161 | R06AX26 | Fexofenadinum | Fexet | 120 mg film-coated tablets | RK-LS-5№014172 |
6162 | R06AX26 | Fexofenadinum | Fexet | 60 mg film-coated tablets | RK-LS-5№014176 |
R06AX27 | Desloratadinum | ||||
6163 | R06AX27 | Desloratadinum | Sophalor® | 0.5 mg/ml oral solution | RK-LS-5№024193 |
6164 | R06AX27 | Desloratadinum | Lorada ODT | 5 mg orodispersible tablets | RK-LS-5№020110 |
6165 | R06AX27 | Desloratadinum | Delorix | 5 mg film-coated tablets | RK-LS-5№023933 |
6166 | R06AX27 | Desloratadinum | Zileta® | 0.5 mg /ml syrup, 60 ml | RK-LS-5№023803 |
6167 | R06AX27 | Desloratadinum | Zileta® | 0.5 mg /ml syrup, 120 ml | RK-LS-5№023803 |
6168 | R06AX27 | Desloratadinum | Zileta® | 0.5 mg /ml syrup, 150 ml | RK-LS-5№023803 |
6169 | R06AX27 | Desloratadinum | Eslotin | 2.5 mg/5ml oral syrup, 60 ml | RK-LS-5№022936 |
6170 | R06AX27 | Desloratadinum | BLOGIR-3 | 5 mg lozenges | RK-LS-5№022158 |
6171 | R06AX27 | Desloratadinum | Algis | 0.5mg/ml oral solution, 60 ml | RK-LS-5№121874 |
6172 | R06AX27 | Desloratadinum |
Lordestin | 5 mg film-coated tablets | RK-LS-5№019160 |
6173 | R06AX27 | Desloratadinum | Aerius® | 5 mg coated tablets | RK-LS-5№005524 |
6174 | R06AX27 | Desloratadinum | Edem | 5 mg coated tablets | RK-LS-5№019801 |
6175 | R06AX27 | Desloratadinum | Desradin | 5 mg film-coated tablets | RK-LS-5№020284 |
6176 | R06AX27 | Desloratadinum | Blogir-3 | 0.50 mg/ml oral solution, 60 ml | RK-LS-5№022192 |
6177 | R06AX27 | Desloratadinum | Blogir-3 | 0.50 mg/ml oral solution, 120 ml | RK-LS-5№022192 |
6178 | R06AX27 | Desloratadinum | Doral | 5 mg film-coated tablets | RK-LS-5№121951 |
6179 | R06AX27 | Desloratadinum | Loreds® | 2.5 mg/5 ml syrup, 100 ml | RK-LS-5№018984 |
6180 | R06AX27 | Desloratadinum | Tades | 0.50 mg/ml oral solution, 120 ml | RK-LS-5№021517 |
6181 | R06AX27 | Desloratadinum | Eslotin | 5 mg film-coated tablets | RK-LS-5№023094 |
6182 | R06AX27 | Desloratadinum | Lordes® | 5 mg film-coated tablets | RK-LS-5№018988 |
6183 | R06AX27 | Desloratadinum | Tades | 5 mg film-coated tablets | RK-LS-5№021408 |
6184 | R06AX27 | Desloratadinum | Algis | 5 mg film-coated tablets | RK-LS-5№121876 |
6185 | R06AX27 | Desloratadinum | Deslor® | 5 mg film-coated tablets | RK-LS-5№019618 |
6186 | R06AX29 | Биластин | Nixar® | 20 mg tablets | RK-LS-5№020369 |
R07 | Other drugs for treating respiratory diseases | ||||
R07AA | Pulmonary surfactants | ||||
R07AA02 | Natural phospholipids | ||||
6187 | R07AA02 | Natural phospholipids | Curosurf® | 80 mg/ml intratracheal suspension | RK-LS-5№018178 |
6188 | R07AA02 | Natural phospholipids | Alveofact® | 45 mg/ml lyophilisate for solution for intratracheal suspension and solvent, 108 mg | RK-LS-5№018881 |
6189 | R07AA02 | Natural phospholipids | Alveofact® | 45 mg/ml lyophilisate for solution for intratracheal suspension and solvent, 54 mg | RK-LS-5№018880 |
R07AA30 | Pulmonary surfactants, combination drug | ||||
6190 | R07AA30 | Pulmonary surfactants, combinations drug | Survanta | 25 mg/ml intratracheal suspension, 4 ml | RK-LS-5№018123 |
6191 | R07AA30 | Pulmonary surfactants, combinations drug | Survanta | 25 mg/ml intratracheal suspension | RK-LS-5№018124 |
R07AB | Ammonia | ||||
6192 | R07AB | Ammonia | Ammonia | 10% topical solution, 10 ml | RK-LS-5№003180 |
6193 | R07AB | Ammonia | Ammonia | 10% topical solution, 20 ml | RK-LS-5№003180 |
6194 | R07AB | Ammonia | Concentrated ammonia solution | Solution, 30 l | RK-LS-5№023648 |
6195 | R07AB | Ammonia | 10 % ammonia solution | 10 % solution | RK-LS-5№003289 |
6196 | R07AB | Ammonia | Ammonia | 10 % solution | RK-LS-5№016190 |
S | Drugs for treating sensory processing disorders | ||||
S01 | Drugs for treating eye diseases | ||||
S01A | Antimicrobial drugs | ||||
S01AA | Antibiotics | ||||
S01AA01 | Chloramphenicolum | ||||
6197 | S01AA01 | Chloramphenicolum | Levomycetin - DF | 0.25% eye drops | RK-LS-5№013203 |
6198 | S01AA01 | Chloramphenicolum | Levomycetin | 0.25% eye drops | RK-LS-5№003991 |
6199 | S01AA01 | Chloramphenicolum | Levomycetin -opti® | 0.25% eye drops | RK-LS-5№016328 |
6200 | S01AA01 | Chloramphenicolum | Levomycetin -opti® | 0.5% eye drops | RK-LS-5№016329 |
6201 | S01AA01 | Chloramphenicolum | Levomycetin -DF | 0.5% eye drops | RK-LS-5№018209 |
6202 | S01AA01 | Chloramphenicolum | Levomycetin | 0.5% eye drops, 10 ml | RK-LS-5№016803 |
S01AA09 | Tetracyclinum | ||||
6203 | S01AA09 | Tetracyclinum | Tetracycline | 1% eye ointment | RK-LS-5№010835 |
S01AA11 | Gentamicinum | ||||
S01AA12 | Tobramycinum | ||||
6204 | S01AA12 | Tobramycinum | Tobrimed | 0.3% eye drops, 5 ml | RK-LS-5№020400 |
6205 | S01AA12 | Tobramycinum | Tobrex | 0.3% eye drops, 5 ml | RK-LS-5№013217 |
6206 | J01GB01 | Tobramycinum | Tobi® Podhaler® | 28 mg powder for ihalation in capsules | RK-LS-5№122055 |
6207 | S01AA12 | Tobramycinum | Tobrex* 2х | 0.3% eye drops, 5 ml | RK-LS-5№014069 |
6208 | S01AA12 | Tobramycinum | Tobrom | 0.3% eye drops | RK-LS-5№023974 |
6209 | S01AA12 | Tobramycinum | Tobrosopt | 3 mg/ml eye drops | RK-LS-5№019826 |
6210 | S01AA12 | Tobramycinum | Tobramens | 3 mg/g eye ointment | RK-LS-5№023607 |
6211 | S01AA12 | Tobramycinum | Tobrex* | 0.3% ophthalmic ointment | RK-LS-5№013919 |
S01AA13 | Fusidic acid | ||||
6212 | S01AA13 | Fusidic acid | Futaron | 1 % eye drops | RK-LS-5№019849 |
S01AD | Antiviral drugs | ||||
S01AD03 | Aciclovirum | ||||
6213 | S01AD03 | Aciclovirum | Zovirax® | 3% eye ointment, 4.5 g | RK-LS-5№011725 |
6214 | S01AD03 | Aciclovirum | ACICLOVIR | 3 % eye ointment, 5 g | RK-LS-5№018590 |
6215 | S01AD03 | Aciclovirum | Virupos | 3% eye ointment, 4.5 g | RK-LS-5№122153 |
S01AD09 | Ganciclovirum | ||||
S01AE | Fluoroquinolones | ||||
S01AE01 | Ofloxacinum | ||||
6216 | S01AE01 | Ofloxacinum | Floxal | 0.3% eye drops, 5 ml | RK-LS-5№004828 |
6217 | S01AE01 | Ofloxacinum | Floxal | 0.3% eye ointment, 3 g | RK-LS-5№004829 |
S01AE03 | Ciprofloxacinum | ||||
6218 | S01AX13 | Ciprofloxacinum | Ciprofloxacin-AKOS | 0.3% eye drops, 5 ml | RK-LS-5№008073 |
6219 | S01AX13 | Ciprofloxacinum | Cipromed | 0.3% eye drops, 5 ml | RK-LS-5№010151 |
6220 | S01AX13 | Ciprofloxacinum | Ciprolet® | 3 mg/ml eye drops, 5 ml | RK-LS-5№014723 |
6221 | S01AX13 | Ciprofloxacinum | Floximed | 0.3% eye ointment , 5 g | RK-LS-5№012686 |
6222 | S02AА15 | Ciprofloxacinum | Cipromed | 3 mg/ml ear drops, 10 ml | RK-LS-5№005092 |
6223 | S01AE03 | Ciprofloxacinum | Floximed | 0.3% eye drops | RK-LS-5№003704 |
S01AE05 | Levofloxacin | ||||
6224 | S01AX19 | Levofloxacin | Signicef | 0.5% eye drops, 5 ml | RK-LS-5№018673 |
6225 | S01AE05 | Levofloxacin | Levofloxacin-DF | 5 mg/ml eye drops | RK-LS-5№024208 |
6226 | S01AE05 | Levofloxacin | Levoyaps | 5 mg/ml eye drops | RK-LS-5№023524 |
6227 | S01AE05 | Levofloxacin | Oftaquix® | 5 mg/ml eye drops | RK-LS-5№023343 |
6228 | S01AE05 | Levofloxacin | Oftaquix® | 5 mg/ml eye drops | RK-LS-5№019486 |
6229 | S01AE05 | Levofloxacin | L-Optic Rompharm | 0.5% eye drops, 5 ml | RK-LS-5№022555 |
S01AE07 | Moxifloxacinum | ||||
6230 | S01AE07 | Moxifloxacinum | Moxioftan® | 5 mg/ml eye drops | RK-LS-5№122078 |
6231 | S01AE07 | Moxifloxacinum | Maxiflox | 5 mg/ml eye drops | RK-LS-5№023950 |
6232 | S01AX22 | Moxifloxacinum | Vigamox™ | eye drops, 5 ml | RK-LS-5№019310 |
6233 | S01AE07 | Moxifloxacinum | Milflox | 0.5% eye drops, 5 ml | RK-LS-5№121681 |
S01B | Anti-inflammatory drugs | ||||
S01BA | Corticosteroids | ||||
S01BA01 | Dexamethasonum | ||||
6234 | S01BA01 | Dexamethasonum | Medexol | 0.1 % eye and ear drops, 5 ml | RK-LS-5№024058 |
6235 | S01BA01 | Dexamethasonum | Dexamethasone | 0.1% eye drops, suspension, 5 ml | RK-LS-5№013903 |
6236 | S01BA01 | Dexamethasonum | Dexamethasone | 0.1% eye drops, 8 ml | RK-LS-5№010723 |
6237 | S01BA01 | Dexamethasonum | Dexamethasone | 0.1 % eye drops, 10 ml | RK-LS-5№003506 |
6238 | S01BA01 | Dexamethasonum | Dexamethasone | 0.1% eye drops, suspension, 5 ml | RK-LS-5№019633 |
6239 | S01BA01 | Dexamethasonum | Dexamethasone | 0.1% eye drops, 10 ml | RK-LS-5№010723 |
6240 | S01BA01 | Dexamethasonum | Dexamethasone | 0.1% eye drops | RK-LS-5№013017 |
6241 | S01BA01 | Dexamethasonum | Oftan® Dexamethasone | 1 mg/ml eye drops | RK-LS-5№009645 |
6242 | S01BA01 | Dexamethasonum | Dexamethasone | 1 mg/ml eye drops | RK-LS-5№017950 |
6243 | S01BA01 | Dexamethasonum | Dexamethasone | 1 mg/ml eye drops | RK-LS-5№017951 |
6244 | S01BA01 | Dexamethasonum | Oftan® Dexamethasone | 1 mg/ml eye drops | RK-LS-5№023439 |
S01BA02 | Hydrocortisonum | ||||
6245 | S01BA02 | Hydrocortisonum | HYDROCORTISONE | 0.5 % eye ointment | RK-LS-5№016893 |
6246 | S01BA02 | Hydrocortisonum | Hydrocortisone | 0.5% eye ointment | RK-LS-5№018250 |
S01BC | Non-steroidal anti-inflammatory drugs (NSAIDs) | ||||
S01BC03 | Diclofenacum | ||||
6247 | S01BC03 | Diclofenacum | DICLOFENAC-DF | 0.1% eye drops | RK-LS-5№023992 |
6248 | S01BC03 | Diclofenacum | Diclo-F | 0.1% eye drops, 5 ml | RK-LS-5№005616 |
6249 | S01BC03 | Diclofenacum | Diclofenac | 1 mg/ml eye drops, 5 ml | RK-LS-5№011045 |
S01BC10 | Nepafenacum | ||||
6250 | S01BC10 | Nepafenacum | Nevanac™ | 1 mg/ml eye drops, suspension | RK-LS-5№019922 |
S01BC11 | Bromfenacum | ||||
6251 | S01BC11 | Bromfenacum | Unibrom | 0.09% eye drops | RK-LS-5№024178 |
6252 | S01BC11 | Bromfenacum | Broxinac | 0.09% eye drops, 1.7 ml | RK-LS-5№020982 |
S01C | Anti-inflammatory drugs in combination with antimicrobial drugs | ||||
S01CA | Corticosteroids in combination with antimicrobial drugs | ||||
S01CA01 | Dexamethasone and Tobramycin | ||||
6253 | S01CA01 | Dexamethasone and Tobramycin | Dexa-Gentamicin | 5 ml eye drops | RK-LS-5№020202 |
6254 | S01CA01 | Dexamethasone in combination with anti-infectives | Filarmex | 5 ml eye drops | RK-LS-5№023626 |
6255 | S01CA01 | Dexamethasone in combination with anti-infectives |
Tamekraz | Eye ointment, 5 g | RK-LS-5№023614 |
6256 | S01CA01 | Dexamethasone in combination with anti-infectives | Sofradex® | eye/ear drops, 5 ml | RK-LS-5№010919 |
6257 | S01CA01 | Dexamethasone in combination with anti-infectives | Dexatrol® | eye drops, 5 ml | RK-LS-5№003744 |
6258 | S01CA01 | Dexamethasone in combination with anti-infectives | Vigadexa ™ | eye drops, 5 ml | RK-LS-5№019277 |
6259 | S01CA01 | Dexamethasone in combination with anti-infectives | Chlorodex® | eye drops, 5 ml | RK-LS-5№018669 |
6260 | S01CA01 | Dexamethasone in combination with anti-infectives | Ovin D | eye drops, 5 ml | RK-LS-5№021599 |
6261 | S01CA01 | Dexamethasone in combination with anti-infectives | Tobradex® | eye drops, suspension, 5 ml | RK-LS-5№013042 |
6262 | S01CA01 | Dexamethasone in combination with anti-infectives | Tobradex® | ophthalmic ointment, 3.5 g | RK-LS-5№014124 |
6263 | S01CA01 | Dexamethasone and Tobramycin | DexaTobrom | eye drops, suspension, 5 ml | RK-LS-5№010915 |
6264 | S01CA01 | Dexamethasone and Tobramycin | Maxitrol® | eye drops, 5 ml | RK-LS-5№012084 |
6265 | S01CA01 | Dexamethasone and Tobramycin | Maxitrol® | ophthalmic ointment, 3.5 g | RK-LS-5№012104 |
6266 | S01CA01 | Dexamethasone and Tobramycin | Tobradex® | eye drops, suspension, 5 ml | RK-LS-5№013042 |
6267 | S01CA01 | Dexamethasone and Tobramycin | Dexaflox | Eye suspension | RK-LS-5№023584 |
S01E | Antiglaucoma drugs and miotics | ||||
S01EA | Sympathomimetics for treating glaucoma | ||||
S01EA05 | Brimonidine | ||||
6268 | S01EA05 | Brimonidine | Biglau | 0.2% eye drops, solution, 5 ml | RK-LS-5№024291 |
6269 | S01EA05 | Brimonidine | Bimanox® | 2 mg/ml eye drops, 5 ml | RK-LS-5№122083 |
6270 | S01EA05 | Brimonidine | Rimonal | 0.2 % eye drops, 5 ml | RK-LS-5№023148 |
6271 | S01EA05 | Brimonidine | Brimo | eye drops | RK-LS-5№018406 |
S01EB | Parasympathomimetics | ||||
S01EB01 | Pilocarpinum | ||||
6272 | S01EB01 | Pilocarpinum | Pilocarpine | 10 mg/ml eye drops, 10 ml | RK-LS-5№006019 |
S01EC | Carbonic anhydrase inhibitors | ||||
S01EC01 | Acetazolamide | ||||
6273 | S01EC01 | Acetazolamide | Diacarb | 250 mg tablets | RK-LS-5№016736 |
6274 | S01EC01 | Acetazolamide | Diacarb | 250 mg tablets | RK-LS-5№003640 |
S01EC03 | Dorzolamide | ||||
6275 | S01EC03 | Dorzolamide | Rozalin® | 20 mg/ml eye drops, 5 ml | RK-LS-5№021552 |
6276 | S01EC03 | Dorzolamide | Glaumax® | 20 mg/ml eye drops, 5 ml | RK-LS-5№121976 |
6277 | S01EC03 | Dorzolamide | Dorsob | 2 % eye drops, 5 ml | RK-LS-5№023546 |
6278 | S01EC03 | Dorzolamide | Dorsamed | 20 mg/ml eye drops | RK-LS-5№023834 |
S01EC04 | Brinzolamidum | ||||
6279 | S01EC04 | Brinzolamidum | Brinex | 1 % eye drops, suspension, 5 ml | RK-LS-5№022836 |
6280 | S01EC04 | Brinzolamidum | Brinex | 1 % eye drops, suspension, 10 ml | RK-LS-5№022836 |
6281 | S01EC04 | Brinzolamidum | Azopt | 1 % eye drops, suspension, 5 ml | RK-LS-5№006525 |
6282 | S01EC04 | Brinzolamidum | Brizal | 10 mg/ml eye drops, suspension, 5 ml | RK-LS-5№023836 |
S01ED | Beta-blockers | ||||
S01ED01 | Timololum | ||||
6283 | S01ED01 | Timololum | Timmal® | 0.25% eye drops, 5 ml | RK-LS-5№012478 |
6284 | S01ED01 | Timololum | Timmal® | 0.5% eye drops, 5 ml | RK-LS-5№012479 |
6285 | S01ED01 | Timololum | Oftan® Timolol | 5 mg/ml eye drops, 5 ml | RK-LS-5№003426 |
6286 | S01ED01 | Timololum | Timolet | 0.5% eye drops, 5 ml | RK-LS-5№121953 |
6287 | S01ED01 | Timololum | Ocumed | 0.5% eye drops, 5 ml | RK-LS-5№005642 |
6288 | S01ED01 | Timololum | Ocumed | 0.5% eye drops, 10 ml | RK-LS-5№005642 |
6289 | S01ED01 | Timololum | Normatin | 0.5% eye drops, 5 ml | RK-LS-5№010740 |
6290 | S01ED01 | Timololum | Arutimol | 0.5% eye drops, 5 ml | RK-LS-5№010935 |
6291 | S01ED01 | Timololum | Timmalol-optic | 0.25% eye drops, 5 ml | RK-LS-5№014627 |
6292 | S01ED01 | Timololum | Timmalol-optic | 0.5% eye drops, 5 ml | RK-LS-5№014625 |
S01ED02 | Betaxololum | ||||
6293 | S01ED02 | Betaxololum | Betoptic* S | eye drops, supension | RK-LS-5№012264 |
6294 | S01ED51 | Timolol in combination with other drugs | DuoTrav* | eye drops, 2.5 ml | RK-LS-5№010918 |
6295 | S01ED51 | Timolol in combination with other drugs | BRINERA | eye drops, suspension, 5 ml | RK-LS-5№024486 |
6296 | S01ED51 | Timolol in combination with other drugs | Brinsopt Plus | 10 mg/ml + 5 mg/ml eye drops, supension | RK-LS-5№024304 |
6297 | S01ED51 | Timolol in combination with other drugs | Tapticom® | Eye drops | RK-LS-5№024090 |
6298 | S01ED51 | Timolol in combination with other drugs | Dorsob-T | eye drops, 5 ml | RK-LS-5№023547 |
6299 | S01ED51 | Timolol in combination with other drugs | Dorzasopt | eye drops, 5 ml | RK-LS-5№018672 |
6300 | S01ED51 | Timolol in combination with other drugs | Dorsopt Plus | 20 mg/ml +5 mg/ml eye drops | RK-LS-5№024064 |
6301 | S01ED51 | Timolol in combination with other drugs | Nodom ECO Combi | 20 mg/ml + 5 mg/ml eye drops | RK-LS-5№024001 |
6302 | S01ED51 | Timolol in combination with other drugs | Glaumax® Plus | 20mg/ml+5mg/ml eye drops | RK-LS-5№122052 |
6303 | S01ED51 | Timolol in combination with other drugs | Rozacom® | eye drops, 5 ml | RK-LS-5№121727 |
6304 | S01ED51 | Timolol in combination with other drugs | Xolamol | eye drops | RK-LS-5№017982 |
6305 | S01ED51 | Timolol in combination with other drugs | Rimosopt | eye drops | RK-LS-5№023540 |
6306 | S01ED51 | Timolol in combination with other drugs | Latamed | eye drops | RK-LS-5№023407 |
6307 | S01ED51 | Timolol in combination with other drugs | Duoprost | eye drops | RK-LS-5№018955 |
6308 | S01ED51 | Timolol in combination with other drugs | TIZOPTAN | eye drops | RK-LS-5№023246 |
6309 | S01ED51 | Timolol in combination with other drugs | Lacoma-T | eye drops | RK-LS-5№016192 |
6310 | S01ED51 | Timolol in combination with other drugs | Xalacom® | eye drops | RK-LS-5№017618 |
6311 | S01ED51 | Timolol in combination with other drugs | Latanol | eye drops | RK-LS-5№122087 |
6312 | S01ED51 | Timolol in combination with other drugs | Latanol | eye drops | RK-LS-5№122044 |
6313 | S01ED51 | Timolol in combination with other drugs | Asaрга® | eye drops, suspension | RK-LS-5№015738 |
S01EE | Prostaglandin analogues | ||||
S01EE01 | Latanoprostum | ||||
6314 | S01EE01 | Latanoprostum | Latasopt | 0.005% eye drops, 2.5 ml | RK-LS-5№017428 |
6315 | S01EE01 | Latanoprostum | Prolatan | 0.005% eye drops, 2.5 ml | RK-LS-5№020007 |
6316 | S01EE01 | Latanoprostum | Akistan | 50 mcg/ml eye drops | RK-LS-5№020870 |
6317 | S01EE01 | Latanoprostum | Xalatamax | 0.005 % eye drops | RK-LS-5№017056 |
6318 | S01EE01 | Latanoprostum | lacoma | 0.005 % eye drops | RK-LS-5№022673 |
6319 | S01EE01 | Latanoprostum | Latano | 0.005 % eye drops | RK-LS-5№023207 |
6320 | S01EE01 | Latanoprostum | Xalatan® | 0.005 % eye drops | RK-LS-5№012357 |
6321 | S01EE01 | Latanoprostum | Lanotan | 0.05mg/ml eye drops | RK-LS-5№020517 |
6322 | S01EE01 | Latanoprostum | Latoprost RT | 0.005% eye drops (microemulsion) | RK-LS-5№020606 |
S01EE04 | Travoprostum | ||||
6323 | S01EE04 | Travoprostum | Travapress Rompharm | 0.04 mg/ml eye drops | RK-LS-5№022646 |
6324 | S01EE04 | Travoprostum | Travatan® | 40 мкг/ml eye drops | RK-LS-5№000268 |
6325 | S01EE04 | Travoprostum | Glautan® | 0.04 mg/ml eye drops | RK-LS-5№023884 |
S01EE05 | Tafluprostum | ||||
6326 | S01EE05 | Tafluprostum | Taflotan® | 15 мкг/ml eye drops | RK-LS-5№016264 |
6327 | S01EE05 | Tafluprostum | Taflotan® | 15 mcg/ml eye drops | RK-LS-5№016263 |
S01F | Mydriatics and cycloplegics | ||||
S01FA | Holinoblockers | ||||
S01FA01 | Atropine sulfate | ||||
6328 | S01FA01 | Atropine sulfate | Atropine sulfate | 10 mg/ml eye drops, 5 ml | RK-LS-5№012400 |
S01FA04 | Cyclopentolatum | ||||
6329 | S01FA04 | Cyclopentolatum | Cyclomed | 1% eye drops | RK-LS-5№003116 |
6330 | S01FA04 | Cyclopentolatum | Cycloptic | eye drops, solution | RK-LS-5№022165 |
6331 | S01FA04 | Cyclopentolatum | Cirelax | 1% eye drops | RK-LS-5№023411 |
6332 | S01FA04 | Cyclopentolatum | Cicloplegicedol | 1.0 % eye drops, solution | RK-LS-5№024255 |
S01FA06 | Tropicamidum | ||||
6333 | S01FA06 | Tropicamidum | Midax | 0.5 % eye drops | RK-LS-5№018608 |
6334 | S01FA06 | Tropicamidum | Midax | 1.0 % eye drops | RK-LS-5№018609 |
6335 | S01FA06 | Tropicamidum | Tropicamide | 1% eye drops | RK-LS-5№010726 |
6336 | S01FA06 | Tropicamidum | Tropicamide | 0.5% eye drops | RK-LS-5№010727 |
6337 | S01FA06 | Tropicamidum | Midriacil | 1 % eye drops | RK-LS-5№008256 |
6338 | S01FA06 | Tropicamidum | Tropicamide | 5mg/ml eye drops | RK-LS-5№006153 |
6339 | S01FA06 | Tropicamidum | Tropicamide | 1 % eye drops | RK-LS-5№006155 |
S01FB | Sympathomimetics (excluding antiglaucoma drugs) | ||||
S01FB01 | Phenylephrinum | ||||
6340 | S01FB01 | Phenylephrinum | Irifrin BK | 2.5 % eye drops, 0.4 ml | RK-LS-5№024358 |
6341 | S01FB01 | Phenylephrinum | Belifrin | 25 mg/ml eye drops, 5 ml | RK-LS-5№023627 |
6342 | S01FB01 | Phenylephrinum | Irifrin | 2.5% eye drops, 5ml | RK-LS-5№004742 |
6343 | S01FB01 | Phenylephrinum | Neosinefrin-POS | 5% eye drops | RK-LS-5№022320 |
6344 | S01FB01 | Phenylephrinum | Neosinefrin-POS | 10% eye drops | RK-LS-5№022334 |
S01GX | Other antiallergic drugs | ||||
S01GX05 | Lodoxamidum | ||||
S01GX07 | Azelastinum | ||||
S01GX08 | Ketotifenum | ||||
6345 | S01GX08 | Ketotifenum | Allergoket® | 0.05% eye drops | RK-LS-5№013677 |
S01GX09 | Olopatadine | ||||
6346 | S01GX09 | Olopatadine | Allereyes | 0.1 % eye drops | RK-LS-5№024348 |
6347 | S01GX09 | Olopatadine | Pallada | 0.1 % eye drops | RK-LS-5№121808 |
6348 | S01GX09 | Olopatadine | Winolap | 0.1 % eye drops | RK-LS-5№121982 |
6349 | S01GX09 | Olopatadine | Winolap DS | 0.2% eye drops | RK-LS-5№022335 |
6350 | S01GX09 | Olopatadine | Alopatin OD | 0.2 % eye drops | RK-LS-5№022891 |
6351 | S01GX09 | Olopatadine | Patanol® | 0.1% eye drops | RK-LS-5№010272 |
6352 | S01GX09 | Olopatadine | Olopatallerg | 1mg/ml eye drops | RK-LS-5№023860 |
6353 | S01GX09 | Olopatadine | Visallergol | 0.2% eye drops | RK-LS-5№121834 |
S01KА | Viscoelastic drugs | ||||
S01KА02 | Hypromellosum | ||||
S01L | Drugs for treating neovascularization | ||||
S01LA04 | Ranibizumab | ||||
6354 | S01LA04 | Ranibizumab | Lucentis® | 10 mg/ml solution for injection | RK-LS-5№016259 |
S01LA05 | Aflibercept | ||||
6355 | S01LA05 | Aflibercept | Eylea® | 40 mg/ml solution for injection, 0.278 ml | RK-LS-5№020045 |
S01H | Local anesthetics | ||||
S01HA02 | Oxybuprocainum | ||||
6356 | S01HA02 | Oxybuprocainum | Inokain | 0.4% eye drops, 5ml | RK-LS-5№012988 |
S01HA04 | Proxymetacainum | ||||
6357 | S01HA04 | Proxymetacainum | Alcaine* | 0.5% eye drops | RK-LS-5№008254 |
S01X | Other drugs for treating eye diseases | ||||
S01XA | Other drugs for treating eye diseases | ||||
S01XA12 | Dexpanthenolum | ||||
6358 | S01XA12 | Dexpanthenolum | Corneregel® | 5% eye gel, 5 g | RK-LS-5№004512 |
6359 | S01XA12 | Dexpanthenolum | Corneregel® | 5% eye gel, 10 g | RK-LS-5№004512 |
S01XA20 | Dextran 70 and Hydroxypropyl methylcellulose | ||||
6360 | S01XA20 | Artificial tears and other indifferent preparations | Ophtolique | eye drops, 10 ml | RK-LS-5№010381 |
6361 | S01XA20 | Artificial tears and other indifferent preparations | Lacrima® | eye drops, 15 ml | RK-LS-5№006521 |
6362 | S01XA20 | Artificial tears and other indifferent preparations | Tear | eye drops, 15 ml | RK-LS-5№021613 |
6363 | S01XA20 | Artificial tears and other indifferent preparations | Slezol Forte | eye drops, 15 ml | RK-LS-5№019777 |
6364 | S01XA20 | Artificial tears and other indifferent preparations | Tear Naturale II | eye drops, 15 ml | RK-LS-5№008410 |
6365 | S01XA20 | Artificial tears and other indifferent preparations | Softdrops | Eye drops | RK-LS-5№023740 |
6366 | S01XA20 | Artificial tears and other indifferent preparations | Oftagel® | 0.25% eye gel | RK-LS-5№010476 |
S02 | Drugs for treating ear diseases | ||||
S02A | Antimicrobial drugs | ||||
S02AA15 | Ciprofloxacinum | ||||
6367 | S02AA15 | Ciprofloxacinum | Cipromed | 3 mg/ml ear drops | RK-LS-5№005092 |
S02C | Corticosteroids in combination with antimicrobial drugs | ||||
S02CA06 | Neomycin sulfate, polymyxin sulfate, dexamethasone, phenylephrine | ||||
6368 | S02CA06 | Dexamethasone in combination with antimicrobial drugs | Polydex with phenylephrine | Nasal spray | RK-LS-5№019079 |
6369 | S02CA06 | Dexamethasone in combination with antimicrobial drugs | Otipol® | Ear drops | RK-LS-5№009628 |
S03 | Drugs for treating eye and ear diseases | ||||
S03A | Antimicrobial drugs | ||||
S03AA07 | Ciprofloxacinum | ||||
6370 | S03AA07 | Ciprofloxacinum | Forcip | 3 mg/ml eye and ear drops | RK-LS-5№023573 |
S03C | Corticosteroids in combination with antimicrobial drugs | ||||
S03CA01 | Dexamethasone and Ciprofloxacin | ||||
6371 | S03CA01 | Dexamethasone in combination with antimicrobial drugs | Neomycin with dexamethasone | eye, ear, nasal drops, 5 ml | RK-LS-5№020974 |
6372 | S03CA01 | Dexamethasone in combination with antimicrobial drugs | Kombinil-Duo | eye and ear drops, 5 ml | RK-LS-5№017665 |
6373 | S03CA01 | Dexamethasone in combination with antimicrobial drugs | Ciprovid-DF® | eye and ear drops, 5 ml | RK-LS-5№024456 |
V | Other drugs | ||||
V01 | Allergens | ||||
V01AA | Allergen extracts | ||||
V01AA20 | Other allergens | ||||
6374 | V01AA20 | Other allergens | Diaskintest® | solution fro intradermal injection, 3 ml | RK-BP-5№022754 |
V03 | Other miscellaneous drugs | ||||
V03AB | Antidotes | ||||
V03AB06 | Sodium thiosulfate | ||||
6375 | V03AB06 | Sodium thiosulfate | Sodium thiosulfate-Darnitsa | 30% solution for injection, 5 ml | RK-LS-5№015864 |
6376 | V03AB06 | Sodium thiosulfate | Sodium thiosulfate | 300 mg/ml intravenous solution, 10 ml | RK-LS-5№004966 |
6377 | V03AB06 | Sodium thiosulfate | Sodium thiosulfate | 30% solution for injection | RK-LS-5№023680 |
6378 | V03AB06 | Sodium thiosulfate | Sodium thiosulfate | 30% solution for injection, 10 ml | RK-LS-3№021441 |
V03AB14 | Protamine | ||||
6379 | V03AB14 | Protamine sulfate | 10 000 IU protamine sulfate | 1000 IU/ml solution for injection, 10 ml | RK-LS-5№021336 |
V03AB15 | Naloxone | ||||
V03AB35 | Sugammadexum | ||||
6380 | V03AB35 | Sugammadexum | Braydan® | 100 mg/ml intravenous solution, 5 ml | RK-LS-5№017632 |
6381 | V03AB35 | Sugammadexum | Braydan® | 100 mg/ml intravenous solution, 2 ml | RK-LS-5№017632 |
V03AB37 | Idarucizumabum | ||||
6382 | V03AB37 | Idarucizumabum | Praxbind® | 2.5 g/50 ml solution for injection and infusion | RK-LS-5№023155 |
V03AC | Iron-binding drugs | ||||
V03AC03 | Deferasirox | orphan drug | |||
6383 | V03AC03 | Deferasirox | Exjade® | 500 mg dispersible tablets | RK-LS-5№014244 |
6384 | V03AC03 | Deferasirox | Jadenu™ | 360 mg film-coated tablets | RK-LS-5№023291 |
6385 | V03AC03 | Deferasirox | Exjade® | 250 mg dispersible tablets | RK-LS-5№014243 |
6386 | V03AC03 | Deferasirox | Rasiroxpine | 125 mg dispersible tablets | RK-LS-5№023912 |
6387 | V03AC03 | Deferasirox | Rasiroxpine | 250 mg dispersible tablets | RK-LS-5№023913 |
6388 | V03AC03 | Deferasirox | Rasiroxpine | 500 mg dispersible tablets | RK-LS-5№023914 |
6389 | V03AC03 | Deferasirox | Jadenu™ | 180 mg film-coated tablets | RK-LS-5№023290 |
V03AE | Drugs for treating hyperkalemia and hyperphosphatemia | ||||
V03AE02 | Sevelamerum | ||||
6390 | V03AE02 | Sevelamerum | Sevelamer | 800 mg film-coated tablets | RK-LS-5№024307 |
6391 | V03AE02 | Sevelamerum | Renvela® | powder for oral suspension, 2.4 g | RK-LS-5№021396 |
6392 | V03AE02 | Sevelamerum | Sevelamer S.K. | 800 mg film-coated tablets | RK-LS-5№023128 |
6393 | V03AE02 | Sevelamerum | Renvela® | 800 mg film-coated tablets | RK-LS-5№018305 |
V03AF01 | Mesnum | orphan drug | |||
6394 | V03AF01 | Mesnum | Mesna | 100 mg/ml solution for injection in a bottle, 10.0ml | orphan drug |
6395 | V03AF01 | Mesnum | Mesna-LANS | 100 mg/ml intravenous solution, 4 ml | RK-LS-5№020869 |
6396 | V03AF01 | Mesnum | Uromitexan | 400 mg/4 ml intravenous solution | RK-LS-5№017565 |
V03AF03 | Calcium folinate | ||||
6397 | V03AF03 | Calcium folinate | Leucovorin-Teva | 10 mg/ml solution for injection | RK-LS-5№013592 |
V03AF06 | Sodium folinate | ||||
6398 | V03AF06 | Sodium folinate | Natriofolin medac | 50 mg/ ml solution for injection or infusion, 400 mg | RK-LS-5№015100 |
6399 | V03AF06 | Sodium folinate | Natriofolin medac | 50 mg/ ml solution for injection or infusion, 100 mg | RK-LS-5№015099 |
6400 | V03AF06 | Sodium folinate | Sodifol | 50 mg/ml solution for injection or infusion, 2 ml | RK-LS-5№024461 |
6401 | V03AF06 | Sodium folinate | Sodifol | 50 mg/ml solution for injection or infusion, 8 ml | RK-LS-5№024461 |
V04 | Diagnostic agents | ||||
V04C | Other diagnostic agents | ||||
V04CF | TB test | ||||
V04CF01 | Tuberculinum | ||||
6402 | V04CF01 | Tuberculinum | Purified tuberculosis allergen in the standard dilution (purified tuberculin in the standard dilution) | 2 ТU/0.1 ml solution for intradermal injection | RK-BP-5№021297 |
6403 | V04CF01 | Tuberculinum | Purified tuberculosis allergen in the standard dilution (purified tuberculin in the standard dilution) | 2 ТU/1 ml solution for intradermal injection | RK-BP-5№021297 |
6404 | V04CF01 | Tuberculinum | Purified tuberculosis allergen in the standard dilution (purified tuberculin in the standard dilution) | 2 ТU/2 ml solution for intradermal injection | RK-BP-5№021297 |
6405 | V04CF01 | Tuberculinum | Purified tuberculosis allergen in the standard dilution (purified tuberculin in the standard dilution) | 2 ТU/3 ml solution for intradermal injection | RK-BP-5№021297 |
6406 | V04CF01 | Tuberculinum | Biolek Tuberculin PPD-L | 2 ТU/0.1 ml solution for intradermal injection | RK-BP-5№010843 |
6407 | V04CF01 | Tuberculinum | Tuberculin | 2 ТU solution for intradermal injection | RK-BP-5№023853 |
6408 | V04CF01 | Tuberculinum | BIOLEK Tuberculin PPD-L | 2 ТU/dose solution for intradermal injection | RK-BP-5№024313 |
V07 | Other miscellaneous non-therapeutic products | ||||
V07AB | Water for injection | ||||
6409 | V07AB | Water for injection | Water for injection | solvent for injection, 5 ml | RK-LS-5№024389 |
6410 | V07AB | Solvents | Water for injection | solvent for injection, 5 ml | RK-LS-5№023385 |
6411 | V07AB | Solvents | Water for injection | solvent for injection, 5 ml | RK-LS-5№010461 |
6412 | V07AB | Solvents | Solvent for non-infectious allergens | Solvent for non-infectious allergens | RK-LS-3№020570 |
6413 | V07AB | Solvents | Sodium chloride | 0.9 % solution for injection | RK-LS-5№021499 |
6414 | V07AB | Solvents | Sodium chloride | 0.9% solvent for injection | RK-LS-5№021382 |
V08 | Contrast media | ||||
V08A | Iodinated contrast media | ||||
V08AA01 | Sodium amidotrizoate | ||||
6415 | V08AA01 | Sodium amidotrizoate | Triombrast® | 60% solution for injection | RK-LS-5№006021 |
6416 | V08AA01 | Sodium amidotrizoate | Triombrast® | 76% solution for injection, 20 ml | RK-LS-5№006026 |
V08AB | Water-soluble low-osmolar contrast media | ||||
V08AB02 | Iohexolum | ||||
6417 | V08AB02 | Iohexolum | Omnipaque™ | 300 mg iodine/ml solution for injection, 20 ml | RK-LS-5№019354 |
6418 | V08AB02 | Iohexolum | Omnipaque™ | 300 mg iodine/ml solution for injection, 50 ml | RK-LS-5№019354 |
6419 | V08AB02 | Iohexolum | Omnipaque™ | 350 mg iodine/ml solution for injection, 100 ml | RK-LS-5№019355 |
6420 | V08AB02 | Iohexolum | Omnipaque™ | 350 mg iodine/ml solution for injection, 200 ml | RK-LS-5№019355 |
6421 | V08AB02 | Iohexolum | Omnipaque™ | 350 mg iodine/ml solution for injection, 500 ml | RK-LS-5№019355 |
6422 | V08AB02 | Iohexolum | Tomohexol® | 350 mg iodine/ml solution for injection, 100 ml | RK-LS-5№018757 |
6423 | V08AB02 | Iohexolum | Vigeksol | 350 mg iodine/ml solution for injection, 100 ml | RK-LS-3№122077 |
6424 | V08AB02 | Iohexolum | Tomohexol | 350 mg iodine/ml solution for injection, 50 ml | RK-LS-5№018756 |
6425 | V08AB02 | Iohexolum | Tomohexol® | 350 mg iodine/ml solution for injection | RK-LS-5№018755 |
6426 | V08AB02 | Iohexolum | Vigeksol | 350 mg iodine/ml solution for injection, 50 ml | RK-LS-3№122077 |
6427 | V08AB02 | Iohexolum | Vigeksol | 300 mg iodine/ml solution for injection, 50 ml | RK-LS-3№122076 |
6428 | V08AB02 | Iohexolum | Tomohexol | 300 mg iodine/ml solution for injection, 50 ml | RK-LS-5№018754 |
6429 | V08AB02 | Iohexolum | Vigeksol | 300 mg iodine/ml solution for injection, 20 ml | RK-LS-3№122076 |
6430 | V08AB02 | Iohexolum | Tomohexol | 340 mg iodine/ml solution for injection, 20 ml | RK-LS-5№018757 |
6431 | V08AB02 | Iohexolum | Vigeksol | 340 mg iodine/ml solution for injection, 20 ml | RK-LS-3№122077 |
V08AB04 | Iopamidolum | ||||
V08AB05 | Iopromidum | ||||
6432 | V08AB05 | Iopromidum | Ultravist® | 370 mg/ml solution for intra-arterial injection, 500 ml | RK-LS-5№015635 |
6433 | V08AB05 | Iopromidum | Ultravist® | 370 mg/ml solution for intra-arterial injection, 200 ml | RK-LS-5№015636 |
6434 | V08AB05 | Iopromidum | Ultravist® | 370 mg/ml solution for intra-arterial injection, 100 ml | RK-LS-5№015636 |
6435 | V08AB05 | Iopromidum | Vipromid | 370 mg/ml solution for intra-arterial injection, 100 ml | RK-LS-5№022721 |
6436 | V08AB05 | Iopromidum | Ultravist® | 300 mg/ml solution for intra-arterial injection, 100 ml | RK-LS-5№015634 |
6437 | V08AB05 | Iopromidum | Vipromid | 300 mg/ml solution for intra-arterial injection, 100 ml | RK-LS-5№022720 |
6438 | V08AB05 | Iopromidum | Ultravist® | 370 mg/ml solution for intra-arterial injection, 50 ml | RK-LS-5№015635 |
6439 | V08AB05 | Iopromidum | Vipromid | 370 mg/ml solution for intra-arterial injection, 50 ml | RK-LS-5№022721 |
6440 | V08AB05 | Iopromidum | Ultravist® | 300 mg/ml solution for intra-arterial injection, 50 ml | RK-LS-5№015633 |
6441 | V08AB05 | Iopromidum | Vipromid | 300 mg/ml solution for intra-arterial injection, 50 ml | RK-LS-5№022720 |
6442 | V08AB05 | Iopromidum | Ultravist® | 300 mg/ml solution for intra-arterial injection, 20 ml | RK-LS-5№015632 |
6443 | V08AB05 | Iopromidum | Vipromid | 300 mg/ml solution for intra-arterial injection, 20 ml | RK-LS-5№022720 |
V08AB09 | Iodixanolum | ||||
6444 | V08AB09 | Iodixanolum | Visipaque™ | 270 mg iodine/ml solution for injection | RK-LS-5№016255 |
6445 | V08AB09 | Iodixanolum | Visipaque™ | 320 mg iodine/ml solution for injection, 100 ml | RK-LS-5№016258 |
6446 | V08AB09 | Iodixanolum | Visipaque™ | 320 mg iodine/ml solution for injection, 20 ml | RK-LS-5№016254 |
6447 | V08AB09 | Iodixanolum | Visipaque™ | 320 mg iodine/ml solution for injection, 50 ml | RK-LS-5№016257 |
6448 | V08AB09 | Iodixanolum | Visipaque™ | solution for inhection, 200 ml | RK-LS-5№016258 |
6449 | V08AB09 | Iodixanolum | Visipaque™ | solution for inhection, 500 ml | RK-LS-5№016258 |
6450 | V08AB09 | Iodixanolum | Vidixanol | 270 mg iodine/ml solution for injection | RK-LS-3№122096 |
6451 | V08AB09 | Iodixanolum | Visipaque™ | 270 mg iodine/ml solution for injection | RK-LS-5№016253 |
6452 | V08AB09 | Iodixanolum | Visipaque™ | 270 mg iodine/ml solution for injection | RK-LS-5№016256 |
6453 | V08AB09 | Iodixanolum | Vidixanol | 320 mg iodine/ml solution for injection, 100 ml | RK-LS-3№122097 |
6454 | V08AB09 | Iodixanolum | Vidixanol | 320 mg iodine/ml solution for injection, 50 ml | RK-LS-3№122097 |
6455 | V08AB09 | Iodixanolum | Vidixanol | 320 mg iodine/ml solution for injection, 20 ml | RK-LS-3№122097 |
V08C | Contrast media for nuclear magnetic resonance imaging | ||||
V08CA | Paramagnetic contrast media | ||||
V08CA01 | Gadopentetic acid | ||||
6456 | V08CA01 | Gadopentetic acid | Magnevist® | 0.5 mmol/ml intravenous solution | RK-LS-5№004654 |
6457 | V08CA01 | Gadopentetic acid | Pentascan | 0.5 mmol/ml intravenous solution | RK-LS-5№022838 |
V08CA03 | Gadodiamidum | ||||
6458 | V08CA03 | Gadodiamidum | Omniscan™ | 0.5 mmol/ml intravenous solution | RK-LS-5№004344 |
V08CA09 | Gadobutrolum | ||||
6459 | V08CA09 | Gadobutrolum | Gadovist® | 1 mmol/ml intravenous solution, 15 ml | RK-LS-5№010980 |
6460 | V08CA09 | Gadobutrolum | Gadovist® | 1 mmol/ml intravenous solution, 7.5 ml | RK-LS-5№010980 |
V10 | Therapeutic radiopharmaceuticals | ||||
V10X | Other therapeutic radiopharmaceuticals | ||||
V10XX | Miscellaneous therapeutic radiopharmaceuticals | ||||
V10XX03 | Radium (223Ra) dichloride | ||||
6461 | V10XX03 | Radium (223Ra) dichloride | Xofigo® | 1100 kBq/ml solution for injection | RK-LS-5№022177 |
V10XX03 |